{"idB": "1006281_12_item7_p100_s0", "idA": "1006281_11_item7_p12_s2", "sentA": "Since we do not generate significant revenue from any of our product candidates, we expect to continue to generate losses in connection with the continued clinical development of taliglucerase alfa and the research and development activities relating to our technology and other drug candidates.", "sentB": "The foregoing table does not include (i) annual license fees, which are currently immaterial, (ii) payments we may be required to make to certain of our licensors in the time periods set forth above upon the achievement of agreed-upon milestones and (iii) royalty payments payable by us to certain of our licensors in connection with the commercial sale of our product candidates, if any.", "type": 2, "words": ["<tag1>", "Since", "we", "do", "not", "generate", "significant", "revenue", "from", "any", "of", "our", "product", "candidates,", "we", "expect", "to", "continue", "to", "generate", "losses", "in", "connection", "with", "the", "continued", "clinical", "development", "of", "taliglucerase", "alfa", "and", "the", "research", "and", "development", "activities", "relating", "to", "our", "technology", "and", "other", "drug", "candidates.", "<tag2>", "The", "foregoing", "table", "does", "not", "include", "(i)", "annual", "license", "fees,", "which", "are", "currently", "immaterial,", "(ii)", "payments", "we", "may", "be", "required", "to", "make", "to", "certain", "of", "our", "licensors", "in", "the", "time", "periods", "set", "forth", "above", "upon", "the", "achievement", "of", "agreed-upon", "milestones", "and", "(iii)", "royalty", "payments", "payable", "by", "us", "to", "certain", "of", "our", "licensors", "in", "connection", "with", "the", "commercial", "sale", "of", "our", "product", "candidates,", "if", "any.", "<tag3>"], "wordsA": ["Since", "we", "do", "not", "generate", "significant", "revenue", "from", "any", "of", "our", "product", "candidates,", "we", "expect", "to", "continue", "to", "generate", "losses", "in", "connection", "with", "the", "continued", "clinical", "development", "of", "taliglucerase", "alfa", "and", "the", "research", "and", "development", "activities", "relating", "to", "our", "technology", "and", "other", "drug", "candidates."], "wordsB": ["The", "foregoing", "table", "does", "not", "include", "(i)", "annual", "license", "fees,", "which", "are", "currently", "immaterial,", "(ii)", "payments", "we", "may", "be", "required", "to", "make", "to", "certain", "of", "our", "licensors", "in", "the", "time", "periods", "set", "forth", "above", "upon", "the", "achievement", "of", "agreed-upon", "milestones", "and", "(iii)", "royalty", "payments", "payable", "by", "us", "to", "certain", "of", "our", "licensors", "in", "connection", "with", "the", "commercial", "sale", "of", "our", "product", "candidates,", "if", "any."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p100_s2", "idA": "1006281_11_item7_p12_s2", "sentA": "Since we do not generate significant revenue from any of our product candidates, we expect to continue to generate losses in connection with the continued clinical development of taliglucerase alfa and the research and development activities relating to our technology and other drug candidates.", "sentB": "The royalty payments payable in connection with sales of each of our product candidates, if at all, shall not exceed low, single-digit percentages of net sales of the product.", "type": 2, "words": ["<tag1>", "Since", "we", "do", "not", "generate", "significant", "revenue", "from", "any", "of", "our", "product", "candidates,", "we", "expect", "to", "continue", "to", "generate", "losses", "in", "connection", "with", "the", "continued", "clinical", "development", "of", "taliglucerase", "alfa", "and", "the", "research", "and", "development", "activities", "relating", "to", "our", "technology", "and", "other", "drug", "candidates.", "<tag2>", "The", "royalty", "payments", "payable", "in", "connection", "with", "sales", "of", "each", "of", "our", "product", "candidates,", "if", "at", "all,", "shall", "not", "exceed", "low,", "single-digit", "percentages", "of", "net", "sales", "of", "the", "product.", "<tag3>"], "wordsA": ["Since", "we", "do", "not", "generate", "significant", "revenue", "from", "any", "of", "our", "product", "candidates,", "we", "expect", "to", "continue", "to", "generate", "losses", "in", "connection", "with", "the", "continued", "clinical", "development", "of", "taliglucerase", "alfa", "and", "the", "research", "and", "development", "activities", "relating", "to", "our", "technology", "and", "other", "drug", "candidates."], "wordsB": ["The", "royalty", "payments", "payable", "in", "connection", "with", "sales", "of", "each", "of", "our", "product", "candidates,", "if", "at", "all,", "shall", "not", "exceed", "low,", "single-digit", "percentages", "of", "net", "sales", "of", "the", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p21_s1", "idA": "1006281_11_item7_p12_s4", "sentA": "As a result, we believe that our operating losses may continue to be substantial over the next several years.", "sentB": "As a result, Pfizer recorded an allowance for sales return.", "type": 2, "words": ["<tag1>", "As", "a", "result,", "we", "believe", "that", "our", "operating", "losses", "may", "continue", "to", "be", "substantial", "over", "the", "next", "several", "years.", "<tag2>", "As", "a", "result,", "Pfizer", "recorded", "an", "allowance", "for", "sales", "return.", "<tag3>"], "wordsA": ["As", "a", "result,", "we", "believe", "that", "our", "operating", "losses", "may", "continue", "to", "be", "substantial", "over", "the", "next", "several", "years."], "wordsB": ["As", "a", "result,", "Pfizer", "recorded", "an", "allowance", "for", "sales", "return."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p66_s1", "idA": "1006281_11_item7_p12_s4", "sentA": "As a result, we believe that our operating losses may continue to be substantial over the next several years.", "sentB": "As a result, Pfizer recorded an allowance for sales return.", "type": 2, "words": ["<tag1>", "As", "a", "result,", "we", "believe", "that", "our", "operating", "losses", "may", "continue", "to", "be", "substantial", "over", "the", "next", "several", "years.", "<tag2>", "As", "a", "result,", "Pfizer", "recorded", "an", "allowance", "for", "sales", "return.", "<tag3>"], "wordsA": ["As", "a", "result,", "we", "believe", "that", "our", "operating", "losses", "may", "continue", "to", "be", "substantial", "over", "the", "next", "several", "years."], "wordsB": ["As", "a", "result,", "Pfizer", "recorded", "an", "allowance", "for", "sales", "return."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p34_s0", "idA": "1006281_11_item7_p13_s1", "sentA": "We believe that the accounting policies below are critical for one to fully understand and evaluate our financial condition and results of operations.", "sentB": "Our significant accounting policies are more fully described in Note 1 to our consolidated financial statements appearing at the end of this Annual Report on Form 10-K. We believe that the accounting policies below are critical for one to fully understand and evaluate our financial condition and results of operations.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "the", "accounting", "policies", "below", "are", "critical", "for", "one", "to", "fully", "understand", "and", "evaluate", "our", "financial", "condition", "and", "results", "of", "operations.", "<tag2>", "Our", "significant", "accounting", "policies", "are", "more", "fully", "described", "in", "Note", "1", "to", "our", "consolidated", "financial", "statements", "appearing", "at", "the", "end", "of", "this", "Annual", "Report", "on", "Form", "10-K.", "We", "believe", "that", "the", "accounting", "policies", "below", "are", "critical", "for", "one", "to", "fully", "understand", "and", "evaluate", "our", "financial", "condition", "and", "results", "of", "operations.", "<tag3>"], "wordsA": ["We", "believe", "that", "the", "accounting", "policies", "below", "are", "critical", "for", "one", "to", "fully", "understand", "and", "evaluate", "our", "financial", "condition", "and", "results", "of", "operations."], "wordsB": ["Our", "significant", "accounting", "policies", "are", "more", "fully", "described", "in", "Note", "1", "to", "our", "consolidated", "financial", "statements", "appearing", "at", "the", "end", "of", "this", "Annual", "Report", "on", "Form", "10-K.", "We", "believe", "that", "the", "accounting", "policies", "below", "are", "critical", "for", "one", "to", "fully", "understand", "and", "evaluate", "our", "financial", "condition", "and", "results", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p36_s0", "idA": "1006281_11_item7_p15_s0", "sentA": "The currency of the primary economic environment in which our operations are conducted is the dollar.", "sentB": "The currency of the primary economic environment in which our operations are conducted is the U.S. dollar.", "type": 2, "words": ["<tag1>", "The", "currency", "of", "the", "primary", "economic", "environment", "in", "which", "our", "operations", "are", "conducted", "is", "the", "dollar.", "<tag2>", "The", "currency", "of", "the", "primary", "economic", "environment", "in", "which", "our", "operations", "are", "conducted", "is", "the", "U.S.", "dollar.", "<tag3>"], "wordsA": ["The", "currency", "of", "the", "primary", "economic", "environment", "in", "which", "our", "operations", "are", "conducted", "is", "the", "dollar."], "wordsB": ["The", "currency", "of", "the", "primary", "economic", "environment", "in", "which", "our", "operations", "are", "conducted", "is", "the", "U.S.", "dollar."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p39_s0", "idA": "1006281_11_item7_p18_s0", "sentA": "Under the terms and conditions of the Pfizer Agreement, we are entitled to 40% of the profits or loss from sales of taliglucerase alfa, and related expenses incurred, except with respect to sales in Israel.", "sentB": "Under the terms and conditions of the Pfizer Agreement, we are entitled to 40% of the net profits or loss from sales of taliglucerase alfa by Pfizer and reimbursement of our certain related expenses we incur in connection with Pfizer's sales.", "type": 2, "words": ["<tag1>", "Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement,", "we", "are", "entitled", "to", "40%", "of", "the", "profits", "or", "loss", "from", "sales", "of", "taliglucerase", "alfa,", "and", "related", "expenses", "incurred,", "except", "with", "respect", "to", "sales", "in", "Israel.", "<tag2>", "Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement,", "we", "are", "entitled", "to", "40%", "of", "the", "net", "profits", "or", "loss", "from", "sales", "of", "taliglucerase", "alfa", "by", "Pfizer", "and", "reimbursement", "of", "our", "certain", "related", "expenses", "we", "incur", "in", "connection", "with", "Pfizer's", "sales.", "<tag3>"], "wordsA": ["Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement,", "we", "are", "entitled", "to", "40%", "of", "the", "profits", "or", "loss", "from", "sales", "of", "taliglucerase", "alfa,", "and", "related", "expenses", "incurred,", "except", "with", "respect", "to", "sales", "in", "Israel."], "wordsB": ["Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement,", "we", "are", "entitled", "to", "40%", "of", "the", "net", "profits", "or", "loss", "from", "sales", "of", "taliglucerase", "alfa", "by", "Pfizer", "and", "reimbursement", "of", "our", "certain", "related", "expenses", "we", "incur", "in", "connection", "with", "Pfizer's", "sales."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p30_s2", "idA": "1006281_11_item7_p1_s0", "sentA": "Using our ProCellEx system, we are developing a pipeline of proprietary and biosimilar or generic versions of recombinant therapeutic proteins based on our plant cell-based expression technology that target large, established pharmaceutical markets and that rely upon known biological mechanisms of action.", "sentB": "We believe that we may be able to reduce the development risks and time to market for our product candidates as our product candidates are based on well-understood proteins with known biological mechanisms of action.", "type": 2, "words": ["<tag1>", "Using", "our", "ProCellEx", "system,", "we", "are", "developing", "a", "pipeline", "of", "proprietary", "and", "biosimilar", "or", "generic", "versions", "of", "recombinant", "therapeutic", "proteins", "based", "on", "our", "plant", "cell-based", "expression", "technology", "that", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "rely", "upon", "known", "biological", "mechanisms", "of", "action.", "<tag2>", "We", "believe", "that", "we", "may", "be", "able", "to", "reduce", "the", "development", "risks", "and", "time", "to", "market", "for", "our", "product", "candidates", "as", "our", "product", "candidates", "are", "based", "on", "well-understood", "proteins", "with", "known", "biological", "mechanisms", "of", "action.", "<tag3>"], "wordsA": ["Using", "our", "ProCellEx", "system,", "we", "are", "developing", "a", "pipeline", "of", "proprietary", "and", "biosimilar", "or", "generic", "versions", "of", "recombinant", "therapeutic", "proteins", "based", "on", "our", "plant", "cell-based", "expression", "technology", "that", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "rely", "upon", "known", "biological", "mechanisms", "of", "action."], "wordsB": ["We", "believe", "that", "we", "may", "be", "able", "to", "reduce", "the", "development", "risks", "and", "time", "to", "market", "for", "our", "product", "candidates", "as", "our", "product", "candidates", "are", "based", "on", "well-understood", "proteins", "with", "known", "biological", "mechanisms", "of", "action."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p5_s2", "idA": "1006281_11_item7_p20_s1", "sentA": "The revenues represent our cost with respect to the product sold.", "sentB": "As part of the MAA procedure, Pfizer, with our cooperation, is challenging VPRIV's orphan market protection with respect to taliglucerase alfa pursuant to the EU orphan drug regulation.", "type": 2, "words": ["<tag1>", "The", "revenues", "represent", "our", "cost", "with", "respect", "to", "the", "product", "sold.", "<tag2>", "As", "part", "of", "the", "MAA", "procedure,", "Pfizer,", "with", "our", "cooperation,", "is", "challenging", "VPRIV's", "orphan", "market", "protection", "with", "respect", "to", "taliglucerase", "alfa", "pursuant", "to", "the", "EU", "orphan", "drug", "regulation.", "<tag3>"], "wordsA": ["The", "revenues", "represent", "our", "cost", "with", "respect", "to", "the", "product", "sold."], "wordsB": ["As", "part", "of", "the", "MAA", "procedure,", "Pfizer,", "with", "our", "cooperation,", "is", "challenging", "VPRIV's", "orphan", "market", "protection", "with", "respect", "to", "taliglucerase", "alfa", "pursuant", "to", "the", "EU", "orphan", "drug", "regulation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p100_s1", "idA": "1006281_11_item7_p24_s1", "sentA": "Most of our research and development costs were incurred in connection with our phase III clinical trial of taliglucerase alfa.", "sentB": "If all of the contingencies with respect to milestone payments under our research and development agreements are met, the aggregate milestone payments payable would be approximately $950,000 and would be payable, if at all, as our projects progress over the course of a number of years.", "type": 2, "words": ["<tag1>", "Most", "of", "our", "research", "and", "development", "costs", "were", "incurred", "in", "connection", "with", "our", "phase", "III", "clinical", "trial", "of", "taliglucerase", "alfa.", "<tag2>", "If", "all", "of", "the", "contingencies", "with", "respect", "to", "milestone", "payments", "under", "our", "research", "and", "development", "agreements", "are", "met,", "the", "aggregate", "milestone", "payments", "payable", "would", "be", "approximately", "$950,000", "and", "would", "be", "payable,", "if", "at", "all,", "as", "our", "projects", "progress", "over", "the", "course", "of", "a", "number", "of", "years.", "<tag3>"], "wordsA": ["Most", "of", "our", "research", "and", "development", "costs", "were", "incurred", "in", "connection", "with", "our", "phase", "III", "clinical", "trial", "of", "taliglucerase", "alfa."], "wordsB": ["If", "all", "of", "the", "contingencies", "with", "respect", "to", "milestone", "payments", "under", "our", "research", "and", "development", "agreements", "are", "met,", "the", "aggregate", "milestone", "payments", "payable", "would", "be", "approximately", "$950,000", "and", "would", "be", "payable,", "if", "at", "all,", "as", "our", "projects", "progress", "over", "the", "course", "of", "a", "number", "of", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p11_s1", "idA": "1006281_11_item7_p24_s1", "sentA": "Most of our research and development costs were incurred in connection with our phase III clinical trial of taliglucerase alfa.", "sentB": "Eligible patients who successfully completed nine months of treatment in our phase III clinical trial were offered the opportunity to participate in the extension study and continue to receive taliglucerase alfa at the same dose they received in the phase III clinical trial for an additional 15 months in a blinded manner.", "type": 2, "words": ["<tag1>", "Most", "of", "our", "research", "and", "development", "costs", "were", "incurred", "in", "connection", "with", "our", "phase", "III", "clinical", "trial", "of", "taliglucerase", "alfa.", "<tag2>", "Eligible", "patients", "who", "successfully", "completed", "nine", "months", "of", "treatment", "in", "our", "phase", "III", "clinical", "trial", "were", "offered", "the", "opportunity", "to", "participate", "in", "the", "extension", "study", "and", "continue", "to", "receive", "taliglucerase", "alfa", "at", "the", "same", "dose", "they", "received", "in", "the", "phase", "III", "clinical", "trial", "for", "an", "additional", "15", "months", "in", "a", "blinded", "manner.", "<tag3>"], "wordsA": ["Most", "of", "our", "research", "and", "development", "costs", "were", "incurred", "in", "connection", "with", "our", "phase", "III", "clinical", "trial", "of", "taliglucerase", "alfa."], "wordsB": ["Eligible", "patients", "who", "successfully", "completed", "nine", "months", "of", "treatment", "in", "our", "phase", "III", "clinical", "trial", "were", "offered", "the", "opportunity", "to", "participate", "in", "the", "extension", "study", "and", "continue", "to", "receive", "taliglucerase", "alfa", "at", "the", "same", "dose", "they", "received", "in", "the", "phase", "III", "clinical", "trial", "for", "an", "additional", "15", "months", "in", "a", "blinded", "manner."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p12_s1", "idA": "1006281_11_item7_p24_s1", "sentA": "Most of our research and development costs were incurred in connection with our phase III clinical trial of taliglucerase alfa.", "sentB": "According to the data, after 24 months, patients continued to demonstrate a significant improvement in all parameters with a similar safety profile as seen in the phase III clinical trial.", "type": 2, "words": ["<tag1>", "Most", "of", "our", "research", "and", "development", "costs", "were", "incurred", "in", "connection", "with", "our", "phase", "III", "clinical", "trial", "of", "taliglucerase", "alfa.", "<tag2>", "According", "to", "the", "data,", "after", "24", "months,", "patients", "continued", "to", "demonstrate", "a", "significant", "improvement", "in", "all", "parameters", "with", "a", "similar", "safety", "profile", "as", "seen", "in", "the", "phase", "III", "clinical", "trial.", "<tag3>"], "wordsA": ["Most", "of", "our", "research", "and", "development", "costs", "were", "incurred", "in", "connection", "with", "our", "phase", "III", "clinical", "trial", "of", "taliglucerase", "alfa."], "wordsB": ["According", "to", "the", "data,", "after", "24", "months,", "patients", "continued", "to", "demonstrate", "a", "significant", "improvement", "in", "all", "parameters", "with", "a", "similar", "safety", "profile", "as", "seen", "in", "the", "phase", "III", "clinical", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p49_s4", "idA": "1006281_11_item7_p28_s4", "sentA": "If we are unable to develop and commercialize our product candidates, our business will be adversely affected and We may not obtain the necessary U.S. or worldwide regulatory approvals to commercialize our drug candidates in a timely manner, if at all, which would have a material adverse effect on our business and results of operations.", "sentB": "If we are unable to develop and commercialize our product candidates, our business will be adversely affected and We may not obtain the necessary U.S., EMA or other worldwide regulatory approvals to commercialize our drug candidates in a timely manner, if at all, which would have a material adverse effect on our business, financial condition and results of operations.", "type": 2, "words": ["<tag1>", "If", "we", "are", "unable", "to", "develop", "and", "commercialize", "our", "product", "candidates,", "our", "business", "will", "be", "adversely", "affected", "and", "We", "may", "not", "obtain", "the", "necessary", "U.S.", "or", "worldwide", "regulatory", "approvals", "to", "commercialize", "our", "drug", "candidates", "in", "a", "timely", "manner,", "if", "at", "all,", "which", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business", "and", "results", "of", "operations.", "<tag2>", "If", "we", "are", "unable", "to", "develop", "and", "commercialize", "our", "product", "candidates,", "our", "business", "will", "be", "adversely", "affected", "and", "We", "may", "not", "obtain", "the", "necessary", "U.S.,", "EMA", "or", "other", "worldwide", "regulatory", "approvals", "to", "commercialize", "our", "drug", "candidates", "in", "a", "timely", "manner,", "if", "at", "all,", "which", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag3>"], "wordsA": ["If", "we", "are", "unable", "to", "develop", "and", "commercialize", "our", "product", "candidates,", "our", "business", "will", "be", "adversely", "affected", "and", "We", "may", "not", "obtain", "the", "necessary", "U.S.", "or", "worldwide", "regulatory", "approvals", "to", "commercialize", "our", "drug", "candidates", "in", "a", "timely", "manner,", "if", "at", "all,", "which", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business", "and", "results", "of", "operations."], "wordsB": ["If", "we", "are", "unable", "to", "develop", "and", "commercialize", "our", "product", "candidates,", "our", "business", "will", "be", "adversely", "affected", "and", "We", "may", "not", "obtain", "the", "necessary", "U.S.,", "EMA", "or", "other", "worldwide", "regulatory", "approvals", "to", "commercialize", "our", "drug", "candidates", "in", "a", "timely", "manner,", "if", "at", "all,", "which", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p16_s0", "idA": "1006281_11_item7_p29_s0", "sentA": "We expect our research and development expenses to continue to be our primary expense in the future as we continue the advancement of our clinical trials and preclinical product development programs for our product candidates other than taliglucerase alfa.", "sentB": "Although taliglucerase alfa has not yet been approved for commercial sale, patients are being treated with taliglucerase alfa, both in the framework of our clinical trials and related studies and in compassionate use programs, special access agreements, named patient provisions and other programs designed to make sure that treatments are available to Gaucher patients in light of recent shortages of approved treatments.", "type": 2, "words": ["<tag1>", "We", "expect", "our", "research", "and", "development", "expenses", "to", "continue", "to", "be", "our", "primary", "expense", "in", "the", "future", "as", "we", "continue", "the", "advancement", "of", "our", "clinical", "trials", "and", "preclinical", "product", "development", "programs", "for", "our", "product", "candidates", "other", "than", "taliglucerase", "alfa.", "<tag2>", "Although", "taliglucerase", "alfa", "has", "not", "yet", "been", "approved", "for", "commercial", "sale,", "patients", "are", "being", "treated", "with", "taliglucerase", "alfa,", "both", "in", "the", "framework", "of", "our", "clinical", "trials", "and", "related", "studies", "and", "in", "compassionate", "use", "programs,", "special", "access", "agreements,", "named", "patient", "provisions", "and", "other", "programs", "designed", "to", "make", "sure", "that", "treatments", "are", "available", "to", "Gaucher", "patients", "in", "light", "of", "recent", "shortages", "of", "approved", "treatments.", "<tag3>"], "wordsA": ["We", "expect", "our", "research", "and", "development", "expenses", "to", "continue", "to", "be", "our", "primary", "expense", "in", "the", "future", "as", "we", "continue", "the", "advancement", "of", "our", "clinical", "trials", "and", "preclinical", "product", "development", "programs", "for", "our", "product", "candidates", "other", "than", "taliglucerase", "alfa."], "wordsB": ["Although", "taliglucerase", "alfa", "has", "not", "yet", "been", "approved", "for", "commercial", "sale,", "patients", "are", "being", "treated", "with", "taliglucerase", "alfa,", "both", "in", "the", "framework", "of", "our", "clinical", "trials", "and", "related", "studies", "and", "in", "compassionate", "use", "programs,", "special", "access", "agreements,", "named", "patient", "provisions", "and", "other", "programs", "designed", "to", "make", "sure", "that", "treatments", "are", "available", "to", "Gaucher", "patients", "in", "light", "of", "recent", "shortages", "of", "approved", "treatments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p2_s1", "idA": "1006281_11_item7_p2_s1", "sentA": "On December 9, 2009, we filed a New Drug Application (NDA) for taliglucerase alfa with the FDA, and in July 2010 we received notification from the FDA that it had accepted the filing of our NDA and assigned taliglucerase alfa a Prescription Drug User Fee Act (PDUFA) date of February 25, 2011.", "sentB": "The FDA has granted taliglucerase alfa a Prescription Drug User Fee Act (PDUFA) date of May 1, 2012.", "type": 2, "words": ["<tag1>", "On", "December", "9,", "2009,", "we", "filed", "a", "New", "Drug", "Application", "(NDA)", "for", "taliglucerase", "alfa", "with", "the", "FDA,", "and", "in", "July", "2010", "we", "received", "notification", "from", "the", "FDA", "that", "it", "had", "accepted", "the", "filing", "of", "our", "NDA", "and", "assigned", "taliglucerase", "alfa", "a", "Prescription", "Drug", "User", "Fee", "Act", "(PDUFA)", "date", "of", "February", "25,", "2011.", "<tag2>", "The", "FDA", "has", "granted", "taliglucerase", "alfa", "a", "Prescription", "Drug", "User", "Fee", "Act", "(PDUFA)", "date", "of", "May", "1,", "2012.", "<tag3>"], "wordsA": ["On", "December", "9,", "2009,", "we", "filed", "a", "New", "Drug", "Application", "(NDA)", "for", "taliglucerase", "alfa", "with", "the", "FDA,", "and", "in", "July", "2010", "we", "received", "notification", "from", "the", "FDA", "that", "it", "had", "accepted", "the", "filing", "of", "our", "NDA", "and", "assigned", "taliglucerase", "alfa", "a", "Prescription", "Drug", "User", "Fee", "Act", "(PDUFA)", "date", "of", "February", "25,", "2011."], "wordsB": ["The", "FDA", "has", "granted", "taliglucerase", "alfa", "a", "Prescription", "Drug", "User", "Fee", "Act", "(PDUFA)", "date", "of", "May", "1,", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p3_s3", "idA": "1006281_11_item7_p2_s1", "sentA": "On December 9, 2009, we filed a New Drug Application (NDA) for taliglucerase alfa with the FDA, and in July 2010 we received notification from the FDA that it had accepted the filing of our NDA and assigned taliglucerase alfa a Prescription Drug User Fee Act (PDUFA) date of February 25, 2011.", "sentB": "In August 2011, the FDA notified us that it had accepted for review the resubmission of the taliglucerase alfa NDA, had deemed the resubmission a class 2, or 6-month, response and established February 1, 2012 as the new PDUFA date.", "type": 2, "words": ["<tag1>", "On", "December", "9,", "2009,", "we", "filed", "a", "New", "Drug", "Application", "(NDA)", "for", "taliglucerase", "alfa", "with", "the", "FDA,", "and", "in", "July", "2010", "we", "received", "notification", "from", "the", "FDA", "that", "it", "had", "accepted", "the", "filing", "of", "our", "NDA", "and", "assigned", "taliglucerase", "alfa", "a", "Prescription", "Drug", "User", "Fee", "Act", "(PDUFA)", "date", "of", "February", "25,", "2011.", "<tag2>", "In", "August", "2011,", "the", "FDA", "notified", "us", "that", "it", "had", "accepted", "for", "review", "the", "resubmission", "of", "the", "taliglucerase", "alfa", "NDA,", "had", "deemed", "the", "resubmission", "a", "class", "2,", "or", "6-month,", "response", "and", "established", "February", "1,", "2012", "as", "the", "new", "PDUFA", "date.", "<tag3>"], "wordsA": ["On", "December", "9,", "2009,", "we", "filed", "a", "New", "Drug", "Application", "(NDA)", "for", "taliglucerase", "alfa", "with", "the", "FDA,", "and", "in", "July", "2010", "we", "received", "notification", "from", "the", "FDA", "that", "it", "had", "accepted", "the", "filing", "of", "our", "NDA", "and", "assigned", "taliglucerase", "alfa", "a", "Prescription", "Drug", "User", "Fee", "Act", "(PDUFA)", "date", "of", "February", "25,", "2011."], "wordsB": ["In", "August", "2011,", "the", "FDA", "notified", "us", "that", "it", "had", "accepted", "for", "review", "the", "resubmission", "of", "the", "taliglucerase", "alfa", "NDA,", "had", "deemed", "the", "resubmission", "a", "class", "2,", "or", "6-month,", "response", "and", "established", "February", "1,", "2012", "as", "the", "new", "PDUFA", "date."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p17_s0", "idA": "1006281_11_item7_p2_s2", "sentA": "In addition, in November 2010 we submitted a marketing application to the Israeli MOH and an MAA to each of the EMEA and ANVISA for taliglucerase alfa for the treatment of Gaucher disease.", "sentB": "In July 2009, following a request by the FDA, we submitted a treatment protocol to the FDA in order to address an expected shortage of the current enzyme replacement therapy approved for Gaucher disease.", "type": 2, "words": ["<tag1>", "In", "addition,", "in", "November", "2010", "we", "submitted", "a", "marketing", "application", "to", "the", "Israeli", "MOH", "and", "an", "MAA", "to", "each", "of", "the", "EMEA", "and", "ANVISA", "for", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag2>", "In", "July", "2009,", "following", "a", "request", "by", "the", "FDA,", "we", "submitted", "a", "treatment", "protocol", "to", "the", "FDA", "in", "order", "to", "address", "an", "expected", "shortage", "of", "the", "current", "enzyme", "replacement", "therapy", "approved", "for", "Gaucher", "disease.", "<tag3>"], "wordsA": ["In", "addition,", "in", "November", "2010", "we", "submitted", "a", "marketing", "application", "to", "the", "Israeli", "MOH", "and", "an", "MAA", "to", "each", "of", "the", "EMEA", "and", "ANVISA", "for", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease."], "wordsB": ["In", "July", "2009,", "following", "a", "request", "by", "the", "FDA,", "we", "submitted", "a", "treatment", "protocol", "to", "the", "FDA", "in", "order", "to", "address", "an", "expected", "shortage", "of", "the", "current", "enzyme", "replacement", "therapy", "approved", "for", "Gaucher", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p17_s2", "idA": "1006281_11_item7_p2_s2", "sentA": "In addition, in November 2010 we submitted a marketing application to the Israeli MOH and an MAA to each of the EMEA and ANVISA for taliglucerase alfa for the treatment of Gaucher disease.", "sentB": "On July 13, 2010, we announced that the French regulatory authority had granted an ATU for taliglucerase alfa for the treatment of Gaucher disease.", "type": 2, "words": ["<tag1>", "In", "addition,", "in", "November", "2010", "we", "submitted", "a", "marketing", "application", "to", "the", "Israeli", "MOH", "and", "an", "MAA", "to", "each", "of", "the", "EMEA", "and", "ANVISA", "for", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag2>", "On", "July", "13,", "2010,", "we", "announced", "that", "the", "French", "regulatory", "authority", "had", "granted", "an", "ATU", "for", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag3>"], "wordsA": ["In", "addition,", "in", "November", "2010", "we", "submitted", "a", "marketing", "application", "to", "the", "Israeli", "MOH", "and", "an", "MAA", "to", "each", "of", "the", "EMEA", "and", "ANVISA", "for", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease."], "wordsB": ["On", "July", "13,", "2010,", "we", "announced", "that", "the", "French", "regulatory", "authority", "had", "granted", "an", "ATU", "for", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p22_s0", "idA": "1006281_11_item7_p2_s2", "sentA": "In addition, in November 2010 we submitted a marketing application to the Israeli MOH and an MAA to each of the EMEA and ANVISA for taliglucerase alfa for the treatment of Gaucher disease.", "sentB": "Although Gaucher disease is a relatively rare disease, it represents a large commercial market due to the severity of the symptoms and the chronic nature of the disease.", "type": 2, "words": ["<tag1>", "In", "addition,", "in", "November", "2010", "we", "submitted", "a", "marketing", "application", "to", "the", "Israeli", "MOH", "and", "an", "MAA", "to", "each", "of", "the", "EMEA", "and", "ANVISA", "for", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag2>", "Although", "Gaucher", "disease", "is", "a", "relatively", "rare", "disease,", "it", "represents", "a", "large", "commercial", "market", "due", "to", "the", "severity", "of", "the", "symptoms", "and", "the", "chronic", "nature", "of", "the", "disease.", "<tag3>"], "wordsA": ["In", "addition,", "in", "November", "2010", "we", "submitted", "a", "marketing", "application", "to", "the", "Israeli", "MOH", "and", "an", "MAA", "to", "each", "of", "the", "EMEA", "and", "ANVISA", "for", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease."], "wordsB": ["Although", "Gaucher", "disease", "is", "a", "relatively", "rare", "disease,", "it", "represents", "a", "large", "commercial", "market", "due", "to", "the", "severity", "of", "the", "symptoms", "and", "the", "chronic", "nature", "of", "the", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p28_s3", "idA": "1006281_11_item7_p2_s2", "sentA": "In addition, in November 2010 we submitted a marketing application to the Israeli MOH and an MAA to each of the EMEA and ANVISA for taliglucerase alfa for the treatment of Gaucher disease.", "sentB": "We are also conducting pre clinical trials of our orally-administrated glucocerebrosidase enzyme for the treatment of Gaucher disease in small and large animals.", "type": 2, "words": ["<tag1>", "In", "addition,", "in", "November", "2010", "we", "submitted", "a", "marketing", "application", "to", "the", "Israeli", "MOH", "and", "an", "MAA", "to", "each", "of", "the", "EMEA", "and", "ANVISA", "for", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag2>", "We", "are", "also", "conducting", "pre", "clinical", "trials", "of", "our", "orally-administrated", "glucocerebrosidase", "enzyme", "for", "the", "treatment", "of", "Gaucher", "disease", "in", "small", "and", "large", "animals.", "<tag3>"], "wordsA": ["In", "addition,", "in", "November", "2010", "we", "submitted", "a", "marketing", "application", "to", "the", "Israeli", "MOH", "and", "an", "MAA", "to", "each", "of", "the", "EMEA", "and", "ANVISA", "for", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease."], "wordsB": ["We", "are", "also", "conducting", "pre", "clinical", "trials", "of", "our", "orally-administrated", "glucocerebrosidase", "enzyme", "for", "the", "treatment", "of", "Gaucher", "disease", "in", "small", "and", "large", "animals."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p7_s0", "idA": "1006281_11_item7_p2_s2", "sentA": "In addition, in November 2010 we submitted a marketing application to the Israeli MOH and an MAA to each of the EMEA and ANVISA for taliglucerase alfa for the treatment of Gaucher disease.", "sentB": "In January 2010, the EMA's Committee for Orphan Medicinal Products, or COMP, after reviewing all relevant clinical data, recommended that the European Commission grant orphan drug designation to taliglucerase alfa for the treatment of Gaucher disease and in March 2010, the European Commission granted orphan designation to taliglucerase alfa.", "type": 2, "words": ["<tag1>", "In", "addition,", "in", "November", "2010", "we", "submitted", "a", "marketing", "application", "to", "the", "Israeli", "MOH", "and", "an", "MAA", "to", "each", "of", "the", "EMEA", "and", "ANVISA", "for", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag2>", "In", "January", "2010,", "the", "EMA's", "Committee", "for", "Orphan", "Medicinal", "Products,", "or", "COMP,", "after", "reviewing", "all", "relevant", "clinical", "data,", "recommended", "that", "the", "European", "Commission", "grant", "orphan", "drug", "designation", "to", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease", "and", "in", "March", "2010,", "the", "European", "Commission", "granted", "orphan", "designation", "to", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["In", "addition,", "in", "November", "2010", "we", "submitted", "a", "marketing", "application", "to", "the", "Israeli", "MOH", "and", "an", "MAA", "to", "each", "of", "the", "EMEA", "and", "ANVISA", "for", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease."], "wordsB": ["In", "January", "2010,", "the", "EMA's", "Committee", "for", "Orphan", "Medicinal", "Products,", "or", "COMP,", "after", "reviewing", "all", "relevant", "clinical", "data,", "recommended", "that", "the", "European", "Commission", "grant", "orphan", "drug", "designation", "to", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease", "and", "in", "March", "2010,", "the", "European", "Commission", "granted", "orphan", "designation", "to", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p8_s0", "idA": "1006281_11_item7_p2_s2", "sentA": "In addition, in November 2010 we submitted a marketing application to the Israeli MOH and an MAA to each of the EMEA and ANVISA for taliglucerase alfa for the treatment of Gaucher disease.", "sentB": "In addition, marketing applications have been submitted for taliglucerase alfa with each of the Israeli MOH, ANVISA and the Australian TGA.", "type": 2, "words": ["<tag1>", "In", "addition,", "in", "November", "2010", "we", "submitted", "a", "marketing", "application", "to", "the", "Israeli", "MOH", "and", "an", "MAA", "to", "each", "of", "the", "EMEA", "and", "ANVISA", "for", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag2>", "In", "addition,", "marketing", "applications", "have", "been", "submitted", "for", "taliglucerase", "alfa", "with", "each", "of", "the", "Israeli", "MOH,", "ANVISA", "and", "the", "Australian", "TGA.", "<tag3>"], "wordsA": ["In", "addition,", "in", "November", "2010", "we", "submitted", "a", "marketing", "application", "to", "the", "Israeli", "MOH", "and", "an", "MAA", "to", "each", "of", "the", "EMEA", "and", "ANVISA", "for", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease."], "wordsB": ["In", "addition,", "marketing", "applications", "have", "been", "submitted", "for", "taliglucerase", "alfa", "with", "each", "of", "the", "Israeli", "MOH,", "ANVISA", "and", "the", "Australian", "TGA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p17_s1", "idA": "1006281_11_item7_p30_s2", "sentA": "We filed an NDA for taliglucerase alfa with the FDA in the last quarter of 2009 and received a PDUFA date of February 25, 2011.", "sentB": "The treatment protocol was approved by the FDA in August 2009, and we are continuing to treat patients in the United States under this protocol.", "type": 2, "words": ["<tag1>", "We", "filed", "an", "NDA", "for", "taliglucerase", "alfa", "with", "the", "FDA", "in", "the", "last", "quarter", "of", "2009", "and", "received", "a", "PDUFA", "date", "of", "February", "25,", "2011.", "<tag2>", "The", "treatment", "protocol", "was", "approved", "by", "the", "FDA", "in", "August", "2009,", "and", "we", "are", "continuing", "to", "treat", "patients", "in", "the", "United", "States", "under", "this", "protocol.", "<tag3>"], "wordsA": ["We", "filed", "an", "NDA", "for", "taliglucerase", "alfa", "with", "the", "FDA", "in", "the", "last", "quarter", "of", "2009", "and", "received", "a", "PDUFA", "date", "of", "February", "25,", "2011."], "wordsB": ["The", "treatment", "protocol", "was", "approved", "by", "the", "FDA", "in", "August", "2009,", "and", "we", "are", "continuing", "to", "treat", "patients", "in", "the", "United", "States", "under", "this", "protocol."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p2_s2", "idA": "1006281_11_item7_p30_s2", "sentA": "We filed an NDA for taliglucerase alfa with the FDA in the last quarter of 2009 and received a PDUFA date of February 25, 2011.", "sentB": "We first filed an NDA for taliglucerase alfa with the FDA on December 9, 2009, and on February 25, 2011, the FDA issued a CRL indicating that the FDA s review was complete but questions remain that preclude the approval of the NDA in its then current form.", "type": 2, "words": ["<tag1>", "We", "filed", "an", "NDA", "for", "taliglucerase", "alfa", "with", "the", "FDA", "in", "the", "last", "quarter", "of", "2009", "and", "received", "a", "PDUFA", "date", "of", "February", "25,", "2011.", "<tag2>", "We", "first", "filed", "an", "NDA", "for", "taliglucerase", "alfa", "with", "the", "FDA", "on", "December", "9,", "2009,", "and", "on", "February", "25,", "2011,", "the", "FDA", "issued", "a", "CRL", "indicating", "that", "the", "FDA", "s", "review", "was", "complete", "but", "questions", "remain", "that", "preclude", "the", "approval", "of", "the", "NDA", "in", "its", "then", "current", "form.", "<tag3>"], "wordsA": ["We", "filed", "an", "NDA", "for", "taliglucerase", "alfa", "with", "the", "FDA", "in", "the", "last", "quarter", "of", "2009", "and", "received", "a", "PDUFA", "date", "of", "February", "25,", "2011."], "wordsB": ["We", "first", "filed", "an", "NDA", "for", "taliglucerase", "alfa", "with", "the", "FDA", "on", "December", "9,", "2009,", "and", "on", "February", "25,", "2011,", "the", "FDA", "issued", "a", "CRL", "indicating", "that", "the", "FDA", "s", "review", "was", "complete", "but", "questions", "remain", "that", "preclude", "the", "approval", "of", "the", "NDA", "in", "its", "then", "current", "form."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p3_s2", "idA": "1006281_11_item7_p30_s2", "sentA": "We filed an NDA for taliglucerase alfa with the FDA in the last quarter of 2009 and received a PDUFA date of February 25, 2011.", "sentB": "We met with the FDA in May 2011 to clarify the FDA s requests, and in July 2011 we submitted our reply to the CRL.", "type": 2, "words": ["<tag1>", "We", "filed", "an", "NDA", "for", "taliglucerase", "alfa", "with", "the", "FDA", "in", "the", "last", "quarter", "of", "2009", "and", "received", "a", "PDUFA", "date", "of", "February", "25,", "2011.", "<tag2>", "We", "met", "with", "the", "FDA", "in", "May", "2011", "to", "clarify", "the", "FDA", "s", "requests,", "and", "in", "July", "2011", "we", "submitted", "our", "reply", "to", "the", "CRL.", "<tag3>"], "wordsA": ["We", "filed", "an", "NDA", "for", "taliglucerase", "alfa", "with", "the", "FDA", "in", "the", "last", "quarter", "of", "2009", "and", "received", "a", "PDUFA", "date", "of", "February", "25,", "2011."], "wordsB": ["We", "met", "with", "the", "FDA", "in", "May", "2011", "to", "clarify", "the", "FDA", "s", "requests,", "and", "in", "July", "2011", "we", "submitted", "our", "reply", "to", "the", "CRL."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p3_s9", "idA": "1006281_11_item7_p30_s2", "sentA": "We filed an NDA for taliglucerase alfa with the FDA in the last quarter of 2009 and received a PDUFA date of February 25, 2011.", "sentB": "No additional data was requested by the FDA in the notification, nor were we notified of any specific deficiency in the taliglucerase alfa NDA.", "type": 2, "words": ["<tag1>", "We", "filed", "an", "NDA", "for", "taliglucerase", "alfa", "with", "the", "FDA", "in", "the", "last", "quarter", "of", "2009", "and", "received", "a", "PDUFA", "date", "of", "February", "25,", "2011.", "<tag2>", "No", "additional", "data", "was", "requested", "by", "the", "FDA", "in", "the", "notification,", "nor", "were", "we", "notified", "of", "any", "specific", "deficiency", "in", "the", "taliglucerase", "alfa", "NDA.", "<tag3>"], "wordsA": ["We", "filed", "an", "NDA", "for", "taliglucerase", "alfa", "with", "the", "FDA", "in", "the", "last", "quarter", "of", "2009", "and", "received", "a", "PDUFA", "date", "of", "February", "25,", "2011."], "wordsB": ["No", "additional", "data", "was", "requested", "by", "the", "FDA", "in", "the", "notification,", "nor", "were", "we", "notified", "of", "any", "specific", "deficiency", "in", "the", "taliglucerase", "alfa", "NDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p4_s0", "idA": "1006281_11_item7_p30_s2", "sentA": "We filed an NDA for taliglucerase alfa with the FDA in the last quarter of 2009 and received a PDUFA date of February 25, 2011.", "sentB": "In the fourth quarter of 2010, Pfizer, our commercialization partner, filed, with our cooperation, an MAA for taliglucerase alfa with the EMA.", "type": 2, "words": ["<tag1>", "We", "filed", "an", "NDA", "for", "taliglucerase", "alfa", "with", "the", "FDA", "in", "the", "last", "quarter", "of", "2009", "and", "received", "a", "PDUFA", "date", "of", "February", "25,", "2011.", "<tag2>", "In", "the", "fourth", "quarter", "of", "2010,", "Pfizer,", "our", "commercialization", "partner,", "filed,", "with", "our", "cooperation,", "an", "MAA", "for", "taliglucerase", "alfa", "with", "the", "EMA.", "<tag3>"], "wordsA": ["We", "filed", "an", "NDA", "for", "taliglucerase", "alfa", "with", "the", "FDA", "in", "the", "last", "quarter", "of", "2009", "and", "received", "a", "PDUFA", "date", "of", "February", "25,", "2011."], "wordsB": ["In", "the", "fourth", "quarter", "of", "2010,", "Pfizer,", "our", "commercialization", "partner,", "filed,", "with", "our", "cooperation,", "an", "MAA", "for", "taliglucerase", "alfa", "with", "the", "EMA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p51_s2", "idA": "1006281_11_item7_p30_s2", "sentA": "We filed an NDA for taliglucerase alfa with the FDA in the last quarter of 2009 and received a PDUFA date of February 25, 2011.", "sentB": "We filed a revised NDA for taliglucerase alfa with the FDA in the third quarter of 2011 and currently have a PDUFA date of May 1, 2012.", "type": 2, "words": ["<tag1>", "We", "filed", "an", "NDA", "for", "taliglucerase", "alfa", "with", "the", "FDA", "in", "the", "last", "quarter", "of", "2009", "and", "received", "a", "PDUFA", "date", "of", "February", "25,", "2011.", "<tag2>", "We", "filed", "a", "revised", "NDA", "for", "taliglucerase", "alfa", "with", "the", "FDA", "in", "the", "third", "quarter", "of", "2011", "and", "currently", "have", "a", "PDUFA", "date", "of", "May", "1,", "2012.", "<tag3>"], "wordsA": ["We", "filed", "an", "NDA", "for", "taliglucerase", "alfa", "with", "the", "FDA", "in", "the", "last", "quarter", "of", "2009", "and", "received", "a", "PDUFA", "date", "of", "February", "25,", "2011."], "wordsB": ["We", "filed", "a", "revised", "NDA", "for", "taliglucerase", "alfa", "with", "the", "FDA", "in", "the", "third", "quarter", "of", "2011", "and", "currently", "have", "a", "PDUFA", "date", "of", "May", "1,", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p19_s1", "idA": "1006281_11_item7_p30_s3", "sentA": "In addition, we submitted a marketing application to the Israeli MOH and an MAA to each of the EMEA and ANVISA in the fourth quarter of 2010 regarding taliglucerase alfa.", "sentB": "In addition to the United States and France, taliglucerase alfa is currently being provided to Gaucher disease patients under special access agreements or Named Patient provisions in Brazil and in the rest of the world.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "submitted", "a", "marketing", "application", "to", "the", "Israeli", "MOH", "and", "an", "MAA", "to", "each", "of", "the", "EMEA", "and", "ANVISA", "in", "the", "fourth", "quarter", "of", "2010", "regarding", "taliglucerase", "alfa.", "<tag2>", "In", "addition", "to", "the", "United", "States", "and", "France,", "taliglucerase", "alfa", "is", "currently", "being", "provided", "to", "Gaucher", "disease", "patients", "under", "special", "access", "agreements", "or", "Named", "Patient", "provisions", "in", "Brazil", "and", "in", "the", "rest", "of", "the", "world.", "<tag3>"], "wordsA": ["In", "addition,", "we", "submitted", "a", "marketing", "application", "to", "the", "Israeli", "MOH", "and", "an", "MAA", "to", "each", "of", "the", "EMEA", "and", "ANVISA", "in", "the", "fourth", "quarter", "of", "2010", "regarding", "taliglucerase", "alfa."], "wordsB": ["In", "addition", "to", "the", "United", "States", "and", "France,", "taliglucerase", "alfa", "is", "currently", "being", "provided", "to", "Gaucher", "disease", "patients", "under", "special", "access", "agreements", "or", "Named", "Patient", "provisions", "in", "Brazil", "and", "in", "the", "rest", "of", "the", "world."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p3_s6", "idA": "1006281_11_item7_p30_s3", "sentA": "In addition, we submitted a marketing application to the Israeli MOH and an MAA to each of the EMEA and ANVISA in the fourth quarter of 2010 regarding taliglucerase alfa.", "sentB": "The requested information related mainly to the presentation of select data provided in the NDA.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "submitted", "a", "marketing", "application", "to", "the", "Israeli", "MOH", "and", "an", "MAA", "to", "each", "of", "the", "EMEA", "and", "ANVISA", "in", "the", "fourth", "quarter", "of", "2010", "regarding", "taliglucerase", "alfa.", "<tag2>", "The", "requested", "information", "related", "mainly", "to", "the", "presentation", "of", "select", "data", "provided", "in", "the", "NDA.", "<tag3>"], "wordsA": ["In", "addition,", "we", "submitted", "a", "marketing", "application", "to", "the", "Israeli", "MOH", "and", "an", "MAA", "to", "each", "of", "the", "EMEA", "and", "ANVISA", "in", "the", "fourth", "quarter", "of", "2010", "regarding", "taliglucerase", "alfa."], "wordsB": ["The", "requested", "information", "related", "mainly", "to", "the", "presentation", "of", "select", "data", "provided", "in", "the", "NDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p51_s3", "idA": "1006281_11_item7_p30_s3", "sentA": "In addition, we submitted a marketing application to the Israeli MOH and an MAA to each of the EMEA and ANVISA in the fourth quarter of 2010 regarding taliglucerase alfa.", "sentB": "In addition, during 2010, we submitted a marketing application regarding taliglucerase alfa to the Israeli MOH and similar applications have been submitted to each of the EMA, ANVISA and the Australian TGA.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "submitted", "a", "marketing", "application", "to", "the", "Israeli", "MOH", "and", "an", "MAA", "to", "each", "of", "the", "EMEA", "and", "ANVISA", "in", "the", "fourth", "quarter", "of", "2010", "regarding", "taliglucerase", "alfa.", "<tag2>", "In", "addition,", "during", "2010,", "we", "submitted", "a", "marketing", "application", "regarding", "taliglucerase", "alfa", "to", "the", "Israeli", "MOH", "and", "similar", "applications", "have", "been", "submitted", "to", "each", "of", "the", "EMA,", "ANVISA", "and", "the", "Australian", "TGA.", "<tag3>"], "wordsA": ["In", "addition,", "we", "submitted", "a", "marketing", "application", "to", "the", "Israeli", "MOH", "and", "an", "MAA", "to", "each", "of", "the", "EMEA", "and", "ANVISA", "in", "the", "fourth", "quarter", "of", "2010", "regarding", "taliglucerase", "alfa."], "wordsB": ["In", "addition,", "during", "2010,", "we", "submitted", "a", "marketing", "application", "regarding", "taliglucerase", "alfa", "to", "the", "Israeli", "MOH", "and", "similar", "applications", "have", "been", "submitted", "to", "each", "of", "the", "EMA,", "ANVISA", "and", "the", "Australian", "TGA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p6_s0", "idA": "1006281_11_item7_p30_s3", "sentA": "In addition, we submitted a marketing application to the Israeli MOH and an MAA to each of the EMEA and ANVISA in the fourth quarter of 2010 regarding taliglucerase alfa.", "sentB": "Following the submission of the taliglucerase alfa MAA to the EMA, a good manufacturing practices, or GMP, audit of our manufacturing facility was performed and it was found compliant with EMA GMP in December 2011.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "submitted", "a", "marketing", "application", "to", "the", "Israeli", "MOH", "and", "an", "MAA", "to", "each", "of", "the", "EMEA", "and", "ANVISA", "in", "the", "fourth", "quarter", "of", "2010", "regarding", "taliglucerase", "alfa.", "<tag2>", "Following", "the", "submission", "of", "the", "taliglucerase", "alfa", "MAA", "to", "the", "EMA,", "a", "good", "manufacturing", "practices,", "or", "GMP,", "audit", "of", "our", "manufacturing", "facility", "was", "performed", "and", "it", "was", "found", "compliant", "with", "EMA", "GMP", "in", "December", "2011.", "<tag3>"], "wordsA": ["In", "addition,", "we", "submitted", "a", "marketing", "application", "to", "the", "Israeli", "MOH", "and", "an", "MAA", "to", "each", "of", "the", "EMEA", "and", "ANVISA", "in", "the", "fourth", "quarter", "of", "2010", "regarding", "taliglucerase", "alfa."], "wordsB": ["Following", "the", "submission", "of", "the", "taliglucerase", "alfa", "MAA", "to", "the", "EMA,", "a", "good", "manufacturing", "practices,", "or", "GMP,", "audit", "of", "our", "manufacturing", "facility", "was", "performed", "and", "it", "was", "found", "compliant", "with", "EMA", "GMP", "in", "December", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p9_s1", "idA": "1006281_11_item7_p30_s3", "sentA": "In addition, we submitted a marketing application to the Israeli MOH and an MAA to each of the EMEA and ANVISA in the fourth quarter of 2010 regarding taliglucerase alfa.", "sentB": "The audit was performed as part of the Israeli MOH s evaluation of our manufacturing process for taliglucerase alfa.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "submitted", "a", "marketing", "application", "to", "the", "Israeli", "MOH", "and", "an", "MAA", "to", "each", "of", "the", "EMEA", "and", "ANVISA", "in", "the", "fourth", "quarter", "of", "2010", "regarding", "taliglucerase", "alfa.", "<tag2>", "The", "audit", "was", "performed", "as", "part", "of", "the", "Israeli", "MOH", "s", "evaluation", "of", "our", "manufacturing", "process", "for", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["In", "addition,", "we", "submitted", "a", "marketing", "application", "to", "the", "Israeli", "MOH", "and", "an", "MAA", "to", "each", "of", "the", "EMEA", "and", "ANVISA", "in", "the", "fourth", "quarter", "of", "2010", "regarding", "taliglucerase", "alfa."], "wordsB": ["The", "audit", "was", "performed", "as", "part", "of", "the", "Israeli", "MOH", "s", "evaluation", "of", "our", "manufacturing", "process", "for", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p57_s0", "idA": "1006281_11_item7_p36_s0", "sentA": "For purposes of determining the fair value of the options to purchase common stock granted to employees and non-employees during the fiscal year ended December 31, 2010, including shares held by non employees that vested during such period, our management used the fair value of our common stock which was the closing sale price of our common stock on the NYSE Amex on the date of calculation.", "sentB": "For purposes of determining the fair value of the options to purchase common stock granted to employees and non-employees during the fiscal year ended December 31, 2011, including shares held by non employees that vested during such period, our management used the fair value of our common stock which was the closing sale price of our common stock on the NYSE Amex on the date of calculation.", "type": 2, "words": ["<tag1>", "For", "purposes", "of", "determining", "the", "fair", "value", "of", "the", "options", "to", "purchase", "common", "stock", "granted", "to", "employees", "and", "non-employees", "during", "the", "fiscal", "year", "ended", "December", "31,", "2010,", "including", "shares", "held", "by", "non", "employees", "that", "vested", "during", "such", "period,", "our", "management", "used", "the", "fair", "value", "of", "our", "common", "stock", "which", "was", "the", "closing", "sale", "price", "of", "our", "common", "stock", "on", "the", "NYSE", "Amex", "on", "the", "date", "of", "calculation.", "<tag2>", "For", "purposes", "of", "determining", "the", "fair", "value", "of", "the", "options", "to", "purchase", "common", "stock", "granted", "to", "employees", "and", "non-employees", "during", "the", "fiscal", "year", "ended", "December", "31,", "2011,", "including", "shares", "held", "by", "non", "employees", "that", "vested", "during", "such", "period,", "our", "management", "used", "the", "fair", "value", "of", "our", "common", "stock", "which", "was", "the", "closing", "sale", "price", "of", "our", "common", "stock", "on", "the", "NYSE", "Amex", "on", "the", "date", "of", "calculation.", "<tag3>"], "wordsA": ["For", "purposes", "of", "determining", "the", "fair", "value", "of", "the", "options", "to", "purchase", "common", "stock", "granted", "to", "employees", "and", "non-employees", "during", "the", "fiscal", "year", "ended", "December", "31,", "2010,", "including", "shares", "held", "by", "non", "employees", "that", "vested", "during", "such", "period,", "our", "management", "used", "the", "fair", "value", "of", "our", "common", "stock", "which", "was", "the", "closing", "sale", "price", "of", "our", "common", "stock", "on", "the", "NYSE", "Amex", "on", "the", "date", "of", "calculation."], "wordsB": ["For", "purposes", "of", "determining", "the", "fair", "value", "of", "the", "options", "to", "purchase", "common", "stock", "granted", "to", "employees", "and", "non-employees", "during", "the", "fiscal", "year", "ended", "December", "31,", "2011,", "including", "shares", "held", "by", "non", "employees", "that", "vested", "during", "such", "period,", "our", "management", "used", "the", "fair", "value", "of", "our", "common", "stock", "which", "was", "the", "closing", "sale", "price", "of", "our", "common", "stock", "on", "the", "NYSE", "Amex", "on", "the", "date", "of", "calculation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p58_s0", "idA": "1006281_11_item7_p37_s0", "sentA": "The guidance allows companies to estimate the expected term of the option rather than simply using the contractual term of an option.", "sentB": "The guidance requires companies to estimate the expected term of the option rather than simply using the contractual term of an option.", "type": 2, "words": ["<tag1>", "The", "guidance", "allows", "companies", "to", "estimate", "the", "expected", "term", "of", "the", "option", "rather", "than", "simply", "using", "the", "contractual", "term", "of", "an", "option.", "<tag2>", "The", "guidance", "requires", "companies", "to", "estimate", "the", "expected", "term", "of", "the", "option", "rather", "than", "simply", "using", "the", "contractual", "term", "of", "an", "option.", "<tag3>"], "wordsA": ["The", "guidance", "allows", "companies", "to", "estimate", "the", "expected", "term", "of", "the", "option", "rather", "than", "simply", "using", "the", "contractual", "term", "of", "an", "option."], "wordsB": ["The", "guidance", "requires", "companies", "to", "estimate", "the", "expected", "term", "of", "the", "option", "rather", "than", "simply", "using", "the", "contractual", "term", "of", "an", "option."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p62_s1", "idA": "1006281_11_item7_p37_s0", "sentA": "The guidance allows companies to estimate the expected term of the option rather than simply using the contractual term of an option.", "sentB": "The remaining term of the bonds used for each valuation was equal to the expected term of the grant.", "type": 2, "words": ["<tag1>", "The", "guidance", "allows", "companies", "to", "estimate", "the", "expected", "term", "of", "the", "option", "rather", "than", "simply", "using", "the", "contractual", "term", "of", "an", "option.", "<tag2>", "The", "remaining", "term", "of", "the", "bonds", "used", "for", "each", "valuation", "was", "equal", "to", "the", "expected", "term", "of", "the", "grant.", "<tag3>"], "wordsA": ["The", "guidance", "allows", "companies", "to", "estimate", "the", "expected", "term", "of", "the", "option", "rather", "than", "simply", "using", "the", "contractual", "term", "of", "an", "option."], "wordsB": ["The", "remaining", "term", "of", "the", "bonds", "used", "for", "each", "valuation", "was", "equal", "to", "the", "expected", "term", "of", "the", "grant."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p11_s0", "idA": "1006281_11_item7_p3_s0", "sentA": "In addition to our recently completed phase III clinical trial, we initiated a double-blind, follow-on extension study as part of the trial during the second quarter of 2008.", "sentB": "In addition to the completed phase III clinical trial we completed in September 2009, we initiated a double-blind, follow-on extension study as part of the trial during the second quarter of 2008.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "our", "recently", "completed", "phase", "III", "clinical", "trial,", "we", "initiated", "a", "double-blind,", "follow-on", "extension", "study", "as", "part", "of", "the", "trial", "during", "the", "second", "quarter", "of", "2008.", "<tag2>", "In", "addition", "to", "the", "completed", "phase", "III", "clinical", "trial", "we", "completed", "in", "September", "2009,", "we", "initiated", "a", "double-blind,", "follow-on", "extension", "study", "as", "part", "of", "the", "trial", "during", "the", "second", "quarter", "of", "2008.", "<tag3>"], "wordsA": ["In", "addition", "to", "our", "recently", "completed", "phase", "III", "clinical", "trial,", "we", "initiated", "a", "double-blind,", "follow-on", "extension", "study", "as", "part", "of", "the", "trial", "during", "the", "second", "quarter", "of", "2008."], "wordsB": ["In", "addition", "to", "the", "completed", "phase", "III", "clinical", "trial", "we", "completed", "in", "September", "2009,", "we", "initiated", "a", "double-blind,", "follow-on", "extension", "study", "as", "part", "of", "the", "trial", "during", "the", "second", "quarter", "of", "2008."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p12_s0", "idA": "1006281_11_item7_p3_s1", "sentA": "We also initiated a home care treatment program for patients enrolled in the extension study and, in December 2008, we initiated a nine-month, worldwide, multi-center, open-label, switch-over clinical study evaluating the safety and efficacy of switching Gaucher patients currently treated under the current standard of care to treatment with taliglucerase alfa.", "sentB": "In February 2012, we announced data from 26 adult patients enrolled in the trial.", "type": 2, "words": ["<tag1>", "We", "also", "initiated", "a", "home", "care", "treatment", "program", "for", "patients", "enrolled", "in", "the", "extension", "study", "and,", "in", "December", "2008,", "we", "initiated", "a", "nine-month,", "worldwide,", "multi-center,", "open-label,", "switch-over", "clinical", "study", "evaluating", "the", "safety", "and", "efficacy", "of", "switching", "Gaucher", "patients", "currently", "treated", "under", "the", "current", "standard", "of", "care", "to", "treatment", "with", "taliglucerase", "alfa.", "<tag2>", "In", "February", "2012,", "we", "announced", "data", "from", "26", "adult", "patients", "enrolled", "in", "the", "trial.", "<tag3>"], "wordsA": ["We", "also", "initiated", "a", "home", "care", "treatment", "program", "for", "patients", "enrolled", "in", "the", "extension", "study", "and,", "in", "December", "2008,", "we", "initiated", "a", "nine-month,", "worldwide,", "multi-center,", "open-label,", "switch-over", "clinical", "study", "evaluating", "the", "safety", "and", "efficacy", "of", "switching", "Gaucher", "patients", "currently", "treated", "under", "the", "current", "standard", "of", "care", "to", "treatment", "with", "taliglucerase", "alfa."], "wordsB": ["In", "February", "2012,", "we", "announced", "data", "from", "26", "adult", "patients", "enrolled", "in", "the", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p12_s3", "idA": "1006281_11_item7_p3_s1", "sentA": "We also initiated a home care treatment program for patients enrolled in the extension study and, in December 2008, we initiated a nine-month, worldwide, multi-center, open-label, switch-over clinical study evaluating the safety and efficacy of switching Gaucher patients currently treated under the current standard of care to treatment with taliglucerase alfa.", "sentB": "We have also initiated a home care treatment program for patients enrolled in the extension study.", "type": 2, "words": ["<tag1>", "We", "also", "initiated", "a", "home", "care", "treatment", "program", "for", "patients", "enrolled", "in", "the", "extension", "study", "and,", "in", "December", "2008,", "we", "initiated", "a", "nine-month,", "worldwide,", "multi-center,", "open-label,", "switch-over", "clinical", "study", "evaluating", "the", "safety", "and", "efficacy", "of", "switching", "Gaucher", "patients", "currently", "treated", "under", "the", "current", "standard", "of", "care", "to", "treatment", "with", "taliglucerase", "alfa.", "<tag2>", "We", "have", "also", "initiated", "a", "home", "care", "treatment", "program", "for", "patients", "enrolled", "in", "the", "extension", "study.", "<tag3>"], "wordsA": ["We", "also", "initiated", "a", "home", "care", "treatment", "program", "for", "patients", "enrolled", "in", "the", "extension", "study", "and,", "in", "December", "2008,", "we", "initiated", "a", "nine-month,", "worldwide,", "multi-center,", "open-label,", "switch-over", "clinical", "study", "evaluating", "the", "safety", "and", "efficacy", "of", "switching", "Gaucher", "patients", "currently", "treated", "under", "the", "current", "standard", "of", "care", "to", "treatment", "with", "taliglucerase", "alfa."], "wordsB": ["We", "have", "also", "initiated", "a", "home", "care", "treatment", "program", "for", "patients", "enrolled", "in", "the", "extension", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p13_s0", "idA": "1006281_11_item7_p3_s1", "sentA": "We also initiated a home care treatment program for patients enrolled in the extension study and, in December 2008, we initiated a nine-month, worldwide, multi-center, open-label, switch-over clinical study evaluating the safety and efficacy of switching Gaucher patients currently treated under the current standard of care to treatment with taliglucerase alfa.", "sentB": "In the second quarter of 2011 we successfully completed a nine-month, worldwide, multi-center, open-label, switch-over clinical study evaluating the safety and efficacy of switching Gaucher patients from with Cerezyme to taliglucerase alfa.", "type": 2, "words": ["<tag1>", "We", "also", "initiated", "a", "home", "care", "treatment", "program", "for", "patients", "enrolled", "in", "the", "extension", "study", "and,", "in", "December", "2008,", "we", "initiated", "a", "nine-month,", "worldwide,", "multi-center,", "open-label,", "switch-over", "clinical", "study", "evaluating", "the", "safety", "and", "efficacy", "of", "switching", "Gaucher", "patients", "currently", "treated", "under", "the", "current", "standard", "of", "care", "to", "treatment", "with", "taliglucerase", "alfa.", "<tag2>", "In", "the", "second", "quarter", "of", "2011", "we", "successfully", "completed", "a", "nine-month,", "worldwide,", "multi-center,", "open-label,", "switch-over", "clinical", "study", "evaluating", "the", "safety", "and", "efficacy", "of", "switching", "Gaucher", "patients", "from", "with", "Cerezyme", "to", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["We", "also", "initiated", "a", "home", "care", "treatment", "program", "for", "patients", "enrolled", "in", "the", "extension", "study", "and,", "in", "December", "2008,", "we", "initiated", "a", "nine-month,", "worldwide,", "multi-center,", "open-label,", "switch-over", "clinical", "study", "evaluating", "the", "safety", "and", "efficacy", "of", "switching", "Gaucher", "patients", "currently", "treated", "under", "the", "current", "standard", "of", "care", "to", "treatment", "with", "taliglucerase", "alfa."], "wordsB": ["In", "the", "second", "quarter", "of", "2011", "we", "successfully", "completed", "a", "nine-month,", "worldwide,", "multi-center,", "open-label,", "switch-over", "clinical", "study", "evaluating", "the", "safety", "and", "efficacy", "of", "switching", "Gaucher", "patients", "from", "with", "Cerezyme", "to", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p13_s3", "idA": "1006281_11_item7_p3_s1", "sentA": "We also initiated a home care treatment program for patients enrolled in the extension study and, in December 2008, we initiated a nine-month, worldwide, multi-center, open-label, switch-over clinical study evaluating the safety and efficacy of switching Gaucher patients currently treated under the current standard of care to treatment with taliglucerase alfa.", "sentB": "Patients in the extension trial and the switchover trial are still being treated with taliglucerase alfa.", "type": 2, "words": ["<tag1>", "We", "also", "initiated", "a", "home", "care", "treatment", "program", "for", "patients", "enrolled", "in", "the", "extension", "study", "and,", "in", "December", "2008,", "we", "initiated", "a", "nine-month,", "worldwide,", "multi-center,", "open-label,", "switch-over", "clinical", "study", "evaluating", "the", "safety", "and", "efficacy", "of", "switching", "Gaucher", "patients", "currently", "treated", "under", "the", "current", "standard", "of", "care", "to", "treatment", "with", "taliglucerase", "alfa.", "<tag2>", "Patients", "in", "the", "extension", "trial", "and", "the", "switchover", "trial", "are", "still", "being", "treated", "with", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["We", "also", "initiated", "a", "home", "care", "treatment", "program", "for", "patients", "enrolled", "in", "the", "extension", "study", "and,", "in", "December", "2008,", "we", "initiated", "a", "nine-month,", "worldwide,", "multi-center,", "open-label,", "switch-over", "clinical", "study", "evaluating", "the", "safety", "and", "efficacy", "of", "switching", "Gaucher", "patients", "currently", "treated", "under", "the", "current", "standard", "of", "care", "to", "treatment", "with", "taliglucerase", "alfa."], "wordsB": ["Patients", "in", "the", "extension", "trial", "and", "the", "switchover", "trial", "are", "still", "being", "treated", "with", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p14_s0", "idA": "1006281_11_item7_p3_s2", "sentA": "In December 2009, we filed a proposed pediatric investigation plan to the Pediatric Committee of the EMEA which was approved during the first quarter of 2010, and have since initiated pediatric studies.", "sentB": "In December 2009, we filed a proposed pediatric investigation plan to the Pediatric Committee of the EMA, which was approved during the first quarter of 2010.", "type": 2, "words": ["<tag1>", "In", "December", "2009,", "we", "filed", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMEA", "which", "was", "approved", "during", "the", "first", "quarter", "of", "2010,", "and", "have", "since", "initiated", "pediatric", "studies.", "<tag2>", "In", "December", "2009,", "we", "filed", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMA,", "which", "was", "approved", "during", "the", "first", "quarter", "of", "2010.", "<tag3>"], "wordsA": ["In", "December", "2009,", "we", "filed", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMEA", "which", "was", "approved", "during", "the", "first", "quarter", "of", "2010,", "and", "have", "since", "initiated", "pediatric", "studies."], "wordsB": ["In", "December", "2009,", "we", "filed", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMA,", "which", "was", "approved", "during", "the", "first", "quarter", "of", "2010."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p14_s1", "idA": "1006281_11_item7_p3_s2", "sentA": "In December 2009, we filed a proposed pediatric investigation plan to the Pediatric Committee of the EMEA which was approved during the first quarter of 2010, and have since initiated pediatric studies.", "sentB": "We have since initiated the pediatric study, completed enrollment of all the na ve pediatric patients required according to the study protocol and are in the final stages of pediatric patient enrollment.", "type": 2, "words": ["<tag1>", "In", "December", "2009,", "we", "filed", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMEA", "which", "was", "approved", "during", "the", "first", "quarter", "of", "2010,", "and", "have", "since", "initiated", "pediatric", "studies.", "<tag2>", "We", "have", "since", "initiated", "the", "pediatric", "study,", "completed", "enrollment", "of", "all", "the", "na", "ve", "pediatric", "patients", "required", "according", "to", "the", "study", "protocol", "and", "are", "in", "the", "final", "stages", "of", "pediatric", "patient", "enrollment.", "<tag3>"], "wordsA": ["In", "December", "2009,", "we", "filed", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMEA", "which", "was", "approved", "during", "the", "first", "quarter", "of", "2010,", "and", "have", "since", "initiated", "pediatric", "studies."], "wordsB": ["We", "have", "since", "initiated", "the", "pediatric", "study,", "completed", "enrollment", "of", "all", "the", "na", "ve", "pediatric", "patients", "required", "according", "to", "the", "study", "protocol", "and", "are", "in", "the", "final", "stages", "of", "pediatric", "patient", "enrollment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p20_s1", "idA": "1006281_11_item7_p3_s2", "sentA": "In December 2009, we filed a proposed pediatric investigation plan to the Pediatric Committee of the EMEA which was approved during the first quarter of 2010, and have since initiated pediatric studies.", "sentB": "During the first quarter of 2011, we and Pfizer supplied the remaining products deliverable under the short-term supply agreement.", "type": 2, "words": ["<tag1>", "In", "December", "2009,", "we", "filed", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMEA", "which", "was", "approved", "during", "the", "first", "quarter", "of", "2010,", "and", "have", "since", "initiated", "pediatric", "studies.", "<tag2>", "During", "the", "first", "quarter", "of", "2011,", "we", "and", "Pfizer", "supplied", "the", "remaining", "products", "deliverable", "under", "the", "short-term", "supply", "agreement.", "<tag3>"], "wordsA": ["In", "December", "2009,", "we", "filed", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMEA", "which", "was", "approved", "during", "the", "first", "quarter", "of", "2010,", "and", "have", "since", "initiated", "pediatric", "studies."], "wordsB": ["During", "the", "first", "quarter", "of", "2011,", "we", "and", "Pfizer", "supplied", "the", "remaining", "products", "deliverable", "under", "the", "short-term", "supply", "agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p61_s0", "idA": "1006281_11_item7_p40_s0", "sentA": "As we do not have any traded shares or options, the expected volatility figures used in this valuation have been calculated by using the historical volatility of traded shares of similar companies.", "sentB": "As we did not have any traded shares or options for periods before December 31, 2006, the expected volatility figures used in this valuation have been calculated utilizing a blended approach by using the historical volatility of traded shares of similar companies for periods prior to December 31, 2006 and our own traded shares for periods subsequent to December 31, 2006.", "type": 2, "words": ["<tag1>", "As", "we", "do", "not", "have", "any", "traded", "shares", "or", "options,", "the", "expected", "volatility", "figures", "used", "in", "this", "valuation", "have", "been", "calculated", "by", "using", "the", "historical", "volatility", "of", "traded", "shares", "of", "similar", "companies.", "<tag2>", "As", "we", "did", "not", "have", "any", "traded", "shares", "or", "options", "for", "periods", "before", "December", "31,", "2006,", "the", "expected", "volatility", "figures", "used", "in", "this", "valuation", "have", "been", "calculated", "utilizing", "a", "blended", "approach", "by", "using", "the", "historical", "volatility", "of", "traded", "shares", "of", "similar", "companies", "for", "periods", "prior", "to", "December", "31,", "2006", "and", "our", "own", "traded", "shares", "for", "periods", "subsequent", "to", "December", "31,", "2006.", "<tag3>"], "wordsA": ["As", "we", "do", "not", "have", "any", "traded", "shares", "or", "options,", "the", "expected", "volatility", "figures", "used", "in", "this", "valuation", "have", "been", "calculated", "by", "using", "the", "historical", "volatility", "of", "traded", "shares", "of", "similar", "companies."], "wordsB": ["As", "we", "did", "not", "have", "any", "traded", "shares", "or", "options", "for", "periods", "before", "December", "31,", "2006,", "the", "expected", "volatility", "figures", "used", "in", "this", "valuation", "have", "been", "calculated", "utilizing", "a", "blended", "approach", "by", "using", "the", "historical", "volatility", "of", "traded", "shares", "of", "similar", "companies", "for", "periods", "prior", "to", "December", "31,", "2006", "and", "our", "own", "traded", "shares", "for", "periods", "subsequent", "to", "December", "31,", "2006."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p64_s0", "idA": "1006281_11_item7_p44_s0", "sentA": "We recorded revenue of $6.6 million for the year ended December 31, 2010 compared to revenue of $388,000 for the year ended December 31, 2009.", "sentB": "We recorded revenue of $8.4 million for the year ended December 31, 2011, an increase of $1.8 million or 27%, compared to revenue of $6.6 million for the year ended December 31, 2010.", "type": 2, "words": ["<tag1>", "We", "recorded", "revenue", "of", "$6.6", "million", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "revenue", "of", "$388,000", "for", "the", "year", "ended", "December", "31,", "2009.", "<tag2>", "We", "recorded", "revenue", "of", "$8.4", "million", "for", "the", "year", "ended", "December", "31,", "2011,", "an", "increase", "of", "$1.8", "million", "or", "27%,", "compared", "to", "revenue", "of", "$6.6", "million", "for", "the", "year", "ended", "December", "31,", "2010.", "<tag3>"], "wordsA": ["We", "recorded", "revenue", "of", "$6.6", "million", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "revenue", "of", "$388,000", "for", "the", "year", "ended", "December", "31,", "2009."], "wordsB": ["We", "recorded", "revenue", "of", "$8.4", "million", "for", "the", "year", "ended", "December", "31,", "2011,", "an", "increase", "of", "$1.8", "million", "or", "27%,", "compared", "to", "revenue", "of", "$6.6", "million", "for", "the", "year", "ended", "December", "31,", "2010."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p64_s2", "idA": "1006281_11_item7_p44_s1", "sentA": "The increase resulted primarily from the amortization of the $65.0 million of upfront and milestone payments received from Pfizer over the entire fiscal year.", "sentB": "Revenues also include the amortization of the $65 million upfront and milestone payments received from Pfizer.", "type": 2, "words": ["<tag1>", "The", "increase", "resulted", "primarily", "from", "the", "amortization", "of", "the", "$65.0", "million", "of", "upfront", "and", "milestone", "payments", "received", "from", "Pfizer", "over", "the", "entire", "fiscal", "year.", "<tag2>", "Revenues", "also", "include", "the", "amortization", "of", "the", "$65", "million", "upfront", "and", "milestone", "payments", "received", "from", "Pfizer.", "<tag3>"], "wordsA": ["The", "increase", "resulted", "primarily", "from", "the", "amortization", "of", "the", "$65.0", "million", "of", "upfront", "and", "milestone", "payments", "received", "from", "Pfizer", "over", "the", "entire", "fiscal", "year."], "wordsB": ["Revenues", "also", "include", "the", "amortization", "of", "the", "$65", "million", "upfront", "and", "milestone", "payments", "received", "from", "Pfizer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p65_s0", "idA": "1006281_11_item7_p45_s0", "sentA": "We recorded $4.6 million of income as our share in the collaboration under the Pfizer Agreement during the year ended December 31, 2010.", "sentB": "We recorded $5.4 million of loss as our share in the collaboration under the Pfizer Agreement during the year ended December 31, 2011, a decrease of $10.0 million, or 217%, compared to the $4.6 million of income recorded for the year ended December 31, 2010.", "type": 2, "words": ["<tag1>", "We", "recorded", "$4.6", "million", "of", "income", "as", "our", "share", "in", "the", "collaboration", "under", "the", "Pfizer", "Agreement", "during", "the", "year", "ended", "December", "31,", "2010.", "<tag2>", "We", "recorded", "$5.4", "million", "of", "loss", "as", "our", "share", "in", "the", "collaboration", "under", "the", "Pfizer", "Agreement", "during", "the", "year", "ended", "December", "31,", "2011,", "a", "decrease", "of", "$10.0", "million,", "or", "217%,", "compared", "to", "the", "$4.6", "million", "of", "income", "recorded", "for", "the", "year", "ended", "December", "31,", "2010.", "<tag3>"], "wordsA": ["We", "recorded", "$4.6", "million", "of", "income", "as", "our", "share", "in", "the", "collaboration", "under", "the", "Pfizer", "Agreement", "during", "the", "year", "ended", "December", "31,", "2010."], "wordsB": ["We", "recorded", "$5.4", "million", "of", "loss", "as", "our", "share", "in", "the", "collaboration", "under", "the", "Pfizer", "Agreement", "during", "the", "year", "ended", "December", "31,", "2011,", "a", "decrease", "of", "$10.0", "million,", "or", "217%,", "compared", "to", "the", "$4.6", "million", "of", "income", "recorded", "for", "the", "year", "ended", "December", "31,", "2010."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p65_s1", "idA": "1006281_11_item7_p45_s1", "sentA": "This income resulted primarily from our share of the approximately $21.8 million of revenues generated by Pfizer s sale of taliglucerase alfa to the Ministry of Health of Brazil under the short term supply agreement during Pfizer s 2010 fiscal year.", "sentB": "Our share in the collaboration's loss for the year ended December 31, 2011 resulted primarily from our 40% share of the allowance for sales return of taliglucerase alfa recorded by Pfizer in connection with the short term supply agreement between Pfizer and the Ministry of Health of Brazil.", "type": 2, "words": ["<tag1>", "This", "income", "resulted", "primarily", "from", "our", "share", "of", "the", "approximately", "$21.8", "million", "of", "revenues", "generated", "by", "Pfizer", "s", "sale", "of", "taliglucerase", "alfa", "to", "the", "Ministry", "of", "Health", "of", "Brazil", "under", "the", "short", "term", "supply", "agreement", "during", "Pfizer", "s", "2010", "fiscal", "year.", "<tag2>", "Our", "share", "in", "the", "collaboration's", "loss", "for", "the", "year", "ended", "December", "31,", "2011", "resulted", "primarily", "from", "our", "40%", "share", "of", "the", "allowance", "for", "sales", "return", "of", "taliglucerase", "alfa", "recorded", "by", "Pfizer", "in", "connection", "with", "the", "short", "term", "supply", "agreement", "between", "Pfizer", "and", "the", "Ministry", "of", "Health", "of", "Brazil.", "<tag3>"], "wordsA": ["This", "income", "resulted", "primarily", "from", "our", "share", "of", "the", "approximately", "$21.8", "million", "of", "revenues", "generated", "by", "Pfizer", "s", "sale", "of", "taliglucerase", "alfa", "to", "the", "Ministry", "of", "Health", "of", "Brazil", "under", "the", "short", "term", "supply", "agreement", "during", "Pfizer", "s", "2010", "fiscal", "year."], "wordsB": ["Our", "share", "in", "the", "collaboration's", "loss", "for", "the", "year", "ended", "December", "31,", "2011", "resulted", "primarily", "from", "our", "40%", "share", "of", "the", "allowance", "for", "sales", "return", "of", "taliglucerase", "alfa", "recorded", "by", "Pfizer", "in", "connection", "with", "the", "short", "term", "supply", "agreement", "between", "Pfizer", "and", "the", "Ministry", "of", "Health", "of", "Brazil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p67_s0", "idA": "1006281_11_item7_p45_s3", "sentA": "Under the terms and conditions of the Pfizer Agreement, we recorded revenue equal to 40% of the profits realized from sales of taliglucerase alfa, and related expenses incurred based on reports we received from Pfizer summarizing the results of the collaborative activities under the agreement for the applicable period.", "sentB": "Under the terms and conditions of the Pfizer Agreement, we record income or loss equal to 40% of the profit or loss realized from sales of taliglucerase alfa and related expenses incurred based on reports we receive from Pfizer summarizing the results of the collaborative activities under the Pfizer Agreement for the applicable period.", "type": 2, "words": ["<tag1>", "Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement,", "we", "recorded", "revenue", "equal", "to", "40%", "of", "the", "profits", "realized", "from", "sales", "of", "taliglucerase", "alfa,", "and", "related", "expenses", "incurred", "based", "on", "reports", "we", "received", "from", "Pfizer", "summarizing", "the", "results", "of", "the", "collaborative", "activities", "under", "the", "agreement", "for", "the", "applicable", "period.", "<tag2>", "Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement,", "we", "record", "income", "or", "loss", "equal", "to", "40%", "of", "the", "profit", "or", "loss", "realized", "from", "sales", "of", "taliglucerase", "alfa", "and", "related", "expenses", "incurred", "based", "on", "reports", "we", "receive", "from", "Pfizer", "summarizing", "the", "results", "of", "the", "collaborative", "activities", "under", "the", "Pfizer", "Agreement", "for", "the", "applicable", "period.", "<tag3>"], "wordsA": ["Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement,", "we", "recorded", "revenue", "equal", "to", "40%", "of", "the", "profits", "realized", "from", "sales", "of", "taliglucerase", "alfa,", "and", "related", "expenses", "incurred", "based", "on", "reports", "we", "received", "from", "Pfizer", "summarizing", "the", "results", "of", "the", "collaborative", "activities", "under", "the", "agreement", "for", "the", "applicable", "period."], "wordsB": ["Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement,", "we", "record", "income", "or", "loss", "equal", "to", "40%", "of", "the", "profit", "or", "loss", "realized", "from", "sales", "of", "taliglucerase", "alfa", "and", "related", "expenses", "incurred", "based", "on", "reports", "we", "receive", "from", "Pfizer", "summarizing", "the", "results", "of", "the", "collaborative", "activities", "under", "the", "Pfizer", "Agreement", "for", "the", "applicable", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p68_s0", "idA": "1006281_11_item7_p46_s0", "sentA": "Under the terms of the Pfizer Agreement, for its subsidiaries operating outside the United States, financial information is included based on the fiscal year ending November 30, while financial information for the U.S. entity is included based on the fiscal year ending December 31.", "sentB": "Under the terms and conditions of the Pfizer Agreement, financial information of Pfizer s subsidiaries that operate outside the United States is included based on the fiscal year ending November 30, while financial information for the U.S. entity is included based on the fiscal year ending December 31.", "type": 2, "words": ["<tag1>", "Under", "the", "terms", "of", "the", "Pfizer", "Agreement,", "for", "its", "subsidiaries", "operating", "outside", "the", "United", "States,", "financial", "information", "is", "included", "based", "on", "the", "fiscal", "year", "ending", "November", "30,", "while", "financial", "information", "for", "the", "U.S.", "entity", "is", "included", "based", "on", "the", "fiscal", "year", "ending", "December", "31.", "<tag2>", "Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement,", "financial", "information", "of", "Pfizer", "s", "subsidiaries", "that", "operate", "outside", "the", "United", "States", "is", "included", "based", "on", "the", "fiscal", "year", "ending", "November", "30,", "while", "financial", "information", "for", "the", "U.S.", "entity", "is", "included", "based", "on", "the", "fiscal", "year", "ending", "December", "31.", "<tag3>"], "wordsA": ["Under", "the", "terms", "of", "the", "Pfizer", "Agreement,", "for", "its", "subsidiaries", "operating", "outside", "the", "United", "States,", "financial", "information", "is", "included", "based", "on", "the", "fiscal", "year", "ending", "November", "30,", "while", "financial", "information", "for", "the", "U.S.", "entity", "is", "included", "based", "on", "the", "fiscal", "year", "ending", "December", "31."], "wordsB": ["Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement,", "financial", "information", "of", "Pfizer", "s", "subsidiaries", "that", "operate", "outside", "the", "United", "States", "is", "included", "based", "on", "the", "fiscal", "year", "ending", "November", "30,", "while", "financial", "information", "for", "the", "U.S.", "entity", "is", "included", "based", "on", "the", "fiscal", "year", "ending", "December", "31."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p69_s0", "idA": "1006281_11_item7_p47_s0", "sentA": "Research and development expenses were $37.7 million for the year ended December 31, 2010, an increase of $10.3 million, or 38%, from $27.4 million for the year ended December 31, 2009.", "sentB": "Research and development expenses were $37.8 million for the year ended December 31, 2011, an increase of $127,000 from $37.7 million for the year ended December 31, 2010.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expenses", "were", "$37.7", "million", "for", "the", "year", "ended", "December", "31,", "2010,", "an", "increase", "of", "$10.3", "million,", "or", "38%,", "from", "$27.4", "million", "for", "the", "year", "ended", "December", "31,", "2009.", "<tag2>", "Research", "and", "development", "expenses", "were", "$37.8", "million", "for", "the", "year", "ended", "December", "31,", "2011,", "an", "increase", "of", "$127,000", "from", "$37.7", "million", "for", "the", "year", "ended", "December", "31,", "2010.", "<tag3>"], "wordsA": ["Research", "and", "development", "expenses", "were", "$37.7", "million", "for", "the", "year", "ended", "December", "31,", "2010,", "an", "increase", "of", "$10.3", "million,", "or", "38%,", "from", "$27.4", "million", "for", "the", "year", "ended", "December", "31,", "2009."], "wordsB": ["Research", "and", "development", "expenses", "were", "$37.8", "million", "for", "the", "year", "ended", "December", "31,", "2011,", "an", "increase", "of", "$127,000", "from", "$37.7", "million", "for", "the", "year", "ended", "December", "31,", "2010."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p71_s0", "idA": "1006281_11_item7_p49_s0", "sentA": "General and administrative expenses were $6.9 million for the year ended December 31, 2010, a decrease of $268,000, or approximately 4%, from $7.1 million for the year ended December 31, 2009.", "sentB": "General and administrative expenses were $6.9 million for the year ended December 31, 2011, an increase $55,000 from $6.9 million for the year ended December 31, 2010.", "type": 2, "words": ["<tag1>", "General", "and", "administrative", "expenses", "were", "$6.9", "million", "for", "the", "year", "ended", "December", "31,", "2010,", "a", "decrease", "of", "$268,000,", "or", "approximately", "4%,", "from", "$7.1", "million", "for", "the", "year", "ended", "December", "31,", "2009.", "<tag2>", "General", "and", "administrative", "expenses", "were", "$6.9", "million", "for", "the", "year", "ended", "December", "31,", "2011,", "an", "increase", "$55,000", "from", "$6.9", "million", "for", "the", "year", "ended", "December", "31,", "2010.", "<tag3>"], "wordsA": ["General", "and", "administrative", "expenses", "were", "$6.9", "million", "for", "the", "year", "ended", "December", "31,", "2010,", "a", "decrease", "of", "$268,000,", "or", "approximately", "4%,", "from", "$7.1", "million", "for", "the", "year", "ended", "December", "31,", "2009."], "wordsB": ["General", "and", "administrative", "expenses", "were", "$6.9", "million", "for", "the", "year", "ended", "December", "31,", "2011,", "an", "increase", "$55,000", "from", "$6.9", "million", "for", "the", "year", "ended", "December", "31,", "2010."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p15_s0", "idA": "1006281_11_item7_p4_s0", "sentA": "On November 30, 2009, Protalix Ltd. and Pfizer entered into an exclusive license and supply agreement pursuant to which Pfizer was granted an exclusive, worldwide license to develop and commercialize taliglucerase alfa.", "sentB": "On November 30, 2009, Protalix Ltd. and Pfizer entered into the Pfizer Agreement pursuant to which Pfizer was granted an exclusive, worldwide license to develop and commercialize taliglucerase alfa.", "type": 2, "words": ["<tag1>", "On", "November", "30,", "2009,", "Protalix", "Ltd.", "and", "Pfizer", "entered", "into", "an", "exclusive", "license", "and", "supply", "agreement", "pursuant", "to", "which", "Pfizer", "was", "granted", "an", "exclusive,", "worldwide", "license", "to", "develop", "and", "commercialize", "taliglucerase", "alfa.", "<tag2>", "On", "November", "30,", "2009,", "Protalix", "Ltd.", "and", "Pfizer", "entered", "into", "the", "Pfizer", "Agreement", "pursuant", "to", "which", "Pfizer", "was", "granted", "an", "exclusive,", "worldwide", "license", "to", "develop", "and", "commercialize", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["On", "November", "30,", "2009,", "Protalix", "Ltd.", "and", "Pfizer", "entered", "into", "an", "exclusive", "license", "and", "supply", "agreement", "pursuant", "to", "which", "Pfizer", "was", "granted", "an", "exclusive,", "worldwide", "license", "to", "develop", "and", "commercialize", "taliglucerase", "alfa."], "wordsB": ["On", "November", "30,", "2009,", "Protalix", "Ltd.", "and", "Pfizer", "entered", "into", "the", "Pfizer", "Agreement", "pursuant", "to", "which", "Pfizer", "was", "granted", "an", "exclusive,", "worldwide", "license", "to", "develop", "and", "commercialize", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p13_s2", "idA": "1006281_11_item7_p4_s1", "sentA": "Under the terms and conditions of the Pfizer agreement, Protalix Ltd. retained the right to commercialize taliglucerase alfa in Israel.", "sentB": "The safety analysis of the switchover trial demonstrated that taliglucerase alfa was well tolerated, and no drug related serious adverse events were reported.", "type": 2, "words": ["<tag1>", "Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "agreement,", "Protalix", "Ltd.", "retained", "the", "right", "to", "commercialize", "taliglucerase", "alfa", "in", "Israel.", "<tag2>", "The", "safety", "analysis", "of", "the", "switchover", "trial", "demonstrated", "that", "taliglucerase", "alfa", "was", "well", "tolerated,", "and", "no", "drug", "related", "serious", "adverse", "events", "were", "reported.", "<tag3>"], "wordsA": ["Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "agreement,", "Protalix", "Ltd.", "retained", "the", "right", "to", "commercialize", "taliglucerase", "alfa", "in", "Israel."], "wordsB": ["The", "safety", "analysis", "of", "the", "switchover", "trial", "demonstrated", "that", "taliglucerase", "alfa", "was", "well", "tolerated,", "and", "no", "drug", "related", "serious", "adverse", "events", "were", "reported."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p29_s0", "idA": "1006281_11_item7_p4_s1", "sentA": "Under the terms and conditions of the Pfizer agreement, Protalix Ltd. retained the right to commercialize taliglucerase alfa in Israel.", "sentB": "Except for the rights to commercialize taliglucerase alfa worldwide (other than Israel) which we licensed to Pfizer, we hold the worldwide commercialization rights to our proprietary development candidates, and we intend to establish an internal, commercial infrastructure and targeted sales force to market taliglucerase alfa in Israel and our other products, if approved, in North America, the European Union and in other significant markets, including Israel.", "type": 2, "words": ["<tag1>", "Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "agreement,", "Protalix", "Ltd.", "retained", "the", "right", "to", "commercialize", "taliglucerase", "alfa", "in", "Israel.", "<tag2>", "Except", "for", "the", "rights", "to", "commercialize", "taliglucerase", "alfa", "worldwide", "(other", "than", "Israel)", "which", "we", "licensed", "to", "Pfizer,", "we", "hold", "the", "worldwide", "commercialization", "rights", "to", "our", "proprietary", "development", "candidates,", "and", "we", "intend", "to", "establish", "an", "internal,", "commercial", "infrastructure", "and", "targeted", "sales", "force", "to", "market", "taliglucerase", "alfa", "in", "Israel", "and", "our", "other", "products,", "if", "approved,", "in", "North", "America,", "the", "European", "Union", "and", "in", "other", "significant", "markets,", "including", "Israel.", "<tag3>"], "wordsA": ["Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "agreement,", "Protalix", "Ltd.", "retained", "the", "right", "to", "commercialize", "taliglucerase", "alfa", "in", "Israel."], "wordsB": ["Except", "for", "the", "rights", "to", "commercialize", "taliglucerase", "alfa", "worldwide", "(other", "than", "Israel)", "which", "we", "licensed", "to", "Pfizer,", "we", "hold", "the", "worldwide", "commercialization", "rights", "to", "our", "proprietary", "development", "candidates,", "and", "we", "intend", "to", "establish", "an", "internal,", "commercial", "infrastructure", "and", "targeted", "sales", "force", "to", "market", "taliglucerase", "alfa", "in", "Israel", "and", "our", "other", "products,", "if", "approved,", "in", "North", "America,", "the", "European", "Union", "and", "in", "other", "significant", "markets,", "including", "Israel."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p39_s1", "idA": "1006281_11_item7_p4_s1", "sentA": "Under the terms and conditions of the Pfizer agreement, Protalix Ltd. retained the right to commercialize taliglucerase alfa in Israel.", "sentB": "We retained all rights to taliglucerase alfa in Israel.", "type": 2, "words": ["<tag1>", "Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "agreement,", "Protalix", "Ltd.", "retained", "the", "right", "to", "commercialize", "taliglucerase", "alfa", "in", "Israel.", "<tag2>", "We", "retained", "all", "rights", "to", "taliglucerase", "alfa", "in", "Israel.", "<tag3>"], "wordsA": ["Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "agreement,", "Protalix", "Ltd.", "retained", "the", "right", "to", "commercialize", "taliglucerase", "alfa", "in", "Israel."], "wordsB": ["We", "retained", "all", "rights", "to", "taliglucerase", "alfa", "in", "Israel."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p15_s2", "idA": "1006281_11_item7_p4_s2", "sentA": "In connection with the execution of the Pfizer agreement, Pfizer made an upfront payment to Protalix Ltd. of $60.0 million in connection with the execution of the agreement and subsequently paid Protalix Ltd. an additional $5.0 million upon its filing of a proposed pediatric investigation plan to the Pediatric Committee of the EMEA.", "sentB": "In connection with the execution of the Pfizer Agreement, Pfizer made an upfront payment to Protalix Ltd. of $60.0 million in connection with the execution of the agreement and subsequently paid Protalix Ltd. an additional $5.0 million upon its filing of a proposed pediatric investigation plan to the Pediatric Committee of the EMA.", "type": 2, "words": ["<tag1>", "In", "connection", "with", "the", "execution", "of", "the", "Pfizer", "agreement,", "Pfizer", "made", "an", "upfront", "payment", "to", "Protalix", "Ltd.", "of", "$60.0", "million", "in", "connection", "with", "the", "execution", "of", "the", "agreement", "and", "subsequently", "paid", "Protalix", "Ltd.", "an", "additional", "$5.0", "million", "upon", "its", "filing", "of", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMEA.", "<tag2>", "In", "connection", "with", "the", "execution", "of", "the", "Pfizer", "Agreement,", "Pfizer", "made", "an", "upfront", "payment", "to", "Protalix", "Ltd.", "of", "$60.0", "million", "in", "connection", "with", "the", "execution", "of", "the", "agreement", "and", "subsequently", "paid", "Protalix", "Ltd.", "an", "additional", "$5.0", "million", "upon", "its", "filing", "of", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMA.", "<tag3>"], "wordsA": ["In", "connection", "with", "the", "execution", "of", "the", "Pfizer", "agreement,", "Pfizer", "made", "an", "upfront", "payment", "to", "Protalix", "Ltd.", "of", "$60.0", "million", "in", "connection", "with", "the", "execution", "of", "the", "agreement", "and", "subsequently", "paid", "Protalix", "Ltd.", "an", "additional", "$5.0", "million", "upon", "its", "filing", "of", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMEA."], "wordsB": ["In", "connection", "with", "the", "execution", "of", "the", "Pfizer", "Agreement,", "Pfizer", "made", "an", "upfront", "payment", "to", "Protalix", "Ltd.", "of", "$60.0", "million", "in", "connection", "with", "the", "execution", "of", "the", "agreement", "and", "subsequently", "paid", "Protalix", "Ltd.", "an", "additional", "$5.0", "million", "upon", "its", "filing", "of", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p15_s4", "idA": "1006281_11_item7_p4_s4", "sentA": "Pfizer and Protalix Ltd. will also share future revenues and expenses for the development and commercialization of taliglucerase alfa on a 60% and 40% basis, respectively, and have also agreed to a specific allocation of the responsibilities for the continued development efforts for taliglucerase alfa.", "sentB": "According to the agreement, Pfizer and Protalix Ltd. are required to share future revenues and expenses for the development and commercialization of taliglucerase alfa on a 60% and 40% basis, respectively, and have agreed to a specific allocation of the responsibilities for the continued development efforts for taliglucerase alfa.", "type": 2, "words": ["<tag1>", "Pfizer", "and", "Protalix", "Ltd.", "will", "also", "share", "future", "revenues", "and", "expenses", "for", "the", "development", "and", "commercialization", "of", "taliglucerase", "alfa", "on", "a", "60%", "and", "40%", "basis,", "respectively,", "and", "have", "also", "agreed", "to", "a", "specific", "allocation", "of", "the", "responsibilities", "for", "the", "continued", "development", "efforts", "for", "taliglucerase", "alfa.", "<tag2>", "According", "to", "the", "agreement,", "Pfizer", "and", "Protalix", "Ltd.", "are", "required", "to", "share", "future", "revenues", "and", "expenses", "for", "the", "development", "and", "commercialization", "of", "taliglucerase", "alfa", "on", "a", "60%", "and", "40%", "basis,", "respectively,", "and", "have", "agreed", "to", "a", "specific", "allocation", "of", "the", "responsibilities", "for", "the", "continued", "development", "efforts", "for", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["Pfizer", "and", "Protalix", "Ltd.", "will", "also", "share", "future", "revenues", "and", "expenses", "for", "the", "development", "and", "commercialization", "of", "taliglucerase", "alfa", "on", "a", "60%", "and", "40%", "basis,", "respectively,", "and", "have", "also", "agreed", "to", "a", "specific", "allocation", "of", "the", "responsibilities", "for", "the", "continued", "development", "efforts", "for", "taliglucerase", "alfa."], "wordsB": ["According", "to", "the", "agreement,", "Pfizer", "and", "Protalix", "Ltd.", "are", "required", "to", "share", "future", "revenues", "and", "expenses", "for", "the", "development", "and", "commercialization", "of", "taliglucerase", "alfa", "on", "a", "60%", "and", "40%", "basis,", "respectively,", "and", "have", "agreed", "to", "a", "specific", "allocation", "of", "the", "responsibilities", "for", "the", "continued", "development", "efforts", "for", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p77_s1", "idA": "1006281_11_item7_p50_s0", "sentA": "resulted primarily from a $389,000 decrease in salaries expense during 2010.", "sentB": "The decrease resulted primarily from a $389,000 decrease in salaries expense during 2010.", "type": 2, "words": ["<tag1>", "resulted", "primarily", "from", "a", "$389,000", "decrease", "in", "salaries", "expense", "during", "2010.", "<tag2>", "The", "decrease", "resulted", "primarily", "from", "a", "$389,000", "decrease", "in", "salaries", "expense", "during", "2010.", "<tag3>"], "wordsA": ["resulted", "primarily", "from", "a", "$389,000", "decrease", "in", "salaries", "expense", "during", "2010."], "wordsB": ["The", "decrease", "resulted", "primarily", "from", "a", "$389,000", "decrease", "in", "salaries", "expense", "during", "2010."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p71_s1", "idA": "1006281_11_item7_p50_s1", "sentA": "We expect that our general and administrative expenses will increase as we add additional personnel and continue to comply with the reporting and other obligations applicable to public companies in the United States.", "sentB": "We expect that our general and administrative expenses will increase as we become a commercial company.", "type": 2, "words": ["<tag1>", "We", "expect", "that", "our", "general", "and", "administrative", "expenses", "will", "increase", "as", "we", "add", "additional", "personnel", "and", "continue", "to", "comply", "with", "the", "reporting", "and", "other", "obligations", "applicable", "to", "public", "companies", "in", "the", "United", "States.", "<tag2>", "We", "expect", "that", "our", "general", "and", "administrative", "expenses", "will", "increase", "as", "we", "become", "a", "commercial", "company.", "<tag3>"], "wordsA": ["We", "expect", "that", "our", "general", "and", "administrative", "expenses", "will", "increase", "as", "we", "add", "additional", "personnel", "and", "continue", "to", "comply", "with", "the", "reporting", "and", "other", "obligations", "applicable", "to", "public", "companies", "in", "the", "United", "States."], "wordsB": ["We", "expect", "that", "our", "general", "and", "administrative", "expenses", "will", "increase", "as", "we", "become", "a", "commercial", "company."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p64_s1", "idA": "1006281_11_item7_p51_s1", "sentA": "The increase resulted primarily from increases in the exchange rate that resulted in income of approximately $546,000.", "sentB": "The increase resulted primarily from increases in the supply of taliglucerase alfa vials to Pfizer during the year ended December 31, 2011.", "type": 2, "words": ["<tag1>", "The", "increase", "resulted", "primarily", "from", "increases", "in", "the", "exchange", "rate", "that", "resulted", "in", "income", "of", "approximately", "$546,000.", "<tag2>", "The", "increase", "resulted", "primarily", "from", "increases", "in", "the", "supply", "of", "taliglucerase", "alfa", "vials", "to", "Pfizer", "during", "the", "year", "ended", "December", "31,", "2011.", "<tag3>"], "wordsA": ["The", "increase", "resulted", "primarily", "from", "increases", "in", "the", "exchange", "rate", "that", "resulted", "in", "income", "of", "approximately", "$546,000."], "wordsB": ["The", "increase", "resulted", "primarily", "from", "increases", "in", "the", "supply", "of", "taliglucerase", "alfa", "vials", "to", "Pfizer", "during", "the", "year", "ended", "December", "31,", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p10_s0", "idA": "1006281_11_item7_p52_s1", "sentA": "The revenue represents the pro rata amortization of the $60.0 million upfront payment and $5.0 million milestone payment we received in connection with our license and supply agreement with Pfizer.", "sentB": "On February 20, 2011, we received a letter from the FDA notifying us that the FDA had completed its review of the Establishment Inspection Report in connection with the FDA s inspection of our facility, and that the FDA had classified our facility as acceptable.", "type": 2, "words": ["<tag1>", "The", "revenue", "represents", "the", "pro", "rata", "amortization", "of", "the", "$60.0", "million", "upfront", "payment", "and", "$5.0", "million", "milestone", "payment", "we", "received", "in", "connection", "with", "our", "license", "and", "supply", "agreement", "with", "Pfizer.", "<tag2>", "On", "February", "20,", "2011,", "we", "received", "a", "letter", "from", "the", "FDA", "notifying", "us", "that", "the", "FDA", "had", "completed", "its", "review", "of", "the", "Establishment", "Inspection", "Report", "in", "connection", "with", "the", "FDA", "s", "inspection", "of", "our", "facility,", "and", "that", "the", "FDA", "had", "classified", "our", "facility", "as", "acceptable.", "<tag3>"], "wordsA": ["The", "revenue", "represents", "the", "pro", "rata", "amortization", "of", "the", "$60.0", "million", "upfront", "payment", "and", "$5.0", "million", "milestone", "payment", "we", "received", "in", "connection", "with", "our", "license", "and", "supply", "agreement", "with", "Pfizer."], "wordsB": ["On", "February", "20,", "2011,", "we", "received", "a", "letter", "from", "the", "FDA", "notifying", "us", "that", "the", "FDA", "had", "completed", "its", "review", "of", "the", "Establishment", "Inspection", "Report", "in", "connection", "with", "the", "FDA", "s", "inspection", "of", "our", "facility,", "and", "that", "the", "FDA", "had", "classified", "our", "facility", "as", "acceptable."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p37_s0", "idA": "1006281_11_item7_p52_s1", "sentA": "The revenue represents the pro rata amortization of the $60.0 million upfront payment and $5.0 million milestone payment we received in connection with our license and supply agreement with Pfizer.", "sentB": "Currently, our sole source of revenues comes from sales of taliglucerase alfa pursuant to our license agreement with Pfizer.", "type": 2, "words": ["<tag1>", "The", "revenue", "represents", "the", "pro", "rata", "amortization", "of", "the", "$60.0", "million", "upfront", "payment", "and", "$5.0", "million", "milestone", "payment", "we", "received", "in", "connection", "with", "our", "license", "and", "supply", "agreement", "with", "Pfizer.", "<tag2>", "Currently,", "our", "sole", "source", "of", "revenues", "comes", "from", "sales", "of", "taliglucerase", "alfa", "pursuant", "to", "our", "license", "agreement", "with", "Pfizer.", "<tag3>"], "wordsA": ["The", "revenue", "represents", "the", "pro", "rata", "amortization", "of", "the", "$60.0", "million", "upfront", "payment", "and", "$5.0", "million", "milestone", "payment", "we", "received", "in", "connection", "with", "our", "license", "and", "supply", "agreement", "with", "Pfizer."], "wordsB": ["Currently,", "our", "sole", "source", "of", "revenues", "comes", "from", "sales", "of", "taliglucerase", "alfa", "pursuant", "to", "our", "license", "agreement", "with", "Pfizer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p72_s1", "idA": "1006281_11_item7_p52_s3", "sentA": "No revenues were recorded during the year ended December 31, 2008.", "sentB": "The decrease resulted primarily from the devaluation of the New Israeli Shekel against the U.S. dollar and lower interest rates available for short term deposits during the year ended December 31, 2011.", "type": 2, "words": ["<tag1>", "No", "revenues", "were", "recorded", "during", "the", "year", "ended", "December", "31,", "2008.", "<tag2>", "The", "decrease", "resulted", "primarily", "from", "the", "devaluation", "of", "the", "New", "Israeli", "Shekel", "against", "the", "U.S.", "dollar", "and", "lower", "interest", "rates", "available", "for", "short", "term", "deposits", "during", "the", "year", "ended", "December", "31,", "2011.", "<tag3>"], "wordsA": ["No", "revenues", "were", "recorded", "during", "the", "year", "ended", "December", "31,", "2008."], "wordsB": ["The", "decrease", "resulted", "primarily", "from", "the", "devaluation", "of", "the", "New", "Israeli", "Shekel", "against", "the", "U.S.", "dollar", "and", "lower", "interest", "rates", "available", "for", "short", "term", "deposits", "during", "the", "year", "ended", "December", "31,", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p70_s0", "idA": "1006281_11_item7_p54_s0", "sentA": "We expect research and development expenses to continue to be our primary expense as we enter into a more advanced stage of preclinical trials for certain of our product candidates and into additional clinical trials for PRX-105.", "sentB": "We expect research and development expenses to continue to be our primary expense as we enter into a more advanced stage of preclinical and clinical trials for certain of our product candidates .", "type": 2, "words": ["<tag1>", "We", "expect", "research", "and", "development", "expenses", "to", "continue", "to", "be", "our", "primary", "expense", "as", "we", "enter", "into", "a", "more", "advanced", "stage", "of", "preclinical", "trials", "for", "certain", "of", "our", "product", "candidates", "and", "into", "additional", "clinical", "trials", "for", "PRX-105.", "<tag2>", "We", "expect", "research", "and", "development", "expenses", "to", "continue", "to", "be", "our", "primary", "expense", "as", "we", "enter", "into", "a", "more", "advanced", "stage", "of", "preclinical", "and", "clinical", "trials", "for", "certain", "of", "our", "product", "candidates", ".", "<tag3>"], "wordsA": ["We", "expect", "research", "and", "development", "expenses", "to", "continue", "to", "be", "our", "primary", "expense", "as", "we", "enter", "into", "a", "more", "advanced", "stage", "of", "preclinical", "trials", "for", "certain", "of", "our", "product", "candidates", "and", "into", "additional", "clinical", "trials", "for", "PRX-105."], "wordsB": ["We", "expect", "research", "and", "development", "expenses", "to", "continue", "to", "be", "our", "primary", "expense", "as", "we", "enter", "into", "a", "more", "advanced", "stage", "of", "preclinical", "and", "clinical", "trials", "for", "certain", "of", "our", "product", "candidates", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p79_s1", "idA": "1006281_11_item7_p58_s0", "sentA": "ordinary shares of Protalix Ltd., and an additional $14.1 million in connection with the exercise of warrants issued in connection with the sale of such ordinary shares, through December 31, 2008.", "sentB": "To date, we have funded our operations primarily with proceeds equal to $31.3 million from the sale of convertible preferred and ordinary shares of Protalix Ltd., and an additional $14.1 million in connection with the exercise of warrants issued in connection with the sale of such shares, through December 31, 2008.", "type": 2, "words": ["<tag1>", "ordinary", "shares", "of", "Protalix", "Ltd.,", "and", "an", "additional", "$14.1", "million", "in", "connection", "with", "the", "exercise", "of", "warrants", "issued", "in", "connection", "with", "the", "sale", "of", "such", "ordinary", "shares,", "through", "December", "31,", "2008.", "<tag2>", "To", "date,", "we", "have", "funded", "our", "operations", "primarily", "with", "proceeds", "equal", "to", "$31.3", "million", "from", "the", "sale", "of", "convertible", "preferred", "and", "ordinary", "shares", "of", "Protalix", "Ltd.,", "and", "an", "additional", "$14.1", "million", "in", "connection", "with", "the", "exercise", "of", "warrants", "issued", "in", "connection", "with", "the", "sale", "of", "such", "shares,", "through", "December", "31,", "2008.", "<tag3>"], "wordsA": ["ordinary", "shares", "of", "Protalix", "Ltd.,", "and", "an", "additional", "$14.1", "million", "in", "connection", "with", "the", "exercise", "of", "warrants", "issued", "in", "connection", "with", "the", "sale", "of", "such", "ordinary", "shares,", "through", "December", "31,", "2008."], "wordsB": ["To", "date,", "we", "have", "funded", "our", "operations", "primarily", "with", "proceeds", "equal", "to", "$31.3", "million", "from", "the", "sale", "of", "convertible", "preferred", "and", "ordinary", "shares", "of", "Protalix", "Ltd.,", "and", "an", "additional", "$14.1", "million", "in", "connection", "with", "the", "exercise", "of", "warrants", "issued", "in", "connection", "with", "the", "sale", "of", "such", "shares,", "through", "December", "31,", "2008."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p79_s2", "idA": "1006281_11_item7_p58_s1", "sentA": "In addition, on October 25, 2007, we generated gross proceeds of $50 million in connection with an underwritten public offering of our common stock.", "sentB": "In addition, on October 25, 2007, we generated gross proceeds of $50 million in connection with an underwritten public offering of our common stock and on each of March 23, 2011 and February 22, 2012, we generated gross proceeds of $22.0 million and $27.2 million, respectively, in connection with underwritten public offerings of our common stock.", "type": 2, "words": ["<tag1>", "In", "addition,", "on", "October", "25,", "2007,", "we", "generated", "gross", "proceeds", "of", "$50", "million", "in", "connection", "with", "an", "underwritten", "public", "offering", "of", "our", "common", "stock.", "<tag2>", "In", "addition,", "on", "October", "25,", "2007,", "we", "generated", "gross", "proceeds", "of", "$50", "million", "in", "connection", "with", "an", "underwritten", "public", "offering", "of", "our", "common", "stock", "and", "on", "each", "of", "March", "23,", "2011", "and", "February", "22,", "2012,", "we", "generated", "gross", "proceeds", "of", "$22.0", "million", "and", "$27.2", "million,", "respectively,", "in", "connection", "with", "underwritten", "public", "offerings", "of", "our", "common", "stock.", "<tag3>"], "wordsA": ["In", "addition,", "on", "October", "25,", "2007,", "we", "generated", "gross", "proceeds", "of", "$50", "million", "in", "connection", "with", "an", "underwritten", "public", "offering", "of", "our", "common", "stock."], "wordsB": ["In", "addition,", "on", "October", "25,", "2007,", "we", "generated", "gross", "proceeds", "of", "$50", "million", "in", "connection", "with", "an", "underwritten", "public", "offering", "of", "our", "common", "stock", "and", "on", "each", "of", "March", "23,", "2011", "and", "February", "22,", "2012,", "we", "generated", "gross", "proceeds", "of", "$22.0", "million", "and", "$27.2", "million,", "respectively,", "in", "connection", "with", "underwritten", "public", "offerings", "of", "our", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p86_s1", "idA": "1006281_11_item7_p58_s2", "sentA": "Furthermore, on November 30, 2009, we entered into an exclusive license and supply agreement with Pfizer, pursuant to which Pfizer made an upfront payment to Protalix Ltd. of $60.0 million in connection with the execution of the agreement and subsequently paid to Protalix Ltd. an additional $5.0 million upon meeting a certain milestone.", "sentB": "$60.0 million as an upfront payment in connection with the execution of the Pfizer Agreement and subsequently paid to Protalix Ltd. an additional $5.0 million upon Protalix Ltd.'s meeting a certain milestone.", "type": 2, "words": ["<tag1>", "Furthermore,", "on", "November", "30,", "2009,", "we", "entered", "into", "an", "exclusive", "license", "and", "supply", "agreement", "with", "Pfizer,", "pursuant", "to", "which", "Pfizer", "made", "an", "upfront", "payment", "to", "Protalix", "Ltd.", "of", "$60.0", "million", "in", "connection", "with", "the", "execution", "of", "the", "agreement", "and", "subsequently", "paid", "to", "Protalix", "Ltd.", "an", "additional", "$5.0", "million", "upon", "meeting", "a", "certain", "milestone.", "<tag2>", "$60.0", "million", "as", "an", "upfront", "payment", "in", "connection", "with", "the", "execution", "of", "the", "Pfizer", "Agreement", "and", "subsequently", "paid", "to", "Protalix", "Ltd.", "an", "additional", "$5.0", "million", "upon", "Protalix", "Ltd.'s", "meeting", "a", "certain", "milestone.", "<tag3>"], "wordsA": ["Furthermore,", "on", "November", "30,", "2009,", "we", "entered", "into", "an", "exclusive", "license", "and", "supply", "agreement", "with", "Pfizer,", "pursuant", "to", "which", "Pfizer", "made", "an", "upfront", "payment", "to", "Protalix", "Ltd.", "of", "$60.0", "million", "in", "connection", "with", "the", "execution", "of", "the", "agreement", "and", "subsequently", "paid", "to", "Protalix", "Ltd.", "an", "additional", "$5.0", "million", "upon", "meeting", "a", "certain", "milestone."], "wordsB": ["$60.0", "million", "as", "an", "upfront", "payment", "in", "connection", "with", "the", "execution", "of", "the", "Pfizer", "Agreement", "and", "subsequently", "paid", "to", "Protalix", "Ltd.", "an", "additional", "$5.0", "million", "upon", "Protalix", "Ltd.'s", "meeting", "a", "certain", "milestone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p86_s3", "idA": "1006281_11_item7_p58_s4", "sentA": "We are also entitled to payments equal to 40% of the net profits earned by Pfizer on its sales of taliglucerase alfa, if any.", "sentB": "Protalix Ltd. is also entitled to payments equal to 40% of the net profits earned by Pfizer on its sales of taliglucerase alfa.", "type": 2, "words": ["<tag1>", "We", "are", "also", "entitled", "to", "payments", "equal", "to", "40%", "of", "the", "net", "profits", "earned", "by", "Pfizer", "on", "its", "sales", "of", "taliglucerase", "alfa,", "if", "any.", "<tag2>", "Protalix", "Ltd.", "is", "also", "entitled", "to", "payments", "equal", "to", "40%", "of", "the", "net", "profits", "earned", "by", "Pfizer", "on", "its", "sales", "of", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["We", "are", "also", "entitled", "to", "payments", "equal", "to", "40%", "of", "the", "net", "profits", "earned", "by", "Pfizer", "on", "its", "sales", "of", "taliglucerase", "alfa,", "if", "any."], "wordsB": ["Protalix", "Ltd.", "is", "also", "entitled", "to", "payments", "equal", "to", "40%", "of", "the", "net", "profits", "earned", "by", "Pfizer", "on", "its", "sales", "of", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p87_s0", "idA": "1006281_11_item7_p59_s0", "sentA": "In calculating net profits there are certain agreed upon limits on the amounts that may be deducted from gross sales for certain expenses and costs of goods sold.", "sentB": "In calculat ing net profits there are certain agreed upon limits on the amounts that may be deducted from gross sales for certain expenses and costs of goods sold.", "type": 2, "words": ["<tag1>", "In", "calculating", "net", "profits", "there", "are", "certain", "agreed", "upon", "limits", "on", "the", "amounts", "that", "may", "be", "deducted", "from", "gross", "sales", "for", "certain", "expenses", "and", "costs", "of", "goods", "sold.", "<tag2>", "In", "calculat", "ing", "net", "profits", "there", "are", "certain", "agreed", "upon", "limits", "on", "the", "amounts", "that", "may", "be", "deducted", "from", "gross", "sales", "for", "certain", "expenses", "and", "costs", "of", "goods", "sold.", "<tag3>"], "wordsA": ["In", "calculating", "net", "profits", "there", "are", "certain", "agreed", "upon", "limits", "on", "the", "amounts", "that", "may", "be", "deducted", "from", "gross", "sales", "for", "certain", "expenses", "and", "costs", "of", "goods", "sold."], "wordsB": ["In", "calculat", "ing", "net", "profits", "there", "are", "certain", "agreed", "upon", "limits", "on", "the", "amounts", "that", "may", "be", "deducted", "from", "gross", "sales", "for", "certain", "expenses", "and", "costs", "of", "goods", "sold."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p10_s2", "idA": "1006281_11_item7_p5_s1", "sentA": "This ATU allows patients with Gaucher disease in France to receive treatment with taliglucerase alfa before marketing authorization for the product is granted in the European Union.", "sentB": "The IMB certificate is accepted by all health authorities in the European Union under the European Union's centralized marketing authorization procedure, and by authorities of several other countries that recognize EU certification.", "type": 2, "words": ["<tag1>", "This", "ATU", "allows", "patients", "with", "Gaucher", "disease", "in", "France", "to", "receive", "treatment", "with", "taliglucerase", "alfa", "before", "marketing", "authorization", "for", "the", "product", "is", "granted", "in", "the", "European", "Union.", "<tag2>", "The", "IMB", "certificate", "is", "accepted", "by", "all", "health", "authorities", "in", "the", "European", "Union", "under", "the", "European", "Union's", "centralized", "marketing", "authorization", "procedure,", "and", "by", "authorities", "of", "several", "other", "countries", "that", "recognize", "EU", "certification.", "<tag3>"], "wordsA": ["This", "ATU", "allows", "patients", "with", "Gaucher", "disease", "in", "France", "to", "receive", "treatment", "with", "taliglucerase", "alfa", "before", "marketing", "authorization", "for", "the", "product", "is", "granted", "in", "the", "European", "Union."], "wordsB": ["The", "IMB", "certificate", "is", "accepted", "by", "all", "health", "authorities", "in", "the", "European", "Union", "under", "the", "European", "Union's", "centralized", "marketing", "authorization", "procedure,", "and", "by", "authorities", "of", "several", "other", "countries", "that", "recognize", "EU", "certification."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p19_s2", "idA": "1006281_11_item7_p5_s1", "sentA": "This ATU allows patients with Gaucher disease in France to receive treatment with taliglucerase alfa before marketing authorization for the product is granted in the European Union.", "sentB": "Hundreds of patients, in the aggregate, have been treated with taliglucerase alfa.", "type": 2, "words": ["<tag1>", "This", "ATU", "allows", "patients", "with", "Gaucher", "disease", "in", "France", "to", "receive", "treatment", "with", "taliglucerase", "alfa", "before", "marketing", "authorization", "for", "the", "product", "is", "granted", "in", "the", "European", "Union.", "<tag2>", "Hundreds", "of", "patients,", "in", "the", "aggregate,", "have", "been", "treated", "with", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["This", "ATU", "allows", "patients", "with", "Gaucher", "disease", "in", "France", "to", "receive", "treatment", "with", "taliglucerase", "alfa", "before", "marketing", "authorization", "for", "the", "product", "is", "granted", "in", "the", "European", "Union."], "wordsB": ["Hundreds", "of", "patients,", "in", "the", "aggregate,", "have", "been", "treated", "with", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p5_s1", "idA": "1006281_11_item7_p5_s1", "sentA": "This ATU allows patients with Gaucher disease in France to receive treatment with taliglucerase alfa before marketing authorization for the product is granted in the European Union.", "sentB": "Among the topics currently in discussion, is the orphan drug designation and exclusivity granted by the EMA/European Commission to VPRIV, which could prevent the marketing authorization of taliglucerase alfa in the European Union for a 10-year market exclusivity period commencing as of the August 2010 marketing authorization of VPRIV in the European Union.", "type": 2, "words": ["<tag1>", "This", "ATU", "allows", "patients", "with", "Gaucher", "disease", "in", "France", "to", "receive", "treatment", "with", "taliglucerase", "alfa", "before", "marketing", "authorization", "for", "the", "product", "is", "granted", "in", "the", "European", "Union.", "<tag2>", "Among", "the", "topics", "currently", "in", "discussion,", "is", "the", "orphan", "drug", "designation", "and", "exclusivity", "granted", "by", "the", "EMA/European", "Commission", "to", "VPRIV,", "which", "could", "prevent", "the", "marketing", "authorization", "of", "taliglucerase", "alfa", "in", "the", "European", "Union", "for", "a", "10-year", "market", "exclusivity", "period", "commencing", "as", "of", "the", "August", "2010", "marketing", "authorization", "of", "VPRIV", "in", "the", "European", "Union.", "<tag3>"], "wordsA": ["This", "ATU", "allows", "patients", "with", "Gaucher", "disease", "in", "France", "to", "receive", "treatment", "with", "taliglucerase", "alfa", "before", "marketing", "authorization", "for", "the", "product", "is", "granted", "in", "the", "European", "Union."], "wordsB": ["Among", "the", "topics", "currently", "in", "discussion,", "is", "the", "orphan", "drug", "designation", "and", "exclusivity", "granted", "by", "the", "EMA/European", "Commission", "to", "VPRIV,", "which", "could", "prevent", "the", "marketing", "authorization", "of", "taliglucerase", "alfa", "in", "the", "European", "Union", "for", "a", "10-year", "market", "exclusivity", "period", "commencing", "as", "of", "the", "August", "2010", "marketing", "authorization", "of", "VPRIV", "in", "the", "European", "Union."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p81_s0", "idA": "1006281_11_item7_p62_s0", "sentA": "Gross proceeds; does not include proceeds from warrant exercises.", "sentB": "(1) Gross proceeds; does not include proceeds from warrant exercises.", "type": 2, "words": ["<tag1>", "Gross", "proceeds;", "does", "not", "include", "proceeds", "from", "warrant", "exercises.", "<tag2>", "(1)", "Gross", "proceeds;", "does", "not", "include", "proceeds", "from", "warrant", "exercises.", "<tag3>"], "wordsA": ["Gross", "proceeds;", "does", "not", "include", "proceeds", "from", "warrant", "exercises."], "wordsB": ["(1)", "Gross", "proceeds;", "does", "not", "include", "proceeds", "from", "warrant", "exercises."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p82_s0", "idA": "1006281_11_item7_p63_s0", "sentA": "Includes the issuance of ordinary shares to founders.", "sentB": "(2) Includes the issuance of ordinary shares to founders.", "type": 2, "words": ["<tag1>", "Includes", "the", "issuance", "of", "ordinary", "shares", "to", "founders.", "<tag2>", "(2)", "Includes", "the", "issuance", "of", "ordinary", "shares", "to", "founders.", "<tag3>"], "wordsA": ["Includes", "the", "issuance", "of", "ordinary", "shares", "to", "founders."], "wordsB": ["(2)", "Includes", "the", "issuance", "of", "ordinary", "shares", "to", "founders."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p83_s0", "idA": "1006281_11_item7_p64_s0", "sentA": "During 2005, 1,035,569 Series B Preferred Shares were converted on a 1:1 basis into Series C Preferred Shares for no additional consideration.", "sentB": "(3) During 2005, 1,035,569 Series B Preferred Shares were converted on a 1:1 basis into Series C Preferred Shares for no additional consideration.", "type": 2, "words": ["<tag1>", "During", "2005,", "1,035,569", "Series", "B", "Preferred", "Shares", "were", "converted", "on", "a", "1:1", "basis", "into", "Series", "C", "Preferred", "Shares", "for", "no", "additional", "consideration.", "<tag2>", "(3)", "During", "2005,", "1,035,569", "Series", "B", "Preferred", "Shares", "were", "converted", "on", "a", "1:1", "basis", "into", "Series", "C", "Preferred", "Shares", "for", "no", "additional", "consideration.", "<tag3>"], "wordsA": ["During", "2005,", "1,035,569", "Series", "B", "Preferred", "Shares", "were", "converted", "on", "a", "1:1", "basis", "into", "Series", "C", "Preferred", "Shares", "for", "no", "additional", "consideration."], "wordsB": ["(3)", "During", "2005,", "1,035,569", "Series", "B", "Preferred", "Shares", "were", "converted", "on", "a", "1:1", "basis", "into", "Series", "C", "Preferred", "Shares", "for", "no", "additional", "consideration."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p84_s0", "idA": "1006281_11_item7_p65_s0", "sentA": "In connection with such funding, warrants to purchase an additional 8,862,803 Series C Preferred Shares were granted to the investors for no additional consideration with a total exercise price equal to $9.0 million.", "sentB": "(4) In connection with such funding, warrants to purchase an additional 8,862,803 Series C Preferred Shares were granted to the investors for no additional consideration with a total exercise price equal to $9.0 million.", "type": 2, "words": ["<tag1>", "In", "connection", "with", "such", "funding,", "warrants", "to", "purchase", "an", "additional", "8,862,803", "Series", "C", "Preferred", "Shares", "were", "granted", "to", "the", "investors", "for", "no", "additional", "consideration", "with", "a", "total", "exercise", "price", "equal", "to", "$9.0", "million.", "<tag2>", "(4)", "In", "connection", "with", "such", "funding,", "warrants", "to", "purchase", "an", "additional", "8,862,803", "Series", "C", "Preferred", "Shares", "were", "granted", "to", "the", "investors", "for", "no", "additional", "consideration", "with", "a", "total", "exercise", "price", "equal", "to", "$9.0", "million.", "<tag3>"], "wordsA": ["In", "connection", "with", "such", "funding,", "warrants", "to", "purchase", "an", "additional", "8,862,803", "Series", "C", "Preferred", "Shares", "were", "granted", "to", "the", "investors", "for", "no", "additional", "consideration", "with", "a", "total", "exercise", "price", "equal", "to", "$9.0", "million."], "wordsB": ["(4)", "In", "connection", "with", "such", "funding,", "warrants", "to", "purchase", "an", "additional", "8,862,803", "Series", "C", "Preferred", "Shares", "were", "granted", "to", "the", "investors", "for", "no", "additional", "consideration", "with", "a", "total", "exercise", "price", "equal", "to", "$9.0", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p85_s0", "idA": "1006281_11_item7_p66_s0", "sentA": "In connection with such funding, warrants to purchase 3,875,416 ordinary shares were issued for no additional consideration with an aggregate exercise price equal to $5.3 million.", "sentB": "(5) In connection with such funding, warrants to purchase 3,875,416 ordinary shares were issued for no additional consideration with an aggregate exercise price equal to $5.3 million.", "type": 2, "words": ["<tag1>", "In", "connection", "with", "such", "funding,", "warrants", "to", "purchase", "3,875,416", "ordinary", "shares", "were", "issued", "for", "no", "additional", "consideration", "with", "an", "aggregate", "exercise", "price", "equal", "to", "$5.3", "million.", "<tag2>", "(5)", "In", "connection", "with", "such", "funding,", "warrants", "to", "purchase", "3,875,416", "ordinary", "shares", "were", "issued", "for", "no", "additional", "consideration", "with", "an", "aggregate", "exercise", "price", "equal", "to", "$5.3", "million.", "<tag3>"], "wordsA": ["In", "connection", "with", "such", "funding,", "warrants", "to", "purchase", "3,875,416", "ordinary", "shares", "were", "issued", "for", "no", "additional", "consideration", "with", "an", "aggregate", "exercise", "price", "equal", "to", "$5.3", "million."], "wordsB": ["(5)", "In", "connection", "with", "such", "funding,", "warrants", "to", "purchase", "3,875,416", "ordinary", "shares", "were", "issued", "for", "no", "additional", "consideration", "with", "an", "aggregate", "exercise", "price", "equal", "to", "$5.3", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p72_s0", "idA": "1006281_11_item7_p67_s0", "sentA": "Net cash used in operations was $38.5 million for the year ended December 31, 2010.", "sentB": "Financial income was $2,000 for the year ended December 31, 2011, a decrease of $966,000, or 99%, from $968,000 for the year ended December 31, 2010.", "type": 2, "words": ["<tag1>", "Net", "cash", "used", "in", "operations", "was", "$38.5", "million", "for", "the", "year", "ended", "December", "31,", "2010.", "<tag2>", "Financial", "income", "was", "$2,000", "for", "the", "year", "ended", "December", "31,", "2011,", "a", "decrease", "of", "$966,000,", "or", "99%,", "from", "$968,000", "for", "the", "year", "ended", "December", "31,", "2010.", "<tag3>"], "wordsA": ["Net", "cash", "used", "in", "operations", "was", "$38.5", "million", "for", "the", "year", "ended", "December", "31,", "2010."], "wordsB": ["Financial", "income", "was", "$2,000", "for", "the", "year", "ended", "December", "31,", "2011,", "a", "decrease", "of", "$966,000,", "or", "99%,", "from", "$968,000", "for", "the", "year", "ended", "December", "31,", "2010."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p88_s0", "idA": "1006281_11_item7_p67_s0", "sentA": "Net cash used in operations was $38.5 million for the year ended December 31, 2010.", "sentB": "Net cash used in operations was $23.6 million for the year ended December 31, 2011.", "type": 2, "words": ["<tag1>", "Net", "cash", "used", "in", "operations", "was", "$38.5", "million", "for", "the", "year", "ended", "December", "31,", "2010.", "<tag2>", "Net", "cash", "used", "in", "operations", "was", "$23.6", "million", "for", "the", "year", "ended", "December", "31,", "2011.", "<tag3>"], "wordsA": ["Net", "cash", "used", "in", "operations", "was", "$38.5", "million", "for", "the", "year", "ended", "December", "31,", "2010."], "wordsB": ["Net", "cash", "used", "in", "operations", "was", "$23.6", "million", "for", "the", "year", "ended", "December", "31,", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p88_s1", "idA": "1006281_11_item7_p67_s1", "sentA": "The net loss for 2010 of $29.0 million was further increased by an increase in accounts receivable of approximately $6.9 million and a decrease of $4.6 million in deferred revenues.", "sentB": "The net loss for 2011 of $36.5 million was further increased by a decrease in deferred revenues of approximately $3.0 million.", "type": 2, "words": ["<tag1>", "The", "net", "loss", "for", "2010", "of", "$29.0", "million", "was", "further", "increased", "by", "an", "increase", "in", "accounts", "receivable", "of", "approximately", "$6.9", "million", "and", "a", "decrease", "of", "$4.6", "million", "in", "deferred", "revenues.", "<tag2>", "The", "net", "loss", "for", "2011", "of", "$36.5", "million", "was", "further", "increased", "by", "a", "decrease", "in", "deferred", "revenues", "of", "approximately", "$3.0", "million.", "<tag3>"], "wordsA": ["The", "net", "loss", "for", "2010", "of", "$29.0", "million", "was", "further", "increased", "by", "an", "increase", "in", "accounts", "receivable", "of", "approximately", "$6.9", "million", "and", "a", "decrease", "of", "$4.6", "million", "in", "deferred", "revenues."], "wordsB": ["The", "net", "loss", "for", "2011", "of", "$36.5", "million", "was", "further", "increased", "by", "a", "decrease", "in", "deferred", "revenues", "of", "approximately", "$3.0", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p88_s2", "idA": "1006281_11_item7_p67_s2", "sentA": "Such net loss was partially offset by non-cash charges for share-based compensation of $1.3 million, and depreciation of $3.1 million.", "sentB": "The net loss was partially offset by non-cash charges for share-based compensation of $886,000, depreciation of $3.6 million and a decrease in accounts receivable of approximately $3.9 million and an increase in accounts payable of $6.1 million.", "type": 2, "words": ["<tag1>", "Such", "net", "loss", "was", "partially", "offset", "by", "non-cash", "charges", "for", "share-based", "compensation", "of", "$1.3", "million,", "and", "depreciation", "of", "$3.1", "million.", "<tag2>", "The", "net", "loss", "was", "partially", "offset", "by", "non-cash", "charges", "for", "share-based", "compensation", "of", "$886,000,", "depreciation", "of", "$3.6", "million", "and", "a", "decrease", "in", "accounts", "receivable", "of", "approximately", "$3.9", "million", "and", "an", "increase", "in", "accounts", "payable", "of", "$6.1", "million.", "<tag3>"], "wordsA": ["Such", "net", "loss", "was", "partially", "offset", "by", "non-cash", "charges", "for", "share-based", "compensation", "of", "$1.3", "million,", "and", "depreciation", "of", "$3.1", "million."], "wordsB": ["The", "net", "loss", "was", "partially", "offset", "by", "non-cash", "charges", "for", "share-based", "compensation", "of", "$886,000,", "depreciation", "of", "$3.6", "million", "and", "a", "decrease", "in", "accounts", "receivable", "of", "approximately", "$3.9", "million", "and", "an", "increase", "in", "accounts", "payable", "of", "$6.1", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p90_s2", "idA": "1006281_11_item7_p67_s2", "sentA": "Such net loss was partially offset by non-cash charges for share-based compensation of $1.3 million, and depreciation of $3.1 million.", "sentB": "The net loss was partially offset by non-cash charges for share-based compensation of $1.3 million, and depreciation of $3.1 million.", "type": 2, "words": ["<tag1>", "Such", "net", "loss", "was", "partially", "offset", "by", "non-cash", "charges", "for", "share-based", "compensation", "of", "$1.3", "million,", "and", "depreciation", "of", "$3.1", "million.", "<tag2>", "The", "net", "loss", "was", "partially", "offset", "by", "non-cash", "charges", "for", "share-based", "compensation", "of", "$1.3", "million,", "and", "depreciation", "of", "$3.1", "million.", "<tag3>"], "wordsA": ["Such", "net", "loss", "was", "partially", "offset", "by", "non-cash", "charges", "for", "share-based", "compensation", "of", "$1.3", "million,", "and", "depreciation", "of", "$3.1", "million."], "wordsB": ["The", "net", "loss", "was", "partially", "offset", "by", "non-cash", "charges", "for", "share-based", "compensation", "of", "$1.3", "million,", "and", "depreciation", "of", "$3.1", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p89_s0", "idA": "1006281_11_item7_p68_s0", "sentA": "Net cash used in investing activities for 2010 was $8.0 million and consisted primarily of purchases of property and equipment.", "sentB": "Net cash used in investing activities for 2011 was $5.9 million and consisted primarily of purchases of property and equipment.", "type": 2, "words": ["<tag1>", "Net", "cash", "used", "in", "investing", "activities", "for", "2010", "was", "$8.0", "million", "and", "consisted", "primarily", "of", "purchases", "of", "property", "and", "equipment.", "<tag2>", "Net", "cash", "used", "in", "investing", "activities", "for", "2011", "was", "$5.9", "million", "and", "consisted", "primarily", "of", "purchases", "of", "property", "and", "equipment.", "<tag3>"], "wordsA": ["Net", "cash", "used", "in", "investing", "activities", "for", "2010", "was", "$8.0", "million", "and", "consisted", "primarily", "of", "purchases", "of", "property", "and", "equipment."], "wordsB": ["Net", "cash", "used", "in", "investing", "activities", "for", "2011", "was", "$5.9", "million", "and", "consisted", "primarily", "of", "purchases", "of", "property", "and", "equipment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p89_s1", "idA": "1006281_11_item7_p68_s1", "sentA": "Net cash provided from financing activities for 2010 was approximately $501,000 due to option exercises.", "sentB": "Net cash provided from financing activities during 2011 was approximately $20.9 million primarily due to our underwritten public offering of common stock in the first quarter of 2011.", "type": 2, "words": ["<tag1>", "Net", "cash", "provided", "from", "financing", "activities", "for", "2010", "was", "approximately", "$501,000", "due", "to", "option", "exercises.", "<tag2>", "Net", "cash", "provided", "from", "financing", "activities", "during", "2011", "was", "approximately", "$20.9", "million", "primarily", "due", "to", "our", "underwritten", "public", "offering", "of", "common", "stock", "in", "the", "first", "quarter", "of", "2011.", "<tag3>"], "wordsA": ["Net", "cash", "provided", "from", "financing", "activities", "for", "2010", "was", "approximately", "$501,000", "due", "to", "option", "exercises."], "wordsB": ["Net", "cash", "provided", "from", "financing", "activities", "during", "2011", "was", "approximately", "$20.9", "million", "primarily", "due", "to", "our", "underwritten", "public", "offering", "of", "common", "stock", "in", "the", "first", "quarter", "of", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p66_s2", "idA": "1006281_11_item7_p69_s2", "sentA": "Such reversal was partially offset by non-cash charges for share-based compensation of $2.7 million, and depreciation of $2.0 million.", "sentB": "The allowance was partially offset by our share in the income generated through sale of taliglucerase alfa via the ATU program in France.", "type": 2, "words": ["<tag1>", "Such", "reversal", "was", "partially", "offset", "by", "non-cash", "charges", "for", "share-based", "compensation", "of", "$2.7", "million,", "and", "depreciation", "of", "$2.0", "million.", "<tag2>", "The", "allowance", "was", "partially", "offset", "by", "our", "share", "in", "the", "income", "generated", "through", "sale", "of", "taliglucerase", "alfa", "via", "the", "ATU", "program", "in", "France.", "<tag3>"], "wordsA": ["Such", "reversal", "was", "partially", "offset", "by", "non-cash", "charges", "for", "share-based", "compensation", "of", "$2.7", "million,", "and", "depreciation", "of", "$2.0", "million."], "wordsB": ["The", "allowance", "was", "partially", "offset", "by", "our", "share", "in", "the", "income", "generated", "through", "sale", "of", "taliglucerase", "alfa", "via", "the", "ATU", "program", "in", "France."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p27_s1", "idA": "1006281_11_item7_p71_s1", "sentA": "However, we anticipate that we will generate revenues to offset any such losses upon the successful launch of taliglucerase alfa, if at all.", "sentB": "However, we anticipate that we will use live nerve gas rather than an analogue in the proposed additional efficacy trials in animals.", "type": 2, "words": ["<tag1>", "However,", "we", "anticipate", "that", "we", "will", "generate", "revenues", "to", "offset", "any", "such", "losses", "upon", "the", "successful", "launch", "of", "taliglucerase", "alfa,", "if", "at", "all.", "<tag2>", "However,", "we", "anticipate", "that", "we", "will", "use", "live", "nerve", "gas", "rather", "than", "an", "analogue", "in", "the", "proposed", "additional", "efficacy", "trials", "in", "animals.", "<tag3>"], "wordsA": ["However,", "we", "anticipate", "that", "we", "will", "generate", "revenues", "to", "offset", "any", "such", "losses", "upon", "the", "successful", "launch", "of", "taliglucerase", "alfa,", "if", "at", "all."], "wordsB": ["However,", "we", "anticipate", "that", "we", "will", "use", "live", "nerve", "gas", "rather", "than", "an", "analogue", "in", "the", "proposed", "additional", "efficacy", "trials", "in", "animals."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p92_s0", "idA": "1006281_11_item7_p72_s0", "sentA": "We believe that our existing cash and cash equivalents and the regulatory milestone payments we anticipate receiving from Pfizer will be sufficient to enable us to fund our operating expenses and capital expenditure requirements at least for the next 12 months.", "sentB": "We believe that our existing cash and cash equivalents and the net proceeds from our public underwritten offering of February 2012 will be sufficient to enable us to fund our operating expenses and capital expenditure requirements at least for the next 12 months.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "our", "existing", "cash", "and", "cash", "equivalents", "and", "the", "regulatory", "milestone", "payments", "we", "anticipate", "receiving", "from", "Pfizer", "will", "be", "sufficient", "to", "enable", "us", "to", "fund", "our", "operating", "expenses", "and", "capital", "expenditure", "requirements", "at", "least", "for", "the", "next", "12", "months.", "<tag2>", "We", "believe", "that", "our", "existing", "cash", "and", "cash", "equivalents", "and", "the", "net", "proceeds", "from", "our", "public", "underwritten", "offering", "of", "February", "2012", "will", "be", "sufficient", "to", "enable", "us", "to", "fund", "our", "operating", "expenses", "and", "capital", "expenditure", "requirements", "at", "least", "for", "the", "next", "12", "months.", "<tag3>"], "wordsA": ["We", "believe", "that", "our", "existing", "cash", "and", "cash", "equivalents", "and", "the", "regulatory", "milestone", "payments", "we", "anticipate", "receiving", "from", "Pfizer", "will", "be", "sufficient", "to", "enable", "us", "to", "fund", "our", "operating", "expenses", "and", "capital", "expenditure", "requirements", "at", "least", "for", "the", "next", "12", "months."], "wordsB": ["We", "believe", "that", "our", "existing", "cash", "and", "cash", "equivalents", "and", "the", "net", "proceeds", "from", "our", "public", "underwritten", "offering", "of", "February", "2012", "will", "be", "sufficient", "to", "enable", "us", "to", "fund", "our", "operating", "expenses", "and", "capital", "expenditure", "requirements", "at", "least", "for", "the", "next", "12", "months."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p94_s4", "idA": "1006281_11_item7_p74_s4", "sentA": "The sale of additional equity or debt securities will likely result in dilution to our shareholders.", "sentB": "Any sale of additional equity or debt securities will likely result in dilution to our shareholders.", "type": 2, "words": ["<tag1>", "The", "sale", "of", "additional", "equity", "or", "debt", "securities", "will", "likely", "result", "in", "dilution", "to", "our", "shareholders.", "<tag2>", "Any", "sale", "of", "additional", "equity", "or", "debt", "securities", "will", "likely", "result", "in", "dilution", "to", "our", "shareholders.", "<tag3>"], "wordsA": ["The", "sale", "of", "additional", "equity", "or", "debt", "securities", "will", "likely", "result", "in", "dilution", "to", "our", "shareholders."], "wordsB": ["Any", "sale", "of", "additional", "equity", "or", "debt", "securities", "will", "likely", "result", "in", "dilution", "to", "our", "shareholders."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p95_s1", "idA": "1006281_11_item7_p75_s1", "sentA": "We do not believe that inflation has had a material effect on our results of operations during the years ended December 31, 2008, 2009 or 2010.", "sentB": "We do not believe that inflation has had a material effect on our results of operations during the years ended December 31, 2009, 2010 or 2011.", "type": 2, "words": ["<tag1>", "We", "do", "not", "believe", "that", "inflation", "has", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2008,", "2009", "or", "2010.", "<tag2>", "We", "do", "not", "believe", "that", "inflation", "has", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2009,", "2010", "or", "2011.", "<tag3>"], "wordsA": ["We", "do", "not", "believe", "that", "inflation", "has", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2008,", "2009", "or", "2010."], "wordsB": ["We", "do", "not", "believe", "that", "inflation", "has", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2009,", "2010", "or", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p96_s1", "idA": "1006281_11_item7_p76_s1", "sentA": "We do not believe currency fluctuations have had a material effect on our results of operations during the years ended December 31, 2008, 2009 or 2010.", "sentB": "We do not believe currency fluctuations have had a material effect on our results of operations during the years ended December 31, 2009, 2010 or 2011.", "type": 2, "words": ["<tag1>", "We", "do", "not", "believe", "currency", "fluctuations", "have", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2008,", "2009", "or", "2010.", "<tag2>", "We", "do", "not", "believe", "currency", "fluctuations", "have", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2009,", "2010", "or", "2011.", "<tag3>"], "wordsA": ["We", "do", "not", "believe", "currency", "fluctuations", "have", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2008,", "2009", "or", "2010."], "wordsB": ["We", "do", "not", "believe", "currency", "fluctuations", "have", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2009,", "2010", "or", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p97_s0", "idA": "1006281_11_item7_p77_s0", "sentA": "We have no off-balance sheet arrangements as of December 31, 2009 and 2010.", "sentB": "We have no off-balance sheet arrangements as of December 31, 2010 and 2011.", "type": 2, "words": ["<tag1>", "We", "have", "no", "off-balance", "sheet", "arrangements", "as", "of", "December", "31,", "2009", "and", "2010.", "<tag2>", "We", "have", "no", "off-balance", "sheet", "arrangements", "as", "of", "December", "31,", "2010", "and", "2011.", "<tag3>"], "wordsA": ["We", "have", "no", "off-balance", "sheet", "arrangements", "as", "of", "December", "31,", "2009", "and", "2010."], "wordsB": ["We", "have", "no", "off-balance", "sheet", "arrangements", "as", "of", "December", "31,", "2010", "and", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p20_s2", "idA": "1006281_11_item7_p7_s1", "sentA": "Revenue generated from the Ministry of Health of Brazil will be recorded by Pfizer and we are entitled to our share of the revenue in accordance with the terms and conditions of the Pfizer Agreement.", "sentB": "Revenue generated from the Ministry of Health of Brazil was recorded by Pfizer, and we recorded our share of the revenue in accordance with the terms and conditions of the Pfizer Agreement.", "type": 2, "words": ["<tag1>", "Revenue", "generated", "from", "the", "Ministry", "of", "Health", "of", "Brazil", "will", "be", "recorded", "by", "Pfizer", "and", "we", "are", "entitled", "to", "our", "share", "of", "the", "revenue", "in", "accordance", "with", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement.", "<tag2>", "Revenue", "generated", "from", "the", "Ministry", "of", "Health", "of", "Brazil", "was", "recorded", "by", "Pfizer,", "and", "we", "recorded", "our", "share", "of", "the", "revenue", "in", "accordance", "with", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement.", "<tag3>"], "wordsA": ["Revenue", "generated", "from", "the", "Ministry", "of", "Health", "of", "Brazil", "will", "be", "recorded", "by", "Pfizer", "and", "we", "are", "entitled", "to", "our", "share", "of", "the", "revenue", "in", "accordance", "with", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement."], "wordsB": ["Revenue", "generated", "from", "the", "Ministry", "of", "Health", "of", "Brazil", "was", "recorded", "by", "Pfizer,", "and", "we", "recorded", "our", "share", "of", "the", "revenue", "in", "accordance", "with", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p21_s0", "idA": "1006281_11_item7_p7_s1", "sentA": "Revenue generated from the Ministry of Health of Brazil will be recorded by Pfizer and we are entitled to our share of the revenue in accordance with the terms and conditions of the Pfizer Agreement.", "sentB": "During the second and fourth quarters of 2011, the Ministry of Health of Brazil requested that Pfizer consider the replacement of certain vials that might expire during 2012.", "type": 2, "words": ["<tag1>", "Revenue", "generated", "from", "the", "Ministry", "of", "Health", "of", "Brazil", "will", "be", "recorded", "by", "Pfizer", "and", "we", "are", "entitled", "to", "our", "share", "of", "the", "revenue", "in", "accordance", "with", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement.", "<tag2>", "During", "the", "second", "and", "fourth", "quarters", "of", "2011,", "the", "Ministry", "of", "Health", "of", "Brazil", "requested", "that", "Pfizer", "consider", "the", "replacement", "of", "certain", "vials", "that", "might", "expire", "during", "2012.", "<tag3>"], "wordsA": ["Revenue", "generated", "from", "the", "Ministry", "of", "Health", "of", "Brazil", "will", "be", "recorded", "by", "Pfizer", "and", "we", "are", "entitled", "to", "our", "share", "of", "the", "revenue", "in", "accordance", "with", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement."], "wordsB": ["During", "the", "second", "and", "fourth", "quarters", "of", "2011,", "the", "Ministry", "of", "Health", "of", "Brazil", "requested", "that", "Pfizer", "consider", "the", "replacement", "of", "certain", "vials", "that", "might", "expire", "during", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p66_s0", "idA": "1006281_11_item7_p7_s1", "sentA": "Revenue generated from the Ministry of Health of Brazil will be recorded by Pfizer and we are entitled to our share of the revenue in accordance with the terms and conditions of the Pfizer Agreement.", "sentB": "During 2011, the Ministry of Health of Brazil requested that Pfizer consider the replacement of certain vials that might expire during 2012.", "type": 2, "words": ["<tag1>", "Revenue", "generated", "from", "the", "Ministry", "of", "Health", "of", "Brazil", "will", "be", "recorded", "by", "Pfizer", "and", "we", "are", "entitled", "to", "our", "share", "of", "the", "revenue", "in", "accordance", "with", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement.", "<tag2>", "During", "2011,", "the", "Ministry", "of", "Health", "of", "Brazil", "requested", "that", "Pfizer", "consider", "the", "replacement", "of", "certain", "vials", "that", "might", "expire", "during", "2012.", "<tag3>"], "wordsA": ["Revenue", "generated", "from", "the", "Ministry", "of", "Health", "of", "Brazil", "will", "be", "recorded", "by", "Pfizer", "and", "we", "are", "entitled", "to", "our", "share", "of", "the", "revenue", "in", "accordance", "with", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement."], "wordsB": ["During", "2011,", "the", "Ministry", "of", "Health", "of", "Brazil", "requested", "that", "Pfizer", "consider", "the", "replacement", "of", "certain", "vials", "that", "might", "expire", "during", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p69_s1", "idA": "1006281_11_item7_p7_s1", "sentA": "Revenue generated from the Ministry of Health of Brazil will be recorded by Pfizer and we are entitled to our share of the revenue in accordance with the terms and conditions of the Pfizer Agreement.", "sentB": "The research and development expenses for the year ended December 31, 2011 were partially offset by grants received from the OCS of approximately $3.3 million, and $3.4 million of reimbursements for certain expenses in accordance with the terms and conditions of the Pfizer Agreement.", "type": 2, "words": ["<tag1>", "Revenue", "generated", "from", "the", "Ministry", "of", "Health", "of", "Brazil", "will", "be", "recorded", "by", "Pfizer", "and", "we", "are", "entitled", "to", "our", "share", "of", "the", "revenue", "in", "accordance", "with", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement.", "<tag2>", "The", "research", "and", "development", "expenses", "for", "the", "year", "ended", "December", "31,", "2011", "were", "partially", "offset", "by", "grants", "received", "from", "the", "OCS", "of", "approximately", "$3.3", "million,", "and", "$3.4", "million", "of", "reimbursements", "for", "certain", "expenses", "in", "accordance", "with", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement.", "<tag3>"], "wordsA": ["Revenue", "generated", "from", "the", "Ministry", "of", "Health", "of", "Brazil", "will", "be", "recorded", "by", "Pfizer", "and", "we", "are", "entitled", "to", "our", "share", "of", "the", "revenue", "in", "accordance", "with", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement."], "wordsB": ["The", "research", "and", "development", "expenses", "for", "the", "year", "ended", "December", "31,", "2011", "were", "partially", "offset", "by", "grants", "received", "from", "the", "OCS", "of", "approximately", "$3.3", "million,", "and", "$3.4", "million", "of", "reimbursements", "for", "certain", "expenses", "in", "accordance", "with", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p21_s4", "idA": "1006281_11_item7_p7_s3", "sentA": "At this time, we are unable to assess whether these discussions will result in an agreement and we can make no assurances that we will be able to enter into such an agreement on favorable terms, if at all.", "sentB": "We are currently unable to assess whether these discussions will result in an agreement and we can make no assurance that we will be able to enter into such an agreement on favorable terms, if at all.", "type": 2, "words": ["<tag1>", "At", "this", "time,", "we", "are", "unable", "to", "assess", "whether", "these", "discussions", "will", "result", "in", "an", "agreement", "and", "we", "can", "make", "no", "assurances", "that", "we", "will", "be", "able", "to", "enter", "into", "such", "an", "agreement", "on", "favorable", "terms,", "if", "at", "all.", "<tag2>", "We", "are", "currently", "unable", "to", "assess", "whether", "these", "discussions", "will", "result", "in", "an", "agreement", "and", "we", "can", "make", "no", "assurance", "that", "we", "will", "be", "able", "to", "enter", "into", "such", "an", "agreement", "on", "favorable", "terms,", "if", "at", "all.", "<tag3>"], "wordsA": ["At", "this", "time,", "we", "are", "unable", "to", "assess", "whether", "these", "discussions", "will", "result", "in", "an", "agreement", "and", "we", "can", "make", "no", "assurances", "that", "we", "will", "be", "able", "to", "enter", "into", "such", "an", "agreement", "on", "favorable", "terms,", "if", "at", "all."], "wordsB": ["We", "are", "currently", "unable", "to", "assess", "whether", "these", "discussions", "will", "result", "in", "an", "agreement", "and", "we", "can", "make", "no", "assurance", "that", "we", "will", "be", "able", "to", "enter", "into", "such", "an", "agreement", "on", "favorable", "terms,", "if", "at", "all."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p24_s0", "idA": "1006281_11_item7_p80_s1", "sentA": "ASU 2010-027 provides guidance concerning the recognition and classification of the new annual fee payable by branded prescription drug manufactures and importers on branded prescription drugs which was mandated under the health care reform legislation enacted in the United States in March 2010.", "sentB": "Shire reported annual worldwide sales of VPRIV of approximately $256 million in 2011, a growth of 79% compared to the same period in 2010 (VPRIV was approved for sale in the United States in February 2010 and in the European Union in August 2010).", "type": 2, "words": ["<tag1>", "ASU", "2010-027", "provides", "guidance", "concerning", "the", "recognition", "and", "classification", "of", "the", "new", "annual", "fee", "payable", "by", "branded", "prescription", "drug", "manufactures", "and", "importers", "on", "branded", "prescription", "drugs", "which", "was", "mandated", "under", "the", "health", "care", "reform", "legislation", "enacted", "in", "the", "United", "States", "in", "March", "2010.", "<tag2>", "Shire", "reported", "annual", "worldwide", "sales", "of", "VPRIV", "of", "approximately", "$256", "million", "in", "2011,", "a", "growth", "of", "79%", "compared", "to", "the", "same", "period", "in", "2010", "(VPRIV", "was", "approved", "for", "sale", "in", "the", "United", "States", "in", "February", "2010", "and", "in", "the", "European", "Union", "in", "August", "2010).", "<tag3>"], "wordsA": ["ASU", "2010-027", "provides", "guidance", "concerning", "the", "recognition", "and", "classification", "of", "the", "new", "annual", "fee", "payable", "by", "branded", "prescription", "drug", "manufactures", "and", "importers", "on", "branded", "prescription", "drugs", "which", "was", "mandated", "under", "the", "health", "care", "reform", "legislation", "enacted", "in", "the", "United", "States", "in", "March", "2010."], "wordsB": ["Shire", "reported", "annual", "worldwide", "sales", "of", "VPRIV", "of", "approximately", "$256", "million", "in", "2011,", "a", "growth", "of", "79%", "compared", "to", "the", "same", "period", "in", "2010", "(VPRIV", "was", "approved", "for", "sale", "in", "the", "United", "States", "in", "February", "2010", "and", "in", "the", "European", "Union", "in", "August", "2010)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p98_s0", "idA": "1006281_11_item7_p81_s0", "sentA": "The following table summarizes our significant contractual obligations at December 31, 2010:", "sentB": "The following table summarizes our significant contractual obligations at December 31, 2011 (in thousands):", "type": 2, "words": ["<tag1>", "The", "following", "table", "summarizes", "our", "significant", "contractual", "obligations", "at", "December", "31,", "2010:", "<tag2>", "The", "following", "table", "summarizes", "our", "significant", "contractual", "obligations", "at", "December", "31,", "2011", "(in", "thousands):", "<tag3>"], "wordsA": ["The", "following", "table", "summarizes", "our", "significant", "contractual", "obligations", "at", "December", "31,", "2010:"], "wordsB": ["The", "following", "table", "summarizes", "our", "significant", "contractual", "obligations", "at", "December", "31,", "2011", "(in", "thousands):"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p99_s0", "idA": "1006281_11_item7_p82_s0", "sentA": "Represents open purchase orders issued to certain suppliers and other vendors mainly in connection with certain improvements to our manufacturing facility that were outstanding as of December 31, 2010.", "sentB": "(1) Represents open purchase orders issued to certain suppliers and other vendors mainly in connection with our research and development activities that were outstanding as of December 31, 2011.", "type": 2, "words": ["<tag1>", "Represents", "open", "purchase", "orders", "issued", "to", "certain", "suppliers", "and", "other", "vendors", "mainly", "in", "connection", "with", "certain", "improvements", "to", "our", "manufacturing", "facility", "that", "were", "outstanding", "as", "of", "December", "31,", "2010.", "<tag2>", "(1)", "Represents", "open", "purchase", "orders", "issued", "to", "certain", "suppliers", "and", "other", "vendors", "mainly", "in", "connection", "with", "our", "research", "and", "development", "activities", "that", "were", "outstanding", "as", "of", "December", "31,", "2011.", "<tag3>"], "wordsA": ["Represents", "open", "purchase", "orders", "issued", "to", "certain", "suppliers", "and", "other", "vendors", "mainly", "in", "connection", "with", "certain", "improvements", "to", "our", "manufacturing", "facility", "that", "were", "outstanding", "as", "of", "December", "31,", "2010."], "wordsB": ["(1)", "Represents", "open", "purchase", "orders", "issued", "to", "certain", "suppliers", "and", "other", "vendors", "mainly", "in", "connection", "with", "our", "research", "and", "development", "activities", "that", "were", "outstanding", "as", "of", "December", "31,", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p1_s0", "idA": "1006281_11_item7_p8_s0", "sentA": "In addition to taliglucerase alfa, we are developing an innovative product pipeline using our ProCellEx protein expression system.", "sentB": "We are a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on our proprietary ProCellEx protein expression system.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "taliglucerase", "alfa,", "we", "are", "developing", "an", "innovative", "product", "pipeline", "using", "our", "ProCellEx", "protein", "expression", "system.", "<tag2>", "We", "are", "a", "biopharmaceutical", "company", "focused", "on", "the", "development", "and", "commercialization", "of", "recombinant", "therapeutic", "proteins", "based", "on", "our", "proprietary", "ProCellEx", "protein", "expression", "system.", "<tag3>"], "wordsA": ["In", "addition", "to", "taliglucerase", "alfa,", "we", "are", "developing", "an", "innovative", "product", "pipeline", "using", "our", "ProCellEx", "protein", "expression", "system."], "wordsB": ["We", "are", "a", "biopharmaceutical", "company", "focused", "on", "the", "development", "and", "commercialization", "of", "recombinant", "therapeutic", "proteins", "based", "on", "our", "proprietary", "ProCellEx", "protein", "expression", "system."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p29_s1", "idA": "1006281_11_item7_p8_s0", "sentA": "In addition to taliglucerase alfa, we are developing an innovative product pipeline using our ProCellEx protein expression system.", "sentB": "In addition we are continuously evaluating potential strategic marketing partnerships.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "taliglucerase", "alfa,", "we", "are", "developing", "an", "innovative", "product", "pipeline", "using", "our", "ProCellEx", "protein", "expression", "system.", "<tag2>", "In", "addition", "we", "are", "continuously", "evaluating", "potential", "strategic", "marketing", "partnerships.", "<tag3>"], "wordsA": ["In", "addition", "to", "taliglucerase", "alfa,", "we", "are", "developing", "an", "innovative", "product", "pipeline", "using", "our", "ProCellEx", "protein", "expression", "system."], "wordsB": ["In", "addition", "we", "are", "continuously", "evaluating", "potential", "strategic", "marketing", "partnerships."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p86_s0", "idA": "1006281_11_item7_p8_s0", "sentA": "In addition to taliglucerase alfa, we are developing an innovative product pipeline using our ProCellEx protein expression system.", "sentB": "In addition to the foregoing, Pfizer paid Protalix Ltd.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "taliglucerase", "alfa,", "we", "are", "developing", "an", "innovative", "product", "pipeline", "using", "our", "ProCellEx", "protein", "expression", "system.", "<tag2>", "In", "addition", "to", "the", "foregoing,", "Pfizer", "paid", "Protalix", "Ltd.", "<tag3>"], "wordsA": ["In", "addition", "to", "taliglucerase", "alfa,", "we", "are", "developing", "an", "innovative", "product", "pipeline", "using", "our", "ProCellEx", "protein", "expression", "system."], "wordsB": ["In", "addition", "to", "the", "foregoing,", "Pfizer", "paid", "Protalix", "Ltd."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p25_s1", "idA": "1006281_11_item7_p8_s1", "sentA": "Our product pipeline currently includes, among other candidates, (1) PRX-102, a therapeutic protein candidate for the treatment of Fabry disease, a rare, genetic lysosomal disorder in humans, (2) PRX-105, a plant cell expressed pegylated recombinant acetylcholinesterase product candidate for biodefense and other indications, (3) pr-antiTNF, a plant cell expressed recombinant fusion protein made from the soluble form of the human TNF receptor (TNFR) and an antibody portion, which is being developed as a treatment of certain immune diseases such as rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing, spondylitis, psoriatic arthritis and plaque psoriasis, (4) an orally administrated glucocerebrosidase enzyme for treating Gaucher patients utilizing the oral delivery of the recombinant enzyme produced within carrot cells and (5) additional undisclosed therapeutic proteins, all of which are currently being evaluated in animal studies.", "sentB": "Our product pipeline currently includes, among other candidates: (1) PRX-102, a therapeutic protein candidate for the treatment of Fabry disease, a rare, genetic lysosomal disorder in humans; (2) PRX-105, a plant cell expressed pegylated recombinant acetylcholinesterase product candidate for biodefense and other indications; (3) PRX-106, or pr-antiTNF, a plant cell expressed recombinant fusion protein made from the soluble form of the human TNF receptor (TNFR) and an antibody portion, which is being developed as a treatment of certain immune diseases such as rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing, spondylitis, psoriatic arthritis and plaque psoriasis; (4) an orally administrated glucocerebrosidase enzyme for treating Gaucher disease patients utilizing the oral delivery of the recombinant enzyme produced within carrot cells; and (5) two additional undisclosed therapeutic proteins, both of which are being evaluated in animal studies.", "type": 2, "words": ["<tag1>", "Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates,", "(1)", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans,", "(2)", "PRX-105,", "a", "plant", "cell", "expressed", "pegylated", "recombinant", "acetylcholinesterase", "product", "candidate", "for", "biodefense", "and", "other", "indications,", "(3)", "pr-antiTNF,", "a", "plant", "cell", "expressed", "recombinant", "fusion", "protein", "made", "from", "the", "soluble", "form", "of", "the", "human", "TNF", "receptor", "(TNFR)", "and", "an", "antibody", "portion,", "which", "is", "being", "developed", "as", "a", "treatment", "of", "certain", "immune", "diseases", "such", "as", "rheumatoid", "arthritis,", "juvenile", "idiopathic", "arthritis,", "ankylosing,", "spondylitis,", "psoriatic", "arthritis", "and", "plaque", "psoriasis,", "(4)", "an", "orally", "administrated", "glucocerebrosidase", "enzyme", "for", "treating", "Gaucher", "patients", "utilizing", "the", "oral", "delivery", "of", "the", "recombinant", "enzyme", "produced", "within", "carrot", "cells", "and", "(5)", "additional", "undisclosed", "therapeutic", "proteins,", "all", "of", "which", "are", "currently", "being", "evaluated", "in", "animal", "studies.", "<tag2>", "Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates:", "(1)", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans;", "(2)", "PRX-105,", "a", "plant", "cell", "expressed", "pegylated", "recombinant", "acetylcholinesterase", "product", "candidate", "for", "biodefense", "and", "other", "indications;", "(3)", "PRX-106,", "or", "pr-antiTNF,", "a", "plant", "cell", "expressed", "recombinant", "fusion", "protein", "made", "from", "the", "soluble", "form", "of", "the", "human", "TNF", "receptor", "(TNFR)", "and", "an", "antibody", "portion,", "which", "is", "being", "developed", "as", "a", "treatment", "of", "certain", "immune", "diseases", "such", "as", "rheumatoid", "arthritis,", "juvenile", "idiopathic", "arthritis,", "ankylosing,", "spondylitis,", "psoriatic", "arthritis", "and", "plaque", "psoriasis;", "(4)", "an", "orally", "administrated", "glucocerebrosidase", "enzyme", "for", "treating", "Gaucher", "disease", "patients", "utilizing", "the", "oral", "delivery", "of", "the", "recombinant", "enzyme", "produced", "within", "carrot", "cells;", "and", "(5)", "two", "additional", "undisclosed", "therapeutic", "proteins,", "both", "of", "which", "are", "being", "evaluated", "in", "animal", "studies.", "<tag3>"], "wordsA": ["Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates,", "(1)", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans,", "(2)", "PRX-105,", "a", "plant", "cell", "expressed", "pegylated", "recombinant", "acetylcholinesterase", "product", "candidate", "for", "biodefense", "and", "other", "indications,", "(3)", "pr-antiTNF,", "a", "plant", "cell", "expressed", "recombinant", "fusion", "protein", "made", "from", "the", "soluble", "form", "of", "the", "human", "TNF", "receptor", "(TNFR)", "and", "an", "antibody", "portion,", "which", "is", "being", "developed", "as", "a", "treatment", "of", "certain", "immune", "diseases", "such", "as", "rheumatoid", "arthritis,", "juvenile", "idiopathic", "arthritis,", "ankylosing,", "spondylitis,", "psoriatic", "arthritis", "and", "plaque", "psoriasis,", "(4)", "an", "orally", "administrated", "glucocerebrosidase", "enzyme", "for", "treating", "Gaucher", "patients", "utilizing", "the", "oral", "delivery", "of", "the", "recombinant", "enzyme", "produced", "within", "carrot", "cells", "and", "(5)", "additional", "undisclosed", "therapeutic", "proteins,", "all", "of", "which", "are", "currently", "being", "evaluated", "in", "animal", "studies."], "wordsB": ["Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates:", "(1)", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans;", "(2)", "PRX-105,", "a", "plant", "cell", "expressed", "pegylated", "recombinant", "acetylcholinesterase", "product", "candidate", "for", "biodefense", "and", "other", "indications;", "(3)", "PRX-106,", "or", "pr-antiTNF,", "a", "plant", "cell", "expressed", "recombinant", "fusion", "protein", "made", "from", "the", "soluble", "form", "of", "the", "human", "TNF", "receptor", "(TNFR)", "and", "an", "antibody", "portion,", "which", "is", "being", "developed", "as", "a", "treatment", "of", "certain", "immune", "diseases", "such", "as", "rheumatoid", "arthritis,", "juvenile", "idiopathic", "arthritis,", "ankylosing,", "spondylitis,", "psoriatic", "arthritis", "and", "plaque", "psoriasis;", "(4)", "an", "orally", "administrated", "glucocerebrosidase", "enzyme", "for", "treating", "Gaucher", "disease", "patients", "utilizing", "the", "oral", "delivery", "of", "the", "recombinant", "enzyme", "produced", "within", "carrot", "cells;", "and", "(5)", "two", "additional", "undisclosed", "therapeutic", "proteins,", "both", "of", "which", "are", "being", "evaluated", "in", "animal", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p26_s0", "idA": "1006281_11_item7_p8_s2", "sentA": "In March 2010, we initiated a preliminary phase I clinical trial of PRX-105, our plant cell expressed pegylated recombinant acetylcholinesterase product candidate for biodefense indications, which we completed in June 2010.", "sentB": "In March 2010, we initiated a preliminary phase I clinical trial of PRX-105 which we completed in June 2010.", "type": 2, "words": ["<tag1>", "In", "March", "2010,", "we", "initiated", "a", "preliminary", "phase", "I", "clinical", "trial", "of", "PRX-105,", "our", "plant", "cell", "expressed", "pegylated", "recombinant", "acetylcholinesterase", "product", "candidate", "for", "biodefense", "indications,", "which", "we", "completed", "in", "June", "2010.", "<tag2>", "In", "March", "2010,", "we", "initiated", "a", "preliminary", "phase", "I", "clinical", "trial", "of", "PRX-105", "which", "we", "completed", "in", "June", "2010.", "<tag3>"], "wordsA": ["In", "March", "2010,", "we", "initiated", "a", "preliminary", "phase", "I", "clinical", "trial", "of", "PRX-105,", "our", "plant", "cell", "expressed", "pegylated", "recombinant", "acetylcholinesterase", "product", "candidate", "for", "biodefense", "indications,", "which", "we", "completed", "in", "June", "2010."], "wordsB": ["In", "March", "2010,", "we", "initiated", "a", "preliminary", "phase", "I", "clinical", "trial", "of", "PRX-105", "which", "we", "completed", "in", "June", "2010."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p26_s1", "idA": "1006281_11_item7_p8_s3", "sentA": "We are currently preparing for further efficacy trials of this product candidate in larger animals and with live nerve gas.", "sentB": "We are currently preparing for further efficacy trials of this product candidate in larger animals.", "type": 2, "words": ["<tag1>", "We", "are", "currently", "preparing", "for", "further", "efficacy", "trials", "of", "this", "product", "candidate", "in", "larger", "animals", "and", "with", "live", "nerve", "gas.", "<tag2>", "We", "are", "currently", "preparing", "for", "further", "efficacy", "trials", "of", "this", "product", "candidate", "in", "larger", "animals.", "<tag3>"], "wordsA": ["We", "are", "currently", "preparing", "for", "further", "efficacy", "trials", "of", "this", "product", "candidate", "in", "larger", "animals", "and", "with", "live", "nerve", "gas."], "wordsB": ["We", "are", "currently", "preparing", "for", "further", "efficacy", "trials", "of", "this", "product", "candidate", "in", "larger", "animals."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p27_s0", "idA": "1006281_11_item7_p8_s3", "sentA": "We are currently preparing for further efficacy trials of this product candidate in larger animals and with live nerve gas.", "sentB": "In our preclinical studies we utilized an analogue to nerve gas.", "type": 2, "words": ["<tag1>", "We", "are", "currently", "preparing", "for", "further", "efficacy", "trials", "of", "this", "product", "candidate", "in", "larger", "animals", "and", "with", "live", "nerve", "gas.", "<tag2>", "In", "our", "preclinical", "studies", "we", "utilized", "an", "analogue", "to", "nerve", "gas.", "<tag3>"], "wordsA": ["We", "are", "currently", "preparing", "for", "further", "efficacy", "trials", "of", "this", "product", "candidate", "in", "larger", "animals", "and", "with", "live", "nerve", "gas."], "wordsB": ["In", "our", "preclinical", "studies", "we", "utilized", "an", "analogue", "to", "nerve", "gas."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p25_s2", "idA": "1006281_11_item7_p9_s0", "sentA": "In December 2010 we held a pre-IND meeting with the FDA with respect to PRX-102.", "sentB": "We participated in a pre IND meeting with respect to one of the undisclosed product candidates in the first quarter of 2012 and a pre IND meeting for the second candidate is planned for later this year.", "type": 2, "words": ["<tag1>", "In", "December", "2010", "we", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "with", "respect", "to", "PRX-102.", "<tag2>", "We", "participated", "in", "a", "pre", "IND", "meeting", "with", "respect", "to", "one", "of", "the", "undisclosed", "product", "candidates", "in", "the", "first", "quarter", "of", "2012", "and", "a", "pre", "IND", "meeting", "for", "the", "second", "candidate", "is", "planned", "for", "later", "this", "year.", "<tag3>"], "wordsA": ["In", "December", "2010", "we", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "with", "respect", "to", "PRX-102."], "wordsB": ["We", "participated", "in", "a", "pre", "IND", "meeting", "with", "respect", "to", "one", "of", "the", "undisclosed", "product", "candidates", "in", "the", "first", "quarter", "of", "2012", "and", "a", "pre", "IND", "meeting", "for", "the", "second", "candidate", "is", "planned", "for", "later", "this", "year."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p28_s2", "idA": "1006281_11_item7_p9_s0", "sentA": "In December 2010 we held a pre-IND meeting with the FDA with respect to PRX-102.", "sentB": "In December 2011 we held a pre IND meeting with respect to PRX 106 and we expect to submit an IND around year end.", "type": 2, "words": ["<tag1>", "In", "December", "2010", "we", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "with", "respect", "to", "PRX-102.", "<tag2>", "In", "December", "2011", "we", "held", "a", "pre", "IND", "meeting", "with", "respect", "to", "PRX", "106", "and", "we", "expect", "to", "submit", "an", "IND", "around", "year", "end.", "<tag3>"], "wordsA": ["In", "December", "2010", "we", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "with", "respect", "to", "PRX-102."], "wordsB": ["In", "December", "2011", "we", "held", "a", "pre", "IND", "meeting", "with", "respect", "to", "PRX", "106", "and", "we", "expect", "to", "submit", "an", "IND", "around", "year", "end."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p30_s3", "idA": "1006281_11_item7_p9_s0", "sentA": "In December 2010 we held a pre-IND meeting with the FDA with respect to PRX-102.", "sentB": "Based on our pre IND meeting with the FDA held in December 2011, we believe we may submit an IND around year end and, if approved, commence a phase I clinical trial shortly thereafter with no need for an external partner.", "type": 2, "words": ["<tag1>", "In", "December", "2010", "we", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "with", "respect", "to", "PRX-102.", "<tag2>", "Based", "on", "our", "pre", "IND", "meeting", "with", "the", "FDA", "held", "in", "December", "2011,", "we", "believe", "we", "may", "submit", "an", "IND", "around", "year", "end", "and,", "if", "approved,", "commence", "a", "phase", "I", "clinical", "trial", "shortly", "thereafter", "with", "no", "need", "for", "an", "external", "partner.", "<tag3>"], "wordsA": ["In", "December", "2010", "we", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "with", "respect", "to", "PRX-102."], "wordsB": ["Based", "on", "our", "pre", "IND", "meeting", "with", "the", "FDA", "held", "in", "December", "2011,", "we", "believe", "we", "may", "submit", "an", "IND", "around", "year", "end", "and,", "if", "approved,", "commence", "a", "phase", "I", "clinical", "trial", "shortly", "thereafter", "with", "no", "need", "for", "an", "external", "partner."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p3_s4", "idA": "1006281_11_item7_p9_s0", "sentA": "In December 2010 we held a pre-IND meeting with the FDA with respect to PRX-102.", "sentB": "In December 2011, the FDA notified us that it had decided to extend the PDUFA date to May 1, 2012.", "type": 2, "words": ["<tag1>", "In", "December", "2010", "we", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "with", "respect", "to", "PRX-102.", "<tag2>", "In", "December", "2011,", "the", "FDA", "notified", "us", "that", "it", "had", "decided", "to", "extend", "the", "PDUFA", "date", "to", "May", "1,", "2012.", "<tag3>"], "wordsA": ["In", "December", "2010", "we", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "with", "respect", "to", "PRX-102."], "wordsB": ["In", "December", "2011,", "the", "FDA", "notified", "us", "that", "it", "had", "decided", "to", "extend", "the", "PDUFA", "date", "to", "May", "1,", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item7_p28_s1", "idA": "1006281_11_item7_p9_s1", "sentA": "We expect to submit an IND to the FDA within the next 12 months in connection with an anticipated phase I/II study of PRX-102 and to initiate the trial once the IND is approved, if at all.", "sentB": "We completed preclinical trials in small and large animals with respect to PRX-102, and we expect to submit an IND to the FDA during the second quarter of 2012 in connection with an anticipated phase I/II clinical study of PRX-102 in Fabry patients, and to initiate the trial once the IND is approved, if at all.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "submit", "an", "IND", "to", "the", "FDA", "within", "the", "next", "12", "months", "in", "connection", "with", "an", "anticipated", "phase", "I/II", "study", "of", "PRX-102", "and", "to", "initiate", "the", "trial", "once", "the", "IND", "is", "approved,", "if", "at", "all.", "<tag2>", "We", "completed", "preclinical", "trials", "in", "small", "and", "large", "animals", "with", "respect", "to", "PRX-102,", "and", "we", "expect", "to", "submit", "an", "IND", "to", "the", "FDA", "during", "the", "second", "quarter", "of", "2012", "in", "connection", "with", "an", "anticipated", "phase", "I/II", "clinical", "study", "of", "PRX-102", "in", "Fabry", "patients,", "and", "to", "initiate", "the", "trial", "once", "the", "IND", "is", "approved,", "if", "at", "all.", "<tag3>"], "wordsA": ["We", "expect", "to", "submit", "an", "IND", "to", "the", "FDA", "within", "the", "next", "12", "months", "in", "connection", "with", "an", "anticipated", "phase", "I/II", "study", "of", "PRX-102", "and", "to", "initiate", "the", "trial", "once", "the", "IND", "is", "approved,", "if", "at", "all."], "wordsB": ["We", "completed", "preclinical", "trials", "in", "small", "and", "large", "animals", "with", "respect", "to", "PRX-102,", "and", "we", "expect", "to", "submit", "an", "IND", "to", "the", "FDA", "during", "the", "second", "quarter", "of", "2012", "in", "connection", "with", "an", "anticipated", "phase", "I/II", "clinical", "study", "of", "PRX-102", "in", "Fabry", "patients,", "and", "to", "initiate", "the", "trial", "once", "the", "IND", "is", "approved,", "if", "at", "all."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p84_s0", "idA": "1006281_12_item7_p100_s0", "sentA": "The foregoing table does not include (i) annual license fees, which are currently immaterial, (ii) payments we may be required to make to certain of our licensors in the time periods set forth above upon the achievement of agreed-upon milestones and (iii) royalty payments payable by us to certain of our licensors in connection with the commercial sale of our product candidates, if any.", "sentB": "The foregoing table does not include (i) annual license fees, which are immaterial, (ii) payments we may be required to make to certain of our licensors in the time periods set forth above upon the achievement of agreed-upon milestones and (iii) royalty payments payable by us to certain of our licensors in connection with the commercial sale of our product candidates, if any.", "type": 2, "words": ["<tag1>", "The", "foregoing", "table", "does", "not", "include", "(i)", "annual", "license", "fees,", "which", "are", "currently", "immaterial,", "(ii)", "payments", "we", "may", "be", "required", "to", "make", "to", "certain", "of", "our", "licensors", "in", "the", "time", "periods", "set", "forth", "above", "upon", "the", "achievement", "of", "agreed-upon", "milestones", "and", "(iii)", "royalty", "payments", "payable", "by", "us", "to", "certain", "of", "our", "licensors", "in", "connection", "with", "the", "commercial", "sale", "of", "our", "product", "candidates,", "if", "any.", "<tag2>", "The", "foregoing", "table", "does", "not", "include", "(i)", "annual", "license", "fees,", "which", "are", "immaterial,", "(ii)", "payments", "we", "may", "be", "required", "to", "make", "to", "certain", "of", "our", "licensors", "in", "the", "time", "periods", "set", "forth", "above", "upon", "the", "achievement", "of", "agreed-upon", "milestones", "and", "(iii)", "royalty", "payments", "payable", "by", "us", "to", "certain", "of", "our", "licensors", "in", "connection", "with", "the", "commercial", "sale", "of", "our", "product", "candidates,", "if", "any.", "<tag3>"], "wordsA": ["The", "foregoing", "table", "does", "not", "include", "(i)", "annual", "license", "fees,", "which", "are", "currently", "immaterial,", "(ii)", "payments", "we", "may", "be", "required", "to", "make", "to", "certain", "of", "our", "licensors", "in", "the", "time", "periods", "set", "forth", "above", "upon", "the", "achievement", "of", "agreed-upon", "milestones", "and", "(iii)", "royalty", "payments", "payable", "by", "us", "to", "certain", "of", "our", "licensors", "in", "connection", "with", "the", "commercial", "sale", "of", "our", "product", "candidates,", "if", "any."], "wordsB": ["The", "foregoing", "table", "does", "not", "include", "(i)", "annual", "license", "fees,", "which", "are", "immaterial,", "(ii)", "payments", "we", "may", "be", "required", "to", "make", "to", "certain", "of", "our", "licensors", "in", "the", "time", "periods", "set", "forth", "above", "upon", "the", "achievement", "of", "agreed-upon", "milestones", "and", "(iii)", "royalty", "payments", "payable", "by", "us", "to", "certain", "of", "our", "licensors", "in", "connection", "with", "the", "commercial", "sale", "of", "our", "product", "candidates,", "if", "any."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p84_s1", "idA": "1006281_12_item7_p100_s1", "sentA": "If all of the contingencies with respect to milestone payments under our research and development agreements are met, the aggregate milestone payments payable would be approximately $950,000 and would be payable, if at all, as our projects progress over the course of a number of years.", "sentB": "If all of the contingencies with respect to milestone payments under our research and license agreements are met, the aggregate milestone payments payable would be approximately $950,000 and would be payable, if at all, as our projects progress over the course of a number of years.", "type": 2, "words": ["<tag1>", "If", "all", "of", "the", "contingencies", "with", "respect", "to", "milestone", "payments", "under", "our", "research", "and", "development", "agreements", "are", "met,", "the", "aggregate", "milestone", "payments", "payable", "would", "be", "approximately", "$950,000", "and", "would", "be", "payable,", "if", "at", "all,", "as", "our", "projects", "progress", "over", "the", "course", "of", "a", "number", "of", "years.", "<tag2>", "If", "all", "of", "the", "contingencies", "with", "respect", "to", "milestone", "payments", "under", "our", "research", "and", "license", "agreements", "are", "met,", "the", "aggregate", "milestone", "payments", "payable", "would", "be", "approximately", "$950,000", "and", "would", "be", "payable,", "if", "at", "all,", "as", "our", "projects", "progress", "over", "the", "course", "of", "a", "number", "of", "years.", "<tag3>"], "wordsA": ["If", "all", "of", "the", "contingencies", "with", "respect", "to", "milestone", "payments", "under", "our", "research", "and", "development", "agreements", "are", "met,", "the", "aggregate", "milestone", "payments", "payable", "would", "be", "approximately", "$950,000", "and", "would", "be", "payable,", "if", "at", "all,", "as", "our", "projects", "progress", "over", "the", "course", "of", "a", "number", "of", "years."], "wordsB": ["If", "all", "of", "the", "contingencies", "with", "respect", "to", "milestone", "payments", "under", "our", "research", "and", "license", "agreements", "are", "met,", "the", "aggregate", "milestone", "payments", "payable", "would", "be", "approximately", "$950,000", "and", "would", "be", "payable,", "if", "at", "all,", "as", "our", "projects", "progress", "over", "the", "course", "of", "a", "number", "of", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p9_s0", "idA": "1006281_12_item7_p11_s0", "sentA": "In addition to the completed phase III clinical trial we completed in September 2009, we initiated a double-blind, follow-on extension study as part of the trial during the second quarter of 2008.", "sentB": "We performed a number of studies on taliglucerase alfa to supplement the pivotal phase III clinical trial which we completed in September 2009.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "the", "completed", "phase", "III", "clinical", "trial", "we", "completed", "in", "September", "2009,", "we", "initiated", "a", "double-blind,", "follow-on", "extension", "study", "as", "part", "of", "the", "trial", "during", "the", "second", "quarter", "of", "2008.", "<tag2>", "We", "performed", "a", "number", "of", "studies", "on", "taliglucerase", "alfa", "to", "supplement", "the", "pivotal", "phase", "III", "clinical", "trial", "which", "we", "completed", "in", "September", "2009.", "<tag3>"], "wordsA": ["In", "addition", "to", "the", "completed", "phase", "III", "clinical", "trial", "we", "completed", "in", "September", "2009,", "we", "initiated", "a", "double-blind,", "follow-on", "extension", "study", "as", "part", "of", "the", "trial", "during", "the", "second", "quarter", "of", "2008."], "wordsB": ["We", "performed", "a", "number", "of", "studies", "on", "taliglucerase", "alfa", "to", "supplement", "the", "pivotal", "phase", "III", "clinical", "trial", "which", "we", "completed", "in", "September", "2009."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p10_s0", "idA": "1006281_12_item7_p11_s1", "sentA": "Eligible patients who successfully completed nine months of treatment in our phase III clinical trial were offered the opportunity to participate in the extension study and continue to receive taliglucerase alfa at the same dose they received in the phase III clinical trial for an additional 15 months in a blinded manner.", "sentB": "We initiated a double-blind, follow-on extension study in 2008 which consisted of eligible patients who had completed nine months of treatment in the pivotal phase III clinical trial.", "type": 2, "words": ["<tag1>", "Eligible", "patients", "who", "successfully", "completed", "nine", "months", "of", "treatment", "in", "our", "phase", "III", "clinical", "trial", "were", "offered", "the", "opportunity", "to", "participate", "in", "the", "extension", "study", "and", "continue", "to", "receive", "taliglucerase", "alfa", "at", "the", "same", "dose", "they", "received", "in", "the", "phase", "III", "clinical", "trial", "for", "an", "additional", "15", "months", "in", "a", "blinded", "manner.", "<tag2>", "We", "initiated", "a", "double-blind,", "follow-on", "extension", "study", "in", "2008", "which", "consisted", "of", "eligible", "patients", "who", "had", "completed", "nine", "months", "of", "treatment", "in", "the", "pivotal", "phase", "III", "clinical", "trial.", "<tag3>"], "wordsA": ["Eligible", "patients", "who", "successfully", "completed", "nine", "months", "of", "treatment", "in", "our", "phase", "III", "clinical", "trial", "were", "offered", "the", "opportunity", "to", "participate", "in", "the", "extension", "study", "and", "continue", "to", "receive", "taliglucerase", "alfa", "at", "the", "same", "dose", "they", "received", "in", "the", "phase", "III", "clinical", "trial", "for", "an", "additional", "15", "months", "in", "a", "blinded", "manner."], "wordsB": ["We", "initiated", "a", "double-blind,", "follow-on", "extension", "study", "in", "2008", "which", "consisted", "of", "eligible", "patients", "who", "had", "completed", "nine", "months", "of", "treatment", "in", "the", "pivotal", "phase", "III", "clinical", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p10_s1", "idA": "1006281_12_item7_p11_s1", "sentA": "Eligible patients who successfully completed nine months of treatment in our phase III clinical trial were offered the opportunity to participate in the extension study and continue to receive taliglucerase alfa at the same dose they received in the phase III clinical trial for an additional 15 months in a blinded manner.", "sentB": "The patients were offered the opportunity to continue to receive taliglucerase alfa at the same dose they received in the pivotal trial for an additional 15 months in a blinded manner.", "type": 2, "words": ["<tag1>", "Eligible", "patients", "who", "successfully", "completed", "nine", "months", "of", "treatment", "in", "our", "phase", "III", "clinical", "trial", "were", "offered", "the", "opportunity", "to", "participate", "in", "the", "extension", "study", "and", "continue", "to", "receive", "taliglucerase", "alfa", "at", "the", "same", "dose", "they", "received", "in", "the", "phase", "III", "clinical", "trial", "for", "an", "additional", "15", "months", "in", "a", "blinded", "manner.", "<tag2>", "The", "patients", "were", "offered", "the", "opportunity", "to", "continue", "to", "receive", "taliglucerase", "alfa", "at", "the", "same", "dose", "they", "received", "in", "the", "pivotal", "trial", "for", "an", "additional", "15", "months", "in", "a", "blinded", "manner.", "<tag3>"], "wordsA": ["Eligible", "patients", "who", "successfully", "completed", "nine", "months", "of", "treatment", "in", "our", "phase", "III", "clinical", "trial", "were", "offered", "the", "opportunity", "to", "participate", "in", "the", "extension", "study", "and", "continue", "to", "receive", "taliglucerase", "alfa", "at", "the", "same", "dose", "they", "received", "in", "the", "phase", "III", "clinical", "trial", "for", "an", "additional", "15", "months", "in", "a", "blinded", "manner."], "wordsB": ["The", "patients", "were", "offered", "the", "opportunity", "to", "continue", "to", "receive", "taliglucerase", "alfa", "at", "the", "same", "dose", "they", "received", "in", "the", "pivotal", "trial", "for", "an", "additional", "15", "months", "in", "a", "blinded", "manner."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p10_s2", "idA": "1006281_12_item7_p13_s0", "sentA": "In the second quarter of 2011 we successfully completed a nine-month, worldwide, multi-center, open-label, switch-over clinical study evaluating the safety and efficacy of switching Gaucher patients from with Cerezyme to taliglucerase alfa.", "sentB": "We also conducted a nine-month, worldwide, multi-center, open-label, switch-over clinical study evaluating the safety and efficacy of switching Gaucher patients currently treated with Cerezyme, which is produced by Genzyme, with taliglucerase alfa which was successfully completed in 2011.", "type": 2, "words": ["<tag1>", "In", "the", "second", "quarter", "of", "2011", "we", "successfully", "completed", "a", "nine-month,", "worldwide,", "multi-center,", "open-label,", "switch-over", "clinical", "study", "evaluating", "the", "safety", "and", "efficacy", "of", "switching", "Gaucher", "patients", "from", "with", "Cerezyme", "to", "taliglucerase", "alfa.", "<tag2>", "We", "also", "conducted", "a", "nine-month,", "worldwide,", "multi-center,", "open-label,", "switch-over", "clinical", "study", "evaluating", "the", "safety", "and", "efficacy", "of", "switching", "Gaucher", "patients", "currently", "treated", "with", "Cerezyme,", "which", "is", "produced", "by", "Genzyme,", "with", "taliglucerase", "alfa", "which", "was", "successfully", "completed", "in", "2011.", "<tag3>"], "wordsA": ["In", "the", "second", "quarter", "of", "2011", "we", "successfully", "completed", "a", "nine-month,", "worldwide,", "multi-center,", "open-label,", "switch-over", "clinical", "study", "evaluating", "the", "safety", "and", "efficacy", "of", "switching", "Gaucher", "patients", "from", "with", "Cerezyme", "to", "taliglucerase", "alfa."], "wordsB": ["We", "also", "conducted", "a", "nine-month,", "worldwide,", "multi-center,", "open-label,", "switch-over", "clinical", "study", "evaluating", "the", "safety", "and", "efficacy", "of", "switching", "Gaucher", "patients", "currently", "treated", "with", "Cerezyme,", "which", "is", "produced", "by", "Genzyme,", "with", "taliglucerase", "alfa", "which", "was", "successfully", "completed", "in", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p7_s5", "idA": "1006281_12_item7_p13_s0", "sentA": "In the second quarter of 2011 we successfully completed a nine-month, worldwide, multi-center, open-label, switch-over clinical study evaluating the safety and efficacy of switching Gaucher patients from with Cerezyme to taliglucerase alfa.", "sentB": "It was not based on the safety and efficacy profile of taliglucerase alfa.", "type": 2, "words": ["<tag1>", "In", "the", "second", "quarter", "of", "2011", "we", "successfully", "completed", "a", "nine-month,", "worldwide,", "multi-center,", "open-label,", "switch-over", "clinical", "study", "evaluating", "the", "safety", "and", "efficacy", "of", "switching", "Gaucher", "patients", "from", "with", "Cerezyme", "to", "taliglucerase", "alfa.", "<tag2>", "It", "was", "not", "based", "on", "the", "safety", "and", "efficacy", "profile", "of", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["In", "the", "second", "quarter", "of", "2011", "we", "successfully", "completed", "a", "nine-month,", "worldwide,", "multi-center,", "open-label,", "switch-over", "clinical", "study", "evaluating", "the", "safety", "and", "efficacy", "of", "switching", "Gaucher", "patients", "from", "with", "Cerezyme", "to", "taliglucerase", "alfa."], "wordsB": ["It", "was", "not", "based", "on", "the", "safety", "and", "efficacy", "profile", "of", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p11_s2", "idA": "1006281_12_item7_p13_s3", "sentA": "Patients in the extension trial and the switchover trial are still being treated with taliglucerase alfa.", "sentB": "In France, Gaucher patients are being treated with taliglucerase alfa through an ATU.", "type": 2, "words": ["<tag1>", "Patients", "in", "the", "extension", "trial", "and", "the", "switchover", "trial", "are", "still", "being", "treated", "with", "taliglucerase", "alfa.", "<tag2>", "In", "France,", "Gaucher", "patients", "are", "being", "treated", "with", "taliglucerase", "alfa", "through", "an", "ATU.", "<tag3>"], "wordsA": ["Patients", "in", "the", "extension", "trial", "and", "the", "switchover", "trial", "are", "still", "being", "treated", "with", "taliglucerase", "alfa."], "wordsB": ["In", "France,", "Gaucher", "patients", "are", "being", "treated", "with", "taliglucerase", "alfa", "through", "an", "ATU."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p6_s1", "idA": "1006281_12_item7_p15_s0", "sentA": "On November 30, 2009, Protalix Ltd. and Pfizer entered into the Pfizer Agreement pursuant to which Pfizer was granted an exclusive, worldwide license to develop and commercialize taliglucerase alfa.", "sentB": "We granted Pfizer an exclusive, worldwide license to develop and commercialize taliglucerase alfa under the Pfizer Agreement, but retained those rights in Israel.", "type": 2, "words": ["<tag1>", "On", "November", "30,", "2009,", "Protalix", "Ltd.", "and", "Pfizer", "entered", "into", "the", "Pfizer", "Agreement", "pursuant", "to", "which", "Pfizer", "was", "granted", "an", "exclusive,", "worldwide", "license", "to", "develop", "and", "commercialize", "taliglucerase", "alfa.", "<tag2>", "We", "granted", "Pfizer", "an", "exclusive,", "worldwide", "license", "to", "develop", "and", "commercialize", "taliglucerase", "alfa", "under", "the", "Pfizer", "Agreement,", "but", "retained", "those", "rights", "in", "Israel.", "<tag3>"], "wordsA": ["On", "November", "30,", "2009,", "Protalix", "Ltd.", "and", "Pfizer", "entered", "into", "the", "Pfizer", "Agreement", "pursuant", "to", "which", "Pfizer", "was", "granted", "an", "exclusive,", "worldwide", "license", "to", "develop", "and", "commercialize", "taliglucerase", "alfa."], "wordsB": ["We", "granted", "Pfizer", "an", "exclusive,", "worldwide", "license", "to", "develop", "and", "commercialize", "taliglucerase", "alfa", "under", "the", "Pfizer", "Agreement,", "but", "retained", "those", "rights", "in", "Israel."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p8_s3", "idA": "1006281_12_item7_p15_s3", "sentA": "Protalix Ltd. is also eligible to receive potential milestone payments totaling $50.0 million for the successful achievement of other regulatory milestones.", "sentB": "Under the terms of the agreement, we were eligible to receive a milestone payment of $8.3 million upon the achievement of certain near-term clinical development milestones.", "type": 2, "words": ["<tag1>", "Protalix", "Ltd.", "is", "also", "eligible", "to", "receive", "potential", "milestone", "payments", "totaling", "$50.0", "million", "for", "the", "successful", "achievement", "of", "other", "regulatory", "milestones.", "<tag2>", "Under", "the", "terms", "of", "the", "agreement,", "we", "were", "eligible", "to", "receive", "a", "milestone", "payment", "of", "$8.3", "million", "upon", "the", "achievement", "of", "certain", "near-term", "clinical", "development", "milestones.", "<tag3>"], "wordsA": ["Protalix", "Ltd.", "is", "also", "eligible", "to", "receive", "potential", "milestone", "payments", "totaling", "$50.0", "million", "for", "the", "successful", "achievement", "of", "other", "regulatory", "milestones."], "wordsB": ["Under", "the", "terms", "of", "the", "agreement,", "we", "were", "eligible", "to", "receive", "a", "milestone", "payment", "of", "$8.3", "million", "upon", "the", "achievement", "of", "certain", "near-term", "clinical", "development", "milestones."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p6_s2", "idA": "1006281_12_item7_p15_s4", "sentA": "According to the agreement, Pfizer and Protalix Ltd. are required to share future revenues and expenses for the development and commercialization of taliglucerase alfa on a 60% and 40% basis, respectively, and have agreed to a specific allocation of the responsibilities for the continued development efforts for taliglucerase alfa.", "sentB": "We have agreed to a specific allocation between Protalix Ltd. and Pfizer of the responsibilities for the continued development efforts for taliglucerase alfa outside of Israel.", "type": 2, "words": ["<tag1>", "According", "to", "the", "agreement,", "Pfizer", "and", "Protalix", "Ltd.", "are", "required", "to", "share", "future", "revenues", "and", "expenses", "for", "the", "development", "and", "commercialization", "of", "taliglucerase", "alfa", "on", "a", "60%", "and", "40%", "basis,", "respectively,", "and", "have", "agreed", "to", "a", "specific", "allocation", "of", "the", "responsibilities", "for", "the", "continued", "development", "efforts", "for", "taliglucerase", "alfa.", "<tag2>", "We", "have", "agreed", "to", "a", "specific", "allocation", "between", "Protalix", "Ltd.", "and", "Pfizer", "of", "the", "responsibilities", "for", "the", "continued", "development", "efforts", "for", "taliglucerase", "alfa", "outside", "of", "Israel.", "<tag3>"], "wordsA": ["According", "to", "the", "agreement,", "Pfizer", "and", "Protalix", "Ltd.", "are", "required", "to", "share", "future", "revenues", "and", "expenses", "for", "the", "development", "and", "commercialization", "of", "taliglucerase", "alfa", "on", "a", "60%", "and", "40%", "basis,", "respectively,", "and", "have", "agreed", "to", "a", "specific", "allocation", "of", "the", "responsibilities", "for", "the", "continued", "development", "efforts", "for", "taliglucerase", "alfa."], "wordsB": ["We", "have", "agreed", "to", "a", "specific", "allocation", "between", "Protalix", "Ltd.", "and", "Pfizer", "of", "the", "responsibilities", "for", "the", "continued", "development", "efforts", "for", "taliglucerase", "alfa", "outside", "of", "Israel."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p11_s1", "idA": "1006281_12_item7_p16_s0", "sentA": "Although taliglucerase alfa has not yet been approved for commercial sale, patients are being treated with taliglucerase alfa, both in the framework of our clinical trials and related studies and in compassionate use programs, special access agreements, named patient provisions and other programs designed to make sure that treatments are available to Gaucher patients in light of recent shortages of approved treatments.", "sentB": "Globally, patients are being treated through our extension trials and related studies, compassionate use programs, special access agreements, named patient provisions and other programs designed to ensure that treatments are available to Gaucher patients in light of recent shortages of approved treatments.", "type": 2, "words": ["<tag1>", "Although", "taliglucerase", "alfa", "has", "not", "yet", "been", "approved", "for", "commercial", "sale,", "patients", "are", "being", "treated", "with", "taliglucerase", "alfa,", "both", "in", "the", "framework", "of", "our", "clinical", "trials", "and", "related", "studies", "and", "in", "compassionate", "use", "programs,", "special", "access", "agreements,", "named", "patient", "provisions", "and", "other", "programs", "designed", "to", "make", "sure", "that", "treatments", "are", "available", "to", "Gaucher", "patients", "in", "light", "of", "recent", "shortages", "of", "approved", "treatments.", "<tag2>", "Globally,", "patients", "are", "being", "treated", "through", "our", "extension", "trials", "and", "related", "studies,", "compassionate", "use", "programs,", "special", "access", "agreements,", "named", "patient", "provisions", "and", "other", "programs", "designed", "to", "ensure", "that", "treatments", "are", "available", "to", "Gaucher", "patients", "in", "light", "of", "recent", "shortages", "of", "approved", "treatments.", "<tag3>"], "wordsA": ["Although", "taliglucerase", "alfa", "has", "not", "yet", "been", "approved", "for", "commercial", "sale,", "patients", "are", "being", "treated", "with", "taliglucerase", "alfa,", "both", "in", "the", "framework", "of", "our", "clinical", "trials", "and", "related", "studies", "and", "in", "compassionate", "use", "programs,", "special", "access", "agreements,", "named", "patient", "provisions", "and", "other", "programs", "designed", "to", "make", "sure", "that", "treatments", "are", "available", "to", "Gaucher", "patients", "in", "light", "of", "recent", "shortages", "of", "approved", "treatments."], "wordsB": ["Globally,", "patients", "are", "being", "treated", "through", "our", "extension", "trials", "and", "related", "studies,", "compassionate", "use", "programs,", "special", "access", "agreements,", "named", "patient", "provisions", "and", "other", "programs", "designed", "to", "ensure", "that", "treatments", "are", "available", "to", "Gaucher", "patients", "in", "light", "of", "recent", "shortages", "of", "approved", "treatments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p8_s6", "idA": "1006281_12_item7_p17_s0", "sentA": "In July 2009, following a request by the FDA, we submitted a treatment protocol to the FDA in order to address an expected shortage of the current enzyme replacement therapy approved for Gaucher disease.", "sentB": "This agreement helps to maintain the continuity of the ongoing clinical trials for Gaucher patients and physicians and reinforces the companies mutual commitment to the Gaucher community.", "type": 2, "words": ["<tag1>", "In", "July", "2009,", "following", "a", "request", "by", "the", "FDA,", "we", "submitted", "a", "treatment", "protocol", "to", "the", "FDA", "in", "order", "to", "address", "an", "expected", "shortage", "of", "the", "current", "enzyme", "replacement", "therapy", "approved", "for", "Gaucher", "disease.", "<tag2>", "This", "agreement", "helps", "to", "maintain", "the", "continuity", "of", "the", "ongoing", "clinical", "trials", "for", "Gaucher", "patients", "and", "physicians", "and", "reinforces", "the", "companies", "mutual", "commitment", "to", "the", "Gaucher", "community.", "<tag3>"], "wordsA": ["In", "July", "2009,", "following", "a", "request", "by", "the", "FDA,", "we", "submitted", "a", "treatment", "protocol", "to", "the", "FDA", "in", "order", "to", "address", "an", "expected", "shortage", "of", "the", "current", "enzyme", "replacement", "therapy", "approved", "for", "Gaucher", "disease."], "wordsB": ["This", "agreement", "helps", "to", "maintain", "the", "continuity", "of", "the", "ongoing", "clinical", "trials", "for", "Gaucher", "patients", "and", "physicians", "and", "reinforces", "the", "companies", "mutual", "commitment", "to", "the", "Gaucher", "community."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p2_s0", "idA": "1006281_12_item7_p17_s2", "sentA": "On July 13, 2010, we announced that the French regulatory authority had granted an ATU for taliglucerase alfa for the treatment of Gaucher disease.", "sentB": "On May 1, 2012, the FDA approved our first commercial product, ELELYSO, as an ERT for the long-term treatment of adult patients with a confirmed diagnosis of type 1 Gaucher disease.", "type": 2, "words": ["<tag1>", "On", "July", "13,", "2010,", "we", "announced", "that", "the", "French", "regulatory", "authority", "had", "granted", "an", "ATU", "for", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag2>", "On", "May", "1,", "2012,", "the", "FDA", "approved", "our", "first", "commercial", "product,", "ELELYSO,", "as", "an", "ERT", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease.", "<tag3>"], "wordsA": ["On", "July", "13,", "2010,", "we", "announced", "that", "the", "French", "regulatory", "authority", "had", "granted", "an", "ATU", "for", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease."], "wordsB": ["On", "May", "1,", "2012,", "the", "FDA", "approved", "our", "first", "commercial", "product,", "ELELYSO,", "as", "an", "ERT", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p7_s2", "idA": "1006281_12_item7_p18_s1", "sentA": "This ATU allows patients with Gaucher disease in France to receive treatment with taliglucerase alfa before marketing authorization for the product is granted in the European Union.", "sentB": "In November 2012, we announced that the European Commission issued a Commission Decision refusing the marketing authorization for taliglucerase alfa in the European Union.", "type": 2, "words": ["<tag1>", "This", "ATU", "allows", "patients", "with", "Gaucher", "disease", "in", "France", "to", "receive", "treatment", "with", "taliglucerase", "alfa", "before", "marketing", "authorization", "for", "the", "product", "is", "granted", "in", "the", "European", "Union.", "<tag2>", "In", "November", "2012,", "we", "announced", "that", "the", "European", "Commission", "issued", "a", "Commission", "Decision", "refusing", "the", "marketing", "authorization", "for", "taliglucerase", "alfa", "in", "the", "European", "Union.", "<tag3>"], "wordsA": ["This", "ATU", "allows", "patients", "with", "Gaucher", "disease", "in", "France", "to", "receive", "treatment", "with", "taliglucerase", "alfa", "before", "marketing", "authorization", "for", "the", "product", "is", "granted", "in", "the", "European", "Union."], "wordsB": ["In", "November", "2012,", "we", "announced", "that", "the", "European", "Commission", "issued", "a", "Commission", "Decision", "refusing", "the", "marketing", "authorization", "for", "taliglucerase", "alfa", "in", "the", "European", "Union."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p11_s0", "idA": "1006281_12_item7_p19_s1", "sentA": "In addition to the United States and France, taliglucerase alfa is currently being provided to Gaucher disease patients under special access agreements or Named Patient provisions in Brazil and in the rest of the world.", "sentB": "Currently, patients are being treated with ELELYSO on a commercial basis in the United States and in Israel shortly.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "the", "United", "States", "and", "France,", "taliglucerase", "alfa", "is", "currently", "being", "provided", "to", "Gaucher", "disease", "patients", "under", "special", "access", "agreements", "or", "Named", "Patient", "provisions", "in", "Brazil", "and", "in", "the", "rest", "of", "the", "world.", "<tag2>", "Currently,", "patients", "are", "being", "treated", "with", "ELELYSO", "on", "a", "commercial", "basis", "in", "the", "United", "States", "and", "in", "Israel", "shortly.", "<tag3>"], "wordsA": ["In", "addition", "to", "the", "United", "States", "and", "France,", "taliglucerase", "alfa", "is", "currently", "being", "provided", "to", "Gaucher", "disease", "patients", "under", "special", "access", "agreements", "or", "Named", "Patient", "provisions", "in", "Brazil", "and", "in", "the", "rest", "of", "the", "world."], "wordsB": ["Currently,", "patients", "are", "being", "treated", "with", "ELELYSO", "on", "a", "commercial", "basis", "in", "the", "United", "States", "and", "in", "Israel", "shortly."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p11_s3", "idA": "1006281_12_item7_p19_s1", "sentA": "In addition to the United States and France, taliglucerase alfa is currently being provided to Gaucher disease patients under special access agreements or Named Patient provisions in Brazil and in the rest of the world.", "sentB": "In addition to the United States and France, taliglucerase alfa is currently being provided to Gaucher patients under special access agreements or named patient provisions in Brazil and in other countries.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "the", "United", "States", "and", "France,", "taliglucerase", "alfa", "is", "currently", "being", "provided", "to", "Gaucher", "disease", "patients", "under", "special", "access", "agreements", "or", "Named", "Patient", "provisions", "in", "Brazil", "and", "in", "the", "rest", "of", "the", "world.", "<tag2>", "In", "addition", "to", "the", "United", "States", "and", "France,", "taliglucerase", "alfa", "is", "currently", "being", "provided", "to", "Gaucher", "patients", "under", "special", "access", "agreements", "or", "named", "patient", "provisions", "in", "Brazil", "and", "in", "other", "countries.", "<tag3>"], "wordsA": ["In", "addition", "to", "the", "United", "States", "and", "France,", "taliglucerase", "alfa", "is", "currently", "being", "provided", "to", "Gaucher", "disease", "patients", "under", "special", "access", "agreements", "or", "Named", "Patient", "provisions", "in", "Brazil", "and", "in", "the", "rest", "of", "the", "world."], "wordsB": ["In", "addition", "to", "the", "United", "States", "and", "France,", "taliglucerase", "alfa", "is", "currently", "being", "provided", "to", "Gaucher", "patients", "under", "special", "access", "agreements", "or", "named", "patient", "provisions", "in", "Brazil", "and", "in", "other", "countries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p54_s3", "idA": "1006281_12_item7_p19_s2", "sentA": "Hundreds of patients, in the aggregate, have been treated with taliglucerase alfa.", "sentB": "Effective as of the FDA approval of taliglucerase alfa on May 1, 2012, we capitalize all manufacturing costs associated with taliglucerase alfa.", "type": 2, "words": ["<tag1>", "Hundreds", "of", "patients,", "in", "the", "aggregate,", "have", "been", "treated", "with", "taliglucerase", "alfa.", "<tag2>", "Effective", "as", "of", "the", "FDA", "approval", "of", "taliglucerase", "alfa", "on", "May", "1,", "2012,", "we", "capitalize", "all", "manufacturing", "costs", "associated", "with", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["Hundreds", "of", "patients,", "in", "the", "aggregate,", "have", "been", "treated", "with", "taliglucerase", "alfa."], "wordsB": ["Effective", "as", "of", "the", "FDA", "approval", "of", "taliglucerase", "alfa", "on", "May", "1,", "2012,", "we", "capitalize", "all", "manufacturing", "costs", "associated", "with", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p1_s1", "idA": "1006281_12_item7_p1_s1", "sentA": "Using our ProCellEx system, we are developing a pipeline of proprietary and biosimilar or generic versions of recombinant therapeutic proteins based on our plant cell-based expression technology that target large, established pharmaceutical markets and that rely upon known biological mechanisms of action.", "sentB": "Using our ProCellEx system, we are developing a pipeline of proprietary and biosimilar versions of recombinant therapeutic proteins based on our plant cell-based expression technology that target large, established pharmaceutical markets and that rely upon known biological mechanisms of action.", "type": 2, "words": ["<tag1>", "Using", "our", "ProCellEx", "system,", "we", "are", "developing", "a", "pipeline", "of", "proprietary", "and", "biosimilar", "or", "generic", "versions", "of", "recombinant", "therapeutic", "proteins", "based", "on", "our", "plant", "cell-based", "expression", "technology", "that", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "rely", "upon", "known", "biological", "mechanisms", "of", "action.", "<tag2>", "Using", "our", "ProCellEx", "system,", "we", "are", "developing", "a", "pipeline", "of", "proprietary", "and", "biosimilar", "versions", "of", "recombinant", "therapeutic", "proteins", "based", "on", "our", "plant", "cell-based", "expression", "technology", "that", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "rely", "upon", "known", "biological", "mechanisms", "of", "action.", "<tag3>"], "wordsA": ["Using", "our", "ProCellEx", "system,", "we", "are", "developing", "a", "pipeline", "of", "proprietary", "and", "biosimilar", "or", "generic", "versions", "of", "recombinant", "therapeutic", "proteins", "based", "on", "our", "plant", "cell-based", "expression", "technology", "that", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "rely", "upon", "known", "biological", "mechanisms", "of", "action."], "wordsB": ["Using", "our", "ProCellEx", "system,", "we", "are", "developing", "a", "pipeline", "of", "proprietary", "and", "biosimilar", "versions", "of", "recombinant", "therapeutic", "proteins", "based", "on", "our", "plant", "cell-based", "expression", "technology", "that", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "rely", "upon", "known", "biological", "mechanisms", "of", "action."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p1_s3", "idA": "1006281_12_item7_p1_s3", "sentA": "We believe our ProCellEx protein expression system will enable us to develop proprietary recombinant proteins that are therapeutically equivalent or superior to existing recombinant proteins currently marketed for the same indications.", "sentB": "We believe ProCellEx will enable us to develop proprietary recombinant proteins that are therapeutically equivalent or superior to existing recombinant proteins currently marketed for the same indications.", "type": 2, "words": ["<tag1>", "We", "believe", "our", "ProCellEx", "protein", "expression", "system", "will", "enable", "us", "to", "develop", "proprietary", "recombinant", "proteins", "that", "are", "therapeutically", "equivalent", "or", "superior", "to", "existing", "recombinant", "proteins", "currently", "marketed", "for", "the", "same", "indications.", "<tag2>", "We", "believe", "ProCellEx", "will", "enable", "us", "to", "develop", "proprietary", "recombinant", "proteins", "that", "are", "therapeutically", "equivalent", "or", "superior", "to", "existing", "recombinant", "proteins", "currently", "marketed", "for", "the", "same", "indications.", "<tag3>"], "wordsA": ["We", "believe", "our", "ProCellEx", "protein", "expression", "system", "will", "enable", "us", "to", "develop", "proprietary", "recombinant", "proteins", "that", "are", "therapeutically", "equivalent", "or", "superior", "to", "existing", "recombinant", "proteins", "currently", "marketed", "for", "the", "same", "indications."], "wordsB": ["We", "believe", "ProCellEx", "will", "enable", "us", "to", "develop", "proprietary", "recombinant", "proteins", "that", "are", "therapeutically", "equivalent", "or", "superior", "to", "existing", "recombinant", "proteins", "currently", "marketed", "for", "the", "same", "indications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p12_s0", "idA": "1006281_12_item7_p20_s0", "sentA": "On August 10, 2010, Pfizer entered into a $30 million short-term supply agreement with the Ministry of Health of Brazil pursuant to which Protalix and Pfizer have provided taliglucerase alfa to the Ministry of Health of Brazil for the treatment of patients with Gaucher disease.", "sentB": "On August 10, 2010, Pfizer entered into a $30.0 million short-term supply agreement with the Brazilian MOH pursuant to which Protalix and Pfizer have provided taliglucerase alfa to the Brazilian MOH for the treatment of Gaucher patients.", "type": 2, "words": ["<tag1>", "On", "August", "10,", "2010,", "Pfizer", "entered", "into", "a", "$30", "million", "short-term", "supply", "agreement", "with", "the", "Ministry", "of", "Health", "of", "Brazil", "pursuant", "to", "which", "Protalix", "and", "Pfizer", "have", "provided", "taliglucerase", "alfa", "to", "the", "Ministry", "of", "Health", "of", "Brazil", "for", "the", "treatment", "of", "patients", "with", "Gaucher", "disease.", "<tag2>", "On", "August", "10,", "2010,", "Pfizer", "entered", "into", "a", "$30.0", "million", "short-term", "supply", "agreement", "with", "the", "Brazilian", "MOH", "pursuant", "to", "which", "Protalix", "and", "Pfizer", "have", "provided", "taliglucerase", "alfa", "to", "the", "Brazilian", "MOH", "for", "the", "treatment", "of", "Gaucher", "patients.", "<tag3>"], "wordsA": ["On", "August", "10,", "2010,", "Pfizer", "entered", "into", "a", "$30", "million", "short-term", "supply", "agreement", "with", "the", "Ministry", "of", "Health", "of", "Brazil", "pursuant", "to", "which", "Protalix", "and", "Pfizer", "have", "provided", "taliglucerase", "alfa", "to", "the", "Ministry", "of", "Health", "of", "Brazil", "for", "the", "treatment", "of", "patients", "with", "Gaucher", "disease."], "wordsB": ["On", "August", "10,", "2010,", "Pfizer", "entered", "into", "a", "$30.0", "million", "short-term", "supply", "agreement", "with", "the", "Brazilian", "MOH", "pursuant", "to", "which", "Protalix", "and", "Pfizer", "have", "provided", "taliglucerase", "alfa", "to", "the", "Brazilian", "MOH", "for", "the", "treatment", "of", "Gaucher", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p12_s1", "idA": "1006281_12_item7_p20_s1", "sentA": "During the first quarter of 2011, we and Pfizer supplied the remaining products deliverable under the short-term supply agreement.", "sentB": "During the remainder of 2010 and the first quarter of 2011, we and Pfizer completed the supply of products deliverable under the short-term supply agreement.", "type": 2, "words": ["<tag1>", "During", "the", "first", "quarter", "of", "2011,", "we", "and", "Pfizer", "supplied", "the", "remaining", "products", "deliverable", "under", "the", "short-term", "supply", "agreement.", "<tag2>", "During", "the", "remainder", "of", "2010", "and", "the", "first", "quarter", "of", "2011,", "we", "and", "Pfizer", "completed", "the", "supply", "of", "products", "deliverable", "under", "the", "short-term", "supply", "agreement.", "<tag3>"], "wordsA": ["During", "the", "first", "quarter", "of", "2011,", "we", "and", "Pfizer", "supplied", "the", "remaining", "products", "deliverable", "under", "the", "short-term", "supply", "agreement."], "wordsB": ["During", "the", "remainder", "of", "2010", "and", "the", "first", "quarter", "of", "2011,", "we", "and", "Pfizer", "completed", "the", "supply", "of", "products", "deliverable", "under", "the", "short-term", "supply", "agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p13_s1", "idA": "1006281_12_item7_p20_s1", "sentA": "During the first quarter of 2011, we and Pfizer supplied the remaining products deliverable under the short-term supply agreement.", "sentB": "During the third quarter of 2012, we and Pfizer resupplied a portion of the returned vials.", "type": 2, "words": ["<tag1>", "During", "the", "first", "quarter", "of", "2011,", "we", "and", "Pfizer", "supplied", "the", "remaining", "products", "deliverable", "under", "the", "short-term", "supply", "agreement.", "<tag2>", "During", "the", "third", "quarter", "of", "2012,", "we", "and", "Pfizer", "resupplied", "a", "portion", "of", "the", "returned", "vials.", "<tag3>"], "wordsA": ["During", "the", "first", "quarter", "of", "2011,", "we", "and", "Pfizer", "supplied", "the", "remaining", "products", "deliverable", "under", "the", "short-term", "supply", "agreement."], "wordsB": ["During", "the", "third", "quarter", "of", "2012,", "we", "and", "Pfizer", "resupplied", "a", "portion", "of", "the", "returned", "vials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p13_s2", "idA": "1006281_12_item7_p21_s3", "sentA": "In addition, we and the Ministry of Health of Brazil are in discussions relating to a possible long-term supply agreement that contemplates, among other matters, providing certain components of our manufacturing technology to the Ministry of Health of Brazil for implementation by it in Brazil.", "sentB": "In addition, we and the Brazilian MOH are in discussions relating to a possible long-term supply agreement that contemplates, among other matters, providing certain components of our manufacturing technology to the Brazilian MOH for implementation by it in Brazil.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "and", "the", "Ministry", "of", "Health", "of", "Brazil", "are", "in", "discussions", "relating", "to", "a", "possible", "long-term", "supply", "agreement", "that", "contemplates,", "among", "other", "matters,", "providing", "certain", "components", "of", "our", "manufacturing", "technology", "to", "the", "Ministry", "of", "Health", "of", "Brazil", "for", "implementation", "by", "it", "in", "Brazil.", "<tag2>", "In", "addition,", "we", "and", "the", "Brazilian", "MOH", "are", "in", "discussions", "relating", "to", "a", "possible", "long-term", "supply", "agreement", "that", "contemplates,", "among", "other", "matters,", "providing", "certain", "components", "of", "our", "manufacturing", "technology", "to", "the", "Brazilian", "MOH", "for", "implementation", "by", "it", "in", "Brazil.", "<tag3>"], "wordsA": ["In", "addition,", "we", "and", "the", "Ministry", "of", "Health", "of", "Brazil", "are", "in", "discussions", "relating", "to", "a", "possible", "long-term", "supply", "agreement", "that", "contemplates,", "among", "other", "matters,", "providing", "certain", "components", "of", "our", "manufacturing", "technology", "to", "the", "Ministry", "of", "Health", "of", "Brazil", "for", "implementation", "by", "it", "in", "Brazil."], "wordsB": ["In", "addition,", "we", "and", "the", "Brazilian", "MOH", "are", "in", "discussions", "relating", "to", "a", "possible", "long-term", "supply", "agreement", "that", "contemplates,", "among", "other", "matters,", "providing", "certain", "components", "of", "our", "manufacturing", "technology", "to", "the", "Brazilian", "MOH", "for", "implementation", "by", "it", "in", "Brazil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p13_s4", "idA": "1006281_12_item7_p21_s5", "sentA": "In any event, we do not expect to enter into a long-term supply agreement with the Ministry of Health of Brazil until we receive marketing approval of taliglucerase alfa from the FDA or ANVISA, if at all.", "sentB": "In any event, we do not expect to supply the Brazilian MOH taliglucerase alfa until ANVISA grants marketing approval to taliglucerase alfa, if at all.", "type": 2, "words": ["<tag1>", "In", "any", "event,", "we", "do", "not", "expect", "to", "enter", "into", "a", "long-term", "supply", "agreement", "with", "the", "Ministry", "of", "Health", "of", "Brazil", "until", "we", "receive", "marketing", "approval", "of", "taliglucerase", "alfa", "from", "the", "FDA", "or", "ANVISA,", "if", "at", "all.", "<tag2>", "In", "any", "event,", "we", "do", "not", "expect", "to", "supply", "the", "Brazilian", "MOH", "taliglucerase", "alfa", "until", "ANVISA", "grants", "marketing", "approval", "to", "taliglucerase", "alfa,", "if", "at", "all.", "<tag3>"], "wordsA": ["In", "any", "event,", "we", "do", "not", "expect", "to", "enter", "into", "a", "long-term", "supply", "agreement", "with", "the", "Ministry", "of", "Health", "of", "Brazil", "until", "we", "receive", "marketing", "approval", "of", "taliglucerase", "alfa", "from", "the", "FDA", "or", "ANVISA,", "if", "at", "all."], "wordsB": ["In", "any", "event,", "we", "do", "not", "expect", "to", "supply", "the", "Brazilian", "MOH", "taliglucerase", "alfa", "until", "ANVISA", "grants", "marketing", "approval", "to", "taliglucerase", "alfa,", "if", "at", "all."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p4_s0", "idA": "1006281_12_item7_p22_s0", "sentA": "Although Gaucher disease is a relatively rare disease, it represents a large commercial market due to the severity of the symptoms and the chronic nature of the disease.", "sentB": "Gaucher disease is a rare and serious lysosomal storage disorder with severe and debilitating symptoms.", "type": 2, "words": ["<tag1>", "Although", "Gaucher", "disease", "is", "a", "relatively", "rare", "disease,", "it", "represents", "a", "large", "commercial", "market", "due", "to", "the", "severity", "of", "the", "symptoms", "and", "the", "chronic", "nature", "of", "the", "disease.", "<tag2>", "Gaucher", "disease", "is", "a", "rare", "and", "serious", "lysosomal", "storage", "disorder", "with", "severe", "and", "debilitating", "symptoms.", "<tag3>"], "wordsA": ["Although", "Gaucher", "disease", "is", "a", "relatively", "rare", "disease,", "it", "represents", "a", "large", "commercial", "market", "due", "to", "the", "severity", "of", "the", "symptoms", "and", "the", "chronic", "nature", "of", "the", "disease."], "wordsB": ["Gaucher", "disease", "is", "a", "rare", "and", "serious", "lysosomal", "storage", "disorder", "with", "severe", "and", "debilitating", "symptoms."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p39_s0", "idA": "1006281_12_item7_p24_s0", "sentA": "Shire reported annual worldwide sales of VPRIV of approximately $256 million in 2011, a growth of 79% compared to the same period in 2010 (VPRIV was approved for sale in the United States in February 2010 and in the European Union in August 2010).", "sentB": "Taliglucerase alfa has been approved for sale in the United States, Israel and Uruguay, and marketing authorization applications are outstanding for Brazil and other countries.", "type": 2, "words": ["<tag1>", "Shire", "reported", "annual", "worldwide", "sales", "of", "VPRIV", "of", "approximately", "$256", "million", "in", "2011,", "a", "growth", "of", "79%", "compared", "to", "the", "same", "period", "in", "2010", "(VPRIV", "was", "approved", "for", "sale", "in", "the", "United", "States", "in", "February", "2010", "and", "in", "the", "European", "Union", "in", "August", "2010).", "<tag2>", "Taliglucerase", "alfa", "has", "been", "approved", "for", "sale", "in", "the", "United", "States,", "Israel", "and", "Uruguay,", "and", "marketing", "authorization", "applications", "are", "outstanding", "for", "Brazil", "and", "other", "countries.", "<tag3>"], "wordsA": ["Shire", "reported", "annual", "worldwide", "sales", "of", "VPRIV", "of", "approximately", "$256", "million", "in", "2011,", "a", "growth", "of", "79%", "compared", "to", "the", "same", "period", "in", "2010", "(VPRIV", "was", "approved", "for", "sale", "in", "the", "United", "States", "in", "February", "2010", "and", "in", "the", "European", "Union", "in", "August", "2010)."], "wordsB": ["Taliglucerase", "alfa", "has", "been", "approved", "for", "sale", "in", "the", "United", "States,", "Israel", "and", "Uruguay,", "and", "marketing", "authorization", "applications", "are", "outstanding", "for", "Brazil", "and", "other", "countries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p14_s1", "idA": "1006281_12_item7_p25_s1", "sentA": "Our product pipeline currently includes, among other candidates: (1) PRX-102, a therapeutic protein candidate for the treatment of Fabry disease, a rare, genetic lysosomal disorder in humans; (2) PRX-105, a plant cell expressed pegylated recombinant acetylcholinesterase product candidate for biodefense and other indications; (3) PRX-106, or pr-antiTNF, a plant cell expressed recombinant fusion protein made from the soluble form of the human TNF receptor (TNFR) and an antibody portion, which is being developed as a treatment of certain immune diseases such as rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing, spondylitis, psoriatic arthritis and plaque psoriasis; (4) an orally administrated glucocerebrosidase enzyme for treating Gaucher disease patients utilizing the oral delivery of the recombinant enzyme produced within carrot cells; and (5) two additional undisclosed therapeutic proteins, both of which are being evaluated in animal studies.", "sentB": "Our product pipeline currently includes, among other candidates: (1) PRX-102, a therapeutic protein candidate for the treatment of Fabry disease, a rare, genetic lysosomal disorder in humans; (2) PRX-105, a plant cell expressed pegylated recombinant acetylcholinesterase product candidate for biodefense and other indications; (3) an orally-administered glucocerebrosidase enzyme for the treatment of Gaucher patients utilizing oral delivery of the recombinant enzyme produced within carrot cells; (4) PRX-106, or pr-antiTNF, a plant cell expressed recombinant fusion protein made from the soluble form of the human TNF receptor (TNFR) and an antibody portion, which is being developed as a treatment of certain immune diseases such as rheumatoid arthritis, Chrohn's disease, placque psoriasis and other autoimmune disorders; and (5) two additional undisclosed therapeutic proteins, both of which are being evaluated in animal studies.", "type": 2, "words": ["<tag1>", "Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates:", "(1)", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans;", "(2)", "PRX-105,", "a", "plant", "cell", "expressed", "pegylated", "recombinant", "acetylcholinesterase", "product", "candidate", "for", "biodefense", "and", "other", "indications;", "(3)", "PRX-106,", "or", "pr-antiTNF,", "a", "plant", "cell", "expressed", "recombinant", "fusion", "protein", "made", "from", "the", "soluble", "form", "of", "the", "human", "TNF", "receptor", "(TNFR)", "and", "an", "antibody", "portion,", "which", "is", "being", "developed", "as", "a", "treatment", "of", "certain", "immune", "diseases", "such", "as", "rheumatoid", "arthritis,", "juvenile", "idiopathic", "arthritis,", "ankylosing,", "spondylitis,", "psoriatic", "arthritis", "and", "plaque", "psoriasis;", "(4)", "an", "orally", "administrated", "glucocerebrosidase", "enzyme", "for", "treating", "Gaucher", "disease", "patients", "utilizing", "the", "oral", "delivery", "of", "the", "recombinant", "enzyme", "produced", "within", "carrot", "cells;", "and", "(5)", "two", "additional", "undisclosed", "therapeutic", "proteins,", "both", "of", "which", "are", "being", "evaluated", "in", "animal", "studies.", "<tag2>", "Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates:", "(1)", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans;", "(2)", "PRX-105,", "a", "plant", "cell", "expressed", "pegylated", "recombinant", "acetylcholinesterase", "product", "candidate", "for", "biodefense", "and", "other", "indications;", "(3)", "an", "orally-administered", "glucocerebrosidase", "enzyme", "for", "the", "treatment", "of", "Gaucher", "patients", "utilizing", "oral", "delivery", "of", "the", "recombinant", "enzyme", "produced", "within", "carrot", "cells;", "(4)", "PRX-106,", "or", "pr-antiTNF,", "a", "plant", "cell", "expressed", "recombinant", "fusion", "protein", "made", "from", "the", "soluble", "form", "of", "the", "human", "TNF", "receptor", "(TNFR)", "and", "an", "antibody", "portion,", "which", "is", "being", "developed", "as", "a", "treatment", "of", "certain", "immune", "diseases", "such", "as", "rheumatoid", "arthritis,", "Chrohn's", "disease,", "placque", "psoriasis", "and", "other", "autoimmune", "disorders;", "and", "(5)", "two", "additional", "undisclosed", "therapeutic", "proteins,", "both", "of", "which", "are", "being", "evaluated", "in", "animal", "studies.", "<tag3>"], "wordsA": ["Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates:", "(1)", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans;", "(2)", "PRX-105,", "a", "plant", "cell", "expressed", "pegylated", "recombinant", "acetylcholinesterase", "product", "candidate", "for", "biodefense", "and", "other", "indications;", "(3)", "PRX-106,", "or", "pr-antiTNF,", "a", "plant", "cell", "expressed", "recombinant", "fusion", "protein", "made", "from", "the", "soluble", "form", "of", "the", "human", "TNF", "receptor", "(TNFR)", "and", "an", "antibody", "portion,", "which", "is", "being", "developed", "as", "a", "treatment", "of", "certain", "immune", "diseases", "such", "as", "rheumatoid", "arthritis,", "juvenile", "idiopathic", "arthritis,", "ankylosing,", "spondylitis,", "psoriatic", "arthritis", "and", "plaque", "psoriasis;", "(4)", "an", "orally", "administrated", "glucocerebrosidase", "enzyme", "for", "treating", "Gaucher", "disease", "patients", "utilizing", "the", "oral", "delivery", "of", "the", "recombinant", "enzyme", "produced", "within", "carrot", "cells;", "and", "(5)", "two", "additional", "undisclosed", "therapeutic", "proteins,", "both", "of", "which", "are", "being", "evaluated", "in", "animal", "studies."], "wordsB": ["Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates:", "(1)", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans;", "(2)", "PRX-105,", "a", "plant", "cell", "expressed", "pegylated", "recombinant", "acetylcholinesterase", "product", "candidate", "for", "biodefense", "and", "other", "indications;", "(3)", "an", "orally-administered", "glucocerebrosidase", "enzyme", "for", "the", "treatment", "of", "Gaucher", "patients", "utilizing", "oral", "delivery", "of", "the", "recombinant", "enzyme", "produced", "within", "carrot", "cells;", "(4)", "PRX-106,", "or", "pr-antiTNF,", "a", "plant", "cell", "expressed", "recombinant", "fusion", "protein", "made", "from", "the", "soluble", "form", "of", "the", "human", "TNF", "receptor", "(TNFR)", "and", "an", "antibody", "portion,", "which", "is", "being", "developed", "as", "a", "treatment", "of", "certain", "immune", "diseases", "such", "as", "rheumatoid", "arthritis,", "Chrohn's", "disease,", "placque", "psoriasis", "and", "other", "autoimmune", "disorders;", "and", "(5)", "two", "additional", "undisclosed", "therapeutic", "proteins,", "both", "of", "which", "are", "being", "evaluated", "in", "animal", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p14_s2", "idA": "1006281_12_item7_p25_s2", "sentA": "We participated in a pre IND meeting with respect to one of the undisclosed product candidates in the first quarter of 2012 and a pre IND meeting for the second candidate is planned for later this year.", "sentB": "We participated in a pre-investigational new drug, or IND, meeting with respect to one of the undisclosed product candidates in the first quarter of 2012 and a pre-IND meeting for the second candidate is planned for 2013.", "type": 2, "words": ["<tag1>", "We", "participated", "in", "a", "pre", "IND", "meeting", "with", "respect", "to", "one", "of", "the", "undisclosed", "product", "candidates", "in", "the", "first", "quarter", "of", "2012", "and", "a", "pre", "IND", "meeting", "for", "the", "second", "candidate", "is", "planned", "for", "later", "this", "year.", "<tag2>", "We", "participated", "in", "a", "pre-investigational", "new", "drug,", "or", "IND,", "meeting", "with", "respect", "to", "one", "of", "the", "undisclosed", "product", "candidates", "in", "the", "first", "quarter", "of", "2012", "and", "a", "pre-IND", "meeting", "for", "the", "second", "candidate", "is", "planned", "for", "2013.", "<tag3>"], "wordsA": ["We", "participated", "in", "a", "pre", "IND", "meeting", "with", "respect", "to", "one", "of", "the", "undisclosed", "product", "candidates", "in", "the", "first", "quarter", "of", "2012", "and", "a", "pre", "IND", "meeting", "for", "the", "second", "candidate", "is", "planned", "for", "later", "this", "year."], "wordsB": ["We", "participated", "in", "a", "pre-investigational", "new", "drug,", "or", "IND,", "meeting", "with", "respect", "to", "one", "of", "the", "undisclosed", "product", "candidates", "in", "the", "first", "quarter", "of", "2012", "and", "a", "pre-IND", "meeting", "for", "the", "second", "candidate", "is", "planned", "for", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p10_s3", "idA": "1006281_12_item7_p26_s0", "sentA": "In March 2010, we initiated a preliminary phase I clinical trial of PRX-105 which we completed in June 2010.", "sentB": "We also conducted a clinical trial of na ve and switchover pediatric patients which we concluded in 2012.", "type": 2, "words": ["<tag1>", "In", "March", "2010,", "we", "initiated", "a", "preliminary", "phase", "I", "clinical", "trial", "of", "PRX-105", "which", "we", "completed", "in", "June", "2010.", "<tag2>", "We", "also", "conducted", "a", "clinical", "trial", "of", "na", "ve", "and", "switchover", "pediatric", "patients", "which", "we", "concluded", "in", "2012.", "<tag3>"], "wordsA": ["In", "March", "2010,", "we", "initiated", "a", "preliminary", "phase", "I", "clinical", "trial", "of", "PRX-105", "which", "we", "completed", "in", "June", "2010."], "wordsB": ["We", "also", "conducted", "a", "clinical", "trial", "of", "na", "ve", "and", "switchover", "pediatric", "patients", "which", "we", "concluded", "in", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p8_s1", "idA": "1006281_12_item7_p26_s1", "sentA": "We are currently preparing for further efficacy trials of this product candidate in larger animals.", "sentB": "We are currently sponsoring adult and pediatric extension studies of ELELYSO.", "type": 2, "words": ["<tag1>", "We", "are", "currently", "preparing", "for", "further", "efficacy", "trials", "of", "this", "product", "candidate", "in", "larger", "animals.", "<tag2>", "We", "are", "currently", "sponsoring", "adult", "and", "pediatric", "extension", "studies", "of", "ELELYSO.", "<tag3>"], "wordsA": ["We", "are", "currently", "preparing", "for", "further", "efficacy", "trials", "of", "this", "product", "candidate", "in", "larger", "animals."], "wordsB": ["We", "are", "currently", "sponsoring", "adult", "and", "pediatric", "extension", "studies", "of", "ELELYSO."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p16_s0", "idA": "1006281_12_item7_p28_s1", "sentA": "We completed preclinical trials in small and large animals with respect to PRX-102, and we expect to submit an IND to the FDA during the second quarter of 2012 in connection with an anticipated phase I/II clinical study of PRX-102 in Fabry patients, and to initiate the trial once the IND is approved, if at all.", "sentB": "In December 2012, the first patient was treated in our phase I/II clinical study of PRX-102 in Fabry patients.", "type": 2, "words": ["<tag1>", "We", "completed", "preclinical", "trials", "in", "small", "and", "large", "animals", "with", "respect", "to", "PRX-102,", "and", "we", "expect", "to", "submit", "an", "IND", "to", "the", "FDA", "during", "the", "second", "quarter", "of", "2012", "in", "connection", "with", "an", "anticipated", "phase", "I/II", "clinical", "study", "of", "PRX-102", "in", "Fabry", "patients,", "and", "to", "initiate", "the", "trial", "once", "the", "IND", "is", "approved,", "if", "at", "all.", "<tag2>", "In", "December", "2012,", "the", "first", "patient", "was", "treated", "in", "our", "phase", "I/II", "clinical", "study", "of", "PRX-102", "in", "Fabry", "patients.", "<tag3>"], "wordsA": ["We", "completed", "preclinical", "trials", "in", "small", "and", "large", "animals", "with", "respect", "to", "PRX-102,", "and", "we", "expect", "to", "submit", "an", "IND", "to", "the", "FDA", "during", "the", "second", "quarter", "of", "2012", "in", "connection", "with", "an", "anticipated", "phase", "I/II", "clinical", "study", "of", "PRX-102", "in", "Fabry", "patients,", "and", "to", "initiate", "the", "trial", "once", "the", "IND", "is", "approved,", "if", "at", "all."], "wordsB": ["In", "December", "2012,", "the", "first", "patient", "was", "treated", "in", "our", "phase", "I/II", "clinical", "study", "of", "PRX-102", "in", "Fabry", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p16_s2", "idA": "1006281_12_item7_p28_s2", "sentA": "In December 2011 we held a pre IND meeting with respect to PRX 106 and we expect to submit an IND around year end.", "sentB": "In December 2011, we held a pre-IND meeting with respect to PRX-106 and we expect to submit an IND during 2013.", "type": 2, "words": ["<tag1>", "In", "December", "2011", "we", "held", "a", "pre", "IND", "meeting", "with", "respect", "to", "PRX", "106", "and", "we", "expect", "to", "submit", "an", "IND", "around", "year", "end.", "<tag2>", "In", "December", "2011,", "we", "held", "a", "pre-IND", "meeting", "with", "respect", "to", "PRX-106", "and", "we", "expect", "to", "submit", "an", "IND", "during", "2013.", "<tag3>"], "wordsA": ["In", "December", "2011", "we", "held", "a", "pre", "IND", "meeting", "with", "respect", "to", "PRX", "106", "and", "we", "expect", "to", "submit", "an", "IND", "around", "year", "end."], "wordsB": ["In", "December", "2011,", "we", "held", "a", "pre-IND", "meeting", "with", "respect", "to", "PRX-106", "and", "we", "expect", "to", "submit", "an", "IND", "during", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p17_s0", "idA": "1006281_12_item7_p29_s0", "sentA": "Except for the rights to commercialize taliglucerase alfa worldwide (other than Israel) which we licensed to Pfizer, we hold the worldwide commercialization rights to our proprietary development candidates, and we intend to establish an internal, commercial infrastructure and targeted sales force to market taliglucerase alfa in Israel and our other products, if approved, in North America, the European Union and in other significant markets, including Israel.", "sentB": "Except for the rights to commercialize taliglucerase alfa worldwide (other than Israel) which we licensed to Pfizer, we hold the worldwide commercialization rights to our proprietary development candidates.", "type": 2, "words": ["<tag1>", "Except", "for", "the", "rights", "to", "commercialize", "taliglucerase", "alfa", "worldwide", "(other", "than", "Israel)", "which", "we", "licensed", "to", "Pfizer,", "we", "hold", "the", "worldwide", "commercialization", "rights", "to", "our", "proprietary", "development", "candidates,", "and", "we", "intend", "to", "establish", "an", "internal,", "commercial", "infrastructure", "and", "targeted", "sales", "force", "to", "market", "taliglucerase", "alfa", "in", "Israel", "and", "our", "other", "products,", "if", "approved,", "in", "North", "America,", "the", "European", "Union", "and", "in", "other", "significant", "markets,", "including", "Israel.", "<tag2>", "Except", "for", "the", "rights", "to", "commercialize", "taliglucerase", "alfa", "worldwide", "(other", "than", "Israel)", "which", "we", "licensed", "to", "Pfizer,", "we", "hold", "the", "worldwide", "commercialization", "rights", "to", "our", "proprietary", "development", "candidates.", "<tag3>"], "wordsA": ["Except", "for", "the", "rights", "to", "commercialize", "taliglucerase", "alfa", "worldwide", "(other", "than", "Israel)", "which", "we", "licensed", "to", "Pfizer,", "we", "hold", "the", "worldwide", "commercialization", "rights", "to", "our", "proprietary", "development", "candidates,", "and", "we", "intend", "to", "establish", "an", "internal,", "commercial", "infrastructure", "and", "targeted", "sales", "force", "to", "market", "taliglucerase", "alfa", "in", "Israel", "and", "our", "other", "products,", "if", "approved,", "in", "North", "America,", "the", "European", "Union", "and", "in", "other", "significant", "markets,", "including", "Israel."], "wordsB": ["Except", "for", "the", "rights", "to", "commercialize", "taliglucerase", "alfa", "worldwide", "(other", "than", "Israel)", "which", "we", "licensed", "to", "Pfizer,", "we", "hold", "the", "worldwide", "commercialization", "rights", "to", "our", "proprietary", "development", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p17_s1", "idA": "1006281_12_item7_p29_s0", "sentA": "Except for the rights to commercialize taliglucerase alfa worldwide (other than Israel) which we licensed to Pfizer, we hold the worldwide commercialization rights to our proprietary development candidates, and we intend to establish an internal, commercial infrastructure and targeted sales force to market taliglucerase alfa in Israel and our other products, if approved, in North America, the European Union and in other significant markets, including Israel.", "sentB": "We have built an internal marketing team designed to serve the Israeli market for taliglucerase alfa and we intend to establish internal commercialization and marketing teams for our other product candidates in North America, the European Union and in other significant markets, including Israel, subject to required marketing approvals, as the need arises.", "type": 2, "words": ["<tag1>", "Except", "for", "the", "rights", "to", "commercialize", "taliglucerase", "alfa", "worldwide", "(other", "than", "Israel)", "which", "we", "licensed", "to", "Pfizer,", "we", "hold", "the", "worldwide", "commercialization", "rights", "to", "our", "proprietary", "development", "candidates,", "and", "we", "intend", "to", "establish", "an", "internal,", "commercial", "infrastructure", "and", "targeted", "sales", "force", "to", "market", "taliglucerase", "alfa", "in", "Israel", "and", "our", "other", "products,", "if", "approved,", "in", "North", "America,", "the", "European", "Union", "and", "in", "other", "significant", "markets,", "including", "Israel.", "<tag2>", "We", "have", "built", "an", "internal", "marketing", "team", "designed", "to", "serve", "the", "Israeli", "market", "for", "taliglucerase", "alfa", "and", "we", "intend", "to", "establish", "internal", "commercialization", "and", "marketing", "teams", "for", "our", "other", "product", "candidates", "in", "North", "America,", "the", "European", "Union", "and", "in", "other", "significant", "markets,", "including", "Israel,", "subject", "to", "required", "marketing", "approvals,", "as", "the", "need", "arises.", "<tag3>"], "wordsA": ["Except", "for", "the", "rights", "to", "commercialize", "taliglucerase", "alfa", "worldwide", "(other", "than", "Israel)", "which", "we", "licensed", "to", "Pfizer,", "we", "hold", "the", "worldwide", "commercialization", "rights", "to", "our", "proprietary", "development", "candidates,", "and", "we", "intend", "to", "establish", "an", "internal,", "commercial", "infrastructure", "and", "targeted", "sales", "force", "to", "market", "taliglucerase", "alfa", "in", "Israel", "and", "our", "other", "products,", "if", "approved,", "in", "North", "America,", "the", "European", "Union", "and", "in", "other", "significant", "markets,", "including", "Israel."], "wordsB": ["We", "have", "built", "an", "internal", "marketing", "team", "designed", "to", "serve", "the", "Israeli", "market", "for", "taliglucerase", "alfa", "and", "we", "intend", "to", "establish", "internal", "commercialization", "and", "marketing", "teams", "for", "our", "other", "product", "candidates", "in", "North", "America,", "the", "European", "Union", "and", "in", "other", "significant", "markets,", "including", "Israel,", "subject", "to", "required", "marketing", "approvals,", "as", "the", "need", "arises."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p17_s2", "idA": "1006281_12_item7_p29_s1", "sentA": "In addition we are continuously evaluating potential strategic marketing partnerships.", "sentB": "In addition, we continuously evaluate potential strategic marketing partnerships.", "type": 2, "words": ["<tag1>", "In", "addition", "we", "are", "continuously", "evaluating", "potential", "strategic", "marketing", "partnerships.", "<tag2>", "In", "addition,", "we", "continuously", "evaluate", "potential", "strategic", "marketing", "partnerships.", "<tag3>"], "wordsA": ["In", "addition", "we", "are", "continuously", "evaluating", "potential", "strategic", "marketing", "partnerships."], "wordsB": ["In", "addition,", "we", "continuously", "evaluate", "potential", "strategic", "marketing", "partnerships."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p6_s0", "idA": "1006281_12_item7_p31_s0", "sentA": "Our business is conducted by our wholly-owned subsidiary, Protalix Ltd., which we acquired through a reverse merger transaction effective December 31, 2006.", "sentB": "Since May 2012, taliglucerase alfa has been marketed in the United States by Pfizer, our commercialization partner, as provided in the exclusive license and supply agreement by and between Protalix Ltd., our wholly-owned subsidiary, and Pfizer, which we refer to as the Pfizer Agreement.", "type": 2, "words": ["<tag1>", "Our", "business", "is", "conducted", "by", "our", "wholly-owned", "subsidiary,", "Protalix", "Ltd.,", "which", "we", "acquired", "through", "a", "reverse", "merger", "transaction", "effective", "December", "31,", "2006.", "<tag2>", "Since", "May", "2012,", "taliglucerase", "alfa", "has", "been", "marketed", "in", "the", "United", "States", "by", "Pfizer,", "our", "commercialization", "partner,", "as", "provided", "in", "the", "exclusive", "license", "and", "supply", "agreement", "by", "and", "between", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary,", "and", "Pfizer,", "which", "we", "refer", "to", "as", "the", "Pfizer", "Agreement.", "<tag3>"], "wordsA": ["Our", "business", "is", "conducted", "by", "our", "wholly-owned", "subsidiary,", "Protalix", "Ltd.,", "which", "we", "acquired", "through", "a", "reverse", "merger", "transaction", "effective", "December", "31,", "2006."], "wordsB": ["Since", "May", "2012,", "taliglucerase", "alfa", "has", "been", "marketed", "in", "the", "United", "States", "by", "Pfizer,", "our", "commercialization", "partner,", "as", "provided", "in", "the", "exclusive", "license", "and", "supply", "agreement", "by", "and", "between", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary,", "and", "Pfizer,", "which", "we", "refer", "to", "as", "the", "Pfizer", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p20_s0", "idA": "1006281_12_item7_p33_s1", "sentA": "Since its inception in December 1993, Protalix Ltd. has generated significant losses in connection with its research and development, including the clinical development of taliglucerase alfa.", "sentB": "Protalix Ltd. was originally incorporated in Israel in December 1993 and, since inception, it has generated significant losses in connection with its research and development, including the clinical development of taliglucerase alfa.", "type": 2, "words": ["<tag1>", "Since", "its", "inception", "in", "December", "1993,", "Protalix", "Ltd.", "has", "generated", "significant", "losses", "in", "connection", "with", "its", "research", "and", "development,", "including", "the", "clinical", "development", "of", "taliglucerase", "alfa.", "<tag2>", "Protalix", "Ltd.", "was", "originally", "incorporated", "in", "Israel", "in", "December", "1993", "and,", "since", "inception,", "it", "has", "generated", "significant", "losses", "in", "connection", "with", "its", "research", "and", "development,", "including", "the", "clinical", "development", "of", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["Since", "its", "inception", "in", "December", "1993,", "Protalix", "Ltd.", "has", "generated", "significant", "losses", "in", "connection", "with", "its", "research", "and", "development,", "including", "the", "clinical", "development", "of", "taliglucerase", "alfa."], "wordsB": ["Protalix", "Ltd.", "was", "originally", "incorporated", "in", "Israel", "in", "December", "1993", "and,", "since", "inception,", "it", "has", "generated", "significant", "losses", "in", "connection", "with", "its", "research", "and", "development,", "including", "the", "clinical", "development", "of", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p70_s2", "idA": "1006281_12_item7_p33_s1", "sentA": "Since its inception in December 1993, Protalix Ltd. has generated significant losses in connection with its research and development, including the clinical development of taliglucerase alfa.", "sentB": "Protalix Ltd. also received a milestone payment of $25.0 in connection with the FDA's approval of taliglucerase alfa in May 2012.", "type": 2, "words": ["<tag1>", "Since", "its", "inception", "in", "December", "1993,", "Protalix", "Ltd.", "has", "generated", "significant", "losses", "in", "connection", "with", "its", "research", "and", "development,", "including", "the", "clinical", "development", "of", "taliglucerase", "alfa.", "<tag2>", "Protalix", "Ltd.", "also", "received", "a", "milestone", "payment", "of", "$25.0", "in", "connection", "with", "the", "FDA's", "approval", "of", "taliglucerase", "alfa", "in", "May", "2012.", "<tag3>"], "wordsA": ["Since", "its", "inception", "in", "December", "1993,", "Protalix", "Ltd.", "has", "generated", "significant", "losses", "in", "connection", "with", "its", "research", "and", "development,", "including", "the", "clinical", "development", "of", "taliglucerase", "alfa."], "wordsB": ["Protalix", "Ltd.", "also", "received", "a", "milestone", "payment", "of", "$25.0", "in", "connection", "with", "the", "FDA's", "approval", "of", "taliglucerase", "alfa", "in", "May", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p20_s1", "idA": "1006281_12_item7_p33_s3", "sentA": "We except that our expenditures in connection with the research and development activities will continue to represent a significant portion of our expenses for the next several years, and will require further financial resources if the activities are successful.", "sentB": "We expect that our expenditures in connection with the research and development activities will continue to represent a significant portion of our expenses for the next several years, and will require further financial resources if the activities are successful.", "type": 2, "words": ["<tag1>", "We", "except", "that", "our", "expenditures", "in", "connection", "with", "the", "research", "and", "development", "activities", "will", "continue", "to", "represent", "a", "significant", "portion", "of", "our", "expenses", "for", "the", "next", "several", "years,", "and", "will", "require", "further", "financial", "resources", "if", "the", "activities", "are", "successful.", "<tag2>", "We", "expect", "that", "our", "expenditures", "in", "connection", "with", "the", "research", "and", "development", "activities", "will", "continue", "to", "represent", "a", "significant", "portion", "of", "our", "expenses", "for", "the", "next", "several", "years,", "and", "will", "require", "further", "financial", "resources", "if", "the", "activities", "are", "successful.", "<tag3>"], "wordsA": ["We", "except", "that", "our", "expenditures", "in", "connection", "with", "the", "research", "and", "development", "activities", "will", "continue", "to", "represent", "a", "significant", "portion", "of", "our", "expenses", "for", "the", "next", "several", "years,", "and", "will", "require", "further", "financial", "resources", "if", "the", "activities", "are", "successful."], "wordsB": ["We", "expect", "that", "our", "expenditures", "in", "connection", "with", "the", "research", "and", "development", "activities", "will", "continue", "to", "represent", "a", "significant", "portion", "of", "our", "expenses", "for", "the", "next", "several", "years,", "and", "will", "require", "further", "financial", "resources", "if", "the", "activities", "are", "successful."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p20_s2", "idA": "1006281_12_item7_p33_s5", "sentA": "However, if taliglucerase alfa is launched successfully, we anticipate that we will generate revenues to offset any such losses.", "sentB": "We believe that if taliglucerase alfa is launched successfully, it will generate revenues to offset any such expenses.", "type": 2, "words": ["<tag1>", "However,", "if", "taliglucerase", "alfa", "is", "launched", "successfully,", "we", "anticipate", "that", "we", "will", "generate", "revenues", "to", "offset", "any", "such", "losses.", "<tag2>", "We", "believe", "that", "if", "taliglucerase", "alfa", "is", "launched", "successfully,", "it", "will", "generate", "revenues", "to", "offset", "any", "such", "expenses.", "<tag3>"], "wordsA": ["However,", "if", "taliglucerase", "alfa", "is", "launched", "successfully,", "we", "anticipate", "that", "we", "will", "generate", "revenues", "to", "offset", "any", "such", "losses."], "wordsB": ["We", "believe", "that", "if", "taliglucerase", "alfa", "is", "launched", "successfully,", "it", "will", "generate", "revenues", "to", "offset", "any", "such", "expenses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p75_s2", "idA": "1006281_12_item7_p33_s5", "sentA": "However, if taliglucerase alfa is launched successfully, we anticipate that we will generate revenues to offset any such losses.", "sentB": "We also anticipate that we will generate additional revenues after additional anticipated marketing approvals of taliglucerase alfa are granted outside of the United States and Israel, including, primarily, in Brazil.", "type": 2, "words": ["<tag1>", "However,", "if", "taliglucerase", "alfa", "is", "launched", "successfully,", "we", "anticipate", "that", "we", "will", "generate", "revenues", "to", "offset", "any", "such", "losses.", "<tag2>", "We", "also", "anticipate", "that", "we", "will", "generate", "additional", "revenues", "after", "additional", "anticipated", "marketing", "approvals", "of", "taliglucerase", "alfa", "are", "granted", "outside", "of", "the", "United", "States", "and", "Israel,", "including,", "primarily,", "in", "Brazil.", "<tag3>"], "wordsA": ["However,", "if", "taliglucerase", "alfa", "is", "launched", "successfully,", "we", "anticipate", "that", "we", "will", "generate", "revenues", "to", "offset", "any", "such", "losses."], "wordsB": ["We", "also", "anticipate", "that", "we", "will", "generate", "additional", "revenues", "after", "additional", "anticipated", "marketing", "approvals", "of", "taliglucerase", "alfa", "are", "granted", "outside", "of", "the", "United", "States", "and", "Israel,", "including,", "primarily,", "in", "Brazil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p20_s3", "idA": "1006281_12_item7_p33_s6", "sentA": "We may need to obtain additional funds for the commercialization of our lead product, taliglucerase alfa, and to further develop the research and clinical development of our other programs.", "sentB": "We may need to obtain additional funds for the commercialization of taliglucerase alfa and to further develop the research and clinical development of our other programs.", "type": 2, "words": ["<tag1>", "We", "may", "need", "to", "obtain", "additional", "funds", "for", "the", "commercialization", "of", "our", "lead", "product,", "taliglucerase", "alfa,", "and", "to", "further", "develop", "the", "research", "and", "clinical", "development", "of", "our", "other", "programs.", "<tag2>", "We", "may", "need", "to", "obtain", "additional", "funds", "for", "the", "commercialization", "of", "taliglucerase", "alfa", "and", "to", "further", "develop", "the", "research", "and", "clinical", "development", "of", "our", "other", "programs.", "<tag3>"], "wordsA": ["We", "may", "need", "to", "obtain", "additional", "funds", "for", "the", "commercialization", "of", "our", "lead", "product,", "taliglucerase", "alfa,", "and", "to", "further", "develop", "the", "research", "and", "clinical", "development", "of", "our", "other", "programs."], "wordsB": ["We", "may", "need", "to", "obtain", "additional", "funds", "for", "the", "commercialization", "of", "taliglucerase", "alfa", "and", "to", "further", "develop", "the", "research", "and", "clinical", "development", "of", "our", "other", "programs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p23_s1", "idA": "1006281_12_item7_p36_s2", "sentA": "Most of our expenses and capital expenditures are incurred in dollars, and a significant source of our financing has been provided in U.S. dollars.", "sentB": "Most of the Company s revenues are derived in dollars.", "type": 2, "words": ["<tag1>", "Most", "of", "our", "expenses", "and", "capital", "expenditures", "are", "incurred", "in", "dollars,", "and", "a", "significant", "source", "of", "our", "financing", "has", "been", "provided", "in", "U.S.", "dollars.", "<tag2>", "Most", "of", "the", "Company", "s", "revenues", "are", "derived", "in", "dollars.", "<tag3>"], "wordsA": ["Most", "of", "our", "expenses", "and", "capital", "expenditures", "are", "incurred", "in", "dollars,", "and", "a", "significant", "source", "of", "our", "financing", "has", "been", "provided", "in", "U.S.", "dollars."], "wordsB": ["Most", "of", "the", "Company", "s", "revenues", "are", "derived", "in", "dollars."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p23_s2", "idA": "1006281_12_item7_p36_s2", "sentA": "Most of our expenses and capital expenditures are incurred in dollars, and a significant source of our financing has been provided in U.S. dollars.", "sentB": "In addition, most of the Company s expenses and capital expenditures are incurred in dollars, and the major source of the Company s financing has been provided in dollars.", "type": 2, "words": ["<tag1>", "Most", "of", "our", "expenses", "and", "capital", "expenditures", "are", "incurred", "in", "dollars,", "and", "a", "significant", "source", "of", "our", "financing", "has", "been", "provided", "in", "U.S.", "dollars.", "<tag2>", "In", "addition,", "most", "of", "the", "Company", "s", "expenses", "and", "capital", "expenditures", "are", "incurred", "in", "dollars,", "and", "the", "major", "source", "of", "the", "Company", "s", "financing", "has", "been", "provided", "in", "dollars.", "<tag3>"], "wordsA": ["Most", "of", "our", "expenses", "and", "capital", "expenditures", "are", "incurred", "in", "dollars,", "and", "a", "significant", "source", "of", "our", "financing", "has", "been", "provided", "in", "U.S.", "dollars."], "wordsB": ["In", "addition,", "most", "of", "the", "Company", "s", "expenses", "and", "capital", "expenditures", "are", "incurred", "in", "dollars,", "and", "the", "major", "source", "of", "the", "Company", "s", "financing", "has", "been", "provided", "in", "dollars."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p24_s0", "idA": "1006281_12_item7_p37_s0", "sentA": "Currently, our sole source of revenues comes from sales of taliglucerase alfa pursuant to our license agreement with Pfizer.", "sentB": "Currently, our sole source of revenues comes from sales of taliglucerase alfa pursuant to our license agreement with Pfizer, our sales of taliglucerase alfa in Israel and from milestone payments under the Pfizer Agreement.", "type": 2, "words": ["<tag1>", "Currently,", "our", "sole", "source", "of", "revenues", "comes", "from", "sales", "of", "taliglucerase", "alfa", "pursuant", "to", "our", "license", "agreement", "with", "Pfizer.", "<tag2>", "Currently,", "our", "sole", "source", "of", "revenues", "comes", "from", "sales", "of", "taliglucerase", "alfa", "pursuant", "to", "our", "license", "agreement", "with", "Pfizer,", "our", "sales", "of", "taliglucerase", "alfa", "in", "Israel", "and", "from", "milestone", "payments", "under", "the", "Pfizer", "Agreement.", "<tag3>"], "wordsA": ["Currently,", "our", "sole", "source", "of", "revenues", "comes", "from", "sales", "of", "taliglucerase", "alfa", "pursuant", "to", "our", "license", "agreement", "with", "Pfizer."], "wordsB": ["Currently,", "our", "sole", "source", "of", "revenues", "comes", "from", "sales", "of", "taliglucerase", "alfa", "pursuant", "to", "our", "license", "agreement", "with", "Pfizer,", "our", "sales", "of", "taliglucerase", "alfa", "in", "Israel", "and", "from", "milestone", "payments", "under", "the", "Pfizer", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p32_s1", "idA": "1006281_12_item7_p37_s0", "sentA": "Currently, our sole source of revenues comes from sales of taliglucerase alfa pursuant to our license agreement with Pfizer.", "sentB": "In addition, we continue to incur costs in connection with our extension studies of taliglucerase alfa, although such costs are offset by the $8.3 million payment we received in connection with our clinical development agreement with Pfizer.", "type": 2, "words": ["<tag1>", "Currently,", "our", "sole", "source", "of", "revenues", "comes", "from", "sales", "of", "taliglucerase", "alfa", "pursuant", "to", "our", "license", "agreement", "with", "Pfizer.", "<tag2>", "In", "addition,", "we", "continue", "to", "incur", "costs", "in", "connection", "with", "our", "extension", "studies", "of", "taliglucerase", "alfa,", "although", "such", "costs", "are", "offset", "by", "the", "$8.3", "million", "payment", "we", "received", "in", "connection", "with", "our", "clinical", "development", "agreement", "with", "Pfizer.", "<tag3>"], "wordsA": ["Currently,", "our", "sole", "source", "of", "revenues", "comes", "from", "sales", "of", "taliglucerase", "alfa", "pursuant", "to", "our", "license", "agreement", "with", "Pfizer."], "wordsB": ["In", "addition,", "we", "continue", "to", "incur", "costs", "in", "connection", "with", "our", "extension", "studies", "of", "taliglucerase", "alfa,", "although", "such", "costs", "are", "offset", "by", "the", "$8.3", "million", "payment", "we", "received", "in", "connection", "with", "our", "clinical", "development", "agreement", "with", "Pfizer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p25_s0", "idA": "1006281_12_item7_p38_s0", "sentA": "We recognize revenue and milestone payments received pursuant to the Pfizer Agreement in accordance with guidance regarding revenue recognition and accounting for revenue arrangements with multiple deliverables.", "sentB": "We recognize revenue from milestone payments received pursuant to the Pfizer Agreement in accordance with guidance regarding revenue recognition and accounting for revenue arrangements with multiple deliverables.", "type": 2, "words": ["<tag1>", "We", "recognize", "revenue", "and", "milestone", "payments", "received", "pursuant", "to", "the", "Pfizer", "Agreement", "in", "accordance", "with", "guidance", "regarding", "revenue", "recognition", "and", "accounting", "for", "revenue", "arrangements", "with", "multiple", "deliverables.", "<tag2>", "We", "recognize", "revenue", "from", "milestone", "payments", "received", "pursuant", "to", "the", "Pfizer", "Agreement", "in", "accordance", "with", "guidance", "regarding", "revenue", "recognition", "and", "accounting", "for", "revenue", "arrangements", "with", "multiple", "deliverables.", "<tag3>"], "wordsA": ["We", "recognize", "revenue", "and", "milestone", "payments", "received", "pursuant", "to", "the", "Pfizer", "Agreement", "in", "accordance", "with", "guidance", "regarding", "revenue", "recognition", "and", "accounting", "for", "revenue", "arrangements", "with", "multiple", "deliverables."], "wordsB": ["We", "recognize", "revenue", "from", "milestone", "payments", "received", "pursuant", "to", "the", "Pfizer", "Agreement", "in", "accordance", "with", "guidance", "regarding", "revenue", "recognition", "and", "accounting", "for", "revenue", "arrangements", "with", "multiple", "deliverables."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p26_s0", "idA": "1006281_12_item7_p39_s0", "sentA": "Under the terms and conditions of the Pfizer Agreement, we are entitled to 40% of the net profits or loss from sales of taliglucerase alfa by Pfizer and reimbursement of our certain related expenses we incur in connection with Pfizer's sales.", "sentB": "Under the terms and conditions of the Pfizer Agreement, we are entitled to 40% of the net profits or loss from sales of taliglucerase alfa by Pfizer and reimbursement of our certain related expenses we incur in connection with Pfizer's sales (other than those related to sales in Israel).", "type": 2, "words": ["<tag1>", "Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement,", "we", "are", "entitled", "to", "40%", "of", "the", "net", "profits", "or", "loss", "from", "sales", "of", "taliglucerase", "alfa", "by", "Pfizer", "and", "reimbursement", "of", "our", "certain", "related", "expenses", "we", "incur", "in", "connection", "with", "Pfizer's", "sales.", "<tag2>", "Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement,", "we", "are", "entitled", "to", "40%", "of", "the", "net", "profits", "or", "loss", "from", "sales", "of", "taliglucerase", "alfa", "by", "Pfizer", "and", "reimbursement", "of", "our", "certain", "related", "expenses", "we", "incur", "in", "connection", "with", "Pfizer's", "sales", "(other", "than", "those", "related", "to", "sales", "in", "Israel).", "<tag3>"], "wordsA": ["Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement,", "we", "are", "entitled", "to", "40%", "of", "the", "net", "profits", "or", "loss", "from", "sales", "of", "taliglucerase", "alfa", "by", "Pfizer", "and", "reimbursement", "of", "our", "certain", "related", "expenses", "we", "incur", "in", "connection", "with", "Pfizer's", "sales."], "wordsB": ["Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement,", "we", "are", "entitled", "to", "40%", "of", "the", "net", "profits", "or", "loss", "from", "sales", "of", "taliglucerase", "alfa", "by", "Pfizer", "and", "reimbursement", "of", "our", "certain", "related", "expenses", "we", "incur", "in", "connection", "with", "Pfizer's", "sales", "(other", "than", "those", "related", "to", "sales", "in", "Israel)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p8_s5", "idA": "1006281_12_item7_p39_s0", "sentA": "Under the terms and conditions of the Pfizer Agreement, we are entitled to 40% of the net profits or loss from sales of taliglucerase alfa by Pfizer and reimbursement of our certain related expenses we incur in connection with Pfizer's sales.", "sentB": "The $8.3 million milestone payment we received in connection with certain clinical development milestones will be recognized as a deduction from the relevant expenses we incur during the relevant periods.", "type": 2, "words": ["<tag1>", "Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement,", "we", "are", "entitled", "to", "40%", "of", "the", "net", "profits", "or", "loss", "from", "sales", "of", "taliglucerase", "alfa", "by", "Pfizer", "and", "reimbursement", "of", "our", "certain", "related", "expenses", "we", "incur", "in", "connection", "with", "Pfizer's", "sales.", "<tag2>", "The", "$8.3", "million", "milestone", "payment", "we", "received", "in", "connection", "with", "certain", "clinical", "development", "milestones", "will", "be", "recognized", "as", "a", "deduction", "from", "the", "relevant", "expenses", "we", "incur", "during", "the", "relevant", "periods.", "<tag3>"], "wordsA": ["Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement,", "we", "are", "entitled", "to", "40%", "of", "the", "net", "profits", "or", "loss", "from", "sales", "of", "taliglucerase", "alfa", "by", "Pfizer", "and", "reimbursement", "of", "our", "certain", "related", "expenses", "we", "incur", "in", "connection", "with", "Pfizer's", "sales."], "wordsB": ["The", "$8.3", "million", "milestone", "payment", "we", "received", "in", "connection", "with", "certain", "clinical", "development", "milestones", "will", "be", "recognized", "as", "a", "deduction", "from", "the", "relevant", "expenses", "we", "incur", "during", "the", "relevant", "periods."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p2_s1", "idA": "1006281_12_item7_p39_s1", "sentA": "We retained all rights to taliglucerase alfa in Israel.", "sentB": "The Israeli MOH approved taliglucerase alfa in September 2012 and it also approved for sale in Uruguay.", "type": 2, "words": ["<tag1>", "We", "retained", "all", "rights", "to", "taliglucerase", "alfa", "in", "Israel.", "<tag2>", "The", "Israeli", "MOH", "approved", "taliglucerase", "alfa", "in", "September", "2012", "and", "it", "also", "approved", "for", "sale", "in", "Uruguay.", "<tag3>"], "wordsA": ["We", "retained", "all", "rights", "to", "taliglucerase", "alfa", "in", "Israel."], "wordsB": ["The", "Israeli", "MOH", "approved", "taliglucerase", "alfa", "in", "September", "2012", "and", "it", "also", "approved", "for", "sale", "in", "Uruguay."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p7_s0", "idA": "1006281_12_item7_p39_s1", "sentA": "We retained all rights to taliglucerase alfa in Israel.", "sentB": "We are cooperating with Pfizer to obtain marketing approval for taliglucerase alfa in additional countries and jurisdictions.", "type": 2, "words": ["<tag1>", "We", "retained", "all", "rights", "to", "taliglucerase", "alfa", "in", "Israel.", "<tag2>", "We", "are", "cooperating", "with", "Pfizer", "to", "obtain", "marketing", "approval", "for", "taliglucerase", "alfa", "in", "additional", "countries", "and", "jurisdictions.", "<tag3>"], "wordsA": ["We", "retained", "all", "rights", "to", "taliglucerase", "alfa", "in", "Israel."], "wordsB": ["We", "are", "cooperating", "with", "Pfizer", "to", "obtain", "marketing", "approval", "for", "taliglucerase", "alfa", "in", "additional", "countries", "and", "jurisdictions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p75_s0", "idA": "1006281_12_item7_p42_s0", "sentA": "We expect our research and development expense to remain our primary expense in the near future as we continue to develop our product candidates.", "sentB": "We expect to continue to incur significant expenditures in the near future.", "type": 2, "words": ["<tag1>", "We", "expect", "our", "research", "and", "development", "expense", "to", "remain", "our", "primary", "expense", "in", "the", "near", "future", "as", "we", "continue", "to", "develop", "our", "product", "candidates.", "<tag2>", "We", "expect", "to", "continue", "to", "incur", "significant", "expenditures", "in", "the", "near", "future.", "<tag3>"], "wordsA": ["We", "expect", "our", "research", "and", "development", "expense", "to", "remain", "our", "primary", "expense", "in", "the", "near", "future", "as", "we", "continue", "to", "develop", "our", "product", "candidates."], "wordsB": ["We", "expect", "to", "continue", "to", "incur", "significant", "expenditures", "in", "the", "near", "future."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p32_s2", "idA": "1006281_12_item7_p45_s0", "sentA": "All of our projects, other than taliglucerase alfa and our acetylcholinesterase product, are in the preclinical or research phase with relatively immaterial costs.", "sentB": "Our other projects are in the early clinical, preclinical or research phases with relatively immaterial costs.", "type": 2, "words": ["<tag1>", "All", "of", "our", "projects,", "other", "than", "taliglucerase", "alfa", "and", "our", "acetylcholinesterase", "product,", "are", "in", "the", "preclinical", "or", "research", "phase", "with", "relatively", "immaterial", "costs.", "<tag2>", "Our", "other", "projects", "are", "in", "the", "early", "clinical,", "preclinical", "or", "research", "phases", "with", "relatively", "immaterial", "costs.", "<tag3>"], "wordsA": ["All", "of", "our", "projects,", "other", "than", "taliglucerase", "alfa", "and", "our", "acetylcholinesterase", "product,", "are", "in", "the", "preclinical", "or", "research", "phase", "with", "relatively", "immaterial", "costs."], "wordsB": ["Our", "other", "projects", "are", "in", "the", "early", "clinical,", "preclinical", "or", "research", "phases", "with", "relatively", "immaterial", "costs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p32_s0", "idA": "1006281_12_item7_p45_s1", "sentA": "Most of our research and development costs were incurred in connection with our phase III clinical trial of taliglucerase alfa.", "sentB": "We anticipate incurring increasing costs in connection with our alpha-galactosidase and oral treatment of Gaucher disease projects.", "type": 2, "words": ["<tag1>", "Most", "of", "our", "research", "and", "development", "costs", "were", "incurred", "in", "connection", "with", "our", "phase", "III", "clinical", "trial", "of", "taliglucerase", "alfa.", "<tag2>", "We", "anticipate", "incurring", "increasing", "costs", "in", "connection", "with", "our", "alpha-galactosidase", "and", "oral", "treatment", "of", "Gaucher", "disease", "projects.", "<tag3>"], "wordsA": ["Most", "of", "our", "research", "and", "development", "costs", "were", "incurred", "in", "connection", "with", "our", "phase", "III", "clinical", "trial", "of", "taliglucerase", "alfa."], "wordsB": ["We", "anticipate", "incurring", "increasing", "costs", "in", "connection", "with", "our", "alpha-galactosidase", "and", "oral", "treatment", "of", "Gaucher", "disease", "projects."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p32_s3", "idA": "1006281_12_item7_p45_s1", "sentA": "Most of our research and development costs were incurred in connection with our phase III clinical trial of taliglucerase alfa.", "sentB": "To date, most of our research and development costs were incurred in connection with our phase III clinical trial of taliglucerase alfa.", "type": 2, "words": ["<tag1>", "Most", "of", "our", "research", "and", "development", "costs", "were", "incurred", "in", "connection", "with", "our", "phase", "III", "clinical", "trial", "of", "taliglucerase", "alfa.", "<tag2>", "To", "date,", "most", "of", "our", "research", "and", "development", "costs", "were", "incurred", "in", "connection", "with", "our", "phase", "III", "clinical", "trial", "of", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["Most", "of", "our", "research", "and", "development", "costs", "were", "incurred", "in", "connection", "with", "our", "phase", "III", "clinical", "trial", "of", "taliglucerase", "alfa."], "wordsB": ["To", "date,", "most", "of", "our", "research", "and", "development", "costs", "were", "incurred", "in", "connection", "with", "our", "phase", "III", "clinical", "trial", "of", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p54_s2", "idA": "1006281_12_item7_p45_s1", "sentA": "Most of our research and development costs were incurred in connection with our phase III clinical trial of taliglucerase alfa.", "sentB": "Prior to the FDA's approval of taliglucerase alfa, manufacturing costs related to taliglucerase alfa were not capitalized; rather, such costs were expensed as research and development expenses.", "type": 2, "words": ["<tag1>", "Most", "of", "our", "research", "and", "development", "costs", "were", "incurred", "in", "connection", "with", "our", "phase", "III", "clinical", "trial", "of", "taliglucerase", "alfa.", "<tag2>", "Prior", "to", "the", "FDA's", "approval", "of", "taliglucerase", "alfa,", "manufacturing", "costs", "related", "to", "taliglucerase", "alfa", "were", "not", "capitalized;", "rather,", "such", "costs", "were", "expensed", "as", "research", "and", "development", "expenses.", "<tag3>"], "wordsA": ["Most", "of", "our", "research", "and", "development", "costs", "were", "incurred", "in", "connection", "with", "our", "phase", "III", "clinical", "trial", "of", "taliglucerase", "alfa."], "wordsB": ["Prior", "to", "the", "FDA's", "approval", "of", "taliglucerase", "alfa,", "manufacturing", "costs", "related", "to", "taliglucerase", "alfa", "were", "not", "capitalized;", "rather,", "such", "costs", "were", "expensed", "as", "research", "and", "development", "expenses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p55_s2", "idA": "1006281_12_item7_p45_s1", "sentA": "Most of our research and development costs were incurred in connection with our phase III clinical trial of taliglucerase alfa.", "sentB": "Such decrease was partially offset by an increase of $4.9 million in salaries expense associated with research and development activities mainly due to share-based compensation, bonuses paid in connection with the FDA s approval of taliglucerase alfa and the initiation of the phase I/II clinical trial of PRX-102 for Fabry disease.", "type": 2, "words": ["<tag1>", "Most", "of", "our", "research", "and", "development", "costs", "were", "incurred", "in", "connection", "with", "our", "phase", "III", "clinical", "trial", "of", "taliglucerase", "alfa.", "<tag2>", "Such", "decrease", "was", "partially", "offset", "by", "an", "increase", "of", "$4.9", "million", "in", "salaries", "expense", "associated", "with", "research", "and", "development", "activities", "mainly", "due", "to", "share-based", "compensation,", "bonuses", "paid", "in", "connection", "with", "the", "FDA", "s", "approval", "of", "taliglucerase", "alfa", "and", "the", "initiation", "of", "the", "phase", "I/II", "clinical", "trial", "of", "PRX-102", "for", "Fabry", "disease.", "<tag3>"], "wordsA": ["Most", "of", "our", "research", "and", "development", "costs", "were", "incurred", "in", "connection", "with", "our", "phase", "III", "clinical", "trial", "of", "taliglucerase", "alfa."], "wordsB": ["Such", "decrease", "was", "partially", "offset", "by", "an", "increase", "of", "$4.9", "million", "in", "salaries", "expense", "associated", "with", "research", "and", "development", "activities", "mainly", "due", "to", "share-based", "compensation,", "bonuses", "paid", "in", "connection", "with", "the", "FDA", "s", "approval", "of", "taliglucerase", "alfa", "and", "the", "initiation", "of", "the", "phase", "I/II", "clinical", "trial", "of", "PRX-102", "for", "Fabry", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p8_s0", "idA": "1006281_12_item7_p47_s0", "sentA": "There can be no assurance that we will continue to receive grants from the OCS in amounts sufficient for our operations, if at all.", "sentB": "In December 2012, we entered into a Clinical Development Agreement with Pfizer under which we will continue to manage, administer and sponsor current, ongoing clinical trials relating to ELELYSO.", "type": 2, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "that", "we", "will", "continue", "to", "receive", "grants", "from", "the", "OCS", "in", "amounts", "sufficient", "for", "our", "operations,", "if", "at", "all.", "<tag2>", "In", "December", "2012,", "we", "entered", "into", "a", "Clinical", "Development", "Agreement", "with", "Pfizer", "under", "which", "we", "will", "continue", "to", "manage,", "administer", "and", "sponsor", "current,", "ongoing", "clinical", "trials", "relating", "to", "ELELYSO.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "that", "we", "will", "continue", "to", "receive", "grants", "from", "the", "OCS", "in", "amounts", "sufficient", "for", "our", "operations,", "if", "at", "all."], "wordsB": ["In", "December", "2012,", "we", "entered", "into", "a", "Clinical", "Development", "Agreement", "with", "Pfizer", "under", "which", "we", "will", "continue", "to", "manage,", "administer", "and", "sponsor", "current,", "ongoing", "clinical", "trials", "relating", "to", "ELELYSO."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p36_s3", "idA": "1006281_12_item7_p49_s4", "sentA": "If we are unable to develop and commercialize our product candidates, our business will be adversely affected and We may not obtain the necessary U.S., EMA or other worldwide regulatory approvals to commercialize our drug candidates in a timely manner, if at all, which would have a material adverse effect on our business, financial condition and results of operations.", "sentB": "See Risk Factors If we are unable to develop and commercialize our product candidates, our business will be adversely affected and We may not obtain the necessary U.S., EMA or other worldwide regulatory approvals to commercialize our drug candidates in a timely manner, if at all, which would have a material adverse effect on our business, financial condition and results of operations.", "type": 2, "words": ["<tag1>", "If", "we", "are", "unable", "to", "develop", "and", "commercialize", "our", "product", "candidates,", "our", "business", "will", "be", "adversely", "affected", "and", "We", "may", "not", "obtain", "the", "necessary", "U.S.,", "EMA", "or", "other", "worldwide", "regulatory", "approvals", "to", "commercialize", "our", "drug", "candidates", "in", "a", "timely", "manner,", "if", "at", "all,", "which", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag2>", "See", "Risk", "Factors", "If", "we", "are", "unable", "to", "develop", "and", "commercialize", "our", "product", "candidates,", "our", "business", "will", "be", "adversely", "affected", "and", "We", "may", "not", "obtain", "the", "necessary", "U.S.,", "EMA", "or", "other", "worldwide", "regulatory", "approvals", "to", "commercialize", "our", "drug", "candidates", "in", "a", "timely", "manner,", "if", "at", "all,", "which", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag3>"], "wordsA": ["If", "we", "are", "unable", "to", "develop", "and", "commercialize", "our", "product", "candidates,", "our", "business", "will", "be", "adversely", "affected", "and", "We", "may", "not", "obtain", "the", "necessary", "U.S.,", "EMA", "or", "other", "worldwide", "regulatory", "approvals", "to", "commercialize", "our", "drug", "candidates", "in", "a", "timely", "manner,", "if", "at", "all,", "which", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "wordsB": ["See", "Risk", "Factors", "If", "we", "are", "unable", "to", "develop", "and", "commercialize", "our", "product", "candidates,", "our", "business", "will", "be", "adversely", "affected", "and", "We", "may", "not", "obtain", "the", "necessary", "U.S.,", "EMA", "or", "other", "worldwide", "regulatory", "approvals", "to", "commercialize", "our", "drug", "candidates", "in", "a", "timely", "manner,", "if", "at", "all,", "which", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p40_s1", "idA": "1006281_12_item7_p52_s1", "sentA": "See Risk Factors Clinical trials are very expensive, time-consuming and difficult to design and implement and may result in unforeseen costs which may have a material adverse effect on our business and results of operations.", "sentB": "See Risk Factors Clinical trials are very expensive, time-consuming and difficult to design and implement and may result in unforeseen costs which may have a material adverse effect on our business, results of operations and financial condition.", "type": 2, "words": ["<tag1>", "See", "Risk", "Factors", "Clinical", "trials", "are", "very", "expensive,", "time-consuming", "and", "difficult", "to", "design", "and", "implement", "and", "may", "result", "in", "unforeseen", "costs", "which", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business", "and", "results", "of", "operations.", "<tag2>", "See", "Risk", "Factors", "Clinical", "trials", "are", "very", "expensive,", "time-consuming", "and", "difficult", "to", "design", "and", "implement", "and", "may", "result", "in", "unforeseen", "costs", "which", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["See", "Risk", "Factors", "Clinical", "trials", "are", "very", "expensive,", "time-consuming", "and", "difficult", "to", "design", "and", "implement", "and", "may", "result", "in", "unforeseen", "costs", "which", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business", "and", "results", "of", "operations."], "wordsB": ["See", "Risk", "Factors", "Clinical", "trials", "are", "very", "expensive,", "time-consuming", "and", "difficult", "to", "design", "and", "implement", "and", "may", "result", "in", "unforeseen", "costs", "which", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p45_s0", "idA": "1006281_12_item7_p57_s0", "sentA": "For purposes of determining the fair value of the options to purchase common stock granted to employees and non-employees during the fiscal year ended December 31, 2011, including shares held by non employees that vested during such period, our management used the fair value of our common stock which was the closing sale price of our common stock on the NYSE Amex on the date of calculation.", "sentB": "For purposes of determining the fair value of the restricted shares of common stock granted to employees during the fiscal year ended December 31, 2012, our management used the fair value of our common stock which was the closing sale price of our common stock on the NYSE MKT on the date of grant.", "type": 2, "words": ["<tag1>", "For", "purposes", "of", "determining", "the", "fair", "value", "of", "the", "options", "to", "purchase", "common", "stock", "granted", "to", "employees", "and", "non-employees", "during", "the", "fiscal", "year", "ended", "December", "31,", "2011,", "including", "shares", "held", "by", "non", "employees", "that", "vested", "during", "such", "period,", "our", "management", "used", "the", "fair", "value", "of", "our", "common", "stock", "which", "was", "the", "closing", "sale", "price", "of", "our", "common", "stock", "on", "the", "NYSE", "Amex", "on", "the", "date", "of", "calculation.", "<tag2>", "For", "purposes", "of", "determining", "the", "fair", "value", "of", "the", "restricted", "shares", "of", "common", "stock", "granted", "to", "employees", "during", "the", "fiscal", "year", "ended", "December", "31,", "2012,", "our", "management", "used", "the", "fair", "value", "of", "our", "common", "stock", "which", "was", "the", "closing", "sale", "price", "of", "our", "common", "stock", "on", "the", "NYSE", "MKT", "on", "the", "date", "of", "grant.", "<tag3>"], "wordsA": ["For", "purposes", "of", "determining", "the", "fair", "value", "of", "the", "options", "to", "purchase", "common", "stock", "granted", "to", "employees", "and", "non-employees", "during", "the", "fiscal", "year", "ended", "December", "31,", "2011,", "including", "shares", "held", "by", "non", "employees", "that", "vested", "during", "such", "period,", "our", "management", "used", "the", "fair", "value", "of", "our", "common", "stock", "which", "was", "the", "closing", "sale", "price", "of", "our", "common", "stock", "on", "the", "NYSE", "Amex", "on", "the", "date", "of", "calculation."], "wordsB": ["For", "purposes", "of", "determining", "the", "fair", "value", "of", "the", "restricted", "shares", "of", "common", "stock", "granted", "to", "employees", "during", "the", "fiscal", "year", "ended", "December", "31,", "2012,", "our", "management", "used", "the", "fair", "value", "of", "our", "common", "stock", "which", "was", "the", "closing", "sale", "price", "of", "our", "common", "stock", "on", "the", "NYSE", "MKT", "on", "the", "date", "of", "grant."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p7_s4", "idA": "1006281_12_item7_p5_s1", "sentA": "Among the topics currently in discussion, is the orphan drug designation and exclusivity granted by the EMA/European Commission to VPRIV, which could prevent the marketing authorization of taliglucerase alfa in the European Union for a 10-year market exclusivity period commencing as of the August 2010 marketing authorization of VPRIV in the European Union.", "sentB": "While the CHMP gave a positive risk-benefit assessment for taliglucerase alfa, its recommendation was based solely on the orphan market exclusivity granted to VPRIV, Shire's Gaucher disease treatment.", "type": 2, "words": ["<tag1>", "Among", "the", "topics", "currently", "in", "discussion,", "is", "the", "orphan", "drug", "designation", "and", "exclusivity", "granted", "by", "the", "EMA/European", "Commission", "to", "VPRIV,", "which", "could", "prevent", "the", "marketing", "authorization", "of", "taliglucerase", "alfa", "in", "the", "European", "Union", "for", "a", "10-year", "market", "exclusivity", "period", "commencing", "as", "of", "the", "August", "2010", "marketing", "authorization", "of", "VPRIV", "in", "the", "European", "Union.", "<tag2>", "While", "the", "CHMP", "gave", "a", "positive", "risk-benefit", "assessment", "for", "taliglucerase", "alfa,", "its", "recommendation", "was", "based", "solely", "on", "the", "orphan", "market", "exclusivity", "granted", "to", "VPRIV,", "Shire's", "Gaucher", "disease", "treatment.", "<tag3>"], "wordsA": ["Among", "the", "topics", "currently", "in", "discussion,", "is", "the", "orphan", "drug", "designation", "and", "exclusivity", "granted", "by", "the", "EMA/European", "Commission", "to", "VPRIV,", "which", "could", "prevent", "the", "marketing", "authorization", "of", "taliglucerase", "alfa", "in", "the", "European", "Union", "for", "a", "10-year", "market", "exclusivity", "period", "commencing", "as", "of", "the", "August", "2010", "marketing", "authorization", "of", "VPRIV", "in", "the", "European", "Union."], "wordsB": ["While", "the", "CHMP", "gave", "a", "positive", "risk-benefit", "assessment", "for", "taliglucerase", "alfa,", "its", "recommendation", "was", "based", "solely", "on", "the", "orphan", "market", "exclusivity", "granted", "to", "VPRIV,", "Shire's", "Gaucher", "disease", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p51_s0", "idA": "1006281_12_item7_p64_s0", "sentA": "We recorded revenue of $8.4 million for the year ended December 31, 2011, an increase of $1.8 million or 27%, compared to revenue of $6.6 million for the year ended December 31, 2010.", "sentB": "We recorded revenue of $34.9 million for the year ended December 31, 2012, an increase of $26.5 million or 315%, compared to revenue of $8.4 million for the year ended December 31, 2011.", "type": 2, "words": ["<tag1>", "We", "recorded", "revenue", "of", "$8.4", "million", "for", "the", "year", "ended", "December", "31,", "2011,", "an", "increase", "of", "$1.8", "million", "or", "27%,", "compared", "to", "revenue", "of", "$6.6", "million", "for", "the", "year", "ended", "December", "31,", "2010.", "<tag2>", "We", "recorded", "revenue", "of", "$34.9", "million", "for", "the", "year", "ended", "December", "31,", "2012,", "an", "increase", "of", "$26.5", "million", "or", "315%,", "compared", "to", "revenue", "of", "$8.4", "million", "for", "the", "year", "ended", "December", "31,", "2011.", "<tag3>"], "wordsA": ["We", "recorded", "revenue", "of", "$8.4", "million", "for", "the", "year", "ended", "December", "31,", "2011,", "an", "increase", "of", "$1.8", "million", "or", "27%,", "compared", "to", "revenue", "of", "$6.6", "million", "for", "the", "year", "ended", "December", "31,", "2010."], "wordsB": ["We", "recorded", "revenue", "of", "$34.9", "million", "for", "the", "year", "ended", "December", "31,", "2012,", "an", "increase", "of", "$26.5", "million", "or", "315%,", "compared", "to", "revenue", "of", "$8.4", "million", "for", "the", "year", "ended", "December", "31,", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p54_s0", "idA": "1006281_12_item7_p64_s0", "sentA": "We recorded revenue of $8.4 million for the year ended December 31, 2011, an increase of $1.8 million or 27%, compared to revenue of $6.6 million for the year ended December 31, 2010.", "sentB": "Cost of revenues was $8.1 million for the year ended December 31, 2012, an increase of $6.6 million, compared to the cost of revenues of $1.5 million for the year ended December 31, 2011.", "type": 2, "words": ["<tag1>", "We", "recorded", "revenue", "of", "$8.4", "million", "for", "the", "year", "ended", "December", "31,", "2011,", "an", "increase", "of", "$1.8", "million", "or", "27%,", "compared", "to", "revenue", "of", "$6.6", "million", "for", "the", "year", "ended", "December", "31,", "2010.", "<tag2>", "Cost", "of", "revenues", "was", "$8.1", "million", "for", "the", "year", "ended", "December", "31,", "2012,", "an", "increase", "of", "$6.6", "million,", "compared", "to", "the", "cost", "of", "revenues", "of", "$1.5", "million", "for", "the", "year", "ended", "December", "31,", "2011.", "<tag3>"], "wordsA": ["We", "recorded", "revenue", "of", "$8.4", "million", "for", "the", "year", "ended", "December", "31,", "2011,", "an", "increase", "of", "$1.8", "million", "or", "27%,", "compared", "to", "revenue", "of", "$6.6", "million", "for", "the", "year", "ended", "December", "31,", "2010."], "wordsB": ["Cost", "of", "revenues", "was", "$8.1", "million", "for", "the", "year", "ended", "December", "31,", "2012,", "an", "increase", "of", "$6.6", "million,", "compared", "to", "the", "cost", "of", "revenues", "of", "$1.5", "million", "for", "the", "year", "ended", "December", "31,", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p51_s2", "idA": "1006281_12_item7_p64_s1", "sentA": "The increase resulted primarily from increases in the supply of taliglucerase alfa vials to Pfizer during the year ended December 31, 2011.", "sentB": "The increase was also due to the increase in the supply of taliglucerase alfa vials to Pfizer during the year ended December 31, 2012.", "type": 2, "words": ["<tag1>", "The", "increase", "resulted", "primarily", "from", "increases", "in", "the", "supply", "of", "taliglucerase", "alfa", "vials", "to", "Pfizer", "during", "the", "year", "ended", "December", "31,", "2011.", "<tag2>", "The", "increase", "was", "also", "due", "to", "the", "increase", "in", "the", "supply", "of", "taliglucerase", "alfa", "vials", "to", "Pfizer", "during", "the", "year", "ended", "December", "31,", "2012.", "<tag3>"], "wordsA": ["The", "increase", "resulted", "primarily", "from", "increases", "in", "the", "supply", "of", "taliglucerase", "alfa", "vials", "to", "Pfizer", "during", "the", "year", "ended", "December", "31,", "2011."], "wordsB": ["The", "increase", "was", "also", "due", "to", "the", "increase", "in", "the", "supply", "of", "taliglucerase", "alfa", "vials", "to", "Pfizer", "during", "the", "year", "ended", "December", "31,", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p54_s1", "idA": "1006281_12_item7_p64_s1", "sentA": "The increase resulted primarily from increases in the supply of taliglucerase alfa vials to Pfizer during the year ended December 31, 2011.", "sentB": "Cost of revenues for the year ended December 31, 2012 includes approximately $2.2 million for royalties due to the OCS and a certain academic institution in connection with gross sales of taliglucerase alfa during the period and $4.1 million for certain fixed costs relating mainly to our manufacturing facility, including rent, depreciation, salary and maintenance expenses, and to a much lesser extent, the direct cost of products delivered to Pfizer during the period.", "type": 2, "words": ["<tag1>", "The", "increase", "resulted", "primarily", "from", "increases", "in", "the", "supply", "of", "taliglucerase", "alfa", "vials", "to", "Pfizer", "during", "the", "year", "ended", "December", "31,", "2011.", "<tag2>", "Cost", "of", "revenues", "for", "the", "year", "ended", "December", "31,", "2012", "includes", "approximately", "$2.2", "million", "for", "royalties", "due", "to", "the", "OCS", "and", "a", "certain", "academic", "institution", "in", "connection", "with", "gross", "sales", "of", "taliglucerase", "alfa", "during", "the", "period", "and", "$4.1", "million", "for", "certain", "fixed", "costs", "relating", "mainly", "to", "our", "manufacturing", "facility,", "including", "rent,", "depreciation,", "salary", "and", "maintenance", "expenses,", "and", "to", "a", "much", "lesser", "extent,", "the", "direct", "cost", "of", "products", "delivered", "to", "Pfizer", "during", "the", "period.", "<tag3>"], "wordsA": ["The", "increase", "resulted", "primarily", "from", "increases", "in", "the", "supply", "of", "taliglucerase", "alfa", "vials", "to", "Pfizer", "during", "the", "year", "ended", "December", "31,", "2011."], "wordsB": ["Cost", "of", "revenues", "for", "the", "year", "ended", "December", "31,", "2012", "includes", "approximately", "$2.2", "million", "for", "royalties", "due", "to", "the", "OCS", "and", "a", "certain", "academic", "institution", "in", "connection", "with", "gross", "sales", "of", "taliglucerase", "alfa", "during", "the", "period", "and", "$4.1", "million", "for", "certain", "fixed", "costs", "relating", "mainly", "to", "our", "manufacturing", "facility,", "including", "rent,", "depreciation,", "salary", "and", "maintenance", "expenses,", "and", "to", "a", "much", "lesser", "extent,", "the", "direct", "cost", "of", "products", "delivered", "to", "Pfizer", "during", "the", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p58_s1", "idA": "1006281_12_item7_p64_s1", "sentA": "The increase resulted primarily from increases in the supply of taliglucerase alfa vials to Pfizer during the year ended December 31, 2011.", "sentB": "The increase resulted primarily from the higher average cash balance during the year 2012 compared to 2011 which earned interest.", "type": 2, "words": ["<tag1>", "The", "increase", "resulted", "primarily", "from", "increases", "in", "the", "supply", "of", "taliglucerase", "alfa", "vials", "to", "Pfizer", "during", "the", "year", "ended", "December", "31,", "2011.", "<tag2>", "The", "increase", "resulted", "primarily", "from", "the", "higher", "average", "cash", "balance", "during", "the", "year", "2012", "compared", "to", "2011", "which", "earned", "interest.", "<tag3>"], "wordsA": ["The", "increase", "resulted", "primarily", "from", "increases", "in", "the", "supply", "of", "taliglucerase", "alfa", "vials", "to", "Pfizer", "during", "the", "year", "ended", "December", "31,", "2011."], "wordsB": ["The", "increase", "resulted", "primarily", "from", "the", "higher", "average", "cash", "balance", "during", "the", "year", "2012", "compared", "to", "2011", "which", "earned", "interest."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p51_s3", "idA": "1006281_12_item7_p64_s2", "sentA": "Revenues also include the amortization of the $65 million upfront and milestone payments received from Pfizer.", "sentB": "Revenues also include the amortization of the $65.0 million upfront and milestone payments received from Pfizer.", "type": 2, "words": ["<tag1>", "Revenues", "also", "include", "the", "amortization", "of", "the", "$65", "million", "upfront", "and", "milestone", "payments", "received", "from", "Pfizer.", "<tag2>", "Revenues", "also", "include", "the", "amortization", "of", "the", "$65.0", "million", "upfront", "and", "milestone", "payments", "received", "from", "Pfizer.", "<tag3>"], "wordsA": ["Revenues", "also", "include", "the", "amortization", "of", "the", "$65", "million", "upfront", "and", "milestone", "payments", "received", "from", "Pfizer."], "wordsB": ["Revenues", "also", "include", "the", "amortization", "of", "the", "$65.0", "million", "upfront", "and", "milestone", "payments", "received", "from", "Pfizer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p59_s2", "idA": "1006281_12_item7_p64_s2", "sentA": "Revenues also include the amortization of the $65 million upfront and milestone payments received from Pfizer.", "sentB": "Revenues also include the amortization of the $65.0 million upfront and milestone payments received from Pfizer.", "type": 2, "words": ["<tag1>", "Revenues", "also", "include", "the", "amortization", "of", "the", "$65", "million", "upfront", "and", "milestone", "payments", "received", "from", "Pfizer.", "<tag2>", "Revenues", "also", "include", "the", "amortization", "of", "the", "$65.0", "million", "upfront", "and", "milestone", "payments", "received", "from", "Pfizer.", "<tag3>"], "wordsA": ["Revenues", "also", "include", "the", "amortization", "of", "the", "$65", "million", "upfront", "and", "milestone", "payments", "received", "from", "Pfizer."], "wordsB": ["Revenues", "also", "include", "the", "amortization", "of", "the", "$65.0", "million", "upfront", "and", "milestone", "payments", "received", "from", "Pfizer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p52_s0", "idA": "1006281_12_item7_p65_s0", "sentA": "We recorded $5.4 million of loss as our share in the collaboration under the Pfizer Agreement during the year ended December 31, 2011, a decrease of $10.0 million, or 217%, compared to the $4.6 million of income recorded for the year ended December 31, 2010.", "sentB": "We recorded a loss of $446,000 as our share in the collaboration under the Pfizer Agreement during the year ended December 31, 2012, a decrease of $5.0 million, or 92%, compared to the $5.4 million of loss recorded for the year ended December 31, 2011.", "type": 2, "words": ["<tag1>", "We", "recorded", "$5.4", "million", "of", "loss", "as", "our", "share", "in", "the", "collaboration", "under", "the", "Pfizer", "Agreement", "during", "the", "year", "ended", "December", "31,", "2011,", "a", "decrease", "of", "$10.0", "million,", "or", "217%,", "compared", "to", "the", "$4.6", "million", "of", "income", "recorded", "for", "the", "year", "ended", "December", "31,", "2010.", "<tag2>", "We", "recorded", "a", "loss", "of", "$446,000", "as", "our", "share", "in", "the", "collaboration", "under", "the", "Pfizer", "Agreement", "during", "the", "year", "ended", "December", "31,", "2012,", "a", "decrease", "of", "$5.0", "million,", "or", "92%,", "compared", "to", "the", "$5.4", "million", "of", "loss", "recorded", "for", "the", "year", "ended", "December", "31,", "2011.", "<tag3>"], "wordsA": ["We", "recorded", "$5.4", "million", "of", "loss", "as", "our", "share", "in", "the", "collaboration", "under", "the", "Pfizer", "Agreement", "during", "the", "year", "ended", "December", "31,", "2011,", "a", "decrease", "of", "$10.0", "million,", "or", "217%,", "compared", "to", "the", "$4.6", "million", "of", "income", "recorded", "for", "the", "year", "ended", "December", "31,", "2010."], "wordsB": ["We", "recorded", "a", "loss", "of", "$446,000", "as", "our", "share", "in", "the", "collaboration", "under", "the", "Pfizer", "Agreement", "during", "the", "year", "ended", "December", "31,", "2012,", "a", "decrease", "of", "$5.0", "million,", "or", "92%,", "compared", "to", "the", "$5.4", "million", "of", "loss", "recorded", "for", "the", "year", "ended", "December", "31,", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p25_s6", "idA": "1006281_12_item7_p65_s1", "sentA": "Our share in the collaboration's loss for the year ended December 31, 2011 resulted primarily from our 40% share of the allowance for sales return of taliglucerase alfa recorded by Pfizer in connection with the short term supply agreement between Pfizer and the Ministry of Health of Brazil.", "sentB": "The $25.0 million milestone payment received in connection with the FDA's approval of taliglucerase alfa in the United States was considered to be a substantive milestone for purposes of revenue recognition, and, accordingly, was recorded as revenue during the period in which the milestone was achieved.", "type": 2, "words": ["<tag1>", "Our", "share", "in", "the", "collaboration's", "loss", "for", "the", "year", "ended", "December", "31,", "2011", "resulted", "primarily", "from", "our", "40%", "share", "of", "the", "allowance", "for", "sales", "return", "of", "taliglucerase", "alfa", "recorded", "by", "Pfizer", "in", "connection", "with", "the", "short", "term", "supply", "agreement", "between", "Pfizer", "and", "the", "Ministry", "of", "Health", "of", "Brazil.", "<tag2>", "The", "$25.0", "million", "milestone", "payment", "received", "in", "connection", "with", "the", "FDA's", "approval", "of", "taliglucerase", "alfa", "in", "the", "United", "States", "was", "considered", "to", "be", "a", "substantive", "milestone", "for", "purposes", "of", "revenue", "recognition,", "and,", "accordingly,", "was", "recorded", "as", "revenue", "during", "the", "period", "in", "which", "the", "milestone", "was", "achieved.", "<tag3>"], "wordsA": ["Our", "share", "in", "the", "collaboration's", "loss", "for", "the", "year", "ended", "December", "31,", "2011", "resulted", "primarily", "from", "our", "40%", "share", "of", "the", "allowance", "for", "sales", "return", "of", "taliglucerase", "alfa", "recorded", "by", "Pfizer", "in", "connection", "with", "the", "short", "term", "supply", "agreement", "between", "Pfizer", "and", "the", "Ministry", "of", "Health", "of", "Brazil."], "wordsB": ["The", "$25.0", "million", "milestone", "payment", "received", "in", "connection", "with", "the", "FDA's", "approval", "of", "taliglucerase", "alfa", "in", "the", "United", "States", "was", "considered", "to", "be", "a", "substantive", "milestone", "for", "purposes", "of", "revenue", "recognition,", "and,", "accordingly,", "was", "recorded", "as", "revenue", "during", "the", "period", "in", "which", "the", "milestone", "was", "achieved."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p52_s1", "idA": "1006281_12_item7_p65_s1", "sentA": "Our share in the collaboration's loss for the year ended December 31, 2011 resulted primarily from our 40% share of the allowance for sales return of taliglucerase alfa recorded by Pfizer in connection with the short term supply agreement between Pfizer and the Ministry of Health of Brazil.", "sentB": "Our share in the collaboration's loss for the year ended December 31, 2012 represents our 40% share of the net loss generated during the period, which was primarily the result of the expenses incurred during the period mainly in connection with activities related to the U.S. launch of taliglucerase alfa which exceeded the revenues generated by Pfizer in the United States, and resupply in Brazil.", "type": 2, "words": ["<tag1>", "Our", "share", "in", "the", "collaboration's", "loss", "for", "the", "year", "ended", "December", "31,", "2011", "resulted", "primarily", "from", "our", "40%", "share", "of", "the", "allowance", "for", "sales", "return", "of", "taliglucerase", "alfa", "recorded", "by", "Pfizer", "in", "connection", "with", "the", "short", "term", "supply", "agreement", "between", "Pfizer", "and", "the", "Ministry", "of", "Health", "of", "Brazil.", "<tag2>", "Our", "share", "in", "the", "collaboration's", "loss", "for", "the", "year", "ended", "December", "31,", "2012", "represents", "our", "40%", "share", "of", "the", "net", "loss", "generated", "during", "the", "period,", "which", "was", "primarily", "the", "result", "of", "the", "expenses", "incurred", "during", "the", "period", "mainly", "in", "connection", "with", "activities", "related", "to", "the", "U.S.", "launch", "of", "taliglucerase", "alfa", "which", "exceeded", "the", "revenues", "generated", "by", "Pfizer", "in", "the", "United", "States,", "and", "resupply", "in", "Brazil.", "<tag3>"], "wordsA": ["Our", "share", "in", "the", "collaboration's", "loss", "for", "the", "year", "ended", "December", "31,", "2011", "resulted", "primarily", "from", "our", "40%", "share", "of", "the", "allowance", "for", "sales", "return", "of", "taliglucerase", "alfa", "recorded", "by", "Pfizer", "in", "connection", "with", "the", "short", "term", "supply", "agreement", "between", "Pfizer", "and", "the", "Ministry", "of", "Health", "of", "Brazil."], "wordsB": ["Our", "share", "in", "the", "collaboration's", "loss", "for", "the", "year", "ended", "December", "31,", "2012", "represents", "our", "40%", "share", "of", "the", "net", "loss", "generated", "during", "the", "period,", "which", "was", "primarily", "the", "result", "of", "the", "expenses", "incurred", "during", "the", "period", "mainly", "in", "connection", "with", "activities", "related", "to", "the", "U.S.", "launch", "of", "taliglucerase", "alfa", "which", "exceeded", "the", "revenues", "generated", "by", "Pfizer", "in", "the", "United", "States,", "and", "resupply", "in", "Brazil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p60_s1", "idA": "1006281_12_item7_p65_s1", "sentA": "Our share in the collaboration's loss for the year ended December 31, 2011 resulted primarily from our 40% share of the allowance for sales return of taliglucerase alfa recorded by Pfizer in connection with the short term supply agreement between Pfizer and the Ministry of Health of Brazil.", "sentB": "Our share in the collaboration's loss for the year ended December 31, 2011 resulted primarily from our 40% share of the allowance for sales return of taliglucerase alfa recorded by Pfizer in connection with the short term supply agreement between Pfizer and the Brazilian MOH.", "type": 2, "words": ["<tag1>", "Our", "share", "in", "the", "collaboration's", "loss", "for", "the", "year", "ended", "December", "31,", "2011", "resulted", "primarily", "from", "our", "40%", "share", "of", "the", "allowance", "for", "sales", "return", "of", "taliglucerase", "alfa", "recorded", "by", "Pfizer", "in", "connection", "with", "the", "short", "term", "supply", "agreement", "between", "Pfizer", "and", "the", "Ministry", "of", "Health", "of", "Brazil.", "<tag2>", "Our", "share", "in", "the", "collaboration's", "loss", "for", "the", "year", "ended", "December", "31,", "2011", "resulted", "primarily", "from", "our", "40%", "share", "of", "the", "allowance", "for", "sales", "return", "of", "taliglucerase", "alfa", "recorded", "by", "Pfizer", "in", "connection", "with", "the", "short", "term", "supply", "agreement", "between", "Pfizer", "and", "the", "Brazilian", "MOH.", "<tag3>"], "wordsA": ["Our", "share", "in", "the", "collaboration's", "loss", "for", "the", "year", "ended", "December", "31,", "2011", "resulted", "primarily", "from", "our", "40%", "share", "of", "the", "allowance", "for", "sales", "return", "of", "taliglucerase", "alfa", "recorded", "by", "Pfizer", "in", "connection", "with", "the", "short", "term", "supply", "agreement", "between", "Pfizer", "and", "the", "Ministry", "of", "Health", "of", "Brazil."], "wordsB": ["Our", "share", "in", "the", "collaboration's", "loss", "for", "the", "year", "ended", "December", "31,", "2011", "resulted", "primarily", "from", "our", "40%", "share", "of", "the", "allowance", "for", "sales", "return", "of", "taliglucerase", "alfa", "recorded", "by", "Pfizer", "in", "connection", "with", "the", "short", "term", "supply", "agreement", "between", "Pfizer", "and", "the", "Brazilian", "MOH."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p13_s0", "idA": "1006281_12_item7_p66_s0", "sentA": "During 2011, the Ministry of Health of Brazil requested that Pfizer consider the replacement of certain vials that might expire during 2012.", "sentB": "During 2011, the Brazilian MOH requested that Pfizer consider the replacement of certain vials that might expire during 2012.", "type": 2, "words": ["<tag1>", "During", "2011,", "the", "Ministry", "of", "Health", "of", "Brazil", "requested", "that", "Pfizer", "consider", "the", "replacement", "of", "certain", "vials", "that", "might", "expire", "during", "2012.", "<tag2>", "During", "2011,", "the", "Brazilian", "MOH", "requested", "that", "Pfizer", "consider", "the", "replacement", "of", "certain", "vials", "that", "might", "expire", "during", "2012.", "<tag3>"], "wordsA": ["During", "2011,", "the", "Ministry", "of", "Health", "of", "Brazil", "requested", "that", "Pfizer", "consider", "the", "replacement", "of", "certain", "vials", "that", "might", "expire", "during", "2012."], "wordsB": ["During", "2011,", "the", "Brazilian", "MOH", "requested", "that", "Pfizer", "consider", "the", "replacement", "of", "certain", "vials", "that", "might", "expire", "during", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p61_s0", "idA": "1006281_12_item7_p66_s0", "sentA": "During 2011, the Ministry of Health of Brazil requested that Pfizer consider the replacement of certain vials that might expire during 2012.", "sentB": "During 2011, the Brazilian MOH requested that Pfizer consider the replacement of certain vials that might expire during 2012.", "type": 2, "words": ["<tag1>", "During", "2011,", "the", "Ministry", "of", "Health", "of", "Brazil", "requested", "that", "Pfizer", "consider", "the", "replacement", "of", "certain", "vials", "that", "might", "expire", "during", "2012.", "<tag2>", "During", "2011,", "the", "Brazilian", "MOH", "requested", "that", "Pfizer", "consider", "the", "replacement", "of", "certain", "vials", "that", "might", "expire", "during", "2012.", "<tag3>"], "wordsA": ["During", "2011,", "the", "Ministry", "of", "Health", "of", "Brazil", "requested", "that", "Pfizer", "consider", "the", "replacement", "of", "certain", "vials", "that", "might", "expire", "during", "2012."], "wordsB": ["During", "2011,", "the", "Brazilian", "MOH", "requested", "that", "Pfizer", "consider", "the", "replacement", "of", "certain", "vials", "that", "might", "expire", "during", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p55_s0", "idA": "1006281_12_item7_p69_s0", "sentA": "Research and development expenses were $37.8 million for the year ended December 31, 2011, an increase of $127,000 from $37.7 million for the year ended December 31, 2010.", "sentB": "Research and development expenses were $36.7 million for the year ended December 31, 2012, a decrease of $1.1 million from $37.8 million for the year ended December 31, 2011.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expenses", "were", "$37.8", "million", "for", "the", "year", "ended", "December", "31,", "2011,", "an", "increase", "of", "$127,000", "from", "$37.7", "million", "for", "the", "year", "ended", "December", "31,", "2010.", "<tag2>", "Research", "and", "development", "expenses", "were", "$36.7", "million", "for", "the", "year", "ended", "December", "31,", "2012,", "a", "decrease", "of", "$1.1", "million", "from", "$37.8", "million", "for", "the", "year", "ended", "December", "31,", "2011.", "<tag3>"], "wordsA": ["Research", "and", "development", "expenses", "were", "$37.8", "million", "for", "the", "year", "ended", "December", "31,", "2011,", "an", "increase", "of", "$127,000", "from", "$37.7", "million", "for", "the", "year", "ended", "December", "31,", "2010."], "wordsB": ["Research", "and", "development", "expenses", "were", "$36.7", "million", "for", "the", "year", "ended", "December", "31,", "2012,", "a", "decrease", "of", "$1.1", "million", "from", "$37.8", "million", "for", "the", "year", "ended", "December", "31,", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p8_s2", "idA": "1006281_12_item7_p70_s0", "sentA": "We expect research and development expenses to continue to be our primary expense as we enter into a more advanced stage of preclinical and clinical trials for certain of our product candidates .", "sentB": "New clinical trials for ELELYSO will be conducted and sponsored by Pfizer.", "type": 2, "words": ["<tag1>", "We", "expect", "research", "and", "development", "expenses", "to", "continue", "to", "be", "our", "primary", "expense", "as", "we", "enter", "into", "a", "more", "advanced", "stage", "of", "preclinical", "and", "clinical", "trials", "for", "certain", "of", "our", "product", "candidates", ".", "<tag2>", "New", "clinical", "trials", "for", "ELELYSO", "will", "be", "conducted", "and", "sponsored", "by", "Pfizer.", "<tag3>"], "wordsA": ["We", "expect", "research", "and", "development", "expenses", "to", "continue", "to", "be", "our", "primary", "expense", "as", "we", "enter", "into", "a", "more", "advanced", "stage", "of", "preclinical", "and", "clinical", "trials", "for", "certain", "of", "our", "product", "candidates", "."], "wordsB": ["New", "clinical", "trials", "for", "ELELYSO", "will", "be", "conducted", "and", "sponsored", "by", "Pfizer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p57_s0", "idA": "1006281_12_item7_p71_s0", "sentA": "General and administrative expenses were $6.9 million for the year ended December 31, 2011, an increase $55,000 from $6.9 million for the year ended December 31, 2010.", "sentB": "General and administrative expenses were $9.8 million for the year ended December 31, 2012, an increase of $2.8 million, or 41%, from $6.9 million for the year ended December 31, 2011.", "type": 2, "words": ["<tag1>", "General", "and", "administrative", "expenses", "were", "$6.9", "million", "for", "the", "year", "ended", "December", "31,", "2011,", "an", "increase", "$55,000", "from", "$6.9", "million", "for", "the", "year", "ended", "December", "31,", "2010.", "<tag2>", "General", "and", "administrative", "expenses", "were", "$9.8", "million", "for", "the", "year", "ended", "December", "31,", "2012,", "an", "increase", "of", "$2.8", "million,", "or", "41%,", "from", "$6.9", "million", "for", "the", "year", "ended", "December", "31,", "2011.", "<tag3>"], "wordsA": ["General", "and", "administrative", "expenses", "were", "$6.9", "million", "for", "the", "year", "ended", "December", "31,", "2011,", "an", "increase", "$55,000", "from", "$6.9", "million", "for", "the", "year", "ended", "December", "31,", "2010."], "wordsB": ["General", "and", "administrative", "expenses", "were", "$9.8", "million", "for", "the", "year", "ended", "December", "31,", "2012,", "an", "increase", "of", "$2.8", "million,", "or", "41%,", "from", "$6.9", "million", "for", "the", "year", "ended", "December", "31,", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p51_s1", "idA": "1006281_12_item7_p73_s1", "sentA": "The increase resulted primarily from the amortization of the $65.0 million of upfront and milestone payments received from Pfizer over the entire fiscal year.", "sentB": "The increase resulted primarily from the $25.0 million milestone payment we received from Pfizer in connection with the FDA's approval of taliglucerase alfa in the United States.", "type": 2, "words": ["<tag1>", "The", "increase", "resulted", "primarily", "from", "the", "amortization", "of", "the", "$65.0", "million", "of", "upfront", "and", "milestone", "payments", "received", "from", "Pfizer", "over", "the", "entire", "fiscal", "year.", "<tag2>", "The", "increase", "resulted", "primarily", "from", "the", "$25.0", "million", "milestone", "payment", "we", "received", "from", "Pfizer", "in", "connection", "with", "the", "FDA's", "approval", "of", "taliglucerase", "alfa", "in", "the", "United", "States.", "<tag3>"], "wordsA": ["The", "increase", "resulted", "primarily", "from", "the", "amortization", "of", "the", "$65.0", "million", "of", "upfront", "and", "milestone", "payments", "received", "from", "Pfizer", "over", "the", "entire", "fiscal", "year."], "wordsB": ["The", "increase", "resulted", "primarily", "from", "the", "$25.0", "million", "milestone", "payment", "we", "received", "from", "Pfizer", "in", "connection", "with", "the", "FDA's", "approval", "of", "taliglucerase", "alfa", "in", "the", "United", "States."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p6_s3", "idA": "1006281_12_item7_p74_s2", "sentA": "No share in the collaboration was recorded for the year ended December 31, 2009.", "sentB": "Our share in the collaboration with Pfizer for 2012 was a loss of approximately $446,000.", "type": 2, "words": ["<tag1>", "No", "share", "in", "the", "collaboration", "was", "recorded", "for", "the", "year", "ended", "December", "31,", "2009.", "<tag2>", "Our", "share", "in", "the", "collaboration", "with", "Pfizer", "for", "2012", "was", "a", "loss", "of", "approximately", "$446,000.", "<tag3>"], "wordsA": ["No", "share", "in", "the", "collaboration", "was", "recorded", "for", "the", "year", "ended", "December", "31,", "2009."], "wordsB": ["Our", "share", "in", "the", "collaboration", "with", "Pfizer", "for", "2012", "was", "a", "loss", "of", "approximately", "$446,000."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p57_s1", "idA": "1006281_12_item7_p76_s1", "sentA": "The increase resulted primarily from an increase of $2.7 million in development expenses related to salaries for personnel involved in research and development, and $4.1 million in related subcontractors and consultants expenses, mainly in connection with our expanded access program for taliglucerase alfa.", "sentB": "The increase resulted primarily from an increase of $3.3 million in salaries expense primarily due to bonuses paid in connection with the FDA's approval of taliglucerase alfa on May 1, 2012 and share-based compensation.", "type": 2, "words": ["<tag1>", "The", "increase", "resulted", "primarily", "from", "an", "increase", "of", "$2.7", "million", "in", "development", "expenses", "related", "to", "salaries", "for", "personnel", "involved", "in", "research", "and", "development,", "and", "$4.1", "million", "in", "related", "subcontractors", "and", "consultants", "expenses,", "mainly", "in", "connection", "with", "our", "expanded", "access", "program", "for", "taliglucerase", "alfa.", "<tag2>", "The", "increase", "resulted", "primarily", "from", "an", "increase", "of", "$3.3", "million", "in", "salaries", "expense", "primarily", "due", "to", "bonuses", "paid", "in", "connection", "with", "the", "FDA's", "approval", "of", "taliglucerase", "alfa", "on", "May", "1,", "2012", "and", "share-based", "compensation.", "<tag3>"], "wordsA": ["The", "increase", "resulted", "primarily", "from", "an", "increase", "of", "$2.7", "million", "in", "development", "expenses", "related", "to", "salaries", "for", "personnel", "involved", "in", "research", "and", "development,", "and", "$4.1", "million", "in", "related", "subcontractors", "and", "consultants", "expenses,", "mainly", "in", "connection", "with", "our", "expanded", "access", "program", "for", "taliglucerase", "alfa."], "wordsB": ["The", "increase", "resulted", "primarily", "from", "an", "increase", "of", "$3.3", "million", "in", "salaries", "expense", "primarily", "due", "to", "bonuses", "paid", "in", "connection", "with", "the", "FDA's", "approval", "of", "taliglucerase", "alfa", "on", "May", "1,", "2012", "and", "share-based", "compensation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p57_s2", "idA": "1006281_12_item7_p76_s2", "sentA": "The increase in research and development expenses was partially offset by the recognition of grants from the OCS and Pfizer s reimbursement of us, collectively equal to $7.7 million.", "sentB": "The increase was partially offset by a decrease of $646,000 in legal and accounting expenses.", "type": 2, "words": ["<tag1>", "The", "increase", "in", "research", "and", "development", "expenses", "was", "partially", "offset", "by", "the", "recognition", "of", "grants", "from", "the", "OCS", "and", "Pfizer", "s", "reimbursement", "of", "us,", "collectively", "equal", "to", "$7.7", "million.", "<tag2>", "The", "increase", "was", "partially", "offset", "by", "a", "decrease", "of", "$646,000", "in", "legal", "and", "accounting", "expenses.", "<tag3>"], "wordsA": ["The", "increase", "in", "research", "and", "development", "expenses", "was", "partially", "offset", "by", "the", "recognition", "of", "grants", "from", "the", "OCS", "and", "Pfizer", "s", "reimbursement", "of", "us,", "collectively", "equal", "to", "$7.7", "million."], "wordsB": ["The", "increase", "was", "partially", "offset", "by", "a", "decrease", "of", "$646,000", "in", "legal", "and", "accounting", "expenses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p55_s1", "idA": "1006281_12_item7_p77_s1", "sentA": "The decrease resulted primarily from a $389,000 decrease in salaries expense during 2010.", "sentB": "The decrease resulted primarily from a decrease of $2.6 million in expenses related to consulting and subcontractors, and a decrease of $2.8 million in certain expenses, such as rent, depreciation and maintenance, that were classified as cost of revenues or capitalized as inventory after the FDA's approval of taliglucerase alfa on May 1, 2012.", "type": 2, "words": ["<tag1>", "The", "decrease", "resulted", "primarily", "from", "a", "$389,000", "decrease", "in", "salaries", "expense", "during", "2010.", "<tag2>", "The", "decrease", "resulted", "primarily", "from", "a", "decrease", "of", "$2.6", "million", "in", "expenses", "related", "to", "consulting", "and", "subcontractors,", "and", "a", "decrease", "of", "$2.8", "million", "in", "certain", "expenses,", "such", "as", "rent,", "depreciation", "and", "maintenance,", "that", "were", "classified", "as", "cost", "of", "revenues", "or", "capitalized", "as", "inventory", "after", "the", "FDA's", "approval", "of", "taliglucerase", "alfa", "on", "May", "1,", "2012.", "<tag3>"], "wordsA": ["The", "decrease", "resulted", "primarily", "from", "a", "$389,000", "decrease", "in", "salaries", "expense", "during", "2010."], "wordsB": ["The", "decrease", "resulted", "primarily", "from", "a", "decrease", "of", "$2.6", "million", "in", "expenses", "related", "to", "consulting", "and", "subcontractors,", "and", "a", "decrease", "of", "$2.8", "million", "in", "certain", "expenses,", "such", "as", "rent,", "depreciation", "and", "maintenance,", "that", "were", "classified", "as", "cost", "of", "revenues", "or", "capitalized", "as", "inventory", "after", "the", "FDA's", "approval", "of", "taliglucerase", "alfa", "on", "May", "1,", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p58_s0", "idA": "1006281_12_item7_p78_s0", "sentA": "Financial income was $968,000 for the year ended December 31, 2010, an increase of $439,000, or approximately 83%, compared to $529,000 for the year ended December 31, 2009.", "sentB": "Financial income was $554,000 for the year ended December 31, 2012, an increase of $552,000 from $2,000 for the year ended December 31, 2011.", "type": 2, "words": ["<tag1>", "Financial", "income", "was", "$968,000", "for", "the", "year", "ended", "December", "31,", "2010,", "an", "increase", "of", "$439,000,", "or", "approximately", "83%,", "compared", "to", "$529,000", "for", "the", "year", "ended", "December", "31,", "2009.", "<tag2>", "Financial", "income", "was", "$554,000", "for", "the", "year", "ended", "December", "31,", "2012,", "an", "increase", "of", "$552,000", "from", "$2,000", "for", "the", "year", "ended", "December", "31,", "2011.", "<tag3>"], "wordsA": ["Financial", "income", "was", "$968,000", "for", "the", "year", "ended", "December", "31,", "2010,", "an", "increase", "of", "$439,000,", "or", "approximately", "83%,", "compared", "to", "$529,000", "for", "the", "year", "ended", "December", "31,", "2009."], "wordsB": ["Financial", "income", "was", "$554,000", "for", "the", "year", "ended", "December", "31,", "2012,", "an", "increase", "of", "$552,000", "from", "$2,000", "for", "the", "year", "ended", "December", "31,", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p68_s0", "idA": "1006281_12_item7_p79_s0", "sentA": "As a result of our significant research and development expenditures and the lack of any approved products to generate significant product sales revenue, we have not been profitable and have generated operating losses since our inception.", "sentB": "As a result of our significant research and development expenditures and the lack of significant product sales revenue due to the recent launch of taliglucerase alfa in the United States and Israel, we have not been profitable and have generated operating losses since our inception.", "type": 2, "words": ["<tag1>", "As", "a", "result", "of", "our", "significant", "research", "and", "development", "expenditures", "and", "the", "lack", "of", "any", "approved", "products", "to", "generate", "significant", "product", "sales", "revenue,", "we", "have", "not", "been", "profitable", "and", "have", "generated", "operating", "losses", "since", "our", "inception.", "<tag2>", "As", "a", "result", "of", "our", "significant", "research", "and", "development", "expenditures", "and", "the", "lack", "of", "significant", "product", "sales", "revenue", "due", "to", "the", "recent", "launch", "of", "taliglucerase", "alfa", "in", "the", "United", "States", "and", "Israel,", "we", "have", "not", "been", "profitable", "and", "have", "generated", "operating", "losses", "since", "our", "inception.", "<tag3>"], "wordsA": ["As", "a", "result", "of", "our", "significant", "research", "and", "development", "expenditures", "and", "the", "lack", "of", "any", "approved", "products", "to", "generate", "significant", "product", "sales", "revenue,", "we", "have", "not", "been", "profitable", "and", "have", "generated", "operating", "losses", "since", "our", "inception."], "wordsB": ["As", "a", "result", "of", "our", "significant", "research", "and", "development", "expenditures", "and", "the", "lack", "of", "significant", "product", "sales", "revenue", "due", "to", "the", "recent", "launch", "of", "taliglucerase", "alfa", "in", "the", "United", "States", "and", "Israel,", "we", "have", "not", "been", "profitable", "and", "have", "generated", "operating", "losses", "since", "our", "inception."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p68_s1", "idA": "1006281_12_item7_p79_s1", "sentA": "To date, we have funded our operations primarily with proceeds equal to $31.3 million from the sale of convertible preferred and ordinary shares of Protalix Ltd., and an additional $14.1 million in connection with the exercise of warrants issued in connection with the sale of such shares, through December 31, 2008.", "sentB": "To date, we have funded our operations primarily with proceeds equal to $31.3 million from the sale of shares of convertible preferred and ordinary shares of Protalix Ltd., and an additional $14.1 million in connection with the exercise of warrants issued in connection with the sale of such shares, through December 31, 2008.", "type": 2, "words": ["<tag1>", "To", "date,", "we", "have", "funded", "our", "operations", "primarily", "with", "proceeds", "equal", "to", "$31.3", "million", "from", "the", "sale", "of", "convertible", "preferred", "and", "ordinary", "shares", "of", "Protalix", "Ltd.,", "and", "an", "additional", "$14.1", "million", "in", "connection", "with", "the", "exercise", "of", "warrants", "issued", "in", "connection", "with", "the", "sale", "of", "such", "shares,", "through", "December", "31,", "2008.", "<tag2>", "To", "date,", "we", "have", "funded", "our", "operations", "primarily", "with", "proceeds", "equal", "to", "$31.3", "million", "from", "the", "sale", "of", "shares", "of", "convertible", "preferred", "and", "ordinary", "shares", "of", "Protalix", "Ltd.,", "and", "an", "additional", "$14.1", "million", "in", "connection", "with", "the", "exercise", "of", "warrants", "issued", "in", "connection", "with", "the", "sale", "of", "such", "shares,", "through", "December", "31,", "2008.", "<tag3>"], "wordsA": ["To", "date,", "we", "have", "funded", "our", "operations", "primarily", "with", "proceeds", "equal", "to", "$31.3", "million", "from", "the", "sale", "of", "convertible", "preferred", "and", "ordinary", "shares", "of", "Protalix", "Ltd.,", "and", "an", "additional", "$14.1", "million", "in", "connection", "with", "the", "exercise", "of", "warrants", "issued", "in", "connection", "with", "the", "sale", "of", "such", "shares,", "through", "December", "31,", "2008."], "wordsB": ["To", "date,", "we", "have", "funded", "our", "operations", "primarily", "with", "proceeds", "equal", "to", "$31.3", "million", "from", "the", "sale", "of", "shares", "of", "convertible", "preferred", "and", "ordinary", "shares", "of", "Protalix", "Ltd.,", "and", "an", "additional", "$14.1", "million", "in", "connection", "with", "the", "exercise", "of", "warrants", "issued", "in", "connection", "with", "the", "sale", "of", "such", "shares,", "through", "December", "31,", "2008."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p69_s0", "idA": "1006281_12_item7_p80_s0", "sentA": "The following table summarizes our past funding sources:", "sentB": "The following table summarizes our public funding sources since 2007:", "type": 2, "words": ["<tag1>", "The", "following", "table", "summarizes", "our", "past", "funding", "sources:", "<tag2>", "The", "following", "table", "summarizes", "our", "public", "funding", "sources", "since", "2007:", "<tag3>"], "wordsA": ["The", "following", "table", "summarizes", "our", "past", "funding", "sources:"], "wordsB": ["The", "following", "table", "summarizes", "our", "public", "funding", "sources", "since", "2007:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p71_s1", "idA": "1006281_12_item7_p86_s0", "sentA": "In addition to the foregoing, Pfizer paid Protalix Ltd.", "sentB": "Pfizer has also paid Protalix Ltd. $8.3 million in connection with the successful achievement of certain milestones under the Clinical Development Agreement between Pfizer and Protalix Ltd.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "the", "foregoing,", "Pfizer", "paid", "Protalix", "Ltd.", "<tag2>", "Pfizer", "has", "also", "paid", "Protalix", "Ltd.", "$8.3", "million", "in", "connection", "with", "the", "successful", "achievement", "of", "certain", "milestones", "under", "the", "Clinical", "Development", "Agreement", "between", "Pfizer", "and", "Protalix", "Ltd.", "<tag3>"], "wordsA": ["In", "addition", "to", "the", "foregoing,", "Pfizer", "paid", "Protalix", "Ltd."], "wordsB": ["Pfizer", "has", "also", "paid", "Protalix", "Ltd.", "$8.3", "million", "in", "connection", "with", "the", "successful", "achievement", "of", "certain", "milestones", "under", "the", "Clinical", "Development", "Agreement", "between", "Pfizer", "and", "Protalix", "Ltd."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p70_s3", "idA": "1006281_12_item7_p86_s3", "sentA": "Protalix Ltd. is also entitled to payments equal to 40% of the net profits earned by Pfizer on its sales of taliglucerase alfa.", "sentB": "Protalix Ltd. is also entitled to payments equal to 40% of the net profits earned by Pfizer on its global sales of taliglucerase alfa (except in Israel).", "type": 2, "words": ["<tag1>", "Protalix", "Ltd.", "is", "also", "entitled", "to", "payments", "equal", "to", "40%", "of", "the", "net", "profits", "earned", "by", "Pfizer", "on", "its", "sales", "of", "taliglucerase", "alfa.", "<tag2>", "Protalix", "Ltd.", "is", "also", "entitled", "to", "payments", "equal", "to", "40%", "of", "the", "net", "profits", "earned", "by", "Pfizer", "on", "its", "global", "sales", "of", "taliglucerase", "alfa", "(except", "in", "Israel).", "<tag3>"], "wordsA": ["Protalix", "Ltd.", "is", "also", "entitled", "to", "payments", "equal", "to", "40%", "of", "the", "net", "profits", "earned", "by", "Pfizer", "on", "its", "sales", "of", "taliglucerase", "alfa."], "wordsB": ["Protalix", "Ltd.", "is", "also", "entitled", "to", "payments", "equal", "to", "40%", "of", "the", "net", "profits", "earned", "by", "Pfizer", "on", "its", "global", "sales", "of", "taliglucerase", "alfa", "(except", "in", "Israel)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p7_s3", "idA": "1006281_12_item7_p86_s3", "sentA": "Protalix Ltd. is also entitled to payments equal to 40% of the net profits earned by Pfizer on its sales of taliglucerase alfa.", "sentB": "This decision is an endorsement of the CHMP s June 2012 opinion recommending against the marketing authorization of taliglucerase alfa.", "type": 2, "words": ["<tag1>", "Protalix", "Ltd.", "is", "also", "entitled", "to", "payments", "equal", "to", "40%", "of", "the", "net", "profits", "earned", "by", "Pfizer", "on", "its", "sales", "of", "taliglucerase", "alfa.", "<tag2>", "This", "decision", "is", "an", "endorsement", "of", "the", "CHMP", "s", "June", "2012", "opinion", "recommending", "against", "the", "marketing", "authorization", "of", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["Protalix", "Ltd.", "is", "also", "entitled", "to", "payments", "equal", "to", "40%", "of", "the", "net", "profits", "earned", "by", "Pfizer", "on", "its", "sales", "of", "taliglucerase", "alfa."], "wordsB": ["This", "decision", "is", "an", "endorsement", "of", "the", "CHMP", "s", "June", "2012", "opinion", "recommending", "against", "the", "marketing", "authorization", "of", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p73_s1", "idA": "1006281_12_item7_p88_s1", "sentA": "The net loss for 2011 of $36.5 million was further increased by a decrease in deferred revenues of approximately $3.0 million.", "sentB": "The net loss for 2011 of $36.5 million was further increased by an increase in deferred revenues of approximately $3.0 million.", "type": 2, "words": ["<tag1>", "The", "net", "loss", "for", "2011", "of", "$36.5", "million", "was", "further", "increased", "by", "a", "decrease", "in", "deferred", "revenues", "of", "approximately", "$3.0", "million.", "<tag2>", "The", "net", "loss", "for", "2011", "of", "$36.5", "million", "was", "further", "increased", "by", "an", "increase", "in", "deferred", "revenues", "of", "approximately", "$3.0", "million.", "<tag3>"], "wordsA": ["The", "net", "loss", "for", "2011", "of", "$36.5", "million", "was", "further", "increased", "by", "a", "decrease", "in", "deferred", "revenues", "of", "approximately", "$3.0", "million."], "wordsB": ["The", "net", "loss", "for", "2011", "of", "$36.5", "million", "was", "further", "increased", "by", "an", "increase", "in", "deferred", "revenues", "of", "approximately", "$3.0", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p72_s1", "idA": "1006281_12_item7_p88_s2", "sentA": "The net loss was partially offset by non-cash charges for share-based compensation of $886,000, depreciation of $3.6 million and a decrease in accounts receivable of approximately $3.9 million and an increase in accounts payable of $6.1 million.", "sentB": "The net loss for the year ended December 31, 2012 of $11.6 million decreased primarily due to $7.8 million in share-based compensation and $3.7 million in depreciation and a $3.0 million increase in accounts payable, which was partially offset by a an increase of $3.8 million in inventory.", "type": 2, "words": ["<tag1>", "The", "net", "loss", "was", "partially", "offset", "by", "non-cash", "charges", "for", "share-based", "compensation", "of", "$886,000,", "depreciation", "of", "$3.6", "million", "and", "a", "decrease", "in", "accounts", "receivable", "of", "approximately", "$3.9", "million", "and", "an", "increase", "in", "accounts", "payable", "of", "$6.1", "million.", "<tag2>", "The", "net", "loss", "for", "the", "year", "ended", "December", "31,", "2012", "of", "$11.6", "million", "decreased", "primarily", "due", "to", "$7.8", "million", "in", "share-based", "compensation", "and", "$3.7", "million", "in", "depreciation", "and", "a", "$3.0", "million", "increase", "in", "accounts", "payable,", "which", "was", "partially", "offset", "by", "a", "an", "increase", "of", "$3.8", "million", "in", "inventory.", "<tag3>"], "wordsA": ["The", "net", "loss", "was", "partially", "offset", "by", "non-cash", "charges", "for", "share-based", "compensation", "of", "$886,000,", "depreciation", "of", "$3.6", "million", "and", "a", "decrease", "in", "accounts", "receivable", "of", "approximately", "$3.9", "million", "and", "an", "increase", "in", "accounts", "payable", "of", "$6.1", "million."], "wordsB": ["The", "net", "loss", "for", "the", "year", "ended", "December", "31,", "2012", "of", "$11.6", "million", "decreased", "primarily", "due", "to", "$7.8", "million", "in", "share-based", "compensation", "and", "$3.7", "million", "in", "depreciation", "and", "a", "$3.0", "million", "increase", "in", "accounts", "payable,", "which", "was", "partially", "offset", "by", "a", "an", "increase", "of", "$3.8", "million", "in", "inventory."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p72_s2", "idA": "1006281_12_item7_p89_s0", "sentA": "Net cash used in investing activities for 2011 was $5.9 million and consisted primarily of purchases of property and equipment.", "sentB": "Net cash used in investing activities for the year ended December 31, 2012 was $2.3 million and consisted primarily of purchases of property and equipment.", "type": 2, "words": ["<tag1>", "Net", "cash", "used", "in", "investing", "activities", "for", "2011", "was", "$5.9", "million", "and", "consisted", "primarily", "of", "purchases", "of", "property", "and", "equipment.", "<tag2>", "Net", "cash", "used", "in", "investing", "activities", "for", "the", "year", "ended", "December", "31,", "2012", "was", "$2.3", "million", "and", "consisted", "primarily", "of", "purchases", "of", "property", "and", "equipment.", "<tag3>"], "wordsA": ["Net", "cash", "used", "in", "investing", "activities", "for", "2011", "was", "$5.9", "million", "and", "consisted", "primarily", "of", "purchases", "of", "property", "and", "equipment."], "wordsB": ["Net", "cash", "used", "in", "investing", "activities", "for", "the", "year", "ended", "December", "31,", "2012", "was", "$2.3", "million", "and", "consisted", "primarily", "of", "purchases", "of", "property", "and", "equipment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p72_s3", "idA": "1006281_12_item7_p89_s1", "sentA": "Net cash provided from financing activities during 2011 was approximately $20.9 million primarily due to our underwritten public offering of common stock in the first quarter of 2011.", "sentB": "Net cash provided by financing activities was $26.6 million, consisting primarily of net proceeds from our February 2012 underwritten public offering of common stock.", "type": 2, "words": ["<tag1>", "Net", "cash", "provided", "from", "financing", "activities", "during", "2011", "was", "approximately", "$20.9", "million", "primarily", "due", "to", "our", "underwritten", "public", "offering", "of", "common", "stock", "in", "the", "first", "quarter", "of", "2011.", "<tag2>", "Net", "cash", "provided", "by", "financing", "activities", "was", "$26.6", "million,", "consisting", "primarily", "of", "net", "proceeds", "from", "our", "February", "2012", "underwritten", "public", "offering", "of", "common", "stock.", "<tag3>"], "wordsA": ["Net", "cash", "provided", "from", "financing", "activities", "during", "2011", "was", "approximately", "$20.9", "million", "primarily", "due", "to", "our", "underwritten", "public", "offering", "of", "common", "stock", "in", "the", "first", "quarter", "of", "2011."], "wordsB": ["Net", "cash", "provided", "by", "financing", "activities", "was", "$26.6", "million,", "consisting", "primarily", "of", "net", "proceeds", "from", "our", "February", "2012", "underwritten", "public", "offering", "of", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p3_s1", "idA": "1006281_12_item7_p8_s0", "sentA": "In addition, marketing applications have been submitted for taliglucerase alfa with each of the Israeli MOH, ANVISA and the Australian TGA.", "sentB": "Taliglucerase alfa is the first plant cell-based recombinant therapeutic protein to be approved by each of the FDA and the Israeli MOH.", "type": 2, "words": ["<tag1>", "In", "addition,", "marketing", "applications", "have", "been", "submitted", "for", "taliglucerase", "alfa", "with", "each", "of", "the", "Israeli", "MOH,", "ANVISA", "and", "the", "Australian", "TGA.", "<tag2>", "Taliglucerase", "alfa", "is", "the", "first", "plant", "cell-based", "recombinant", "therapeutic", "protein", "to", "be", "approved", "by", "each", "of", "the", "FDA", "and", "the", "Israeli", "MOH.", "<tag3>"], "wordsA": ["In", "addition,", "marketing", "applications", "have", "been", "submitted", "for", "taliglucerase", "alfa", "with", "each", "of", "the", "Israeli", "MOH,", "ANVISA", "and", "the", "Australian", "TGA."], "wordsB": ["Taliglucerase", "alfa", "is", "the", "first", "plant", "cell-based", "recombinant", "therapeutic", "protein", "to", "be", "approved", "by", "each", "of", "the", "FDA", "and", "the", "Israeli", "MOH."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p7_s1", "idA": "1006281_12_item7_p8_s0", "sentA": "In addition, marketing applications have been submitted for taliglucerase alfa with each of the Israeli MOH, ANVISA and the Australian TGA.", "sentB": "Currently, marketing authorization applications have been filed with ANVISA as well as in other countries.", "type": 2, "words": ["<tag1>", "In", "addition,", "marketing", "applications", "have", "been", "submitted", "for", "taliglucerase", "alfa", "with", "each", "of", "the", "Israeli", "MOH,", "ANVISA", "and", "the", "Australian", "TGA.", "<tag2>", "Currently,", "marketing", "authorization", "applications", "have", "been", "filed", "with", "ANVISA", "as", "well", "as", "in", "other", "countries.", "<tag3>"], "wordsA": ["In", "addition,", "marketing", "applications", "have", "been", "submitted", "for", "taliglucerase", "alfa", "with", "each", "of", "the", "Israeli", "MOH,", "ANVISA", "and", "the", "Australian", "TGA."], "wordsB": ["Currently,", "marketing", "authorization", "applications", "have", "been", "filed", "with", "ANVISA", "as", "well", "as", "in", "other", "countries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p72_s0", "idA": "1006281_12_item7_p90_s0", "sentA": "Net cash used in operations was $38.5 million for the year ended December 31, 2010.", "sentB": "Net cash provided by operations was $635,000 for the year ended December 31, 2012.", "type": 2, "words": ["<tag1>", "Net", "cash", "used", "in", "operations", "was", "$38.5", "million", "for", "the", "year", "ended", "December", "31,", "2010.", "<tag2>", "Net", "cash", "provided", "by", "operations", "was", "$635,000", "for", "the", "year", "ended", "December", "31,", "2012.", "<tag3>"], "wordsA": ["Net", "cash", "used", "in", "operations", "was", "$38.5", "million", "for", "the", "year", "ended", "December", "31,", "2010."], "wordsB": ["Net", "cash", "provided", "by", "operations", "was", "$635,000", "for", "the", "year", "ended", "December", "31,", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p75_s1", "idA": "1006281_12_item7_p91_s1", "sentA": "However, we anticipate that we will generate revenues to offset any such losses upon the successful launch of taliglucerase alfa, if at all.", "sentB": "However, we anticipate that we will generate revenues to offset such losses as Pfizer's commercialization efforts for taliglucerase alfa progress after the FDA's approval in May 2012, and as we begin to generate revenues from the commercialization of taliglucerase alfa in Israel after the Israeli MOH's approval in September 2012.", "type": 2, "words": ["<tag1>", "However,", "we", "anticipate", "that", "we", "will", "generate", "revenues", "to", "offset", "any", "such", "losses", "upon", "the", "successful", "launch", "of", "taliglucerase", "alfa,", "if", "at", "all.", "<tag2>", "However,", "we", "anticipate", "that", "we", "will", "generate", "revenues", "to", "offset", "such", "losses", "as", "Pfizer's", "commercialization", "efforts", "for", "taliglucerase", "alfa", "progress", "after", "the", "FDA's", "approval", "in", "May", "2012,", "and", "as", "we", "begin", "to", "generate", "revenues", "from", "the", "commercialization", "of", "taliglucerase", "alfa", "in", "Israel", "after", "the", "Israeli", "MOH's", "approval", "in", "September", "2012.", "<tag3>"], "wordsA": ["However,", "we", "anticipate", "that", "we", "will", "generate", "revenues", "to", "offset", "any", "such", "losses", "upon", "the", "successful", "launch", "of", "taliglucerase", "alfa,", "if", "at", "all."], "wordsB": ["However,", "we", "anticipate", "that", "we", "will", "generate", "revenues", "to", "offset", "such", "losses", "as", "Pfizer's", "commercialization", "efforts", "for", "taliglucerase", "alfa", "progress", "after", "the", "FDA's", "approval", "in", "May", "2012,", "and", "as", "we", "begin", "to", "generate", "revenues", "from", "the", "commercialization", "of", "taliglucerase", "alfa", "in", "Israel", "after", "the", "Israeli", "MOH's", "approval", "in", "September", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p75_s3", "idA": "1006281_12_item7_p91_s2", "sentA": "We expect to incur significant research and development expenses, including expenses related to the hiring of personnel and the advancement of our additional pipeline of product candidate into the various clinical trials.", "sentB": "We expect to continue to incur significant research and development expenses, including expenses related to the hiring of personnel and the advancement of PRX-102 and oral glucocerebrosidase and any other product candidates in our pipeline into clinical trials.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "incur", "significant", "research", "and", "development", "expenses,", "including", "expenses", "related", "to", "the", "hiring", "of", "personnel", "and", "the", "advancement", "of", "our", "additional", "pipeline", "of", "product", "candidate", "into", "the", "various", "clinical", "trials.", "<tag2>", "We", "expect", "to", "continue", "to", "incur", "significant", "research", "and", "development", "expenses,", "including", "expenses", "related", "to", "the", "hiring", "of", "personnel", "and", "the", "advancement", "of", "PRX-102", "and", "oral", "glucocerebrosidase", "and", "any", "other", "product", "candidates", "in", "our", "pipeline", "into", "clinical", "trials.", "<tag3>"], "wordsA": ["We", "expect", "to", "incur", "significant", "research", "and", "development", "expenses,", "including", "expenses", "related", "to", "the", "hiring", "of", "personnel", "and", "the", "advancement", "of", "our", "additional", "pipeline", "of", "product", "candidate", "into", "the", "various", "clinical", "trials."], "wordsB": ["We", "expect", "to", "continue", "to", "incur", "significant", "research", "and", "development", "expenses,", "including", "expenses", "related", "to", "the", "hiring", "of", "personnel", "and", "the", "advancement", "of", "PRX-102", "and", "oral", "glucocerebrosidase", "and", "any", "other", "product", "candidates", "in", "our", "pipeline", "into", "clinical", "trials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p75_s4", "idA": "1006281_12_item7_p91_s3", "sentA": "We expect that general and administrative expenses will increase as we expand our finance and administrative staff, add infrastructure, and incur additional costs related to our preparation for the commercial phase for our lead product candidate, taliglucerase alfa.", "sentB": "We expect that general and administrative expenses will marginally increase as we expand our administrative staff, add infrastructure and incur additional costs related to the continued progression of the commercialization of taliglucerase alfa.", "type": 2, "words": ["<tag1>", "We", "expect", "that", "general", "and", "administrative", "expenses", "will", "increase", "as", "we", "expand", "our", "finance", "and", "administrative", "staff,", "add", "infrastructure,", "and", "incur", "additional", "costs", "related", "to", "our", "preparation", "for", "the", "commercial", "phase", "for", "our", "lead", "product", "candidate,", "taliglucerase", "alfa.", "<tag2>", "We", "expect", "that", "general", "and", "administrative", "expenses", "will", "marginally", "increase", "as", "we", "expand", "our", "administrative", "staff,", "add", "infrastructure", "and", "incur", "additional", "costs", "related", "to", "the", "continued", "progression", "of", "the", "commercialization", "of", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["We", "expect", "that", "general", "and", "administrative", "expenses", "will", "increase", "as", "we", "expand", "our", "finance", "and", "administrative", "staff,", "add", "infrastructure,", "and", "incur", "additional", "costs", "related", "to", "our", "preparation", "for", "the", "commercial", "phase", "for", "our", "lead", "product", "candidate,", "taliglucerase", "alfa."], "wordsB": ["We", "expect", "that", "general", "and", "administrative", "expenses", "will", "marginally", "increase", "as", "we", "expand", "our", "administrative", "staff,", "add", "infrastructure", "and", "incur", "additional", "costs", "related", "to", "the", "continued", "progression", "of", "the", "commercialization", "of", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p76_s0", "idA": "1006281_12_item7_p92_s0", "sentA": "We believe that our existing cash and cash equivalents and the net proceeds from our public underwritten offering of February 2012 will be sufficient to enable us to fund our operating expenses and capital expenditure requirements at least for the next 12 months.", "sentB": "We believe that our existing cash and cash equivalents will be sufficient to enable us to fund our operating expenses and capital expenditure requirements for at least the next 12 months.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "our", "existing", "cash", "and", "cash", "equivalents", "and", "the", "net", "proceeds", "from", "our", "public", "underwritten", "offering", "of", "February", "2012", "will", "be", "sufficient", "to", "enable", "us", "to", "fund", "our", "operating", "expenses", "and", "capital", "expenditure", "requirements", "at", "least", "for", "the", "next", "12", "months.", "<tag2>", "We", "believe", "that", "our", "existing", "cash", "and", "cash", "equivalents", "will", "be", "sufficient", "to", "enable", "us", "to", "fund", "our", "operating", "expenses", "and", "capital", "expenditure", "requirements", "for", "at", "least", "the", "next", "12", "months.", "<tag3>"], "wordsA": ["We", "believe", "that", "our", "existing", "cash", "and", "cash", "equivalents", "and", "the", "net", "proceeds", "from", "our", "public", "underwritten", "offering", "of", "February", "2012", "will", "be", "sufficient", "to", "enable", "us", "to", "fund", "our", "operating", "expenses", "and", "capital", "expenditure", "requirements", "at", "least", "for", "the", "next", "12", "months."], "wordsB": ["We", "believe", "that", "our", "existing", "cash", "and", "cash", "equivalents", "will", "be", "sufficient", "to", "enable", "us", "to", "fund", "our", "operating", "expenses", "and", "capital", "expenditure", "requirements", "for", "at", "least", "the", "next", "12", "months."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p77_s0", "idA": "1006281_12_item7_p93_s0", "sentA": "Our future capital requirements will depend on many factors, including the progress and results of our clinical trials, costs of commercialization activities, including product marketing, sales and distribution and whether these efforts will be performed internally or through some form of collaboration with third parties, the duration and cost of discovery and preclinical development, and laboratory testing and clinical trials for our product candidates, the timing and outcome of regulatory review of our product candidates, the costs involved in preparing, filing, prosecuting, maintaining, defending and enforcing patent claims and other intellectual property rights and the number and development requirements of other product candidates that we pursue.", "sentB": "Our future capital requirements will depend on many factors, including the progress of Pfizer's commercialization efforts in the United States, the progress of our commercialization efforts in Israel and, if anticipated marketing approvals of taliglucerase alfa are granted in other jurisdictions, the progress of Pfizer's global commercialization efforts, the progress and results of our clinical trials, the duration and cost of discovery and preclinical development and laboratory testing and clinical trials for our product candidates, the timing and outcome of regulatory review of our product candidates, the costs involved in preparing, filing, prosecuting, maintaining, defending and enforcing patent claims and other intellectual property rights, the number and development requirements of other product candidates that we pursue and the costs of commercialization activities, including product marketing, sales and distribution.", "type": 2, "words": ["<tag1>", "Our", "future", "capital", "requirements", "will", "depend", "on", "many", "factors,", "including", "the", "progress", "and", "results", "of", "our", "clinical", "trials,", "costs", "of", "commercialization", "activities,", "including", "product", "marketing,", "sales", "and", "distribution", "and", "whether", "these", "efforts", "will", "be", "performed", "internally", "or", "through", "some", "form", "of", "collaboration", "with", "third", "parties,", "the", "duration", "and", "cost", "of", "discovery", "and", "preclinical", "development,", "and", "laboratory", "testing", "and", "clinical", "trials", "for", "our", "product", "candidates,", "the", "timing", "and", "outcome", "of", "regulatory", "review", "of", "our", "product", "candidates,", "the", "costs", "involved", "in", "preparing,", "filing,", "prosecuting,", "maintaining,", "defending", "and", "enforcing", "patent", "claims", "and", "other", "intellectual", "property", "rights", "and", "the", "number", "and", "development", "requirements", "of", "other", "product", "candidates", "that", "we", "pursue.", "<tag2>", "Our", "future", "capital", "requirements", "will", "depend", "on", "many", "factors,", "including", "the", "progress", "of", "Pfizer's", "commercialization", "efforts", "in", "the", "United", "States,", "the", "progress", "of", "our", "commercialization", "efforts", "in", "Israel", "and,", "if", "anticipated", "marketing", "approvals", "of", "taliglucerase", "alfa", "are", "granted", "in", "other", "jurisdictions,", "the", "progress", "of", "Pfizer's", "global", "commercialization", "efforts,", "the", "progress", "and", "results", "of", "our", "clinical", "trials,", "the", "duration", "and", "cost", "of", "discovery", "and", "preclinical", "development", "and", "laboratory", "testing", "and", "clinical", "trials", "for", "our", "product", "candidates,", "the", "timing", "and", "outcome", "of", "regulatory", "review", "of", "our", "product", "candidates,", "the", "costs", "involved", "in", "preparing,", "filing,", "prosecuting,", "maintaining,", "defending", "and", "enforcing", "patent", "claims", "and", "other", "intellectual", "property", "rights,", "the", "number", "and", "development", "requirements", "of", "other", "product", "candidates", "that", "we", "pursue", "and", "the", "costs", "of", "commercialization", "activities,", "including", "product", "marketing,", "sales", "and", "distribution.", "<tag3>"], "wordsA": ["Our", "future", "capital", "requirements", "will", "depend", "on", "many", "factors,", "including", "the", "progress", "and", "results", "of", "our", "clinical", "trials,", "costs", "of", "commercialization", "activities,", "including", "product", "marketing,", "sales", "and", "distribution", "and", "whether", "these", "efforts", "will", "be", "performed", "internally", "or", "through", "some", "form", "of", "collaboration", "with", "third", "parties,", "the", "duration", "and", "cost", "of", "discovery", "and", "preclinical", "development,", "and", "laboratory", "testing", "and", "clinical", "trials", "for", "our", "product", "candidates,", "the", "timing", "and", "outcome", "of", "regulatory", "review", "of", "our", "product", "candidates,", "the", "costs", "involved", "in", "preparing,", "filing,", "prosecuting,", "maintaining,", "defending", "and", "enforcing", "patent", "claims", "and", "other", "intellectual", "property", "rights", "and", "the", "number", "and", "development", "requirements", "of", "other", "product", "candidates", "that", "we", "pursue."], "wordsB": ["Our", "future", "capital", "requirements", "will", "depend", "on", "many", "factors,", "including", "the", "progress", "of", "Pfizer's", "commercialization", "efforts", "in", "the", "United", "States,", "the", "progress", "of", "our", "commercialization", "efforts", "in", "Israel", "and,", "if", "anticipated", "marketing", "approvals", "of", "taliglucerase", "alfa", "are", "granted", "in", "other", "jurisdictions,", "the", "progress", "of", "Pfizer's", "global", "commercialization", "efforts,", "the", "progress", "and", "results", "of", "our", "clinical", "trials,", "the", "duration", "and", "cost", "of", "discovery", "and", "preclinical", "development", "and", "laboratory", "testing", "and", "clinical", "trials", "for", "our", "product", "candidates,", "the", "timing", "and", "outcome", "of", "regulatory", "review", "of", "our", "product", "candidates,", "the", "costs", "involved", "in", "preparing,", "filing,", "prosecuting,", "maintaining,", "defending", "and", "enforcing", "patent", "claims", "and", "other", "intellectual", "property", "rights,", "the", "number", "and", "development", "requirements", "of", "other", "product", "candidates", "that", "we", "pursue", "and", "the", "costs", "of", "commercialization", "activities,", "including", "product", "marketing,", "sales", "and", "distribution."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p78_s1", "idA": "1006281_12_item7_p94_s1", "sentA": "We currently do not have any commitments for future external funding, other than the potential regulatory-related milestone payments from Pfizer.", "sentB": "We currently do not have any commitments for future external funding.", "type": 2, "words": ["<tag1>", "We", "currently", "do", "not", "have", "any", "commitments", "for", "future", "external", "funding,", "other", "than", "the", "potential", "regulatory-related", "milestone", "payments", "from", "Pfizer.", "<tag2>", "We", "currently", "do", "not", "have", "any", "commitments", "for", "future", "external", "funding.", "<tag3>"], "wordsA": ["We", "currently", "do", "not", "have", "any", "commitments", "for", "future", "external", "funding,", "other", "than", "the", "potential", "regulatory-related", "milestone", "payments", "from", "Pfizer."], "wordsB": ["We", "currently", "do", "not", "have", "any", "commitments", "for", "future", "external", "funding."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p79_s1", "idA": "1006281_12_item7_p95_s1", "sentA": "We do not believe that inflation has had a material effect on our results of operations during the years ended December 31, 2009, 2010 or 2011.", "sentB": "We do not believe that inflation has had a material effect on our results of operations during the years ended December 31, 2010, 2011 or 2012.", "type": 2, "words": ["<tag1>", "We", "do", "not", "believe", "that", "inflation", "has", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2009,", "2010", "or", "2011.", "<tag2>", "We", "do", "not", "believe", "that", "inflation", "has", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2010,", "2011", "or", "2012.", "<tag3>"], "wordsA": ["We", "do", "not", "believe", "that", "inflation", "has", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2009,", "2010", "or", "2011."], "wordsB": ["We", "do", "not", "believe", "that", "inflation", "has", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2010,", "2011", "or", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p80_s1", "idA": "1006281_12_item7_p96_s1", "sentA": "We do not believe currency fluctuations have had a material effect on our results of operations during the years ended December 31, 2009, 2010 or 2011.", "sentB": "We do not believe currency fluctuations have had a material effect on our results of operations during the years ended December 31, 2010, 2011 or 2012.", "type": 2, "words": ["<tag1>", "We", "do", "not", "believe", "currency", "fluctuations", "have", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2009,", "2010", "or", "2011.", "<tag2>", "We", "do", "not", "believe", "currency", "fluctuations", "have", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2010,", "2011", "or", "2012.", "<tag3>"], "wordsA": ["We", "do", "not", "believe", "currency", "fluctuations", "have", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2009,", "2010", "or", "2011."], "wordsB": ["We", "do", "not", "believe", "currency", "fluctuations", "have", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2010,", "2011", "or", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p81_s0", "idA": "1006281_12_item7_p97_s0", "sentA": "We have no off-balance sheet arrangements as of December 31, 2010 and 2011.", "sentB": "We have no off-balance sheet arrangements as of December 31, 2011 and 2012.", "type": 2, "words": ["<tag1>", "We", "have", "no", "off-balance", "sheet", "arrangements", "as", "of", "December", "31,", "2010", "and", "2011.", "<tag2>", "We", "have", "no", "off-balance", "sheet", "arrangements", "as", "of", "December", "31,", "2011", "and", "2012.", "<tag3>"], "wordsA": ["We", "have", "no", "off-balance", "sheet", "arrangements", "as", "of", "December", "31,", "2010", "and", "2011."], "wordsB": ["We", "have", "no", "off-balance", "sheet", "arrangements", "as", "of", "December", "31,", "2011", "and", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p82_s0", "idA": "1006281_12_item7_p98_s0", "sentA": "The following table summarizes our significant contractual obligations at December 31, 2011 (in thousands):", "sentB": "The following table summarizes our significant contractual obligations at December 31, 2012:", "type": 2, "words": ["<tag1>", "The", "following", "table", "summarizes", "our", "significant", "contractual", "obligations", "at", "December", "31,", "2011", "(in", "thousands):", "<tag2>", "The", "following", "table", "summarizes", "our", "significant", "contractual", "obligations", "at", "December", "31,", "2012:", "<tag3>"], "wordsA": ["The", "following", "table", "summarizes", "our", "significant", "contractual", "obligations", "at", "December", "31,", "2011", "(in", "thousands):"], "wordsB": ["The", "following", "table", "summarizes", "our", "significant", "contractual", "obligations", "at", "December", "31,", "2012:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_13_item7_p83_s0", "idA": "1006281_12_item7_p99_s0", "sentA": "(1) Represents open purchase orders issued to certain suppliers and other vendors mainly in connection with our research and development activities that were outstanding as of December 31, 2011.", "sentB": "(1) Represents open purchase orders issued to certain suppliers and other vendors mainly in connection with our research and development activities that were outstanding as of December 31, 2012.", "type": 2, "words": ["<tag1>", "(1)", "Represents", "open", "purchase", "orders", "issued", "to", "certain", "suppliers", "and", "other", "vendors", "mainly", "in", "connection", "with", "our", "research", "and", "development", "activities", "that", "were", "outstanding", "as", "of", "December", "31,", "2011.", "<tag2>", "(1)", "Represents", "open", "purchase", "orders", "issued", "to", "certain", "suppliers", "and", "other", "vendors", "mainly", "in", "connection", "with", "our", "research", "and", "development", "activities", "that", "were", "outstanding", "as", "of", "December", "31,", "2012.", "<tag3>"], "wordsA": ["(1)", "Represents", "open", "purchase", "orders", "issued", "to", "certain", "suppliers", "and", "other", "vendors", "mainly", "in", "connection", "with", "our", "research", "and", "development", "activities", "that", "were", "outstanding", "as", "of", "December", "31,", "2011."], "wordsB": ["(1)", "Represents", "open", "purchase", "orders", "issued", "to", "certain", "suppliers", "and", "other", "vendors", "mainly", "in", "connection", "with", "our", "research", "and", "development", "activities", "that", "were", "outstanding", "as", "of", "December", "31,", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p12_s3", "idA": "1006281_13_item7_p10_s3", "sentA": "We also conducted a clinical trial of na ve and switchover pediatric patients which we concluded in 2012.", "sentB": "We also conducted a 12-month clinical trial of na ve and switchover pediatric patients, which was successfully completed in 2012.", "type": 2, "words": ["<tag1>", "We", "also", "conducted", "a", "clinical", "trial", "of", "na", "ve", "and", "switchover", "pediatric", "patients", "which", "we", "concluded", "in", "2012.", "<tag2>", "We", "also", "conducted", "a", "12-month", "clinical", "trial", "of", "na", "ve", "and", "switchover", "pediatric", "patients,", "which", "was", "successfully", "completed", "in", "2012.", "<tag3>"], "wordsA": ["We", "also", "conducted", "a", "clinical", "trial", "of", "na", "ve", "and", "switchover", "pediatric", "patients", "which", "we", "concluded", "in", "2012."], "wordsB": ["We", "also", "conducted", "a", "12-month", "clinical", "trial", "of", "na", "ve", "and", "switchover", "pediatric", "patients,", "which", "was", "successfully", "completed", "in", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p12_s5", "idA": "1006281_13_item7_p10_s4", "sentA": "Patients in the extension trial and the switchover trial are still being treated with taliglucerase alfa.", "sentB": "Patients in the extension trials are still being treated with taliglucerase alfa.", "type": 2, "words": ["<tag1>", "Patients", "in", "the", "extension", "trial", "and", "the", "switchover", "trial", "are", "still", "being", "treated", "with", "taliglucerase", "alfa.", "<tag2>", "Patients", "in", "the", "extension", "trials", "are", "still", "being", "treated", "with", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["Patients", "in", "the", "extension", "trial", "and", "the", "switchover", "trial", "are", "still", "being", "treated", "with", "taliglucerase", "alfa."], "wordsB": ["Patients", "in", "the", "extension", "trials", "are", "still", "being", "treated", "with", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p13_s0", "idA": "1006281_13_item7_p11_s0", "sentA": "Currently, patients are being treated with ELELYSO on a commercial basis in the United States and in Israel shortly.", "sentB": "Currently, patients are being treated with taliglucerase alfa on a commercial basis in the United States, Brazil, Israel and Chile.", "type": 2, "words": ["<tag1>", "Currently,", "patients", "are", "being", "treated", "with", "ELELYSO", "on", "a", "commercial", "basis", "in", "the", "United", "States", "and", "in", "Israel", "shortly.", "<tag2>", "Currently,", "patients", "are", "being", "treated", "with", "taliglucerase", "alfa", "on", "a", "commercial", "basis", "in", "the", "United", "States,", "Brazil,", "Israel", "and", "Chile.", "<tag3>"], "wordsA": ["Currently,", "patients", "are", "being", "treated", "with", "ELELYSO", "on", "a", "commercial", "basis", "in", "the", "United", "States", "and", "in", "Israel", "shortly."], "wordsB": ["Currently,", "patients", "are", "being", "treated", "with", "taliglucerase", "alfa", "on", "a", "commercial", "basis", "in", "the", "United", "States,", "Brazil,", "Israel", "and", "Chile."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p13_s2", "idA": "1006281_13_item7_p11_s2", "sentA": "In France, Gaucher patients are being treated with taliglucerase alfa through an ATU.", "sentB": "In France, Gaucher patients are being treated with taliglucerase alfa through an Autorisation Temporaire d Utilisation (ATU), or Temporary Authorization for Use, a regulatory mechanism used by the French Health Products and Safety Agency to make non-approved drugs available to patients in France when a genuine public health need exists.", "type": 2, "words": ["<tag1>", "In", "France,", "Gaucher", "patients", "are", "being", "treated", "with", "taliglucerase", "alfa", "through", "an", "ATU.", "<tag2>", "In", "France,", "Gaucher", "patients", "are", "being", "treated", "with", "taliglucerase", "alfa", "through", "an", "Autorisation", "Temporaire", "d", "Utilisation", "(ATU),", "or", "Temporary", "Authorization", "for", "Use,", "a", "regulatory", "mechanism", "used", "by", "the", "French", "Health", "Products", "and", "Safety", "Agency", "to", "make", "non-approved", "drugs", "available", "to", "patients", "in", "France", "when", "a", "genuine", "public", "health", "need", "exists.", "<tag3>"], "wordsA": ["In", "France,", "Gaucher", "patients", "are", "being", "treated", "with", "taliglucerase", "alfa", "through", "an", "ATU."], "wordsB": ["In", "France,", "Gaucher", "patients", "are", "being", "treated", "with", "taliglucerase", "alfa", "through", "an", "Autorisation", "Temporaire", "d", "Utilisation", "(ATU),", "or", "Temporary", "Authorization", "for", "Use,", "a", "regulatory", "mechanism", "used", "by", "the", "French", "Health", "Products", "and", "Safety", "Agency", "to", "make", "non-approved", "drugs", "available", "to", "patients", "in", "France", "when", "a", "genuine", "public", "health", "need", "exists."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p8_s0", "idA": "1006281_13_item7_p11_s4", "sentA": "Hundreds of patients, in the aggregate, have been treated with taliglucerase alfa.", "sentB": "On June 18, 2013, we entered into the Brazil Agreement with Fiocruz for taliglucerase alfa.", "type": 2, "words": ["<tag1>", "Hundreds", "of", "patients,", "in", "the", "aggregate,", "have", "been", "treated", "with", "taliglucerase", "alfa.", "<tag2>", "On", "June", "18,", "2013,", "we", "entered", "into", "the", "Brazil", "Agreement", "with", "Fiocruz", "for", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["Hundreds", "of", "patients,", "in", "the", "aggregate,", "have", "been", "treated", "with", "taliglucerase", "alfa."], "wordsB": ["On", "June", "18,", "2013,", "we", "entered", "into", "the", "Brazil", "Agreement", "with", "Fiocruz", "for", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p14_s1", "idA": "1006281_13_item7_p14_s1", "sentA": "Our product pipeline currently includes, among other candidates: (1) PRX-102, a therapeutic protein candidate for the treatment of Fabry disease, a rare, genetic lysosomal disorder in humans; (2) PRX-105, a plant cell expressed pegylated recombinant acetylcholinesterase product candidate for biodefense and other indications; (3) an orally-administered glucocerebrosidase enzyme for the treatment of Gaucher patients utilizing oral delivery of the recombinant enzyme produced within carrot cells; (4) PRX-106, or pr-antiTNF, a plant cell expressed recombinant fusion protein made from the soluble form of the human TNF receptor (TNFR) and an antibody portion, which is being developed as a treatment of certain immune diseases such as rheumatoid arthritis, Chrohn's disease, placque psoriasis and other autoimmune disorders; and (5) two additional undisclosed therapeutic proteins, both of which are being evaluated in animal studies.", "sentB": "Our product pipeline currently includes, among other candidates: PRX-102, a therapeutic protein candidate for the treatment of Fabry disease; PRX-112, an orally administered glucocerebrosidase enzyme for the treatment of Gaucher patients utilizing oral delivery of the recombinant GCD enzyme produced and encapsulated within carrot cells; PRX-106, an oral antiTNF, a plant cell expressed recombinant fusion protein combined of the binding domain of the human TNF receptor (TNFR) and an antibody portion, which is being developed for the treatment of certain immune and inflammatory diseases, such as rheumatoid arthritis, colitis, Crohn s disease, psoriasis and other autoimmune and inflammatory disorders; PRX-110, a proprietary plant cell recombinant human Deoxyribonuclease 1 under development for the treatment of cystic fibrosis, to be administered by inhalation; PRX-107, a proprietary plant cell recombinant AAT; and others.", "type": 2, "words": ["<tag1>", "Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates:", "(1)", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans;", "(2)", "PRX-105,", "a", "plant", "cell", "expressed", "pegylated", "recombinant", "acetylcholinesterase", "product", "candidate", "for", "biodefense", "and", "other", "indications;", "(3)", "an", "orally-administered", "glucocerebrosidase", "enzyme", "for", "the", "treatment", "of", "Gaucher", "patients", "utilizing", "oral", "delivery", "of", "the", "recombinant", "enzyme", "produced", "within", "carrot", "cells;", "(4)", "PRX-106,", "or", "pr-antiTNF,", "a", "plant", "cell", "expressed", "recombinant", "fusion", "protein", "made", "from", "the", "soluble", "form", "of", "the", "human", "TNF", "receptor", "(TNFR)", "and", "an", "antibody", "portion,", "which", "is", "being", "developed", "as", "a", "treatment", "of", "certain", "immune", "diseases", "such", "as", "rheumatoid", "arthritis,", "Chrohn's", "disease,", "placque", "psoriasis", "and", "other", "autoimmune", "disorders;", "and", "(5)", "two", "additional", "undisclosed", "therapeutic", "proteins,", "both", "of", "which", "are", "being", "evaluated", "in", "animal", "studies.", "<tag2>", "Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates:", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease;", "PRX-112,", "an", "orally", "administered", "glucocerebrosidase", "enzyme", "for", "the", "treatment", "of", "Gaucher", "patients", "utilizing", "oral", "delivery", "of", "the", "recombinant", "GCD", "enzyme", "produced", "and", "encapsulated", "within", "carrot", "cells;", "PRX-106,", "an", "oral", "antiTNF,", "a", "plant", "cell", "expressed", "recombinant", "fusion", "protein", "combined", "of", "the", "binding", "domain", "of", "the", "human", "TNF", "receptor", "(TNFR)", "and", "an", "antibody", "portion,", "which", "is", "being", "developed", "for", "the", "treatment", "of", "certain", "immune", "and", "inflammatory", "diseases,", "such", "as", "rheumatoid", "arthritis,", "colitis,", "Crohn", "s", "disease,", "psoriasis", "and", "other", "autoimmune", "and", "inflammatory", "disorders;", "PRX-110,", "a", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1", "under", "development", "for", "the", "treatment", "of", "cystic", "fibrosis,", "to", "be", "administered", "by", "inhalation;", "PRX-107,", "a", "proprietary", "plant", "cell", "recombinant", "AAT;", "and", "others.", "<tag3>"], "wordsA": ["Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates:", "(1)", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans;", "(2)", "PRX-105,", "a", "plant", "cell", "expressed", "pegylated", "recombinant", "acetylcholinesterase", "product", "candidate", "for", "biodefense", "and", "other", "indications;", "(3)", "an", "orally-administered", "glucocerebrosidase", "enzyme", "for", "the", "treatment", "of", "Gaucher", "patients", "utilizing", "oral", "delivery", "of", "the", "recombinant", "enzyme", "produced", "within", "carrot", "cells;", "(4)", "PRX-106,", "or", "pr-antiTNF,", "a", "plant", "cell", "expressed", "recombinant", "fusion", "protein", "made", "from", "the", "soluble", "form", "of", "the", "human", "TNF", "receptor", "(TNFR)", "and", "an", "antibody", "portion,", "which", "is", "being", "developed", "as", "a", "treatment", "of", "certain", "immune", "diseases", "such", "as", "rheumatoid", "arthritis,", "Chrohn's", "disease,", "placque", "psoriasis", "and", "other", "autoimmune", "disorders;", "and", "(5)", "two", "additional", "undisclosed", "therapeutic", "proteins,", "both", "of", "which", "are", "being", "evaluated", "in", "animal", "studies."], "wordsB": ["Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates:", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease;", "PRX-112,", "an", "orally", "administered", "glucocerebrosidase", "enzyme", "for", "the", "treatment", "of", "Gaucher", "patients", "utilizing", "oral", "delivery", "of", "the", "recombinant", "GCD", "enzyme", "produced", "and", "encapsulated", "within", "carrot", "cells;", "PRX-106,", "an", "oral", "antiTNF,", "a", "plant", "cell", "expressed", "recombinant", "fusion", "protein", "combined", "of", "the", "binding", "domain", "of", "the", "human", "TNF", "receptor", "(TNFR)", "and", "an", "antibody", "portion,", "which", "is", "being", "developed", "for", "the", "treatment", "of", "certain", "immune", "and", "inflammatory", "diseases,", "such", "as", "rheumatoid", "arthritis,", "colitis,", "Crohn", "s", "disease,", "psoriasis", "and", "other", "autoimmune", "and", "inflammatory", "disorders;", "PRX-110,", "a", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1", "under", "development", "for", "the", "treatment", "of", "cystic", "fibrosis,", "to", "be", "administered", "by", "inhalation;", "PRX-107,", "a", "proprietary", "plant", "cell", "recombinant", "AAT;", "and", "others."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p2_s3", "idA": "1006281_13_item7_p14_s2", "sentA": "We participated in a pre-investigational new drug, or IND, meeting with respect to one of the undisclosed product candidates in the first quarter of 2012 and a pre-IND meeting for the second candidate is planned for 2013.", "sentB": "We are now also applying the unique properties of our ProCellEx system for the oral delivery of therapeutic proteins, with the first two product candidates being glucocerebrosidase and antiTNF fusion protein.", "type": 2, "words": ["<tag1>", "We", "participated", "in", "a", "pre-investigational", "new", "drug,", "or", "IND,", "meeting", "with", "respect", "to", "one", "of", "the", "undisclosed", "product", "candidates", "in", "the", "first", "quarter", "of", "2012", "and", "a", "pre-IND", "meeting", "for", "the", "second", "candidate", "is", "planned", "for", "2013.", "<tag2>", "We", "are", "now", "also", "applying", "the", "unique", "properties", "of", "our", "ProCellEx", "system", "for", "the", "oral", "delivery", "of", "therapeutic", "proteins,", "with", "the", "first", "two", "product", "candidates", "being", "glucocerebrosidase", "and", "antiTNF", "fusion", "protein.", "<tag3>"], "wordsA": ["We", "participated", "in", "a", "pre-investigational", "new", "drug,", "or", "IND,", "meeting", "with", "respect", "to", "one", "of", "the", "undisclosed", "product", "candidates", "in", "the", "first", "quarter", "of", "2012", "and", "a", "pre-IND", "meeting", "for", "the", "second", "candidate", "is", "planned", "for", "2013."], "wordsB": ["We", "are", "now", "also", "applying", "the", "unique", "properties", "of", "our", "ProCellEx", "system", "for", "the", "oral", "delivery", "of", "therapeutic", "proteins,", "with", "the", "first", "two", "product", "candidates", "being", "glucocerebrosidase", "and", "antiTNF", "fusion", "protein."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p15_s0", "idA": "1006281_13_item7_p17_s0", "sentA": "Except for the rights to commercialize taliglucerase alfa worldwide (other than Israel) which we licensed to Pfizer, we hold the worldwide commercialization rights to our proprietary development candidates.", "sentB": "Except for the rights to commercialize taliglucerase alfa worldwide (other than Brazil and Israel), which we licensed to Pfizer, we hold the worldwide commercialization rights to all of our proprietary development candidates.", "type": 2, "words": ["<tag1>", "Except", "for", "the", "rights", "to", "commercialize", "taliglucerase", "alfa", "worldwide", "(other", "than", "Israel)", "which", "we", "licensed", "to", "Pfizer,", "we", "hold", "the", "worldwide", "commercialization", "rights", "to", "our", "proprietary", "development", "candidates.", "<tag2>", "Except", "for", "the", "rights", "to", "commercialize", "taliglucerase", "alfa", "worldwide", "(other", "than", "Brazil", "and", "Israel),", "which", "we", "licensed", "to", "Pfizer,", "we", "hold", "the", "worldwide", "commercialization", "rights", "to", "all", "of", "our", "proprietary", "development", "candidates.", "<tag3>"], "wordsA": ["Except", "for", "the", "rights", "to", "commercialize", "taliglucerase", "alfa", "worldwide", "(other", "than", "Israel)", "which", "we", "licensed", "to", "Pfizer,", "we", "hold", "the", "worldwide", "commercialization", "rights", "to", "our", "proprietary", "development", "candidates."], "wordsB": ["Except", "for", "the", "rights", "to", "commercialize", "taliglucerase", "alfa", "worldwide", "(other", "than", "Brazil", "and", "Israel),", "which", "we", "licensed", "to", "Pfizer,", "we", "hold", "the", "worldwide", "commercialization", "rights", "to", "all", "of", "our", "proprietary", "development", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p15_s2", "idA": "1006281_13_item7_p17_s2", "sentA": "In addition, we continuously evaluate potential strategic marketing partnerships.", "sentB": "In addition, we continuously evaluate potential strategic marketing partnerships as well as collaboration programs with biotechnology and pharmaceutical companies and academic research institutes.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "continuously", "evaluate", "potential", "strategic", "marketing", "partnerships.", "<tag2>", "In", "addition,", "we", "continuously", "evaluate", "potential", "strategic", "marketing", "partnerships", "as", "well", "as", "collaboration", "programs", "with", "biotechnology", "and", "pharmaceutical", "companies", "and", "academic", "research", "institutes.", "<tag3>"], "wordsA": ["In", "addition,", "we", "continuously", "evaluate", "potential", "strategic", "marketing", "partnerships."], "wordsB": ["In", "addition,", "we", "continuously", "evaluate", "potential", "strategic", "marketing", "partnerships", "as", "well", "as", "collaboration", "programs", "with", "biotechnology", "and", "pharmaceutical", "companies", "and", "academic", "research", "institutes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p1_s1", "idA": "1006281_13_item7_p1_s1", "sentA": "Using our ProCellEx system, we are developing a pipeline of proprietary and biosimilar versions of recombinant therapeutic proteins based on our plant cell-based expression technology that target large, established pharmaceutical markets and that rely upon known biological mechanisms of action.", "sentB": "Using our ProCellEx system, we are developing a pipeline of proprietary, biobetter and biosimilar versions of recombinant therapeutic proteins, based on our plant cell-based expression technology, that primarily target large, established pharmaceutical markets and that rely upon known biological mechanisms of action.", "type": 2, "words": ["<tag1>", "Using", "our", "ProCellEx", "system,", "we", "are", "developing", "a", "pipeline", "of", "proprietary", "and", "biosimilar", "versions", "of", "recombinant", "therapeutic", "proteins", "based", "on", "our", "plant", "cell-based", "expression", "technology", "that", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "rely", "upon", "known", "biological", "mechanisms", "of", "action.", "<tag2>", "Using", "our", "ProCellEx", "system,", "we", "are", "developing", "a", "pipeline", "of", "proprietary,", "biobetter", "and", "biosimilar", "versions", "of", "recombinant", "therapeutic", "proteins,", "based", "on", "our", "plant", "cell-based", "expression", "technology,", "that", "primarily", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "rely", "upon", "known", "biological", "mechanisms", "of", "action.", "<tag3>"], "wordsA": ["Using", "our", "ProCellEx", "system,", "we", "are", "developing", "a", "pipeline", "of", "proprietary", "and", "biosimilar", "versions", "of", "recombinant", "therapeutic", "proteins", "based", "on", "our", "plant", "cell-based", "expression", "technology", "that", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "rely", "upon", "known", "biological", "mechanisms", "of", "action."], "wordsB": ["Using", "our", "ProCellEx", "system,", "we", "are", "developing", "a", "pipeline", "of", "proprietary,", "biobetter", "and", "biosimilar", "versions", "of", "recombinant", "therapeutic", "proteins,", "based", "on", "our", "plant", "cell-based", "expression", "technology,", "that", "primarily", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "rely", "upon", "known", "biological", "mechanisms", "of", "action."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p8_s2", "idA": "1006281_13_item7_p20_s3", "sentA": "We may need to obtain additional funds for the commercialization of taliglucerase alfa and to further develop the research and clinical development of our other programs.", "sentB": "The technology transfer is designed to be completed in four stages and is intended to transfer to Fiocruz the capacity and skills required for the Brazilian government to construct its own manufacturing facility, at its sole expense, and to produce a sustainable, high-quality, and cost-effective supply of taliglucerase alfa.", "type": 2, "words": ["<tag1>", "We", "may", "need", "to", "obtain", "additional", "funds", "for", "the", "commercialization", "of", "taliglucerase", "alfa", "and", "to", "further", "develop", "the", "research", "and", "clinical", "development", "of", "our", "other", "programs.", "<tag2>", "The", "technology", "transfer", "is", "designed", "to", "be", "completed", "in", "four", "stages", "and", "is", "intended", "to", "transfer", "to", "Fiocruz", "the", "capacity", "and", "skills", "required", "for", "the", "Brazilian", "government", "to", "construct", "its", "own", "manufacturing", "facility,", "at", "its", "sole", "expense,", "and", "to", "produce", "a", "sustainable,", "high-quality,", "and", "cost-effective", "supply", "of", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["We", "may", "need", "to", "obtain", "additional", "funds", "for", "the", "commercialization", "of", "taliglucerase", "alfa", "and", "to", "further", "develop", "the", "research", "and", "clinical", "development", "of", "our", "other", "programs."], "wordsB": ["The", "technology", "transfer", "is", "designed", "to", "be", "completed", "in", "four", "stages", "and", "is", "intended", "to", "transfer", "to", "Fiocruz", "the", "capacity", "and", "skills", "required", "for", "the", "Brazilian", "government", "to", "construct", "its", "own", "manufacturing", "facility,", "at", "its", "sole", "expense,", "and", "to", "produce", "a", "sustainable,", "high-quality,", "and", "cost-effective", "supply", "of", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p18_s1", "idA": "1006281_13_item7_p23_s1", "sentA": "Most of the Company s revenues are derived in dollars.", "sentB": "Most of our revenues are derived in dollars.", "type": 2, "words": ["<tag1>", "Most", "of", "the", "Company", "s", "revenues", "are", "derived", "in", "dollars.", "<tag2>", "Most", "of", "our", "revenues", "are", "derived", "in", "dollars.", "<tag3>"], "wordsA": ["Most", "of", "the", "Company", "s", "revenues", "are", "derived", "in", "dollars."], "wordsB": ["Most", "of", "our", "revenues", "are", "derived", "in", "dollars."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p18_s2", "idA": "1006281_13_item7_p23_s2", "sentA": "In addition, most of the Company s expenses and capital expenditures are incurred in dollars, and the major source of the Company s financing has been provided in dollars.", "sentB": "In addition, most of our expenses and capital expenditures are incurred in dollars, and the major source of our financing has been provided in dollars.", "type": 2, "words": ["<tag1>", "In", "addition,", "most", "of", "the", "Company", "s", "expenses", "and", "capital", "expenditures", "are", "incurred", "in", "dollars,", "and", "the", "major", "source", "of", "the", "Company", "s", "financing", "has", "been", "provided", "in", "dollars.", "<tag2>", "In", "addition,", "most", "of", "our", "expenses", "and", "capital", "expenditures", "are", "incurred", "in", "dollars,", "and", "the", "major", "source", "of", "our", "financing", "has", "been", "provided", "in", "dollars.", "<tag3>"], "wordsA": ["In", "addition,", "most", "of", "the", "Company", "s", "expenses", "and", "capital", "expenditures", "are", "incurred", "in", "dollars,", "and", "the", "major", "source", "of", "the", "Company", "s", "financing", "has", "been", "provided", "in", "dollars."], "wordsB": ["In", "addition,", "most", "of", "our", "expenses", "and", "capital", "expenditures", "are", "incurred", "in", "dollars,", "and", "the", "major", "source", "of", "our", "financing", "has", "been", "provided", "in", "dollars."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p19_s0", "idA": "1006281_13_item7_p24_s0", "sentA": "Currently, our sole source of revenues comes from sales of taliglucerase alfa pursuant to our license agreement with Pfizer, our sales of taliglucerase alfa in Israel and from milestone payments under the Pfizer Agreement.", "sentB": "Currently, our source of revenues comes from sales of taliglucerase alfa pursuant to our license agreement with Pfizer, our sales of taliglucerase alfa in Israel and Brazil and from milestone payments under the Pfizer Agreement.", "type": 2, "words": ["<tag1>", "Currently,", "our", "sole", "source", "of", "revenues", "comes", "from", "sales", "of", "taliglucerase", "alfa", "pursuant", "to", "our", "license", "agreement", "with", "Pfizer,", "our", "sales", "of", "taliglucerase", "alfa", "in", "Israel", "and", "from", "milestone", "payments", "under", "the", "Pfizer", "Agreement.", "<tag2>", "Currently,", "our", "source", "of", "revenues", "comes", "from", "sales", "of", "taliglucerase", "alfa", "pursuant", "to", "our", "license", "agreement", "with", "Pfizer,", "our", "sales", "of", "taliglucerase", "alfa", "in", "Israel", "and", "Brazil", "and", "from", "milestone", "payments", "under", "the", "Pfizer", "Agreement.", "<tag3>"], "wordsA": ["Currently,", "our", "sole", "source", "of", "revenues", "comes", "from", "sales", "of", "taliglucerase", "alfa", "pursuant", "to", "our", "license", "agreement", "with", "Pfizer,", "our", "sales", "of", "taliglucerase", "alfa", "in", "Israel", "and", "from", "milestone", "payments", "under", "the", "Pfizer", "Agreement."], "wordsB": ["Currently,", "our", "source", "of", "revenues", "comes", "from", "sales", "of", "taliglucerase", "alfa", "pursuant", "to", "our", "license", "agreement", "with", "Pfizer,", "our", "sales", "of", "taliglucerase", "alfa", "in", "Israel", "and", "Brazil", "and", "from", "milestone", "payments", "under", "the", "Pfizer", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p24_s0", "idA": "1006281_13_item7_p24_s1", "sentA": "We recognize revenue when the earnings process is complete, which is when revenue is realized or realizable and earned, there is persuasive evidence a revenue arrangement exists, delivery of goods or services has occurred, the sales price is fixed or determinable and collectability is reasonably assured.", "sentB": "We recognize net product revenue from our sales of ELELYSO in Israel when persuasive evidence of an arrangement exists, the product has been delivered to the customer, title and risk of loss have passed to the customer, the price to the buyer is fixed or determinable and collection from the customer is reasonably assured.", "type": 2, "words": ["<tag1>", "We", "recognize", "revenue", "when", "the", "earnings", "process", "is", "complete,", "which", "is", "when", "revenue", "is", "realized", "or", "realizable", "and", "earned,", "there", "is", "persuasive", "evidence", "a", "revenue", "arrangement", "exists,", "delivery", "of", "goods", "or", "services", "has", "occurred,", "the", "sales", "price", "is", "fixed", "or", "determinable", "and", "collectability", "is", "reasonably", "assured.", "<tag2>", "We", "recognize", "net", "product", "revenue", "from", "our", "sales", "of", "ELELYSO", "in", "Israel", "when", "persuasive", "evidence", "of", "an", "arrangement", "exists,", "the", "product", "has", "been", "delivered", "to", "the", "customer,", "title", "and", "risk", "of", "loss", "have", "passed", "to", "the", "customer,", "the", "price", "to", "the", "buyer", "is", "fixed", "or", "determinable", "and", "collection", "from", "the", "customer", "is", "reasonably", "assured.", "<tag3>"], "wordsA": ["We", "recognize", "revenue", "when", "the", "earnings", "process", "is", "complete,", "which", "is", "when", "revenue", "is", "realized", "or", "realizable", "and", "earned,", "there", "is", "persuasive", "evidence", "a", "revenue", "arrangement", "exists,", "delivery", "of", "goods", "or", "services", "has", "occurred,", "the", "sales", "price", "is", "fixed", "or", "determinable", "and", "collectability", "is", "reasonably", "assured."], "wordsB": ["We", "recognize", "net", "product", "revenue", "from", "our", "sales", "of", "ELELYSO", "in", "Israel", "when", "persuasive", "evidence", "of", "an", "arrangement", "exists,", "the", "product", "has", "been", "delivered", "to", "the", "customer,", "title", "and", "risk", "of", "loss", "have", "passed", "to", "the", "customer,", "the", "price", "to", "the", "buyer", "is", "fixed", "or", "determinable", "and", "collection", "from", "the", "customer", "is", "reasonably", "assured."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p21_s1", "idA": "1006281_13_item7_p26_s1", "sentA": "We retained all rights to taliglucerase alfa in Israel.", "sentB": "We hold all rights to taliglucerase alfa in Israel and Brazil.", "type": 2, "words": ["<tag1>", "We", "retained", "all", "rights", "to", "taliglucerase", "alfa", "in", "Israel.", "<tag2>", "We", "hold", "all", "rights", "to", "taliglucerase", "alfa", "in", "Israel", "and", "Brazil.", "<tag3>"], "wordsA": ["We", "retained", "all", "rights", "to", "taliglucerase", "alfa", "in", "Israel."], "wordsB": ["We", "hold", "all", "rights", "to", "taliglucerase", "alfa", "in", "Israel", "and", "Brazil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p23_s0", "idA": "1006281_13_item7_p28_s0", "sentA": "We recognize revenues received from the sale of a product to Pfizer upon delivery to Pfizer.", "sentB": "We recognize revenues received from the sale of a product when the sales price is fixed or determinable and collectability is reasonably assured.", "type": 2, "words": ["<tag1>", "We", "recognize", "revenues", "received", "from", "the", "sale", "of", "a", "product", "to", "Pfizer", "upon", "delivery", "to", "Pfizer.", "<tag2>", "We", "recognize", "revenues", "received", "from", "the", "sale", "of", "a", "product", "when", "the", "sales", "price", "is", "fixed", "or", "determinable", "and", "collectability", "is", "reasonably", "assured.", "<tag3>"], "wordsA": ["We", "recognize", "revenues", "received", "from", "the", "sale", "of", "a", "product", "to", "Pfizer", "upon", "delivery", "to", "Pfizer."], "wordsB": ["We", "recognize", "revenues", "received", "from", "the", "sale", "of", "a", "product", "when", "the", "sales", "price", "is", "fixed", "or", "determinable", "and", "collectability", "is", "reasonably", "assured."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p3_s0", "idA": "1006281_13_item7_p2_s0", "sentA": "On May 1, 2012, the FDA approved our first commercial product, ELELYSO, as an ERT for the long-term treatment of adult patients with a confirmed diagnosis of type 1 Gaucher disease.", "sentB": "On May 1, 2012, the FDA approved for sale our first commercial product, taliglucerase alfa for injection, which is being marketed in the United States and Israel under the brand name ELELYSO, as an enzyme replacement therapy, or ERT, for the long-term treatment of adult patients with a confirmed diagnosis of type 1 Gaucher disease.", "type": 2, "words": ["<tag1>", "On", "May", "1,", "2012,", "the", "FDA", "approved", "our", "first", "commercial", "product,", "ELELYSO,", "as", "an", "ERT", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease.", "<tag2>", "On", "May", "1,", "2012,", "the", "FDA", "approved", "for", "sale", "our", "first", "commercial", "product,", "taliglucerase", "alfa", "for", "injection,", "which", "is", "being", "marketed", "in", "the", "United", "States", "and", "Israel", "under", "the", "brand", "name", "ELELYSO,", "as", "an", "enzyme", "replacement", "therapy,", "or", "ERT,", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease.", "<tag3>"], "wordsA": ["On", "May", "1,", "2012,", "the", "FDA", "approved", "our", "first", "commercial", "product,", "ELELYSO,", "as", "an", "ERT", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease."], "wordsB": ["On", "May", "1,", "2012,", "the", "FDA", "approved", "for", "sale", "our", "first", "commercial", "product,", "taliglucerase", "alfa", "for", "injection,", "which", "is", "being", "marketed", "in", "the", "United", "States", "and", "Israel", "under", "the", "brand", "name", "ELELYSO,", "as", "an", "enzyme", "replacement", "therapy,", "or", "ERT,", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p3_s1", "idA": "1006281_13_item7_p2_s1", "sentA": "The Israeli MOH approved taliglucerase alfa in September 2012 and it also approved for sale in Uruguay.", "sentB": "Subsequently, taliglucerase alfa was approved by ANVISA in March 2013, by the Israeli MOH in September 2012, and by the applicable regulatory authorities in Uruguay, Mexico and Chile.", "type": 2, "words": ["<tag1>", "The", "Israeli", "MOH", "approved", "taliglucerase", "alfa", "in", "September", "2012", "and", "it", "also", "approved", "for", "sale", "in", "Uruguay.", "<tag2>", "Subsequently,", "taliglucerase", "alfa", "was", "approved", "by", "ANVISA", "in", "March", "2013,", "by", "the", "Israeli", "MOH", "in", "September", "2012,", "and", "by", "the", "applicable", "regulatory", "authorities", "in", "Uruguay,", "Mexico", "and", "Chile.", "<tag3>"], "wordsA": ["The", "Israeli", "MOH", "approved", "taliglucerase", "alfa", "in", "September", "2012", "and", "it", "also", "approved", "for", "sale", "in", "Uruguay."], "wordsB": ["Subsequently,", "taliglucerase", "alfa", "was", "approved", "by", "ANVISA", "in", "March", "2013,", "by", "the", "Israeli", "MOH", "in", "September", "2012,", "and", "by", "the", "applicable", "regulatory", "authorities", "in", "Uruguay,", "Mexico", "and", "Chile."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p28_s0", "idA": "1006281_13_item7_p32_s0", "sentA": "We anticipate incurring increasing costs in connection with our alpha-galactosidase and oral treatment of Gaucher disease projects.", "sentB": "We anticipate incurring increasing costs in connection with our PRX-102 and oral glucocerebrosidase projects which will be partially off set by the decrease in costs incurred due to the continued winding down of our taliglucerase alfa clinical trials during 2014.", "type": 2, "words": ["<tag1>", "We", "anticipate", "incurring", "increasing", "costs", "in", "connection", "with", "our", "alpha-galactosidase", "and", "oral", "treatment", "of", "Gaucher", "disease", "projects.", "<tag2>", "We", "anticipate", "incurring", "increasing", "costs", "in", "connection", "with", "our", "PRX-102", "and", "oral", "glucocerebrosidase", "projects", "which", "will", "be", "partially", "off", "set", "by", "the", "decrease", "in", "costs", "incurred", "due", "to", "the", "continued", "winding", "down", "of", "our", "taliglucerase", "alfa", "clinical", "trials", "during", "2014.", "<tag3>"], "wordsA": ["We", "anticipate", "incurring", "increasing", "costs", "in", "connection", "with", "our", "alpha-galactosidase", "and", "oral", "treatment", "of", "Gaucher", "disease", "projects."], "wordsB": ["We", "anticipate", "incurring", "increasing", "costs", "in", "connection", "with", "our", "PRX-102", "and", "oral", "glucocerebrosidase", "projects", "which", "will", "be", "partially", "off", "set", "by", "the", "decrease", "in", "costs", "incurred", "due", "to", "the", "continued", "winding", "down", "of", "our", "taliglucerase", "alfa", "clinical", "trials", "during", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p3_s2", "idA": "1006281_13_item7_p39_s0", "sentA": "Taliglucerase alfa has been approved for sale in the United States, Israel and Uruguay, and marketing authorization applications are outstanding for Brazil and other countries.", "sentB": "Taliglucerase alfa will be marketed under the name UPLYSO in Brazil and certain other Latin American countries.", "type": 2, "words": ["<tag1>", "Taliglucerase", "alfa", "has", "been", "approved", "for", "sale", "in", "the", "United", "States,", "Israel", "and", "Uruguay,", "and", "marketing", "authorization", "applications", "are", "outstanding", "for", "Brazil", "and", "other", "countries.", "<tag2>", "Taliglucerase", "alfa", "will", "be", "marketed", "under", "the", "name", "UPLYSO", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries.", "<tag3>"], "wordsA": ["Taliglucerase", "alfa", "has", "been", "approved", "for", "sale", "in", "the", "United", "States,", "Israel", "and", "Uruguay,", "and", "marketing", "authorization", "applications", "are", "outstanding", "for", "Brazil", "and", "other", "countries."], "wordsB": ["Taliglucerase", "alfa", "will", "be", "marketed", "under", "the", "name", "UPLYSO", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p4_s0", "idA": "1006281_13_item7_p3_s0", "sentA": "Taliglucerase alfa is a proprietary, recombinant form of glucocerebrosidase (GCD) that is expressed or produced through ProCellEx.", "sentB": "Taliglucerase alfa is our proprietary, recombinant form of glucocerebrosidase, or GCD, that is produced or expressed through ProCellEx.", "type": 2, "words": ["<tag1>", "Taliglucerase", "alfa", "is", "a", "proprietary,", "recombinant", "form", "of", "glucocerebrosidase", "(GCD)", "that", "is", "expressed", "or", "produced", "through", "ProCellEx.", "<tag2>", "Taliglucerase", "alfa", "is", "our", "proprietary,", "recombinant", "form", "of", "glucocerebrosidase,", "or", "GCD,", "that", "is", "produced", "or", "expressed", "through", "ProCellEx.", "<tag3>"], "wordsA": ["Taliglucerase", "alfa", "is", "a", "proprietary,", "recombinant", "form", "of", "glucocerebrosidase", "(GCD)", "that", "is", "expressed", "or", "produced", "through", "ProCellEx."], "wordsB": ["Taliglucerase", "alfa", "is", "our", "proprietary,", "recombinant", "form", "of", "glucocerebrosidase,", "or", "GCD,", "that", "is", "produced", "or", "expressed", "through", "ProCellEx."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p4_s1", "idA": "1006281_13_item7_p3_s1", "sentA": "Taliglucerase alfa is the first plant cell-based recombinant therapeutic protein to be approved by each of the FDA and the Israeli MOH.", "sentB": "Taliglucerase alfa is the first plant cell-based recombinant therapeutic protein to be approved by the FDA or by the regulatory authorities with jurisdiction over any substantial market.", "type": 2, "words": ["<tag1>", "Taliglucerase", "alfa", "is", "the", "first", "plant", "cell-based", "recombinant", "therapeutic", "protein", "to", "be", "approved", "by", "each", "of", "the", "FDA", "and", "the", "Israeli", "MOH.", "<tag2>", "Taliglucerase", "alfa", "is", "the", "first", "plant", "cell-based", "recombinant", "therapeutic", "protein", "to", "be", "approved", "by", "the", "FDA", "or", "by", "the", "regulatory", "authorities", "with", "jurisdiction", "over", "any", "substantial", "market.", "<tag3>"], "wordsA": ["Taliglucerase", "alfa", "is", "the", "first", "plant", "cell-based", "recombinant", "therapeutic", "protein", "to", "be", "approved", "by", "each", "of", "the", "FDA", "and", "the", "Israeli", "MOH."], "wordsB": ["Taliglucerase", "alfa", "is", "the", "first", "plant", "cell-based", "recombinant", "therapeutic", "protein", "to", "be", "approved", "by", "the", "FDA", "or", "by", "the", "regulatory", "authorities", "with", "jurisdiction", "over", "any", "substantial", "market."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p40_s0", "idA": "1006281_13_item7_p45_s0", "sentA": "For purposes of determining the fair value of the restricted shares of common stock granted to employees during the fiscal year ended December 31, 2012, our management used the fair value of our common stock which was the closing sale price of our common stock on the NYSE MKT on the date of grant.", "sentB": "For purposes of determining the fair value of the restricted shares of common stock granted to employees during the fiscal year ended December 31, 2013, our management used the fair value of our common stock which was the closing sale price of our common stock on the NYSE MKT on the date of grant.", "type": 2, "words": ["<tag1>", "For", "purposes", "of", "determining", "the", "fair", "value", "of", "the", "restricted", "shares", "of", "common", "stock", "granted", "to", "employees", "during", "the", "fiscal", "year", "ended", "December", "31,", "2012,", "our", "management", "used", "the", "fair", "value", "of", "our", "common", "stock", "which", "was", "the", "closing", "sale", "price", "of", "our", "common", "stock", "on", "the", "NYSE", "MKT", "on", "the", "date", "of", "grant.", "<tag2>", "For", "purposes", "of", "determining", "the", "fair", "value", "of", "the", "restricted", "shares", "of", "common", "stock", "granted", "to", "employees", "during", "the", "fiscal", "year", "ended", "December", "31,", "2013,", "our", "management", "used", "the", "fair", "value", "of", "our", "common", "stock", "which", "was", "the", "closing", "sale", "price", "of", "our", "common", "stock", "on", "the", "NYSE", "MKT", "on", "the", "date", "of", "grant.", "<tag3>"], "wordsA": ["For", "purposes", "of", "determining", "the", "fair", "value", "of", "the", "restricted", "shares", "of", "common", "stock", "granted", "to", "employees", "during", "the", "fiscal", "year", "ended", "December", "31,", "2012,", "our", "management", "used", "the", "fair", "value", "of", "our", "common", "stock", "which", "was", "the", "closing", "sale", "price", "of", "our", "common", "stock", "on", "the", "NYSE", "MKT", "on", "the", "date", "of", "grant."], "wordsB": ["For", "purposes", "of", "determining", "the", "fair", "value", "of", "the", "restricted", "shares", "of", "common", "stock", "granted", "to", "employees", "during", "the", "fiscal", "year", "ended", "December", "31,", "2013,", "our", "management", "used", "the", "fair", "value", "of", "our", "common", "stock", "which", "was", "the", "closing", "sale", "price", "of", "our", "common", "stock", "on", "the", "NYSE", "MKT", "on", "the", "date", "of", "grant."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p8_s3", "idA": "1006281_13_item7_p49_s1", "sentA": "The remaining term of the bonds used for each valuation was equal to the expected term of the grant.", "sentB": "The initial term of the technology transfer is seven years.", "type": 2, "words": ["<tag1>", "The", "remaining", "term", "of", "the", "bonds", "used", "for", "each", "valuation", "was", "equal", "to", "the", "expected", "term", "of", "the", "grant.", "<tag2>", "The", "initial", "term", "of", "the", "technology", "transfer", "is", "seven", "years.", "<tag3>"], "wordsA": ["The", "remaining", "term", "of", "the", "bonds", "used", "for", "each", "valuation", "was", "equal", "to", "the", "expected", "term", "of", "the", "grant."], "wordsB": ["The", "initial", "term", "of", "the", "technology", "transfer", "is", "seven", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p46_s0", "idA": "1006281_13_item7_p51_s0", "sentA": "We recorded revenue of $34.9 million for the year ended December 31, 2012, an increase of $26.5 million or 315%, compared to revenue of $8.4 million for the year ended December 31, 2011.", "sentB": "We recorded revenue of $10.5 million for the year ended December 31, 2013, an increase of approximately $609,000, or 6%, compared to revenue of $9.9 million for the year ended December 31, 2012, excluding the one time $25.0 million payment we received from Pfizer under the Pfizer Agreement in connection with the FDA s approval of taliglucerase alfa on May 1, 2012.", "type": 2, "words": ["<tag1>", "We", "recorded", "revenue", "of", "$34.9", "million", "for", "the", "year", "ended", "December", "31,", "2012,", "an", "increase", "of", "$26.5", "million", "or", "315%,", "compared", "to", "revenue", "of", "$8.4", "million", "for", "the", "year", "ended", "December", "31,", "2011.", "<tag2>", "We", "recorded", "revenue", "of", "$10.5", "million", "for", "the", "year", "ended", "December", "31,", "2013,", "an", "increase", "of", "approximately", "$609,000,", "or", "6%,", "compared", "to", "revenue", "of", "$9.9", "million", "for", "the", "year", "ended", "December", "31,", "2012,", "excluding", "the", "one", "time", "$25.0", "million", "payment", "we", "received", "from", "Pfizer", "under", "the", "Pfizer", "Agreement", "in", "connection", "with", "the", "FDA", "s", "approval", "of", "taliglucerase", "alfa", "on", "May", "1,", "2012.", "<tag3>"], "wordsA": ["We", "recorded", "revenue", "of", "$34.9", "million", "for", "the", "year", "ended", "December", "31,", "2012,", "an", "increase", "of", "$26.5", "million", "or", "315%,", "compared", "to", "revenue", "of", "$8.4", "million", "for", "the", "year", "ended", "December", "31,", "2011."], "wordsB": ["We", "recorded", "revenue", "of", "$10.5", "million", "for", "the", "year", "ended", "December", "31,", "2013,", "an", "increase", "of", "approximately", "$609,000,", "or", "6%,", "compared", "to", "revenue", "of", "$9.9", "million", "for", "the", "year", "ended", "December", "31,", "2012,", "excluding", "the", "one", "time", "$25.0", "million", "payment", "we", "received", "from", "Pfizer", "under", "the", "Pfizer", "Agreement", "in", "connection", "with", "the", "FDA", "s", "approval", "of", "taliglucerase", "alfa", "on", "May", "1,", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p47_s0", "idA": "1006281_13_item7_p52_s0", "sentA": "We recorded a loss of $446,000 as our share in the collaboration under the Pfizer Agreement during the year ended December 31, 2012, a decrease of $5.0 million, or 92%, compared to the $5.4 million of loss recorded for the year ended December 31, 2011.", "sentB": "We recorded revenue of $1.0 million as our share of net income in the collaboration under the Pfizer Agreement during the year ended December 31, 2013, compared to the $446,000 of loss recorded for the year ended December 31, 2012.", "type": 2, "words": ["<tag1>", "We", "recorded", "a", "loss", "of", "$446,000", "as", "our", "share", "in", "the", "collaboration", "under", "the", "Pfizer", "Agreement", "during", "the", "year", "ended", "December", "31,", "2012,", "a", "decrease", "of", "$5.0", "million,", "or", "92%,", "compared", "to", "the", "$5.4", "million", "of", "loss", "recorded", "for", "the", "year", "ended", "December", "31,", "2011.", "<tag2>", "We", "recorded", "revenue", "of", "$1.0", "million", "as", "our", "share", "of", "net", "income", "in", "the", "collaboration", "under", "the", "Pfizer", "Agreement", "during", "the", "year", "ended", "December", "31,", "2013,", "compared", "to", "the", "$446,000", "of", "loss", "recorded", "for", "the", "year", "ended", "December", "31,", "2012.", "<tag3>"], "wordsA": ["We", "recorded", "a", "loss", "of", "$446,000", "as", "our", "share", "in", "the", "collaboration", "under", "the", "Pfizer", "Agreement", "during", "the", "year", "ended", "December", "31,", "2012,", "a", "decrease", "of", "$5.0", "million,", "or", "92%,", "compared", "to", "the", "$5.4", "million", "of", "loss", "recorded", "for", "the", "year", "ended", "December", "31,", "2011."], "wordsB": ["We", "recorded", "revenue", "of", "$1.0", "million", "as", "our", "share", "of", "net", "income", "in", "the", "collaboration", "under", "the", "Pfizer", "Agreement", "during", "the", "year", "ended", "December", "31,", "2013,", "compared", "to", "the", "$446,000", "of", "loss", "recorded", "for", "the", "year", "ended", "December", "31,", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p47_s1", "idA": "1006281_13_item7_p52_s1", "sentA": "Our share in the collaboration's loss for the year ended December 31, 2012 represents our 40% share of the net loss generated during the period, which was primarily the result of the expenses incurred during the period mainly in connection with activities related to the U.S. launch of taliglucerase alfa which exceeded the revenues generated by Pfizer in the United States, and resupply in Brazil.", "sentB": "Our share in the collaboration recorded for the year ended December 31, 2013 represents our 40% share of the net income generated during the period, which was primarily the result of revenues generated by Pfizer in the United States which exceeded the expenses during such period.", "type": 2, "words": ["<tag1>", "Our", "share", "in", "the", "collaboration's", "loss", "for", "the", "year", "ended", "December", "31,", "2012", "represents", "our", "40%", "share", "of", "the", "net", "loss", "generated", "during", "the", "period,", "which", "was", "primarily", "the", "result", "of", "the", "expenses", "incurred", "during", "the", "period", "mainly", "in", "connection", "with", "activities", "related", "to", "the", "U.S.", "launch", "of", "taliglucerase", "alfa", "which", "exceeded", "the", "revenues", "generated", "by", "Pfizer", "in", "the", "United", "States,", "and", "resupply", "in", "Brazil.", "<tag2>", "Our", "share", "in", "the", "collaboration", "recorded", "for", "the", "year", "ended", "December", "31,", "2013", "represents", "our", "40%", "share", "of", "the", "net", "income", "generated", "during", "the", "period,", "which", "was", "primarily", "the", "result", "of", "revenues", "generated", "by", "Pfizer", "in", "the", "United", "States", "which", "exceeded", "the", "expenses", "during", "such", "period.", "<tag3>"], "wordsA": ["Our", "share", "in", "the", "collaboration's", "loss", "for", "the", "year", "ended", "December", "31,", "2012", "represents", "our", "40%", "share", "of", "the", "net", "loss", "generated", "during", "the", "period,", "which", "was", "primarily", "the", "result", "of", "the", "expenses", "incurred", "during", "the", "period", "mainly", "in", "connection", "with", "activities", "related", "to", "the", "U.S.", "launch", "of", "taliglucerase", "alfa", "which", "exceeded", "the", "revenues", "generated", "by", "Pfizer", "in", "the", "United", "States,", "and", "resupply", "in", "Brazil."], "wordsB": ["Our", "share", "in", "the", "collaboration", "recorded", "for", "the", "year", "ended", "December", "31,", "2013", "represents", "our", "40%", "share", "of", "the", "net", "income", "generated", "during", "the", "period,", "which", "was", "primarily", "the", "result", "of", "revenues", "generated", "by", "Pfizer", "in", "the", "United", "States", "which", "exceeded", "the", "expenses", "during", "such", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p49_s0", "idA": "1006281_13_item7_p54_s0", "sentA": "Cost of revenues was $8.1 million for the year ended December 31, 2012, an increase of $6.6 million, compared to the cost of revenues of $1.5 million for the year ended December 31, 2011.", "sentB": "Cost of revenues was $5.4 million for the year ended December 31, 2013, a decrease of $2.7 million, or 33%, compared to the cost of revenues of $8.1 million for the year ended December 31, 2012.", "type": 2, "words": ["<tag1>", "Cost", "of", "revenues", "was", "$8.1", "million", "for", "the", "year", "ended", "December", "31,", "2012,", "an", "increase", "of", "$6.6", "million,", "compared", "to", "the", "cost", "of", "revenues", "of", "$1.5", "million", "for", "the", "year", "ended", "December", "31,", "2011.", "<tag2>", "Cost", "of", "revenues", "was", "$5.4", "million", "for", "the", "year", "ended", "December", "31,", "2013,", "a", "decrease", "of", "$2.7", "million,", "or", "33%,", "compared", "to", "the", "cost", "of", "revenues", "of", "$8.1", "million", "for", "the", "year", "ended", "December", "31,", "2012.", "<tag3>"], "wordsA": ["Cost", "of", "revenues", "was", "$8.1", "million", "for", "the", "year", "ended", "December", "31,", "2012,", "an", "increase", "of", "$6.6", "million,", "compared", "to", "the", "cost", "of", "revenues", "of", "$1.5", "million", "for", "the", "year", "ended", "December", "31,", "2011."], "wordsB": ["Cost", "of", "revenues", "was", "$5.4", "million", "for", "the", "year", "ended", "December", "31,", "2013,", "a", "decrease", "of", "$2.7", "million,", "or", "33%,", "compared", "to", "the", "cost", "of", "revenues", "of", "$8.1", "million", "for", "the", "year", "ended", "December", "31,", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p49_s1", "idA": "1006281_13_item7_p54_s1", "sentA": "Cost of revenues for the year ended December 31, 2012 includes approximately $2.2 million for royalties due to the OCS and a certain academic institution in connection with gross sales of taliglucerase alfa during the period and $4.1 million for certain fixed costs relating mainly to our manufacturing facility, including rent, depreciation, salary and maintenance expenses, and to a much lesser extent, the direct cost of products delivered to Pfizer during the period.", "sentB": "Cost of revenues for the year ended December 31, 2013 consists primarily of certain fixed costs relating to our manufacturing facility, including rent, depreciation, salary and maintenance expenses amounting to approximately $4.9 million, and to a much lesser extent, the direct cost of products we sold in Israel and products we delivered to Pfizer for which revenues were recognized during the period.", "type": 2, "words": ["<tag1>", "Cost", "of", "revenues", "for", "the", "year", "ended", "December", "31,", "2012", "includes", "approximately", "$2.2", "million", "for", "royalties", "due", "to", "the", "OCS", "and", "a", "certain", "academic", "institution", "in", "connection", "with", "gross", "sales", "of", "taliglucerase", "alfa", "during", "the", "period", "and", "$4.1", "million", "for", "certain", "fixed", "costs", "relating", "mainly", "to", "our", "manufacturing", "facility,", "including", "rent,", "depreciation,", "salary", "and", "maintenance", "expenses,", "and", "to", "a", "much", "lesser", "extent,", "the", "direct", "cost", "of", "products", "delivered", "to", "Pfizer", "during", "the", "period.", "<tag2>", "Cost", "of", "revenues", "for", "the", "year", "ended", "December", "31,", "2013", "consists", "primarily", "of", "certain", "fixed", "costs", "relating", "to", "our", "manufacturing", "facility,", "including", "rent,", "depreciation,", "salary", "and", "maintenance", "expenses", "amounting", "to", "approximately", "$4.9", "million,", "and", "to", "a", "much", "lesser", "extent,", "the", "direct", "cost", "of", "products", "we", "sold", "in", "Israel", "and", "products", "we", "delivered", "to", "Pfizer", "for", "which", "revenues", "were", "recognized", "during", "the", "period.", "<tag3>"], "wordsA": ["Cost", "of", "revenues", "for", "the", "year", "ended", "December", "31,", "2012", "includes", "approximately", "$2.2", "million", "for", "royalties", "due", "to", "the", "OCS", "and", "a", "certain", "academic", "institution", "in", "connection", "with", "gross", "sales", "of", "taliglucerase", "alfa", "during", "the", "period", "and", "$4.1", "million", "for", "certain", "fixed", "costs", "relating", "mainly", "to", "our", "manufacturing", "facility,", "including", "rent,", "depreciation,", "salary", "and", "maintenance", "expenses,", "and", "to", "a", "much", "lesser", "extent,", "the", "direct", "cost", "of", "products", "delivered", "to", "Pfizer", "during", "the", "period."], "wordsB": ["Cost", "of", "revenues", "for", "the", "year", "ended", "December", "31,", "2013", "consists", "primarily", "of", "certain", "fixed", "costs", "relating", "to", "our", "manufacturing", "facility,", "including", "rent,", "depreciation,", "salary", "and", "maintenance", "expenses", "amounting", "to", "approximately", "$4.9", "million,", "and", "to", "a", "much", "lesser", "extent,", "the", "direct", "cost", "of", "products", "we", "sold", "in", "Israel", "and", "products", "we", "delivered", "to", "Pfizer", "for", "which", "revenues", "were", "recognized", "during", "the", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p49_s2", "idA": "1006281_13_item7_p54_s1", "sentA": "Cost of revenues for the year ended December 31, 2012 includes approximately $2.2 million for royalties due to the OCS and a certain academic institution in connection with gross sales of taliglucerase alfa during the period and $4.1 million for certain fixed costs relating mainly to our manufacturing facility, including rent, depreciation, salary and maintenance expenses, and to a much lesser extent, the direct cost of products delivered to Pfizer during the period.", "sentB": "Cost of revenues for the years ended December 31, 2012 and 2013 include an aggregate of $2.2 million and $472,000, respectively, in royalties payable to the OCS and to a certain academic institution in connection with gross sales of taliglucerase alfa during the period.", "type": 2, "words": ["<tag1>", "Cost", "of", "revenues", "for", "the", "year", "ended", "December", "31,", "2012", "includes", "approximately", "$2.2", "million", "for", "royalties", "due", "to", "the", "OCS", "and", "a", "certain", "academic", "institution", "in", "connection", "with", "gross", "sales", "of", "taliglucerase", "alfa", "during", "the", "period", "and", "$4.1", "million", "for", "certain", "fixed", "costs", "relating", "mainly", "to", "our", "manufacturing", "facility,", "including", "rent,", "depreciation,", "salary", "and", "maintenance", "expenses,", "and", "to", "a", "much", "lesser", "extent,", "the", "direct", "cost", "of", "products", "delivered", "to", "Pfizer", "during", "the", "period.", "<tag2>", "Cost", "of", "revenues", "for", "the", "years", "ended", "December", "31,", "2012", "and", "2013", "include", "an", "aggregate", "of", "$2.2", "million", "and", "$472,000,", "respectively,", "in", "royalties", "payable", "to", "the", "OCS", "and", "to", "a", "certain", "academic", "institution", "in", "connection", "with", "gross", "sales", "of", "taliglucerase", "alfa", "during", "the", "period.", "<tag3>"], "wordsA": ["Cost", "of", "revenues", "for", "the", "year", "ended", "December", "31,", "2012", "includes", "approximately", "$2.2", "million", "for", "royalties", "due", "to", "the", "OCS", "and", "a", "certain", "academic", "institution", "in", "connection", "with", "gross", "sales", "of", "taliglucerase", "alfa", "during", "the", "period", "and", "$4.1", "million", "for", "certain", "fixed", "costs", "relating", "mainly", "to", "our", "manufacturing", "facility,", "including", "rent,", "depreciation,", "salary", "and", "maintenance", "expenses,", "and", "to", "a", "much", "lesser", "extent,", "the", "direct", "cost", "of", "products", "delivered", "to", "Pfizer", "during", "the", "period."], "wordsB": ["Cost", "of", "revenues", "for", "the", "years", "ended", "December", "31,", "2012", "and", "2013", "include", "an", "aggregate", "of", "$2.2", "million", "and", "$472,000,", "respectively,", "in", "royalties", "payable", "to", "the", "OCS", "and", "to", "a", "certain", "academic", "institution", "in", "connection", "with", "gross", "sales", "of", "taliglucerase", "alfa", "during", "the", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p49_s3", "idA": "1006281_13_item7_p54_s2", "sentA": "Prior to the FDA's approval of taliglucerase alfa, manufacturing costs related to taliglucerase alfa were not capitalized; rather, such costs were expensed as research and development expenses.", "sentB": "Prior to the FDA s approval of taliglucerase alfa, manufacturing costs related to taliglucerase alfa were classified as research and development expenses.", "type": 2, "words": ["<tag1>", "Prior", "to", "the", "FDA's", "approval", "of", "taliglucerase", "alfa,", "manufacturing", "costs", "related", "to", "taliglucerase", "alfa", "were", "not", "capitalized;", "rather,", "such", "costs", "were", "expensed", "as", "research", "and", "development", "expenses.", "<tag2>", "Prior", "to", "the", "FDA", "s", "approval", "of", "taliglucerase", "alfa,", "manufacturing", "costs", "related", "to", "taliglucerase", "alfa", "were", "classified", "as", "research", "and", "development", "expenses.", "<tag3>"], "wordsA": ["Prior", "to", "the", "FDA's", "approval", "of", "taliglucerase", "alfa,", "manufacturing", "costs", "related", "to", "taliglucerase", "alfa", "were", "not", "capitalized;", "rather,", "such", "costs", "were", "expensed", "as", "research", "and", "development", "expenses."], "wordsB": ["Prior", "to", "the", "FDA", "s", "approval", "of", "taliglucerase", "alfa,", "manufacturing", "costs", "related", "to", "taliglucerase", "alfa", "were", "classified", "as", "research", "and", "development", "expenses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p49_s4", "idA": "1006281_13_item7_p54_s3", "sentA": "Effective as of the FDA approval of taliglucerase alfa on May 1, 2012, we capitalize all manufacturing costs associated with taliglucerase alfa.", "sentB": "Effective as of the FDA approval of taliglucerase alfa, we capitalize all manufacturing costs associated with taliglucerase alfa and expense such costs as cost of revenues, as applicable.", "type": 2, "words": ["<tag1>", "Effective", "as", "of", "the", "FDA", "approval", "of", "taliglucerase", "alfa", "on", "May", "1,", "2012,", "we", "capitalize", "all", "manufacturing", "costs", "associated", "with", "taliglucerase", "alfa.", "<tag2>", "Effective", "as", "of", "the", "FDA", "approval", "of", "taliglucerase", "alfa,", "we", "capitalize", "all", "manufacturing", "costs", "associated", "with", "taliglucerase", "alfa", "and", "expense", "such", "costs", "as", "cost", "of", "revenues,", "as", "applicable.", "<tag3>"], "wordsA": ["Effective", "as", "of", "the", "FDA", "approval", "of", "taliglucerase", "alfa", "on", "May", "1,", "2012,", "we", "capitalize", "all", "manufacturing", "costs", "associated", "with", "taliglucerase", "alfa."], "wordsB": ["Effective", "as", "of", "the", "FDA", "approval", "of", "taliglucerase", "alfa,", "we", "capitalize", "all", "manufacturing", "costs", "associated", "with", "taliglucerase", "alfa", "and", "expense", "such", "costs", "as", "cost", "of", "revenues,", "as", "applicable."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p50_s0", "idA": "1006281_13_item7_p55_s0", "sentA": "Research and development expenses were $36.7 million for the year ended December 31, 2012, a decrease of $1.1 million from $37.8 million for the year ended December 31, 2011.", "sentB": "Research and development expenses were $33.3 million for the year ended December 31, 2013, a decrease of $3.4 million, or 9.1% from $36.7 million for the year ended December 31, 2012.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expenses", "were", "$36.7", "million", "for", "the", "year", "ended", "December", "31,", "2012,", "a", "decrease", "of", "$1.1", "million", "from", "$37.8", "million", "for", "the", "year", "ended", "December", "31,", "2011.", "<tag2>", "Research", "and", "development", "expenses", "were", "$33.3", "million", "for", "the", "year", "ended", "December", "31,", "2013,", "a", "decrease", "of", "$3.4", "million,", "or", "9.1%", "from", "$36.7", "million", "for", "the", "year", "ended", "December", "31,", "2012.", "<tag3>"], "wordsA": ["Research", "and", "development", "expenses", "were", "$36.7", "million", "for", "the", "year", "ended", "December", "31,", "2012,", "a", "decrease", "of", "$1.1", "million", "from", "$37.8", "million", "for", "the", "year", "ended", "December", "31,", "2011."], "wordsB": ["Research", "and", "development", "expenses", "were", "$33.3", "million", "for", "the", "year", "ended", "December", "31,", "2013,", "a", "decrease", "of", "$3.4", "million,", "or", "9.1%", "from", "$36.7", "million", "for", "the", "year", "ended", "December", "31,", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p50_s1", "idA": "1006281_13_item7_p55_s1", "sentA": "The decrease resulted primarily from a decrease of $2.6 million in expenses related to consulting and subcontractors, and a decrease of $2.8 million in certain expenses, such as rent, depreciation and maintenance, that were classified as cost of revenues or capitalized as inventory after the FDA's approval of taliglucerase alfa on May 1, 2012.", "sentB": "The decrease resulted primarily from a decrease of $2.1 million in payroll and related expenses primarily due to a decrease in share-based compensation and a decrease of $1.2 million resulting from the winding down of certain clinical trials for taliglucerase alfa.", "type": 2, "words": ["<tag1>", "The", "decrease", "resulted", "primarily", "from", "a", "decrease", "of", "$2.6", "million", "in", "expenses", "related", "to", "consulting", "and", "subcontractors,", "and", "a", "decrease", "of", "$2.8", "million", "in", "certain", "expenses,", "such", "as", "rent,", "depreciation", "and", "maintenance,", "that", "were", "classified", "as", "cost", "of", "revenues", "or", "capitalized", "as", "inventory", "after", "the", "FDA's", "approval", "of", "taliglucerase", "alfa", "on", "May", "1,", "2012.", "<tag2>", "The", "decrease", "resulted", "primarily", "from", "a", "decrease", "of", "$2.1", "million", "in", "payroll", "and", "related", "expenses", "primarily", "due", "to", "a", "decrease", "in", "share-based", "compensation", "and", "a", "decrease", "of", "$1.2", "million", "resulting", "from", "the", "winding", "down", "of", "certain", "clinical", "trials", "for", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["The", "decrease", "resulted", "primarily", "from", "a", "decrease", "of", "$2.6", "million", "in", "expenses", "related", "to", "consulting", "and", "subcontractors,", "and", "a", "decrease", "of", "$2.8", "million", "in", "certain", "expenses,", "such", "as", "rent,", "depreciation", "and", "maintenance,", "that", "were", "classified", "as", "cost", "of", "revenues", "or", "capitalized", "as", "inventory", "after", "the", "FDA's", "approval", "of", "taliglucerase", "alfa", "on", "May", "1,", "2012."], "wordsB": ["The", "decrease", "resulted", "primarily", "from", "a", "decrease", "of", "$2.1", "million", "in", "payroll", "and", "related", "expenses", "primarily", "due", "to", "a", "decrease", "in", "share-based", "compensation", "and", "a", "decrease", "of", "$1.2", "million", "resulting", "from", "the", "winding", "down", "of", "certain", "clinical", "trials", "for", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p52_s0", "idA": "1006281_13_item7_p57_s0", "sentA": "General and administrative expenses were $9.8 million for the year ended December 31, 2012, an increase of $2.8 million, or 41%, from $6.9 million for the year ended December 31, 2011.", "sentB": "General and administrative expenses were $8.4 million for the year ended December 31, 2013, a decrease of $1.4 million, or 14%, from $9.8 million for the year ended December 31, 2012.", "type": 2, "words": ["<tag1>", "General", "and", "administrative", "expenses", "were", "$9.8", "million", "for", "the", "year", "ended", "December", "31,", "2012,", "an", "increase", "of", "$2.8", "million,", "or", "41%,", "from", "$6.9", "million", "for", "the", "year", "ended", "December", "31,", "2011.", "<tag2>", "General", "and", "administrative", "expenses", "were", "$8.4", "million", "for", "the", "year", "ended", "December", "31,", "2013,", "a", "decrease", "of", "$1.4", "million,", "or", "14%,", "from", "$9.8", "million", "for", "the", "year", "ended", "December", "31,", "2012.", "<tag3>"], "wordsA": ["General", "and", "administrative", "expenses", "were", "$9.8", "million", "for", "the", "year", "ended", "December", "31,", "2012,", "an", "increase", "of", "$2.8", "million,", "or", "41%,", "from", "$6.9", "million", "for", "the", "year", "ended", "December", "31,", "2011."], "wordsB": ["General", "and", "administrative", "expenses", "were", "$8.4", "million", "for", "the", "year", "ended", "December", "31,", "2013,", "a", "decrease", "of", "$1.4", "million,", "or", "14%,", "from", "$9.8", "million", "for", "the", "year", "ended", "December", "31,", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p52_s1", "idA": "1006281_13_item7_p57_s1", "sentA": "The increase resulted primarily from an increase of $3.3 million in salaries expense primarily due to bonuses paid in connection with the FDA's approval of taliglucerase alfa on May 1, 2012 and share-based compensation.", "sentB": "The decrease resulted primarily from a decrease of $1.5 million in payroll and related expenses primarily due to a decrease in share-based compensation.", "type": 2, "words": ["<tag1>", "The", "increase", "resulted", "primarily", "from", "an", "increase", "of", "$3.3", "million", "in", "salaries", "expense", "primarily", "due", "to", "bonuses", "paid", "in", "connection", "with", "the", "FDA's", "approval", "of", "taliglucerase", "alfa", "on", "May", "1,", "2012", "and", "share-based", "compensation.", "<tag2>", "The", "decrease", "resulted", "primarily", "from", "a", "decrease", "of", "$1.5", "million", "in", "payroll", "and", "related", "expenses", "primarily", "due", "to", "a", "decrease", "in", "share-based", "compensation.", "<tag3>"], "wordsA": ["The", "increase", "resulted", "primarily", "from", "an", "increase", "of", "$3.3", "million", "in", "salaries", "expense", "primarily", "due", "to", "bonuses", "paid", "in", "connection", "with", "the", "FDA's", "approval", "of", "taliglucerase", "alfa", "on", "May", "1,", "2012", "and", "share-based", "compensation."], "wordsB": ["The", "decrease", "resulted", "primarily", "from", "a", "decrease", "of", "$1.5", "million", "in", "payroll", "and", "related", "expenses", "primarily", "due", "to", "a", "decrease", "in", "share-based", "compensation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p46_s1", "idA": "1006281_13_item7_p59_s2", "sentA": "Revenues also include the amortization of the $65.0 million upfront and milestone payments received from Pfizer.", "sentB": "The revenues represent our sales of taliglucerase alfa in Israel, the cost of products we deliver to Pfizer under the Pfizer Agreement and a pro rata amortization equal to $1.1 million in each quarterly period resulting from the $65.0 million upfront and milestone payments we received from Pfizer in 2009.", "type": 2, "words": ["<tag1>", "Revenues", "also", "include", "the", "amortization", "of", "the", "$65.0", "million", "upfront", "and", "milestone", "payments", "received", "from", "Pfizer.", "<tag2>", "The", "revenues", "represent", "our", "sales", "of", "taliglucerase", "alfa", "in", "Israel,", "the", "cost", "of", "products", "we", "deliver", "to", "Pfizer", "under", "the", "Pfizer", "Agreement", "and", "a", "pro", "rata", "amortization", "equal", "to", "$1.1", "million", "in", "each", "quarterly", "period", "resulting", "from", "the", "$65.0", "million", "upfront", "and", "milestone", "payments", "we", "received", "from", "Pfizer", "in", "2009.", "<tag3>"], "wordsA": ["Revenues", "also", "include", "the", "amortization", "of", "the", "$65.0", "million", "upfront", "and", "milestone", "payments", "received", "from", "Pfizer."], "wordsB": ["The", "revenues", "represent", "our", "sales", "of", "taliglucerase", "alfa", "in", "Israel,", "the", "cost", "of", "products", "we", "deliver", "to", "Pfizer", "under", "the", "Pfizer", "Agreement", "and", "a", "pro", "rata", "amortization", "equal", "to", "$1.1", "million", "in", "each", "quarterly", "period", "resulting", "from", "the", "$65.0", "million", "upfront", "and", "milestone", "payments", "we", "received", "from", "Pfizer", "in", "2009."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p7_s0", "idA": "1006281_13_item7_p6_s0", "sentA": "Since May 2012, taliglucerase alfa has been marketed in the United States by Pfizer, our commercialization partner, as provided in the exclusive license and supply agreement by and between Protalix Ltd., our wholly-owned subsidiary, and Pfizer, which we refer to as the Pfizer Agreement.", "sentB": "Since May 2012, taliglucerase alfa has been marketed in the United States by Pfizer, our commercialization partner, as provided in the Pfizer Agreement.", "type": 2, "words": ["<tag1>", "Since", "May", "2012,", "taliglucerase", "alfa", "has", "been", "marketed", "in", "the", "United", "States", "by", "Pfizer,", "our", "commercialization", "partner,", "as", "provided", "in", "the", "exclusive", "license", "and", "supply", "agreement", "by", "and", "between", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary,", "and", "Pfizer,", "which", "we", "refer", "to", "as", "the", "Pfizer", "Agreement.", "<tag2>", "Since", "May", "2012,", "taliglucerase", "alfa", "has", "been", "marketed", "in", "the", "United", "States", "by", "Pfizer,", "our", "commercialization", "partner,", "as", "provided", "in", "the", "Pfizer", "Agreement.", "<tag3>"], "wordsA": ["Since", "May", "2012,", "taliglucerase", "alfa", "has", "been", "marketed", "in", "the", "United", "States", "by", "Pfizer,", "our", "commercialization", "partner,", "as", "provided", "in", "the", "exclusive", "license", "and", "supply", "agreement", "by", "and", "between", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary,", "and", "Pfizer,", "which", "we", "refer", "to", "as", "the", "Pfizer", "Agreement."], "wordsB": ["Since", "May", "2012,", "taliglucerase", "alfa", "has", "been", "marketed", "in", "the", "United", "States", "by", "Pfizer,", "our", "commercialization", "partner,", "as", "provided", "in", "the", "Pfizer", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p7_s3", "idA": "1006281_13_item7_p6_s0", "sentA": "Since May 2012, taliglucerase alfa has been marketed in the United States by Pfizer, our commercialization partner, as provided in the exclusive license and supply agreement by and between Protalix Ltd., our wholly-owned subsidiary, and Pfizer, which we refer to as the Pfizer Agreement.", "sentB": "Since 2013, taliglucerase alfa has been marketed in Israel by Protalix Ltd.", "type": 2, "words": ["<tag1>", "Since", "May", "2012,", "taliglucerase", "alfa", "has", "been", "marketed", "in", "the", "United", "States", "by", "Pfizer,", "our", "commercialization", "partner,", "as", "provided", "in", "the", "exclusive", "license", "and", "supply", "agreement", "by", "and", "between", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary,", "and", "Pfizer,", "which", "we", "refer", "to", "as", "the", "Pfizer", "Agreement.", "<tag2>", "Since", "2013,", "taliglucerase", "alfa", "has", "been", "marketed", "in", "Israel", "by", "Protalix", "Ltd.", "<tag3>"], "wordsA": ["Since", "May", "2012,", "taliglucerase", "alfa", "has", "been", "marketed", "in", "the", "United", "States", "by", "Pfizer,", "our", "commercialization", "partner,", "as", "provided", "in", "the", "exclusive", "license", "and", "supply", "agreement", "by", "and", "between", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary,", "and", "Pfizer,", "which", "we", "refer", "to", "as", "the", "Pfizer", "Agreement."], "wordsB": ["Since", "2013,", "taliglucerase", "alfa", "has", "been", "marketed", "in", "Israel", "by", "Protalix", "Ltd."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p7_s1", "idA": "1006281_13_item7_p6_s1", "sentA": "We granted Pfizer an exclusive, worldwide license to develop and commercialize taliglucerase alfa under the Pfizer Agreement, but retained those rights in Israel.", "sentB": "We granted Pfizer an exclusive, worldwide license to develop and commercialize taliglucerase alfa under the Pfizer Agreement, but we retained those rights in Israel and in Brazil.", "type": 2, "words": ["<tag1>", "We", "granted", "Pfizer", "an", "exclusive,", "worldwide", "license", "to", "develop", "and", "commercialize", "taliglucerase", "alfa", "under", "the", "Pfizer", "Agreement,", "but", "retained", "those", "rights", "in", "Israel.", "<tag2>", "We", "granted", "Pfizer", "an", "exclusive,", "worldwide", "license", "to", "develop", "and", "commercialize", "taliglucerase", "alfa", "under", "the", "Pfizer", "Agreement,", "but", "we", "retained", "those", "rights", "in", "Israel", "and", "in", "Brazil.", "<tag3>"], "wordsA": ["We", "granted", "Pfizer", "an", "exclusive,", "worldwide", "license", "to", "develop", "and", "commercialize", "taliglucerase", "alfa", "under", "the", "Pfizer", "Agreement,", "but", "retained", "those", "rights", "in", "Israel."], "wordsB": ["We", "granted", "Pfizer", "an", "exclusive,", "worldwide", "license", "to", "develop", "and", "commercialize", "taliglucerase", "alfa", "under", "the", "Pfizer", "Agreement,", "but", "we", "retained", "those", "rights", "in", "Israel", "and", "in", "Brazil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p64_s0", "idA": "1006281_13_item7_p70_s0", "sentA": "In addition to the foregoing, Pfizer paid Protalix Ltd.", "sentB": "In addition to the foregoing, on September 18, 2013, we completed a private placement of $69.0 million in aggregate principal amount of 4.50% convertible notes due 2018, or the Notes, including $9.0 million aggregate principal amount of Notes related to the offering s initial purchaser s over-allotment option, which was exercised in full.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "the", "foregoing,", "Pfizer", "paid", "Protalix", "Ltd.", "<tag2>", "In", "addition", "to", "the", "foregoing,", "on", "September", "18,", "2013,", "we", "completed", "a", "private", "placement", "of", "$69.0", "million", "in", "aggregate", "principal", "amount", "of", "4.50%", "convertible", "notes", "due", "2018,", "or", "the", "Notes,", "including", "$9.0", "million", "aggregate", "principal", "amount", "of", "Notes", "related", "to", "the", "offering", "s", "initial", "purchaser", "s", "over-allotment", "option,", "which", "was", "exercised", "in", "full.", "<tag3>"], "wordsA": ["In", "addition", "to", "the", "foregoing,", "Pfizer", "paid", "Protalix", "Ltd."], "wordsB": ["In", "addition", "to", "the", "foregoing,", "on", "September", "18,", "2013,", "we", "completed", "a", "private", "placement", "of", "$69.0", "million", "in", "aggregate", "principal", "amount", "of", "4.50%", "convertible", "notes", "due", "2018,", "or", "the", "Notes,", "including", "$9.0", "million", "aggregate", "principal", "amount", "of", "Notes", "related", "to", "the", "offering", "s", "initial", "purchaser", "s", "over-allotment", "option,", "which", "was", "exercised", "in", "full."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p65_s0", "idA": "1006281_13_item7_p70_s1", "sentA": "$60.0 million as an upfront payment in connection with the execution of the Pfizer Agreement and subsequently paid to Protalix Ltd. an additional $5.0 million upon Protalix Ltd.'s meeting a certain milestone.", "sentB": "Pfizer paid Protalix Ltd. $60.0 million as an upfront payment in connection with the execution of the Pfizer Agreement and subsequently paid to Protalix Ltd. an additional $5.0 million upon Protalix Ltd. s meeting a certain milestone.", "type": 2, "words": ["<tag1>", "$60.0", "million", "as", "an", "upfront", "payment", "in", "connection", "with", "the", "execution", "of", "the", "Pfizer", "Agreement", "and", "subsequently", "paid", "to", "Protalix", "Ltd.", "an", "additional", "$5.0", "million", "upon", "Protalix", "Ltd.'s", "meeting", "a", "certain", "milestone.", "<tag2>", "Pfizer", "paid", "Protalix", "Ltd.", "$60.0", "million", "as", "an", "upfront", "payment", "in", "connection", "with", "the", "execution", "of", "the", "Pfizer", "Agreement", "and", "subsequently", "paid", "to", "Protalix", "Ltd.", "an", "additional", "$5.0", "million", "upon", "Protalix", "Ltd.", "s", "meeting", "a", "certain", "milestone.", "<tag3>"], "wordsA": ["$60.0", "million", "as", "an", "upfront", "payment", "in", "connection", "with", "the", "execution", "of", "the", "Pfizer", "Agreement", "and", "subsequently", "paid", "to", "Protalix", "Ltd.", "an", "additional", "$5.0", "million", "upon", "Protalix", "Ltd.'s", "meeting", "a", "certain", "milestone."], "wordsB": ["Pfizer", "paid", "Protalix", "Ltd.", "$60.0", "million", "as", "an", "upfront", "payment", "in", "connection", "with", "the", "execution", "of", "the", "Pfizer", "Agreement", "and", "subsequently", "paid", "to", "Protalix", "Ltd.", "an", "additional", "$5.0", "million", "upon", "Protalix", "Ltd.", "s", "meeting", "a", "certain", "milestone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p46_s2", "idA": "1006281_13_item7_p72_s0", "sentA": "Net cash provided by operations was $635,000 for the year ended December 31, 2012.", "sentB": "The revenues for the year ended December 31, 2013 include $5.0 million from products we sold in Israel.", "type": 2, "words": ["<tag1>", "Net", "cash", "provided", "by", "operations", "was", "$635,000", "for", "the", "year", "ended", "December", "31,", "2012.", "<tag2>", "The", "revenues", "for", "the", "year", "ended", "December", "31,", "2013", "include", "$5.0", "million", "from", "products", "we", "sold", "in", "Israel.", "<tag3>"], "wordsA": ["Net", "cash", "provided", "by", "operations", "was", "$635,000", "for", "the", "year", "ended", "December", "31,", "2012."], "wordsB": ["The", "revenues", "for", "the", "year", "ended", "December", "31,", "2013", "include", "$5.0", "million", "from", "products", "we", "sold", "in", "Israel."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p53_s0", "idA": "1006281_13_item7_p72_s0", "sentA": "Net cash provided by operations was $635,000 for the year ended December 31, 2012.", "sentB": "Financial expense was $674,000 for the year ended December 31, 2013, compared to financial income of $554,000 for the year ended December 31, 2012.", "type": 2, "words": ["<tag1>", "Net", "cash", "provided", "by", "operations", "was", "$635,000", "for", "the", "year", "ended", "December", "31,", "2012.", "<tag2>", "Financial", "expense", "was", "$674,000", "for", "the", "year", "ended", "December", "31,", "2013,", "compared", "to", "financial", "income", "of", "$554,000", "for", "the", "year", "ended", "December", "31,", "2012.", "<tag3>"], "wordsA": ["Net", "cash", "provided", "by", "operations", "was", "$635,000", "for", "the", "year", "ended", "December", "31,", "2012."], "wordsB": ["Financial", "expense", "was", "$674,000", "for", "the", "year", "ended", "December", "31,", "2013,", "compared", "to", "financial", "income", "of", "$554,000", "for", "the", "year", "ended", "December", "31,", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p53_s1", "idA": "1006281_13_item7_p72_s1", "sentA": "The net loss for the year ended December 31, 2012 of $11.6 million decreased primarily due to $7.8 million in share-based compensation and $3.7 million in depreciation and a $3.0 million increase in accounts payable, which was partially offset by a an increase of $3.8 million in inventory.", "sentB": "Financial expense resulted primarily from interest expense of $1.0 million for the 4.5% convertible note which was partially offset by financial income which resulted primarily from interest earned on short term deposits.", "type": 2, "words": ["<tag1>", "The", "net", "loss", "for", "the", "year", "ended", "December", "31,", "2012", "of", "$11.6", "million", "decreased", "primarily", "due", "to", "$7.8", "million", "in", "share-based", "compensation", "and", "$3.7", "million", "in", "depreciation", "and", "a", "$3.0", "million", "increase", "in", "accounts", "payable,", "which", "was", "partially", "offset", "by", "a", "an", "increase", "of", "$3.8", "million", "in", "inventory.", "<tag2>", "Financial", "expense", "resulted", "primarily", "from", "interest", "expense", "of", "$1.0", "million", "for", "the", "4.5%", "convertible", "note", "which", "was", "partially", "offset", "by", "financial", "income", "which", "resulted", "primarily", "from", "interest", "earned", "on", "short", "term", "deposits.", "<tag3>"], "wordsA": ["The", "net", "loss", "for", "the", "year", "ended", "December", "31,", "2012", "of", "$11.6", "million", "decreased", "primarily", "due", "to", "$7.8", "million", "in", "share-based", "compensation", "and", "$3.7", "million", "in", "depreciation", "and", "a", "$3.0", "million", "increase", "in", "accounts", "payable,", "which", "was", "partially", "offset", "by", "a", "an", "increase", "of", "$3.8", "million", "in", "inventory."], "wordsB": ["Financial", "expense", "resulted", "primarily", "from", "interest", "expense", "of", "$1.0", "million", "for", "the", "4.5%", "convertible", "note", "which", "was", "partially", "offset", "by", "financial", "income", "which", "resulted", "primarily", "from", "interest", "earned", "on", "short", "term", "deposits."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p67_s1", "idA": "1006281_13_item7_p72_s1", "sentA": "The net loss for the year ended December 31, 2012 of $11.6 million decreased primarily due to $7.8 million in share-based compensation and $3.7 million in depreciation and a $3.0 million increase in accounts payable, which was partially offset by a an increase of $3.8 million in inventory.", "sentB": "The net loss for the year ended December 31, 2013 of $27.8 million was further increased by a decrease of $7.2 million in deferred revenues and an increase of $3.9 million in inventories, but was partially offset by share based compensation of $4.1 million and $3.5 million in depreciation.", "type": 2, "words": ["<tag1>", "The", "net", "loss", "for", "the", "year", "ended", "December", "31,", "2012", "of", "$11.6", "million", "decreased", "primarily", "due", "to", "$7.8", "million", "in", "share-based", "compensation", "and", "$3.7", "million", "in", "depreciation", "and", "a", "$3.0", "million", "increase", "in", "accounts", "payable,", "which", "was", "partially", "offset", "by", "a", "an", "increase", "of", "$3.8", "million", "in", "inventory.", "<tag2>", "The", "net", "loss", "for", "the", "year", "ended", "December", "31,", "2013", "of", "$27.8", "million", "was", "further", "increased", "by", "a", "decrease", "of", "$7.2", "million", "in", "deferred", "revenues", "and", "an", "increase", "of", "$3.9", "million", "in", "inventories,", "but", "was", "partially", "offset", "by", "share", "based", "compensation", "of", "$4.1", "million", "and", "$3.5", "million", "in", "depreciation.", "<tag3>"], "wordsA": ["The", "net", "loss", "for", "the", "year", "ended", "December", "31,", "2012", "of", "$11.6", "million", "decreased", "primarily", "due", "to", "$7.8", "million", "in", "share-based", "compensation", "and", "$3.7", "million", "in", "depreciation", "and", "a", "$3.0", "million", "increase", "in", "accounts", "payable,", "which", "was", "partially", "offset", "by", "a", "an", "increase", "of", "$3.8", "million", "in", "inventory."], "wordsB": ["The", "net", "loss", "for", "the", "year", "ended", "December", "31,", "2013", "of", "$27.8", "million", "was", "further", "increased", "by", "a", "decrease", "of", "$7.2", "million", "in", "deferred", "revenues", "and", "an", "increase", "of", "$3.9", "million", "in", "inventories,", "but", "was", "partially", "offset", "by", "share", "based", "compensation", "of", "$4.1", "million", "and", "$3.5", "million", "in", "depreciation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p67_s2", "idA": "1006281_13_item7_p72_s2", "sentA": "Net cash used in investing activities for the year ended December 31, 2012 was $2.3 million and consisted primarily of purchases of property and equipment.", "sentB": "Net cash used in investing activities for the year ended December 31, 2013 was $2.1 million and consisted primarily of purchases of property and equipment.", "type": 2, "words": ["<tag1>", "Net", "cash", "used", "in", "investing", "activities", "for", "the", "year", "ended", "December", "31,", "2012", "was", "$2.3", "million", "and", "consisted", "primarily", "of", "purchases", "of", "property", "and", "equipment.", "<tag2>", "Net", "cash", "used", "in", "investing", "activities", "for", "the", "year", "ended", "December", "31,", "2013", "was", "$2.1", "million", "and", "consisted", "primarily", "of", "purchases", "of", "property", "and", "equipment.", "<tag3>"], "wordsA": ["Net", "cash", "used", "in", "investing", "activities", "for", "the", "year", "ended", "December", "31,", "2012", "was", "$2.3", "million", "and", "consisted", "primarily", "of", "purchases", "of", "property", "and", "equipment."], "wordsB": ["Net", "cash", "used", "in", "investing", "activities", "for", "the", "year", "ended", "December", "31,", "2013", "was", "$2.1", "million", "and", "consisted", "primarily", "of", "purchases", "of", "property", "and", "equipment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p67_s3", "idA": "1006281_13_item7_p72_s3", "sentA": "Net cash provided by financing activities was $26.6 million, consisting primarily of net proceeds from our February 2012 underwritten public offering of common stock.", "sentB": "Net cash provided by financing activities was $66.9 million, consisting primarily of net proceeds from our offering of 2018 4.5% convertible notes.", "type": 2, "words": ["<tag1>", "Net", "cash", "provided", "by", "financing", "activities", "was", "$26.6", "million,", "consisting", "primarily", "of", "net", "proceeds", "from", "our", "February", "2012", "underwritten", "public", "offering", "of", "common", "stock.", "<tag2>", "Net", "cash", "provided", "by", "financing", "activities", "was", "$66.9", "million,", "consisting", "primarily", "of", "net", "proceeds", "from", "our", "offering", "of", "2018", "4.5%", "convertible", "notes.", "<tag3>"], "wordsA": ["Net", "cash", "provided", "by", "financing", "activities", "was", "$26.6", "million,", "consisting", "primarily", "of", "net", "proceeds", "from", "our", "February", "2012", "underwritten", "public", "offering", "of", "common", "stock."], "wordsB": ["Net", "cash", "provided", "by", "financing", "activities", "was", "$66.9", "million,", "consisting", "primarily", "of", "net", "proceeds", "from", "our", "offering", "of", "2018", "4.5%", "convertible", "notes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p67_s0", "idA": "1006281_13_item7_p73_s0", "sentA": "Net cash used in operations was $23.6 million for the year ended December 31, 2011.", "sentB": "Net cash used in operations was $30.7 million for the year ended December 31, 2013.", "type": 2, "words": ["<tag1>", "Net", "cash", "used", "in", "operations", "was", "$23.6", "million", "for", "the", "year", "ended", "December", "31,", "2011.", "<tag2>", "Net", "cash", "used", "in", "operations", "was", "$30.7", "million", "for", "the", "year", "ended", "December", "31,", "2013.", "<tag3>"], "wordsA": ["Net", "cash", "used", "in", "operations", "was", "$23.6", "million", "for", "the", "year", "ended", "December", "31,", "2011."], "wordsB": ["Net", "cash", "used", "in", "operations", "was", "$30.7", "million", "for", "the", "year", "ended", "December", "31,", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p69_s1", "idA": "1006281_13_item7_p75_s1", "sentA": "However, we anticipate that we will generate revenues to offset such losses as Pfizer's commercialization efforts for taliglucerase alfa progress after the FDA's approval in May 2012, and as we begin to generate revenues from the commercialization of taliglucerase alfa in Israel after the Israeli MOH's approval in September 2012.", "sentB": "However, we anticipate that we will generate revenues to offset such losses as Pfizer s commercialization efforts for taliglucerase alfa in the United States and as our commercialization efforts for taliglucerase alfa in Brazil and Israel progress, and as taliglucerase alfa is launched by Pfizer in other countries in which taliglucerase alfa was recently approved.", "type": 2, "words": ["<tag1>", "However,", "we", "anticipate", "that", "we", "will", "generate", "revenues", "to", "offset", "such", "losses", "as", "Pfizer's", "commercialization", "efforts", "for", "taliglucerase", "alfa", "progress", "after", "the", "FDA's", "approval", "in", "May", "2012,", "and", "as", "we", "begin", "to", "generate", "revenues", "from", "the", "commercialization", "of", "taliglucerase", "alfa", "in", "Israel", "after", "the", "Israeli", "MOH's", "approval", "in", "September", "2012.", "<tag2>", "However,", "we", "anticipate", "that", "we", "will", "generate", "revenues", "to", "offset", "such", "losses", "as", "Pfizer", "s", "commercialization", "efforts", "for", "taliglucerase", "alfa", "in", "the", "United", "States", "and", "as", "our", "commercialization", "efforts", "for", "taliglucerase", "alfa", "in", "Brazil", "and", "Israel", "progress,", "and", "as", "taliglucerase", "alfa", "is", "launched", "by", "Pfizer", "in", "other", "countries", "in", "which", "taliglucerase", "alfa", "was", "recently", "approved.", "<tag3>"], "wordsA": ["However,", "we", "anticipate", "that", "we", "will", "generate", "revenues", "to", "offset", "such", "losses", "as", "Pfizer's", "commercialization", "efforts", "for", "taliglucerase", "alfa", "progress", "after", "the", "FDA's", "approval", "in", "May", "2012,", "and", "as", "we", "begin", "to", "generate", "revenues", "from", "the", "commercialization", "of", "taliglucerase", "alfa", "in", "Israel", "after", "the", "Israeli", "MOH's", "approval", "in", "September", "2012."], "wordsB": ["However,", "we", "anticipate", "that", "we", "will", "generate", "revenues", "to", "offset", "such", "losses", "as", "Pfizer", "s", "commercialization", "efforts", "for", "taliglucerase", "alfa", "in", "the", "United", "States", "and", "as", "our", "commercialization", "efforts", "for", "taliglucerase", "alfa", "in", "Brazil", "and", "Israel", "progress,", "and", "as", "taliglucerase", "alfa", "is", "launched", "by", "Pfizer", "in", "other", "countries", "in", "which", "taliglucerase", "alfa", "was", "recently", "approved."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p69_s2", "idA": "1006281_13_item7_p75_s2", "sentA": "We also anticipate that we will generate additional revenues after additional anticipated marketing approvals of taliglucerase alfa are granted outside of the United States and Israel, including, primarily, in Brazil.", "sentB": "We also anticipate that we will generate additional revenues after additional anticipated marketing approvals of taliglucerase alfa are granted in new countries.", "type": 2, "words": ["<tag1>", "We", "also", "anticipate", "that", "we", "will", "generate", "additional", "revenues", "after", "additional", "anticipated", "marketing", "approvals", "of", "taliglucerase", "alfa", "are", "granted", "outside", "of", "the", "United", "States", "and", "Israel,", "including,", "primarily,", "in", "Brazil.", "<tag2>", "We", "also", "anticipate", "that", "we", "will", "generate", "additional", "revenues", "after", "additional", "anticipated", "marketing", "approvals", "of", "taliglucerase", "alfa", "are", "granted", "in", "new", "countries.", "<tag3>"], "wordsA": ["We", "also", "anticipate", "that", "we", "will", "generate", "additional", "revenues", "after", "additional", "anticipated", "marketing", "approvals", "of", "taliglucerase", "alfa", "are", "granted", "outside", "of", "the", "United", "States", "and", "Israel,", "including,", "primarily,", "in", "Brazil."], "wordsB": ["We", "also", "anticipate", "that", "we", "will", "generate", "additional", "revenues", "after", "additional", "anticipated", "marketing", "approvals", "of", "taliglucerase", "alfa", "are", "granted", "in", "new", "countries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p69_s3", "idA": "1006281_13_item7_p75_s3", "sentA": "We expect to continue to incur significant research and development expenses, including expenses related to the hiring of personnel and the advancement of PRX-102 and oral glucocerebrosidase and any other product candidates in our pipeline into clinical trials.", "sentB": "We expect to continue to incur significant research and development expenses, including expenses related primarily to the clinical trials of PRX-102 and oral glucocerebrosidase and the advancement of our other product candidates into clinical trials.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "continue", "to", "incur", "significant", "research", "and", "development", "expenses,", "including", "expenses", "related", "to", "the", "hiring", "of", "personnel", "and", "the", "advancement", "of", "PRX-102", "and", "oral", "glucocerebrosidase", "and", "any", "other", "product", "candidates", "in", "our", "pipeline", "into", "clinical", "trials.", "<tag2>", "We", "expect", "to", "continue", "to", "incur", "significant", "research", "and", "development", "expenses,", "including", "expenses", "related", "primarily", "to", "the", "clinical", "trials", "of", "PRX-102", "and", "oral", "glucocerebrosidase", "and", "the", "advancement", "of", "our", "other", "product", "candidates", "into", "clinical", "trials.", "<tag3>"], "wordsA": ["We", "expect", "to", "continue", "to", "incur", "significant", "research", "and", "development", "expenses,", "including", "expenses", "related", "to", "the", "hiring", "of", "personnel", "and", "the", "advancement", "of", "PRX-102", "and", "oral", "glucocerebrosidase", "and", "any", "other", "product", "candidates", "in", "our", "pipeline", "into", "clinical", "trials."], "wordsB": ["We", "expect", "to", "continue", "to", "incur", "significant", "research", "and", "development", "expenses,", "including", "expenses", "related", "primarily", "to", "the", "clinical", "trials", "of", "PRX-102", "and", "oral", "glucocerebrosidase", "and", "the", "advancement", "of", "our", "other", "product", "candidates", "into", "clinical", "trials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p70_s0", "idA": "1006281_13_item7_p76_s0", "sentA": "We believe that our existing cash and cash equivalents will be sufficient to enable us to fund our operating expenses and capital expenditure requirements for at least the next 12 months.", "sentB": "We believe that our existing cash and cash equivalents will be sufficient to enable us to fund our operating expenses and capital expenditure requirements for the foreseeable future.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "our", "existing", "cash", "and", "cash", "equivalents", "will", "be", "sufficient", "to", "enable", "us", "to", "fund", "our", "operating", "expenses", "and", "capital", "expenditure", "requirements", "for", "at", "least", "the", "next", "12", "months.", "<tag2>", "We", "believe", "that", "our", "existing", "cash", "and", "cash", "equivalents", "will", "be", "sufficient", "to", "enable", "us", "to", "fund", "our", "operating", "expenses", "and", "capital", "expenditure", "requirements", "for", "the", "foreseeable", "future.", "<tag3>"], "wordsA": ["We", "believe", "that", "our", "existing", "cash", "and", "cash", "equivalents", "will", "be", "sufficient", "to", "enable", "us", "to", "fund", "our", "operating", "expenses", "and", "capital", "expenditure", "requirements", "for", "at", "least", "the", "next", "12", "months."], "wordsB": ["We", "believe", "that", "our", "existing", "cash", "and", "cash", "equivalents", "will", "be", "sufficient", "to", "enable", "us", "to", "fund", "our", "operating", "expenses", "and", "capital", "expenditure", "requirements", "for", "the", "foreseeable", "future."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p71_s0", "idA": "1006281_13_item7_p77_s0", "sentA": "Our future capital requirements will depend on many factors, including the progress of Pfizer's commercialization efforts in the United States, the progress of our commercialization efforts in Israel and, if anticipated marketing approvals of taliglucerase alfa are granted in other jurisdictions, the progress of Pfizer's global commercialization efforts, the progress and results of our clinical trials, the duration and cost of discovery and preclinical development and laboratory testing and clinical trials for our product candidates, the timing and outcome of regulatory review of our product candidates, the costs involved in preparing, filing, prosecuting, maintaining, defending and enforcing patent claims and other intellectual property rights, the number and development requirements of other product candidates that we pursue and the costs of commercialization activities, including product marketing, sales and distribution.", "sentB": "Our future capital requirements will depend on many factors, including the progress of Pfizer s commercialization efforts for taliglucerase alfa in the United States and other countries, the progress of our commercialization efforts for taliglucerase alfa in Brazil and Israel and, if anticipated marketing approvals of taliglucerase alfa are granted in other jurisdictions, the progress of Pfizer s global commercialization efforts for taliglucerase alfa, the progress and results of our clinical trials, the duration and cost of discovery and preclinical development and laboratory testing and clinical trials for our product candidates, the timing and outcome of regulatory review of our product candidates, the costs involved in preparing, filing, prosecuting, maintaining, defending and enforcing patent claims and other intellectual property rights, the number and development requirements of other product candidates that we pursue and the costs of commercialization activities, including product marketing, sales and distribution.", "type": 2, "words": ["<tag1>", "Our", "future", "capital", "requirements", "will", "depend", "on", "many", "factors,", "including", "the", "progress", "of", "Pfizer's", "commercialization", "efforts", "in", "the", "United", "States,", "the", "progress", "of", "our", "commercialization", "efforts", "in", "Israel", "and,", "if", "anticipated", "marketing", "approvals", "of", "taliglucerase", "alfa", "are", "granted", "in", "other", "jurisdictions,", "the", "progress", "of", "Pfizer's", "global", "commercialization", "efforts,", "the", "progress", "and", "results", "of", "our", "clinical", "trials,", "the", "duration", "and", "cost", "of", "discovery", "and", "preclinical", "development", "and", "laboratory", "testing", "and", "clinical", "trials", "for", "our", "product", "candidates,", "the", "timing", "and", "outcome", "of", "regulatory", "review", "of", "our", "product", "candidates,", "the", "costs", "involved", "in", "preparing,", "filing,", "prosecuting,", "maintaining,", "defending", "and", "enforcing", "patent", "claims", "and", "other", "intellectual", "property", "rights,", "the", "number", "and", "development", "requirements", "of", "other", "product", "candidates", "that", "we", "pursue", "and", "the", "costs", "of", "commercialization", "activities,", "including", "product", "marketing,", "sales", "and", "distribution.", "<tag2>", "Our", "future", "capital", "requirements", "will", "depend", "on", "many", "factors,", "including", "the", "progress", "of", "Pfizer", "s", "commercialization", "efforts", "for", "taliglucerase", "alfa", "in", "the", "United", "States", "and", "other", "countries,", "the", "progress", "of", "our", "commercialization", "efforts", "for", "taliglucerase", "alfa", "in", "Brazil", "and", "Israel", "and,", "if", "anticipated", "marketing", "approvals", "of", "taliglucerase", "alfa", "are", "granted", "in", "other", "jurisdictions,", "the", "progress", "of", "Pfizer", "s", "global", "commercialization", "efforts", "for", "taliglucerase", "alfa,", "the", "progress", "and", "results", "of", "our", "clinical", "trials,", "the", "duration", "and", "cost", "of", "discovery", "and", "preclinical", "development", "and", "laboratory", "testing", "and", "clinical", "trials", "for", "our", "product", "candidates,", "the", "timing", "and", "outcome", "of", "regulatory", "review", "of", "our", "product", "candidates,", "the", "costs", "involved", "in", "preparing,", "filing,", "prosecuting,", "maintaining,", "defending", "and", "enforcing", "patent", "claims", "and", "other", "intellectual", "property", "rights,", "the", "number", "and", "development", "requirements", "of", "other", "product", "candidates", "that", "we", "pursue", "and", "the", "costs", "of", "commercialization", "activities,", "including", "product", "marketing,", "sales", "and", "distribution.", "<tag3>"], "wordsA": ["Our", "future", "capital", "requirements", "will", "depend", "on", "many", "factors,", "including", "the", "progress", "of", "Pfizer's", "commercialization", "efforts", "in", "the", "United", "States,", "the", "progress", "of", "our", "commercialization", "efforts", "in", "Israel", "and,", "if", "anticipated", "marketing", "approvals", "of", "taliglucerase", "alfa", "are", "granted", "in", "other", "jurisdictions,", "the", "progress", "of", "Pfizer's", "global", "commercialization", "efforts,", "the", "progress", "and", "results", "of", "our", "clinical", "trials,", "the", "duration", "and", "cost", "of", "discovery", "and", "preclinical", "development", "and", "laboratory", "testing", "and", "clinical", "trials", "for", "our", "product", "candidates,", "the", "timing", "and", "outcome", "of", "regulatory", "review", "of", "our", "product", "candidates,", "the", "costs", "involved", "in", "preparing,", "filing,", "prosecuting,", "maintaining,", "defending", "and", "enforcing", "patent", "claims", "and", "other", "intellectual", "property", "rights,", "the", "number", "and", "development", "requirements", "of", "other", "product", "candidates", "that", "we", "pursue", "and", "the", "costs", "of", "commercialization", "activities,", "including", "product", "marketing,", "sales", "and", "distribution."], "wordsB": ["Our", "future", "capital", "requirements", "will", "depend", "on", "many", "factors,", "including", "the", "progress", "of", "Pfizer", "s", "commercialization", "efforts", "for", "taliglucerase", "alfa", "in", "the", "United", "States", "and", "other", "countries,", "the", "progress", "of", "our", "commercialization", "efforts", "for", "taliglucerase", "alfa", "in", "Brazil", "and", "Israel", "and,", "if", "anticipated", "marketing", "approvals", "of", "taliglucerase", "alfa", "are", "granted", "in", "other", "jurisdictions,", "the", "progress", "of", "Pfizer", "s", "global", "commercialization", "efforts", "for", "taliglucerase", "alfa,", "the", "progress", "and", "results", "of", "our", "clinical", "trials,", "the", "duration", "and", "cost", "of", "discovery", "and", "preclinical", "development", "and", "laboratory", "testing", "and", "clinical", "trials", "for", "our", "product", "candidates,", "the", "timing", "and", "outcome", "of", "regulatory", "review", "of", "our", "product", "candidates,", "the", "costs", "involved", "in", "preparing,", "filing,", "prosecuting,", "maintaining,", "defending", "and", "enforcing", "patent", "claims", "and", "other", "intellectual", "property", "rights,", "the", "number", "and", "development", "requirements", "of", "other", "product", "candidates", "that", "we", "pursue", "and", "the", "costs", "of", "commercialization", "activities,", "including", "product", "marketing,", "sales", "and", "distribution."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p73_s1", "idA": "1006281_13_item7_p79_s1", "sentA": "We do not believe that inflation has had a material effect on our results of operations during the years ended December 31, 2010, 2011 or 2012.", "sentB": "We do not believe that inflation has had a material effect on our results of operations during the years ended December 31, 2011, 2012 or 2013.", "type": 2, "words": ["<tag1>", "We", "do", "not", "believe", "that", "inflation", "has", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2010,", "2011", "or", "2012.", "<tag2>", "We", "do", "not", "believe", "that", "inflation", "has", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2011,", "2012", "or", "2013.", "<tag3>"], "wordsA": ["We", "do", "not", "believe", "that", "inflation", "has", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2010,", "2011", "or", "2012."], "wordsB": ["We", "do", "not", "believe", "that", "inflation", "has", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2011,", "2012", "or", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p9_s1", "idA": "1006281_13_item7_p7_s1", "sentA": "Currently, marketing authorization applications have been filed with ANVISA as well as in other countries.", "sentB": "In addition to those countries in which taliglucerase alfa has been approved, marketing authorization applications have been filed in other countries.", "type": 2, "words": ["<tag1>", "Currently,", "marketing", "authorization", "applications", "have", "been", "filed", "with", "ANVISA", "as", "well", "as", "in", "other", "countries.", "<tag2>", "In", "addition", "to", "those", "countries", "in", "which", "taliglucerase", "alfa", "has", "been", "approved,", "marketing", "authorization", "applications", "have", "been", "filed", "in", "other", "countries.", "<tag3>"], "wordsA": ["Currently,", "marketing", "authorization", "applications", "have", "been", "filed", "with", "ANVISA", "as", "well", "as", "in", "other", "countries."], "wordsB": ["In", "addition", "to", "those", "countries", "in", "which", "taliglucerase", "alfa", "has", "been", "approved,", "marketing", "authorization", "applications", "have", "been", "filed", "in", "other", "countries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p8_s4", "idA": "1006281_13_item7_p7_s3", "sentA": "This decision is an endorsement of the CHMP s June 2012 opinion recommending against the marketing authorization of taliglucerase alfa.", "sentB": "Under the agreement, Fiocruz has committed to purchase at least approximately $40 million worth of taliglucerase alfa during the first two years of the term.", "type": 2, "words": ["<tag1>", "This", "decision", "is", "an", "endorsement", "of", "the", "CHMP", "s", "June", "2012", "opinion", "recommending", "against", "the", "marketing", "authorization", "of", "taliglucerase", "alfa.", "<tag2>", "Under", "the", "agreement,", "Fiocruz", "has", "committed", "to", "purchase", "at", "least", "approximately", "$40", "million", "worth", "of", "taliglucerase", "alfa", "during", "the", "first", "two", "years", "of", "the", "term.", "<tag3>"], "wordsA": ["This", "decision", "is", "an", "endorsement", "of", "the", "CHMP", "s", "June", "2012", "opinion", "recommending", "against", "the", "marketing", "authorization", "of", "taliglucerase", "alfa."], "wordsB": ["Under", "the", "agreement,", "Fiocruz", "has", "committed", "to", "purchase", "at", "least", "approximately", "$40", "million", "worth", "of", "taliglucerase", "alfa", "during", "the", "first", "two", "years", "of", "the", "term."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p8_s6", "idA": "1006281_13_item7_p7_s3", "sentA": "This decision is an endorsement of the CHMP s June 2012 opinion recommending against the marketing authorization of taliglucerase alfa.", "sentB": "Additionally, we are not required to complete the final stage of the technology transfer until Fiocruz purchases at least approximately $280 million worth of taliglucerase alfa.", "type": 2, "words": ["<tag1>", "This", "decision", "is", "an", "endorsement", "of", "the", "CHMP", "s", "June", "2012", "opinion", "recommending", "against", "the", "marketing", "authorization", "of", "taliglucerase", "alfa.", "<tag2>", "Additionally,", "we", "are", "not", "required", "to", "complete", "the", "final", "stage", "of", "the", "technology", "transfer", "until", "Fiocruz", "purchases", "at", "least", "approximately", "$280", "million", "worth", "of", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["This", "decision", "is", "an", "endorsement", "of", "the", "CHMP", "s", "June", "2012", "opinion", "recommending", "against", "the", "marketing", "authorization", "of", "taliglucerase", "alfa."], "wordsB": ["Additionally,", "we", "are", "not", "required", "to", "complete", "the", "final", "stage", "of", "the", "technology", "transfer", "until", "Fiocruz", "purchases", "at", "least", "approximately", "$280", "million", "worth", "of", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p8_s5", "idA": "1006281_13_item7_p7_s5", "sentA": "It was not based on the safety and efficacy profile of taliglucerase alfa.", "sentB": "In subsequent years, Fiocruz is required to purchase at least approximately $40 million worth of taliglucerase alfa per year.", "type": 2, "words": ["<tag1>", "It", "was", "not", "based", "on", "the", "safety", "and", "efficacy", "profile", "of", "taliglucerase", "alfa.", "<tag2>", "In", "subsequent", "years,", "Fiocruz", "is", "required", "to", "purchase", "at", "least", "approximately", "$40", "million", "worth", "of", "taliglucerase", "alfa", "per", "year.", "<tag3>"], "wordsA": ["It", "was", "not", "based", "on", "the", "safety", "and", "efficacy", "profile", "of", "taliglucerase", "alfa."], "wordsB": ["In", "subsequent", "years,", "Fiocruz", "is", "required", "to", "purchase", "at", "least", "approximately", "$40", "million", "worth", "of", "taliglucerase", "alfa", "per", "year."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p74_s1", "idA": "1006281_13_item7_p80_s1", "sentA": "We do not believe currency fluctuations have had a material effect on our results of operations during the years ended December 31, 2010, 2011 or 2012.", "sentB": "We do not believe currency fluctuations have had a material effect on our results of operations during the years ended December 31, 2011, 2012 or 2013.", "type": 2, "words": ["<tag1>", "We", "do", "not", "believe", "currency", "fluctuations", "have", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2010,", "2011", "or", "2012.", "<tag2>", "We", "do", "not", "believe", "currency", "fluctuations", "have", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2011,", "2012", "or", "2013.", "<tag3>"], "wordsA": ["We", "do", "not", "believe", "currency", "fluctuations", "have", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2010,", "2011", "or", "2012."], "wordsB": ["We", "do", "not", "believe", "currency", "fluctuations", "have", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2011,", "2012", "or", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p75_s0", "idA": "1006281_13_item7_p81_s0", "sentA": "We have no off-balance sheet arrangements as of December 31, 2011 and 2012.", "sentB": "We have no off-balance sheet arrangements as of December 31, 2012 and 2013.", "type": 2, "words": ["<tag1>", "We", "have", "no", "off-balance", "sheet", "arrangements", "as", "of", "December", "31,", "2011", "and", "2012.", "<tag2>", "We", "have", "no", "off-balance", "sheet", "arrangements", "as", "of", "December", "31,", "2012", "and", "2013.", "<tag3>"], "wordsA": ["We", "have", "no", "off-balance", "sheet", "arrangements", "as", "of", "December", "31,", "2011", "and", "2012."], "wordsB": ["We", "have", "no", "off-balance", "sheet", "arrangements", "as", "of", "December", "31,", "2012", "and", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p76_s0", "idA": "1006281_13_item7_p82_s0", "sentA": "The following table summarizes our significant contractual obligations at December 31, 2012:", "sentB": "The following table summarizes our significant contractual obligations at December 31, 2013:", "type": 2, "words": ["<tag1>", "The", "following", "table", "summarizes", "our", "significant", "contractual", "obligations", "at", "December", "31,", "2012:", "<tag2>", "The", "following", "table", "summarizes", "our", "significant", "contractual", "obligations", "at", "December", "31,", "2013:", "<tag3>"], "wordsA": ["The", "following", "table", "summarizes", "our", "significant", "contractual", "obligations", "at", "December", "31,", "2012:"], "wordsB": ["The", "following", "table", "summarizes", "our", "significant", "contractual", "obligations", "at", "December", "31,", "2013:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p77_s0", "idA": "1006281_13_item7_p83_s0", "sentA": "(1) Represents open purchase orders issued to certain suppliers and other vendors mainly in connection with our research and development activities that were outstanding as of December 31, 2012.", "sentB": "(1) Represents open purchase orders issued to certain suppliers and other vendors mainly in connection with our research and development activities that were outstanding as of December 31, 2013.", "type": 2, "words": ["<tag1>", "(1)", "Represents", "open", "purchase", "orders", "issued", "to", "certain", "suppliers", "and", "other", "vendors", "mainly", "in", "connection", "with", "our", "research", "and", "development", "activities", "that", "were", "outstanding", "as", "of", "December", "31,", "2012.", "<tag2>", "(1)", "Represents", "open", "purchase", "orders", "issued", "to", "certain", "suppliers", "and", "other", "vendors", "mainly", "in", "connection", "with", "our", "research", "and", "development", "activities", "that", "were", "outstanding", "as", "of", "December", "31,", "2013.", "<tag3>"], "wordsA": ["(1)", "Represents", "open", "purchase", "orders", "issued", "to", "certain", "suppliers", "and", "other", "vendors", "mainly", "in", "connection", "with", "our", "research", "and", "development", "activities", "that", "were", "outstanding", "as", "of", "December", "31,", "2012."], "wordsB": ["(1)", "Represents", "open", "purchase", "orders", "issued", "to", "certain", "suppliers", "and", "other", "vendors", "mainly", "in", "connection", "with", "our", "research", "and", "development", "activities", "that", "were", "outstanding", "as", "of", "December", "31,", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p78_s1", "idA": "1006281_13_item7_p84_s1", "sentA": "If all of the contingencies with respect to milestone payments under our research and license agreements are met, the aggregate milestone payments payable would be approximately $950,000 and would be payable, if at all, as our projects progress over the course of a number of years.", "sentB": "If all of the contingencies with respect to milestone payments under our research and license agreements are met, the aggregate milestone payments payable would be approximately $0.3 million and would be payable, if at all, as our projects progress over the course of a number of years.", "type": 2, "words": ["<tag1>", "If", "all", "of", "the", "contingencies", "with", "respect", "to", "milestone", "payments", "under", "our", "research", "and", "license", "agreements", "are", "met,", "the", "aggregate", "milestone", "payments", "payable", "would", "be", "approximately", "$950,000", "and", "would", "be", "payable,", "if", "at", "all,", "as", "our", "projects", "progress", "over", "the", "course", "of", "a", "number", "of", "years.", "<tag2>", "If", "all", "of", "the", "contingencies", "with", "respect", "to", "milestone", "payments", "under", "our", "research", "and", "license", "agreements", "are", "met,", "the", "aggregate", "milestone", "payments", "payable", "would", "be", "approximately", "$0.3", "million", "and", "would", "be", "payable,", "if", "at", "all,", "as", "our", "projects", "progress", "over", "the", "course", "of", "a", "number", "of", "years.", "<tag3>"], "wordsA": ["If", "all", "of", "the", "contingencies", "with", "respect", "to", "milestone", "payments", "under", "our", "research", "and", "license", "agreements", "are", "met,", "the", "aggregate", "milestone", "payments", "payable", "would", "be", "approximately", "$950,000", "and", "would", "be", "payable,", "if", "at", "all,", "as", "our", "projects", "progress", "over", "the", "course", "of", "a", "number", "of", "years."], "wordsB": ["If", "all", "of", "the", "contingencies", "with", "respect", "to", "milestone", "payments", "under", "our", "research", "and", "license", "agreements", "are", "met,", "the", "aggregate", "milestone", "payments", "payable", "would", "be", "approximately", "$0.3", "million", "and", "would", "be", "payable,", "if", "at", "all,", "as", "our", "projects", "progress", "over", "the", "course", "of", "a", "number", "of", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p10_s1", "idA": "1006281_13_item7_p8_s1", "sentA": "We are currently sponsoring adult and pediatric extension studies of ELELYSO.", "sentB": "We are currently sponsoring extension studies of ELELYSO in adult and pediatric patients.", "type": 2, "words": ["<tag1>", "We", "are", "currently", "sponsoring", "adult", "and", "pediatric", "extension", "studies", "of", "ELELYSO.", "<tag2>", "We", "are", "currently", "sponsoring", "extension", "studies", "of", "ELELYSO", "in", "adult", "and", "pediatric", "patients.", "<tag3>"], "wordsA": ["We", "are", "currently", "sponsoring", "adult", "and", "pediatric", "extension", "studies", "of", "ELELYSO."], "wordsB": ["We", "are", "currently", "sponsoring", "extension", "studies", "of", "ELELYSO", "in", "adult", "and", "pediatric", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p10_s2", "idA": "1006281_13_item7_p8_s2", "sentA": "New clinical trials for ELELYSO will be conducted and sponsored by Pfizer.", "sentB": "New clinical trials for ELELYSO, if it is elected that any such clinical trial be performed, will be conducted and sponsored by Pfizer.", "type": 2, "words": ["<tag1>", "New", "clinical", "trials", "for", "ELELYSO", "will", "be", "conducted", "and", "sponsored", "by", "Pfizer.", "<tag2>", "New", "clinical", "trials", "for", "ELELYSO,", "if", "it", "is", "elected", "that", "any", "such", "clinical", "trial", "be", "performed,", "will", "be", "conducted", "and", "sponsored", "by", "Pfizer.", "<tag3>"], "wordsA": ["New", "clinical", "trials", "for", "ELELYSO", "will", "be", "conducted", "and", "sponsored", "by", "Pfizer."], "wordsB": ["New", "clinical", "trials", "for", "ELELYSO,", "if", "it", "is", "elected", "that", "any", "such", "clinical", "trial", "be", "performed,", "will", "be", "conducted", "and", "sponsored", "by", "Pfizer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p10_s3", "idA": "1006281_13_item7_p8_s3", "sentA": "Under the terms of the agreement, we were eligible to receive a milestone payment of $8.3 million upon the achievement of certain near-term clinical development milestones.", "sentB": "Under the terms of the agreement, we were eligible to receive a payment of $8.3 million upon the achievement of certain near-term clinical development goals.", "type": 2, "words": ["<tag1>", "Under", "the", "terms", "of", "the", "agreement,", "we", "were", "eligible", "to", "receive", "a", "milestone", "payment", "of", "$8.3", "million", "upon", "the", "achievement", "of", "certain", "near-term", "clinical", "development", "milestones.", "<tag2>", "Under", "the", "terms", "of", "the", "agreement,", "we", "were", "eligible", "to", "receive", "a", "payment", "of", "$8.3", "million", "upon", "the", "achievement", "of", "certain", "near-term", "clinical", "development", "goals.", "<tag3>"], "wordsA": ["Under", "the", "terms", "of", "the", "agreement,", "we", "were", "eligible", "to", "receive", "a", "milestone", "payment", "of", "$8.3", "million", "upon", "the", "achievement", "of", "certain", "near-term", "clinical", "development", "milestones."], "wordsB": ["Under", "the", "terms", "of", "the", "agreement,", "we", "were", "eligible", "to", "receive", "a", "payment", "of", "$8.3", "million", "upon", "the", "achievement", "of", "certain", "near-term", "clinical", "development", "goals."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_14_item7_p10_s4", "idA": "1006281_13_item7_p8_s4", "sentA": "The milestones were achieved prior to the end of fiscal year 2012 and have been paid in full.", "sentB": "The goals were achieved prior to the end of fiscal year 2012 and the $8.3 million payment has been paid in full.", "type": 2, "words": ["<tag1>", "The", "milestones", "were", "achieved", "prior", "to", "the", "end", "of", "fiscal", "year", "2012", "and", "have", "been", "paid", "in", "full.", "<tag2>", "The", "goals", "were", "achieved", "prior", "to", "the", "end", "of", "fiscal", "year", "2012", "and", "the", "$8.3", "million", "payment", "has", "been", "paid", "in", "full.", "<tag3>"], "wordsA": ["The", "milestones", "were", "achieved", "prior", "to", "the", "end", "of", "fiscal", "year", "2012", "and", "have", "been", "paid", "in", "full."], "wordsB": ["The", "goals", "were", "achieved", "prior", "to", "the", "end", "of", "fiscal", "year", "2012", "and", "the", "$8.3", "million", "payment", "has", "been", "paid", "in", "full."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p15_s1", "idA": "1006281_14_item7_p13_s3", "sentA": "In addition to the United States and France, taliglucerase alfa is currently being provided to Gaucher patients under special access agreements or named patient provisions in Brazil and in other countries.", "sentB": "In addition taliglucerase alfa is currently being provided to Gaucher patients under special access agreements or named patient provisions in certain countries.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "the", "United", "States", "and", "France,", "taliglucerase", "alfa", "is", "currently", "being", "provided", "to", "Gaucher", "patients", "under", "special", "access", "agreements", "or", "named", "patient", "provisions", "in", "Brazil", "and", "in", "other", "countries.", "<tag2>", "In", "addition", "taliglucerase", "alfa", "is", "currently", "being", "provided", "to", "Gaucher", "patients", "under", "special", "access", "agreements", "or", "named", "patient", "provisions", "in", "certain", "countries.", "<tag3>"], "wordsA": ["In", "addition", "to", "the", "United", "States", "and", "France,", "taliglucerase", "alfa", "is", "currently", "being", "provided", "to", "Gaucher", "patients", "under", "special", "access", "agreements", "or", "named", "patient", "provisions", "in", "Brazil", "and", "in", "other", "countries."], "wordsB": ["In", "addition", "taliglucerase", "alfa", "is", "currently", "being", "provided", "to", "Gaucher", "patients", "under", "special", "access", "agreements", "or", "named", "patient", "provisions", "in", "certain", "countries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p16_s1", "idA": "1006281_14_item7_p14_s1", "sentA": "Our product pipeline currently includes, among other candidates: PRX-102, a therapeutic protein candidate for the treatment of Fabry disease; PRX-112, an orally administered glucocerebrosidase enzyme for the treatment of Gaucher patients utilizing oral delivery of the recombinant GCD enzyme produced and encapsulated within carrot cells; PRX-106, an oral antiTNF, a plant cell expressed recombinant fusion protein combined of the binding domain of the human TNF receptor (TNFR) and an antibody portion, which is being developed for the treatment of certain immune and inflammatory diseases, such as rheumatoid arthritis, colitis, Crohn s disease, psoriasis and other autoimmune and inflammatory disorders; PRX-110, a proprietary plant cell recombinant human Deoxyribonuclease 1 under development for the treatment of cystic fibrosis, to be administered by inhalation; PRX-107, a proprietary plant cell recombinant AAT; and others.", "sentB": "Our product pipeline currently includes, among other candidates:", "type": 2, "words": ["<tag1>", "Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates:", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease;", "PRX-112,", "an", "orally", "administered", "glucocerebrosidase", "enzyme", "for", "the", "treatment", "of", "Gaucher", "patients", "utilizing", "oral", "delivery", "of", "the", "recombinant", "GCD", "enzyme", "produced", "and", "encapsulated", "within", "carrot", "cells;", "PRX-106,", "an", "oral", "antiTNF,", "a", "plant", "cell", "expressed", "recombinant", "fusion", "protein", "combined", "of", "the", "binding", "domain", "of", "the", "human", "TNF", "receptor", "(TNFR)", "and", "an", "antibody", "portion,", "which", "is", "being", "developed", "for", "the", "treatment", "of", "certain", "immune", "and", "inflammatory", "diseases,", "such", "as", "rheumatoid", "arthritis,", "colitis,", "Crohn", "s", "disease,", "psoriasis", "and", "other", "autoimmune", "and", "inflammatory", "disorders;", "PRX-110,", "a", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1", "under", "development", "for", "the", "treatment", "of", "cystic", "fibrosis,", "to", "be", "administered", "by", "inhalation;", "PRX-107,", "a", "proprietary", "plant", "cell", "recombinant", "AAT;", "and", "others.", "<tag2>", "Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates:", "<tag3>"], "wordsA": ["Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates:", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease;", "PRX-112,", "an", "orally", "administered", "glucocerebrosidase", "enzyme", "for", "the", "treatment", "of", "Gaucher", "patients", "utilizing", "oral", "delivery", "of", "the", "recombinant", "GCD", "enzyme", "produced", "and", "encapsulated", "within", "carrot", "cells;", "PRX-106,", "an", "oral", "antiTNF,", "a", "plant", "cell", "expressed", "recombinant", "fusion", "protein", "combined", "of", "the", "binding", "domain", "of", "the", "human", "TNF", "receptor", "(TNFR)", "and", "an", "antibody", "portion,", "which", "is", "being", "developed", "for", "the", "treatment", "of", "certain", "immune", "and", "inflammatory", "diseases,", "such", "as", "rheumatoid", "arthritis,", "colitis,", "Crohn", "s", "disease,", "psoriasis", "and", "other", "autoimmune", "and", "inflammatory", "disorders;", "PRX-110,", "a", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1", "under", "development", "for", "the", "treatment", "of", "cystic", "fibrosis,", "to", "be", "administered", "by", "inhalation;", "PRX-107,", "a", "proprietary", "plant", "cell", "recombinant", "AAT;", "and", "others."], "wordsB": ["Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p17_s0", "idA": "1006281_14_item7_p14_s1", "sentA": "Our product pipeline currently includes, among other candidates: PRX-102, a therapeutic protein candidate for the treatment of Fabry disease; PRX-112, an orally administered glucocerebrosidase enzyme for the treatment of Gaucher patients utilizing oral delivery of the recombinant GCD enzyme produced and encapsulated within carrot cells; PRX-106, an oral antiTNF, a plant cell expressed recombinant fusion protein combined of the binding domain of the human TNF receptor (TNFR) and an antibody portion, which is being developed for the treatment of certain immune and inflammatory diseases, such as rheumatoid arthritis, colitis, Crohn s disease, psoriasis and other autoimmune and inflammatory disorders; PRX-110, a proprietary plant cell recombinant human Deoxyribonuclease 1 under development for the treatment of cystic fibrosis, to be administered by inhalation; PRX-107, a proprietary plant cell recombinant AAT; and others.", "sentB": "(1) PRX-102, or alpha-GAL-A , a therapeutic protein candidate for the treatment of Fabry disease, a rare, genetic lysosomal disorder in humans, currently in an ongoing phase I/II clinical trial.", "type": 2, "words": ["<tag1>", "Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates:", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease;", "PRX-112,", "an", "orally", "administered", "glucocerebrosidase", "enzyme", "for", "the", "treatment", "of", "Gaucher", "patients", "utilizing", "oral", "delivery", "of", "the", "recombinant", "GCD", "enzyme", "produced", "and", "encapsulated", "within", "carrot", "cells;", "PRX-106,", "an", "oral", "antiTNF,", "a", "plant", "cell", "expressed", "recombinant", "fusion", "protein", "combined", "of", "the", "binding", "domain", "of", "the", "human", "TNF", "receptor", "(TNFR)", "and", "an", "antibody", "portion,", "which", "is", "being", "developed", "for", "the", "treatment", "of", "certain", "immune", "and", "inflammatory", "diseases,", "such", "as", "rheumatoid", "arthritis,", "colitis,", "Crohn", "s", "disease,", "psoriasis", "and", "other", "autoimmune", "and", "inflammatory", "disorders;", "PRX-110,", "a", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1", "under", "development", "for", "the", "treatment", "of", "cystic", "fibrosis,", "to", "be", "administered", "by", "inhalation;", "PRX-107,", "a", "proprietary", "plant", "cell", "recombinant", "AAT;", "and", "others.", "<tag2>", "(1)", "PRX-102,", "or", "alpha-GAL-A", ",", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans,", "currently", "in", "an", "ongoing", "phase", "I/II", "clinical", "trial.", "<tag3>"], "wordsA": ["Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates:", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease;", "PRX-112,", "an", "orally", "administered", "glucocerebrosidase", "enzyme", "for", "the", "treatment", "of", "Gaucher", "patients", "utilizing", "oral", "delivery", "of", "the", "recombinant", "GCD", "enzyme", "produced", "and", "encapsulated", "within", "carrot", "cells;", "PRX-106,", "an", "oral", "antiTNF,", "a", "plant", "cell", "expressed", "recombinant", "fusion", "protein", "combined", "of", "the", "binding", "domain", "of", "the", "human", "TNF", "receptor", "(TNFR)", "and", "an", "antibody", "portion,", "which", "is", "being", "developed", "for", "the", "treatment", "of", "certain", "immune", "and", "inflammatory", "diseases,", "such", "as", "rheumatoid", "arthritis,", "colitis,", "Crohn", "s", "disease,", "psoriasis", "and", "other", "autoimmune", "and", "inflammatory", "disorders;", "PRX-110,", "a", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1", "under", "development", "for", "the", "treatment", "of", "cystic", "fibrosis,", "to", "be", "administered", "by", "inhalation;", "PRX-107,", "a", "proprietary", "plant", "cell", "recombinant", "AAT;", "and", "others."], "wordsB": ["(1)", "PRX-102,", "or", "alpha-GAL-A", ",", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans,", "currently", "in", "an", "ongoing", "phase", "I/II", "clinical", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p19_s0", "idA": "1006281_14_item7_p14_s1", "sentA": "Our product pipeline currently includes, among other candidates: PRX-102, a therapeutic protein candidate for the treatment of Fabry disease; PRX-112, an orally administered glucocerebrosidase enzyme for the treatment of Gaucher patients utilizing oral delivery of the recombinant GCD enzyme produced and encapsulated within carrot cells; PRX-106, an oral antiTNF, a plant cell expressed recombinant fusion protein combined of the binding domain of the human TNF receptor (TNFR) and an antibody portion, which is being developed for the treatment of certain immune and inflammatory diseases, such as rheumatoid arthritis, colitis, Crohn s disease, psoriasis and other autoimmune and inflammatory disorders; PRX-110, a proprietary plant cell recombinant human Deoxyribonuclease 1 under development for the treatment of cystic fibrosis, to be administered by inhalation; PRX-107, a proprietary plant cell recombinant AAT; and others.", "sentB": "(3) PRX-110, a proprietary plant cell recombinant human DNase under development for the treatment of cystic fibrosis, to be administered by inhalation.", "type": 2, "words": ["<tag1>", "Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates:", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease;", "PRX-112,", "an", "orally", "administered", "glucocerebrosidase", "enzyme", "for", "the", "treatment", "of", "Gaucher", "patients", "utilizing", "oral", "delivery", "of", "the", "recombinant", "GCD", "enzyme", "produced", "and", "encapsulated", "within", "carrot", "cells;", "PRX-106,", "an", "oral", "antiTNF,", "a", "plant", "cell", "expressed", "recombinant", "fusion", "protein", "combined", "of", "the", "binding", "domain", "of", "the", "human", "TNF", "receptor", "(TNFR)", "and", "an", "antibody", "portion,", "which", "is", "being", "developed", "for", "the", "treatment", "of", "certain", "immune", "and", "inflammatory", "diseases,", "such", "as", "rheumatoid", "arthritis,", "colitis,", "Crohn", "s", "disease,", "psoriasis", "and", "other", "autoimmune", "and", "inflammatory", "disorders;", "PRX-110,", "a", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1", "under", "development", "for", "the", "treatment", "of", "cystic", "fibrosis,", "to", "be", "administered", "by", "inhalation;", "PRX-107,", "a", "proprietary", "plant", "cell", "recombinant", "AAT;", "and", "others.", "<tag2>", "(3)", "PRX-110,", "a", "proprietary", "plant", "cell", "recombinant", "human", "DNase", "under", "development", "for", "the", "treatment", "of", "cystic", "fibrosis,", "to", "be", "administered", "by", "inhalation.", "<tag3>"], "wordsA": ["Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates:", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease;", "PRX-112,", "an", "orally", "administered", "glucocerebrosidase", "enzyme", "for", "the", "treatment", "of", "Gaucher", "patients", "utilizing", "oral", "delivery", "of", "the", "recombinant", "GCD", "enzyme", "produced", "and", "encapsulated", "within", "carrot", "cells;", "PRX-106,", "an", "oral", "antiTNF,", "a", "plant", "cell", "expressed", "recombinant", "fusion", "protein", "combined", "of", "the", "binding", "domain", "of", "the", "human", "TNF", "receptor", "(TNFR)", "and", "an", "antibody", "portion,", "which", "is", "being", "developed", "for", "the", "treatment", "of", "certain", "immune", "and", "inflammatory", "diseases,", "such", "as", "rheumatoid", "arthritis,", "colitis,", "Crohn", "s", "disease,", "psoriasis", "and", "other", "autoimmune", "and", "inflammatory", "disorders;", "PRX-110,", "a", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1", "under", "development", "for", "the", "treatment", "of", "cystic", "fibrosis,", "to", "be", "administered", "by", "inhalation;", "PRX-107,", "a", "proprietary", "plant", "cell", "recombinant", "AAT;", "and", "others."], "wordsB": ["(3)", "PRX-110,", "a", "proprietary", "plant", "cell", "recombinant", "human", "DNase", "under", "development", "for", "the", "treatment", "of", "cystic", "fibrosis,", "to", "be", "administered", "by", "inhalation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p20_s0", "idA": "1006281_14_item7_p14_s1", "sentA": "Our product pipeline currently includes, among other candidates: PRX-102, a therapeutic protein candidate for the treatment of Fabry disease; PRX-112, an orally administered glucocerebrosidase enzyme for the treatment of Gaucher patients utilizing oral delivery of the recombinant GCD enzyme produced and encapsulated within carrot cells; PRX-106, an oral antiTNF, a plant cell expressed recombinant fusion protein combined of the binding domain of the human TNF receptor (TNFR) and an antibody portion, which is being developed for the treatment of certain immune and inflammatory diseases, such as rheumatoid arthritis, colitis, Crohn s disease, psoriasis and other autoimmune and inflammatory disorders; PRX-110, a proprietary plant cell recombinant human Deoxyribonuclease 1 under development for the treatment of cystic fibrosis, to be administered by inhalation; PRX-107, a proprietary plant cell recombinant AAT; and others.", "sentB": "(4) PRX-112, an orally administered glucocerebrosidase enzyme for the treatment of Gaucher patients utilizing oral delivery of the recombinant GCD enzyme produced and encapsulated within carrot cells.", "type": 2, "words": ["<tag1>", "Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates:", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease;", "PRX-112,", "an", "orally", "administered", "glucocerebrosidase", "enzyme", "for", "the", "treatment", "of", "Gaucher", "patients", "utilizing", "oral", "delivery", "of", "the", "recombinant", "GCD", "enzyme", "produced", "and", "encapsulated", "within", "carrot", "cells;", "PRX-106,", "an", "oral", "antiTNF,", "a", "plant", "cell", "expressed", "recombinant", "fusion", "protein", "combined", "of", "the", "binding", "domain", "of", "the", "human", "TNF", "receptor", "(TNFR)", "and", "an", "antibody", "portion,", "which", "is", "being", "developed", "for", "the", "treatment", "of", "certain", "immune", "and", "inflammatory", "diseases,", "such", "as", "rheumatoid", "arthritis,", "colitis,", "Crohn", "s", "disease,", "psoriasis", "and", "other", "autoimmune", "and", "inflammatory", "disorders;", "PRX-110,", "a", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1", "under", "development", "for", "the", "treatment", "of", "cystic", "fibrosis,", "to", "be", "administered", "by", "inhalation;", "PRX-107,", "a", "proprietary", "plant", "cell", "recombinant", "AAT;", "and", "others.", "<tag2>", "(4)", "PRX-112,", "an", "orally", "administered", "glucocerebrosidase", "enzyme", "for", "the", "treatment", "of", "Gaucher", "patients", "utilizing", "oral", "delivery", "of", "the", "recombinant", "GCD", "enzyme", "produced", "and", "encapsulated", "within", "carrot", "cells.", "<tag3>"], "wordsA": ["Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates:", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease;", "PRX-112,", "an", "orally", "administered", "glucocerebrosidase", "enzyme", "for", "the", "treatment", "of", "Gaucher", "patients", "utilizing", "oral", "delivery", "of", "the", "recombinant", "GCD", "enzyme", "produced", "and", "encapsulated", "within", "carrot", "cells;", "PRX-106,", "an", "oral", "antiTNF,", "a", "plant", "cell", "expressed", "recombinant", "fusion", "protein", "combined", "of", "the", "binding", "domain", "of", "the", "human", "TNF", "receptor", "(TNFR)", "and", "an", "antibody", "portion,", "which", "is", "being", "developed", "for", "the", "treatment", "of", "certain", "immune", "and", "inflammatory", "diseases,", "such", "as", "rheumatoid", "arthritis,", "colitis,", "Crohn", "s", "disease,", "psoriasis", "and", "other", "autoimmune", "and", "inflammatory", "disorders;", "PRX-110,", "a", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1", "under", "development", "for", "the", "treatment", "of", "cystic", "fibrosis,", "to", "be", "administered", "by", "inhalation;", "PRX-107,", "a", "proprietary", "plant", "cell", "recombinant", "AAT;", "and", "others."], "wordsB": ["(4)", "PRX-112,", "an", "orally", "administered", "glucocerebrosidase", "enzyme", "for", "the", "treatment", "of", "Gaucher", "patients", "utilizing", "oral", "delivery", "of", "the", "recombinant", "GCD", "enzyme", "produced", "and", "encapsulated", "within", "carrot", "cells."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p21_s1", "idA": "1006281_14_item7_p15_s1", "sentA": "We have built an internal marketing team designed to serve the Israeli market for taliglucerase alfa and we intend to establish internal commercialization and marketing teams for our other product candidates in North America, the European Union and in other significant markets, including Israel, subject to required marketing approvals, as the need arises.", "sentB": "We have built an internal marketing team designed to serve the Israeli and Brazilian market for taliglucerase alfa and we intend to establish internal commercialization and marketing teams for some of our other product candidates in certain regions, subject to required marketing approvals, as the need arises.", "type": 2, "words": ["<tag1>", "We", "have", "built", "an", "internal", "marketing", "team", "designed", "to", "serve", "the", "Israeli", "market", "for", "taliglucerase", "alfa", "and", "we", "intend", "to", "establish", "internal", "commercialization", "and", "marketing", "teams", "for", "our", "other", "product", "candidates", "in", "North", "America,", "the", "European", "Union", "and", "in", "other", "significant", "markets,", "including", "Israel,", "subject", "to", "required", "marketing", "approvals,", "as", "the", "need", "arises.", "<tag2>", "We", "have", "built", "an", "internal", "marketing", "team", "designed", "to", "serve", "the", "Israeli", "and", "Brazilian", "market", "for", "taliglucerase", "alfa", "and", "we", "intend", "to", "establish", "internal", "commercialization", "and", "marketing", "teams", "for", "some", "of", "our", "other", "product", "candidates", "in", "certain", "regions,", "subject", "to", "required", "marketing", "approvals,", "as", "the", "need", "arises.", "<tag3>"], "wordsA": ["We", "have", "built", "an", "internal", "marketing", "team", "designed", "to", "serve", "the", "Israeli", "market", "for", "taliglucerase", "alfa", "and", "we", "intend", "to", "establish", "internal", "commercialization", "and", "marketing", "teams", "for", "our", "other", "product", "candidates", "in", "North", "America,", "the", "European", "Union", "and", "in", "other", "significant", "markets,", "including", "Israel,", "subject", "to", "required", "marketing", "approvals,", "as", "the", "need", "arises."], "wordsB": ["We", "have", "built", "an", "internal", "marketing", "team", "designed", "to", "serve", "the", "Israeli", "and", "Brazilian", "market", "for", "taliglucerase", "alfa", "and", "we", "intend", "to", "establish", "internal", "commercialization", "and", "marketing", "teams", "for", "some", "of", "our", "other", "product", "candidates", "in", "certain", "regions,", "subject", "to", "required", "marketing", "approvals,", "as", "the", "need", "arises."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p82_s0", "idA": "1006281_14_item7_p16_s0", "sentA": "Our significant accounting policies are more fully described in Note 1 to our consolidated financial statements appearing at the end of this Annual Report on Form 10-K. We believe that the accounting policies below are critical for one to fully understand and evaluate our financial condition and results of operations.", "sentB": "Certain recently issued accounting pronouncements are discussed in Note 1(p) of the financial statements included in Item 8 of this Annual Report on Form 10-K.", "type": 2, "words": ["<tag1>", "Our", "significant", "accounting", "policies", "are", "more", "fully", "described", "in", "Note", "1", "to", "our", "consolidated", "financial", "statements", "appearing", "at", "the", "end", "of", "this", "Annual", "Report", "on", "Form", "10-K.", "We", "believe", "that", "the", "accounting", "policies", "below", "are", "critical", "for", "one", "to", "fully", "understand", "and", "evaluate", "our", "financial", "condition", "and", "results", "of", "operations.", "<tag2>", "Certain", "recently", "issued", "accounting", "pronouncements", "are", "discussed", "in", "Note", "1(p)", "of", "the", "financial", "statements", "included", "in", "Item", "8", "of", "this", "Annual", "Report", "on", "Form", "10-K.", "<tag3>"], "wordsA": ["Our", "significant", "accounting", "policies", "are", "more", "fully", "described", "in", "Note", "1", "to", "our", "consolidated", "financial", "statements", "appearing", "at", "the", "end", "of", "this", "Annual", "Report", "on", "Form", "10-K.", "We", "believe", "that", "the", "accounting", "policies", "below", "are", "critical", "for", "one", "to", "fully", "understand", "and", "evaluate", "our", "financial", "condition", "and", "results", "of", "operations."], "wordsB": ["Certain", "recently", "issued", "accounting", "pronouncements", "are", "discussed", "in", "Note", "1(p)", "of", "the", "financial", "statements", "included", "in", "Item", "8", "of", "this", "Annual", "Report", "on", "Form", "10-K."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p4_s1", "idA": "1006281_14_item7_p18_s0", "sentA": "The currency of the primary economic environment in which our operations are conducted is the U.S. dollar.", "sentB": "Prior to the U.S. pediatric approval, Elelyso was approved for pediatric indications in Australia and Canada but in no other jurisdiction.", "type": 2, "words": ["<tag1>", "The", "currency", "of", "the", "primary", "economic", "environment", "in", "which", "our", "operations", "are", "conducted", "is", "the", "U.S.", "dollar.", "<tag2>", "Prior", "to", "the", "U.S.", "pediatric", "approval,", "Elelyso", "was", "approved", "for", "pediatric", "indications", "in", "Australia", "and", "Canada", "but", "in", "no", "other", "jurisdiction.", "<tag3>"], "wordsA": ["The", "currency", "of", "the", "primary", "economic", "environment", "in", "which", "our", "operations", "are", "conducted", "is", "the", "U.S.", "dollar."], "wordsB": ["Prior", "to", "the", "U.S.", "pediatric", "approval,", "Elelyso", "was", "approved", "for", "pediatric", "indications", "in", "Australia", "and", "Canada", "but", "in", "no", "other", "jurisdiction."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p1_s1", "idA": "1006281_14_item7_p1_s1", "sentA": "Using our ProCellEx system, we are developing a pipeline of proprietary, biobetter and biosimilar versions of recombinant therapeutic proteins, based on our plant cell-based expression technology, that primarily target large, established pharmaceutical markets and that rely upon known biological mechanisms of action.", "sentB": "Using our ProCellEx system, we are developing a pipeline of proprietary, clinically superior versions of recombinant therapeutic proteins that primarily target large, established pharmaceutical markets and that rely upon known biological mechanisms of action.", "type": 2, "words": ["<tag1>", "Using", "our", "ProCellEx", "system,", "we", "are", "developing", "a", "pipeline", "of", "proprietary,", "biobetter", "and", "biosimilar", "versions", "of", "recombinant", "therapeutic", "proteins,", "based", "on", "our", "plant", "cell-based", "expression", "technology,", "that", "primarily", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "rely", "upon", "known", "biological", "mechanisms", "of", "action.", "<tag2>", "Using", "our", "ProCellEx", "system,", "we", "are", "developing", "a", "pipeline", "of", "proprietary,", "clinically", "superior", "versions", "of", "recombinant", "therapeutic", "proteins", "that", "primarily", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "rely", "upon", "known", "biological", "mechanisms", "of", "action.", "<tag3>"], "wordsA": ["Using", "our", "ProCellEx", "system,", "we", "are", "developing", "a", "pipeline", "of", "proprietary,", "biobetter", "and", "biosimilar", "versions", "of", "recombinant", "therapeutic", "proteins,", "based", "on", "our", "plant", "cell-based", "expression", "technology,", "that", "primarily", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "rely", "upon", "known", "biological", "mechanisms", "of", "action."], "wordsB": ["Using", "our", "ProCellEx", "system,", "we", "are", "developing", "a", "pipeline", "of", "proprietary,", "clinically", "superior", "versions", "of", "recombinant", "therapeutic", "proteins", "that", "primarily", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "rely", "upon", "known", "biological", "mechanisms", "of", "action."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p27_s0", "idA": "1006281_14_item7_p21_s0", "sentA": "Under the terms and conditions of the Pfizer Agreement, we are entitled to 40% of the net profits or loss from sales of taliglucerase alfa by Pfizer and reimbursement of our certain related expenses we incur in connection with Pfizer s sales (other than those related to sales in Israel).", "sentB": "Under the terms and conditions of the Pfizer Agreement, we are entitled to 40% of the net profits or loss from sales of taliglucerase alfa by Pfizer and reimbursement of our certain related expenses we incur in connection with Pfizer s sales (other than those related to sales in Israel and Brazil).", "type": 2, "words": ["<tag1>", "Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement,", "we", "are", "entitled", "to", "40%", "of", "the", "net", "profits", "or", "loss", "from", "sales", "of", "taliglucerase", "alfa", "by", "Pfizer", "and", "reimbursement", "of", "our", "certain", "related", "expenses", "we", "incur", "in", "connection", "with", "Pfizer", "s", "sales", "(other", "than", "those", "related", "to", "sales", "in", "Israel).", "<tag2>", "Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement,", "we", "are", "entitled", "to", "40%", "of", "the", "net", "profits", "or", "loss", "from", "sales", "of", "taliglucerase", "alfa", "by", "Pfizer", "and", "reimbursement", "of", "our", "certain", "related", "expenses", "we", "incur", "in", "connection", "with", "Pfizer", "s", "sales", "(other", "than", "those", "related", "to", "sales", "in", "Israel", "and", "Brazil).", "<tag3>"], "wordsA": ["Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement,", "we", "are", "entitled", "to", "40%", "of", "the", "net", "profits", "or", "loss", "from", "sales", "of", "taliglucerase", "alfa", "by", "Pfizer", "and", "reimbursement", "of", "our", "certain", "related", "expenses", "we", "incur", "in", "connection", "with", "Pfizer", "s", "sales", "(other", "than", "those", "related", "to", "sales", "in", "Israel)."], "wordsB": ["Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement,", "we", "are", "entitled", "to", "40%", "of", "the", "net", "profits", "or", "loss", "from", "sales", "of", "taliglucerase", "alfa", "by", "Pfizer", "and", "reimbursement", "of", "our", "certain", "related", "expenses", "we", "incur", "in", "connection", "with", "Pfizer", "s", "sales", "(other", "than", "those", "related", "to", "sales", "in", "Israel", "and", "Brazil)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p12_s0", "idA": "1006281_14_item7_p21_s1", "sentA": "We hold all rights to taliglucerase alfa in Israel and Brazil.", "sentB": "To facilitate the arrangement with Fiocruz, we and Pfizer agreed to an amendment of our exclusive license and supply agreement, which amendment provides for the transfer of the commercialization and other rights to taliglucerase alfa in Brazil back to us.", "type": 2, "words": ["<tag1>", "We", "hold", "all", "rights", "to", "taliglucerase", "alfa", "in", "Israel", "and", "Brazil.", "<tag2>", "To", "facilitate", "the", "arrangement", "with", "Fiocruz,", "we", "and", "Pfizer", "agreed", "to", "an", "amendment", "of", "our", "exclusive", "license", "and", "supply", "agreement,", "which", "amendment", "provides", "for", "the", "transfer", "of", "the", "commercialization", "and", "other", "rights", "to", "taliglucerase", "alfa", "in", "Brazil", "back", "to", "us.", "<tag3>"], "wordsA": ["We", "hold", "all", "rights", "to", "taliglucerase", "alfa", "in", "Israel", "and", "Brazil."], "wordsB": ["To", "facilitate", "the", "arrangement", "with", "Fiocruz,", "we", "and", "Pfizer", "agreed", "to", "an", "amendment", "of", "our", "exclusive", "license", "and", "supply", "agreement,", "which", "amendment", "provides", "for", "the", "transfer", "of", "the", "commercialization", "and", "other", "rights", "to", "taliglucerase", "alfa", "in", "Brazil", "back", "to", "us."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p13_s1", "idA": "1006281_14_item7_p23_s1", "sentA": "The revenues represent our cost with respect to the product sold.", "sentB": "The agency agreement will remain in effect with respect to the Brazil Agreement until the termination thereof.", "type": 2, "words": ["<tag1>", "The", "revenues", "represent", "our", "cost", "with", "respect", "to", "the", "product", "sold.", "<tag2>", "The", "agency", "agreement", "will", "remain", "in", "effect", "with", "respect", "to", "the", "Brazil", "Agreement", "until", "the", "termination", "thereof.", "<tag3>"], "wordsA": ["The", "revenues", "represent", "our", "cost", "with", "respect", "to", "the", "product", "sold."], "wordsB": ["The", "agency", "agreement", "will", "remain", "in", "effect", "with", "respect", "to", "the", "Brazil", "Agreement", "until", "the", "termination", "thereof."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p34_s0", "idA": "1006281_14_item7_p28_s0", "sentA": "We anticipate incurring increasing costs in connection with our PRX-102 and oral glucocerebrosidase projects which will be partially off set by the decrease in costs incurred due to the continued winding down of our taliglucerase alfa clinical trials during 2014.", "sentB": "We anticipate incurring increasing costs in connection with the continued development of all four of the product candidates in our pipeline.", "type": 2, "words": ["<tag1>", "We", "anticipate", "incurring", "increasing", "costs", "in", "connection", "with", "our", "PRX-102", "and", "oral", "glucocerebrosidase", "projects", "which", "will", "be", "partially", "off", "set", "by", "the", "decrease", "in", "costs", "incurred", "due", "to", "the", "continued", "winding", "down", "of", "our", "taliglucerase", "alfa", "clinical", "trials", "during", "2014.", "<tag2>", "We", "anticipate", "incurring", "increasing", "costs", "in", "connection", "with", "the", "continued", "development", "of", "all", "four", "of", "the", "product", "candidates", "in", "our", "pipeline.", "<tag3>"], "wordsA": ["We", "anticipate", "incurring", "increasing", "costs", "in", "connection", "with", "our", "PRX-102", "and", "oral", "glucocerebrosidase", "projects", "which", "will", "be", "partially", "off", "set", "by", "the", "decrease", "in", "costs", "incurred", "due", "to", "the", "continued", "winding", "down", "of", "our", "taliglucerase", "alfa", "clinical", "trials", "during", "2014."], "wordsB": ["We", "anticipate", "incurring", "increasing", "costs", "in", "connection", "with", "the", "continued", "development", "of", "all", "four", "of", "the", "product", "candidates", "in", "our", "pipeline."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p1_s3", "idA": "1006281_14_item7_p2_s1", "sentA": "We believe ProCellEx will enable us to develop proprietary recombinant proteins that are therapeutically equivalent or superior to existing recombinant proteins currently marketed for the same indications.", "sentB": "With our experience, and having successfully developed Elelyso, our first drug product, we believe ProCellEx will enable us to develop additional proprietary recombinant proteins that are therapeutically superior to existing recombinant proteins currently marketed for the same indications.", "type": 2, "words": ["<tag1>", "We", "believe", "ProCellEx", "will", "enable", "us", "to", "develop", "proprietary", "recombinant", "proteins", "that", "are", "therapeutically", "equivalent", "or", "superior", "to", "existing", "recombinant", "proteins", "currently", "marketed", "for", "the", "same", "indications.", "<tag2>", "With", "our", "experience,", "and", "having", "successfully", "developed", "Elelyso,", "our", "first", "drug", "product,", "we", "believe", "ProCellEx", "will", "enable", "us", "to", "develop", "additional", "proprietary", "recombinant", "proteins", "that", "are", "therapeutically", "superior", "to", "existing", "recombinant", "proteins", "currently", "marketed", "for", "the", "same", "indications.", "<tag3>"], "wordsA": ["We", "believe", "ProCellEx", "will", "enable", "us", "to", "develop", "proprietary", "recombinant", "proteins", "that", "are", "therapeutically", "equivalent", "or", "superior", "to", "existing", "recombinant", "proteins", "currently", "marketed", "for", "the", "same", "indications."], "wordsB": ["With", "our", "experience,", "and", "having", "successfully", "developed", "Elelyso,", "our", "first", "drug", "product,", "we", "believe", "ProCellEx", "will", "enable", "us", "to", "develop", "additional", "proprietary", "recombinant", "proteins", "that", "are", "therapeutically", "superior", "to", "existing", "recombinant", "proteins", "currently", "marketed", "for", "the", "same", "indications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p1_s4", "idA": "1006281_14_item7_p2_s2", "sentA": "Because we are primarily targeting biologically equivalent versions of highly active, well-tolerated and commercially successful therapeutic proteins, we believe our development process is associated with relatively less risk compared to other biopharmaceutical development processes for completely novel therapeutic proteins.", "sentB": "Because we are primarily targeting biologically superior versions of highly active, well-tolerated and commercially successful therapeutic proteins, we believe our development process is associated with relatively less risk compared to other biopharmaceutical development processes for completely novel therapeutic proteins.", "type": 2, "words": ["<tag1>", "Because", "we", "are", "primarily", "targeting", "biologically", "equivalent", "versions", "of", "highly", "active,", "well-tolerated", "and", "commercially", "successful", "therapeutic", "proteins,", "we", "believe", "our", "development", "process", "is", "associated", "with", "relatively", "less", "risk", "compared", "to", "other", "biopharmaceutical", "development", "processes", "for", "completely", "novel", "therapeutic", "proteins.", "<tag2>", "Because", "we", "are", "primarily", "targeting", "biologically", "superior", "versions", "of", "highly", "active,", "well-tolerated", "and", "commercially", "successful", "therapeutic", "proteins,", "we", "believe", "our", "development", "process", "is", "associated", "with", "relatively", "less", "risk", "compared", "to", "other", "biopharmaceutical", "development", "processes", "for", "completely", "novel", "therapeutic", "proteins.", "<tag3>"], "wordsA": ["Because", "we", "are", "primarily", "targeting", "biologically", "equivalent", "versions", "of", "highly", "active,", "well-tolerated", "and", "commercially", "successful", "therapeutic", "proteins,", "we", "believe", "our", "development", "process", "is", "associated", "with", "relatively", "less", "risk", "compared", "to", "other", "biopharmaceutical", "development", "processes", "for", "completely", "novel", "therapeutic", "proteins."], "wordsB": ["Because", "we", "are", "primarily", "targeting", "biologically", "superior", "versions", "of", "highly", "active,", "well-tolerated", "and", "commercially", "successful", "therapeutic", "proteins,", "we", "believe", "our", "development", "process", "is", "associated", "with", "relatively", "less", "risk", "compared", "to", "other", "biopharmaceutical", "development", "processes", "for", "completely", "novel", "therapeutic", "proteins."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p1_s5", "idA": "1006281_14_item7_p2_s3", "sentA": "We are now also applying the unique properties of our ProCellEx system for the oral delivery of therapeutic proteins, with the first two product candidates being glucocerebrosidase and antiTNF fusion protein.", "sentB": "We are now also applying the unique properties of our ProCellEx system for the oral delivery of therapeutic proteins.", "type": 2, "words": ["<tag1>", "We", "are", "now", "also", "applying", "the", "unique", "properties", "of", "our", "ProCellEx", "system", "for", "the", "oral", "delivery", "of", "therapeutic", "proteins,", "with", "the", "first", "two", "product", "candidates", "being", "glucocerebrosidase", "and", "antiTNF", "fusion", "protein.", "<tag2>", "We", "are", "now", "also", "applying", "the", "unique", "properties", "of", "our", "ProCellEx", "system", "for", "the", "oral", "delivery", "of", "therapeutic", "proteins.", "<tag3>"], "wordsA": ["We", "are", "now", "also", "applying", "the", "unique", "properties", "of", "our", "ProCellEx", "system", "for", "the", "oral", "delivery", "of", "therapeutic", "proteins,", "with", "the", "first", "two", "product", "candidates", "being", "glucocerebrosidase", "and", "antiTNF", "fusion", "protein."], "wordsB": ["We", "are", "now", "also", "applying", "the", "unique", "properties", "of", "our", "ProCellEx", "system", "for", "the", "oral", "delivery", "of", "therapeutic", "proteins."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p39_s0", "idA": "1006281_14_item7_p33_s0", "sentA": "We expect our research and development expenses to continue to be our primary expense in the future as we continue the advancement of our clinical trials and preclinical product development programs for our product candidates other than taliglucerase alfa.", "sentB": "We expect our research and development expenses to continue to be our primary expense in the future as we continue the advancement of our clinical trials and preclinical product development programs for our product candidates.", "type": 2, "words": ["<tag1>", "We", "expect", "our", "research", "and", "development", "expenses", "to", "continue", "to", "be", "our", "primary", "expense", "in", "the", "future", "as", "we", "continue", "the", "advancement", "of", "our", "clinical", "trials", "and", "preclinical", "product", "development", "programs", "for", "our", "product", "candidates", "other", "than", "taliglucerase", "alfa.", "<tag2>", "We", "expect", "our", "research", "and", "development", "expenses", "to", "continue", "to", "be", "our", "primary", "expense", "in", "the", "future", "as", "we", "continue", "the", "advancement", "of", "our", "clinical", "trials", "and", "preclinical", "product", "development", "programs", "for", "our", "product", "candidates.", "<tag3>"], "wordsA": ["We", "expect", "our", "research", "and", "development", "expenses", "to", "continue", "to", "be", "our", "primary", "expense", "in", "the", "future", "as", "we", "continue", "the", "advancement", "of", "our", "clinical", "trials", "and", "preclinical", "product", "development", "programs", "for", "our", "product", "candidates", "other", "than", "taliglucerase", "alfa."], "wordsB": ["We", "expect", "our", "research", "and", "development", "expenses", "to", "continue", "to", "be", "our", "primary", "expense", "in", "the", "future", "as", "we", "continue", "the", "advancement", "of", "our", "clinical", "trials", "and", "preclinical", "product", "development", "programs", "for", "our", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p42_s0", "idA": "1006281_14_item7_p36_s0", "sentA": "The discussion below regarding share-based compensation relates to share-based compensation paid by Protalix Ltd., our wholly-owned subsidiary.", "sentB": "The discussion below regarding share-based compensation relates to our share-based compensation.", "type": 2, "words": ["<tag1>", "The", "discussion", "below", "regarding", "share-based", "compensation", "relates", "to", "share-based", "compensation", "paid", "by", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary.", "<tag2>", "The", "discussion", "below", "regarding", "share-based", "compensation", "relates", "to", "our", "share-based", "compensation.", "<tag3>"], "wordsA": ["The", "discussion", "below", "regarding", "share-based", "compensation", "relates", "to", "share-based", "compensation", "paid", "by", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary."], "wordsB": ["The", "discussion", "below", "regarding", "share-based", "compensation", "relates", "to", "our", "share-based", "compensation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p18_s0", "idA": "1006281_14_item7_p3_s0", "sentA": "On May 1, 2012, the FDA approved for sale our first commercial product, taliglucerase alfa for injection, which is being marketed in the United States and Israel under the brand name ELELYSO, as an enzyme replacement therapy, or ERT, for the long-term treatment of adult patients with a confirmed diagnosis of type 1 Gaucher disease.", "sentB": "(2) PRX-106, our oral antiTNF product candidate which is being developed as an orally-delivered anti inflammatory treatment for various inflammatory diseases using plant cells as a natural capsule for the expressed protein.", "type": 2, "words": ["<tag1>", "On", "May", "1,", "2012,", "the", "FDA", "approved", "for", "sale", "our", "first", "commercial", "product,", "taliglucerase", "alfa", "for", "injection,", "which", "is", "being", "marketed", "in", "the", "United", "States", "and", "Israel", "under", "the", "brand", "name", "ELELYSO,", "as", "an", "enzyme", "replacement", "therapy,", "or", "ERT,", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease.", "<tag2>", "(2)", "PRX-106,", "our", "oral", "antiTNF", "product", "candidate", "which", "is", "being", "developed", "as", "an", "orally-delivered", "anti", "inflammatory", "treatment", "for", "various", "inflammatory", "diseases", "using", "plant", "cells", "as", "a", "natural", "capsule", "for", "the", "expressed", "protein.", "<tag3>"], "wordsA": ["On", "May", "1,", "2012,", "the", "FDA", "approved", "for", "sale", "our", "first", "commercial", "product,", "taliglucerase", "alfa", "for", "injection,", "which", "is", "being", "marketed", "in", "the", "United", "States", "and", "Israel", "under", "the", "brand", "name", "ELELYSO,", "as", "an", "enzyme", "replacement", "therapy,", "or", "ERT,", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease."], "wordsB": ["(2)", "PRX-106,", "our", "oral", "antiTNF", "product", "candidate", "which", "is", "being", "developed", "as", "an", "orally-delivered", "anti", "inflammatory", "treatment", "for", "various", "inflammatory", "diseases", "using", "plant", "cells", "as", "a", "natural", "capsule", "for", "the", "expressed", "protein."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p2_s0", "idA": "1006281_14_item7_p3_s0", "sentA": "On May 1, 2012, the FDA approved for sale our first commercial product, taliglucerase alfa for injection, which is being marketed in the United States and Israel under the brand name ELELYSO, as an enzyme replacement therapy, or ERT, for the long-term treatment of adult patients with a confirmed diagnosis of type 1 Gaucher disease.", "sentB": "On May 1, 2012, the U.S. Food and Drug Administration, or the FDA, approved for sale our first commercial product, taliglucerase alfa for injection, which is being marketed in the United States and Israel under the brand name Elelyso, as an enzyme replacement therapy, or ERT, for the long-term treatment of adult patients with a confirmed diagnosis of type 1 Gaucher disease.", "type": 2, "words": ["<tag1>", "On", "May", "1,", "2012,", "the", "FDA", "approved", "for", "sale", "our", "first", "commercial", "product,", "taliglucerase", "alfa", "for", "injection,", "which", "is", "being", "marketed", "in", "the", "United", "States", "and", "Israel", "under", "the", "brand", "name", "ELELYSO,", "as", "an", "enzyme", "replacement", "therapy,", "or", "ERT,", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease.", "<tag2>", "On", "May", "1,", "2012,", "the", "U.S.", "Food", "and", "Drug", "Administration,", "or", "the", "FDA,", "approved", "for", "sale", "our", "first", "commercial", "product,", "taliglucerase", "alfa", "for", "injection,", "which", "is", "being", "marketed", "in", "the", "United", "States", "and", "Israel", "under", "the", "brand", "name", "Elelyso,", "as", "an", "enzyme", "replacement", "therapy,", "or", "ERT,", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease.", "<tag3>"], "wordsA": ["On", "May", "1,", "2012,", "the", "FDA", "approved", "for", "sale", "our", "first", "commercial", "product,", "taliglucerase", "alfa", "for", "injection,", "which", "is", "being", "marketed", "in", "the", "United", "States", "and", "Israel", "under", "the", "brand", "name", "ELELYSO,", "as", "an", "enzyme", "replacement", "therapy,", "or", "ERT,", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease."], "wordsB": ["On", "May", "1,", "2012,", "the", "U.S.", "Food", "and", "Drug", "Administration,", "or", "the", "FDA,", "approved", "for", "sale", "our", "first", "commercial", "product,", "taliglucerase", "alfa", "for", "injection,", "which", "is", "being", "marketed", "in", "the", "United", "States", "and", "Israel", "under", "the", "brand", "name", "Elelyso,", "as", "an", "enzyme", "replacement", "therapy,", "or", "ERT,", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p5_s0", "idA": "1006281_14_item7_p3_s0", "sentA": "On May 1, 2012, the FDA approved for sale our first commercial product, taliglucerase alfa for injection, which is being marketed in the United States and Israel under the brand name ELELYSO, as an enzyme replacement therapy, or ERT, for the long-term treatment of adult patients with a confirmed diagnosis of type 1 Gaucher disease.", "sentB": "In September 2014, CONITEC announced that it had decided to give a positive funding recommendation for Uplyso in the treatment of adult patients with types 1 and 3 Gaucher disease, and established that Uplyso will be the first choice for treatment for new adult Gaucher patients in Brazil.", "type": 2, "words": ["<tag1>", "On", "May", "1,", "2012,", "the", "FDA", "approved", "for", "sale", "our", "first", "commercial", "product,", "taliglucerase", "alfa", "for", "injection,", "which", "is", "being", "marketed", "in", "the", "United", "States", "and", "Israel", "under", "the", "brand", "name", "ELELYSO,", "as", "an", "enzyme", "replacement", "therapy,", "or", "ERT,", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease.", "<tag2>", "In", "September", "2014,", "CONITEC", "announced", "that", "it", "had", "decided", "to", "give", "a", "positive", "funding", "recommendation", "for", "Uplyso", "in", "the", "treatment", "of", "adult", "patients", "with", "types", "1", "and", "3", "Gaucher", "disease,", "and", "established", "that", "Uplyso", "will", "be", "the", "first", "choice", "for", "treatment", "for", "new", "adult", "Gaucher", "patients", "in", "Brazil.", "<tag3>"], "wordsA": ["On", "May", "1,", "2012,", "the", "FDA", "approved", "for", "sale", "our", "first", "commercial", "product,", "taliglucerase", "alfa", "for", "injection,", "which", "is", "being", "marketed", "in", "the", "United", "States", "and", "Israel", "under", "the", "brand", "name", "ELELYSO,", "as", "an", "enzyme", "replacement", "therapy,", "or", "ERT,", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease."], "wordsB": ["In", "September", "2014,", "CONITEC", "announced", "that", "it", "had", "decided", "to", "give", "a", "positive", "funding", "recommendation", "for", "Uplyso", "in", "the", "treatment", "of", "adult", "patients", "with", "types", "1", "and", "3", "Gaucher", "disease,", "and", "established", "that", "Uplyso", "will", "be", "the", "first", "choice", "for", "treatment", "for", "new", "adult", "Gaucher", "patients", "in", "Brazil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p2_s1", "idA": "1006281_14_item7_p3_s1", "sentA": "Subsequently, taliglucerase alfa was approved by ANVISA in March 2013, by the Israeli MOH in September 2012, and by the applicable regulatory authorities in Uruguay, Mexico and Chile.", "sentB": "Subsequently, taliglucerase alfa was approved by ANVISA in March 2013, by the Israeli MOH in September 2012 and by other regulatory agencies in other countries.", "type": 2, "words": ["<tag1>", "Subsequently,", "taliglucerase", "alfa", "was", "approved", "by", "ANVISA", "in", "March", "2013,", "by", "the", "Israeli", "MOH", "in", "September", "2012,", "and", "by", "the", "applicable", "regulatory", "authorities", "in", "Uruguay,", "Mexico", "and", "Chile.", "<tag2>", "Subsequently,", "taliglucerase", "alfa", "was", "approved", "by", "ANVISA", "in", "March", "2013,", "by", "the", "Israeli", "MOH", "in", "September", "2012", "and", "by", "other", "regulatory", "agencies", "in", "other", "countries.", "<tag3>"], "wordsA": ["Subsequently,", "taliglucerase", "alfa", "was", "approved", "by", "ANVISA", "in", "March", "2013,", "by", "the", "Israeli", "MOH", "in", "September", "2012,", "and", "by", "the", "applicable", "regulatory", "authorities", "in", "Uruguay,", "Mexico", "and", "Chile."], "wordsB": ["Subsequently,", "taliglucerase", "alfa", "was", "approved", "by", "ANVISA", "in", "March", "2013,", "by", "the", "Israeli", "MOH", "in", "September", "2012", "and", "by", "other", "regulatory", "agencies", "in", "other", "countries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p11_s3", "idA": "1006281_14_item7_p3_s2", "sentA": "Taliglucerase alfa will be marketed under the name UPLYSO in Brazil and certain other Latin American countries.", "sentB": "During such period, Fiocruz will be the sole provider of this important treatment option for Gaucher patients in Brazil and shall pay us a single-digit royalty on net sales.", "type": 2, "words": ["<tag1>", "Taliglucerase", "alfa", "will", "be", "marketed", "under", "the", "name", "UPLYSO", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries.", "<tag2>", "During", "such", "period,", "Fiocruz", "will", "be", "the", "sole", "provider", "of", "this", "important", "treatment", "option", "for", "Gaucher", "patients", "in", "Brazil", "and", "shall", "pay", "us", "a", "single-digit", "royalty", "on", "net", "sales.", "<tag3>"], "wordsA": ["Taliglucerase", "alfa", "will", "be", "marketed", "under", "the", "name", "UPLYSO", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries."], "wordsB": ["During", "such", "period,", "Fiocruz", "will", "be", "the", "sole", "provider", "of", "this", "important", "treatment", "option", "for", "Gaucher", "patients", "in", "Brazil", "and", "shall", "pay", "us", "a", "single-digit", "royalty", "on", "net", "sales."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p3_s0", "idA": "1006281_14_item7_p3_s2", "sentA": "Taliglucerase alfa will be marketed under the name UPLYSO in Brazil and certain other Latin American countries.", "sentB": "Taliglucerase alfa is being marketed under the name Uplyso in Brazil and certain other Latin American countries.", "type": 2, "words": ["<tag1>", "Taliglucerase", "alfa", "will", "be", "marketed", "under", "the", "name", "UPLYSO", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries.", "<tag2>", "Taliglucerase", "alfa", "is", "being", "marketed", "under", "the", "name", "Uplyso", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries.", "<tag3>"], "wordsA": ["Taliglucerase", "alfa", "will", "be", "marketed", "under", "the", "name", "UPLYSO", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries."], "wordsB": ["Taliglucerase", "alfa", "is", "being", "marketed", "under", "the", "name", "Uplyso", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p52_s1", "idA": "1006281_14_item7_p46_s2", "sentA": "The revenues for the year ended December 31, 2013 include $5.0 million from products we sold in Israel.", "sentB": "Revenues for the year ended December 31, 2014 include $5.2 million of products sold in Israel and $3.5 million in Brazil.", "type": 2, "words": ["<tag1>", "The", "revenues", "for", "the", "year", "ended", "December", "31,", "2013", "include", "$5.0", "million", "from", "products", "we", "sold", "in", "Israel.", "<tag2>", "Revenues", "for", "the", "year", "ended", "December", "31,", "2014", "include", "$5.2", "million", "of", "products", "sold", "in", "Israel", "and", "$3.5", "million", "in", "Brazil.", "<tag3>"], "wordsA": ["The", "revenues", "for", "the", "year", "ended", "December", "31,", "2013", "include", "$5.0", "million", "from", "products", "we", "sold", "in", "Israel."], "wordsB": ["Revenues", "for", "the", "year", "ended", "December", "31,", "2014", "include", "$5.2", "million", "of", "products", "sold", "in", "Israel", "and", "$3.5", "million", "in", "Brazil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p53_s0", "idA": "1006281_14_item7_p47_s0", "sentA": "We recorded revenue of $1.0 million as our share of net income in the collaboration under the Pfizer Agreement during the year ended December 31, 2013, compared to the $446,000 of loss recorded for the year ended December 31, 2012.", "sentB": "We recorded revenue of $1.5 million as our share of net income in the collaboration under the Pfizer Agreement during the year ended December 31, 2014, an increase of approximately $475,000, or 46%, compared to revenue of $1.0 million recorded for the year ended December 31, 2013.", "type": 2, "words": ["<tag1>", "We", "recorded", "revenue", "of", "$1.0", "million", "as", "our", "share", "of", "net", "income", "in", "the", "collaboration", "under", "the", "Pfizer", "Agreement", "during", "the", "year", "ended", "December", "31,", "2013,", "compared", "to", "the", "$446,000", "of", "loss", "recorded", "for", "the", "year", "ended", "December", "31,", "2012.", "<tag2>", "We", "recorded", "revenue", "of", "$1.5", "million", "as", "our", "share", "of", "net", "income", "in", "the", "collaboration", "under", "the", "Pfizer", "Agreement", "during", "the", "year", "ended", "December", "31,", "2014,", "an", "increase", "of", "approximately", "$475,000,", "or", "46%,", "compared", "to", "revenue", "of", "$1.0", "million", "recorded", "for", "the", "year", "ended", "December", "31,", "2013.", "<tag3>"], "wordsA": ["We", "recorded", "revenue", "of", "$1.0", "million", "as", "our", "share", "of", "net", "income", "in", "the", "collaboration", "under", "the", "Pfizer", "Agreement", "during", "the", "year", "ended", "December", "31,", "2013,", "compared", "to", "the", "$446,000", "of", "loss", "recorded", "for", "the", "year", "ended", "December", "31,", "2012."], "wordsB": ["We", "recorded", "revenue", "of", "$1.5", "million", "as", "our", "share", "of", "net", "income", "in", "the", "collaboration", "under", "the", "Pfizer", "Agreement", "during", "the", "year", "ended", "December", "31,", "2014,", "an", "increase", "of", "approximately", "$475,000,", "or", "46%,", "compared", "to", "revenue", "of", "$1.0", "million", "recorded", "for", "the", "year", "ended", "December", "31,", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p53_s1", "idA": "1006281_14_item7_p47_s1", "sentA": "Our share in the collaboration recorded for the year ended December 31, 2013 represents our 40% share of the net income generated during the period, which was primarily the result of revenues generated by Pfizer in the United States which exceeded the expenses during such period.", "sentB": "Our share in the collaboration recorded for the year ended December 31, 2014 represents our 40% share of the net income generated during the period, which was primarily the result of revenues generated by Pfizer in the United States which exceeded the expenses during such period.", "type": 2, "words": ["<tag1>", "Our", "share", "in", "the", "collaboration", "recorded", "for", "the", "year", "ended", "December", "31,", "2013", "represents", "our", "40%", "share", "of", "the", "net", "income", "generated", "during", "the", "period,", "which", "was", "primarily", "the", "result", "of", "revenues", "generated", "by", "Pfizer", "in", "the", "United", "States", "which", "exceeded", "the", "expenses", "during", "such", "period.", "<tag2>", "Our", "share", "in", "the", "collaboration", "recorded", "for", "the", "year", "ended", "December", "31,", "2014", "represents", "our", "40%", "share", "of", "the", "net", "income", "generated", "during", "the", "period,", "which", "was", "primarily", "the", "result", "of", "revenues", "generated", "by", "Pfizer", "in", "the", "United", "States", "which", "exceeded", "the", "expenses", "during", "such", "period.", "<tag3>"], "wordsA": ["Our", "share", "in", "the", "collaboration", "recorded", "for", "the", "year", "ended", "December", "31,", "2013", "represents", "our", "40%", "share", "of", "the", "net", "income", "generated", "during", "the", "period,", "which", "was", "primarily", "the", "result", "of", "revenues", "generated", "by", "Pfizer", "in", "the", "United", "States", "which", "exceeded", "the", "expenses", "during", "such", "period."], "wordsB": ["Our", "share", "in", "the", "collaboration", "recorded", "for", "the", "year", "ended", "December", "31,", "2014", "represents", "our", "40%", "share", "of", "the", "net", "income", "generated", "during", "the", "period,", "which", "was", "primarily", "the", "result", "of", "revenues", "generated", "by", "Pfizer", "in", "the", "United", "States", "which", "exceeded", "the", "expenses", "during", "such", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p55_s1", "idA": "1006281_14_item7_p49_s1", "sentA": "Cost of revenues for the year ended December 31, 2013 consists primarily of certain fixed costs relating to our manufacturing facility, including rent, depreciation, salary and maintenance expenses amounting to approximately $4.9 million, and to a much lesser extent, the direct cost of products we sold in Israel and products we delivered to Pfizer for which revenues were recognized during the period.", "sentB": "Cost of revenues for the year ended December 31, 2014 consists primarily of the costs of the $1.1 million of products we delivered at cost to Pfizer under the Pfizer Agreement, write-down of inventory of $1.7 million, and certain fixed costs relating to our manufacturing facility, including rent, depreciation, salary and maintenance expenses, amounting to approximately $4.2 million, and to a much lesser extent, the direct cost of products we sold in Israel and Brazil for which revenues were recognized during the period.", "type": 2, "words": ["<tag1>", "Cost", "of", "revenues", "for", "the", "year", "ended", "December", "31,", "2013", "consists", "primarily", "of", "certain", "fixed", "costs", "relating", "to", "our", "manufacturing", "facility,", "including", "rent,", "depreciation,", "salary", "and", "maintenance", "expenses", "amounting", "to", "approximately", "$4.9", "million,", "and", "to", "a", "much", "lesser", "extent,", "the", "direct", "cost", "of", "products", "we", "sold", "in", "Israel", "and", "products", "we", "delivered", "to", "Pfizer", "for", "which", "revenues", "were", "recognized", "during", "the", "period.", "<tag2>", "Cost", "of", "revenues", "for", "the", "year", "ended", "December", "31,", "2014", "consists", "primarily", "of", "the", "costs", "of", "the", "$1.1", "million", "of", "products", "we", "delivered", "at", "cost", "to", "Pfizer", "under", "the", "Pfizer", "Agreement,", "write-down", "of", "inventory", "of", "$1.7", "million,", "and", "certain", "fixed", "costs", "relating", "to", "our", "manufacturing", "facility,", "including", "rent,", "depreciation,", "salary", "and", "maintenance", "expenses,", "amounting", "to", "approximately", "$4.2", "million,", "and", "to", "a", "much", "lesser", "extent,", "the", "direct", "cost", "of", "products", "we", "sold", "in", "Israel", "and", "Brazil", "for", "which", "revenues", "were", "recognized", "during", "the", "period.", "<tag3>"], "wordsA": ["Cost", "of", "revenues", "for", "the", "year", "ended", "December", "31,", "2013", "consists", "primarily", "of", "certain", "fixed", "costs", "relating", "to", "our", "manufacturing", "facility,", "including", "rent,", "depreciation,", "salary", "and", "maintenance", "expenses", "amounting", "to", "approximately", "$4.9", "million,", "and", "to", "a", "much", "lesser", "extent,", "the", "direct", "cost", "of", "products", "we", "sold", "in", "Israel", "and", "products", "we", "delivered", "to", "Pfizer", "for", "which", "revenues", "were", "recognized", "during", "the", "period."], "wordsB": ["Cost", "of", "revenues", "for", "the", "year", "ended", "December", "31,", "2014", "consists", "primarily", "of", "the", "costs", "of", "the", "$1.1", "million", "of", "products", "we", "delivered", "at", "cost", "to", "Pfizer", "under", "the", "Pfizer", "Agreement,", "write-down", "of", "inventory", "of", "$1.7", "million,", "and", "certain", "fixed", "costs", "relating", "to", "our", "manufacturing", "facility,", "including", "rent,", "depreciation,", "salary", "and", "maintenance", "expenses,", "amounting", "to", "approximately", "$4.2", "million,", "and", "to", "a", "much", "lesser", "extent,", "the", "direct", "cost", "of", "products", "we", "sold", "in", "Israel", "and", "Brazil", "for", "which", "revenues", "were", "recognized", "during", "the", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p55_s2", "idA": "1006281_14_item7_p49_s2", "sentA": "Cost of revenues for the years ended December 31, 2012 and 2013 include an aggregate of $2.2 million and $472,000, respectively, in royalties payable to the OCS and to a certain academic institution in connection with gross sales of taliglucerase alfa during the period.", "sentB": "Cost of revenues for the years ended December 31, 2013 and 2014 include an aggregate of $472,000 and $1.1 million, respectively, in royalties payable to the OCS and to a certain academic institution in connection with gross sales of taliglucerase alfa during the period.", "type": 2, "words": ["<tag1>", "Cost", "of", "revenues", "for", "the", "years", "ended", "December", "31,", "2012", "and", "2013", "include", "an", "aggregate", "of", "$2.2", "million", "and", "$472,000,", "respectively,", "in", "royalties", "payable", "to", "the", "OCS", "and", "to", "a", "certain", "academic", "institution", "in", "connection", "with", "gross", "sales", "of", "taliglucerase", "alfa", "during", "the", "period.", "<tag2>", "Cost", "of", "revenues", "for", "the", "years", "ended", "December", "31,", "2013", "and", "2014", "include", "an", "aggregate", "of", "$472,000", "and", "$1.1", "million,", "respectively,", "in", "royalties", "payable", "to", "the", "OCS", "and", "to", "a", "certain", "academic", "institution", "in", "connection", "with", "gross", "sales", "of", "taliglucerase", "alfa", "during", "the", "period.", "<tag3>"], "wordsA": ["Cost", "of", "revenues", "for", "the", "years", "ended", "December", "31,", "2012", "and", "2013", "include", "an", "aggregate", "of", "$2.2", "million", "and", "$472,000,", "respectively,", "in", "royalties", "payable", "to", "the", "OCS", "and", "to", "a", "certain", "academic", "institution", "in", "connection", "with", "gross", "sales", "of", "taliglucerase", "alfa", "during", "the", "period."], "wordsB": ["Cost", "of", "revenues", "for", "the", "years", "ended", "December", "31,", "2013", "and", "2014", "include", "an", "aggregate", "of", "$472,000", "and", "$1.1", "million,", "respectively,", "in", "royalties", "payable", "to", "the", "OCS", "and", "to", "a", "certain", "academic", "institution", "in", "connection", "with", "gross", "sales", "of", "taliglucerase", "alfa", "during", "the", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p6_s0", "idA": "1006281_14_item7_p4_s0", "sentA": "Taliglucerase alfa is our proprietary, recombinant form of glucocerebrosidase, or GCD, that is produced or expressed through ProCellEx.", "sentB": "Taliglucerase alfa is our proprietary, recombinant form of GCD that is produced or expressed through ProCellEx.", "type": 2, "words": ["<tag1>", "Taliglucerase", "alfa", "is", "our", "proprietary,", "recombinant", "form", "of", "glucocerebrosidase,", "or", "GCD,", "that", "is", "produced", "or", "expressed", "through", "ProCellEx.", "<tag2>", "Taliglucerase", "alfa", "is", "our", "proprietary,", "recombinant", "form", "of", "GCD", "that", "is", "produced", "or", "expressed", "through", "ProCellEx.", "<tag3>"], "wordsA": ["Taliglucerase", "alfa", "is", "our", "proprietary,", "recombinant", "form", "of", "glucocerebrosidase,", "or", "GCD,", "that", "is", "produced", "or", "expressed", "through", "ProCellEx."], "wordsB": ["Taliglucerase", "alfa", "is", "our", "proprietary,", "recombinant", "form", "of", "GCD", "that", "is", "produced", "or", "expressed", "through", "ProCellEx."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p56_s0", "idA": "1006281_14_item7_p50_s0", "sentA": "Research and development expenses were $33.3 million for the year ended December 31, 2013, a decrease of $3.4 million, or 9.1% from $36.7 million for the year ended December 31, 2012.", "sentB": "Research and development expenses were $29.8 million for the year ended December 31, 2014, a decrease of $3.6 million, or 11% from $33.3 million for the year ended December 31, 2013.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expenses", "were", "$33.3", "million", "for", "the", "year", "ended", "December", "31,", "2013,", "a", "decrease", "of", "$3.4", "million,", "or", "9.1%", "from", "$36.7", "million", "for", "the", "year", "ended", "December", "31,", "2012.", "<tag2>", "Research", "and", "development", "expenses", "were", "$29.8", "million", "for", "the", "year", "ended", "December", "31,", "2014,", "a", "decrease", "of", "$3.6", "million,", "or", "11%", "from", "$33.3", "million", "for", "the", "year", "ended", "December", "31,", "2013.", "<tag3>"], "wordsA": ["Research", "and", "development", "expenses", "were", "$33.3", "million", "for", "the", "year", "ended", "December", "31,", "2013,", "a", "decrease", "of", "$3.4", "million,", "or", "9.1%", "from", "$36.7", "million", "for", "the", "year", "ended", "December", "31,", "2012."], "wordsB": ["Research", "and", "development", "expenses", "were", "$29.8", "million", "for", "the", "year", "ended", "December", "31,", "2014,", "a", "decrease", "of", "$3.6", "million,", "or", "11%", "from", "$33.3", "million", "for", "the", "year", "ended", "December", "31,", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p58_s0", "idA": "1006281_14_item7_p52_s0", "sentA": "General and administrative expenses were $8.4 million for the year ended December 31, 2013, a decrease of $1.4 million, or 14%, from $9.8 million for the year ended December 31, 2012.", "sentB": "General and administrative expenses were $9.7 million for the year ended December 31, 2014, an increase of $1.3 million, or 15%, from $8.4 million for the year ended December 31, 2013.", "type": 2, "words": ["<tag1>", "General", "and", "administrative", "expenses", "were", "$8.4", "million", "for", "the", "year", "ended", "December", "31,", "2013,", "a", "decrease", "of", "$1.4", "million,", "or", "14%,", "from", "$9.8", "million", "for", "the", "year", "ended", "December", "31,", "2012.", "<tag2>", "General", "and", "administrative", "expenses", "were", "$9.7", "million", "for", "the", "year", "ended", "December", "31,", "2014,", "an", "increase", "of", "$1.3", "million,", "or", "15%,", "from", "$8.4", "million", "for", "the", "year", "ended", "December", "31,", "2013.", "<tag3>"], "wordsA": ["General", "and", "administrative", "expenses", "were", "$8.4", "million", "for", "the", "year", "ended", "December", "31,", "2013,", "a", "decrease", "of", "$1.4", "million,", "or", "14%,", "from", "$9.8", "million", "for", "the", "year", "ended", "December", "31,", "2012."], "wordsB": ["General", "and", "administrative", "expenses", "were", "$9.7", "million", "for", "the", "year", "ended", "December", "31,", "2014,", "an", "increase", "of", "$1.3", "million,", "or", "15%,", "from", "$8.4", "million", "for", "the", "year", "ended", "December", "31,", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p56_s1", "idA": "1006281_14_item7_p52_s1", "sentA": "The decrease resulted primarily from a decrease of $1.5 million in payroll and related expenses primarily due to a decrease in share-based compensation.", "sentB": "The decrease resulted primarily from a decrease of $1.4 million in payroll and related expenses primarily due to a decrease in share-based compensation and a decrease of $1.0 million in cost of materials.", "type": 2, "words": ["<tag1>", "The", "decrease", "resulted", "primarily", "from", "a", "decrease", "of", "$1.5", "million", "in", "payroll", "and", "related", "expenses", "primarily", "due", "to", "a", "decrease", "in", "share-based", "compensation.", "<tag2>", "The", "decrease", "resulted", "primarily", "from", "a", "decrease", "of", "$1.4", "million", "in", "payroll", "and", "related", "expenses", "primarily", "due", "to", "a", "decrease", "in", "share-based", "compensation", "and", "a", "decrease", "of", "$1.0", "million", "in", "cost", "of", "materials.", "<tag3>"], "wordsA": ["The", "decrease", "resulted", "primarily", "from", "a", "decrease", "of", "$1.5", "million", "in", "payroll", "and", "related", "expenses", "primarily", "due", "to", "a", "decrease", "in", "share-based", "compensation."], "wordsB": ["The", "decrease", "resulted", "primarily", "from", "a", "decrease", "of", "$1.4", "million", "in", "payroll", "and", "related", "expenses", "primarily", "due", "to", "a", "decrease", "in", "share-based", "compensation", "and", "a", "decrease", "of", "$1.0", "million", "in", "cost", "of", "materials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p59_s1", "idA": "1006281_14_item7_p53_s1", "sentA": "Financial expense resulted primarily from interest expense of $1.0 million for the 4.5% convertible note which was partially offset by financial income which resulted primarily from interest earned on short term deposits.", "sentB": "Financial expenses resulted primarily from interest expense of $3.1 million for the 4.5% convertible note and from the devaluation of the New Israeli Shekel against the U.S. dollar in the amount of $1.3 million, which was partially offset by financial income which resulted primarily from interest earned on short term deposits.", "type": 2, "words": ["<tag1>", "Financial", "expense", "resulted", "primarily", "from", "interest", "expense", "of", "$1.0", "million", "for", "the", "4.5%", "convertible", "note", "which", "was", "partially", "offset", "by", "financial", "income", "which", "resulted", "primarily", "from", "interest", "earned", "on", "short", "term", "deposits.", "<tag2>", "Financial", "expenses", "resulted", "primarily", "from", "interest", "expense", "of", "$3.1", "million", "for", "the", "4.5%", "convertible", "note", "and", "from", "the", "devaluation", "of", "the", "New", "Israeli", "Shekel", "against", "the", "U.S.", "dollar", "in", "the", "amount", "of", "$1.3", "million,", "which", "was", "partially", "offset", "by", "financial", "income", "which", "resulted", "primarily", "from", "interest", "earned", "on", "short", "term", "deposits.", "<tag3>"], "wordsA": ["Financial", "expense", "resulted", "primarily", "from", "interest", "expense", "of", "$1.0", "million", "for", "the", "4.5%", "convertible", "note", "which", "was", "partially", "offset", "by", "financial", "income", "which", "resulted", "primarily", "from", "interest", "earned", "on", "short", "term", "deposits."], "wordsB": ["Financial", "expenses", "resulted", "primarily", "from", "interest", "expense", "of", "$3.1", "million", "for", "the", "4.5%", "convertible", "note", "and", "from", "the", "devaluation", "of", "the", "New", "Israeli", "Shekel", "against", "the", "U.S.", "dollar", "in", "the", "amount", "of", "$1.3", "million,", "which", "was", "partially", "offset", "by", "financial", "income", "which", "resulted", "primarily", "from", "interest", "earned", "on", "short", "term", "deposits."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p52_s0", "idA": "1006281_14_item7_p54_s0", "sentA": "We recorded revenue of $34.9 million for the year ended December 31, 2012, an increase of $26.5 million or 315%, compared to revenue of $8.4 million for the year ended December 31, 2011.", "sentB": "We recorded revenue of $13.7 million for the year ended December 31, 2014, an increase of approximately $3.2 million, or 30%, compared to revenue of $10.5 million for the year ended December 31, 2013.", "type": 2, "words": ["<tag1>", "We", "recorded", "revenue", "of", "$34.9", "million", "for", "the", "year", "ended", "December", "31,", "2012,", "an", "increase", "of", "$26.5", "million", "or", "315%,", "compared", "to", "revenue", "of", "$8.4", "million", "for", "the", "year", "ended", "December", "31,", "2011.", "<tag2>", "We", "recorded", "revenue", "of", "$13.7", "million", "for", "the", "year", "ended", "December", "31,", "2014,", "an", "increase", "of", "approximately", "$3.2", "million,", "or", "30%,", "compared", "to", "revenue", "of", "$10.5", "million", "for", "the", "year", "ended", "December", "31,", "2013.", "<tag3>"], "wordsA": ["We", "recorded", "revenue", "of", "$34.9", "million", "for", "the", "year", "ended", "December", "31,", "2012,", "an", "increase", "of", "$26.5", "million", "or", "315%,", "compared", "to", "revenue", "of", "$8.4", "million", "for", "the", "year", "ended", "December", "31,", "2011."], "wordsB": ["We", "recorded", "revenue", "of", "$13.7", "million", "for", "the", "year", "ended", "December", "31,", "2014,", "an", "increase", "of", "approximately", "$3.2", "million,", "or", "30%,", "compared", "to", "revenue", "of", "$10.5", "million", "for", "the", "year", "ended", "December", "31,", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p52_s2", "idA": "1006281_14_item7_p54_s3", "sentA": "Revenues also include the amortization of the $65.0 million upfront and milestone payments received from Pfizer.", "sentB": "Revenues also represent a pro rata amortization of the $65.0 million upfront and milestone payments of $1.1 million in each quarterly period.", "type": 2, "words": ["<tag1>", "Revenues", "also", "include", "the", "amortization", "of", "the", "$65.0", "million", "upfront", "and", "milestone", "payments", "received", "from", "Pfizer.", "<tag2>", "Revenues", "also", "represent", "a", "pro", "rata", "amortization", "of", "the", "$65.0", "million", "upfront", "and", "milestone", "payments", "of", "$1.1", "million", "in", "each", "quarterly", "period.", "<tag3>"], "wordsA": ["Revenues", "also", "include", "the", "amortization", "of", "the", "$65.0", "million", "upfront", "and", "milestone", "payments", "received", "from", "Pfizer."], "wordsB": ["Revenues", "also", "represent", "a", "pro", "rata", "amortization", "of", "the", "$65.0", "million", "upfront", "and", "milestone", "payments", "of", "$1.1", "million", "in", "each", "quarterly", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p55_s0", "idA": "1006281_14_item7_p57_s0", "sentA": "Cost of revenues was $8.1 million for the year ended December 31, 2012, an increase of $6.6 million, compared to the cost of revenues of $1.5 million for the year ended December 31, 2011.", "sentB": "Cost of revenues was $9.1 million for the year ended December 31, 2014, an increase of $3.6 million, or 67%, compared to the cost of revenues of $5.4 million for the year ended December 31, 2013.", "type": 2, "words": ["<tag1>", "Cost", "of", "revenues", "was", "$8.1", "million", "for", "the", "year", "ended", "December", "31,", "2012,", "an", "increase", "of", "$6.6", "million,", "compared", "to", "the", "cost", "of", "revenues", "of", "$1.5", "million", "for", "the", "year", "ended", "December", "31,", "2011.", "<tag2>", "Cost", "of", "revenues", "was", "$9.1", "million", "for", "the", "year", "ended", "December", "31,", "2014,", "an", "increase", "of", "$3.6", "million,", "or", "67%,", "compared", "to", "the", "cost", "of", "revenues", "of", "$5.4", "million", "for", "the", "year", "ended", "December", "31,", "2013.", "<tag3>"], "wordsA": ["Cost", "of", "revenues", "was", "$8.1", "million", "for", "the", "year", "ended", "December", "31,", "2012,", "an", "increase", "of", "$6.6", "million,", "compared", "to", "the", "cost", "of", "revenues", "of", "$1.5", "million", "for", "the", "year", "ended", "December", "31,", "2011."], "wordsB": ["Cost", "of", "revenues", "was", "$9.1", "million", "for", "the", "year", "ended", "December", "31,", "2014,", "an", "increase", "of", "$3.6", "million,", "or", "67%,", "compared", "to", "the", "cost", "of", "revenues", "of", "$5.4", "million", "for", "the", "year", "ended", "December", "31,", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p58_s1", "idA": "1006281_14_item7_p60_s2", "sentA": "The increase was partially offset by a decrease of $646,000 in legal and accounting expenses.", "sentB": "The increase resulted primarily from sales and marketing expenses of approximately $1.8 million, primarily in connection with sales in Brazil, which was partially offset by a decrease of $383,000 in salaries expense.", "type": 2, "words": ["<tag1>", "The", "increase", "was", "partially", "offset", "by", "a", "decrease", "of", "$646,000", "in", "legal", "and", "accounting", "expenses.", "<tag2>", "The", "increase", "resulted", "primarily", "from", "sales", "and", "marketing", "expenses", "of", "approximately", "$1.8", "million,", "primarily", "in", "connection", "with", "sales", "in", "Brazil,", "which", "was", "partially", "offset", "by", "a", "decrease", "of", "$383,000", "in", "salaries", "expense.", "<tag3>"], "wordsA": ["The", "increase", "was", "partially", "offset", "by", "a", "decrease", "of", "$646,000", "in", "legal", "and", "accounting", "expenses."], "wordsB": ["The", "increase", "resulted", "primarily", "from", "sales", "and", "marketing", "expenses", "of", "approximately", "$1.8", "million,", "primarily", "in", "connection", "with", "sales", "in", "Brazil,", "which", "was", "partially", "offset", "by", "a", "decrease", "of", "$383,000", "in", "salaries", "expense."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p12_s2", "idA": "1006281_14_item7_p65_s1", "sentA": "Protalix Ltd. also received a milestone payment of $25.0 in connection with the FDA s approval of taliglucerase alfa in May 2012.", "sentB": "Pfizer has also agreed to perform certain transitional services in Brazil on our behalf in connection with the supply of taliglucerase alfa to Fiocruz.", "type": 2, "words": ["<tag1>", "Protalix", "Ltd.", "also", "received", "a", "milestone", "payment", "of", "$25.0", "in", "connection", "with", "the", "FDA", "s", "approval", "of", "taliglucerase", "alfa", "in", "May", "2012.", "<tag2>", "Pfizer", "has", "also", "agreed", "to", "perform", "certain", "transitional", "services", "in", "Brazil", "on", "our", "behalf", "in", "connection", "with", "the", "supply", "of", "taliglucerase", "alfa", "to", "Fiocruz.", "<tag3>"], "wordsA": ["Protalix", "Ltd.", "also", "received", "a", "milestone", "payment", "of", "$25.0", "in", "connection", "with", "the", "FDA", "s", "approval", "of", "taliglucerase", "alfa", "in", "May", "2012."], "wordsB": ["Pfizer", "has", "also", "agreed", "to", "perform", "certain", "transitional", "services", "in", "Brazil", "on", "our", "behalf", "in", "connection", "with", "the", "supply", "of", "taliglucerase", "alfa", "to", "Fiocruz."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p13_s0", "idA": "1006281_14_item7_p65_s2", "sentA": "Protalix Ltd. is also entitled to payments equal to 40% of the net profits earned by Pfizer on its global sales of taliglucerase alfa (except in Israel).", "sentB": "We will pay a fee equal to 5% of the net proceeds generated in Brazil to our agent for services provided in assisting us complete the Brazil Agreement pursuant to an agency agreement between us and the agent.", "type": 2, "words": ["<tag1>", "Protalix", "Ltd.", "is", "also", "entitled", "to", "payments", "equal", "to", "40%", "of", "the", "net", "profits", "earned", "by", "Pfizer", "on", "its", "global", "sales", "of", "taliglucerase", "alfa", "(except", "in", "Israel).", "<tag2>", "We", "will", "pay", "a", "fee", "equal", "to", "5%", "of", "the", "net", "proceeds", "generated", "in", "Brazil", "to", "our", "agent", "for", "services", "provided", "in", "assisting", "us", "complete", "the", "Brazil", "Agreement", "pursuant", "to", "an", "agency", "agreement", "between", "us", "and", "the", "agent.", "<tag3>"], "wordsA": ["Protalix", "Ltd.", "is", "also", "entitled", "to", "payments", "equal", "to", "40%", "of", "the", "net", "profits", "earned", "by", "Pfizer", "on", "its", "global", "sales", "of", "taliglucerase", "alfa", "(except", "in", "Israel)."], "wordsB": ["We", "will", "pay", "a", "fee", "equal", "to", "5%", "of", "the", "net", "proceeds", "generated", "in", "Brazil", "to", "our", "agent", "for", "services", "provided", "in", "assisting", "us", "complete", "the", "Brazil", "Agreement", "pursuant", "to", "an", "agency", "agreement", "between", "us", "and", "the", "agent."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p71_s2", "idA": "1006281_14_item7_p65_s2", "sentA": "Protalix Ltd. is also entitled to payments equal to 40% of the net profits earned by Pfizer on its global sales of taliglucerase alfa (except in Israel).", "sentB": "Protalix Ltd. is also entitled to payments equal to 40% of the net profits earned by Pfizer on its global sales of taliglucerase alfa (except in Israel and Brazil).", "type": 2, "words": ["<tag1>", "Protalix", "Ltd.", "is", "also", "entitled", "to", "payments", "equal", "to", "40%", "of", "the", "net", "profits", "earned", "by", "Pfizer", "on", "its", "global", "sales", "of", "taliglucerase", "alfa", "(except", "in", "Israel).", "<tag2>", "Protalix", "Ltd.", "is", "also", "entitled", "to", "payments", "equal", "to", "40%", "of", "the", "net", "profits", "earned", "by", "Pfizer", "on", "its", "global", "sales", "of", "taliglucerase", "alfa", "(except", "in", "Israel", "and", "Brazil).", "<tag3>"], "wordsA": ["Protalix", "Ltd.", "is", "also", "entitled", "to", "payments", "equal", "to", "40%", "of", "the", "net", "profits", "earned", "by", "Pfizer", "on", "its", "global", "sales", "of", "taliglucerase", "alfa", "(except", "in", "Israel)."], "wordsB": ["Protalix", "Ltd.", "is", "also", "entitled", "to", "payments", "equal", "to", "40%", "of", "the", "net", "profits", "earned", "by", "Pfizer", "on", "its", "global", "sales", "of", "taliglucerase", "alfa", "(except", "in", "Israel", "and", "Brazil)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p59_s0", "idA": "1006281_14_item7_p67_s0", "sentA": "Net cash used in operations was $30.7 million for the year ended December 31, 2013.", "sentB": "Financial expenses were $4.7 million for the year ended December 31, 2014, compared to $674,000 for the year ended December 31, 2013.", "type": 2, "words": ["<tag1>", "Net", "cash", "used", "in", "operations", "was", "$30.7", "million", "for", "the", "year", "ended", "December", "31,", "2013.", "<tag2>", "Financial", "expenses", "were", "$4.7", "million", "for", "the", "year", "ended", "December", "31,", "2014,", "compared", "to", "$674,000", "for", "the", "year", "ended", "December", "31,", "2013.", "<tag3>"], "wordsA": ["Net", "cash", "used", "in", "operations", "was", "$30.7", "million", "for", "the", "year", "ended", "December", "31,", "2013."], "wordsB": ["Financial", "expenses", "were", "$4.7", "million", "for", "the", "year", "ended", "December", "31,", "2014,", "compared", "to", "$674,000", "for", "the", "year", "ended", "December", "31,", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p73_s0", "idA": "1006281_14_item7_p67_s0", "sentA": "Net cash used in operations was $30.7 million for the year ended December 31, 2013.", "sentB": "Net cash used in operations was $29.2 million for the year ended December 31, 2014.", "type": 2, "words": ["<tag1>", "Net", "cash", "used", "in", "operations", "was", "$30.7", "million", "for", "the", "year", "ended", "December", "31,", "2013.", "<tag2>", "Net", "cash", "used", "in", "operations", "was", "$29.2", "million", "for", "the", "year", "ended", "December", "31,", "2014.", "<tag3>"], "wordsA": ["Net", "cash", "used", "in", "operations", "was", "$30.7", "million", "for", "the", "year", "ended", "December", "31,", "2013."], "wordsB": ["Net", "cash", "used", "in", "operations", "was", "$29.2", "million", "for", "the", "year", "ended", "December", "31,", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p73_s1", "idA": "1006281_14_item7_p67_s1", "sentA": "The net loss for the year ended December 31, 2013 of $27.8 million was further increased by a decrease of $7.2 million in deferred revenues and an increase of $3.9 million in inventories, but was partially offset by share based compensation of $4.1 million and $3.5 million in depreciation.", "sentB": "The net loss for the year ended December 31, 2014 of $29.9 million was further increased by a decrease of $7.2 million in deferred revenues, but was partially offset by $3.1 million in depreciation, $1.4 million in financial expenses mainly due to exchange rate differences and share based compensation of $1.2 million.", "type": 2, "words": ["<tag1>", "The", "net", "loss", "for", "the", "year", "ended", "December", "31,", "2013", "of", "$27.8", "million", "was", "further", "increased", "by", "a", "decrease", "of", "$7.2", "million", "in", "deferred", "revenues", "and", "an", "increase", "of", "$3.9", "million", "in", "inventories,", "but", "was", "partially", "offset", "by", "share", "based", "compensation", "of", "$4.1", "million", "and", "$3.5", "million", "in", "depreciation.", "<tag2>", "The", "net", "loss", "for", "the", "year", "ended", "December", "31,", "2014", "of", "$29.9", "million", "was", "further", "increased", "by", "a", "decrease", "of", "$7.2", "million", "in", "deferred", "revenues,", "but", "was", "partially", "offset", "by", "$3.1", "million", "in", "depreciation,", "$1.4", "million", "in", "financial", "expenses", "mainly", "due", "to", "exchange", "rate", "differences", "and", "share", "based", "compensation", "of", "$1.2", "million.", "<tag3>"], "wordsA": ["The", "net", "loss", "for", "the", "year", "ended", "December", "31,", "2013", "of", "$27.8", "million", "was", "further", "increased", "by", "a", "decrease", "of", "$7.2", "million", "in", "deferred", "revenues", "and", "an", "increase", "of", "$3.9", "million", "in", "inventories,", "but", "was", "partially", "offset", "by", "share", "based", "compensation", "of", "$4.1", "million", "and", "$3.5", "million", "in", "depreciation."], "wordsB": ["The", "net", "loss", "for", "the", "year", "ended", "December", "31,", "2014", "of", "$29.9", "million", "was", "further", "increased", "by", "a", "decrease", "of", "$7.2", "million", "in", "deferred", "revenues,", "but", "was", "partially", "offset", "by", "$3.1", "million", "in", "depreciation,", "$1.4", "million", "in", "financial", "expenses", "mainly", "due", "to", "exchange", "rate", "differences", "and", "share", "based", "compensation", "of", "$1.2", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p73_s2", "idA": "1006281_14_item7_p68_s2", "sentA": "Net cash used in investing activities for the year ended December 31, 2012 was $2.3 million and consisted primarily of purchases of property and equipment.", "sentB": "Net cash used in investing activities for the year ended December 31, 2014 was $1.0 million and consisted primarily of purchases of property and equipment.", "type": 2, "words": ["<tag1>", "Net", "cash", "used", "in", "investing", "activities", "for", "the", "year", "ended", "December", "31,", "2012", "was", "$2.3", "million", "and", "consisted", "primarily", "of", "purchases", "of", "property", "and", "equipment.", "<tag2>", "Net", "cash", "used", "in", "investing", "activities", "for", "the", "year", "ended", "December", "31,", "2014", "was", "$1.0", "million", "and", "consisted", "primarily", "of", "purchases", "of", "property", "and", "equipment.", "<tag3>"], "wordsA": ["Net", "cash", "used", "in", "investing", "activities", "for", "the", "year", "ended", "December", "31,", "2012", "was", "$2.3", "million", "and", "consisted", "primarily", "of", "purchases", "of", "property", "and", "equipment."], "wordsB": ["Net", "cash", "used", "in", "investing", "activities", "for", "the", "year", "ended", "December", "31,", "2014", "was", "$1.0", "million", "and", "consisted", "primarily", "of", "purchases", "of", "property", "and", "equipment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p17_s2", "idA": "1006281_14_item7_p69_s0", "sentA": "We expect to continue to incur significant expenditures in the near future.", "sentB": "We expect to enter into a pivotal phase III by early 2016.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "continue", "to", "incur", "significant", "expenditures", "in", "the", "near", "future.", "<tag2>", "We", "expect", "to", "enter", "into", "a", "pivotal", "phase", "III", "by", "early", "2016.", "<tag3>"], "wordsA": ["We", "expect", "to", "continue", "to", "incur", "significant", "expenditures", "in", "the", "near", "future."], "wordsB": ["We", "expect", "to", "enter", "into", "a", "pivotal", "phase", "III", "by", "early", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p18_s1", "idA": "1006281_14_item7_p69_s0", "sentA": "We expect to continue to incur significant expenditures in the near future.", "sentB": "We expect to initiate a proof of concept efficacy study during 2015 and announce results by early 2016.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "continue", "to", "incur", "significant", "expenditures", "in", "the", "near", "future.", "<tag2>", "We", "expect", "to", "initiate", "a", "proof", "of", "concept", "efficacy", "study", "during", "2015", "and", "announce", "results", "by", "early", "2016.", "<tag3>"], "wordsA": ["We", "expect", "to", "continue", "to", "incur", "significant", "expenditures", "in", "the", "near", "future."], "wordsB": ["We", "expect", "to", "initiate", "a", "proof", "of", "concept", "efficacy", "study", "during", "2015", "and", "announce", "results", "by", "early", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p19_s1", "idA": "1006281_14_item7_p69_s0", "sentA": "We expect to continue to incur significant expenditures in the near future.", "sentB": "We expect to initiate a proof of concept efficacy study during 2015 and announce results by early 2016 .", "type": 2, "words": ["<tag1>", "We", "expect", "to", "continue", "to", "incur", "significant", "expenditures", "in", "the", "near", "future.", "<tag2>", "We", "expect", "to", "initiate", "a", "proof", "of", "concept", "efficacy", "study", "during", "2015", "and", "announce", "results", "by", "early", "2016", ".", "<tag3>"], "wordsA": ["We", "expect", "to", "continue", "to", "incur", "significant", "expenditures", "in", "the", "near", "future."], "wordsB": ["We", "expect", "to", "initiate", "a", "proof", "of", "concept", "efficacy", "study", "during", "2015", "and", "announce", "results", "by", "early", "2016", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p75_s1", "idA": "1006281_14_item7_p69_s3", "sentA": "We expect to continue to incur significant research and development expenses, including expenses related primarily to the clinical trials of PRX-102 and oral glucocerebrosidase and the advancement of our other product candidates into clinical trials.", "sentB": "We expect to continue to incur significant research and development expenses, including expenses related primarily to the clinical trials of PRX-102 and the advancement of our other product candidates into clinical trials.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "continue", "to", "incur", "significant", "research", "and", "development", "expenses,", "including", "expenses", "related", "primarily", "to", "the", "clinical", "trials", "of", "PRX-102", "and", "oral", "glucocerebrosidase", "and", "the", "advancement", "of", "our", "other", "product", "candidates", "into", "clinical", "trials.", "<tag2>", "We", "expect", "to", "continue", "to", "incur", "significant", "research", "and", "development", "expenses,", "including", "expenses", "related", "primarily", "to", "the", "clinical", "trials", "of", "PRX-102", "and", "the", "advancement", "of", "our", "other", "product", "candidates", "into", "clinical", "trials.", "<tag3>"], "wordsA": ["We", "expect", "to", "continue", "to", "incur", "significant", "research", "and", "development", "expenses,", "including", "expenses", "related", "primarily", "to", "the", "clinical", "trials", "of", "PRX-102", "and", "oral", "glucocerebrosidase", "and", "the", "advancement", "of", "our", "other", "product", "candidates", "into", "clinical", "trials."], "wordsB": ["We", "expect", "to", "continue", "to", "incur", "significant", "research", "and", "development", "expenses,", "including", "expenses", "related", "primarily", "to", "the", "clinical", "trials", "of", "PRX-102", "and", "the", "advancement", "of", "our", "other", "product", "candidates", "into", "clinical", "trials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p76_s0", "idA": "1006281_14_item7_p70_s0", "sentA": "We believe that our existing cash and cash equivalents will be sufficient to enable us to fund our operating expenses and capital expenditure requirements for the foreseeable future.", "sentB": "We believe that our existing cash and cash equivalents will be sufficient for at least 12 months.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "our", "existing", "cash", "and", "cash", "equivalents", "will", "be", "sufficient", "to", "enable", "us", "to", "fund", "our", "operating", "expenses", "and", "capital", "expenditure", "requirements", "for", "the", "foreseeable", "future.", "<tag2>", "We", "believe", "that", "our", "existing", "cash", "and", "cash", "equivalents", "will", "be", "sufficient", "for", "at", "least", "12", "months.", "<tag3>"], "wordsA": ["We", "believe", "that", "our", "existing", "cash", "and", "cash", "equivalents", "will", "be", "sufficient", "to", "enable", "us", "to", "fund", "our", "operating", "expenses", "and", "capital", "expenditure", "requirements", "for", "the", "foreseeable", "future."], "wordsB": ["We", "believe", "that", "our", "existing", "cash", "and", "cash", "equivalents", "will", "be", "sufficient", "for", "at", "least", "12", "months."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p77_s0", "idA": "1006281_14_item7_p71_s0", "sentA": "Our future capital requirements will depend on many factors, including the progress of Pfizer s commercialization efforts for taliglucerase alfa in the United States and other countries, the progress of our commercialization efforts for taliglucerase alfa in Brazil and Israel and, if anticipated marketing approvals of taliglucerase alfa are granted in other jurisdictions, the progress of Pfizer s global commercialization efforts for taliglucerase alfa, the progress and results of our clinical trials, the duration and cost of discovery and preclinical development and laboratory testing and clinical trials for our product candidates, the timing and outcome of regulatory review of our product candidates, the costs involved in preparing, filing, prosecuting, maintaining, defending and enforcing patent claims and other intellectual property rights, the number and development requirements of other product candidates that we pursue and the costs of commercialization activities, including product marketing, sales and distribution.", "sentB": "Our future capital requirements will depend on many factors, including the progress of Pfizer s commercialization efforts for taliglucerase alfa in the United States and other countries and, if anticipated marketing approvals of taliglucerase alfa are granted in other jurisdictions, the progress of Pfizer s global commercialization efforts for taliglucerase alfa, the progress and results of our clinical trials, the duration and cost of discovery and preclinical development and laboratory testing and clinical trials for our product candidates, the timing and outcome of regulatory review of our product candidates, the costs involved in preparing, filing, prosecuting, maintaining, defending and enforcing patent claims and other intellectual property rights, the number and development requirements of other product candidates that we pursue and the costs of commercialization activities, including product marketing, sales and distribution.", "type": 2, "words": ["<tag1>", "Our", "future", "capital", "requirements", "will", "depend", "on", "many", "factors,", "including", "the", "progress", "of", "Pfizer", "s", "commercialization", "efforts", "for", "taliglucerase", "alfa", "in", "the", "United", "States", "and", "other", "countries,", "the", "progress", "of", "our", "commercialization", "efforts", "for", "taliglucerase", "alfa", "in", "Brazil", "and", "Israel", "and,", "if", "anticipated", "marketing", "approvals", "of", "taliglucerase", "alfa", "are", "granted", "in", "other", "jurisdictions,", "the", "progress", "of", "Pfizer", "s", "global", "commercialization", "efforts", "for", "taliglucerase", "alfa,", "the", "progress", "and", "results", "of", "our", "clinical", "trials,", "the", "duration", "and", "cost", "of", "discovery", "and", "preclinical", "development", "and", "laboratory", "testing", "and", "clinical", "trials", "for", "our", "product", "candidates,", "the", "timing", "and", "outcome", "of", "regulatory", "review", "of", "our", "product", "candidates,", "the", "costs", "involved", "in", "preparing,", "filing,", "prosecuting,", "maintaining,", "defending", "and", "enforcing", "patent", "claims", "and", "other", "intellectual", "property", "rights,", "the", "number", "and", "development", "requirements", "of", "other", "product", "candidates", "that", "we", "pursue", "and", "the", "costs", "of", "commercialization", "activities,", "including", "product", "marketing,", "sales", "and", "distribution.", "<tag2>", "Our", "future", "capital", "requirements", "will", "depend", "on", "many", "factors,", "including", "the", "progress", "of", "Pfizer", "s", "commercialization", "efforts", "for", "taliglucerase", "alfa", "in", "the", "United", "States", "and", "other", "countries", "and,", "if", "anticipated", "marketing", "approvals", "of", "taliglucerase", "alfa", "are", "granted", "in", "other", "jurisdictions,", "the", "progress", "of", "Pfizer", "s", "global", "commercialization", "efforts", "for", "taliglucerase", "alfa,", "the", "progress", "and", "results", "of", "our", "clinical", "trials,", "the", "duration", "and", "cost", "of", "discovery", "and", "preclinical", "development", "and", "laboratory", "testing", "and", "clinical", "trials", "for", "our", "product", "candidates,", "the", "timing", "and", "outcome", "of", "regulatory", "review", "of", "our", "product", "candidates,", "the", "costs", "involved", "in", "preparing,", "filing,", "prosecuting,", "maintaining,", "defending", "and", "enforcing", "patent", "claims", "and", "other", "intellectual", "property", "rights,", "the", "number", "and", "development", "requirements", "of", "other", "product", "candidates", "that", "we", "pursue", "and", "the", "costs", "of", "commercialization", "activities,", "including", "product", "marketing,", "sales", "and", "distribution.", "<tag3>"], "wordsA": ["Our", "future", "capital", "requirements", "will", "depend", "on", "many", "factors,", "including", "the", "progress", "of", "Pfizer", "s", "commercialization", "efforts", "for", "taliglucerase", "alfa", "in", "the", "United", "States", "and", "other", "countries,", "the", "progress", "of", "our", "commercialization", "efforts", "for", "taliglucerase", "alfa", "in", "Brazil", "and", "Israel", "and,", "if", "anticipated", "marketing", "approvals", "of", "taliglucerase", "alfa", "are", "granted", "in", "other", "jurisdictions,", "the", "progress", "of", "Pfizer", "s", "global", "commercialization", "efforts", "for", "taliglucerase", "alfa,", "the", "progress", "and", "results", "of", "our", "clinical", "trials,", "the", "duration", "and", "cost", "of", "discovery", "and", "preclinical", "development", "and", "laboratory", "testing", "and", "clinical", "trials", "for", "our", "product", "candidates,", "the", "timing", "and", "outcome", "of", "regulatory", "review", "of", "our", "product", "candidates,", "the", "costs", "involved", "in", "preparing,", "filing,", "prosecuting,", "maintaining,", "defending", "and", "enforcing", "patent", "claims", "and", "other", "intellectual", "property", "rights,", "the", "number", "and", "development", "requirements", "of", "other", "product", "candidates", "that", "we", "pursue", "and", "the", "costs", "of", "commercialization", "activities,", "including", "product", "marketing,", "sales", "and", "distribution."], "wordsB": ["Our", "future", "capital", "requirements", "will", "depend", "on", "many", "factors,", "including", "the", "progress", "of", "Pfizer", "s", "commercialization", "efforts", "for", "taliglucerase", "alfa", "in", "the", "United", "States", "and", "other", "countries", "and,", "if", "anticipated", "marketing", "approvals", "of", "taliglucerase", "alfa", "are", "granted", "in", "other", "jurisdictions,", "the", "progress", "of", "Pfizer", "s", "global", "commercialization", "efforts", "for", "taliglucerase", "alfa,", "the", "progress", "and", "results", "of", "our", "clinical", "trials,", "the", "duration", "and", "cost", "of", "discovery", "and", "preclinical", "development", "and", "laboratory", "testing", "and", "clinical", "trials", "for", "our", "product", "candidates,", "the", "timing", "and", "outcome", "of", "regulatory", "review", "of", "our", "product", "candidates,", "the", "costs", "involved", "in", "preparing,", "filing,", "prosecuting,", "maintaining,", "defending", "and", "enforcing", "patent", "claims", "and", "other", "intellectual", "property", "rights,", "the", "number", "and", "development", "requirements", "of", "other", "product", "candidates", "that", "we", "pursue", "and", "the", "costs", "of", "commercialization", "activities,", "including", "product", "marketing,", "sales", "and", "distribution."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p78_s0", "idA": "1006281_14_item7_p72_s0", "sentA": "We may need to finance our future cash needs through public or private equity offerings, debt financings, or corporate collaboration and licensing arrangements.", "sentB": "We may need to finance our future cash needs through corporate collaboration, licensing or similar arrangements, public or private equity offerings or debt financings.", "type": 2, "words": ["<tag1>", "We", "may", "need", "to", "finance", "our", "future", "cash", "needs", "through", "public", "or", "private", "equity", "offerings,", "debt", "financings,", "or", "corporate", "collaboration", "and", "licensing", "arrangements.", "<tag2>", "We", "may", "need", "to", "finance", "our", "future", "cash", "needs", "through", "corporate", "collaboration,", "licensing", "or", "similar", "arrangements,", "public", "or", "private", "equity", "offerings", "or", "debt", "financings.", "<tag3>"], "wordsA": ["We", "may", "need", "to", "finance", "our", "future", "cash", "needs", "through", "public", "or", "private", "equity", "offerings,", "debt", "financings,", "or", "corporate", "collaboration", "and", "licensing", "arrangements."], "wordsB": ["We", "may", "need", "to", "finance", "our", "future", "cash", "needs", "through", "corporate", "collaboration,", "licensing", "or", "similar", "arrangements,", "public", "or", "private", "equity", "offerings", "or", "debt", "financings."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p79_s1", "idA": "1006281_14_item7_p73_s1", "sentA": "We do not believe that inflation has had a material effect on our results of operations during the years ended December 31, 2011, 2012 or 2013.", "sentB": "We do not believe that inflation has had a material effect on our results of operations during the years ended December 31, 2012, 2013 or 2014.", "type": 2, "words": ["<tag1>", "We", "do", "not", "believe", "that", "inflation", "has", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2011,", "2012", "or", "2013.", "<tag2>", "We", "do", "not", "believe", "that", "inflation", "has", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2012,", "2013", "or", "2014.", "<tag3>"], "wordsA": ["We", "do", "not", "believe", "that", "inflation", "has", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2011,", "2012", "or", "2013."], "wordsB": ["We", "do", "not", "believe", "that", "inflation", "has", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2012,", "2013", "or", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p80_s1", "idA": "1006281_14_item7_p74_s1", "sentA": "We do not believe currency fluctuations have had a material effect on our results of operations during the years ended December 31, 2011, 2012 or 2013.", "sentB": "We do not believe currency fluctuations have had a material effect on our results of operations during the years ended December 31, 2012, 2013 or 2014.", "type": 2, "words": ["<tag1>", "We", "do", "not", "believe", "currency", "fluctuations", "have", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2011,", "2012", "or", "2013.", "<tag2>", "We", "do", "not", "believe", "currency", "fluctuations", "have", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2012,", "2013", "or", "2014.", "<tag3>"], "wordsA": ["We", "do", "not", "believe", "currency", "fluctuations", "have", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2011,", "2012", "or", "2013."], "wordsB": ["We", "do", "not", "believe", "currency", "fluctuations", "have", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2012,", "2013", "or", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p81_s0", "idA": "1006281_14_item7_p75_s0", "sentA": "We have no off-balance sheet arrangements as of December 31, 2012 and 2013.", "sentB": "We have no off-balance sheet arrangements as of December 31, 2013 and 2014.", "type": 2, "words": ["<tag1>", "We", "have", "no", "off-balance", "sheet", "arrangements", "as", "of", "December", "31,", "2012", "and", "2013.", "<tag2>", "We", "have", "no", "off-balance", "sheet", "arrangements", "as", "of", "December", "31,", "2013", "and", "2014.", "<tag3>"], "wordsA": ["We", "have", "no", "off-balance", "sheet", "arrangements", "as", "of", "December", "31,", "2012", "and", "2013."], "wordsB": ["We", "have", "no", "off-balance", "sheet", "arrangements", "as", "of", "December", "31,", "2013", "and", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p83_s0", "idA": "1006281_14_item7_p76_s0", "sentA": "The following table summarizes our significant contractual obligations at December 31, 2013:", "sentB": "The following table summarizes our significant contractual obligations at December 31, 2014:", "type": 2, "words": ["<tag1>", "The", "following", "table", "summarizes", "our", "significant", "contractual", "obligations", "at", "December", "31,", "2013:", "<tag2>", "The", "following", "table", "summarizes", "our", "significant", "contractual", "obligations", "at", "December", "31,", "2014:", "<tag3>"], "wordsA": ["The", "following", "table", "summarizes", "our", "significant", "contractual", "obligations", "at", "December", "31,", "2013:"], "wordsB": ["The", "following", "table", "summarizes", "our", "significant", "contractual", "obligations", "at", "December", "31,", "2014:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p84_s0", "idA": "1006281_14_item7_p77_s0", "sentA": "(1) Represents open purchase orders issued to certain suppliers and other vendors mainly in connection with our research and development activities that were outstanding as of December 31, 2013.", "sentB": "(1) Represents open purchase orders issued to certain suppliers and other vendors mainly in connection with our research and development activities that were outstanding as of December 31, 2014.", "type": 2, "words": ["<tag1>", "(1)", "Represents", "open", "purchase", "orders", "issued", "to", "certain", "suppliers", "and", "other", "vendors", "mainly", "in", "connection", "with", "our", "research", "and", "development", "activities", "that", "were", "outstanding", "as", "of", "December", "31,", "2013.", "<tag2>", "(1)", "Represents", "open", "purchase", "orders", "issued", "to", "certain", "suppliers", "and", "other", "vendors", "mainly", "in", "connection", "with", "our", "research", "and", "development", "activities", "that", "were", "outstanding", "as", "of", "December", "31,", "2014.", "<tag3>"], "wordsA": ["(1)", "Represents", "open", "purchase", "orders", "issued", "to", "certain", "suppliers", "and", "other", "vendors", "mainly", "in", "connection", "with", "our", "research", "and", "development", "activities", "that", "were", "outstanding", "as", "of", "December", "31,", "2013."], "wordsB": ["(1)", "Represents", "open", "purchase", "orders", "issued", "to", "certain", "suppliers", "and", "other", "vendors", "mainly", "in", "connection", "with", "our", "research", "and", "development", "activities", "that", "were", "outstanding", "as", "of", "December", "31,", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p85_s2", "idA": "1006281_14_item7_p78_s2", "sentA": "The royalty payments payable in connection with sales of each of our product candidates, if at all, shall not exceed low, single-digit percentages of net sales of the product.", "sentB": "The royalty payments payable in connection with sales of each of our product candidates, if any, shall not exceed low, single-digit percentages of net sales of the product.", "type": 2, "words": ["<tag1>", "The", "royalty", "payments", "payable", "in", "connection", "with", "sales", "of", "each", "of", "our", "product", "candidates,", "if", "at", "all,", "shall", "not", "exceed", "low,", "single-digit", "percentages", "of", "net", "sales", "of", "the", "product.", "<tag2>", "The", "royalty", "payments", "payable", "in", "connection", "with", "sales", "of", "each", "of", "our", "product", "candidates,", "if", "any,", "shall", "not", "exceed", "low,", "single-digit", "percentages", "of", "net", "sales", "of", "the", "product.", "<tag3>"], "wordsA": ["The", "royalty", "payments", "payable", "in", "connection", "with", "sales", "of", "each", "of", "our", "product", "candidates,", "if", "at", "all,", "shall", "not", "exceed", "low,", "single-digit", "percentages", "of", "net", "sales", "of", "the", "product."], "wordsB": ["The", "royalty", "payments", "payable", "in", "connection", "with", "sales", "of", "each", "of", "our", "product", "candidates,", "if", "any,", "shall", "not", "exceed", "low,", "single-digit", "percentages", "of", "net", "sales", "of", "the", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p9_s0", "idA": "1006281_14_item7_p7_s0", "sentA": "Since May 2012, taliglucerase alfa has been marketed in the United States by Pfizer, our commercialization partner, as provided in the Pfizer Agreement.", "sentB": "Since May 2012, taliglucerase alfa has been marketed in the United States by Pfizer Inc., or Pfizer, our commercialization partner, as provided in the exclusive license and supply agreement by and between Protalix Ltd., our wholly-owned subsidiary, and Pfizer, which we refer to as the Pfizer Agreement.", "type": 2, "words": ["<tag1>", "Since", "May", "2012,", "taliglucerase", "alfa", "has", "been", "marketed", "in", "the", "United", "States", "by", "Pfizer,", "our", "commercialization", "partner,", "as", "provided", "in", "the", "Pfizer", "Agreement.", "<tag2>", "Since", "May", "2012,", "taliglucerase", "alfa", "has", "been", "marketed", "in", "the", "United", "States", "by", "Pfizer", "Inc.,", "or", "Pfizer,", "our", "commercialization", "partner,", "as", "provided", "in", "the", "exclusive", "license", "and", "supply", "agreement", "by", "and", "between", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary,", "and", "Pfizer,", "which", "we", "refer", "to", "as", "the", "Pfizer", "Agreement.", "<tag3>"], "wordsA": ["Since", "May", "2012,", "taliglucerase", "alfa", "has", "been", "marketed", "in", "the", "United", "States", "by", "Pfizer,", "our", "commercialization", "partner,", "as", "provided", "in", "the", "Pfizer", "Agreement."], "wordsB": ["Since", "May", "2012,", "taliglucerase", "alfa", "has", "been", "marketed", "in", "the", "United", "States", "by", "Pfizer", "Inc.,", "or", "Pfizer,", "our", "commercialization", "partner,", "as", "provided", "in", "the", "exclusive", "license", "and", "supply", "agreement", "by", "and", "between", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary,", "and", "Pfizer,", "which", "we", "refer", "to", "as", "the", "Pfizer", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p9_s1", "idA": "1006281_14_item7_p7_s1", "sentA": "We granted Pfizer an exclusive, worldwide license to develop and commercialize taliglucerase alfa under the Pfizer Agreement, but we retained those rights in Israel and in Brazil.", "sentB": "We granted Pfizer an exclusive, worldwide license to develop and commercialize taliglucerase alfa under the Pfizer Agreement, but we retained those rights in Israel, and later in Brazil.", "type": 2, "words": ["<tag1>", "We", "granted", "Pfizer", "an", "exclusive,", "worldwide", "license", "to", "develop", "and", "commercialize", "taliglucerase", "alfa", "under", "the", "Pfizer", "Agreement,", "but", "we", "retained", "those", "rights", "in", "Israel", "and", "in", "Brazil.", "<tag2>", "We", "granted", "Pfizer", "an", "exclusive,", "worldwide", "license", "to", "develop", "and", "commercialize", "taliglucerase", "alfa", "under", "the", "Pfizer", "Agreement,", "but", "we", "retained", "those", "rights", "in", "Israel,", "and", "later", "in", "Brazil.", "<tag3>"], "wordsA": ["We", "granted", "Pfizer", "an", "exclusive,", "worldwide", "license", "to", "develop", "and", "commercialize", "taliglucerase", "alfa", "under", "the", "Pfizer", "Agreement,", "but", "we", "retained", "those", "rights", "in", "Israel", "and", "in", "Brazil."], "wordsB": ["We", "granted", "Pfizer", "an", "exclusive,", "worldwide", "license", "to", "develop", "and", "commercialize", "taliglucerase", "alfa", "under", "the", "Pfizer", "Agreement,", "but", "we", "retained", "those", "rights", "in", "Israel,", "and", "later", "in", "Brazil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p12_s1", "idA": "1006281_14_item7_p7_s2", "sentA": "We have agreed to a specific allocation between Protalix Ltd. and Pfizer of the responsibilities for the continued development efforts for taliglucerase alfa outside of Israel.", "sentB": "As consideration for the transfer of the commercialization and supply rights, we agreed to pay Pfizer a maximum amount of approximately $12.5 million from its net profits (as defined in the license and supply agreement) per year.", "type": 2, "words": ["<tag1>", "We", "have", "agreed", "to", "a", "specific", "allocation", "between", "Protalix", "Ltd.", "and", "Pfizer", "of", "the", "responsibilities", "for", "the", "continued", "development", "efforts", "for", "taliglucerase", "alfa", "outside", "of", "Israel.", "<tag2>", "As", "consideration", "for", "the", "transfer", "of", "the", "commercialization", "and", "supply", "rights,", "we", "agreed", "to", "pay", "Pfizer", "a", "maximum", "amount", "of", "approximately", "$12.5", "million", "from", "its", "net", "profits", "(as", "defined", "in", "the", "license", "and", "supply", "agreement)", "per", "year.", "<tag3>"], "wordsA": ["We", "have", "agreed", "to", "a", "specific", "allocation", "between", "Protalix", "Ltd.", "and", "Pfizer", "of", "the", "responsibilities", "for", "the", "continued", "development", "efforts", "for", "taliglucerase", "alfa", "outside", "of", "Israel."], "wordsB": ["As", "consideration", "for", "the", "transfer", "of", "the", "commercialization", "and", "supply", "rights,", "we", "agreed", "to", "pay", "Pfizer", "a", "maximum", "amount", "of", "approximately", "$12.5", "million", "from", "its", "net", "profits", "(as", "defined", "in", "the", "license", "and", "supply", "agreement)", "per", "year."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p9_s3", "idA": "1006281_14_item7_p7_s3", "sentA": "Since 2013, taliglucerase alfa has been marketed in Israel by Protalix Ltd.", "sentB": "Protalix Ltd. has been marketing taliglucerase alfa in Israel since 2013 and in Brazil since January 2014.", "type": 2, "words": ["<tag1>", "Since", "2013,", "taliglucerase", "alfa", "has", "been", "marketed", "in", "Israel", "by", "Protalix", "Ltd.", "<tag2>", "Protalix", "Ltd.", "has", "been", "marketing", "taliglucerase", "alfa", "in", "Israel", "since", "2013", "and", "in", "Brazil", "since", "January", "2014.", "<tag3>"], "wordsA": ["Since", "2013,", "taliglucerase", "alfa", "has", "been", "marketed", "in", "Israel", "by", "Protalix", "Ltd."], "wordsB": ["Protalix", "Ltd.", "has", "been", "marketing", "taliglucerase", "alfa", "in", "Israel", "since", "2013", "and", "in", "Brazil", "since", "January", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p10_s0", "idA": "1006281_14_item7_p8_s0", "sentA": "On June 18, 2013, we entered into the Brazil Agreement with Fiocruz for taliglucerase alfa.", "sentB": "On June 18, 2013, we entered into a Supply and Technology Transfer Agreement, or the Brazil Agreement, with Fiocruz, for taliglucerase alfa.", "type": 2, "words": ["<tag1>", "On", "June", "18,", "2013,", "we", "entered", "into", "the", "Brazil", "Agreement", "with", "Fiocruz", "for", "taliglucerase", "alfa.", "<tag2>", "On", "June", "18,", "2013,", "we", "entered", "into", "a", "Supply", "and", "Technology", "Transfer", "Agreement,", "or", "the", "Brazil", "Agreement,", "with", "Fiocruz,", "for", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["On", "June", "18,", "2013,", "we", "entered", "into", "the", "Brazil", "Agreement", "with", "Fiocruz", "for", "taliglucerase", "alfa."], "wordsB": ["On", "June", "18,", "2013,", "we", "entered", "into", "a", "Supply", "and", "Technology", "Transfer", "Agreement,", "or", "the", "Brazil", "Agreement,", "with", "Fiocruz,", "for", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p10_s4", "idA": "1006281_14_item7_p8_s4", "sentA": "Under the agreement, Fiocruz has committed to purchase at least approximately $40 million worth of taliglucerase alfa during the first two years of the term.", "sentB": "Under the agreement, Fiocruz committed to purchase at least approximately $40 million worth of taliglucerase alfa during the first two years of the term.", "type": 2, "words": ["<tag1>", "Under", "the", "agreement,", "Fiocruz", "has", "committed", "to", "purchase", "at", "least", "approximately", "$40", "million", "worth", "of", "taliglucerase", "alfa", "during", "the", "first", "two", "years", "of", "the", "term.", "<tag2>", "Under", "the", "agreement,", "Fiocruz", "committed", "to", "purchase", "at", "least", "approximately", "$40", "million", "worth", "of", "taliglucerase", "alfa", "during", "the", "first", "two", "years", "of", "the", "term.", "<tag3>"], "wordsA": ["Under", "the", "agreement,", "Fiocruz", "has", "committed", "to", "purchase", "at", "least", "approximately", "$40", "million", "worth", "of", "taliglucerase", "alfa", "during", "the", "first", "two", "years", "of", "the", "term."], "wordsB": ["Under", "the", "agreement,", "Fiocruz", "committed", "to", "purchase", "at", "least", "approximately", "$40", "million", "worth", "of", "taliglucerase", "alfa", "during", "the", "first", "two", "years", "of", "the", "term."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p10_s5", "idA": "1006281_14_item7_p8_s4", "sentA": "Under the agreement, Fiocruz has committed to purchase at least approximately $40 million worth of taliglucerase alfa during the first two years of the term.", "sentB": "Since the agreement went into effect, we have recorded revenues of approximately $3.5 million for sales of taliglucerase alfa to Fiocruz in 2014 and, during the first quarter of 2015, we received a purchase order for approximately $5.7 million of taliglucerase alfa out of which we have delivered approximately $1.7 million of the product.", "type": 2, "words": ["<tag1>", "Under", "the", "agreement,", "Fiocruz", "has", "committed", "to", "purchase", "at", "least", "approximately", "$40", "million", "worth", "of", "taliglucerase", "alfa", "during", "the", "first", "two", "years", "of", "the", "term.", "<tag2>", "Since", "the", "agreement", "went", "into", "effect,", "we", "have", "recorded", "revenues", "of", "approximately", "$3.5", "million", "for", "sales", "of", "taliglucerase", "alfa", "to", "Fiocruz", "in", "2014", "and,", "during", "the", "first", "quarter", "of", "2015,", "we", "received", "a", "purchase", "order", "for", "approximately", "$5.7", "million", "of", "taliglucerase", "alfa", "out", "of", "which", "we", "have", "delivered", "approximately", "$1.7", "million", "of", "the", "product.", "<tag3>"], "wordsA": ["Under", "the", "agreement,", "Fiocruz", "has", "committed", "to", "purchase", "at", "least", "approximately", "$40", "million", "worth", "of", "taliglucerase", "alfa", "during", "the", "first", "two", "years", "of", "the", "term."], "wordsB": ["Since", "the", "agreement", "went", "into", "effect,", "we", "have", "recorded", "revenues", "of", "approximately", "$3.5", "million", "for", "sales", "of", "taliglucerase", "alfa", "to", "Fiocruz", "in", "2014", "and,", "during", "the", "first", "quarter", "of", "2015,", "we", "received", "a", "purchase", "order", "for", "approximately", "$5.7", "million", "of", "taliglucerase", "alfa", "out", "of", "which", "we", "have", "delivered", "approximately", "$1.7", "million", "of", "the", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p11_s1", "idA": "1006281_14_item7_p8_s4", "sentA": "Under the agreement, Fiocruz has committed to purchase at least approximately $40 million worth of taliglucerase alfa during the first two years of the term.", "sentB": "All of the terms of the arrangement, including the minimum annual purchases, will apply during the additional term.", "type": 2, "words": ["<tag1>", "Under", "the", "agreement,", "Fiocruz", "has", "committed", "to", "purchase", "at", "least", "approximately", "$40", "million", "worth", "of", "taliglucerase", "alfa", "during", "the", "first", "two", "years", "of", "the", "term.", "<tag2>", "All", "of", "the", "terms", "of", "the", "arrangement,", "including", "the", "minimum", "annual", "purchases,", "will", "apply", "during", "the", "additional", "term.", "<tag3>"], "wordsA": ["Under", "the", "agreement,", "Fiocruz", "has", "committed", "to", "purchase", "at", "least", "approximately", "$40", "million", "worth", "of", "taliglucerase", "alfa", "during", "the", "first", "two", "years", "of", "the", "term."], "wordsB": ["All", "of", "the", "terms", "of", "the", "arrangement,", "including", "the", "minimum", "annual", "purchases,", "will", "apply", "during", "the", "additional", "term."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p10_s7", "idA": "1006281_14_item7_p8_s6", "sentA": "Additionally, we are not required to complete the final stage of the technology transfer until Fiocruz purchases at least approximately $280 million worth of taliglucerase alfa.", "sentB": "We are not required to complete the final stage of the technology transfer until Fiocruz purchases at least approximately $280 million worth of taliglucerase alfa.", "type": 2, "words": ["<tag1>", "Additionally,", "we", "are", "not", "required", "to", "complete", "the", "final", "stage", "of", "the", "technology", "transfer", "until", "Fiocruz", "purchases", "at", "least", "approximately", "$280", "million", "worth", "of", "taliglucerase", "alfa.", "<tag2>", "We", "are", "not", "required", "to", "complete", "the", "final", "stage", "of", "the", "technology", "transfer", "until", "Fiocruz", "purchases", "at", "least", "approximately", "$280", "million", "worth", "of", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["Additionally,", "we", "are", "not", "required", "to", "complete", "the", "final", "stage", "of", "the", "technology", "transfer", "until", "Fiocruz", "purchases", "at", "least", "approximately", "$280", "million", "worth", "of", "taliglucerase", "alfa."], "wordsB": ["We", "are", "not", "required", "to", "complete", "the", "final", "stage", "of", "the", "technology", "transfer", "until", "Fiocruz", "purchases", "at", "least", "approximately", "$280", "million", "worth", "of", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p11_s0", "idA": "1006281_14_item7_p8_s6", "sentA": "Additionally, we are not required to complete the final stage of the technology transfer until Fiocruz purchases at least approximately $280 million worth of taliglucerase alfa.", "sentB": "The Brazil Agreement may be extended for an additional five-year term, as needed, to complete the technology transfer.", "type": 2, "words": ["<tag1>", "Additionally,", "we", "are", "not", "required", "to", "complete", "the", "final", "stage", "of", "the", "technology", "transfer", "until", "Fiocruz", "purchases", "at", "least", "approximately", "$280", "million", "worth", "of", "taliglucerase", "alfa.", "<tag2>", "The", "Brazil", "Agreement", "may", "be", "extended", "for", "an", "additional", "five-year", "term,", "as", "needed,", "to", "complete", "the", "technology", "transfer.", "<tag3>"], "wordsA": ["Additionally,", "we", "are", "not", "required", "to", "complete", "the", "final", "stage", "of", "the", "technology", "transfer", "until", "Fiocruz", "purchases", "at", "least", "approximately", "$280", "million", "worth", "of", "taliglucerase", "alfa."], "wordsB": ["The", "Brazil", "Agreement", "may", "be", "extended", "for", "an", "additional", "five-year", "term,", "as", "needed,", "to", "complete", "the", "technology", "transfer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item7_p11_s2", "idA": "1006281_14_item7_p8_s6", "sentA": "Additionally, we are not required to complete the final stage of the technology transfer until Fiocruz purchases at least approximately $280 million worth of taliglucerase alfa.", "sentB": "Upon completion of the technology transfer, and subject to Fiocruz receiving approval from ANVISA to manufacture taliglucerase alfa in its facility in Brazil, the agreement will enter into the final term and will remain in effect until our last patent in Brazil expires.", "type": 2, "words": ["<tag1>", "Additionally,", "we", "are", "not", "required", "to", "complete", "the", "final", "stage", "of", "the", "technology", "transfer", "until", "Fiocruz", "purchases", "at", "least", "approximately", "$280", "million", "worth", "of", "taliglucerase", "alfa.", "<tag2>", "Upon", "completion", "of", "the", "technology", "transfer,", "and", "subject", "to", "Fiocruz", "receiving", "approval", "from", "ANVISA", "to", "manufacture", "taliglucerase", "alfa", "in", "its", "facility", "in", "Brazil,", "the", "agreement", "will", "enter", "into", "the", "final", "term", "and", "will", "remain", "in", "effect", "until", "our", "last", "patent", "in", "Brazil", "expires.", "<tag3>"], "wordsA": ["Additionally,", "we", "are", "not", "required", "to", "complete", "the", "final", "stage", "of", "the", "technology", "transfer", "until", "Fiocruz", "purchases", "at", "least", "approximately", "$280", "million", "worth", "of", "taliglucerase", "alfa."], "wordsB": ["Upon", "completion", "of", "the", "technology", "transfer,", "and", "subject", "to", "Fiocruz", "receiving", "approval", "from", "ANVISA", "to", "manufacture", "taliglucerase", "alfa", "in", "its", "facility", "in", "Brazil,", "the", "agreement", "will", "enter", "into", "the", "final", "term", "and", "will", "remain", "in", "effect", "until", "our", "last", "patent", "in", "Brazil", "expires."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p6_s0", "idA": "1006281_15_item7_p10_s0", "sentA": "On June 18, 2013, we entered into a Supply and Technology Transfer Agreement, or the Brazil Agreement, with Fiocruz, for taliglucerase alfa.", "sentB": "On June 18, 2013, we entered into the Brazil Agreement with Fiocruz.", "type": 2, "words": ["<tag1>", "On", "June", "18,", "2013,", "we", "entered", "into", "a", "Supply", "and", "Technology", "Transfer", "Agreement,", "or", "the", "Brazil", "Agreement,", "with", "Fiocruz,", "for", "taliglucerase", "alfa.", "<tag2>", "On", "June", "18,", "2013,", "we", "entered", "into", "the", "Brazil", "Agreement", "with", "Fiocruz.", "<tag3>"], "wordsA": ["On", "June", "18,", "2013,", "we", "entered", "into", "a", "Supply", "and", "Technology", "Transfer", "Agreement,", "or", "the", "Brazil", "Agreement,", "with", "Fiocruz,", "for", "taliglucerase", "alfa."], "wordsB": ["On", "June", "18,", "2013,", "we", "entered", "into", "the", "Brazil", "Agreement", "with", "Fiocruz."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p6_s1", "idA": "1006281_15_item7_p13_s1", "sentA": "The agency agreement will remain in effect with respect to the Brazil Agreement until the termination thereof.", "sentB": "Fiocruz's purchases of Uplyso to date have been significantly below certain agreed upon purchase milestones and, accordingly, we have the right to terminate the Brazil Agreement.", "type": 2, "words": ["<tag1>", "The", "agency", "agreement", "will", "remain", "in", "effect", "with", "respect", "to", "the", "Brazil", "Agreement", "until", "the", "termination", "thereof.", "<tag2>", "Fiocruz's", "purchases", "of", "Uplyso", "to", "date", "have", "been", "significantly", "below", "certain", "agreed", "upon", "purchase", "milestones", "and,", "accordingly,", "we", "have", "the", "right", "to", "terminate", "the", "Brazil", "Agreement.", "<tag3>"], "wordsA": ["The", "agency", "agreement", "will", "remain", "in", "effect", "with", "respect", "to", "the", "Brazil", "Agreement", "until", "the", "termination", "thereof."], "wordsB": ["Fiocruz's", "purchases", "of", "Uplyso", "to", "date", "have", "been", "significantly", "below", "certain", "agreed", "upon", "purchase", "milestones", "and,", "accordingly,", "we", "have", "the", "right", "to", "terminate", "the", "Brazil", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p7_s0", "idA": "1006281_15_item7_p16_s0", "sentA": "In addition to taliglucerase alfa, we are developing an innovative product pipeline using our ProCellEx protein expression system.", "sentB": "We are developing an innovative product pipeline using our ProCellEx protein expression system.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "taliglucerase", "alfa,", "we", "are", "developing", "an", "innovative", "product", "pipeline", "using", "our", "ProCellEx", "protein", "expression", "system.", "<tag2>", "We", "are", "developing", "an", "innovative", "product", "pipeline", "using", "our", "ProCellEx", "protein", "expression", "system.", "<tag3>"], "wordsA": ["In", "addition", "to", "taliglucerase", "alfa,", "we", "are", "developing", "an", "innovative", "product", "pipeline", "using", "our", "ProCellEx", "protein", "expression", "system."], "wordsB": ["We", "are", "developing", "an", "innovative", "product", "pipeline", "using", "our", "ProCellEx", "protein", "expression", "system."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p10_s0", "idA": "1006281_15_item7_p18_s0", "sentA": "(2) PRX-106, our oral antiTNF product candidate which is being developed as an orally-delivered anti inflammatory treatment for various inflammatory diseases using plant cells as a natural capsule for the expressed protein.", "sentB": "(3) OPRX-106, our oral antiTNF product candidate which is being developed as an orally-delivered anti-inflammatory treatment using plant cells as a natural capsule for the expressed protein.", "type": 2, "words": ["<tag1>", "(2)", "PRX-106,", "our", "oral", "antiTNF", "product", "candidate", "which", "is", "being", "developed", "as", "an", "orally-delivered", "anti", "inflammatory", "treatment", "for", "various", "inflammatory", "diseases", "using", "plant", "cells", "as", "a", "natural", "capsule", "for", "the", "expressed", "protein.", "<tag2>", "(3)", "OPRX-106,", "our", "oral", "antiTNF", "product", "candidate", "which", "is", "being", "developed", "as", "an", "orally-delivered", "anti-inflammatory", "treatment", "using", "plant", "cells", "as", "a", "natural", "capsule", "for", "the", "expressed", "protein.", "<tag3>"], "wordsA": ["(2)", "PRX-106,", "our", "oral", "antiTNF", "product", "candidate", "which", "is", "being", "developed", "as", "an", "orally-delivered", "anti", "inflammatory", "treatment", "for", "various", "inflammatory", "diseases", "using", "plant", "cells", "as", "a", "natural", "capsule", "for", "the", "expressed", "protein."], "wordsB": ["(3)", "OPRX-106,", "our", "oral", "antiTNF", "product", "candidate", "which", "is", "being", "developed", "as", "an", "orally-delivered", "anti-inflammatory", "treatment", "using", "plant", "cells", "as", "a", "natural", "capsule", "for", "the", "expressed", "protein."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p9_s0", "idA": "1006281_15_item7_p19_s0", "sentA": "(3) PRX-110, a proprietary plant cell recombinant human DNase under development for the treatment of cystic fibrosis, to be administered by inhalation.", "sentB": "(2) PRX-110, a proprietary plant cell recombinant human Deoxyribonuclease 1, or AIR DNase TM , under development for the treatment of cystic fibrosis, to be administered by inhalation.", "type": 2, "words": ["<tag1>", "(3)", "PRX-110,", "a", "proprietary", "plant", "cell", "recombinant", "human", "DNase", "under", "development", "for", "the", "treatment", "of", "cystic", "fibrosis,", "to", "be", "administered", "by", "inhalation.", "<tag2>", "(2)", "PRX-110,", "a", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1,", "or", "AIR", "DNase", "TM", ",", "under", "development", "for", "the", "treatment", "of", "cystic", "fibrosis,", "to", "be", "administered", "by", "inhalation.", "<tag3>"], "wordsA": ["(3)", "PRX-110,", "a", "proprietary", "plant", "cell", "recombinant", "human", "DNase", "under", "development", "for", "the", "treatment", "of", "cystic", "fibrosis,", "to", "be", "administered", "by", "inhalation."], "wordsB": ["(2)", "PRX-110,", "a", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1,", "or", "AIR", "DNase", "TM", ",", "under", "development", "for", "the", "treatment", "of", "cystic", "fibrosis,", "to", "be", "administered", "by", "inhalation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p10_s2", "idA": "1006281_15_item7_p19_s1", "sentA": "We expect to initiate a proof of concept efficacy study during 2015 and announce results by early 2016 .", "sentB": "We expect to initiate a proof of concept efficacy study in Ulcerative Colitis in mid-year, 2016.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "initiate", "a", "proof", "of", "concept", "efficacy", "study", "during", "2015", "and", "announce", "results", "by", "early", "2016", ".", "<tag2>", "We", "expect", "to", "initiate", "a", "proof", "of", "concept", "efficacy", "study", "in", "Ulcerative", "Colitis", "in", "mid-year,", "2016.", "<tag3>"], "wordsA": ["We", "expect", "to", "initiate", "a", "proof", "of", "concept", "efficacy", "study", "during", "2015", "and", "announce", "results", "by", "early", "2016", "."], "wordsB": ["We", "expect", "to", "initiate", "a", "proof", "of", "concept", "efficacy", "study", "in", "Ulcerative", "Colitis", "in", "mid-year,", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p9_s1", "idA": "1006281_15_item7_p19_s1", "sentA": "We expect to initiate a proof of concept efficacy study during 2015 and announce results by early 2016 .", "sentB": "We have commenced a phase I clinical trial of AIR DNase in healthy volunteers and intend to initiate a proof of concept efficacy study in patients in mid-year, 2016.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "initiate", "a", "proof", "of", "concept", "efficacy", "study", "during", "2015", "and", "announce", "results", "by", "early", "2016", ".", "<tag2>", "We", "have", "commenced", "a", "phase", "I", "clinical", "trial", "of", "AIR", "DNase", "in", "healthy", "volunteers", "and", "intend", "to", "initiate", "a", "proof", "of", "concept", "efficacy", "study", "in", "patients", "in", "mid-year,", "2016.", "<tag3>"], "wordsA": ["We", "expect", "to", "initiate", "a", "proof", "of", "concept", "efficacy", "study", "during", "2015", "and", "announce", "results", "by", "early", "2016", "."], "wordsB": ["We", "have", "commenced", "a", "phase", "I", "clinical", "trial", "of", "AIR", "DNase", "in", "healthy", "volunteers", "and", "intend", "to", "initiate", "a", "proof", "of", "concept", "efficacy", "study", "in", "patients", "in", "mid-year,", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p1_s1", "idA": "1006281_15_item7_p1_s1", "sentA": "Using our ProCellEx system, we are developing a pipeline of proprietary, clinically superior versions of recombinant therapeutic proteins that primarily target large, established pharmaceutical markets and that rely upon known biological mechanisms of action.", "sentB": "We developed our first commercial drug product, Elelyso TM , using our ProCellEx system and we are focused on utilizing the system to develop a pipeline of proprietary, clinically superior versions of recombinant therapeutic proteins that primarily target large, established pharmaceutical markets and that in most cases rely upon known biological mechanisms of action.", "type": 2, "words": ["<tag1>", "Using", "our", "ProCellEx", "system,", "we", "are", "developing", "a", "pipeline", "of", "proprietary,", "clinically", "superior", "versions", "of", "recombinant", "therapeutic", "proteins", "that", "primarily", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "rely", "upon", "known", "biological", "mechanisms", "of", "action.", "<tag2>", "We", "developed", "our", "first", "commercial", "drug", "product,", "Elelyso", "TM", ",", "using", "our", "ProCellEx", "system", "and", "we", "are", "focused", "on", "utilizing", "the", "system", "to", "develop", "a", "pipeline", "of", "proprietary,", "clinically", "superior", "versions", "of", "recombinant", "therapeutic", "proteins", "that", "primarily", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "in", "most", "cases", "rely", "upon", "known", "biological", "mechanisms", "of", "action.", "<tag3>"], "wordsA": ["Using", "our", "ProCellEx", "system,", "we", "are", "developing", "a", "pipeline", "of", "proprietary,", "clinically", "superior", "versions", "of", "recombinant", "therapeutic", "proteins", "that", "primarily", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "rely", "upon", "known", "biological", "mechanisms", "of", "action."], "wordsB": ["We", "developed", "our", "first", "commercial", "drug", "product,", "Elelyso", "TM", ",", "using", "our", "ProCellEx", "system", "and", "we", "are", "focused", "on", "utilizing", "the", "system", "to", "develop", "a", "pipeline", "of", "proprietary,", "clinically", "superior", "versions", "of", "recombinant", "therapeutic", "proteins", "that", "primarily", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "in", "most", "cases", "rely", "upon", "known", "biological", "mechanisms", "of", "action."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p1_s2", "idA": "1006281_15_item7_p1_s3", "sentA": "With our experience, and having successfully developed Elelyso, our first drug product, we believe ProCellEx will enable us to develop additional proprietary recombinant proteins that are therapeutically superior to existing recombinant proteins currently marketed for the same indications.", "sentB": "With our experience to date, we believe ProCellEx will enable us to develop additional proprietary recombinant proteins that are therapeutically superior to existing recombinant proteins currently marketed for the same indications.", "type": 2, "words": ["<tag1>", "With", "our", "experience,", "and", "having", "successfully", "developed", "Elelyso,", "our", "first", "drug", "product,", "we", "believe", "ProCellEx", "will", "enable", "us", "to", "develop", "additional", "proprietary", "recombinant", "proteins", "that", "are", "therapeutically", "superior", "to", "existing", "recombinant", "proteins", "currently", "marketed", "for", "the", "same", "indications.", "<tag2>", "With", "our", "experience", "to", "date,", "we", "believe", "ProCellEx", "will", "enable", "us", "to", "develop", "additional", "proprietary", "recombinant", "proteins", "that", "are", "therapeutically", "superior", "to", "existing", "recombinant", "proteins", "currently", "marketed", "for", "the", "same", "indications.", "<tag3>"], "wordsA": ["With", "our", "experience,", "and", "having", "successfully", "developed", "Elelyso,", "our", "first", "drug", "product,", "we", "believe", "ProCellEx", "will", "enable", "us", "to", "develop", "additional", "proprietary", "recombinant", "proteins", "that", "are", "therapeutically", "superior", "to", "existing", "recombinant", "proteins", "currently", "marketed", "for", "the", "same", "indications."], "wordsB": ["With", "our", "experience", "to", "date,", "we", "believe", "ProCellEx", "will", "enable", "us", "to", "develop", "additional", "proprietary", "recombinant", "proteins", "that", "are", "therapeutically", "superior", "to", "existing", "recombinant", "proteins", "currently", "marketed", "for", "the", "same", "indications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p11_s0", "idA": "1006281_15_item7_p21_s0", "sentA": "Except for the rights to commercialize taliglucerase alfa worldwide (other than Brazil and Israel), which we licensed to Pfizer, we hold the worldwide commercialization rights to all of our proprietary development candidates.", "sentB": "Except for the rights to commercialize taliglucerase alfa worldwide (other than Brazil), which we licensed to Pfizer, we hold the worldwide commercialization rights to all of our proprietary development candidates.", "type": 2, "words": ["<tag1>", "Except", "for", "the", "rights", "to", "commercialize", "taliglucerase", "alfa", "worldwide", "(other", "than", "Brazil", "and", "Israel),", "which", "we", "licensed", "to", "Pfizer,", "we", "hold", "the", "worldwide", "commercialization", "rights", "to", "all", "of", "our", "proprietary", "development", "candidates.", "<tag2>", "Except", "for", "the", "rights", "to", "commercialize", "taliglucerase", "alfa", "worldwide", "(other", "than", "Brazil),", "which", "we", "licensed", "to", "Pfizer,", "we", "hold", "the", "worldwide", "commercialization", "rights", "to", "all", "of", "our", "proprietary", "development", "candidates.", "<tag3>"], "wordsA": ["Except", "for", "the", "rights", "to", "commercialize", "taliglucerase", "alfa", "worldwide", "(other", "than", "Brazil", "and", "Israel),", "which", "we", "licensed", "to", "Pfizer,", "we", "hold", "the", "worldwide", "commercialization", "rights", "to", "all", "of", "our", "proprietary", "development", "candidates."], "wordsB": ["Except", "for", "the", "rights", "to", "commercialize", "taliglucerase", "alfa", "worldwide", "(other", "than", "Brazil),", "which", "we", "licensed", "to", "Pfizer,", "we", "hold", "the", "worldwide", "commercialization", "rights", "to", "all", "of", "our", "proprietary", "development", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p15_s0", "idA": "1006281_15_item7_p25_s0", "sentA": "Currently, our source of revenues comes from sales of taliglucerase alfa pursuant to our license agreement with Pfizer, our sales of taliglucerase alfa in Israel and Brazil and from milestone payments under the Pfizer Agreement.", "sentB": "Until we entered into the Amended Pfizer Agreement, our sole source of revenues came from sales of taliglucerase alfa pursuant to our license with Pfizer, our sales of taliglucerase alfa in Israel and Brazil and from milestone payments under the Pfizer Agreement.", "type": 2, "words": ["<tag1>", "Currently,", "our", "source", "of", "revenues", "comes", "from", "sales", "of", "taliglucerase", "alfa", "pursuant", "to", "our", "license", "agreement", "with", "Pfizer,", "our", "sales", "of", "taliglucerase", "alfa", "in", "Israel", "and", "Brazil", "and", "from", "milestone", "payments", "under", "the", "Pfizer", "Agreement.", "<tag2>", "Until", "we", "entered", "into", "the", "Amended", "Pfizer", "Agreement,", "our", "sole", "source", "of", "revenues", "came", "from", "sales", "of", "taliglucerase", "alfa", "pursuant", "to", "our", "license", "with", "Pfizer,", "our", "sales", "of", "taliglucerase", "alfa", "in", "Israel", "and", "Brazil", "and", "from", "milestone", "payments", "under", "the", "Pfizer", "Agreement.", "<tag3>"], "wordsA": ["Currently,", "our", "source", "of", "revenues", "comes", "from", "sales", "of", "taliglucerase", "alfa", "pursuant", "to", "our", "license", "agreement", "with", "Pfizer,", "our", "sales", "of", "taliglucerase", "alfa", "in", "Israel", "and", "Brazil", "and", "from", "milestone", "payments", "under", "the", "Pfizer", "Agreement."], "wordsB": ["Until", "we", "entered", "into", "the", "Amended", "Pfizer", "Agreement,", "our", "sole", "source", "of", "revenues", "came", "from", "sales", "of", "taliglucerase", "alfa", "pursuant", "to", "our", "license", "with", "Pfizer,", "our", "sales", "of", "taliglucerase", "alfa", "in", "Israel", "and", "Brazil", "and", "from", "milestone", "payments", "under", "the", "Pfizer", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p15_s1", "idA": "1006281_15_item7_p25_s0", "sentA": "Currently, our source of revenues comes from sales of taliglucerase alfa pursuant to our license agreement with Pfizer, our sales of taliglucerase alfa in Israel and Brazil and from milestone payments under the Pfizer Agreement.", "sentB": "Following entry into the Amended Pfizer Agreement, our primary source of revenues will be our sales of taliglucerase alfa in Brazil, which have not been substantial to date.", "type": 2, "words": ["<tag1>", "Currently,", "our", "source", "of", "revenues", "comes", "from", "sales", "of", "taliglucerase", "alfa", "pursuant", "to", "our", "license", "agreement", "with", "Pfizer,", "our", "sales", "of", "taliglucerase", "alfa", "in", "Israel", "and", "Brazil", "and", "from", "milestone", "payments", "under", "the", "Pfizer", "Agreement.", "<tag2>", "Following", "entry", "into", "the", "Amended", "Pfizer", "Agreement,", "our", "primary", "source", "of", "revenues", "will", "be", "our", "sales", "of", "taliglucerase", "alfa", "in", "Brazil,", "which", "have", "not", "been", "substantial", "to", "date.", "<tag3>"], "wordsA": ["Currently,", "our", "source", "of", "revenues", "comes", "from", "sales", "of", "taliglucerase", "alfa", "pursuant", "to", "our", "license", "agreement", "with", "Pfizer,", "our", "sales", "of", "taliglucerase", "alfa", "in", "Israel", "and", "Brazil", "and", "from", "milestone", "payments", "under", "the", "Pfizer", "Agreement."], "wordsB": ["Following", "entry", "into", "the", "Amended", "Pfizer", "Agreement,", "our", "primary", "source", "of", "revenues", "will", "be", "our", "sales", "of", "taliglucerase", "alfa", "in", "Brazil,", "which", "have", "not", "been", "substantial", "to", "date."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p16_s0", "idA": "1006281_15_item7_p26_s0", "sentA": "We recognize revenue from milestone payments received pursuant to the Pfizer Agreement in accordance with guidance regarding revenue recognition and accounting for revenue arrangements with multiple deliverables.", "sentB": "We recognized revenue from milestone payments received pursuant to the Pfizer Agreement in accordance with guidance regarding revenue recognition and accounting for revenue arrangements with multiple deliverables.", "type": 2, "words": ["<tag1>", "We", "recognize", "revenue", "from", "milestone", "payments", "received", "pursuant", "to", "the", "Pfizer", "Agreement", "in", "accordance", "with", "guidance", "regarding", "revenue", "recognition", "and", "accounting", "for", "revenue", "arrangements", "with", "multiple", "deliverables.", "<tag2>", "We", "recognized", "revenue", "from", "milestone", "payments", "received", "pursuant", "to", "the", "Pfizer", "Agreement", "in", "accordance", "with", "guidance", "regarding", "revenue", "recognition", "and", "accounting", "for", "revenue", "arrangements", "with", "multiple", "deliverables.", "<tag3>"], "wordsA": ["We", "recognize", "revenue", "from", "milestone", "payments", "received", "pursuant", "to", "the", "Pfizer", "Agreement", "in", "accordance", "with", "guidance", "regarding", "revenue", "recognition", "and", "accounting", "for", "revenue", "arrangements", "with", "multiple", "deliverables."], "wordsB": ["We", "recognized", "revenue", "from", "milestone", "payments", "received", "pursuant", "to", "the", "Pfizer", "Agreement", "in", "accordance", "with", "guidance", "regarding", "revenue", "recognition", "and", "accounting", "for", "revenue", "arrangements", "with", "multiple", "deliverables."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p16_s2", "idA": "1006281_15_item7_p26_s2", "sentA": "If we determine that there are multiple units of accounting, the consideration from the arrangement is allocated among the separate units based on a relative fair value allocation.", "sentB": "If we determined that there are multiple units of accounting, the consideration from the arrangement is allocated among the separate units based on a relative fair value allocation.", "type": 2, "words": ["<tag1>", "If", "we", "determine", "that", "there", "are", "multiple", "units", "of", "accounting,", "the", "consideration", "from", "the", "arrangement", "is", "allocated", "among", "the", "separate", "units", "based", "on", "a", "relative", "fair", "value", "allocation.", "<tag2>", "If", "we", "determined", "that", "there", "are", "multiple", "units", "of", "accounting,", "the", "consideration", "from", "the", "arrangement", "is", "allocated", "among", "the", "separate", "units", "based", "on", "a", "relative", "fair", "value", "allocation.", "<tag3>"], "wordsA": ["If", "we", "determine", "that", "there", "are", "multiple", "units", "of", "accounting,", "the", "consideration", "from", "the", "arrangement", "is", "allocated", "among", "the", "separate", "units", "based", "on", "a", "relative", "fair", "value", "allocation."], "wordsB": ["If", "we", "determined", "that", "there", "are", "multiple", "units", "of", "accounting,", "the", "consideration", "from", "the", "arrangement", "is", "allocated", "among", "the", "separate", "units", "based", "on", "a", "relative", "fair", "value", "allocation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p16_s4", "idA": "1006281_15_item7_p26_s4", "sentA": "As the arrangement with Pfizer requires our continued involvement with respect to the proposed commercialization of taliglucerase alfa, the non-refundable, up-front license payments we received from Pfizer are deferred and recognized over the related performance period.", "sentB": "As the arrangement with Pfizer required our continued involvement with respect to the proposed commercialization of taliglucerase alfa, the non-refundable, up-front license payments we received from Pfizer to date have been deferred and recognized over the related performance period.", "type": 2, "words": ["<tag1>", "As", "the", "arrangement", "with", "Pfizer", "requires", "our", "continued", "involvement", "with", "respect", "to", "the", "proposed", "commercialization", "of", "taliglucerase", "alfa,", "the", "non-refundable,", "up-front", "license", "payments", "we", "received", "from", "Pfizer", "are", "deferred", "and", "recognized", "over", "the", "related", "performance", "period.", "<tag2>", "As", "the", "arrangement", "with", "Pfizer", "required", "our", "continued", "involvement", "with", "respect", "to", "the", "proposed", "commercialization", "of", "taliglucerase", "alfa,", "the", "non-refundable,", "up-front", "license", "payments", "we", "received", "from", "Pfizer", "to", "date", "have", "been", "deferred", "and", "recognized", "over", "the", "related", "performance", "period.", "<tag3>"], "wordsA": ["As", "the", "arrangement", "with", "Pfizer", "requires", "our", "continued", "involvement", "with", "respect", "to", "the", "proposed", "commercialization", "of", "taliglucerase", "alfa,", "the", "non-refundable,", "up-front", "license", "payments", "we", "received", "from", "Pfizer", "are", "deferred", "and", "recognized", "over", "the", "related", "performance", "period."], "wordsB": ["As", "the", "arrangement", "with", "Pfizer", "required", "our", "continued", "involvement", "with", "respect", "to", "the", "proposed", "commercialization", "of", "taliglucerase", "alfa,", "the", "non-refundable,", "up-front", "license", "payments", "we", "received", "from", "Pfizer", "to", "date", "have", "been", "deferred", "and", "recognized", "over", "the", "related", "performance", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p16_s5", "idA": "1006281_15_item7_p26_s5", "sentA": "We estimated the performance period of 14 years based on the date that the last relevant patent relating to taliglucerase alfa expires.", "sentB": "For this purpose, we estimated the performance period of 14 years based on the date that the last relevant patent relating to taliglucerase alfa expires.", "type": 2, "words": ["<tag1>", "We", "estimated", "the", "performance", "period", "of", "14", "years", "based", "on", "the", "date", "that", "the", "last", "relevant", "patent", "relating", "to", "taliglucerase", "alfa", "expires.", "<tag2>", "For", "this", "purpose,", "we", "estimated", "the", "performance", "period", "of", "14", "years", "based", "on", "the", "date", "that", "the", "last", "relevant", "patent", "relating", "to", "taliglucerase", "alfa", "expires.", "<tag3>"], "wordsA": ["We", "estimated", "the", "performance", "period", "of", "14", "years", "based", "on", "the", "date", "that", "the", "last", "relevant", "patent", "relating", "to", "taliglucerase", "alfa", "expires."], "wordsB": ["For", "this", "purpose,", "we", "estimated", "the", "performance", "period", "of", "14", "years", "based", "on", "the", "date", "that", "the", "last", "relevant", "patent", "relating", "to", "taliglucerase", "alfa", "expires."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p17_s0", "idA": "1006281_15_item7_p27_s0", "sentA": "Under the terms and conditions of the Pfizer Agreement, we are entitled to 40% of the net profits or loss from sales of taliglucerase alfa by Pfizer and reimbursement of our certain related expenses we incur in connection with Pfizer s sales (other than those related to sales in Israel and Brazil).", "sentB": "Under the terms and conditions of the initial Pfizer Agreement, we were entitled to 40% of the net profits or loss from sales of taliglucerase alfa by Pfizer and reimbursement of our certain related expenses we incur in connection with Pfizer s sales (other than those related to sales in Israel and Brazil).", "type": 2, "words": ["<tag1>", "Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement,", "we", "are", "entitled", "to", "40%", "of", "the", "net", "profits", "or", "loss", "from", "sales", "of", "taliglucerase", "alfa", "by", "Pfizer", "and", "reimbursement", "of", "our", "certain", "related", "expenses", "we", "incur", "in", "connection", "with", "Pfizer", "s", "sales", "(other", "than", "those", "related", "to", "sales", "in", "Israel", "and", "Brazil).", "<tag2>", "Under", "the", "terms", "and", "conditions", "of", "the", "initial", "Pfizer", "Agreement,", "we", "were", "entitled", "to", "40%", "of", "the", "net", "profits", "or", "loss", "from", "sales", "of", "taliglucerase", "alfa", "by", "Pfizer", "and", "reimbursement", "of", "our", "certain", "related", "expenses", "we", "incur", "in", "connection", "with", "Pfizer", "s", "sales", "(other", "than", "those", "related", "to", "sales", "in", "Israel", "and", "Brazil).", "<tag3>"], "wordsA": ["Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement,", "we", "are", "entitled", "to", "40%", "of", "the", "net", "profits", "or", "loss", "from", "sales", "of", "taliglucerase", "alfa", "by", "Pfizer", "and", "reimbursement", "of", "our", "certain", "related", "expenses", "we", "incur", "in", "connection", "with", "Pfizer", "s", "sales", "(other", "than", "those", "related", "to", "sales", "in", "Israel", "and", "Brazil)."], "wordsB": ["Under", "the", "terms", "and", "conditions", "of", "the", "initial", "Pfizer", "Agreement,", "we", "were", "entitled", "to", "40%", "of", "the", "net", "profits", "or", "loss", "from", "sales", "of", "taliglucerase", "alfa", "by", "Pfizer", "and", "reimbursement", "of", "our", "certain", "related", "expenses", "we", "incur", "in", "connection", "with", "Pfizer", "s", "sales", "(other", "than", "those", "related", "to", "sales", "in", "Israel", "and", "Brazil)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p21_s2", "idA": "1006281_15_item7_p27_s0", "sentA": "Under the terms and conditions of the Pfizer Agreement, we are entitled to 40% of the net profits or loss from sales of taliglucerase alfa by Pfizer and reimbursement of our certain related expenses we incur in connection with Pfizer s sales (other than those related to sales in Israel and Brazil).", "sentB": "Under the Amended Pfizer Agreement, Pfizer is responsible for 100% of expenses, and entitled to all of the revenues, globally, for Elelyso, excluding Brazil where we are responsible for all expenses and retain all revenues.", "type": 2, "words": ["<tag1>", "Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement,", "we", "are", "entitled", "to", "40%", "of", "the", "net", "profits", "or", "loss", "from", "sales", "of", "taliglucerase", "alfa", "by", "Pfizer", "and", "reimbursement", "of", "our", "certain", "related", "expenses", "we", "incur", "in", "connection", "with", "Pfizer", "s", "sales", "(other", "than", "those", "related", "to", "sales", "in", "Israel", "and", "Brazil).", "<tag2>", "Under", "the", "Amended", "Pfizer", "Agreement,", "Pfizer", "is", "responsible", "for", "100%", "of", "expenses,", "and", "entitled", "to", "all", "of", "the", "revenues,", "globally,", "for", "Elelyso,", "excluding", "Brazil", "where", "we", "are", "responsible", "for", "all", "expenses", "and", "retain", "all", "revenues.", "<tag3>"], "wordsA": ["Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement,", "we", "are", "entitled", "to", "40%", "of", "the", "net", "profits", "or", "loss", "from", "sales", "of", "taliglucerase", "alfa", "by", "Pfizer", "and", "reimbursement", "of", "our", "certain", "related", "expenses", "we", "incur", "in", "connection", "with", "Pfizer", "s", "sales", "(other", "than", "those", "related", "to", "sales", "in", "Israel", "and", "Brazil)."], "wordsB": ["Under", "the", "Amended", "Pfizer", "Agreement,", "Pfizer", "is", "responsible", "for", "100%", "of", "expenses,", "and", "entitled", "to", "all", "of", "the", "revenues,", "globally,", "for", "Elelyso,", "excluding", "Brazil", "where", "we", "are", "responsible", "for", "all", "expenses", "and", "retain", "all", "revenues."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p3_s1", "idA": "1006281_15_item7_p27_s0", "sentA": "Under the terms and conditions of the Pfizer Agreement, we are entitled to 40% of the net profits or loss from sales of taliglucerase alfa by Pfizer and reimbursement of our certain related expenses we incur in connection with Pfizer s sales (other than those related to sales in Israel and Brazil).", "sentB": "Under our current arrangement with Pfizer, which was amended in October 2015, Pfizer has the rights to market Elelyso globally except for Brazil, where we have the sole marketing rights; Pfizer is responsible for 100% of expenses, and entitled to all of the revenues, globally, for Elelyso, excluding Brazil, and we are responsible for all expenses and retain all revenues from sales in Brazil.", "type": 2, "words": ["<tag1>", "Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement,", "we", "are", "entitled", "to", "40%", "of", "the", "net", "profits", "or", "loss", "from", "sales", "of", "taliglucerase", "alfa", "by", "Pfizer", "and", "reimbursement", "of", "our", "certain", "related", "expenses", "we", "incur", "in", "connection", "with", "Pfizer", "s", "sales", "(other", "than", "those", "related", "to", "sales", "in", "Israel", "and", "Brazil).", "<tag2>", "Under", "our", "current", "arrangement", "with", "Pfizer,", "which", "was", "amended", "in", "October", "2015,", "Pfizer", "has", "the", "rights", "to", "market", "Elelyso", "globally", "except", "for", "Brazil,", "where", "we", "have", "the", "sole", "marketing", "rights;", "Pfizer", "is", "responsible", "for", "100%", "of", "expenses,", "and", "entitled", "to", "all", "of", "the", "revenues,", "globally,", "for", "Elelyso,", "excluding", "Brazil,", "and", "we", "are", "responsible", "for", "all", "expenses", "and", "retain", "all", "revenues", "from", "sales", "in", "Brazil.", "<tag3>"], "wordsA": ["Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement,", "we", "are", "entitled", "to", "40%", "of", "the", "net", "profits", "or", "loss", "from", "sales", "of", "taliglucerase", "alfa", "by", "Pfizer", "and", "reimbursement", "of", "our", "certain", "related", "expenses", "we", "incur", "in", "connection", "with", "Pfizer", "s", "sales", "(other", "than", "those", "related", "to", "sales", "in", "Israel", "and", "Brazil)."], "wordsB": ["Under", "our", "current", "arrangement", "with", "Pfizer,", "which", "was", "amended", "in", "October", "2015,", "Pfizer", "has", "the", "rights", "to", "market", "Elelyso", "globally", "except", "for", "Brazil,", "where", "we", "have", "the", "sole", "marketing", "rights;", "Pfizer", "is", "responsible", "for", "100%", "of", "expenses,", "and", "entitled", "to", "all", "of", "the", "revenues,", "globally,", "for", "Elelyso,", "excluding", "Brazil,", "and", "we", "are", "responsible", "for", "all", "expenses", "and", "retain", "all", "revenues", "from", "sales", "in", "Brazil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p21_s1", "idA": "1006281_15_item7_p27_s1", "sentA": "We hold all rights to taliglucerase alfa in Israel and Brazil.", "sentB": "As part of the sale, we agreed to transfer our rights to Elelyso in Israel to Pfizer while gaining full rights to Elelyso in Brazil.", "type": 2, "words": ["<tag1>", "We", "hold", "all", "rights", "to", "taliglucerase", "alfa", "in", "Israel", "and", "Brazil.", "<tag2>", "As", "part", "of", "the", "sale,", "we", "agreed", "to", "transfer", "our", "rights", "to", "Elelyso", "in", "Israel", "to", "Pfizer", "while", "gaining", "full", "rights", "to", "Elelyso", "in", "Brazil.", "<tag3>"], "wordsA": ["We", "hold", "all", "rights", "to", "taliglucerase", "alfa", "in", "Israel", "and", "Brazil."], "wordsB": ["As", "part", "of", "the", "sale,", "we", "agreed", "to", "transfer", "our", "rights", "to", "Elelyso", "in", "Israel", "to", "Pfizer", "while", "gaining", "full", "rights", "to", "Elelyso", "in", "Brazil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p17_s1", "idA": "1006281_15_item7_p27_s2", "sentA": "We recognize our share of net profit or loss under the Pfizer Agreement based on reports we receive from Pfizer summarizing the results of the collaborative activities under the agreement for the applicable period.", "sentB": "We recognized our share of net profit or loss under the initial Pfizer Agreement (prior to its amendment) based on reports we receive from Pfizer summarizing the results of the collaborative activities under the former agreement for the applicable period.", "type": 2, "words": ["<tag1>", "We", "recognize", "our", "share", "of", "net", "profit", "or", "loss", "under", "the", "Pfizer", "Agreement", "based", "on", "reports", "we", "receive", "from", "Pfizer", "summarizing", "the", "results", "of", "the", "collaborative", "activities", "under", "the", "agreement", "for", "the", "applicable", "period.", "<tag2>", "We", "recognized", "our", "share", "of", "net", "profit", "or", "loss", "under", "the", "initial", "Pfizer", "Agreement", "(prior", "to", "its", "amendment)", "based", "on", "reports", "we", "receive", "from", "Pfizer", "summarizing", "the", "results", "of", "the", "collaborative", "activities", "under", "the", "former", "agreement", "for", "the", "applicable", "period.", "<tag3>"], "wordsA": ["We", "recognize", "our", "share", "of", "net", "profit", "or", "loss", "under", "the", "Pfizer", "Agreement", "based", "on", "reports", "we", "receive", "from", "Pfizer", "summarizing", "the", "results", "of", "the", "collaborative", "activities", "under", "the", "agreement", "for", "the", "applicable", "period."], "wordsB": ["We", "recognized", "our", "share", "of", "net", "profit", "or", "loss", "under", "the", "initial", "Pfizer", "Agreement", "(prior", "to", "its", "amendment)", "based", "on", "reports", "we", "receive", "from", "Pfizer", "summarizing", "the", "results", "of", "the", "collaborative", "activities", "under", "the", "former", "agreement", "for", "the", "applicable", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p18_s0", "idA": "1006281_15_item7_p28_s0", "sentA": "Under the terms of the Pfizer Agreement, for its subsidiaries operating outside the United States, financial information is included based on the fiscal year ending November 30, while financial information for the U.S. entity is included based on the fiscal year ending December 31.", "sentB": "Under the terms of the initial Pfizer Agreement, for its subsidiaries operating outside the United States, financial information is included based on the fiscal year ending November 30, while financial information for the U.S. entity is included based on the fiscal year ending December 31.", "type": 2, "words": ["<tag1>", "Under", "the", "terms", "of", "the", "Pfizer", "Agreement,", "for", "its", "subsidiaries", "operating", "outside", "the", "United", "States,", "financial", "information", "is", "included", "based", "on", "the", "fiscal", "year", "ending", "November", "30,", "while", "financial", "information", "for", "the", "U.S.", "entity", "is", "included", "based", "on", "the", "fiscal", "year", "ending", "December", "31.", "<tag2>", "Under", "the", "terms", "of", "the", "initial", "Pfizer", "Agreement,", "for", "its", "subsidiaries", "operating", "outside", "the", "United", "States,", "financial", "information", "is", "included", "based", "on", "the", "fiscal", "year", "ending", "November", "30,", "while", "financial", "information", "for", "the", "U.S.", "entity", "is", "included", "based", "on", "the", "fiscal", "year", "ending", "December", "31.", "<tag3>"], "wordsA": ["Under", "the", "terms", "of", "the", "Pfizer", "Agreement,", "for", "its", "subsidiaries", "operating", "outside", "the", "United", "States,", "financial", "information", "is", "included", "based", "on", "the", "fiscal", "year", "ending", "November", "30,", "while", "financial", "information", "for", "the", "U.S.", "entity", "is", "included", "based", "on", "the", "fiscal", "year", "ending", "December", "31."], "wordsB": ["Under", "the", "terms", "of", "the", "initial", "Pfizer", "Agreement,", "for", "its", "subsidiaries", "operating", "outside", "the", "United", "States,", "financial", "information", "is", "included", "based", "on", "the", "fiscal", "year", "ending", "November", "30,", "while", "financial", "information", "for", "the", "U.S.", "entity", "is", "included", "based", "on", "the", "fiscal", "year", "ending", "December", "31."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p3_s2", "idA": "1006281_15_item7_p29_s1", "sentA": "The revenues represent our cost with respect to the product sold.", "sentB": "Pfizer is no longer entitled to any payments with respect to sales of Elelyso in Brazil.", "type": 2, "words": ["<tag1>", "The", "revenues", "represent", "our", "cost", "with", "respect", "to", "the", "product", "sold.", "<tag2>", "Pfizer", "is", "no", "longer", "entitled", "to", "any", "payments", "with", "respect", "to", "sales", "of", "Elelyso", "in", "Brazil.", "<tag3>"], "wordsA": ["The", "revenues", "represent", "our", "cost", "with", "respect", "to", "the", "product", "sold."], "wordsB": ["Pfizer", "is", "no", "longer", "entitled", "to", "any", "payments", "with", "respect", "to", "sales", "of", "Elelyso", "in", "Brazil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p5_s1", "idA": "1006281_15_item7_p29_s1", "sentA": "The revenues represent our cost with respect to the product sold.", "sentB": "As part of the Stock Purchase Agreement, Pfizer agreed to a 180-day lock-up with respect to the purchased shares of common stock.", "type": 2, "words": ["<tag1>", "The", "revenues", "represent", "our", "cost", "with", "respect", "to", "the", "product", "sold.", "<tag2>", "As", "part", "of", "the", "Stock", "Purchase", "Agreement,", "Pfizer", "agreed", "to", "a", "180-day", "lock-up", "with", "respect", "to", "the", "purchased", "shares", "of", "common", "stock.", "<tag3>"], "wordsA": ["The", "revenues", "represent", "our", "cost", "with", "respect", "to", "the", "product", "sold."], "wordsB": ["As", "part", "of", "the", "Stock", "Purchase", "Agreement,", "Pfizer", "agreed", "to", "a", "180-day", "lock-up", "with", "respect", "to", "the", "purchased", "shares", "of", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p2_s0", "idA": "1006281_15_item7_p2_s0", "sentA": "On May 1, 2012, the U.S. Food and Drug Administration, or the FDA, approved for sale our first commercial product, taliglucerase alfa for injection, which is being marketed in the United States and Israel under the brand name Elelyso, as an enzyme replacement therapy, or ERT, for the long-term treatment of adult patients with a confirmed diagnosis of type 1 Gaucher disease.", "sentB": "On May 1, 2012, the FDA approved for sale our first commercial product, taliglucerase alfa for injection, an enzyme replacement therapy, or ERT, for the long-term treatment of adult patients with a confirmed diagnosis of type 1 Gaucher disease.", "type": 2, "words": ["<tag1>", "On", "May", "1,", "2012,", "the", "U.S.", "Food", "and", "Drug", "Administration,", "or", "the", "FDA,", "approved", "for", "sale", "our", "first", "commercial", "product,", "taliglucerase", "alfa", "for", "injection,", "which", "is", "being", "marketed", "in", "the", "United", "States", "and", "Israel", "under", "the", "brand", "name", "Elelyso,", "as", "an", "enzyme", "replacement", "therapy,", "or", "ERT,", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease.", "<tag2>", "On", "May", "1,", "2012,", "the", "FDA", "approved", "for", "sale", "our", "first", "commercial", "product,", "taliglucerase", "alfa", "for", "injection,", "an", "enzyme", "replacement", "therapy,", "or", "ERT,", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease.", "<tag3>"], "wordsA": ["On", "May", "1,", "2012,", "the", "U.S.", "Food", "and", "Drug", "Administration,", "or", "the", "FDA,", "approved", "for", "sale", "our", "first", "commercial", "product,", "taliglucerase", "alfa", "for", "injection,", "which", "is", "being", "marketed", "in", "the", "United", "States", "and", "Israel", "under", "the", "brand", "name", "Elelyso,", "as", "an", "enzyme", "replacement", "therapy,", "or", "ERT,", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease."], "wordsB": ["On", "May", "1,", "2012,", "the", "FDA", "approved", "for", "sale", "our", "first", "commercial", "product,", "taliglucerase", "alfa", "for", "injection,", "an", "enzyme", "replacement", "therapy,", "or", "ERT,", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p2_s1", "idA": "1006281_15_item7_p2_s1", "sentA": "Subsequently, taliglucerase alfa was approved by ANVISA in March 2013, by the Israeli MOH in September 2012 and by other regulatory agencies in other countries.", "sentB": "Subsequently, taliglucerase alfa was approved for marketing by the regulatory authorities of other countries.", "type": 2, "words": ["<tag1>", "Subsequently,", "taliglucerase", "alfa", "was", "approved", "by", "ANVISA", "in", "March", "2013,", "by", "the", "Israeli", "MOH", "in", "September", "2012", "and", "by", "other", "regulatory", "agencies", "in", "other", "countries.", "<tag2>", "Subsequently,", "taliglucerase", "alfa", "was", "approved", "for", "marketing", "by", "the", "regulatory", "authorities", "of", "other", "countries.", "<tag3>"], "wordsA": ["Subsequently,", "taliglucerase", "alfa", "was", "approved", "by", "ANVISA", "in", "March", "2013,", "by", "the", "Israeli", "MOH", "in", "September", "2012", "and", "by", "other", "regulatory", "agencies", "in", "other", "countries."], "wordsB": ["Subsequently,", "taliglucerase", "alfa", "was", "approved", "for", "marketing", "by", "the", "regulatory", "authorities", "of", "other", "countries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p25_s0", "idA": "1006281_15_item7_p30_s2", "sentA": "Amounts collected from customers and remitted to governmental authorities, which represents value-added taxes related to Elelyso sales in Israel, are presented on a net basis in our Consolidated Statements of Operations, in that taxes billed to customers are not included as a component of net product revenues.", "sentB": "The following summarized financial information related to our share in the former collaboration, including our rights to Elelyso in Israel, have been segregated from continuing operations and have been reported as discontinued operations in our consolidated statements of operations (in thousands):", "type": 2, "words": ["<tag1>", "Amounts", "collected", "from", "customers", "and", "remitted", "to", "governmental", "authorities,", "which", "represents", "value-added", "taxes", "related", "to", "Elelyso", "sales", "in", "Israel,", "are", "presented", "on", "a", "net", "basis", "in", "our", "Consolidated", "Statements", "of", "Operations,", "in", "that", "taxes", "billed", "to", "customers", "are", "not", "included", "as", "a", "component", "of", "net", "product", "revenues.", "<tag2>", "The", "following", "summarized", "financial", "information", "related", "to", "our", "share", "in", "the", "former", "collaboration,", "including", "our", "rights", "to", "Elelyso", "in", "Israel,", "have", "been", "segregated", "from", "continuing", "operations", "and", "have", "been", "reported", "as", "discontinued", "operations", "in", "our", "consolidated", "statements", "of", "operations", "(in", "thousands):", "<tag3>"], "wordsA": ["Amounts", "collected", "from", "customers", "and", "remitted", "to", "governmental", "authorities,", "which", "represents", "value-added", "taxes", "related", "to", "Elelyso", "sales", "in", "Israel,", "are", "presented", "on", "a", "net", "basis", "in", "our", "Consolidated", "Statements", "of", "Operations,", "in", "that", "taxes", "billed", "to", "customers", "are", "not", "included", "as", "a", "component", "of", "net", "product", "revenues."], "wordsB": ["The", "following", "summarized", "financial", "information", "related", "to", "our", "share", "in", "the", "former", "collaboration,", "including", "our", "rights", "to", "Elelyso", "in", "Israel,", "have", "been", "segregated", "from", "continuing", "operations", "and", "have", "been", "reported", "as", "discontinued", "operations", "in", "our", "consolidated", "statements", "of", "operations", "(in", "thousands):"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p29_s0", "idA": "1006281_15_item7_p34_s0", "sentA": "We anticipate incurring increasing costs in connection with the continued development of all four of the product candidates in our pipeline.", "sentB": "We anticipate incurring increasing costs in connection with the continued development of all of the product candidates in our pipeline.", "type": 2, "words": ["<tag1>", "We", "anticipate", "incurring", "increasing", "costs", "in", "connection", "with", "the", "continued", "development", "of", "all", "four", "of", "the", "product", "candidates", "in", "our", "pipeline.", "<tag2>", "We", "anticipate", "incurring", "increasing", "costs", "in", "connection", "with", "the", "continued", "development", "of", "all", "of", "the", "product", "candidates", "in", "our", "pipeline.", "<tag3>"], "wordsA": ["We", "anticipate", "incurring", "increasing", "costs", "in", "connection", "with", "the", "continued", "development", "of", "all", "four", "of", "the", "product", "candidates", "in", "our", "pipeline."], "wordsB": ["We", "anticipate", "incurring", "increasing", "costs", "in", "connection", "with", "the", "continued", "development", "of", "all", "of", "the", "product", "candidates", "in", "our", "pipeline."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p2_s2", "idA": "1006281_15_item7_p3_s0", "sentA": "Taliglucerase alfa is being marketed under the name Uplyso in Brazil and certain other Latin American countries.", "sentB": "Taliglucerase alfa is being marketed under the name Uplyso TM in Brazil and certain other Latin American countries, and as Elelyso in all other territories.", "type": 2, "words": ["<tag1>", "Taliglucerase", "alfa", "is", "being", "marketed", "under", "the", "name", "Uplyso", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries.", "<tag2>", "Taliglucerase", "alfa", "is", "being", "marketed", "under", "the", "name", "Uplyso", "TM", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries,", "and", "as", "Elelyso", "in", "all", "other", "territories.", "<tag3>"], "wordsA": ["Taliglucerase", "alfa", "is", "being", "marketed", "under", "the", "name", "Uplyso", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries."], "wordsB": ["Taliglucerase", "alfa", "is", "being", "marketed", "under", "the", "name", "Uplyso", "TM", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries,", "and", "as", "Elelyso", "in", "all", "other", "territories."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p6_s2", "idA": "1006281_15_item7_p3_s0", "sentA": "Taliglucerase alfa is being marketed under the name Uplyso in Brazil and certain other Latin American countries.", "sentB": "Notwithstanding the low purchase amounts, we are, at this time, continuing to supply Uplyso to Fiocruz under the Brazil Agreement, and patients continue to be treated with Uplyso in Brazil.", "type": 2, "words": ["<tag1>", "Taliglucerase", "alfa", "is", "being", "marketed", "under", "the", "name", "Uplyso", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries.", "<tag2>", "Notwithstanding", "the", "low", "purchase", "amounts,", "we", "are,", "at", "this", "time,", "continuing", "to", "supply", "Uplyso", "to", "Fiocruz", "under", "the", "Brazil", "Agreement,", "and", "patients", "continue", "to", "be", "treated", "with", "Uplyso", "in", "Brazil.", "<tag3>"], "wordsA": ["Taliglucerase", "alfa", "is", "being", "marketed", "under", "the", "name", "Uplyso", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries."], "wordsB": ["Notwithstanding", "the", "low", "purchase", "amounts,", "we", "are,", "at", "this", "time,", "continuing", "to", "supply", "Uplyso", "to", "Fiocruz", "under", "the", "Brazil", "Agreement,", "and", "patients", "continue", "to", "be", "treated", "with", "Uplyso", "in", "Brazil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p5_s0", "idA": "1006281_15_item7_p46_s0", "sentA": "For purposes of determining the fair value of the restricted shares of common stock granted to employees during the fiscal year ended December 31, 2013, our management used the fair value of our common stock which was the closing sale price of our common stock on the NYSE MKT on the date of grant.", "sentB": "On October 12, 2015, we also entered into a Stock Purchase Agreement with Pfizer pursuant to which we issued 5,649,079 shares of our common stock for an aggregate purchase price equal to $10.0 million subject to certain other terms set forth in the Stock Purchase Agreement.", "type": 2, "words": ["<tag1>", "For", "purposes", "of", "determining", "the", "fair", "value", "of", "the", "restricted", "shares", "of", "common", "stock", "granted", "to", "employees", "during", "the", "fiscal", "year", "ended", "December", "31,", "2013,", "our", "management", "used", "the", "fair", "value", "of", "our", "common", "stock", "which", "was", "the", "closing", "sale", "price", "of", "our", "common", "stock", "on", "the", "NYSE", "MKT", "on", "the", "date", "of", "grant.", "<tag2>", "On", "October", "12,", "2015,", "we", "also", "entered", "into", "a", "Stock", "Purchase", "Agreement", "with", "Pfizer", "pursuant", "to", "which", "we", "issued", "5,649,079", "shares", "of", "our", "common", "stock", "for", "an", "aggregate", "purchase", "price", "equal", "to", "$10.0", "million", "subject", "to", "certain", "other", "terms", "set", "forth", "in", "the", "Stock", "Purchase", "Agreement.", "<tag3>"], "wordsA": ["For", "purposes", "of", "determining", "the", "fair", "value", "of", "the", "restricted", "shares", "of", "common", "stock", "granted", "to", "employees", "during", "the", "fiscal", "year", "ended", "December", "31,", "2013,", "our", "management", "used", "the", "fair", "value", "of", "our", "common", "stock", "which", "was", "the", "closing", "sale", "price", "of", "our", "common", "stock", "on", "the", "NYSE", "MKT", "on", "the", "date", "of", "grant."], "wordsB": ["On", "October", "12,", "2015,", "we", "also", "entered", "into", "a", "Stock", "Purchase", "Agreement", "with", "Pfizer", "pursuant", "to", "which", "we", "issued", "5,649,079", "shares", "of", "our", "common", "stock", "for", "an", "aggregate", "purchase", "price", "equal", "to", "$10.0", "million", "subject", "to", "certain", "other", "terms", "set", "forth", "in", "the", "Stock", "Purchase", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p45_s0", "idA": "1006281_15_item7_p50_s0", "sentA": "The risk-free interest rate described above has been based on the implied yield of U.S. federal reserve zero coupon government bonds.", "sentB": "The risk-free interest rate used in the valuation of the options is based on the implied yield of U.S. federal reserve zero coupon government bonds.", "type": 2, "words": ["<tag1>", "The", "risk-free", "interest", "rate", "described", "above", "has", "been", "based", "on", "the", "implied", "yield", "of", "U.S.", "federal", "reserve", "zero", "coupon", "government", "bonds.", "<tag2>", "The", "risk-free", "interest", "rate", "used", "in", "the", "valuation", "of", "the", "options", "is", "based", "on", "the", "implied", "yield", "of", "U.S.", "federal", "reserve", "zero", "coupon", "government", "bonds.", "<tag3>"], "wordsA": ["The", "risk-free", "interest", "rate", "described", "above", "has", "been", "based", "on", "the", "implied", "yield", "of", "U.S.", "federal", "reserve", "zero", "coupon", "government", "bonds."], "wordsB": ["The", "risk-free", "interest", "rate", "used", "in", "the", "valuation", "of", "the", "options", "is", "based", "on", "the", "implied", "yield", "of", "U.S.", "federal", "reserve", "zero", "coupon", "government", "bonds."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p47_s0", "idA": "1006281_15_item7_p52_s0", "sentA": "We recorded revenue of $13.7 million for the year ended December 31, 2014, an increase of approximately $3.2 million, or 30%, compared to revenue of $10.5 million for the year ended December 31, 2013.", "sentB": "We recorded revenues of $4.4 million for the year ended December 31, 2015, an increase of approximately $841,000, or 24%, compared to revenues of $3.5 million for the year ended December 31, 2014.", "type": 2, "words": ["<tag1>", "We", "recorded", "revenue", "of", "$13.7", "million", "for", "the", "year", "ended", "December", "31,", "2014,", "an", "increase", "of", "approximately", "$3.2", "million,", "or", "30%,", "compared", "to", "revenue", "of", "$10.5", "million", "for", "the", "year", "ended", "December", "31,", "2013.", "<tag2>", "We", "recorded", "revenues", "of", "$4.4", "million", "for", "the", "year", "ended", "December", "31,", "2015,", "an", "increase", "of", "approximately", "$841,000,", "or", "24%,", "compared", "to", "revenues", "of", "$3.5", "million", "for", "the", "year", "ended", "December", "31,", "2014.", "<tag3>"], "wordsA": ["We", "recorded", "revenue", "of", "$13.7", "million", "for", "the", "year", "ended", "December", "31,", "2014,", "an", "increase", "of", "approximately", "$3.2", "million,", "or", "30%,", "compared", "to", "revenue", "of", "$10.5", "million", "for", "the", "year", "ended", "December", "31,", "2013."], "wordsB": ["We", "recorded", "revenues", "of", "$4.4", "million", "for", "the", "year", "ended", "December", "31,", "2015,", "an", "increase", "of", "approximately", "$841,000,", "or", "24%,", "compared", "to", "revenues", "of", "$3.5", "million", "for", "the", "year", "ended", "December", "31,", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p53_s0", "idA": "1006281_15_item7_p52_s0", "sentA": "We recorded revenue of $13.7 million for the year ended December 31, 2014, an increase of approximately $3.2 million, or 30%, compared to revenue of $10.5 million for the year ended December 31, 2013.", "sentB": "We recorded revenue of $3.5 million for the year ended December 31, 2014, and no revenues for the year ended December 31, 2013.", "type": 2, "words": ["<tag1>", "We", "recorded", "revenue", "of", "$13.7", "million", "for", "the", "year", "ended", "December", "31,", "2014,", "an", "increase", "of", "approximately", "$3.2", "million,", "or", "30%,", "compared", "to", "revenue", "of", "$10.5", "million", "for", "the", "year", "ended", "December", "31,", "2013.", "<tag2>", "We", "recorded", "revenue", "of", "$3.5", "million", "for", "the", "year", "ended", "December", "31,", "2014,", "and", "no", "revenues", "for", "the", "year", "ended", "December", "31,", "2013.", "<tag3>"], "wordsA": ["We", "recorded", "revenue", "of", "$13.7", "million", "for", "the", "year", "ended", "December", "31,", "2014,", "an", "increase", "of", "approximately", "$3.2", "million,", "or", "30%,", "compared", "to", "revenue", "of", "$10.5", "million", "for", "the", "year", "ended", "December", "31,", "2013."], "wordsB": ["We", "recorded", "revenue", "of", "$3.5", "million", "for", "the", "year", "ended", "December", "31,", "2014,", "and", "no", "revenues", "for", "the", "year", "ended", "December", "31,", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p21_s3", "idA": "1006281_15_item7_p52_s1", "sentA": "Revenues for the year ended December 31, 2014 include $5.2 million of products sold in Israel and $3.5 million in Brazil.", "sentB": "The Amended Pfizer Agreement eliminates Pfizer s entitlement to annual payments of up to $12.5 million in relation to commercialization of Elelyso in Brazil.", "type": 2, "words": ["<tag1>", "Revenues", "for", "the", "year", "ended", "December", "31,", "2014", "include", "$5.2", "million", "of", "products", "sold", "in", "Israel", "and", "$3.5", "million", "in", "Brazil.", "<tag2>", "The", "Amended", "Pfizer", "Agreement", "eliminates", "Pfizer", "s", "entitlement", "to", "annual", "payments", "of", "up", "to", "$12.5", "million", "in", "relation", "to", "commercialization", "of", "Elelyso", "in", "Brazil.", "<tag3>"], "wordsA": ["Revenues", "for", "the", "year", "ended", "December", "31,", "2014", "include", "$5.2", "million", "of", "products", "sold", "in", "Israel", "and", "$3.5", "million", "in", "Brazil."], "wordsB": ["The", "Amended", "Pfizer", "Agreement", "eliminates", "Pfizer", "s", "entitlement", "to", "annual", "payments", "of", "up", "to", "$12.5", "million", "in", "relation", "to", "commercialization", "of", "Elelyso", "in", "Brazil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p47_s1", "idA": "1006281_15_item7_p52_s1", "sentA": "Revenues for the year ended December 31, 2014 include $5.2 million of products sold in Israel and $3.5 million in Brazil.", "sentB": "Revenues represent products sold in Brazil.", "type": 2, "words": ["<tag1>", "Revenues", "for", "the", "year", "ended", "December", "31,", "2014", "include", "$5.2", "million", "of", "products", "sold", "in", "Israel", "and", "$3.5", "million", "in", "Brazil.", "<tag2>", "Revenues", "represent", "products", "sold", "in", "Brazil.", "<tag3>"], "wordsA": ["Revenues", "for", "the", "year", "ended", "December", "31,", "2014", "include", "$5.2", "million", "of", "products", "sold", "in", "Israel", "and", "$3.5", "million", "in", "Brazil."], "wordsB": ["Revenues", "represent", "products", "sold", "in", "Brazil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p53_s1", "idA": "1006281_15_item7_p52_s1", "sentA": "Revenues for the year ended December 31, 2014 include $5.2 million of products sold in Israel and $3.5 million in Brazil.", "sentB": "Revenues for the year ended December 31, 2014 represent products sold in Brazil.", "type": 2, "words": ["<tag1>", "Revenues", "for", "the", "year", "ended", "December", "31,", "2014", "include", "$5.2", "million", "of", "products", "sold", "in", "Israel", "and", "$3.5", "million", "in", "Brazil.", "<tag2>", "Revenues", "for", "the", "year", "ended", "December", "31,", "2014", "represent", "products", "sold", "in", "Brazil.", "<tag3>"], "wordsA": ["Revenues", "for", "the", "year", "ended", "December", "31,", "2014", "include", "$5.2", "million", "of", "products", "sold", "in", "Israel", "and", "$3.5", "million", "in", "Brazil."], "wordsB": ["Revenues", "for", "the", "year", "ended", "December", "31,", "2014", "represent", "products", "sold", "in", "Brazil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p48_s0", "idA": "1006281_15_item7_p55_s0", "sentA": "Cost of revenues was $9.1 million for the year ended December 31, 2014, an increase of $3.6 million, or 67%, compared to the cost of revenues of $5.4 million for the year ended December 31, 2013.", "sentB": "Cost of revenues was $730,000 for the year ended December 31, 2015, an increase of $100,000, or 16%, compared to the cost of revenues of $630,000 for the year ended December 31, 2014.", "type": 2, "words": ["<tag1>", "Cost", "of", "revenues", "was", "$9.1", "million", "for", "the", "year", "ended", "December", "31,", "2014,", "an", "increase", "of", "$3.6", "million,", "or", "67%,", "compared", "to", "the", "cost", "of", "revenues", "of", "$5.4", "million", "for", "the", "year", "ended", "December", "31,", "2013.", "<tag2>", "Cost", "of", "revenues", "was", "$730,000", "for", "the", "year", "ended", "December", "31,", "2015,", "an", "increase", "of", "$100,000,", "or", "16%,", "compared", "to", "the", "cost", "of", "revenues", "of", "$630,000", "for", "the", "year", "ended", "December", "31,", "2014.", "<tag3>"], "wordsA": ["Cost", "of", "revenues", "was", "$9.1", "million", "for", "the", "year", "ended", "December", "31,", "2014,", "an", "increase", "of", "$3.6", "million,", "or", "67%,", "compared", "to", "the", "cost", "of", "revenues", "of", "$5.4", "million", "for", "the", "year", "ended", "December", "31,", "2013."], "wordsB": ["Cost", "of", "revenues", "was", "$730,000", "for", "the", "year", "ended", "December", "31,", "2015,", "an", "increase", "of", "$100,000,", "or", "16%,", "compared", "to", "the", "cost", "of", "revenues", "of", "$630,000", "for", "the", "year", "ended", "December", "31,", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p49_s0", "idA": "1006281_15_item7_p56_s0", "sentA": "Research and development expenses were $29.8 million for the year ended December 31, 2014, a decrease of $3.6 million, or 11% from $33.3 million for the year ended December 31, 2013.", "sentB": "Research and development expenses were $24.9 million for the year ended December 31, 2015, a decrease of $2.5 million, or 9% from $27.4 million for the year ended December 31, 2014.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expenses", "were", "$29.8", "million", "for", "the", "year", "ended", "December", "31,", "2014,", "a", "decrease", "of", "$3.6", "million,", "or", "11%", "from", "$33.3", "million", "for", "the", "year", "ended", "December", "31,", "2013.", "<tag2>", "Research", "and", "development", "expenses", "were", "$24.9", "million", "for", "the", "year", "ended", "December", "31,", "2015,", "a", "decrease", "of", "$2.5", "million,", "or", "9%", "from", "$27.4", "million", "for", "the", "year", "ended", "December", "31,", "2014.", "<tag3>"], "wordsA": ["Research", "and", "development", "expenses", "were", "$29.8", "million", "for", "the", "year", "ended", "December", "31,", "2014,", "a", "decrease", "of", "$3.6", "million,", "or", "11%", "from", "$33.3", "million", "for", "the", "year", "ended", "December", "31,", "2013."], "wordsB": ["Research", "and", "development", "expenses", "were", "$24.9", "million", "for", "the", "year", "ended", "December", "31,", "2015,", "a", "decrease", "of", "$2.5", "million,", "or", "9%", "from", "$27.4", "million", "for", "the", "year", "ended", "December", "31,", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p55_s1", "idA": "1006281_15_item7_p56_s1", "sentA": "The decrease resulted primarily from a decrease of $1.4 million in payroll and related expenses primarily due to a decrease in share-based compensation and a decrease of $1.0 million in cost of materials.", "sentB": "The decrease resulted primarily from a decrease of $1.5 million in payroll and related expenses primarily due to a decrease in share-based compensation and a decrease of $1.0 million in cost of materials.", "type": 2, "words": ["<tag1>", "The", "decrease", "resulted", "primarily", "from", "a", "decrease", "of", "$1.4", "million", "in", "payroll", "and", "related", "expenses", "primarily", "due", "to", "a", "decrease", "in", "share-based", "compensation", "and", "a", "decrease", "of", "$1.0", "million", "in", "cost", "of", "materials.", "<tag2>", "The", "decrease", "resulted", "primarily", "from", "a", "decrease", "of", "$1.5", "million", "in", "payroll", "and", "related", "expenses", "primarily", "due", "to", "a", "decrease", "in", "share-based", "compensation", "and", "a", "decrease", "of", "$1.0", "million", "in", "cost", "of", "materials.", "<tag3>"], "wordsA": ["The", "decrease", "resulted", "primarily", "from", "a", "decrease", "of", "$1.4", "million", "in", "payroll", "and", "related", "expenses", "primarily", "due", "to", "a", "decrease", "in", "share-based", "compensation", "and", "a", "decrease", "of", "$1.0", "million", "in", "cost", "of", "materials."], "wordsB": ["The", "decrease", "resulted", "primarily", "from", "a", "decrease", "of", "$1.5", "million", "in", "payroll", "and", "related", "expenses", "primarily", "due", "to", "a", "decrease", "in", "share-based", "compensation", "and", "a", "decrease", "of", "$1.0", "million", "in", "cost", "of", "materials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p57_s0", "idA": "1006281_15_item7_p58_s0", "sentA": "General and administrative expenses were $9.7 million for the year ended December 31, 2014, an increase of $1.3 million, or 15%, from $8.4 million for the year ended December 31, 2013.", "sentB": "Selling, general and administrative expenses were $9.2 million for the year ended December 31, 2014, an increase of $1.2 million, or 15%, from $8.1 million for the year ended December 31, 2013.", "type": 2, "words": ["<tag1>", "General", "and", "administrative", "expenses", "were", "$9.7", "million", "for", "the", "year", "ended", "December", "31,", "2014,", "an", "increase", "of", "$1.3", "million,", "or", "15%,", "from", "$8.4", "million", "for", "the", "year", "ended", "December", "31,", "2013.", "<tag2>", "Selling,", "general", "and", "administrative", "expenses", "were", "$9.2", "million", "for", "the", "year", "ended", "December", "31,", "2014,", "an", "increase", "of", "$1.2", "million,", "or", "15%,", "from", "$8.1", "million", "for", "the", "year", "ended", "December", "31,", "2013.", "<tag3>"], "wordsA": ["General", "and", "administrative", "expenses", "were", "$9.7", "million", "for", "the", "year", "ended", "December", "31,", "2014,", "an", "increase", "of", "$1.3", "million,", "or", "15%,", "from", "$8.4", "million", "for", "the", "year", "ended", "December", "31,", "2013."], "wordsB": ["Selling,", "general", "and", "administrative", "expenses", "were", "$9.2", "million", "for", "the", "year", "ended", "December", "31,", "2014,", "an", "increase", "of", "$1.2", "million,", "or", "15%,", "from", "$8.1", "million", "for", "the", "year", "ended", "December", "31,", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p51_s1", "idA": "1006281_15_item7_p58_s1", "sentA": "The increase resulted primarily from sales and marketing expenses of approximately $1.8 million, primarily in connection with sales in Brazil, which was partially offset by a decrease of $383,000 in salaries expense.", "sentB": "The decrease resulted primarily from a decrease of $885,000 in sales and marketing expenses and $532,000 in costs related to salaries expense.", "type": 2, "words": ["<tag1>", "The", "increase", "resulted", "primarily", "from", "sales", "and", "marketing", "expenses", "of", "approximately", "$1.8", "million,", "primarily", "in", "connection", "with", "sales", "in", "Brazil,", "which", "was", "partially", "offset", "by", "a", "decrease", "of", "$383,000", "in", "salaries", "expense.", "<tag2>", "The", "decrease", "resulted", "primarily", "from", "a", "decrease", "of", "$885,000", "in", "sales", "and", "marketing", "expenses", "and", "$532,000", "in", "costs", "related", "to", "salaries", "expense.", "<tag3>"], "wordsA": ["The", "increase", "resulted", "primarily", "from", "sales", "and", "marketing", "expenses", "of", "approximately", "$1.8", "million,", "primarily", "in", "connection", "with", "sales", "in", "Brazil,", "which", "was", "partially", "offset", "by", "a", "decrease", "of", "$383,000", "in", "salaries", "expense."], "wordsB": ["The", "decrease", "resulted", "primarily", "from", "a", "decrease", "of", "$885,000", "in", "sales", "and", "marketing", "expenses", "and", "$532,000", "in", "costs", "related", "to", "salaries", "expense."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p57_s1", "idA": "1006281_15_item7_p58_s1", "sentA": "The increase resulted primarily from sales and marketing expenses of approximately $1.8 million, primarily in connection with sales in Brazil, which was partially offset by a decrease of $383,000 in salaries expense.", "sentB": "The increase resulted primarily from sales and marketing expenses of approximately $1.5 million, which was partially offset by a decrease of $470,000 in salaries expense.", "type": 2, "words": ["<tag1>", "The", "increase", "resulted", "primarily", "from", "sales", "and", "marketing", "expenses", "of", "approximately", "$1.8", "million,", "primarily", "in", "connection", "with", "sales", "in", "Brazil,", "which", "was", "partially", "offset", "by", "a", "decrease", "of", "$383,000", "in", "salaries", "expense.", "<tag2>", "The", "increase", "resulted", "primarily", "from", "sales", "and", "marketing", "expenses", "of", "approximately", "$1.5", "million,", "which", "was", "partially", "offset", "by", "a", "decrease", "of", "$470,000", "in", "salaries", "expense.", "<tag3>"], "wordsA": ["The", "increase", "resulted", "primarily", "from", "sales", "and", "marketing", "expenses", "of", "approximately", "$1.8", "million,", "primarily", "in", "connection", "with", "sales", "in", "Brazil,", "which", "was", "partially", "offset", "by", "a", "decrease", "of", "$383,000", "in", "salaries", "expense."], "wordsB": ["The", "increase", "resulted", "primarily", "from", "sales", "and", "marketing", "expenses", "of", "approximately", "$1.5", "million,", "which", "was", "partially", "offset", "by", "a", "decrease", "of", "$470,000", "in", "salaries", "expense."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p52_s0", "idA": "1006281_15_item7_p59_s0", "sentA": "Financial expenses were $4.7 million for the year ended December 31, 2014, compared to $674,000 for the year ended December 31, 2013.", "sentB": "Financial expenses were $3.6 million for the year ended December 31, 2015, compared to $4.7 million for the year ended December 31, 2014.", "type": 2, "words": ["<tag1>", "Financial", "expenses", "were", "$4.7", "million", "for", "the", "year", "ended", "December", "31,", "2014,", "compared", "to", "$674,000", "for", "the", "year", "ended", "December", "31,", "2013.", "<tag2>", "Financial", "expenses", "were", "$3.6", "million", "for", "the", "year", "ended", "December", "31,", "2015,", "compared", "to", "$4.7", "million", "for", "the", "year", "ended", "December", "31,", "2014.", "<tag3>"], "wordsA": ["Financial", "expenses", "were", "$4.7", "million", "for", "the", "year", "ended", "December", "31,", "2014,", "compared", "to", "$674,000", "for", "the", "year", "ended", "December", "31,", "2013."], "wordsB": ["Financial", "expenses", "were", "$3.6", "million", "for", "the", "year", "ended", "December", "31,", "2015,", "compared", "to", "$4.7", "million", "for", "the", "year", "ended", "December", "31,", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p49_s1", "idA": "1006281_15_item7_p59_s1", "sentA": "Financial expenses resulted primarily from interest expense of $3.1 million for the 4.5% convertible note and from the devaluation of the New Israeli Shekel against the U.S. dollar in the amount of $1.3 million, which was partially offset by financial income which resulted primarily from interest earned on short term deposits.", "sentB": "The decrease resulted primarily from a decrease of $2.3 million in costs related to salaries expense, mainly due to higher bonuses that were paid during the year ended December 31, 2014 and the devaluation of the New Israeli Shekel against the U.S. dollar during the period ended December 31, 2015.", "type": 2, "words": ["<tag1>", "Financial", "expenses", "resulted", "primarily", "from", "interest", "expense", "of", "$3.1", "million", "for", "the", "4.5%", "convertible", "note", "and", "from", "the", "devaluation", "of", "the", "New", "Israeli", "Shekel", "against", "the", "U.S.", "dollar", "in", "the", "amount", "of", "$1.3", "million,", "which", "was", "partially", "offset", "by", "financial", "income", "which", "resulted", "primarily", "from", "interest", "earned", "on", "short", "term", "deposits.", "<tag2>", "The", "decrease", "resulted", "primarily", "from", "a", "decrease", "of", "$2.3", "million", "in", "costs", "related", "to", "salaries", "expense,", "mainly", "due", "to", "higher", "bonuses", "that", "were", "paid", "during", "the", "year", "ended", "December", "31,", "2014", "and", "the", "devaluation", "of", "the", "New", "Israeli", "Shekel", "against", "the", "U.S.", "dollar", "during", "the", "period", "ended", "December", "31,", "2015.", "<tag3>"], "wordsA": ["Financial", "expenses", "resulted", "primarily", "from", "interest", "expense", "of", "$3.1", "million", "for", "the", "4.5%", "convertible", "note", "and", "from", "the", "devaluation", "of", "the", "New", "Israeli", "Shekel", "against", "the", "U.S.", "dollar", "in", "the", "amount", "of", "$1.3", "million,", "which", "was", "partially", "offset", "by", "financial", "income", "which", "resulted", "primarily", "from", "interest", "earned", "on", "short", "term", "deposits."], "wordsB": ["The", "decrease", "resulted", "primarily", "from", "a", "decrease", "of", "$2.3", "million", "in", "costs", "related", "to", "salaries", "expense,", "mainly", "due", "to", "higher", "bonuses", "that", "were", "paid", "during", "the", "year", "ended", "December", "31,", "2014", "and", "the", "devaluation", "of", "the", "New", "Israeli", "Shekel", "against", "the", "U.S.", "dollar", "during", "the", "period", "ended", "December", "31,", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p52_s1", "idA": "1006281_15_item7_p59_s1", "sentA": "Financial expenses resulted primarily from interest expense of $3.1 million for the 4.5% convertible note and from the devaluation of the New Israeli Shekel against the U.S. dollar in the amount of $1.3 million, which was partially offset by financial income which resulted primarily from interest earned on short term deposits.", "sentB": "Financial expenses resulted primarily from interest expense of $3.1 million for the notes.", "type": 2, "words": ["<tag1>", "Financial", "expenses", "resulted", "primarily", "from", "interest", "expense", "of", "$3.1", "million", "for", "the", "4.5%", "convertible", "note", "and", "from", "the", "devaluation", "of", "the", "New", "Israeli", "Shekel", "against", "the", "U.S.", "dollar", "in", "the", "amount", "of", "$1.3", "million,", "which", "was", "partially", "offset", "by", "financial", "income", "which", "resulted", "primarily", "from", "interest", "earned", "on", "short", "term", "deposits.", "<tag2>", "Financial", "expenses", "resulted", "primarily", "from", "interest", "expense", "of", "$3.1", "million", "for", "the", "notes.", "<tag3>"], "wordsA": ["Financial", "expenses", "resulted", "primarily", "from", "interest", "expense", "of", "$3.1", "million", "for", "the", "4.5%", "convertible", "note", "and", "from", "the", "devaluation", "of", "the", "New", "Israeli", "Shekel", "against", "the", "U.S.", "dollar", "in", "the", "amount", "of", "$1.3", "million,", "which", "was", "partially", "offset", "by", "financial", "income", "which", "resulted", "primarily", "from", "interest", "earned", "on", "short", "term", "deposits."], "wordsB": ["Financial", "expenses", "resulted", "primarily", "from", "interest", "expense", "of", "$3.1", "million", "for", "the", "notes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p52_s2", "idA": "1006281_15_item7_p59_s1", "sentA": "Financial expenses resulted primarily from interest expense of $3.1 million for the 4.5% convertible note and from the devaluation of the New Israeli Shekel against the U.S. dollar in the amount of $1.3 million, which was partially offset by financial income which resulted primarily from interest earned on short term deposits.", "sentB": "The decrease in financial expense resulted primarily from the devaluation of the New Israeli Shekel against the U.S. dollar during the year ended December 31, 2015 which was partially offset by financial income which resulted primarily from interest earned on short term deposits.", "type": 2, "words": ["<tag1>", "Financial", "expenses", "resulted", "primarily", "from", "interest", "expense", "of", "$3.1", "million", "for", "the", "4.5%", "convertible", "note", "and", "from", "the", "devaluation", "of", "the", "New", "Israeli", "Shekel", "against", "the", "U.S.", "dollar", "in", "the", "amount", "of", "$1.3", "million,", "which", "was", "partially", "offset", "by", "financial", "income", "which", "resulted", "primarily", "from", "interest", "earned", "on", "short", "term", "deposits.", "<tag2>", "The", "decrease", "in", "financial", "expense", "resulted", "primarily", "from", "the", "devaluation", "of", "the", "New", "Israeli", "Shekel", "against", "the", "U.S.", "dollar", "during", "the", "year", "ended", "December", "31,", "2015", "which", "was", "partially", "offset", "by", "financial", "income", "which", "resulted", "primarily", "from", "interest", "earned", "on", "short", "term", "deposits.", "<tag3>"], "wordsA": ["Financial", "expenses", "resulted", "primarily", "from", "interest", "expense", "of", "$3.1", "million", "for", "the", "4.5%", "convertible", "note", "and", "from", "the", "devaluation", "of", "the", "New", "Israeli", "Shekel", "against", "the", "U.S.", "dollar", "in", "the", "amount", "of", "$1.3", "million,", "which", "was", "partially", "offset", "by", "financial", "income", "which", "resulted", "primarily", "from", "interest", "earned", "on", "short", "term", "deposits."], "wordsB": ["The", "decrease", "in", "financial", "expense", "resulted", "primarily", "from", "the", "devaluation", "of", "the", "New", "Israeli", "Shekel", "against", "the", "U.S.", "dollar", "during", "the", "year", "ended", "December", "31,", "2015", "which", "was", "partially", "offset", "by", "financial", "income", "which", "resulted", "primarily", "from", "interest", "earned", "on", "short", "term", "deposits."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p21_s0", "idA": "1006281_15_item7_p61_s0", "sentA": "We recorded revenue of $1.0 million as our share of net income in the collaboration under the Pfizer Agreement during the year ended December 31, 2013, compared to the $446,000 of loss recorded for the year ended December 31, 2012.", "sentB": "Pursuant to the Amended Pfizer Agreement, we sold to Pfizer our share in the collaboration created under the initial Pfizer Agreement for the commercialization of Elelyso.", "type": 2, "words": ["<tag1>", "We", "recorded", "revenue", "of", "$1.0", "million", "as", "our", "share", "of", "net", "income", "in", "the", "collaboration", "under", "the", "Pfizer", "Agreement", "during", "the", "year", "ended", "December", "31,", "2013,", "compared", "to", "the", "$446,000", "of", "loss", "recorded", "for", "the", "year", "ended", "December", "31,", "2012.", "<tag2>", "Pursuant", "to", "the", "Amended", "Pfizer", "Agreement,", "we", "sold", "to", "Pfizer", "our", "share", "in", "the", "collaboration", "created", "under", "the", "initial", "Pfizer", "Agreement", "for", "the", "commercialization", "of", "Elelyso.", "<tag3>"], "wordsA": ["We", "recorded", "revenue", "of", "$1.0", "million", "as", "our", "share", "of", "net", "income", "in", "the", "collaboration", "under", "the", "Pfizer", "Agreement", "during", "the", "year", "ended", "December", "31,", "2013,", "compared", "to", "the", "$446,000", "of", "loss", "recorded", "for", "the", "year", "ended", "December", "31,", "2012."], "wordsB": ["Pursuant", "to", "the", "Amended", "Pfizer", "Agreement,", "we", "sold", "to", "Pfizer", "our", "share", "in", "the", "collaboration", "created", "under", "the", "initial", "Pfizer", "Agreement", "for", "the", "commercialization", "of", "Elelyso."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p22_s0", "idA": "1006281_15_item7_p61_s0", "sentA": "We recorded revenue of $1.0 million as our share of net income in the collaboration under the Pfizer Agreement during the year ended December 31, 2013, compared to the $446,000 of loss recorded for the year ended December 31, 2012.", "sentB": "We accounted for the sale of our share in the collaboration created under the initial Pfizer Agreement, including the transfer of our rights to Elelyso in Israel, in accordance with ASU No. 2014-08.", "type": 2, "words": ["<tag1>", "We", "recorded", "revenue", "of", "$1.0", "million", "as", "our", "share", "of", "net", "income", "in", "the", "collaboration", "under", "the", "Pfizer", "Agreement", "during", "the", "year", "ended", "December", "31,", "2013,", "compared", "to", "the", "$446,000", "of", "loss", "recorded", "for", "the", "year", "ended", "December", "31,", "2012.", "<tag2>", "We", "accounted", "for", "the", "sale", "of", "our", "share", "in", "the", "collaboration", "created", "under", "the", "initial", "Pfizer", "Agreement,", "including", "the", "transfer", "of", "our", "rights", "to", "Elelyso", "in", "Israel,", "in", "accordance", "with", "ASU", "No.", "2014-08.", "<tag3>"], "wordsA": ["We", "recorded", "revenue", "of", "$1.0", "million", "as", "our", "share", "of", "net", "income", "in", "the", "collaboration", "under", "the", "Pfizer", "Agreement", "during", "the", "year", "ended", "December", "31,", "2013,", "compared", "to", "the", "$446,000", "of", "loss", "recorded", "for", "the", "year", "ended", "December", "31,", "2012."], "wordsB": ["We", "accounted", "for", "the", "sale", "of", "our", "share", "in", "the", "collaboration", "created", "under", "the", "initial", "Pfizer", "Agreement,", "including", "the", "transfer", "of", "our", "rights", "to", "Elelyso", "in", "Israel,", "in", "accordance", "with", "ASU", "No.", "2014-08."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p24_s0", "idA": "1006281_15_item7_p63_s0", "sentA": "Cost of revenues was $5.4 million for the year ended December 31, 2013, a decrease of $2.7 million, or 33%, compared to the cost of revenues of $8.1 million for the year ended December 31, 2012.", "sentB": "* During the years ended December 31, 2014 and 2015, we recorded approximately $1.6 million and $0, respectively, for write-down of inventory under the cost of revenues.", "type": 2, "words": ["<tag1>", "Cost", "of", "revenues", "was", "$5.4", "million", "for", "the", "year", "ended", "December", "31,", "2013,", "a", "decrease", "of", "$2.7", "million,", "or", "33%,", "compared", "to", "the", "cost", "of", "revenues", "of", "$8.1", "million", "for", "the", "year", "ended", "December", "31,", "2012.", "<tag2>", "*", "During", "the", "years", "ended", "December", "31,", "2014", "and", "2015,", "we", "recorded", "approximately", "$1.6", "million", "and", "$0,", "respectively,", "for", "write-down", "of", "inventory", "under", "the", "cost", "of", "revenues.", "<tag3>"], "wordsA": ["Cost", "of", "revenues", "was", "$5.4", "million", "for", "the", "year", "ended", "December", "31,", "2013,", "a", "decrease", "of", "$2.7", "million,", "or", "33%,", "compared", "to", "the", "cost", "of", "revenues", "of", "$8.1", "million", "for", "the", "year", "ended", "December", "31,", "2012."], "wordsB": ["*", "During", "the", "years", "ended", "December", "31,", "2014", "and", "2015,", "we", "recorded", "approximately", "$1.6", "million", "and", "$0,", "respectively,", "for", "write-down", "of", "inventory", "under", "the", "cost", "of", "revenues."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p48_s1", "idA": "1006281_15_item7_p63_s2", "sentA": "Cost of revenues for the years ended December 31, 2012 and 2013 include an aggregate of $2.2 million and $472,000, respectively, in royalties payable to the OCS and to a certain academic institution in connection with gross sales of taliglucerase alfa during the period.", "sentB": "Cost of revenues consists primarily of products we sold in Brazil for which revenues were recognized during the period and royalties payable to the OCS and to a certain academic institution in connection with such sales.", "type": 2, "words": ["<tag1>", "Cost", "of", "revenues", "for", "the", "years", "ended", "December", "31,", "2012", "and", "2013", "include", "an", "aggregate", "of", "$2.2", "million", "and", "$472,000,", "respectively,", "in", "royalties", "payable", "to", "the", "OCS", "and", "to", "a", "certain", "academic", "institution", "in", "connection", "with", "gross", "sales", "of", "taliglucerase", "alfa", "during", "the", "period.", "<tag2>", "Cost", "of", "revenues", "consists", "primarily", "of", "products", "we", "sold", "in", "Brazil", "for", "which", "revenues", "were", "recognized", "during", "the", "period", "and", "royalties", "payable", "to", "the", "OCS", "and", "to", "a", "certain", "academic", "institution", "in", "connection", "with", "such", "sales.", "<tag3>"], "wordsA": ["Cost", "of", "revenues", "for", "the", "years", "ended", "December", "31,", "2012", "and", "2013", "include", "an", "aggregate", "of", "$2.2", "million", "and", "$472,000,", "respectively,", "in", "royalties", "payable", "to", "the", "OCS", "and", "to", "a", "certain", "academic", "institution", "in", "connection", "with", "gross", "sales", "of", "taliglucerase", "alfa", "during", "the", "period."], "wordsB": ["Cost", "of", "revenues", "consists", "primarily", "of", "products", "we", "sold", "in", "Brazil", "for", "which", "revenues", "were", "recognized", "during", "the", "period", "and", "royalties", "payable", "to", "the", "OCS", "and", "to", "a", "certain", "academic", "institution", "in", "connection", "with", "such", "sales."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p54_s1", "idA": "1006281_15_item7_p63_s2", "sentA": "Cost of revenues for the years ended December 31, 2012 and 2013 include an aggregate of $2.2 million and $472,000, respectively, in royalties payable to the OCS and to a certain academic institution in connection with gross sales of taliglucerase alfa during the period.", "sentB": "Cost of revenues consists primarily of products we sold in Brazil for which revenues were recognized during the period, and royalties payable to the OCS and to a certain academic institution in connection with such sales.", "type": 2, "words": ["<tag1>", "Cost", "of", "revenues", "for", "the", "years", "ended", "December", "31,", "2012", "and", "2013", "include", "an", "aggregate", "of", "$2.2", "million", "and", "$472,000,", "respectively,", "in", "royalties", "payable", "to", "the", "OCS", "and", "to", "a", "certain", "academic", "institution", "in", "connection", "with", "gross", "sales", "of", "taliglucerase", "alfa", "during", "the", "period.", "<tag2>", "Cost", "of", "revenues", "consists", "primarily", "of", "products", "we", "sold", "in", "Brazil", "for", "which", "revenues", "were", "recognized", "during", "the", "period,", "and", "royalties", "payable", "to", "the", "OCS", "and", "to", "a", "certain", "academic", "institution", "in", "connection", "with", "such", "sales.", "<tag3>"], "wordsA": ["Cost", "of", "revenues", "for", "the", "years", "ended", "December", "31,", "2012", "and", "2013", "include", "an", "aggregate", "of", "$2.2", "million", "and", "$472,000,", "respectively,", "in", "royalties", "payable", "to", "the", "OCS", "and", "to", "a", "certain", "academic", "institution", "in", "connection", "with", "gross", "sales", "of", "taliglucerase", "alfa", "during", "the", "period."], "wordsB": ["Cost", "of", "revenues", "consists", "primarily", "of", "products", "we", "sold", "in", "Brazil", "for", "which", "revenues", "were", "recognized", "during", "the", "period,", "and", "royalties", "payable", "to", "the", "OCS", "and", "to", "a", "certain", "academic", "institution", "in", "connection", "with", "such", "sales."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p51_s0", "idA": "1006281_15_item7_p66_s0", "sentA": "General and administrative expenses were $8.4 million for the year ended December 31, 2013, a decrease of $1.4 million, or 14%, from $9.8 million for the year ended December 31, 2012.", "sentB": "Selling, general and administrative expenses were $7.3 million for the year ended December 31, 2015, a decrease of $1.9 million, or 21%, from $9.2 million for the year ended December 31, 2014.", "type": 2, "words": ["<tag1>", "General", "and", "administrative", "expenses", "were", "$8.4", "million", "for", "the", "year", "ended", "December", "31,", "2013,", "a", "decrease", "of", "$1.4", "million,", "or", "14%,", "from", "$9.8", "million", "for", "the", "year", "ended", "December", "31,", "2012.", "<tag2>", "Selling,", "general", "and", "administrative", "expenses", "were", "$7.3", "million", "for", "the", "year", "ended", "December", "31,", "2015,", "a", "decrease", "of", "$1.9", "million,", "or", "21%,", "from", "$9.2", "million", "for", "the", "year", "ended", "December", "31,", "2014.", "<tag3>"], "wordsA": ["General", "and", "administrative", "expenses", "were", "$8.4", "million", "for", "the", "year", "ended", "December", "31,", "2013,", "a", "decrease", "of", "$1.4", "million,", "or", "14%,", "from", "$9.8", "million", "for", "the", "year", "ended", "December", "31,", "2012."], "wordsB": ["Selling,", "general", "and", "administrative", "expenses", "were", "$7.3", "million", "for", "the", "year", "ended", "December", "31,", "2015,", "a", "decrease", "of", "$1.9", "million,", "or", "21%,", "from", "$9.2", "million", "for", "the", "year", "ended", "December", "31,", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p59_s0", "idA": "1006281_15_item7_p68_s0", "sentA": "As a result of our significant research and development expenditures and the lack of significant product sales revenue due to the recent launch of taliglucerase alfa in the United States and Israel, we have not been profitable and have generated operating losses since our inception.", "sentB": "As a result of our significant research and development expenditures and the lack of significant revenue from sales of taliglucerase alfa, we have generated operating losses from our continuing operations since our inception.", "type": 2, "words": ["<tag1>", "As", "a", "result", "of", "our", "significant", "research", "and", "development", "expenditures", "and", "the", "lack", "of", "significant", "product", "sales", "revenue", "due", "to", "the", "recent", "launch", "of", "taliglucerase", "alfa", "in", "the", "United", "States", "and", "Israel,", "we", "have", "not", "been", "profitable", "and", "have", "generated", "operating", "losses", "since", "our", "inception.", "<tag2>", "As", "a", "result", "of", "our", "significant", "research", "and", "development", "expenditures", "and", "the", "lack", "of", "significant", "revenue", "from", "sales", "of", "taliglucerase", "alfa,", "we", "have", "generated", "operating", "losses", "from", "our", "continuing", "operations", "since", "our", "inception.", "<tag3>"], "wordsA": ["As", "a", "result", "of", "our", "significant", "research", "and", "development", "expenditures", "and", "the", "lack", "of", "significant", "product", "sales", "revenue", "due", "to", "the", "recent", "launch", "of", "taliglucerase", "alfa", "in", "the", "United", "States", "and", "Israel,", "we", "have", "not", "been", "profitable", "and", "have", "generated", "operating", "losses", "since", "our", "inception."], "wordsB": ["As", "a", "result", "of", "our", "significant", "research", "and", "development", "expenditures", "and", "the", "lack", "of", "significant", "revenue", "from", "sales", "of", "taliglucerase", "alfa,", "we", "have", "generated", "operating", "losses", "from", "our", "continuing", "operations", "since", "our", "inception."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p62_s3", "idA": "1006281_15_item7_p71_s0", "sentA": "Pfizer paid Protalix Ltd. $60.0 million as an upfront payment in connection with the execution of the Pfizer Agreement and subsequently paid to Protalix Ltd. an additional $5.0 million upon Protalix Ltd. s meeting a certain milestone.", "sentB": "In connection with the execution of the Amended Pfizer Agreement, we received a $36.0 million payment from Pfizer, and Pfizer purchased 5,649,079 shares of our common stock for $10.0 million.", "type": 2, "words": ["<tag1>", "Pfizer", "paid", "Protalix", "Ltd.", "$60.0", "million", "as", "an", "upfront", "payment", "in", "connection", "with", "the", "execution", "of", "the", "Pfizer", "Agreement", "and", "subsequently", "paid", "to", "Protalix", "Ltd.", "an", "additional", "$5.0", "million", "upon", "Protalix", "Ltd.", "s", "meeting", "a", "certain", "milestone.", "<tag2>", "In", "connection", "with", "the", "execution", "of", "the", "Amended", "Pfizer", "Agreement,", "we", "received", "a", "$36.0", "million", "payment", "from", "Pfizer,", "and", "Pfizer", "purchased", "5,649,079", "shares", "of", "our", "common", "stock", "for", "$10.0", "million.", "<tag3>"], "wordsA": ["Pfizer", "paid", "Protalix", "Ltd.", "$60.0", "million", "as", "an", "upfront", "payment", "in", "connection", "with", "the", "execution", "of", "the", "Pfizer", "Agreement", "and", "subsequently", "paid", "to", "Protalix", "Ltd.", "an", "additional", "$5.0", "million", "upon", "Protalix", "Ltd.", "s", "meeting", "a", "certain", "milestone."], "wordsB": ["In", "connection", "with", "the", "execution", "of", "the", "Amended", "Pfizer", "Agreement,", "we", "received", "a", "$36.0", "million", "payment", "from", "Pfizer,", "and", "Pfizer", "purchased", "5,649,079", "shares", "of", "our", "common", "stock", "for", "$10.0", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p54_s0", "idA": "1006281_15_item7_p73_s0", "sentA": "Net cash used in operations was $29.2 million for the year ended December 31, 2014.", "sentB": "Cost of revenues was $630,000 for the year ended December 31, 2014.", "type": 2, "words": ["<tag1>", "Net", "cash", "used", "in", "operations", "was", "$29.2", "million", "for", "the", "year", "ended", "December", "31,", "2014.", "<tag2>", "Cost", "of", "revenues", "was", "$630,000", "for", "the", "year", "ended", "December", "31,", "2014.", "<tag3>"], "wordsA": ["Net", "cash", "used", "in", "operations", "was", "$29.2", "million", "for", "the", "year", "ended", "December", "31,", "2014."], "wordsB": ["Cost", "of", "revenues", "was", "$630,000", "for", "the", "year", "ended", "December", "31,", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p63_s0", "idA": "1006281_15_item7_p73_s0", "sentA": "Net cash used in operations was $29.2 million for the year ended December 31, 2014.", "sentB": "Net cash used in operations was $24.2 million for the year ended December 31, 2015.", "type": 2, "words": ["<tag1>", "Net", "cash", "used", "in", "operations", "was", "$29.2", "million", "for", "the", "year", "ended", "December", "31,", "2014.", "<tag2>", "Net", "cash", "used", "in", "operations", "was", "$24.2", "million", "for", "the", "year", "ended", "December", "31,", "2015.", "<tag3>"], "wordsA": ["Net", "cash", "used", "in", "operations", "was", "$29.2", "million", "for", "the", "year", "ended", "December", "31,", "2014."], "wordsB": ["Net", "cash", "used", "in", "operations", "was", "$24.2", "million", "for", "the", "year", "ended", "December", "31,", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p63_s4", "idA": "1006281_15_item7_p73_s0", "sentA": "Net cash used in operations was $29.2 million for the year ended December 31, 2014.", "sentB": "Net cash used in operations was $29.3 million for the year ended December 31, 2014.", "type": 2, "words": ["<tag1>", "Net", "cash", "used", "in", "operations", "was", "$29.2", "million", "for", "the", "year", "ended", "December", "31,", "2014.", "<tag2>", "Net", "cash", "used", "in", "operations", "was", "$29.3", "million", "for", "the", "year", "ended", "December", "31,", "2014.", "<tag3>"], "wordsA": ["Net", "cash", "used", "in", "operations", "was", "$29.2", "million", "for", "the", "year", "ended", "December", "31,", "2014."], "wordsB": ["Net", "cash", "used", "in", "operations", "was", "$29.3", "million", "for", "the", "year", "ended", "December", "31,", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p63_s5", "idA": "1006281_15_item7_p73_s1", "sentA": "The net loss for the year ended December 31, 2014 of $29.9 million was further increased by a decrease of $7.2 million in deferred revenues, but was partially offset by $3.1 million in depreciation, $1.4 million in financial expenses mainly due to exchange rate differences and share based compensation of $1.2 million.", "sentB": "The net loss from continuing operations for the year ended December 31, 2014 of $33.3 million was further increased by an increase of $3.5 million in inventories, but was partially offset by $3.1 million in depreciation, $1.4 million in accounts payable.", "type": 2, "words": ["<tag1>", "The", "net", "loss", "for", "the", "year", "ended", "December", "31,", "2014", "of", "$29.9", "million", "was", "further", "increased", "by", "a", "decrease", "of", "$7.2", "million", "in", "deferred", "revenues,", "but", "was", "partially", "offset", "by", "$3.1", "million", "in", "depreciation,", "$1.4", "million", "in", "financial", "expenses", "mainly", "due", "to", "exchange", "rate", "differences", "and", "share", "based", "compensation", "of", "$1.2", "million.", "<tag2>", "The", "net", "loss", "from", "continuing", "operations", "for", "the", "year", "ended", "December", "31,", "2014", "of", "$33.3", "million", "was", "further", "increased", "by", "an", "increase", "of", "$3.5", "million", "in", "inventories,", "but", "was", "partially", "offset", "by", "$3.1", "million", "in", "depreciation,", "$1.4", "million", "in", "accounts", "payable.", "<tag3>"], "wordsA": ["The", "net", "loss", "for", "the", "year", "ended", "December", "31,", "2014", "of", "$29.9", "million", "was", "further", "increased", "by", "a", "decrease", "of", "$7.2", "million", "in", "deferred", "revenues,", "but", "was", "partially", "offset", "by", "$3.1", "million", "in", "depreciation,", "$1.4", "million", "in", "financial", "expenses", "mainly", "due", "to", "exchange", "rate", "differences", "and", "share", "based", "compensation", "of", "$1.2", "million."], "wordsB": ["The", "net", "loss", "from", "continuing", "operations", "for", "the", "year", "ended", "December", "31,", "2014", "of", "$33.3", "million", "was", "further", "increased", "by", "an", "increase", "of", "$3.5", "million", "in", "inventories,", "but", "was", "partially", "offset", "by", "$3.1", "million", "in", "depreciation,", "$1.4", "million", "in", "accounts", "payable."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p63_s1", "idA": "1006281_15_item7_p74_s1", "sentA": "The net loss for the year ended December 31, 2013 of $27.8 million was further increased by a decrease of $7.2 million in deferred revenues and an increase of $3.9 million in inventories, but was partially offset by share based compensation of $4.1 million and $3.5 million in depreciation.", "sentB": "The net loss from continuing operations for the year ended December 31, 2015 of $27.2 million was further increased by an increase of $2.3 million in inventories and a decrease of $1.9 million in accounts payable, but was partially offset by $2.4 million in depreciation and $1.8 million in share based compensation.", "type": 2, "words": ["<tag1>", "The", "net", "loss", "for", "the", "year", "ended", "December", "31,", "2013", "of", "$27.8", "million", "was", "further", "increased", "by", "a", "decrease", "of", "$7.2", "million", "in", "deferred", "revenues", "and", "an", "increase", "of", "$3.9", "million", "in", "inventories,", "but", "was", "partially", "offset", "by", "share", "based", "compensation", "of", "$4.1", "million", "and", "$3.5", "million", "in", "depreciation.", "<tag2>", "The", "net", "loss", "from", "continuing", "operations", "for", "the", "year", "ended", "December", "31,", "2015", "of", "$27.2", "million", "was", "further", "increased", "by", "an", "increase", "of", "$2.3", "million", "in", "inventories", "and", "a", "decrease", "of", "$1.9", "million", "in", "accounts", "payable,", "but", "was", "partially", "offset", "by", "$2.4", "million", "in", "depreciation", "and", "$1.8", "million", "in", "share", "based", "compensation.", "<tag3>"], "wordsA": ["The", "net", "loss", "for", "the", "year", "ended", "December", "31,", "2013", "of", "$27.8", "million", "was", "further", "increased", "by", "a", "decrease", "of", "$7.2", "million", "in", "deferred", "revenues", "and", "an", "increase", "of", "$3.9", "million", "in", "inventories,", "but", "was", "partially", "offset", "by", "share", "based", "compensation", "of", "$4.1", "million", "and", "$3.5", "million", "in", "depreciation."], "wordsB": ["The", "net", "loss", "from", "continuing", "operations", "for", "the", "year", "ended", "December", "31,", "2015", "of", "$27.2", "million", "was", "further", "increased", "by", "an", "increase", "of", "$2.3", "million", "in", "inventories", "and", "a", "decrease", "of", "$1.9", "million", "in", "accounts", "payable,", "but", "was", "partially", "offset", "by", "$2.4", "million", "in", "depreciation", "and", "$1.8", "million", "in", "share", "based", "compensation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p63_s2", "idA": "1006281_15_item7_p74_s2", "sentA": "Net cash used in investing activities for the year ended December 31, 2013 was $2.1 million and consisted primarily of purchases of property and equipment.", "sentB": "Net cash provided by investing activities for the year ended December 31, 2015 was $39.4 million and consisted primarily of proceeds from the sale of our share in collaboration to Pfizer.", "type": 2, "words": ["<tag1>", "Net", "cash", "used", "in", "investing", "activities", "for", "the", "year", "ended", "December", "31,", "2013", "was", "$2.1", "million", "and", "consisted", "primarily", "of", "purchases", "of", "property", "and", "equipment.", "<tag2>", "Net", "cash", "provided", "by", "investing", "activities", "for", "the", "year", "ended", "December", "31,", "2015", "was", "$39.4", "million", "and", "consisted", "primarily", "of", "proceeds", "from", "the", "sale", "of", "our", "share", "in", "collaboration", "to", "Pfizer.", "<tag3>"], "wordsA": ["Net", "cash", "used", "in", "investing", "activities", "for", "the", "year", "ended", "December", "31,", "2013", "was", "$2.1", "million", "and", "consisted", "primarily", "of", "purchases", "of", "property", "and", "equipment."], "wordsB": ["Net", "cash", "provided", "by", "investing", "activities", "for", "the", "year", "ended", "December", "31,", "2015", "was", "$39.4", "million", "and", "consisted", "primarily", "of", "proceeds", "from", "the", "sale", "of", "our", "share", "in", "collaboration", "to", "Pfizer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p63_s3", "idA": "1006281_15_item7_p74_s3", "sentA": "Net cash provided by financing activities was $66.9 million, consisting primarily of net proceeds from our offering of 2018 4.5% convertible notes.", "sentB": "Net cash provided by financing activities was $6.6 million and consisted primarily from the issuance of shares to Pfizer in connection with the sale of our share in collaboration to Pfizer.", "type": 2, "words": ["<tag1>", "Net", "cash", "provided", "by", "financing", "activities", "was", "$66.9", "million,", "consisting", "primarily", "of", "net", "proceeds", "from", "our", "offering", "of", "2018", "4.5%", "convertible", "notes.", "<tag2>", "Net", "cash", "provided", "by", "financing", "activities", "was", "$6.6", "million", "and", "consisted", "primarily", "from", "the", "issuance", "of", "shares", "to", "Pfizer", "in", "connection", "with", "the", "sale", "of", "our", "share", "in", "collaboration", "to", "Pfizer.", "<tag3>"], "wordsA": ["Net", "cash", "provided", "by", "financing", "activities", "was", "$66.9", "million,", "consisting", "primarily", "of", "net", "proceeds", "from", "our", "offering", "of", "2018", "4.5%", "convertible", "notes."], "wordsB": ["Net", "cash", "provided", "by", "financing", "activities", "was", "$6.6", "million", "and", "consisted", "primarily", "from", "the", "issuance", "of", "shares", "to", "Pfizer", "in", "connection", "with", "the", "sale", "of", "our", "share", "in", "collaboration", "to", "Pfizer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p64_s0", "idA": "1006281_15_item7_p75_s1", "sentA": "We expect to continue to incur significant research and development expenses, including expenses related primarily to the clinical trials of PRX-102 and the advancement of our other product candidates into clinical trials.", "sentB": "We expect to continue to incur significant expenditures in the near future, including significant research and development expenses related primarily to the clinical trials of PRX-102 and the advancement of our other product candidates into anticipated later stage clinical trials.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "continue", "to", "incur", "significant", "research", "and", "development", "expenses,", "including", "expenses", "related", "primarily", "to", "the", "clinical", "trials", "of", "PRX-102", "and", "the", "advancement", "of", "our", "other", "product", "candidates", "into", "clinical", "trials.", "<tag2>", "We", "expect", "to", "continue", "to", "incur", "significant", "expenditures", "in", "the", "near", "future,", "including", "significant", "research", "and", "development", "expenses", "related", "primarily", "to", "the", "clinical", "trials", "of", "PRX-102", "and", "the", "advancement", "of", "our", "other", "product", "candidates", "into", "anticipated", "later", "stage", "clinical", "trials.", "<tag3>"], "wordsA": ["We", "expect", "to", "continue", "to", "incur", "significant", "research", "and", "development", "expenses,", "including", "expenses", "related", "primarily", "to", "the", "clinical", "trials", "of", "PRX-102", "and", "the", "advancement", "of", "our", "other", "product", "candidates", "into", "clinical", "trials."], "wordsB": ["We", "expect", "to", "continue", "to", "incur", "significant", "expenditures", "in", "the", "near", "future,", "including", "significant", "research", "and", "development", "expenses", "related", "primarily", "to", "the", "clinical", "trials", "of", "PRX-102", "and", "the", "advancement", "of", "our", "other", "product", "candidates", "into", "anticipated", "later", "stage", "clinical", "trials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p8_s1", "idA": "1006281_15_item7_p75_s1", "sentA": "We expect to continue to incur significant research and development expenses, including expenses related primarily to the clinical trials of PRX-102 and the advancement of our other product candidates into clinical trials.", "sentB": "We expect to commence phase III clinical trials of PRX-102 during the first half of 2016 shortly after we finalize the ongoing special protocol assessment (SPA) process with the FDA in connection with our proposed protocol for the trial.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "continue", "to", "incur", "significant", "research", "and", "development", "expenses,", "including", "expenses", "related", "primarily", "to", "the", "clinical", "trials", "of", "PRX-102", "and", "the", "advancement", "of", "our", "other", "product", "candidates", "into", "clinical", "trials.", "<tag2>", "We", "expect", "to", "commence", "phase", "III", "clinical", "trials", "of", "PRX-102", "during", "the", "first", "half", "of", "2016", "shortly", "after", "we", "finalize", "the", "ongoing", "special", "protocol", "assessment", "(SPA)", "process", "with", "the", "FDA", "in", "connection", "with", "our", "proposed", "protocol", "for", "the", "trial.", "<tag3>"], "wordsA": ["We", "expect", "to", "continue", "to", "incur", "significant", "research", "and", "development", "expenses,", "including", "expenses", "related", "primarily", "to", "the", "clinical", "trials", "of", "PRX-102", "and", "the", "advancement", "of", "our", "other", "product", "candidates", "into", "clinical", "trials."], "wordsB": ["We", "expect", "to", "commence", "phase", "III", "clinical", "trials", "of", "PRX-102", "during", "the", "first", "half", "of", "2016", "shortly", "after", "we", "finalize", "the", "ongoing", "special", "protocol", "assessment", "(SPA)", "process", "with", "the", "FDA", "in", "connection", "with", "our", "proposed", "protocol", "for", "the", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p66_s0", "idA": "1006281_15_item7_p77_s0", "sentA": "Our future capital requirements will depend on many factors, including the progress of Pfizer s commercialization efforts for taliglucerase alfa in the United States and other countries and, if anticipated marketing approvals of taliglucerase alfa are granted in other jurisdictions, the progress of Pfizer s global commercialization efforts for taliglucerase alfa, the progress and results of our clinical trials, the duration and cost of discovery and preclinical development and laboratory testing and clinical trials for our product candidates, the timing and outcome of regulatory review of our product candidates, the costs involved in preparing, filing, prosecuting, maintaining, defending and enforcing patent claims and other intellectual property rights, the number and development requirements of other product candidates that we pursue and the costs of commercialization activities, including product marketing, sales and distribution.", "sentB": "Our future capital requirements will depend on many factors, including our progress in commercializing Uplyso in Brazil, the progress and results of our clinical trials, the duration and cost of discovery and preclinical development and laboratory testing and clinical trials for our product candidates, the timing and outcome of regulatory review of our product candidates, the costs involved in preparing, filing, prosecuting, maintaining, defending and enforcing patent claims and other intellectual property rights, the number and development requirements of other product candidates that we pursue and the costs of commercialization activities, including product marketing, sales and distribution.", "type": 2, "words": ["<tag1>", "Our", "future", "capital", "requirements", "will", "depend", "on", "many", "factors,", "including", "the", "progress", "of", "Pfizer", "s", "commercialization", "efforts", "for", "taliglucerase", "alfa", "in", "the", "United", "States", "and", "other", "countries", "and,", "if", "anticipated", "marketing", "approvals", "of", "taliglucerase", "alfa", "are", "granted", "in", "other", "jurisdictions,", "the", "progress", "of", "Pfizer", "s", "global", "commercialization", "efforts", "for", "taliglucerase", "alfa,", "the", "progress", "and", "results", "of", "our", "clinical", "trials,", "the", "duration", "and", "cost", "of", "discovery", "and", "preclinical", "development", "and", "laboratory", "testing", "and", "clinical", "trials", "for", "our", "product", "candidates,", "the", "timing", "and", "outcome", "of", "regulatory", "review", "of", "our", "product", "candidates,", "the", "costs", "involved", "in", "preparing,", "filing,", "prosecuting,", "maintaining,", "defending", "and", "enforcing", "patent", "claims", "and", "other", "intellectual", "property", "rights,", "the", "number", "and", "development", "requirements", "of", "other", "product", "candidates", "that", "we", "pursue", "and", "the", "costs", "of", "commercialization", "activities,", "including", "product", "marketing,", "sales", "and", "distribution.", "<tag2>", "Our", "future", "capital", "requirements", "will", "depend", "on", "many", "factors,", "including", "our", "progress", "in", "commercializing", "Uplyso", "in", "Brazil,", "the", "progress", "and", "results", "of", "our", "clinical", "trials,", "the", "duration", "and", "cost", "of", "discovery", "and", "preclinical", "development", "and", "laboratory", "testing", "and", "clinical", "trials", "for", "our", "product", "candidates,", "the", "timing", "and", "outcome", "of", "regulatory", "review", "of", "our", "product", "candidates,", "the", "costs", "involved", "in", "preparing,", "filing,", "prosecuting,", "maintaining,", "defending", "and", "enforcing", "patent", "claims", "and", "other", "intellectual", "property", "rights,", "the", "number", "and", "development", "requirements", "of", "other", "product", "candidates", "that", "we", "pursue", "and", "the", "costs", "of", "commercialization", "activities,", "including", "product", "marketing,", "sales", "and", "distribution.", "<tag3>"], "wordsA": ["Our", "future", "capital", "requirements", "will", "depend", "on", "many", "factors,", "including", "the", "progress", "of", "Pfizer", "s", "commercialization", "efforts", "for", "taliglucerase", "alfa", "in", "the", "United", "States", "and", "other", "countries", "and,", "if", "anticipated", "marketing", "approvals", "of", "taliglucerase", "alfa", "are", "granted", "in", "other", "jurisdictions,", "the", "progress", "of", "Pfizer", "s", "global", "commercialization", "efforts", "for", "taliglucerase", "alfa,", "the", "progress", "and", "results", "of", "our", "clinical", "trials,", "the", "duration", "and", "cost", "of", "discovery", "and", "preclinical", "development", "and", "laboratory", "testing", "and", "clinical", "trials", "for", "our", "product", "candidates,", "the", "timing", "and", "outcome", "of", "regulatory", "review", "of", "our", "product", "candidates,", "the", "costs", "involved", "in", "preparing,", "filing,", "prosecuting,", "maintaining,", "defending", "and", "enforcing", "patent", "claims", "and", "other", "intellectual", "property", "rights,", "the", "number", "and", "development", "requirements", "of", "other", "product", "candidates", "that", "we", "pursue", "and", "the", "costs", "of", "commercialization", "activities,", "including", "product", "marketing,", "sales", "and", "distribution."], "wordsB": ["Our", "future", "capital", "requirements", "will", "depend", "on", "many", "factors,", "including", "our", "progress", "in", "commercializing", "Uplyso", "in", "Brazil,", "the", "progress", "and", "results", "of", "our", "clinical", "trials,", "the", "duration", "and", "cost", "of", "discovery", "and", "preclinical", "development", "and", "laboratory", "testing", "and", "clinical", "trials", "for", "our", "product", "candidates,", "the", "timing", "and", "outcome", "of", "regulatory", "review", "of", "our", "product", "candidates,", "the", "costs", "involved", "in", "preparing,", "filing,", "prosecuting,", "maintaining,", "defending", "and", "enforcing", "patent", "claims", "and", "other", "intellectual", "property", "rights,", "the", "number", "and", "development", "requirements", "of", "other", "product", "candidates", "that", "we", "pursue", "and", "the", "costs", "of", "commercialization", "activities,", "including", "product", "marketing,", "sales", "and", "distribution."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p68_s1", "idA": "1006281_15_item7_p79_s1", "sentA": "We do not believe that inflation has had a material effect on our results of operations during the years ended December 31, 2012, 2013 or 2014.", "sentB": "We do not believe that inflation has had a material effect on our results of operations during the years ended December 31, 2013, 2014 or 2015.", "type": 2, "words": ["<tag1>", "We", "do", "not", "believe", "that", "inflation", "has", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2012,", "2013", "or", "2014.", "<tag2>", "We", "do", "not", "believe", "that", "inflation", "has", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2013,", "2014", "or", "2015.", "<tag3>"], "wordsA": ["We", "do", "not", "believe", "that", "inflation", "has", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2012,", "2013", "or", "2014."], "wordsB": ["We", "do", "not", "believe", "that", "inflation", "has", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2013,", "2014", "or", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p69_s1", "idA": "1006281_15_item7_p80_s1", "sentA": "We do not believe currency fluctuations have had a material effect on our results of operations during the years ended December 31, 2012, 2013 or 2014.", "sentB": "We do not believe currency fluctuations have had a material effect on our results of operations during the years ended December 31, 2013, 2014 or 2015.", "type": 2, "words": ["<tag1>", "We", "do", "not", "believe", "currency", "fluctuations", "have", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2012,", "2013", "or", "2014.", "<tag2>", "We", "do", "not", "believe", "currency", "fluctuations", "have", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2013,", "2014", "or", "2015.", "<tag3>"], "wordsA": ["We", "do", "not", "believe", "currency", "fluctuations", "have", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2012,", "2013", "or", "2014."], "wordsB": ["We", "do", "not", "believe", "currency", "fluctuations", "have", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2013,", "2014", "or", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p70_s0", "idA": "1006281_15_item7_p81_s0", "sentA": "We have no off-balance sheet arrangements as of December 31, 2013 and 2014.", "sentB": "We have no off-balance sheet arrangements as of December 31, 2014 and 2015.", "type": 2, "words": ["<tag1>", "We", "have", "no", "off-balance", "sheet", "arrangements", "as", "of", "December", "31,", "2013", "and", "2014.", "<tag2>", "We", "have", "no", "off-balance", "sheet", "arrangements", "as", "of", "December", "31,", "2014", "and", "2015.", "<tag3>"], "wordsA": ["We", "have", "no", "off-balance", "sheet", "arrangements", "as", "of", "December", "31,", "2013", "and", "2014."], "wordsB": ["We", "have", "no", "off-balance", "sheet", "arrangements", "as", "of", "December", "31,", "2014", "and", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p21_s4", "idA": "1006281_15_item7_p82_s0", "sentA": "Certain recently issued accounting pronouncements are discussed in Note 1(p) of the financial statements included in Item 8 of this Annual Report on Form 10-K.", "sentB": "For further details please see notes 2 and 12 to the financial statements.", "type": 2, "words": ["<tag1>", "Certain", "recently", "issued", "accounting", "pronouncements", "are", "discussed", "in", "Note", "1(p)", "of", "the", "financial", "statements", "included", "in", "Item", "8", "of", "this", "Annual", "Report", "on", "Form", "10-K.", "<tag2>", "For", "further", "details", "please", "see", "notes", "2", "and", "12", "to", "the", "financial", "statements.", "<tag3>"], "wordsA": ["Certain", "recently", "issued", "accounting", "pronouncements", "are", "discussed", "in", "Note", "1(p)", "of", "the", "financial", "statements", "included", "in", "Item", "8", "of", "this", "Annual", "Report", "on", "Form", "10-K."], "wordsB": ["For", "further", "details", "please", "see", "notes", "2", "and", "12", "to", "the", "financial", "statements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p72_s0", "idA": "1006281_15_item7_p83_s0", "sentA": "The following table summarizes our significant contractual obligations at December 31, 2014:", "sentB": "The following table summarizes our significant contractual obligations at December 31, 2015:", "type": 2, "words": ["<tag1>", "The", "following", "table", "summarizes", "our", "significant", "contractual", "obligations", "at", "December", "31,", "2014:", "<tag2>", "The", "following", "table", "summarizes", "our", "significant", "contractual", "obligations", "at", "December", "31,", "2015:", "<tag3>"], "wordsA": ["The", "following", "table", "summarizes", "our", "significant", "contractual", "obligations", "at", "December", "31,", "2014:"], "wordsB": ["The", "following", "table", "summarizes", "our", "significant", "contractual", "obligations", "at", "December", "31,", "2015:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p23_s0", "idA": "1006281_15_item7_p84_s0", "sentA": "(1) Represents open purchase orders issued to certain suppliers and other vendors mainly in connection with our research and development activities that were outstanding as of December 31, 2014.", "sentB": "The following assets and liabilities associated with our share in the former collaboration, including our rights to Elelyso in Israel, have been segregated and classified as assets and liabilities of discontinued operations, as appropriate, in the consolidated balance sheets as of December 31, 2014 and 2015, respectively (in thousands):", "type": 2, "words": ["<tag1>", "(1)", "Represents", "open", "purchase", "orders", "issued", "to", "certain", "suppliers", "and", "other", "vendors", "mainly", "in", "connection", "with", "our", "research", "and", "development", "activities", "that", "were", "outstanding", "as", "of", "December", "31,", "2014.", "<tag2>", "The", "following", "assets", "and", "liabilities", "associated", "with", "our", "share", "in", "the", "former", "collaboration,", "including", "our", "rights", "to", "Elelyso", "in", "Israel,", "have", "been", "segregated", "and", "classified", "as", "assets", "and", "liabilities", "of", "discontinued", "operations,", "as", "appropriate,", "in", "the", "consolidated", "balance", "sheets", "as", "of", "December", "31,", "2014", "and", "2015,", "respectively", "(in", "thousands):", "<tag3>"], "wordsA": ["(1)", "Represents", "open", "purchase", "orders", "issued", "to", "certain", "suppliers", "and", "other", "vendors", "mainly", "in", "connection", "with", "our", "research", "and", "development", "activities", "that", "were", "outstanding", "as", "of", "December", "31,", "2014."], "wordsB": ["The", "following", "assets", "and", "liabilities", "associated", "with", "our", "share", "in", "the", "former", "collaboration,", "including", "our", "rights", "to", "Elelyso", "in", "Israel,", "have", "been", "segregated", "and", "classified", "as", "assets", "and", "liabilities", "of", "discontinued", "operations,", "as", "appropriate,", "in", "the", "consolidated", "balance", "sheets", "as", "of", "December", "31,", "2014", "and", "2015,", "respectively", "(in", "thousands):"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p73_s0", "idA": "1006281_15_item7_p84_s0", "sentA": "(1) Represents open purchase orders issued to certain suppliers and other vendors mainly in connection with our research and development activities that were outstanding as of December 31, 2014.", "sentB": "(1) Represents open purchase orders issued to certain suppliers and other vendors mainly in connection with our research and development activities that were outstanding as of December 31, 2015.", "type": 2, "words": ["<tag1>", "(1)", "Represents", "open", "purchase", "orders", "issued", "to", "certain", "suppliers", "and", "other", "vendors", "mainly", "in", "connection", "with", "our", "research", "and", "development", "activities", "that", "were", "outstanding", "as", "of", "December", "31,", "2014.", "<tag2>", "(1)", "Represents", "open", "purchase", "orders", "issued", "to", "certain", "suppliers", "and", "other", "vendors", "mainly", "in", "connection", "with", "our", "research", "and", "development", "activities", "that", "were", "outstanding", "as", "of", "December", "31,", "2015.", "<tag3>"], "wordsA": ["(1)", "Represents", "open", "purchase", "orders", "issued", "to", "certain", "suppliers", "and", "other", "vendors", "mainly", "in", "connection", "with", "our", "research", "and", "development", "activities", "that", "were", "outstanding", "as", "of", "December", "31,", "2014."], "wordsB": ["(1)", "Represents", "open", "purchase", "orders", "issued", "to", "certain", "suppliers", "and", "other", "vendors", "mainly", "in", "connection", "with", "our", "research", "and", "development", "activities", "that", "were", "outstanding", "as", "of", "December", "31,", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p74_s1", "idA": "1006281_15_item7_p85_s1", "sentA": "If all of the contingencies with respect to milestone payments under our research and license agreements are met, the aggregate milestone payments payable would be approximately $0.3 million and would be payable, if at all, as our projects progress over the course of a number of years.", "sentB": "If all of the contingencies with respect to milestone payments under our research and license agreements are met, the aggregate milestone payments payable would be approximately $8.7 million and would be payable, if at all, as our projects progress over the course of a number of years.", "type": 2, "words": ["<tag1>", "If", "all", "of", "the", "contingencies", "with", "respect", "to", "milestone", "payments", "under", "our", "research", "and", "license", "agreements", "are", "met,", "the", "aggregate", "milestone", "payments", "payable", "would", "be", "approximately", "$0.3", "million", "and", "would", "be", "payable,", "if", "at", "all,", "as", "our", "projects", "progress", "over", "the", "course", "of", "a", "number", "of", "years.", "<tag2>", "If", "all", "of", "the", "contingencies", "with", "respect", "to", "milestone", "payments", "under", "our", "research", "and", "license", "agreements", "are", "met,", "the", "aggregate", "milestone", "payments", "payable", "would", "be", "approximately", "$8.7", "million", "and", "would", "be", "payable,", "if", "at", "all,", "as", "our", "projects", "progress", "over", "the", "course", "of", "a", "number", "of", "years.", "<tag3>"], "wordsA": ["If", "all", "of", "the", "contingencies", "with", "respect", "to", "milestone", "payments", "under", "our", "research", "and", "license", "agreements", "are", "met,", "the", "aggregate", "milestone", "payments", "payable", "would", "be", "approximately", "$0.3", "million", "and", "would", "be", "payable,", "if", "at", "all,", "as", "our", "projects", "progress", "over", "the", "course", "of", "a", "number", "of", "years."], "wordsB": ["If", "all", "of", "the", "contingencies", "with", "respect", "to", "milestone", "payments", "under", "our", "research", "and", "license", "agreements", "are", "met,", "the", "aggregate", "milestone", "payments", "payable", "would", "be", "approximately", "$8.7", "million", "and", "would", "be", "payable,", "if", "at", "all,", "as", "our", "projects", "progress", "over", "the", "course", "of", "a", "number", "of", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p3_s0", "idA": "1006281_15_item7_p9_s0", "sentA": "Since May 2012, taliglucerase alfa has been marketed in the United States by Pfizer Inc., or Pfizer, our commercialization partner, as provided in the exclusive license and supply agreement by and between Protalix Ltd., our wholly-owned subsidiary, and Pfizer, which we refer to as the Pfizer Agreement.", "sentB": "Since its approval by the FDA, taliglucerase alfa has been marketed mainly in the United States by Pfizer, as provided in the exclusive license and supply agreement by and between Protalix Ltd., our wholly-owned subsidiary, and Pfizer.", "type": 2, "words": ["<tag1>", "Since", "May", "2012,", "taliglucerase", "alfa", "has", "been", "marketed", "in", "the", "United", "States", "by", "Pfizer", "Inc.,", "or", "Pfizer,", "our", "commercialization", "partner,", "as", "provided", "in", "the", "exclusive", "license", "and", "supply", "agreement", "by", "and", "between", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary,", "and", "Pfizer,", "which", "we", "refer", "to", "as", "the", "Pfizer", "Agreement.", "<tag2>", "Since", "its", "approval", "by", "the", "FDA,", "taliglucerase", "alfa", "has", "been", "marketed", "mainly", "in", "the", "United", "States", "by", "Pfizer,", "as", "provided", "in", "the", "exclusive", "license", "and", "supply", "agreement", "by", "and", "between", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary,", "and", "Pfizer.", "<tag3>"], "wordsA": ["Since", "May", "2012,", "taliglucerase", "alfa", "has", "been", "marketed", "in", "the", "United", "States", "by", "Pfizer", "Inc.,", "or", "Pfizer,", "our", "commercialization", "partner,", "as", "provided", "in", "the", "exclusive", "license", "and", "supply", "agreement", "by", "and", "between", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary,", "and", "Pfizer,", "which", "we", "refer", "to", "as", "the", "Pfizer", "Agreement."], "wordsB": ["Since", "its", "approval", "by", "the", "FDA,", "taliglucerase", "alfa", "has", "been", "marketed", "mainly", "in", "the", "United", "States", "by", "Pfizer,", "as", "provided", "in", "the", "exclusive", "license", "and", "supply", "agreement", "by", "and", "between", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary,", "and", "Pfizer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item7_p4_s0", "idA": "1006281_15_item7_p9_s2", "sentA": "We have agreed to a specific allocation between Protalix Ltd. and Pfizer of the responsibilities for the continued development efforts for taliglucerase alfa outside of Israel.", "sentB": "For the first 10-year period after the execution of the Amended Pfizer Agreement, we have agreed to sell drug substance to Pfizer for the production of Elelyso, and Pfizer maintains the right to extend the supply period for up to two additional 30-month periods subject to certain terms and conditions.", "type": 2, "words": ["<tag1>", "We", "have", "agreed", "to", "a", "specific", "allocation", "between", "Protalix", "Ltd.", "and", "Pfizer", "of", "the", "responsibilities", "for", "the", "continued", "development", "efforts", "for", "taliglucerase", "alfa", "outside", "of", "Israel.", "<tag2>", "For", "the", "first", "10-year", "period", "after", "the", "execution", "of", "the", "Amended", "Pfizer", "Agreement,", "we", "have", "agreed", "to", "sell", "drug", "substance", "to", "Pfizer", "for", "the", "production", "of", "Elelyso,", "and", "Pfizer", "maintains", "the", "right", "to", "extend", "the", "supply", "period", "for", "up", "to", "two", "additional", "30-month", "periods", "subject", "to", "certain", "terms", "and", "conditions.", "<tag3>"], "wordsA": ["We", "have", "agreed", "to", "a", "specific", "allocation", "between", "Protalix", "Ltd.", "and", "Pfizer", "of", "the", "responsibilities", "for", "the", "continued", "development", "efforts", "for", "taliglucerase", "alfa", "outside", "of", "Israel."], "wordsB": ["For", "the", "first", "10-year", "period", "after", "the", "execution", "of", "the", "Amended", "Pfizer", "Agreement,", "we", "have", "agreed", "to", "sell", "drug", "substance", "to", "Pfizer", "for", "the", "production", "of", "Elelyso,", "and", "Pfizer", "maintains", "the", "right", "to", "extend", "the", "supply", "period", "for", "up", "to", "two", "additional", "30-month", "periods", "subject", "to", "certain", "terms", "and", "conditions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p4_s1", "idA": "1006281_16_item7_p15_s0", "sentA": "Until we entered into the Amended Pfizer Agreement, our sole source of revenues came from sales of taliglucerase alfa pursuant to our license with Pfizer, our sales of taliglucerase alfa in Israel and Brazil and from milestone payments under the Pfizer Agreement.", "sentB": "In October 2015, we entered into the Amended Pfizer Agreement which amends and restates the Pfizer Agreement in its entirety.", "type": 2, "words": ["<tag1>", "Until", "we", "entered", "into", "the", "Amended", "Pfizer", "Agreement,", "our", "sole", "source", "of", "revenues", "came", "from", "sales", "of", "taliglucerase", "alfa", "pursuant", "to", "our", "license", "with", "Pfizer,", "our", "sales", "of", "taliglucerase", "alfa", "in", "Israel", "and", "Brazil", "and", "from", "milestone", "payments", "under", "the", "Pfizer", "Agreement.", "<tag2>", "In", "October", "2015,", "we", "entered", "into", "the", "Amended", "Pfizer", "Agreement", "which", "amends", "and", "restates", "the", "Pfizer", "Agreement", "in", "its", "entirety.", "<tag3>"], "wordsA": ["Until", "we", "entered", "into", "the", "Amended", "Pfizer", "Agreement,", "our", "sole", "source", "of", "revenues", "came", "from", "sales", "of", "taliglucerase", "alfa", "pursuant", "to", "our", "license", "with", "Pfizer,", "our", "sales", "of", "taliglucerase", "alfa", "in", "Israel", "and", "Brazil", "and", "from", "milestone", "payments", "under", "the", "Pfizer", "Agreement."], "wordsB": ["In", "October", "2015,", "we", "entered", "into", "the", "Amended", "Pfizer", "Agreement", "which", "amends", "and", "restates", "the", "Pfizer", "Agreement", "in", "its", "entirety."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p17_s1", "idA": "1006281_16_item7_p15_s1", "sentA": "Following entry into the Amended Pfizer Agreement, our primary source of revenues will be our sales of taliglucerase alfa in Brazil, which have not been substantial to date.", "sentB": "Following the entry into the Amended Pfizer Agreement, our primary source of revenues will be our sales of taliglucerase alfa in Brazil.", "type": 2, "words": ["<tag1>", "Following", "entry", "into", "the", "Amended", "Pfizer", "Agreement,", "our", "primary", "source", "of", "revenues", "will", "be", "our", "sales", "of", "taliglucerase", "alfa", "in", "Brazil,", "which", "have", "not", "been", "substantial", "to", "date.", "<tag2>", "Following", "the", "entry", "into", "the", "Amended", "Pfizer", "Agreement,", "our", "primary", "source", "of", "revenues", "will", "be", "our", "sales", "of", "taliglucerase", "alfa", "in", "Brazil.", "<tag3>"], "wordsA": ["Following", "entry", "into", "the", "Amended", "Pfizer", "Agreement,", "our", "primary", "source", "of", "revenues", "will", "be", "our", "sales", "of", "taliglucerase", "alfa", "in", "Brazil,", "which", "have", "not", "been", "substantial", "to", "date."], "wordsB": ["Following", "the", "entry", "into", "the", "Amended", "Pfizer", "Agreement,", "our", "primary", "source", "of", "revenues", "will", "be", "our", "sales", "of", "taliglucerase", "alfa", "in", "Brazil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p46_s3", "idA": "1006281_16_item7_p16_s1", "sentA": "Pursuant to this guidance, we determined whether our arrangement with Pfizer involves multiple revenue-generating deliverables that should be accounted for as a combined unit of accounting or separate units of accounting for revenue recognition purposes.", "sentB": "The conversion feature for our 7.5% convertible notes is accounted for as a derivative which is bifurcated from the debt host contract and is measured at fair value through the statement of operations.", "type": 2, "words": ["<tag1>", "Pursuant", "to", "this", "guidance,", "we", "determined", "whether", "our", "arrangement", "with", "Pfizer", "involves", "multiple", "revenue-generating", "deliverables", "that", "should", "be", "accounted", "for", "as", "a", "combined", "unit", "of", "accounting", "or", "separate", "units", "of", "accounting", "for", "revenue", "recognition", "purposes.", "<tag2>", "The", "conversion", "feature", "for", "our", "7.5%", "convertible", "notes", "is", "accounted", "for", "as", "a", "derivative", "which", "is", "bifurcated", "from", "the", "debt", "host", "contract", "and", "is", "measured", "at", "fair", "value", "through", "the", "statement", "of", "operations.", "<tag3>"], "wordsA": ["Pursuant", "to", "this", "guidance,", "we", "determined", "whether", "our", "arrangement", "with", "Pfizer", "involves", "multiple", "revenue-generating", "deliverables", "that", "should", "be", "accounted", "for", "as", "a", "combined", "unit", "of", "accounting", "or", "separate", "units", "of", "accounting", "for", "revenue", "recognition", "purposes."], "wordsB": ["The", "conversion", "feature", "for", "our", "7.5%", "convertible", "notes", "is", "accounted", "for", "as", "a", "derivative", "which", "is", "bifurcated", "from", "the", "debt", "host", "contract", "and", "is", "measured", "at", "fair", "value", "through", "the", "statement", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p1_s0", "idA": "1006281_16_item7_p1_s0", "sentA": "We are a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on our proprietary ProCellEx protein expression system.", "sentB": "We are a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on our proprietary ProCellEx system.", "type": 2, "words": ["<tag1>", "We", "are", "a", "biopharmaceutical", "company", "focused", "on", "the", "development", "and", "commercialization", "of", "recombinant", "therapeutic", "proteins", "based", "on", "our", "proprietary", "ProCellEx", "protein", "expression", "system.", "<tag2>", "We", "are", "a", "biopharmaceutical", "company", "focused", "on", "the", "development", "and", "commercialization", "of", "recombinant", "therapeutic", "proteins", "based", "on", "our", "proprietary", "ProCellEx", "system.", "<tag3>"], "wordsA": ["We", "are", "a", "biopharmaceutical", "company", "focused", "on", "the", "development", "and", "commercialization", "of", "recombinant", "therapeutic", "proteins", "based", "on", "our", "proprietary", "ProCellEx", "protein", "expression", "system."], "wordsB": ["We", "are", "a", "biopharmaceutical", "company", "focused", "on", "the", "development", "and", "commercialization", "of", "recombinant", "therapeutic", "proteins", "based", "on", "our", "proprietary", "ProCellEx", "system."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p1_s1", "idA": "1006281_16_item7_p1_s1", "sentA": "We developed our first commercial drug product, Elelyso TM , using our ProCellEx system and we are focused on utilizing the system to develop a pipeline of proprietary, clinically superior versions of recombinant therapeutic proteins that primarily target large, established pharmaceutical markets and that in most cases rely upon known biological mechanisms of action.", "sentB": "We developed our first commercial drug product, Elelyso , using our ProCellEx system and we are now focused on utilizing the system to develop a pipeline of proprietary, clinically superior versions of recombinant therapeutic proteins that primarily target large, established pharmaceutical markets and that, in most cases, rely upon known biological mechanisms of action.", "type": 2, "words": ["<tag1>", "We", "developed", "our", "first", "commercial", "drug", "product,", "Elelyso", "TM", ",", "using", "our", "ProCellEx", "system", "and", "we", "are", "focused", "on", "utilizing", "the", "system", "to", "develop", "a", "pipeline", "of", "proprietary,", "clinically", "superior", "versions", "of", "recombinant", "therapeutic", "proteins", "that", "primarily", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "in", "most", "cases", "rely", "upon", "known", "biological", "mechanisms", "of", "action.", "<tag2>", "We", "developed", "our", "first", "commercial", "drug", "product,", "Elelyso", ",", "using", "our", "ProCellEx", "system", "and", "we", "are", "now", "focused", "on", "utilizing", "the", "system", "to", "develop", "a", "pipeline", "of", "proprietary,", "clinically", "superior", "versions", "of", "recombinant", "therapeutic", "proteins", "that", "primarily", "target", "large,", "established", "pharmaceutical", "markets", "and", "that,", "in", "most", "cases,", "rely", "upon", "known", "biological", "mechanisms", "of", "action.", "<tag3>"], "wordsA": ["We", "developed", "our", "first", "commercial", "drug", "product,", "Elelyso", "TM", ",", "using", "our", "ProCellEx", "system", "and", "we", "are", "focused", "on", "utilizing", "the", "system", "to", "develop", "a", "pipeline", "of", "proprietary,", "clinically", "superior", "versions", "of", "recombinant", "therapeutic", "proteins", "that", "primarily", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "in", "most", "cases", "rely", "upon", "known", "biological", "mechanisms", "of", "action."], "wordsB": ["We", "developed", "our", "first", "commercial", "drug", "product,", "Elelyso", ",", "using", "our", "ProCellEx", "system", "and", "we", "are", "now", "focused", "on", "utilizing", "the", "system", "to", "develop", "a", "pipeline", "of", "proprietary,", "clinically", "superior", "versions", "of", "recombinant", "therapeutic", "proteins", "that", "primarily", "target", "large,", "established", "pharmaceutical", "markets", "and", "that,", "in", "most", "cases,", "rely", "upon", "known", "biological", "mechanisms", "of", "action."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p4_s2", "idA": "1006281_16_item7_p21_s0", "sentA": "Pursuant to the Amended Pfizer Agreement, we sold to Pfizer our share in the collaboration created under the initial Pfizer Agreement for the commercialization of Elelyso.", "sentB": "Pursuant to the Amended Pfizer Agreement, we sold to Pfizer our share in the collaboration created under the initial Pfizer Agreement for the commercialization of Elelyso in exchange for a cash payment equal to $36.0 million.", "type": 2, "words": ["<tag1>", "Pursuant", "to", "the", "Amended", "Pfizer", "Agreement,", "we", "sold", "to", "Pfizer", "our", "share", "in", "the", "collaboration", "created", "under", "the", "initial", "Pfizer", "Agreement", "for", "the", "commercialization", "of", "Elelyso.", "<tag2>", "Pursuant", "to", "the", "Amended", "Pfizer", "Agreement,", "we", "sold", "to", "Pfizer", "our", "share", "in", "the", "collaboration", "created", "under", "the", "initial", "Pfizer", "Agreement", "for", "the", "commercialization", "of", "Elelyso", "in", "exchange", "for", "a", "cash", "payment", "equal", "to", "$36.0", "million.", "<tag3>"], "wordsA": ["Pursuant", "to", "the", "Amended", "Pfizer", "Agreement,", "we", "sold", "to", "Pfizer", "our", "share", "in", "the", "collaboration", "created", "under", "the", "initial", "Pfizer", "Agreement", "for", "the", "commercialization", "of", "Elelyso."], "wordsB": ["Pursuant", "to", "the", "Amended", "Pfizer", "Agreement,", "we", "sold", "to", "Pfizer", "our", "share", "in", "the", "collaboration", "created", "under", "the", "initial", "Pfizer", "Agreement", "for", "the", "commercialization", "of", "Elelyso", "in", "exchange", "for", "a", "cash", "payment", "equal", "to", "$36.0", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p50_s1", "idA": "1006281_16_item7_p21_s0", "sentA": "Pursuant to the Amended Pfizer Agreement, we sold to Pfizer our share in the collaboration created under the initial Pfizer Agreement for the commercialization of Elelyso.", "sentB": "The increase is mainly due to cost of revenues that were attributed to an increase in the amount of drug substance sold to Pfizer at cost during the period and that a substantial portion of activities performed during 2015 were attributed to the development and production of PRX-102 for the entire period during which the phase III clinical trial is to be performed.", "type": 2, "words": ["<tag1>", "Pursuant", "to", "the", "Amended", "Pfizer", "Agreement,", "we", "sold", "to", "Pfizer", "our", "share", "in", "the", "collaboration", "created", "under", "the", "initial", "Pfizer", "Agreement", "for", "the", "commercialization", "of", "Elelyso.", "<tag2>", "The", "increase", "is", "mainly", "due", "to", "cost", "of", "revenues", "that", "were", "attributed", "to", "an", "increase", "in", "the", "amount", "of", "drug", "substance", "sold", "to", "Pfizer", "at", "cost", "during", "the", "period", "and", "that", "a", "substantial", "portion", "of", "activities", "performed", "during", "2015", "were", "attributed", "to", "the", "development", "and", "production", "of", "PRX-102", "for", "the", "entire", "period", "during", "which", "the", "phase", "III", "clinical", "trial", "is", "to", "be", "performed.", "<tag3>"], "wordsA": ["Pursuant", "to", "the", "Amended", "Pfizer", "Agreement,", "we", "sold", "to", "Pfizer", "our", "share", "in", "the", "collaboration", "created", "under", "the", "initial", "Pfizer", "Agreement", "for", "the", "commercialization", "of", "Elelyso."], "wordsB": ["The", "increase", "is", "mainly", "due", "to", "cost", "of", "revenues", "that", "were", "attributed", "to", "an", "increase", "in", "the", "amount", "of", "drug", "substance", "sold", "to", "Pfizer", "at", "cost", "during", "the", "period", "and", "that", "a", "substantial", "portion", "of", "activities", "performed", "during", "2015", "were", "attributed", "to", "the", "development", "and", "production", "of", "PRX-102", "for", "the", "entire", "period", "during", "which", "the", "phase", "III", "clinical", "trial", "is", "to", "be", "performed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p5_s0", "idA": "1006281_16_item7_p21_s0", "sentA": "Pursuant to the Amended Pfizer Agreement, we sold to Pfizer our share in the collaboration created under the initial Pfizer Agreement for the commercialization of Elelyso.", "sentB": "Under the initial Pfizer Agreement, Pfizer shared revenues and expenses for the development and commercialization of Elelyso with us on a 60%/40% basis globally, excluding Israel and Brazil.", "type": 2, "words": ["<tag1>", "Pursuant", "to", "the", "Amended", "Pfizer", "Agreement,", "we", "sold", "to", "Pfizer", "our", "share", "in", "the", "collaboration", "created", "under", "the", "initial", "Pfizer", "Agreement", "for", "the", "commercialization", "of", "Elelyso.", "<tag2>", "Under", "the", "initial", "Pfizer", "Agreement,", "Pfizer", "shared", "revenues", "and", "expenses", "for", "the", "development", "and", "commercialization", "of", "Elelyso", "with", "us", "on", "a", "60%/40%", "basis", "globally,", "excluding", "Israel", "and", "Brazil.", "<tag3>"], "wordsA": ["Pursuant", "to", "the", "Amended", "Pfizer", "Agreement,", "we", "sold", "to", "Pfizer", "our", "share", "in", "the", "collaboration", "created", "under", "the", "initial", "Pfizer", "Agreement", "for", "the", "commercialization", "of", "Elelyso."], "wordsB": ["Under", "the", "initial", "Pfizer", "Agreement,", "Pfizer", "shared", "revenues", "and", "expenses", "for", "the", "development", "and", "commercialization", "of", "Elelyso", "with", "us", "on", "a", "60%/40%", "basis", "globally,", "excluding", "Israel", "and", "Brazil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p5_s1", "idA": "1006281_16_item7_p21_s2", "sentA": "Under the Amended Pfizer Agreement, Pfizer is responsible for 100% of expenses, and entitled to all of the revenues, globally, for Elelyso, excluding Brazil where we are responsible for all expenses and retain all revenues.", "sentB": "Under the Amended Pfizer Agreement, Pfizer is responsible for 100% of expenses, and entitled to all revenues globally for Elelyso, excluding Brazil, where we are responsible for all expenses and retain all revenues.", "type": 2, "words": ["<tag1>", "Under", "the", "Amended", "Pfizer", "Agreement,", "Pfizer", "is", "responsible", "for", "100%", "of", "expenses,", "and", "entitled", "to", "all", "of", "the", "revenues,", "globally,", "for", "Elelyso,", "excluding", "Brazil", "where", "we", "are", "responsible", "for", "all", "expenses", "and", "retain", "all", "revenues.", "<tag2>", "Under", "the", "Amended", "Pfizer", "Agreement,", "Pfizer", "is", "responsible", "for", "100%", "of", "expenses,", "and", "entitled", "to", "all", "revenues", "globally", "for", "Elelyso,", "excluding", "Brazil,", "where", "we", "are", "responsible", "for", "all", "expenses", "and", "retain", "all", "revenues.", "<tag3>"], "wordsA": ["Under", "the", "Amended", "Pfizer", "Agreement,", "Pfizer", "is", "responsible", "for", "100%", "of", "expenses,", "and", "entitled", "to", "all", "of", "the", "revenues,", "globally,", "for", "Elelyso,", "excluding", "Brazil", "where", "we", "are", "responsible", "for", "all", "expenses", "and", "retain", "all", "revenues."], "wordsB": ["Under", "the", "Amended", "Pfizer", "Agreement,", "Pfizer", "is", "responsible", "for", "100%", "of", "expenses,", "and", "entitled", "to", "all", "revenues", "globally", "for", "Elelyso,", "excluding", "Brazil,", "where", "we", "are", "responsible", "for", "all", "expenses", "and", "retain", "all", "revenues."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p23_s3", "idA": "1006281_16_item7_p21_s3", "sentA": "The Amended Pfizer Agreement eliminates Pfizer s entitlement to annual payments of up to $12.5 million in relation to commercialization of Elelyso in Brazil.", "sentB": "The Amended Pfizer Agreement eliminated Pfizer s entitlement to annual payments of up to $12.5 million in relation to commercialization of Elelyso in Brazil.", "type": 2, "words": ["<tag1>", "The", "Amended", "Pfizer", "Agreement", "eliminates", "Pfizer", "s", "entitlement", "to", "annual", "payments", "of", "up", "to", "$12.5", "million", "in", "relation", "to", "commercialization", "of", "Elelyso", "in", "Brazil.", "<tag2>", "The", "Amended", "Pfizer", "Agreement", "eliminated", "Pfizer", "s", "entitlement", "to", "annual", "payments", "of", "up", "to", "$12.5", "million", "in", "relation", "to", "commercialization", "of", "Elelyso", "in", "Brazil.", "<tag3>"], "wordsA": ["The", "Amended", "Pfizer", "Agreement", "eliminates", "Pfizer", "s", "entitlement", "to", "annual", "payments", "of", "up", "to", "$12.5", "million", "in", "relation", "to", "commercialization", "of", "Elelyso", "in", "Brazil."], "wordsB": ["The", "Amended", "Pfizer", "Agreement", "eliminated", "Pfizer", "s", "entitlement", "to", "annual", "payments", "of", "up", "to", "$12.5", "million", "in", "relation", "to", "commercialization", "of", "Elelyso", "in", "Brazil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p25_s2", "idA": "1006281_16_item7_p21_s4", "sentA": "For further details please see notes 2 and 12 to the financial statements.", "sentB": "See note 12 to the financial statements.", "type": 2, "words": ["<tag1>", "For", "further", "details", "please", "see", "notes", "2", "and", "12", "to", "the", "financial", "statements.", "<tag2>", "See", "note", "12", "to", "the", "financial", "statements.", "<tag3>"], "wordsA": ["For", "further", "details", "please", "see", "notes", "2", "and", "12", "to", "the", "financial", "statements."], "wordsB": ["See", "note", "12", "to", "the", "financial", "statements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p25_s0", "idA": "1006281_16_item7_p23_s0", "sentA": "The following assets and liabilities associated with our share in the former collaboration, including our rights to Elelyso in Israel, have been segregated and classified as assets and liabilities of discontinued operations, as appropriate, in the consolidated balance sheets as of December 31, 2014 and 2015, respectively (in thousands):", "sentB": "Certain of our assets and liabilities associated with our share in the former collaboration, including our rights to Elelyso in Israel, have been segregated and classified as assets and liabilities of discontinued operations, as appropriate, in our consolidated balance sheets as of December 31, 2015 and 2016.", "type": 2, "words": ["<tag1>", "The", "following", "assets", "and", "liabilities", "associated", "with", "our", "share", "in", "the", "former", "collaboration,", "including", "our", "rights", "to", "Elelyso", "in", "Israel,", "have", "been", "segregated", "and", "classified", "as", "assets", "and", "liabilities", "of", "discontinued", "operations,", "as", "appropriate,", "in", "the", "consolidated", "balance", "sheets", "as", "of", "December", "31,", "2014", "and", "2015,", "respectively", "(in", "thousands):", "<tag2>", "Certain", "of", "our", "assets", "and", "liabilities", "associated", "with", "our", "share", "in", "the", "former", "collaboration,", "including", "our", "rights", "to", "Elelyso", "in", "Israel,", "have", "been", "segregated", "and", "classified", "as", "assets", "and", "liabilities", "of", "discontinued", "operations,", "as", "appropriate,", "in", "our", "consolidated", "balance", "sheets", "as", "of", "December", "31,", "2015", "and", "2016.", "<tag3>"], "wordsA": ["The", "following", "assets", "and", "liabilities", "associated", "with", "our", "share", "in", "the", "former", "collaboration,", "including", "our", "rights", "to", "Elelyso", "in", "Israel,", "have", "been", "segregated", "and", "classified", "as", "assets", "and", "liabilities", "of", "discontinued", "operations,", "as", "appropriate,", "in", "the", "consolidated", "balance", "sheets", "as", "of", "December", "31,", "2014", "and", "2015,", "respectively", "(in", "thousands):"], "wordsB": ["Certain", "of", "our", "assets", "and", "liabilities", "associated", "with", "our", "share", "in", "the", "former", "collaboration,", "including", "our", "rights", "to", "Elelyso", "in", "Israel,", "have", "been", "segregated", "and", "classified", "as", "assets", "and", "liabilities", "of", "discontinued", "operations,", "as", "appropriate,", "in", "our", "consolidated", "balance", "sheets", "as", "of", "December", "31,", "2015", "and", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p25_s1", "idA": "1006281_16_item7_p25_s0", "sentA": "The following summarized financial information related to our share in the former collaboration, including our rights to Elelyso in Israel, have been segregated from continuing operations and have been reported as discontinued operations in our consolidated statements of operations (in thousands):", "sentB": "In addition, certain financial information related to our share in the former collaboration, including our rights to Elelyso in Israel, have been segregated from continuing operations and have been reported as discontinued operations in our consolidated statements of operations.", "type": 2, "words": ["<tag1>", "The", "following", "summarized", "financial", "information", "related", "to", "our", "share", "in", "the", "former", "collaboration,", "including", "our", "rights", "to", "Elelyso", "in", "Israel,", "have", "been", "segregated", "from", "continuing", "operations", "and", "have", "been", "reported", "as", "discontinued", "operations", "in", "our", "consolidated", "statements", "of", "operations", "(in", "thousands):", "<tag2>", "In", "addition,", "certain", "financial", "information", "related", "to", "our", "share", "in", "the", "former", "collaboration,", "including", "our", "rights", "to", "Elelyso", "in", "Israel,", "have", "been", "segregated", "from", "continuing", "operations", "and", "have", "been", "reported", "as", "discontinued", "operations", "in", "our", "consolidated", "statements", "of", "operations.", "<tag3>"], "wordsA": ["The", "following", "summarized", "financial", "information", "related", "to", "our", "share", "in", "the", "former", "collaboration,", "including", "our", "rights", "to", "Elelyso", "in", "Israel,", "have", "been", "segregated", "from", "continuing", "operations", "and", "have", "been", "reported", "as", "discontinued", "operations", "in", "our", "consolidated", "statements", "of", "operations", "(in", "thousands):"], "wordsB": ["In", "addition,", "certain", "financial", "information", "related", "to", "our", "share", "in", "the", "former", "collaboration,", "including", "our", "rights", "to", "Elelyso", "in", "Israel,", "have", "been", "segregated", "from", "continuing", "operations", "and", "have", "been", "reported", "as", "discontinued", "operations", "in", "our", "consolidated", "statements", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p2_s0", "idA": "1006281_16_item7_p2_s0", "sentA": "On May 1, 2012, the FDA approved for sale our first commercial product, taliglucerase alfa for injection, an enzyme replacement therapy, or ERT, for the long-term treatment of adult patients with a confirmed diagnosis of type 1 Gaucher disease.", "sentB": "On May 1, 2012, the FDA approved for sale our first commercial product, taliglucerase alfa for injection, an ERT for the long-term treatment of adult patients with a confirmed diagnosis of type 1 Gaucher disease.", "type": 2, "words": ["<tag1>", "On", "May", "1,", "2012,", "the", "FDA", "approved", "for", "sale", "our", "first", "commercial", "product,", "taliglucerase", "alfa", "for", "injection,", "an", "enzyme", "replacement", "therapy,", "or", "ERT,", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease.", "<tag2>", "On", "May", "1,", "2012,", "the", "FDA", "approved", "for", "sale", "our", "first", "commercial", "product,", "taliglucerase", "alfa", "for", "injection,", "an", "ERT", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease.", "<tag3>"], "wordsA": ["On", "May", "1,", "2012,", "the", "FDA", "approved", "for", "sale", "our", "first", "commercial", "product,", "taliglucerase", "alfa", "for", "injection,", "an", "enzyme", "replacement", "therapy,", "or", "ERT,", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease."], "wordsB": ["On", "May", "1,", "2012,", "the", "FDA", "approved", "for", "sale", "our", "first", "commercial", "product,", "taliglucerase", "alfa", "for", "injection,", "an", "ERT", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p3_s0", "idA": "1006281_16_item7_p2_s2", "sentA": "Taliglucerase alfa is being marketed under the name Uplyso TM in Brazil and certain other Latin American countries, and as Elelyso in all other territories.", "sentB": "Taliglucerase alfa is called alfataliglicerase in Brazil and certain other Latin American countries, where it is marketed under the name Uplyso TM .", "type": 2, "words": ["<tag1>", "Taliglucerase", "alfa", "is", "being", "marketed", "under", "the", "name", "Uplyso", "TM", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries,", "and", "as", "Elelyso", "in", "all", "other", "territories.", "<tag2>", "Taliglucerase", "alfa", "is", "called", "alfataliglicerase", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries,", "where", "it", "is", "marketed", "under", "the", "name", "Uplyso", "TM", ".", "<tag3>"], "wordsA": ["Taliglucerase", "alfa", "is", "being", "marketed", "under", "the", "name", "Uplyso", "TM", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries,", "and", "as", "Elelyso", "in", "all", "other", "territories."], "wordsB": ["Taliglucerase", "alfa", "is", "called", "alfataliglicerase", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries,", "where", "it", "is", "marketed", "under", "the", "name", "Uplyso", "TM", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p3_s1", "idA": "1006281_16_item7_p2_s2", "sentA": "Taliglucerase alfa is being marketed under the name Uplyso TM in Brazil and certain other Latin American countries, and as Elelyso in all other territories.", "sentB": "Taliglucerase alfa is marketed under the name Elelyso in other territories.", "type": 2, "words": ["<tag1>", "Taliglucerase", "alfa", "is", "being", "marketed", "under", "the", "name", "Uplyso", "TM", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries,", "and", "as", "Elelyso", "in", "all", "other", "territories.", "<tag2>", "Taliglucerase", "alfa", "is", "marketed", "under", "the", "name", "Elelyso", "in", "other", "territories.", "<tag3>"], "wordsA": ["Taliglucerase", "alfa", "is", "being", "marketed", "under", "the", "name", "Uplyso", "TM", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries,", "and", "as", "Elelyso", "in", "all", "other", "territories."], "wordsB": ["Taliglucerase", "alfa", "is", "marketed", "under", "the", "name", "Elelyso", "in", "other", "territories."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p30_s0", "idA": "1006281_16_item7_p30_s0", "sentA": "The costs and expenses of our projects are partially funded by grants we have received from the OCS.", "sentB": "The costs and expenses of our projects are partially funded by grants we have received from NATI.", "type": 2, "words": ["<tag1>", "The", "costs", "and", "expenses", "of", "our", "projects", "are", "partially", "funded", "by", "grants", "we", "have", "received", "from", "the", "OCS.", "<tag2>", "The", "costs", "and", "expenses", "of", "our", "projects", "are", "partially", "funded", "by", "grants", "we", "have", "received", "from", "NATI.", "<tag3>"], "wordsA": ["The", "costs", "and", "expenses", "of", "our", "projects", "are", "partially", "funded", "by", "grants", "we", "have", "received", "from", "the", "OCS."], "wordsB": ["The", "costs", "and", "expenses", "of", "our", "projects", "are", "partially", "funded", "by", "grants", "we", "have", "received", "from", "NATI."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p30_s2", "idA": "1006281_16_item7_p30_s2", "sentA": "For additional information regarding the grant process, see Business Israeli Government Programs Encouragement of Industrial Research and Development Law, 1984 in Item 1 of this Annual Report.", "sentB": "For additional information regarding the grant process, see Business Israeli Government Programs Encouragement of Industrial Research, Development and Technology Innovation, 1984 in Item 1 of this Annual Report.", "type": 2, "words": ["<tag1>", "For", "additional", "information", "regarding", "the", "grant", "process,", "see", "Business", "Israeli", "Government", "Programs", "Encouragement", "of", "Industrial", "Research", "and", "Development", "Law,", "1984", "in", "Item", "1", "of", "this", "Annual", "Report.", "<tag2>", "For", "additional", "information", "regarding", "the", "grant", "process,", "see", "Business", "Israeli", "Government", "Programs", "Encouragement", "of", "Industrial", "Research,", "Development", "and", "Technology", "Innovation,", "1984", "in", "Item", "1", "of", "this", "Annual", "Report.", "<tag3>"], "wordsA": ["For", "additional", "information", "regarding", "the", "grant", "process,", "see", "Business", "Israeli", "Government", "Programs", "Encouragement", "of", "Industrial", "Research", "and", "Development", "Law,", "1984", "in", "Item", "1", "of", "this", "Annual", "Report."], "wordsB": ["For", "additional", "information", "regarding", "the", "grant", "process,", "see", "Business", "Israeli", "Government", "Programs", "Encouragement", "of", "Industrial", "Research,", "Development", "and", "Technology", "Innovation,", "1984", "in", "Item", "1", "of", "this", "Annual", "Report."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p31_s0", "idA": "1006281_16_item7_p31_s0", "sentA": "There can be no assurance that we will continue to receive grants from the OCS in amounts sufficient for our operations, if at all.", "sentB": "There can be no assurance that we will continue to receive grants from NATI in amounts sufficient for our operations, if at all.", "type": 2, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "that", "we", "will", "continue", "to", "receive", "grants", "from", "the", "OCS", "in", "amounts", "sufficient", "for", "our", "operations,", "if", "at", "all.", "<tag2>", "There", "can", "be", "no", "assurance", "that", "we", "will", "continue", "to", "receive", "grants", "from", "NATI", "in", "amounts", "sufficient", "for", "our", "operations,", "if", "at", "all.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "that", "we", "will", "continue", "to", "receive", "grants", "from", "the", "OCS", "in", "amounts", "sufficient", "for", "our", "operations,", "if", "at", "all."], "wordsB": ["There", "can", "be", "no", "assurance", "that", "we", "will", "continue", "to", "receive", "grants", "from", "NATI", "in", "amounts", "sufficient", "for", "our", "operations,", "if", "at", "all."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p6_s1", "idA": "1006281_16_item7_p36_s1", "sentA": "See Risk Factors Clinical trials are very expensive, time-consuming and difficult to design and implement and may result in unforeseen costs which may have a material adverse effect on our business, results of operations and financial condition.", "sentB": "Any failure to comply with our supply commitments may subject us to substantial financial penalties, which will have a material adverse effect on our business, results of operations and financial condition.", "type": 2, "words": ["<tag1>", "See", "Risk", "Factors", "Clinical", "trials", "are", "very", "expensive,", "time-consuming", "and", "difficult", "to", "design", "and", "implement", "and", "may", "result", "in", "unforeseen", "costs", "which", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "Any", "failure", "to", "comply", "with", "our", "supply", "commitments", "may", "subject", "us", "to", "substantial", "financial", "penalties,", "which", "will", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["See", "Risk", "Factors", "Clinical", "trials", "are", "very", "expensive,", "time-consuming", "and", "difficult", "to", "design", "and", "implement", "and", "may", "result", "in", "unforeseen", "costs", "which", "may", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["Any", "failure", "to", "comply", "with", "our", "supply", "commitments", "may", "subject", "us", "to", "substantial", "financial", "penalties,", "which", "will", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p4_s0", "idA": "1006281_16_item7_p3_s0", "sentA": "Since its approval by the FDA, taliglucerase alfa has been marketed mainly in the United States by Pfizer, as provided in the exclusive license and supply agreement by and between Protalix Ltd., our wholly-owned subsidiary, and Pfizer.", "sentB": "Since its approval by the FDA, taliglucerase alfa has been marketed mainly in the United States by Pfizer, as provided in the Pfizer Agreement.", "type": 2, "words": ["<tag1>", "Since", "its", "approval", "by", "the", "FDA,", "taliglucerase", "alfa", "has", "been", "marketed", "mainly", "in", "the", "United", "States", "by", "Pfizer,", "as", "provided", "in", "the", "exclusive", "license", "and", "supply", "agreement", "by", "and", "between", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary,", "and", "Pfizer.", "<tag2>", "Since", "its", "approval", "by", "the", "FDA,", "taliglucerase", "alfa", "has", "been", "marketed", "mainly", "in", "the", "United", "States", "by", "Pfizer,", "as", "provided", "in", "the", "Pfizer", "Agreement.", "<tag3>"], "wordsA": ["Since", "its", "approval", "by", "the", "FDA,", "taliglucerase", "alfa", "has", "been", "marketed", "mainly", "in", "the", "United", "States", "by", "Pfizer,", "as", "provided", "in", "the", "exclusive", "license", "and", "supply", "agreement", "by", "and", "between", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary,", "and", "Pfizer."], "wordsB": ["Since", "its", "approval", "by", "the", "FDA,", "taliglucerase", "alfa", "has", "been", "marketed", "mainly", "in", "the", "United", "States", "by", "Pfizer,", "as", "provided", "in", "the", "Pfizer", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p54_s2", "idA": "1006281_16_item7_p41_s0", "sentA": "For purposes of determining the fair value of the restricted shares of common stock granted to employees during the fiscal year ended December 31, 2013, our management used the fair value of our common stock which was the closing sale price of our common stock on the NYSE MKT on the date of grant.", "sentB": "The exchange was accounted for as extinguishment of notes, and the difference between the net carrying value of the 4.5% notes exchanged and the fair value of the new notes and shares issued were accounted for as a gain on extinguishment of $14.1 million.", "type": 2, "words": ["<tag1>", "For", "purposes", "of", "determining", "the", "fair", "value", "of", "the", "restricted", "shares", "of", "common", "stock", "granted", "to", "employees", "during", "the", "fiscal", "year", "ended", "December", "31,", "2013,", "our", "management", "used", "the", "fair", "value", "of", "our", "common", "stock", "which", "was", "the", "closing", "sale", "price", "of", "our", "common", "stock", "on", "the", "NYSE", "MKT", "on", "the", "date", "of", "grant.", "<tag2>", "The", "exchange", "was", "accounted", "for", "as", "extinguishment", "of", "notes,", "and", "the", "difference", "between", "the", "net", "carrying", "value", "of", "the", "4.5%", "notes", "exchanged", "and", "the", "fair", "value", "of", "the", "new", "notes", "and", "shares", "issued", "were", "accounted", "for", "as", "a", "gain", "on", "extinguishment", "of", "$14.1", "million.", "<tag3>"], "wordsA": ["For", "purposes", "of", "determining", "the", "fair", "value", "of", "the", "restricted", "shares", "of", "common", "stock", "granted", "to", "employees", "during", "the", "fiscal", "year", "ended", "December", "31,", "2013,", "our", "management", "used", "the", "fair", "value", "of", "our", "common", "stock", "which", "was", "the", "closing", "sale", "price", "of", "our", "common", "stock", "on", "the", "NYSE", "MKT", "on", "the", "date", "of", "grant."], "wordsB": ["The", "exchange", "was", "accounted", "for", "as", "extinguishment", "of", "notes,", "and", "the", "difference", "between", "the", "net", "carrying", "value", "of", "the", "4.5%", "notes", "exchanged", "and", "the", "fair", "value", "of", "the", "new", "notes", "and", "shares", "issued", "were", "accounted", "for", "as", "a", "gain", "on", "extinguishment", "of", "$14.1", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p49_s0", "idA": "1006281_16_item7_p47_s0", "sentA": "We recorded revenues of $4.4 million for the year ended December 31, 2015, an increase of approximately $841,000, or 24%, compared to revenues of $3.5 million for the year ended December 31, 2014.", "sentB": "We recorded revenues of $9.2 million for the year ended December 31, 2016, an increase of approximately $4.8 million, or 111%, compared to revenues of $4.4 million for the year ended December 31, 2015.", "type": 2, "words": ["<tag1>", "We", "recorded", "revenues", "of", "$4.4", "million", "for", "the", "year", "ended", "December", "31,", "2015,", "an", "increase", "of", "approximately", "$841,000,", "or", "24%,", "compared", "to", "revenues", "of", "$3.5", "million", "for", "the", "year", "ended", "December", "31,", "2014.", "<tag2>", "We", "recorded", "revenues", "of", "$9.2", "million", "for", "the", "year", "ended", "December", "31,", "2016,", "an", "increase", "of", "approximately", "$4.8", "million,", "or", "111%,", "compared", "to", "revenues", "of", "$4.4", "million", "for", "the", "year", "ended", "December", "31,", "2015.", "<tag3>"], "wordsA": ["We", "recorded", "revenues", "of", "$4.4", "million", "for", "the", "year", "ended", "December", "31,", "2015,", "an", "increase", "of", "approximately", "$841,000,", "or", "24%,", "compared", "to", "revenues", "of", "$3.5", "million", "for", "the", "year", "ended", "December", "31,", "2014."], "wordsB": ["We", "recorded", "revenues", "of", "$9.2", "million", "for", "the", "year", "ended", "December", "31,", "2016,", "an", "increase", "of", "approximately", "$4.8", "million,", "or", "111%,", "compared", "to", "revenues", "of", "$4.4", "million", "for", "the", "year", "ended", "December", "31,", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p49_s2", "idA": "1006281_16_item7_p47_s0", "sentA": "We recorded revenues of $4.4 million for the year ended December 31, 2015, an increase of approximately $841,000, or 24%, compared to revenues of $3.5 million for the year ended December 31, 2014.", "sentB": "The increase is mainly due to an increase of $4.8 million of drug substance sold to Pfizer.", "type": 2, "words": ["<tag1>", "We", "recorded", "revenues", "of", "$4.4", "million", "for", "the", "year", "ended", "December", "31,", "2015,", "an", "increase", "of", "approximately", "$841,000,", "or", "24%,", "compared", "to", "revenues", "of", "$3.5", "million", "for", "the", "year", "ended", "December", "31,", "2014.", "<tag2>", "The", "increase", "is", "mainly", "due", "to", "an", "increase", "of", "$4.8", "million", "of", "drug", "substance", "sold", "to", "Pfizer.", "<tag3>"], "wordsA": ["We", "recorded", "revenues", "of", "$4.4", "million", "for", "the", "year", "ended", "December", "31,", "2015,", "an", "increase", "of", "approximately", "$841,000,", "or", "24%,", "compared", "to", "revenues", "of", "$3.5", "million", "for", "the", "year", "ended", "December", "31,", "2014."], "wordsB": ["The", "increase", "is", "mainly", "due", "to", "an", "increase", "of", "$4.8", "million", "of", "drug", "substance", "sold", "to", "Pfizer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p49_s1", "idA": "1006281_16_item7_p47_s1", "sentA": "Revenues represent products sold in Brazil.", "sentB": "Revenues represent products sold in Brazil and drug substance sold to Pfizer.", "type": 2, "words": ["<tag1>", "Revenues", "represent", "products", "sold", "in", "Brazil.", "<tag2>", "Revenues", "represent", "products", "sold", "in", "Brazil", "and", "drug", "substance", "sold", "to", "Pfizer.", "<tag3>"], "wordsA": ["Revenues", "represent", "products", "sold", "in", "Brazil."], "wordsB": ["Revenues", "represent", "products", "sold", "in", "Brazil", "and", "drug", "substance", "sold", "to", "Pfizer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p8_s0", "idA": "1006281_16_item7_p47_s1", "sentA": "Revenues represent products sold in Brazil.", "sentB": "In December 2016, we received a letter from Fiocruz regarding an order from the Brazilian MoH to purchase alfataliglicerase to treat Gaucher patients in Brazil.", "type": 2, "words": ["<tag1>", "Revenues", "represent", "products", "sold", "in", "Brazil.", "<tag2>", "In", "December", "2016,", "we", "received", "a", "letter", "from", "Fiocruz", "regarding", "an", "order", "from", "the", "Brazilian", "MoH", "to", "purchase", "alfataliglicerase", "to", "treat", "Gaucher", "patients", "in", "Brazil.", "<tag3>"], "wordsA": ["Revenues", "represent", "products", "sold", "in", "Brazil."], "wordsB": ["In", "December", "2016,", "we", "received", "a", "letter", "from", "Fiocruz", "regarding", "an", "order", "from", "the", "Brazilian", "MoH", "to", "purchase", "alfataliglicerase", "to", "treat", "Gaucher", "patients", "in", "Brazil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p50_s0", "idA": "1006281_16_item7_p48_s0", "sentA": "Cost of revenues was $730,000 for the year ended December 31, 2015, an increase of $100,000, or 16%, compared to the cost of revenues of $630,000 for the year ended December 31, 2014.", "sentB": "Cost of revenues was $8.4 million for the year ended December 31, 2016 compared to the cost of revenues of $730,000 for the year ended December 31, 2015.", "type": 2, "words": ["<tag1>", "Cost", "of", "revenues", "was", "$730,000", "for", "the", "year", "ended", "December", "31,", "2015,", "an", "increase", "of", "$100,000,", "or", "16%,", "compared", "to", "the", "cost", "of", "revenues", "of", "$630,000", "for", "the", "year", "ended", "December", "31,", "2014.", "<tag2>", "Cost", "of", "revenues", "was", "$8.4", "million", "for", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "cost", "of", "revenues", "of", "$730,000", "for", "the", "year", "ended", "December", "31,", "2015.", "<tag3>"], "wordsA": ["Cost", "of", "revenues", "was", "$730,000", "for", "the", "year", "ended", "December", "31,", "2015,", "an", "increase", "of", "$100,000,", "or", "16%,", "compared", "to", "the", "cost", "of", "revenues", "of", "$630,000", "for", "the", "year", "ended", "December", "31,", "2014."], "wordsB": ["Cost", "of", "revenues", "was", "$8.4", "million", "for", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "cost", "of", "revenues", "of", "$730,000", "for", "the", "year", "ended", "December", "31,", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p56_s1", "idA": "1006281_16_item7_p48_s1", "sentA": "Cost of revenues consists primarily of products we sold in Brazil for which revenues were recognized during the period and royalties payable to the OCS and to a certain academic institution in connection with such sales.", "sentB": "Cost of revenues consists primarily of products we sold in Brazil for which revenues were recognized during the period and royalties payable to NATI and to a certain academic institution in connection with such sales.", "type": 2, "words": ["<tag1>", "Cost", "of", "revenues", "consists", "primarily", "of", "products", "we", "sold", "in", "Brazil", "for", "which", "revenues", "were", "recognized", "during", "the", "period", "and", "royalties", "payable", "to", "the", "OCS", "and", "to", "a", "certain", "academic", "institution", "in", "connection", "with", "such", "sales.", "<tag2>", "Cost", "of", "revenues", "consists", "primarily", "of", "products", "we", "sold", "in", "Brazil", "for", "which", "revenues", "were", "recognized", "during", "the", "period", "and", "royalties", "payable", "to", "NATI", "and", "to", "a", "certain", "academic", "institution", "in", "connection", "with", "such", "sales.", "<tag3>"], "wordsA": ["Cost", "of", "revenues", "consists", "primarily", "of", "products", "we", "sold", "in", "Brazil", "for", "which", "revenues", "were", "recognized", "during", "the", "period", "and", "royalties", "payable", "to", "the", "OCS", "and", "to", "a", "certain", "academic", "institution", "in", "connection", "with", "such", "sales."], "wordsB": ["Cost", "of", "revenues", "consists", "primarily", "of", "products", "we", "sold", "in", "Brazil", "for", "which", "revenues", "were", "recognized", "during", "the", "period", "and", "royalties", "payable", "to", "NATI", "and", "to", "a", "certain", "academic", "institution", "in", "connection", "with", "such", "sales."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p51_s0", "idA": "1006281_16_item7_p49_s0", "sentA": "Research and development expenses were $24.9 million for the year ended December 31, 2015, a decrease of $2.5 million, or 9% from $27.4 million for the year ended December 31, 2014.", "sentB": "Research and development expenses were $30.4 million for the year ended December 31, 2016, an increase of $5.5 million, or 22% from $24.9 million for the year ended December 31, 2015.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expenses", "were", "$24.9", "million", "for", "the", "year", "ended", "December", "31,", "2015,", "a", "decrease", "of", "$2.5", "million,", "or", "9%", "from", "$27.4", "million", "for", "the", "year", "ended", "December", "31,", "2014.", "<tag2>", "Research", "and", "development", "expenses", "were", "$30.4", "million", "for", "the", "year", "ended", "December", "31,", "2016,", "an", "increase", "of", "$5.5", "million,", "or", "22%", "from", "$24.9", "million", "for", "the", "year", "ended", "December", "31,", "2015.", "<tag3>"], "wordsA": ["Research", "and", "development", "expenses", "were", "$24.9", "million", "for", "the", "year", "ended", "December", "31,", "2015,", "a", "decrease", "of", "$2.5", "million,", "or", "9%", "from", "$27.4", "million", "for", "the", "year", "ended", "December", "31,", "2014."], "wordsB": ["Research", "and", "development", "expenses", "were", "$30.4", "million", "for", "the", "year", "ended", "December", "31,", "2016,", "an", "increase", "of", "$5.5", "million,", "or", "22%", "from", "$24.9", "million", "for", "the", "year", "ended", "December", "31,", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p4_s4", "idA": "1006281_16_item7_p4_s0", "sentA": "For the first 10-year period after the execution of the Amended Pfizer Agreement, we have agreed to sell drug substance to Pfizer for the production of Elelyso, and Pfizer maintains the right to extend the supply period for up to two additional 30-month periods subject to certain terms and conditions.", "sentB": "We will continue to manufacture drug substance for Pfizer, subject to certain terms and conditions.", "type": 2, "words": ["<tag1>", "For", "the", "first", "10-year", "period", "after", "the", "execution", "of", "the", "Amended", "Pfizer", "Agreement,", "we", "have", "agreed", "to", "sell", "drug", "substance", "to", "Pfizer", "for", "the", "production", "of", "Elelyso,", "and", "Pfizer", "maintains", "the", "right", "to", "extend", "the", "supply", "period", "for", "up", "to", "two", "additional", "30-month", "periods", "subject", "to", "certain", "terms", "and", "conditions.", "<tag2>", "We", "will", "continue", "to", "manufacture", "drug", "substance", "for", "Pfizer,", "subject", "to", "certain", "terms", "and", "conditions.", "<tag3>"], "wordsA": ["For", "the", "first", "10-year", "period", "after", "the", "execution", "of", "the", "Amended", "Pfizer", "Agreement,", "we", "have", "agreed", "to", "sell", "drug", "substance", "to", "Pfizer", "for", "the", "production", "of", "Elelyso,", "and", "Pfizer", "maintains", "the", "right", "to", "extend", "the", "supply", "period", "for", "up", "to", "two", "additional", "30-month", "periods", "subject", "to", "certain", "terms", "and", "conditions."], "wordsB": ["We", "will", "continue", "to", "manufacture", "drug", "substance", "for", "Pfizer,", "subject", "to", "certain", "terms", "and", "conditions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p6_s2", "idA": "1006281_16_item7_p4_s1", "sentA": "The Amended Pfizer Agreement also includes provisions regarding cooperation for regulatory matters, supply of the drug substance to Pfizer, including provisions addressing failure to supply, and patent enforcement, and contains customary provisions regarding termination, indemnification and insurance requirements.", "sentB": "The Amended Pfizer Agreement also includes customary provisions regarding cooperation for regulatory matters, patent enforcement, termination, indemnification and insurance requirements.", "type": 2, "words": ["<tag1>", "The", "Amended", "Pfizer", "Agreement", "also", "includes", "provisions", "regarding", "cooperation", "for", "regulatory", "matters,", "supply", "of", "the", "drug", "substance", "to", "Pfizer,", "including", "provisions", "addressing", "failure", "to", "supply,", "and", "patent", "enforcement,", "and", "contains", "customary", "provisions", "regarding", "termination,", "indemnification", "and", "insurance", "requirements.", "<tag2>", "The", "Amended", "Pfizer", "Agreement", "also", "includes", "customary", "provisions", "regarding", "cooperation", "for", "regulatory", "matters,", "patent", "enforcement,", "termination,", "indemnification", "and", "insurance", "requirements.", "<tag3>"], "wordsA": ["The", "Amended", "Pfizer", "Agreement", "also", "includes", "provisions", "regarding", "cooperation", "for", "regulatory", "matters,", "supply", "of", "the", "drug", "substance", "to", "Pfizer,", "including", "provisions", "addressing", "failure", "to", "supply,", "and", "patent", "enforcement,", "and", "contains", "customary", "provisions", "regarding", "termination,", "indemnification", "and", "insurance", "requirements."], "wordsB": ["The", "Amended", "Pfizer", "Agreement", "also", "includes", "customary", "provisions", "regarding", "cooperation", "for", "regulatory", "matters,", "patent", "enforcement,", "termination,", "indemnification", "and", "insurance", "requirements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p54_s0", "idA": "1006281_16_item7_p52_s0", "sentA": "Financial expenses were $3.6 million for the year ended December 31, 2015, compared to $4.7 million for the year ended December 31, 2014.", "sentB": "Financial income was $4.0 million for the year ended December 31, 2016, compared to financial expense of $3.6 million for the year ended December 31, 2015.", "type": 2, "words": ["<tag1>", "Financial", "expenses", "were", "$3.6", "million", "for", "the", "year", "ended", "December", "31,", "2015,", "compared", "to", "$4.7", "million", "for", "the", "year", "ended", "December", "31,", "2014.", "<tag2>", "Financial", "income", "was", "$4.0", "million", "for", "the", "year", "ended", "December", "31,", "2016,", "compared", "to", "financial", "expense", "of", "$3.6", "million", "for", "the", "year", "ended", "December", "31,", "2015.", "<tag3>"], "wordsA": ["Financial", "expenses", "were", "$3.6", "million", "for", "the", "year", "ended", "December", "31,", "2015,", "compared", "to", "$4.7", "million", "for", "the", "year", "ended", "December", "31,", "2014."], "wordsB": ["Financial", "income", "was", "$4.0", "million", "for", "the", "year", "ended", "December", "31,", "2016,", "compared", "to", "financial", "expense", "of", "$3.6", "million", "for", "the", "year", "ended", "December", "31,", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p51_s1", "idA": "1006281_16_item7_p52_s1", "sentA": "Financial expenses resulted primarily from interest expense of $3.1 million for the notes.", "sentB": "The increase resulted primarily from an increase of $3.7 million in clinical trial related costs.", "type": 2, "words": ["<tag1>", "Financial", "expenses", "resulted", "primarily", "from", "interest", "expense", "of", "$3.1", "million", "for", "the", "notes.", "<tag2>", "The", "increase", "resulted", "primarily", "from", "an", "increase", "of", "$3.7", "million", "in", "clinical", "trial", "related", "costs.", "<tag3>"], "wordsA": ["Financial", "expenses", "resulted", "primarily", "from", "interest", "expense", "of", "$3.1", "million", "for", "the", "notes."], "wordsB": ["The", "increase", "resulted", "primarily", "from", "an", "increase", "of", "$3.7", "million", "in", "clinical", "trial", "related", "costs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p60_s1", "idA": "1006281_16_item7_p52_s1", "sentA": "Financial expenses resulted primarily from interest expense of $3.1 million for the notes.", "sentB": "Financial expenses resulted primarily from interest expense of $3.1 million for our outstanding 4.5% convertible notes.", "type": 2, "words": ["<tag1>", "Financial", "expenses", "resulted", "primarily", "from", "interest", "expense", "of", "$3.1", "million", "for", "the", "notes.", "<tag2>", "Financial", "expenses", "resulted", "primarily", "from", "interest", "expense", "of", "$3.1", "million", "for", "our", "outstanding", "4.5%", "convertible", "notes.", "<tag3>"], "wordsA": ["Financial", "expenses", "resulted", "primarily", "from", "interest", "expense", "of", "$3.1", "million", "for", "the", "notes."], "wordsB": ["Financial", "expenses", "resulted", "primarily", "from", "interest", "expense", "of", "$3.1", "million", "for", "our", "outstanding", "4.5%", "convertible", "notes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p53_s0", "idA": "1006281_16_item7_p57_s0", "sentA": "Selling, general and administrative expenses were $9.2 million for the year ended December 31, 2014, an increase of $1.2 million, or 15%, from $8.1 million for the year ended December 31, 2013.", "sentB": "Selling, general and administrative expenses were $9.4 million for the year ended December 31, 2016, an increase of $2.1 million, or 29%, from $7.3 million for the year ended December 31, 2015.", "type": 2, "words": ["<tag1>", "Selling,", "general", "and", "administrative", "expenses", "were", "$9.2", "million", "for", "the", "year", "ended", "December", "31,", "2014,", "an", "increase", "of", "$1.2", "million,", "or", "15%,", "from", "$8.1", "million", "for", "the", "year", "ended", "December", "31,", "2013.", "<tag2>", "Selling,", "general", "and", "administrative", "expenses", "were", "$9.4", "million", "for", "the", "year", "ended", "December", "31,", "2016,", "an", "increase", "of", "$2.1", "million,", "or", "29%,", "from", "$7.3", "million", "for", "the", "year", "ended", "December", "31,", "2015.", "<tag3>"], "wordsA": ["Selling,", "general", "and", "administrative", "expenses", "were", "$9.2", "million", "for", "the", "year", "ended", "December", "31,", "2014,", "an", "increase", "of", "$1.2", "million,", "or", "15%,", "from", "$8.1", "million", "for", "the", "year", "ended", "December", "31,", "2013."], "wordsB": ["Selling,", "general", "and", "administrative", "expenses", "were", "$9.4", "million", "for", "the", "year", "ended", "December", "31,", "2016,", "an", "increase", "of", "$2.1", "million,", "or", "29%,", "from", "$7.3", "million", "for", "the", "year", "ended", "December", "31,", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p53_s1", "idA": "1006281_16_item7_p57_s1", "sentA": "The increase resulted primarily from sales and marketing expenses of approximately $1.5 million, which was partially offset by a decrease of $470,000 in salaries expense.", "sentB": "The increase resulted primarily from an increase in sales and marketing activities in connection with the sale of alfataliglicerase in Brazil.", "type": 2, "words": ["<tag1>", "The", "increase", "resulted", "primarily", "from", "sales", "and", "marketing", "expenses", "of", "approximately", "$1.5", "million,", "which", "was", "partially", "offset", "by", "a", "decrease", "of", "$470,000", "in", "salaries", "expense.", "<tag2>", "The", "increase", "resulted", "primarily", "from", "an", "increase", "in", "sales", "and", "marketing", "activities", "in", "connection", "with", "the", "sale", "of", "alfataliglicerase", "in", "Brazil.", "<tag3>"], "wordsA": ["The", "increase", "resulted", "primarily", "from", "sales", "and", "marketing", "expenses", "of", "approximately", "$1.5", "million,", "which", "was", "partially", "offset", "by", "a", "decrease", "of", "$470,000", "in", "salaries", "expense."], "wordsB": ["The", "increase", "resulted", "primarily", "from", "an", "increase", "in", "sales", "and", "marketing", "activities", "in", "connection", "with", "the", "sale", "of", "alfataliglicerase", "in", "Brazil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p46_s2", "idA": "1006281_16_item7_p58_s1", "sentA": "Financial expenses resulted primarily from interest expense of $3.1 million for the 4.5% convertible note and from the devaluation of the New Israeli Shekel against the U.S. dollar in the amount of $1.5 million, which was partially offset by financial income which resulted primarily from interest earned on short term deposits.", "sentB": "We account for the 4.5% convertible notes as liability, on an aggregated basis, in their entirety.", "type": 2, "words": ["<tag1>", "Financial", "expenses", "resulted", "primarily", "from", "interest", "expense", "of", "$3.1", "million", "for", "the", "4.5%", "convertible", "note", "and", "from", "the", "devaluation", "of", "the", "New", "Israeli", "Shekel", "against", "the", "U.S.", "dollar", "in", "the", "amount", "of", "$1.5", "million,", "which", "was", "partially", "offset", "by", "financial", "income", "which", "resulted", "primarily", "from", "interest", "earned", "on", "short", "term", "deposits.", "<tag2>", "We", "account", "for", "the", "4.5%", "convertible", "notes", "as", "liability,", "on", "an", "aggregated", "basis,", "in", "their", "entirety.", "<tag3>"], "wordsA": ["Financial", "expenses", "resulted", "primarily", "from", "interest", "expense", "of", "$3.1", "million", "for", "the", "4.5%", "convertible", "note", "and", "from", "the", "devaluation", "of", "the", "New", "Israeli", "Shekel", "against", "the", "U.S.", "dollar", "in", "the", "amount", "of", "$1.5", "million,", "which", "was", "partially", "offset", "by", "financial", "income", "which", "resulted", "primarily", "from", "interest", "earned", "on", "short", "term", "deposits."], "wordsB": ["We", "account", "for", "the", "4.5%", "convertible", "notes", "as", "liability,", "on", "an", "aggregated", "basis,", "in", "their", "entirety."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p54_s3", "idA": "1006281_16_item7_p58_s1", "sentA": "Financial expenses resulted primarily from interest expense of $3.1 million for the 4.5% convertible note and from the devaluation of the New Israeli Shekel against the U.S. dollar in the amount of $1.5 million, which was partially offset by financial income which resulted primarily from interest earned on short term deposits.", "sentB": "The financial income was partially offset by $3.2 million of expenses resulting primarily from interest expense related to our outstanding convertible notes and by $6.5 million of change in fair value of convertible notes embedded derivative.", "type": 2, "words": ["<tag1>", "Financial", "expenses", "resulted", "primarily", "from", "interest", "expense", "of", "$3.1", "million", "for", "the", "4.5%", "convertible", "note", "and", "from", "the", "devaluation", "of", "the", "New", "Israeli", "Shekel", "against", "the", "U.S.", "dollar", "in", "the", "amount", "of", "$1.5", "million,", "which", "was", "partially", "offset", "by", "financial", "income", "which", "resulted", "primarily", "from", "interest", "earned", "on", "short", "term", "deposits.", "<tag2>", "The", "financial", "income", "was", "partially", "offset", "by", "$3.2", "million", "of", "expenses", "resulting", "primarily", "from", "interest", "expense", "related", "to", "our", "outstanding", "convertible", "notes", "and", "by", "$6.5", "million", "of", "change", "in", "fair", "value", "of", "convertible", "notes", "embedded", "derivative.", "<tag3>"], "wordsA": ["Financial", "expenses", "resulted", "primarily", "from", "interest", "expense", "of", "$3.1", "million", "for", "the", "4.5%", "convertible", "note", "and", "from", "the", "devaluation", "of", "the", "New", "Israeli", "Shekel", "against", "the", "U.S.", "dollar", "in", "the", "amount", "of", "$1.5", "million,", "which", "was", "partially", "offset", "by", "financial", "income", "which", "resulted", "primarily", "from", "interest", "earned", "on", "short", "term", "deposits."], "wordsB": ["The", "financial", "income", "was", "partially", "offset", "by", "$3.2", "million", "of", "expenses", "resulting", "primarily", "from", "interest", "expense", "related", "to", "our", "outstanding", "convertible", "notes", "and", "by", "$6.5", "million", "of", "change", "in", "fair", "value", "of", "convertible", "notes", "embedded", "derivative."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p48_s0", "idA": "1006281_16_item7_p5_s1", "sentA": "As part of the Stock Purchase Agreement, Pfizer agreed to a 180-day lock-up with respect to the purchased shares of common stock.", "sentB": "Issuance costs regarding the issuance of our 7.5% convertible notes were allocated to the liability, equity component, derivative and shares of common stock based on their relative fair values.", "type": 2, "words": ["<tag1>", "As", "part", "of", "the", "Stock", "Purchase", "Agreement,", "Pfizer", "agreed", "to", "a", "180-day", "lock-up", "with", "respect", "to", "the", "purchased", "shares", "of", "common", "stock.", "<tag2>", "Issuance", "costs", "regarding", "the", "issuance", "of", "our", "7.5%", "convertible", "notes", "were", "allocated", "to", "the", "liability,", "equity", "component,", "derivative", "and", "shares", "of", "common", "stock", "based", "on", "their", "relative", "fair", "values.", "<tag3>"], "wordsA": ["As", "part", "of", "the", "Stock", "Purchase", "Agreement,", "Pfizer", "agreed", "to", "a", "180-day", "lock-up", "with", "respect", "to", "the", "purchased", "shares", "of", "common", "stock."], "wordsB": ["Issuance", "costs", "regarding", "the", "issuance", "of", "our", "7.5%", "convertible", "notes", "were", "allocated", "to", "the", "liability,", "equity", "component,", "derivative", "and", "shares", "of", "common", "stock", "based", "on", "their", "relative", "fair", "values."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p63_s0", "idA": "1006281_16_item7_p61_s0", "sentA": "In addition to the foregoing, on September 18, 2013, we completed a private placement of $69.0 million in aggregate principal amount of 4.50% convertible notes due 2018, or the Notes, including $9.0 million aggregate principal amount of Notes related to the offering s initial purchaser s over-allotment option, which was exercised in full.", "sentB": "In addition to the foregoing, on September 18, 2013, we completed a private placement of $69.0 million in aggregate principal amount of 4.50% convertible notes due 2018, including $9.0 million aggregate principal amount of Notes related to the offering s initial purchaser s over-allotment option, which was exercised in full.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "the", "foregoing,", "on", "September", "18,", "2013,", "we", "completed", "a", "private", "placement", "of", "$69.0", "million", "in", "aggregate", "principal", "amount", "of", "4.50%", "convertible", "notes", "due", "2018,", "or", "the", "Notes,", "including", "$9.0", "million", "aggregate", "principal", "amount", "of", "Notes", "related", "to", "the", "offering", "s", "initial", "purchaser", "s", "over-allotment", "option,", "which", "was", "exercised", "in", "full.", "<tag2>", "In", "addition", "to", "the", "foregoing,", "on", "September", "18,", "2013,", "we", "completed", "a", "private", "placement", "of", "$69.0", "million", "in", "aggregate", "principal", "amount", "of", "4.50%", "convertible", "notes", "due", "2018,", "including", "$9.0", "million", "aggregate", "principal", "amount", "of", "Notes", "related", "to", "the", "offering", "s", "initial", "purchaser", "s", "over-allotment", "option,", "which", "was", "exercised", "in", "full.", "<tag3>"], "wordsA": ["In", "addition", "to", "the", "foregoing,", "on", "September", "18,", "2013,", "we", "completed", "a", "private", "placement", "of", "$69.0", "million", "in", "aggregate", "principal", "amount", "of", "4.50%", "convertible", "notes", "due", "2018,", "or", "the", "Notes,", "including", "$9.0", "million", "aggregate", "principal", "amount", "of", "Notes", "related", "to", "the", "offering", "s", "initial", "purchaser", "s", "over-allotment", "option,", "which", "was", "exercised", "in", "full."], "wordsB": ["In", "addition", "to", "the", "foregoing,", "on", "September", "18,", "2013,", "we", "completed", "a", "private", "placement", "of", "$69.0", "million", "in", "aggregate", "principal", "amount", "of", "4.50%", "convertible", "notes", "due", "2018,", "including", "$9.0", "million", "aggregate", "principal", "amount", "of", "Notes", "related", "to", "the", "offering", "s", "initial", "purchaser", "s", "over-allotment", "option,", "which", "was", "exercised", "in", "full."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p63_s1", "idA": "1006281_16_item7_p61_s0", "sentA": "In addition to the foregoing, on September 18, 2013, we completed a private placement of $69.0 million in aggregate principal amount of 4.50% convertible notes due 2018, or the Notes, including $9.0 million aggregate principal amount of Notes related to the offering s initial purchaser s over-allotment option, which was exercised in full.", "sentB": "In December 2016, we completed a private placement of $22.5 million in aggregate principal amount of 7.5% convertible notes due 2021.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "the", "foregoing,", "on", "September", "18,", "2013,", "we", "completed", "a", "private", "placement", "of", "$69.0", "million", "in", "aggregate", "principal", "amount", "of", "4.50%", "convertible", "notes", "due", "2018,", "or", "the", "Notes,", "including", "$9.0", "million", "aggregate", "principal", "amount", "of", "Notes", "related", "to", "the", "offering", "s", "initial", "purchaser", "s", "over-allotment", "option,", "which", "was", "exercised", "in", "full.", "<tag2>", "In", "December", "2016,", "we", "completed", "a", "private", "placement", "of", "$22.5", "million", "in", "aggregate", "principal", "amount", "of", "7.5%", "convertible", "notes", "due", "2021.", "<tag3>"], "wordsA": ["In", "addition", "to", "the", "foregoing,", "on", "September", "18,", "2013,", "we", "completed", "a", "private", "placement", "of", "$69.0", "million", "in", "aggregate", "principal", "amount", "of", "4.50%", "convertible", "notes", "due", "2018,", "or", "the", "Notes,", "including", "$9.0", "million", "aggregate", "principal", "amount", "of", "Notes", "related", "to", "the", "offering", "s", "initial", "purchaser", "s", "over-allotment", "option,", "which", "was", "exercised", "in", "full."], "wordsB": ["In", "December", "2016,", "we", "completed", "a", "private", "placement", "of", "$22.5", "million", "in", "aggregate", "principal", "amount", "of", "7.5%", "convertible", "notes", "due", "2021."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p64_s1", "idA": "1006281_16_item7_p62_s1", "sentA": "Protalix Ltd. also received a milestone payment of $25.0 in connection with the FDA s approval of taliglucerase alfa in May 2012.", "sentB": "Protalix Ltd. also received a milestone payment of $25.0 million in connection with the FDA s approval of taliglucerase alfa in May 2012.", "type": 2, "words": ["<tag1>", "Protalix", "Ltd.", "also", "received", "a", "milestone", "payment", "of", "$25.0", "in", "connection", "with", "the", "FDA", "s", "approval", "of", "taliglucerase", "alfa", "in", "May", "2012.", "<tag2>", "Protalix", "Ltd.", "also", "received", "a", "milestone", "payment", "of", "$25.0", "million", "in", "connection", "with", "the", "FDA", "s", "approval", "of", "taliglucerase", "alfa", "in", "May", "2012.", "<tag3>"], "wordsA": ["Protalix", "Ltd.", "also", "received", "a", "milestone", "payment", "of", "$25.0", "in", "connection", "with", "the", "FDA", "s", "approval", "of", "taliglucerase", "alfa", "in", "May", "2012."], "wordsB": ["Protalix", "Ltd.", "also", "received", "a", "milestone", "payment", "of", "$25.0", "million", "in", "connection", "with", "the", "FDA", "s", "approval", "of", "taliglucerase", "alfa", "in", "May", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p67_s4", "idA": "1006281_16_item7_p62_s3", "sentA": "In connection with the execution of the Amended Pfizer Agreement, we received a $36.0 million payment from Pfizer, and Pfizer purchased 5,649,079 shares of our common stock for $10.0 million.", "sentB": "Additionally, as previously disclosed, we are contractually limited, until we receive stockholder approval, in our ability to settle conversions of, or pay interest on, our outstanding 7.5% convertible notes with shares of our common stock.", "type": 2, "words": ["<tag1>", "In", "connection", "with", "the", "execution", "of", "the", "Amended", "Pfizer", "Agreement,", "we", "received", "a", "$36.0", "million", "payment", "from", "Pfizer,", "and", "Pfizer", "purchased", "5,649,079", "shares", "of", "our", "common", "stock", "for", "$10.0", "million.", "<tag2>", "Additionally,", "as", "previously", "disclosed,", "we", "are", "contractually", "limited,", "until", "we", "receive", "stockholder", "approval,", "in", "our", "ability", "to", "settle", "conversions", "of,", "or", "pay", "interest", "on,", "our", "outstanding", "7.5%", "convertible", "notes", "with", "shares", "of", "our", "common", "stock.", "<tag3>"], "wordsA": ["In", "connection", "with", "the", "execution", "of", "the", "Amended", "Pfizer", "Agreement,", "we", "received", "a", "$36.0", "million", "payment", "from", "Pfizer,", "and", "Pfizer", "purchased", "5,649,079", "shares", "of", "our", "common", "stock", "for", "$10.0", "million."], "wordsB": ["Additionally,", "as", "previously", "disclosed,", "we", "are", "contractually", "limited,", "until", "we", "receive", "stockholder", "approval,", "in", "our", "ability", "to", "settle", "conversions", "of,", "or", "pay", "interest", "on,", "our", "outstanding", "7.5%", "convertible", "notes", "with", "shares", "of", "our", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p54_s1", "idA": "1006281_16_item7_p63_s0", "sentA": "Net cash used in operations was $24.2 million for the year ended December 31, 2015.", "sentB": "Financial income for the year ended December 31, 2016 resulted primarily from the exchange of $54.1 million of our 4.5% notes into $40.2 million aggregate principal amount of 7.5% senior secured notes and 23.8 million shares of our common stock.", "type": 2, "words": ["<tag1>", "Net", "cash", "used", "in", "operations", "was", "$24.2", "million", "for", "the", "year", "ended", "December", "31,", "2015.", "<tag2>", "Financial", "income", "for", "the", "year", "ended", "December", "31,", "2016", "resulted", "primarily", "from", "the", "exchange", "of", "$54.1", "million", "of", "our", "4.5%", "notes", "into", "$40.2", "million", "aggregate", "principal", "amount", "of", "7.5%", "senior", "secured", "notes", "and", "23.8", "million", "shares", "of", "our", "common", "stock.", "<tag3>"], "wordsA": ["Net", "cash", "used", "in", "operations", "was", "$24.2", "million", "for", "the", "year", "ended", "December", "31,", "2015."], "wordsB": ["Financial", "income", "for", "the", "year", "ended", "December", "31,", "2016", "resulted", "primarily", "from", "the", "exchange", "of", "$54.1", "million", "of", "our", "4.5%", "notes", "into", "$40.2", "million", "aggregate", "principal", "amount", "of", "7.5%", "senior", "secured", "notes", "and", "23.8", "million", "shares", "of", "our", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p65_s0", "idA": "1006281_16_item7_p63_s0", "sentA": "Net cash used in operations was $24.2 million for the year ended December 31, 2015.", "sentB": "Net cash used in operations was $32.1 million for the year ended December 31, 2016.", "type": 2, "words": ["<tag1>", "Net", "cash", "used", "in", "operations", "was", "$24.2", "million", "for", "the", "year", "ended", "December", "31,", "2015.", "<tag2>", "Net", "cash", "used", "in", "operations", "was", "$32.1", "million", "for", "the", "year", "ended", "December", "31,", "2016.", "<tag3>"], "wordsA": ["Net", "cash", "used", "in", "operations", "was", "$24.2", "million", "for", "the", "year", "ended", "December", "31,", "2015."], "wordsB": ["Net", "cash", "used", "in", "operations", "was", "$32.1", "million", "for", "the", "year", "ended", "December", "31,", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p65_s3", "idA": "1006281_16_item7_p63_s3", "sentA": "Net cash provided by financing activities was $6.6 million and consisted primarily from the issuance of shares to Pfizer in connection with the sale of our share in collaboration to Pfizer.", "sentB": "Net cash provided by financing activities was $19.7 million and consisted primarily of proceeds from the private offering of our 7.5% convertible notes.", "type": 2, "words": ["<tag1>", "Net", "cash", "provided", "by", "financing", "activities", "was", "$6.6", "million", "and", "consisted", "primarily", "from", "the", "issuance", "of", "shares", "to", "Pfizer", "in", "connection", "with", "the", "sale", "of", "our", "share", "in", "collaboration", "to", "Pfizer.", "<tag2>", "Net", "cash", "provided", "by", "financing", "activities", "was", "$19.7", "million", "and", "consisted", "primarily", "of", "proceeds", "from", "the", "private", "offering", "of", "our", "7.5%", "convertible", "notes.", "<tag3>"], "wordsA": ["Net", "cash", "provided", "by", "financing", "activities", "was", "$6.6", "million", "and", "consisted", "primarily", "from", "the", "issuance", "of", "shares", "to", "Pfizer", "in", "connection", "with", "the", "sale", "of", "our", "share", "in", "collaboration", "to", "Pfizer."], "wordsB": ["Net", "cash", "provided", "by", "financing", "activities", "was", "$19.7", "million", "and", "consisted", "primarily", "of", "proceeds", "from", "the", "private", "offering", "of", "our", "7.5%", "convertible", "notes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p65_s1", "idA": "1006281_16_item7_p63_s5", "sentA": "The net loss from continuing operations for the year ended December 31, 2014 of $33.3 million was further increased by an increase of $3.5 million in inventories, but was partially offset by $3.1 million in depreciation, $1.4 million in accounts payable.", "sentB": "The net loss from continuing operations for the year ended December 31, 2016 of $29.2 million was further increased by $7.6 million non cash financial income, but was partially offset by $2.0 million in depreciation and a $2.1 million increase in accounts payable.", "type": 2, "words": ["<tag1>", "The", "net", "loss", "from", "continuing", "operations", "for", "the", "year", "ended", "December", "31,", "2014", "of", "$33.3", "million", "was", "further", "increased", "by", "an", "increase", "of", "$3.5", "million", "in", "inventories,", "but", "was", "partially", "offset", "by", "$3.1", "million", "in", "depreciation,", "$1.4", "million", "in", "accounts", "payable.", "<tag2>", "The", "net", "loss", "from", "continuing", "operations", "for", "the", "year", "ended", "December", "31,", "2016", "of", "$29.2", "million", "was", "further", "increased", "by", "$7.6", "million", "non", "cash", "financial", "income,", "but", "was", "partially", "offset", "by", "$2.0", "million", "in", "depreciation", "and", "a", "$2.1", "million", "increase", "in", "accounts", "payable.", "<tag3>"], "wordsA": ["The", "net", "loss", "from", "continuing", "operations", "for", "the", "year", "ended", "December", "31,", "2014", "of", "$33.3", "million", "was", "further", "increased", "by", "an", "increase", "of", "$3.5", "million", "in", "inventories,", "but", "was", "partially", "offset", "by", "$3.1", "million", "in", "depreciation,", "$1.4", "million", "in", "accounts", "payable."], "wordsB": ["The", "net", "loss", "from", "continuing", "operations", "for", "the", "year", "ended", "December", "31,", "2016", "of", "$29.2", "million", "was", "further", "increased", "by", "$7.6", "million", "non", "cash", "financial", "income,", "but", "was", "partially", "offset", "by", "$2.0", "million", "in", "depreciation", "and", "a", "$2.1", "million", "increase", "in", "accounts", "payable."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p65_s2", "idA": "1006281_16_item7_p63_s6", "sentA": "Net cash used in investing activities for the year ended December 31, 2014 was $1.0 million and consisted primarily of purchases of property and equipment.", "sentB": "Net cash used in investing activities for the year ended December 31, 2016 was $967,000 and consisted primarily of equipment purchases.", "type": 2, "words": ["<tag1>", "Net", "cash", "used", "in", "investing", "activities", "for", "the", "year", "ended", "December", "31,", "2014", "was", "$1.0", "million", "and", "consisted", "primarily", "of", "purchases", "of", "property", "and", "equipment.", "<tag2>", "Net", "cash", "used", "in", "investing", "activities", "for", "the", "year", "ended", "December", "31,", "2016", "was", "$967,000", "and", "consisted", "primarily", "of", "equipment", "purchases.", "<tag3>"], "wordsA": ["Net", "cash", "used", "in", "investing", "activities", "for", "the", "year", "ended", "December", "31,", "2014", "was", "$1.0", "million", "and", "consisted", "primarily", "of", "purchases", "of", "property", "and", "equipment."], "wordsB": ["Net", "cash", "used", "in", "investing", "activities", "for", "the", "year", "ended", "December", "31,", "2016", "was", "$967,000", "and", "consisted", "primarily", "of", "equipment", "purchases."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p67_s0", "idA": "1006281_16_item7_p64_s0", "sentA": "We expect to continue to incur significant expenditures in the near future, including significant research and development expenses related primarily to the clinical trials of PRX-102 and the advancement of our other product candidates into anticipated later stage clinical trials.", "sentB": "We expect to continue to incur significant expenditures in the near future, including significant research and development expenses related primarily to the clinical trials of PRX-102, alidornase alfa and OPRX-106, and the advancement of our other product candidates into anticipated later stage clinical trials.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "continue", "to", "incur", "significant", "expenditures", "in", "the", "near", "future,", "including", "significant", "research", "and", "development", "expenses", "related", "primarily", "to", "the", "clinical", "trials", "of", "PRX-102", "and", "the", "advancement", "of", "our", "other", "product", "candidates", "into", "anticipated", "later", "stage", "clinical", "trials.", "<tag2>", "We", "expect", "to", "continue", "to", "incur", "significant", "expenditures", "in", "the", "near", "future,", "including", "significant", "research", "and", "development", "expenses", "related", "primarily", "to", "the", "clinical", "trials", "of", "PRX-102,", "alidornase", "alfa", "and", "OPRX-106,", "and", "the", "advancement", "of", "our", "other", "product", "candidates", "into", "anticipated", "later", "stage", "clinical", "trials.", "<tag3>"], "wordsA": ["We", "expect", "to", "continue", "to", "incur", "significant", "expenditures", "in", "the", "near", "future,", "including", "significant", "research", "and", "development", "expenses", "related", "primarily", "to", "the", "clinical", "trials", "of", "PRX-102", "and", "the", "advancement", "of", "our", "other", "product", "candidates", "into", "anticipated", "later", "stage", "clinical", "trials."], "wordsB": ["We", "expect", "to", "continue", "to", "incur", "significant", "expenditures", "in", "the", "near", "future,", "including", "significant", "research", "and", "development", "expenses", "related", "primarily", "to", "the", "clinical", "trials", "of", "PRX-102,", "alidornase", "alfa", "and", "OPRX-106,", "and", "the", "advancement", "of", "our", "other", "product", "candidates", "into", "anticipated", "later", "stage", "clinical", "trials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p67_s5", "idA": "1006281_16_item7_p65_s1", "sentA": "We have based this estimate on assumptions that are subject to change and may prove to be wrong, and we may be required to use our available capital resources sooner than we currently expect.", "sentB": "Accordingly we may be required to cash-settle a significant part of, or all, conversion requests of any convertible notes prior to obtaining stockholder approval.", "type": 2, "words": ["<tag1>", "We", "have", "based", "this", "estimate", "on", "assumptions", "that", "are", "subject", "to", "change", "and", "may", "prove", "to", "be", "wrong,", "and", "we", "may", "be", "required", "to", "use", "our", "available", "capital", "resources", "sooner", "than", "we", "currently", "expect.", "<tag2>", "Accordingly", "we", "may", "be", "required", "to", "cash-settle", "a", "significant", "part", "of,", "or", "all,", "conversion", "requests", "of", "any", "convertible", "notes", "prior", "to", "obtaining", "stockholder", "approval.", "<tag3>"], "wordsA": ["We", "have", "based", "this", "estimate", "on", "assumptions", "that", "are", "subject", "to", "change", "and", "may", "prove", "to", "be", "wrong,", "and", "we", "may", "be", "required", "to", "use", "our", "available", "capital", "resources", "sooner", "than", "we", "currently", "expect."], "wordsB": ["Accordingly", "we", "may", "be", "required", "to", "cash-settle", "a", "significant", "part", "of,", "or", "all,", "conversion", "requests", "of", "any", "convertible", "notes", "prior", "to", "obtaining", "stockholder", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p68_s0", "idA": "1006281_16_item7_p66_s0", "sentA": "Our future capital requirements will depend on many factors, including our progress in commercializing Uplyso in Brazil, the progress and results of our clinical trials, the duration and cost of discovery and preclinical development and laboratory testing and clinical trials for our product candidates, the timing and outcome of regulatory review of our product candidates, the costs involved in preparing, filing, prosecuting, maintaining, defending and enforcing patent claims and other intellectual property rights, the number and development requirements of other product candidates that we pursue and the costs of commercialization activities, including product marketing, sales and distribution.", "sentB": "Our future capital requirements will depend on many other factors, including our progress in commercializing Uplyso in Brazil, the progress and results of our clinical trials, the duration and cost of discovery and preclinical development and laboratory testing and clinical trials for our product candidates, conversions of our convertible notes from time to time, the timing and outcome of regulatory review of our product candidates, the costs involved in preparing, filing, prosecuting, maintaining, defending and enforcing patent claims and other intellectual property rights, the number and development requirements of other product candidates that we pursue and the costs of commercialization activities, including product marketing, sales and distribution.", "type": 2, "words": ["<tag1>", "Our", "future", "capital", "requirements", "will", "depend", "on", "many", "factors,", "including", "our", "progress", "in", "commercializing", "Uplyso", "in", "Brazil,", "the", "progress", "and", "results", "of", "our", "clinical", "trials,", "the", "duration", "and", "cost", "of", "discovery", "and", "preclinical", "development", "and", "laboratory", "testing", "and", "clinical", "trials", "for", "our", "product", "candidates,", "the", "timing", "and", "outcome", "of", "regulatory", "review", "of", "our", "product", "candidates,", "the", "costs", "involved", "in", "preparing,", "filing,", "prosecuting,", "maintaining,", "defending", "and", "enforcing", "patent", "claims", "and", "other", "intellectual", "property", "rights,", "the", "number", "and", "development", "requirements", "of", "other", "product", "candidates", "that", "we", "pursue", "and", "the", "costs", "of", "commercialization", "activities,", "including", "product", "marketing,", "sales", "and", "distribution.", "<tag2>", "Our", "future", "capital", "requirements", "will", "depend", "on", "many", "other", "factors,", "including", "our", "progress", "in", "commercializing", "Uplyso", "in", "Brazil,", "the", "progress", "and", "results", "of", "our", "clinical", "trials,", "the", "duration", "and", "cost", "of", "discovery", "and", "preclinical", "development", "and", "laboratory", "testing", "and", "clinical", "trials", "for", "our", "product", "candidates,", "conversions", "of", "our", "convertible", "notes", "from", "time", "to", "time,", "the", "timing", "and", "outcome", "of", "regulatory", "review", "of", "our", "product", "candidates,", "the", "costs", "involved", "in", "preparing,", "filing,", "prosecuting,", "maintaining,", "defending", "and", "enforcing", "patent", "claims", "and", "other", "intellectual", "property", "rights,", "the", "number", "and", "development", "requirements", "of", "other", "product", "candidates", "that", "we", "pursue", "and", "the", "costs", "of", "commercialization", "activities,", "including", "product", "marketing,", "sales", "and", "distribution.", "<tag3>"], "wordsA": ["Our", "future", "capital", "requirements", "will", "depend", "on", "many", "factors,", "including", "our", "progress", "in", "commercializing", "Uplyso", "in", "Brazil,", "the", "progress", "and", "results", "of", "our", "clinical", "trials,", "the", "duration", "and", "cost", "of", "discovery", "and", "preclinical", "development", "and", "laboratory", "testing", "and", "clinical", "trials", "for", "our", "product", "candidates,", "the", "timing", "and", "outcome", "of", "regulatory", "review", "of", "our", "product", "candidates,", "the", "costs", "involved", "in", "preparing,", "filing,", "prosecuting,", "maintaining,", "defending", "and", "enforcing", "patent", "claims", "and", "other", "intellectual", "property", "rights,", "the", "number", "and", "development", "requirements", "of", "other", "product", "candidates", "that", "we", "pursue", "and", "the", "costs", "of", "commercialization", "activities,", "including", "product", "marketing,", "sales", "and", "distribution."], "wordsB": ["Our", "future", "capital", "requirements", "will", "depend", "on", "many", "other", "factors,", "including", "our", "progress", "in", "commercializing", "Uplyso", "in", "Brazil,", "the", "progress", "and", "results", "of", "our", "clinical", "trials,", "the", "duration", "and", "cost", "of", "discovery", "and", "preclinical", "development", "and", "laboratory", "testing", "and", "clinical", "trials", "for", "our", "product", "candidates,", "conversions", "of", "our", "convertible", "notes", "from", "time", "to", "time,", "the", "timing", "and", "outcome", "of", "regulatory", "review", "of", "our", "product", "candidates,", "the", "costs", "involved", "in", "preparing,", "filing,", "prosecuting,", "maintaining,", "defending", "and", "enforcing", "patent", "claims", "and", "other", "intellectual", "property", "rights,", "the", "number", "and", "development", "requirements", "of", "other", "product", "candidates", "that", "we", "pursue", "and", "the", "costs", "of", "commercialization", "activities,", "including", "product", "marketing,", "sales", "and", "distribution."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p70_s1", "idA": "1006281_16_item7_p68_s1", "sentA": "We do not believe that inflation has had a material effect on our results of operations during the years ended December 31, 2013, 2014 or 2015.", "sentB": "We do not believe that inflation has had a material effect on our results of operations during the years ended December 31, 2014, 2015 or 2016.", "type": 2, "words": ["<tag1>", "We", "do", "not", "believe", "that", "inflation", "has", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2013,", "2014", "or", "2015.", "<tag2>", "We", "do", "not", "believe", "that", "inflation", "has", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2014,", "2015", "or", "2016.", "<tag3>"], "wordsA": ["We", "do", "not", "believe", "that", "inflation", "has", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2013,", "2014", "or", "2015."], "wordsB": ["We", "do", "not", "believe", "that", "inflation", "has", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2014,", "2015", "or", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p71_s1", "idA": "1006281_16_item7_p69_s1", "sentA": "We do not believe currency fluctuations have had a material effect on our results of operations during the years ended December 31, 2013, 2014 or 2015.", "sentB": "We do not believe currency fluctuations have had a material effect on our results of operations during the years ended December 31, 2014, 2015 or 2016.", "type": 2, "words": ["<tag1>", "We", "do", "not", "believe", "currency", "fluctuations", "have", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2013,", "2014", "or", "2015.", "<tag2>", "We", "do", "not", "believe", "currency", "fluctuations", "have", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2014,", "2015", "or", "2016.", "<tag3>"], "wordsA": ["We", "do", "not", "believe", "currency", "fluctuations", "have", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2013,", "2014", "or", "2015."], "wordsB": ["We", "do", "not", "believe", "currency", "fluctuations", "have", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2014,", "2015", "or", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p7_s0", "idA": "1006281_16_item7_p6_s0", "sentA": "On June 18, 2013, we entered into the Brazil Agreement with Fiocruz.", "sentB": "On June 18, 2013, we entered into the Brazil Agreement with Fiocruz, an arm of the Brazilian MoH, for taliglucerase alfa.", "type": 2, "words": ["<tag1>", "On", "June", "18,", "2013,", "we", "entered", "into", "the", "Brazil", "Agreement", "with", "Fiocruz.", "<tag2>", "On", "June", "18,", "2013,", "we", "entered", "into", "the", "Brazil", "Agreement", "with", "Fiocruz,", "an", "arm", "of", "the", "Brazilian", "MoH,", "for", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["On", "June", "18,", "2013,", "we", "entered", "into", "the", "Brazil", "Agreement", "with", "Fiocruz."], "wordsB": ["On", "June", "18,", "2013,", "we", "entered", "into", "the", "Brazil", "Agreement", "with", "Fiocruz,", "an", "arm", "of", "the", "Brazilian", "MoH,", "for", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p8_s3", "idA": "1006281_16_item7_p6_s1", "sentA": "Fiocruz's purchases of Uplyso to date have been significantly below certain agreed upon purchase milestones and, accordingly, we have the right to terminate the Brazil Agreement.", "sentB": "Fiocruz s purchases of Uplyso to date have been significantly below certain agreed upon purchase milestones and, accordingly, we have the right to terminate the Brazil Agreement.", "type": 2, "words": ["<tag1>", "Fiocruz's", "purchases", "of", "Uplyso", "to", "date", "have", "been", "significantly", "below", "certain", "agreed", "upon", "purchase", "milestones", "and,", "accordingly,", "we", "have", "the", "right", "to", "terminate", "the", "Brazil", "Agreement.", "<tag2>", "Fiocruz", "s", "purchases", "of", "Uplyso", "to", "date", "have", "been", "significantly", "below", "certain", "agreed", "upon", "purchase", "milestones", "and,", "accordingly,", "we", "have", "the", "right", "to", "terminate", "the", "Brazil", "Agreement.", "<tag3>"], "wordsA": ["Fiocruz's", "purchases", "of", "Uplyso", "to", "date", "have", "been", "significantly", "below", "certain", "agreed", "upon", "purchase", "milestones", "and,", "accordingly,", "we", "have", "the", "right", "to", "terminate", "the", "Brazil", "Agreement."], "wordsB": ["Fiocruz", "s", "purchases", "of", "Uplyso", "to", "date", "have", "been", "significantly", "below", "certain", "agreed", "upon", "purchase", "milestones", "and,", "accordingly,", "we", "have", "the", "right", "to", "terminate", "the", "Brazil", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p72_s0", "idA": "1006281_16_item7_p70_s0", "sentA": "We have no off-balance sheet arrangements as of December 31, 2014 and 2015.", "sentB": "We have no off-balance sheet arrangements as of December 31, 2015 and 2016.", "type": 2, "words": ["<tag1>", "We", "have", "no", "off-balance", "sheet", "arrangements", "as", "of", "December", "31,", "2014", "and", "2015.", "<tag2>", "We", "have", "no", "off-balance", "sheet", "arrangements", "as", "of", "December", "31,", "2015", "and", "2016.", "<tag3>"], "wordsA": ["We", "have", "no", "off-balance", "sheet", "arrangements", "as", "of", "December", "31,", "2014", "and", "2015."], "wordsB": ["We", "have", "no", "off-balance", "sheet", "arrangements", "as", "of", "December", "31,", "2015", "and", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p74_s0", "idA": "1006281_16_item7_p72_s0", "sentA": "The following table summarizes our significant contractual obligations at December 31, 2015:", "sentB": "The following table summarizes our significant contractual obligations at December 31, 2016:", "type": 2, "words": ["<tag1>", "The", "following", "table", "summarizes", "our", "significant", "contractual", "obligations", "at", "December", "31,", "2015:", "<tag2>", "The", "following", "table", "summarizes", "our", "significant", "contractual", "obligations", "at", "December", "31,", "2016:", "<tag3>"], "wordsA": ["The", "following", "table", "summarizes", "our", "significant", "contractual", "obligations", "at", "December", "31,", "2015:"], "wordsB": ["The", "following", "table", "summarizes", "our", "significant", "contractual", "obligations", "at", "December", "31,", "2016:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p75_s0", "idA": "1006281_16_item7_p73_s0", "sentA": "(1) Represents open purchase orders issued to certain suppliers and other vendors mainly in connection with our research and development activities that were outstanding as of December 31, 2015.", "sentB": "1) Represents open purchase orders issued to certain suppliers and other vendors mainly in connection with our research and development activities that were outstanding as of December 31, 2016.", "type": 2, "words": ["<tag1>", "(1)", "Represents", "open", "purchase", "orders", "issued", "to", "certain", "suppliers", "and", "other", "vendors", "mainly", "in", "connection", "with", "our", "research", "and", "development", "activities", "that", "were", "outstanding", "as", "of", "December", "31,", "2015.", "<tag2>", "1)", "Represents", "open", "purchase", "orders", "issued", "to", "certain", "suppliers", "and", "other", "vendors", "mainly", "in", "connection", "with", "our", "research", "and", "development", "activities", "that", "were", "outstanding", "as", "of", "December", "31,", "2016.", "<tag3>"], "wordsA": ["(1)", "Represents", "open", "purchase", "orders", "issued", "to", "certain", "suppliers", "and", "other", "vendors", "mainly", "in", "connection", "with", "our", "research", "and", "development", "activities", "that", "were", "outstanding", "as", "of", "December", "31,", "2015."], "wordsB": ["1)", "Represents", "open", "purchase", "orders", "issued", "to", "certain", "suppliers", "and", "other", "vendors", "mainly", "in", "connection", "with", "our", "research", "and", "development", "activities", "that", "were", "outstanding", "as", "of", "December", "31,", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p8_s1", "idA": "1006281_16_item7_p74_s1", "sentA": "If all of the contingencies with respect to milestone payments under our research and license agreements are met, the aggregate milestone payments payable would be approximately $8.7 million and would be payable, if at all, as our projects progress over the course of a number of years.", "sentB": "The Brazilian MoH s order consists of a number of shipments during 2017 for a total of approximately $24.3 million.", "type": 2, "words": ["<tag1>", "If", "all", "of", "the", "contingencies", "with", "respect", "to", "milestone", "payments", "under", "our", "research", "and", "license", "agreements", "are", "met,", "the", "aggregate", "milestone", "payments", "payable", "would", "be", "approximately", "$8.7", "million", "and", "would", "be", "payable,", "if", "at", "all,", "as", "our", "projects", "progress", "over", "the", "course", "of", "a", "number", "of", "years.", "<tag2>", "The", "Brazilian", "MoH", "s", "order", "consists", "of", "a", "number", "of", "shipments", "during", "2017", "for", "a", "total", "of", "approximately", "$24.3", "million.", "<tag3>"], "wordsA": ["If", "all", "of", "the", "contingencies", "with", "respect", "to", "milestone", "payments", "under", "our", "research", "and", "license", "agreements", "are", "met,", "the", "aggregate", "milestone", "payments", "payable", "would", "be", "approximately", "$8.7", "million", "and", "would", "be", "payable,", "if", "at", "all,", "as", "our", "projects", "progress", "over", "the", "course", "of", "a", "number", "of", "years."], "wordsB": ["The", "Brazilian", "MoH", "s", "order", "consists", "of", "a", "number", "of", "shipments", "during", "2017", "for", "a", "total", "of", "approximately", "$24.3", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p12_s1", "idA": "1006281_16_item7_p8_s0", "sentA": "(1) PRX-102, or alpha-GAL-A , a therapeutic protein candidate for the treatment of Fabry disease, a rare, genetic lysosomal disorder in humans, currently in an ongoing phase I/II clinical trial.", "sentB": "Patient enrollment in our phase II clinical trial of OPRX-106 for the treatment of ulcerative colitis was initiated in the fourth quarter of 2016 .", "type": 2, "words": ["<tag1>", "(1)", "PRX-102,", "or", "alpha-GAL-A", ",", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans,", "currently", "in", "an", "ongoing", "phase", "I/II", "clinical", "trial.", "<tag2>", "Patient", "enrollment", "in", "our", "phase", "II", "clinical", "trial", "of", "OPRX-106", "for", "the", "treatment", "of", "ulcerative", "colitis", "was", "initiated", "in", "the", "fourth", "quarter", "of", "2016", ".", "<tag3>"], "wordsA": ["(1)", "PRX-102,", "or", "alpha-GAL-A", ",", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans,", "currently", "in", "an", "ongoing", "phase", "I/II", "clinical", "trial."], "wordsB": ["Patient", "enrollment", "in", "our", "phase", "II", "clinical", "trial", "of", "OPRX-106", "for", "the", "treatment", "of", "ulcerative", "colitis", "was", "initiated", "in", "the", "fourth", "quarter", "of", "2016", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item7_p11_s0", "idA": "1006281_16_item7_p9_s0", "sentA": "(2) PRX-110, a proprietary plant cell recombinant human Deoxyribonuclease 1, or AIR DNase TM , under development for the treatment of cystic fibrosis, to be administered by inhalation.", "sentB": "(2) PRX-110, a proprietary plant cell recombinant human Deoxyribonuclease 1, or alidornase alfa, under development for the treatment of cystic fibrosis, to be administered by inhalation.", "type": 2, "words": ["<tag1>", "(2)", "PRX-110,", "a", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1,", "or", "AIR", "DNase", "TM", ",", "under", "development", "for", "the", "treatment", "of", "cystic", "fibrosis,", "to", "be", "administered", "by", "inhalation.", "<tag2>", "(2)", "PRX-110,", "a", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1,", "or", "alidornase", "alfa,", "under", "development", "for", "the", "treatment", "of", "cystic", "fibrosis,", "to", "be", "administered", "by", "inhalation.", "<tag3>"], "wordsA": ["(2)", "PRX-110,", "a", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1,", "or", "AIR", "DNase", "TM", ",", "under", "development", "for", "the", "treatment", "of", "cystic", "fibrosis,", "to", "be", "administered", "by", "inhalation."], "wordsB": ["(2)", "PRX-110,", "a", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1,", "or", "alidornase", "alfa,", "under", "development", "for", "the", "treatment", "of", "cystic", "fibrosis,", "to", "be", "administered", "by", "inhalation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p15_s0", "idA": "1006281_17_item7_p10_s0", "sentA": "(1) PRX-102, or alpha-GAL-A , a therapeutic protein candidate for the treatment of Fabry disease, a rare, genetic lysosomal disorder in humans, currently in an ongoing phase III clinical trial.", "sentB": "(1) pegunigalsidase alfa, or PRX-102, a therapeutic protein candidate for the treatment of Fabry disease, a rare, genetic lysosomal disorder in humans, currently in an ongoing phase III clinical trial.", "type": 2, "words": ["<tag1>", "(1)", "PRX-102,", "or", "alpha-GAL-A", ",", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans,", "currently", "in", "an", "ongoing", "phase", "III", "clinical", "trial.", "<tag2>", "(1)", "pegunigalsidase", "alfa,", "or", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans,", "currently", "in", "an", "ongoing", "phase", "III", "clinical", "trial.", "<tag3>"], "wordsA": ["(1)", "PRX-102,", "or", "alpha-GAL-A", ",", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans,", "currently", "in", "an", "ongoing", "phase", "III", "clinical", "trial."], "wordsB": ["(1)", "pegunigalsidase", "alfa,", "or", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans,", "currently", "in", "an", "ongoing", "phase", "III", "clinical", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p3_s0", "idA": "1006281_17_item7_p10_s0", "sentA": "(1) PRX-102, or alpha-GAL-A , a therapeutic protein candidate for the treatment of Fabry disease, a rare, genetic lysosomal disorder in humans, currently in an ongoing phase III clinical trial.", "sentB": "Pegunigalsidase alfa is our chemically modified version of the recombinant protein alpha-Galactosidase-A protein that is currently being evaluated in phase III clinical trials for the treatment of Fabry disease .", "type": 2, "words": ["<tag1>", "(1)", "PRX-102,", "or", "alpha-GAL-A", ",", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans,", "currently", "in", "an", "ongoing", "phase", "III", "clinical", "trial.", "<tag2>", "Pegunigalsidase", "alfa", "is", "our", "chemically", "modified", "version", "of", "the", "recombinant", "protein", "alpha-Galactosidase-A", "protein", "that", "is", "currently", "being", "evaluated", "in", "phase", "III", "clinical", "trials", "for", "the", "treatment", "of", "Fabry", "disease", ".", "<tag3>"], "wordsA": ["(1)", "PRX-102,", "or", "alpha-GAL-A", ",", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans,", "currently", "in", "an", "ongoing", "phase", "III", "clinical", "trial."], "wordsB": ["Pegunigalsidase", "alfa", "is", "our", "chemically", "modified", "version", "of", "the", "recombinant", "protein", "alpha-Galactosidase-A", "protein", "that", "is", "currently", "being", "evaluated", "in", "phase", "III", "clinical", "trials", "for", "the", "treatment", "of", "Fabry", "disease", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p4_s0", "idA": "1006281_17_item7_p10_s0", "sentA": "(1) PRX-102, or alpha-GAL-A , a therapeutic protein candidate for the treatment of Fabry disease, a rare, genetic lysosomal disorder in humans, currently in an ongoing phase III clinical trial.", "sentB": "In December 2017, the European Commission granted Orphan Drug Designation for pegunigalsidase alfa for the treatment of Fabry disease.", "type": 2, "words": ["<tag1>", "(1)", "PRX-102,", "or", "alpha-GAL-A", ",", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans,", "currently", "in", "an", "ongoing", "phase", "III", "clinical", "trial.", "<tag2>", "In", "December", "2017,", "the", "European", "Commission", "granted", "Orphan", "Drug", "Designation", "for", "pegunigalsidase", "alfa", "for", "the", "treatment", "of", "Fabry", "disease.", "<tag3>"], "wordsA": ["(1)", "PRX-102,", "or", "alpha-GAL-A", ",", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans,", "currently", "in", "an", "ongoing", "phase", "III", "clinical", "trial."], "wordsB": ["In", "December", "2017,", "the", "European", "Commission", "granted", "Orphan", "Drug", "Designation", "for", "pegunigalsidase", "alfa", "for", "the", "treatment", "of", "Fabry", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p16_s0", "idA": "1006281_17_item7_p11_s0", "sentA": "(2) PRX-110, a proprietary plant cell recombinant human Deoxyribonuclease 1, or alidornase alfa, under development for the treatment of cystic fibrosis, to be administered by inhalation.", "sentB": "(2) alidornase alfa, or PRX-110, a proprietary plant cell recombinant human Deoxyribonuclease 1 under development for the treatment of CF, to be administered by inhalation.", "type": 2, "words": ["<tag1>", "(2)", "PRX-110,", "a", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1,", "or", "alidornase", "alfa,", "under", "development", "for", "the", "treatment", "of", "cystic", "fibrosis,", "to", "be", "administered", "by", "inhalation.", "<tag2>", "(2)", "alidornase", "alfa,", "or", "PRX-110,", "a", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1", "under", "development", "for", "the", "treatment", "of", "CF,", "to", "be", "administered", "by", "inhalation.", "<tag3>"], "wordsA": ["(2)", "PRX-110,", "a", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1,", "or", "alidornase", "alfa,", "under", "development", "for", "the", "treatment", "of", "cystic", "fibrosis,", "to", "be", "administered", "by", "inhalation."], "wordsB": ["(2)", "alidornase", "alfa,", "or", "PRX-110,", "a", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1", "under", "development", "for", "the", "treatment", "of", "CF,", "to", "be", "administered", "by", "inhalation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p16_s1", "idA": "1006281_17_item7_p11_s1", "sentA": "alidornase alfa is currently the subject of a phase II efficacy and safety study.", "sentB": "We recently completed a phase IIa efficacy and safety study of alidornase alfa for the treatment of CF.", "type": 2, "words": ["<tag1>", "alidornase", "alfa", "is", "currently", "the", "subject", "of", "a", "phase", "II", "efficacy", "and", "safety", "study.", "<tag2>", "We", "recently", "completed", "a", "phase", "IIa", "efficacy", "and", "safety", "study", "of", "alidornase", "alfa", "for", "the", "treatment", "of", "CF.", "<tag3>"], "wordsA": ["alidornase", "alfa", "is", "currently", "the", "subject", "of", "a", "phase", "II", "efficacy", "and", "safety", "study."], "wordsB": ["We", "recently", "completed", "a", "phase", "IIa", "efficacy", "and", "safety", "study", "of", "alidornase", "alfa", "for", "the", "treatment", "of", "CF."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p17_s1", "idA": "1006281_17_item7_p12_s1", "sentA": "Patient enrollment in our phase II clinical trial of OPRX-106 for the treatment of ulcerative colitis was initiated in the fourth quarter of 2016 .", "sentB": "We expect to release final data generated in our phase II clinical trial of OPRX-106 for the treatment of ulcerative colitis by the end of March, 2018 .", "type": 2, "words": ["<tag1>", "Patient", "enrollment", "in", "our", "phase", "II", "clinical", "trial", "of", "OPRX-106", "for", "the", "treatment", "of", "ulcerative", "colitis", "was", "initiated", "in", "the", "fourth", "quarter", "of", "2016", ".", "<tag2>", "We", "expect", "to", "release", "final", "data", "generated", "in", "our", "phase", "II", "clinical", "trial", "of", "OPRX-106", "for", "the", "treatment", "of", "ulcerative", "colitis", "by", "the", "end", "of", "March,", "2018", ".", "<tag3>"], "wordsA": ["Patient", "enrollment", "in", "our", "phase", "II", "clinical", "trial", "of", "OPRX-106", "for", "the", "treatment", "of", "ulcerative", "colitis", "was", "initiated", "in", "the", "fourth", "quarter", "of", "2016", "."], "wordsB": ["We", "expect", "to", "release", "final", "data", "generated", "in", "our", "phase", "II", "clinical", "trial", "of", "OPRX-106", "for", "the", "treatment", "of", "ulcerative", "colitis", "by", "the", "end", "of", "March,", "2018", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p4_s1", "idA": "1006281_17_item7_p12_s1", "sentA": "Patient enrollment in our phase II clinical trial of OPRX-106 for the treatment of ulcerative colitis was initiated in the fourth quarter of 2016 .", "sentB": "The designation was granted after the COMP issued a positive opinion supporting the designation noting that we had established that there was medically plausible evidence that pegunigalsidase alfa will provide a significant benefit over existing approved therapies in the European Union for the treatment of Fabry disease.", "type": 2, "words": ["<tag1>", "Patient", "enrollment", "in", "our", "phase", "II", "clinical", "trial", "of", "OPRX-106", "for", "the", "treatment", "of", "ulcerative", "colitis", "was", "initiated", "in", "the", "fourth", "quarter", "of", "2016", ".", "<tag2>", "The", "designation", "was", "granted", "after", "the", "COMP", "issued", "a", "positive", "opinion", "supporting", "the", "designation", "noting", "that", "we", "had", "established", "that", "there", "was", "medically", "plausible", "evidence", "that", "pegunigalsidase", "alfa", "will", "provide", "a", "significant", "benefit", "over", "existing", "approved", "therapies", "in", "the", "European", "Union", "for", "the", "treatment", "of", "Fabry", "disease.", "<tag3>"], "wordsA": ["Patient", "enrollment", "in", "our", "phase", "II", "clinical", "trial", "of", "OPRX-106", "for", "the", "treatment", "of", "ulcerative", "colitis", "was", "initiated", "in", "the", "fourth", "quarter", "of", "2016", "."], "wordsB": ["The", "designation", "was", "granted", "after", "the", "COMP", "issued", "a", "positive", "opinion", "supporting", "the", "designation", "noting", "that", "we", "had", "established", "that", "there", "was", "medically", "plausible", "evidence", "that", "pegunigalsidase", "alfa", "will", "provide", "a", "significant", "benefit", "over", "existing", "approved", "therapies", "in", "the", "European", "Union", "for", "the", "treatment", "of", "Fabry", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p18_s0", "idA": "1006281_17_item7_p13_s0", "sentA": "Except for the rights to commercialize taliglucerase alfa worldwide (other than Brazil), which we licensed to Pfizer, we hold the worldwide commercialization rights to all of our proprietary development candidates.", "sentB": "Except for the rights to commercialize taliglucerase alfa worldwide (other than Brazil), which we licensed to Pfizer, and the rights to pegunigalsidase alfa Chiesi outside the United States, which we licensed to Chiesi, we hold the worldwide commercialization rights to all of our proprietary development candidates.", "type": 2, "words": ["<tag1>", "Except", "for", "the", "rights", "to", "commercialize", "taliglucerase", "alfa", "worldwide", "(other", "than", "Brazil),", "which", "we", "licensed", "to", "Pfizer,", "we", "hold", "the", "worldwide", "commercialization", "rights", "to", "all", "of", "our", "proprietary", "development", "candidates.", "<tag2>", "Except", "for", "the", "rights", "to", "commercialize", "taliglucerase", "alfa", "worldwide", "(other", "than", "Brazil),", "which", "we", "licensed", "to", "Pfizer,", "and", "the", "rights", "to", "pegunigalsidase", "alfa", "Chiesi", "outside", "the", "United", "States,", "which", "we", "licensed", "to", "Chiesi,", "we", "hold", "the", "worldwide", "commercialization", "rights", "to", "all", "of", "our", "proprietary", "development", "candidates.", "<tag3>"], "wordsA": ["Except", "for", "the", "rights", "to", "commercialize", "taliglucerase", "alfa", "worldwide", "(other", "than", "Brazil),", "which", "we", "licensed", "to", "Pfizer,", "we", "hold", "the", "worldwide", "commercialization", "rights", "to", "all", "of", "our", "proprietary", "development", "candidates."], "wordsB": ["Except", "for", "the", "rights", "to", "commercialize", "taliglucerase", "alfa", "worldwide", "(other", "than", "Brazil),", "which", "we", "licensed", "to", "Pfizer,", "and", "the", "rights", "to", "pegunigalsidase", "alfa", "Chiesi", "outside", "the", "United", "States,", "which", "we", "licensed", "to", "Chiesi,", "we", "hold", "the", "worldwide", "commercialization", "rights", "to", "all", "of", "our", "proprietary", "development", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p21_s1", "idA": "1006281_17_item7_p16_s1", "sentA": "Most of our revenues are derived in dollars.", "sentB": "All of our revenues are derived in dollars.", "type": 2, "words": ["<tag1>", "Most", "of", "our", "revenues", "are", "derived", "in", "dollars.", "<tag2>", "All", "of", "our", "revenues", "are", "derived", "in", "dollars.", "<tag3>"], "wordsA": ["Most", "of", "our", "revenues", "are", "derived", "in", "dollars."], "wordsB": ["All", "of", "our", "revenues", "are", "derived", "in", "dollars."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p22_s0", "idA": "1006281_17_item7_p17_s1", "sentA": "Following the entry into the Amended Pfizer Agreement, our primary source of revenues will be our sales of taliglucerase alfa in Brazil.", "sentB": "Our primary sources of revenues include our sales of taliglucerase alfa in Brazil and of drug substance to Pfizer under our Amended Pfizer Agreement.", "type": 2, "words": ["<tag1>", "Following", "the", "entry", "into", "the", "Amended", "Pfizer", "Agreement,", "our", "primary", "source", "of", "revenues", "will", "be", "our", "sales", "of", "taliglucerase", "alfa", "in", "Brazil.", "<tag2>", "Our", "primary", "sources", "of", "revenues", "include", "our", "sales", "of", "taliglucerase", "alfa", "in", "Brazil", "and", "of", "drug", "substance", "to", "Pfizer", "under", "our", "Amended", "Pfizer", "Agreement.", "<tag3>"], "wordsA": ["Following", "the", "entry", "into", "the", "Amended", "Pfizer", "Agreement,", "our", "primary", "source", "of", "revenues", "will", "be", "our", "sales", "of", "taliglucerase", "alfa", "in", "Brazil."], "wordsB": ["Our", "primary", "sources", "of", "revenues", "include", "our", "sales", "of", "taliglucerase", "alfa", "in", "Brazil", "and", "of", "drug", "substance", "to", "Pfizer", "under", "our", "Amended", "Pfizer", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p3_s1", "idA": "1006281_17_item7_p19_s0", "sentA": "Under the terms and conditions of the initial Pfizer Agreement, we were entitled to 40% of the net profits or loss from sales of taliglucerase alfa by Pfizer and reimbursement of our certain related expenses we incur in connection with Pfizer s sales (other than those related to sales in Israel and Brazil).", "sentB": "Under the terms and conditions of the Chiesi Agreement, Protalix Ltd. retained the right to commercialize pegunigalsidase alfa in the United States.", "type": 2, "words": ["<tag1>", "Under", "the", "terms", "and", "conditions", "of", "the", "initial", "Pfizer", "Agreement,", "we", "were", "entitled", "to", "40%", "of", "the", "net", "profits", "or", "loss", "from", "sales", "of", "taliglucerase", "alfa", "by", "Pfizer", "and", "reimbursement", "of", "our", "certain", "related", "expenses", "we", "incur", "in", "connection", "with", "Pfizer", "s", "sales", "(other", "than", "those", "related", "to", "sales", "in", "Israel", "and", "Brazil).", "<tag2>", "Under", "the", "terms", "and", "conditions", "of", "the", "Chiesi", "Agreement,", "Protalix", "Ltd.", "retained", "the", "right", "to", "commercialize", "pegunigalsidase", "alfa", "in", "the", "United", "States.", "<tag3>"], "wordsA": ["Under", "the", "terms", "and", "conditions", "of", "the", "initial", "Pfizer", "Agreement,", "we", "were", "entitled", "to", "40%", "of", "the", "net", "profits", "or", "loss", "from", "sales", "of", "taliglucerase", "alfa", "by", "Pfizer", "and", "reimbursement", "of", "our", "certain", "related", "expenses", "we", "incur", "in", "connection", "with", "Pfizer", "s", "sales", "(other", "than", "those", "related", "to", "sales", "in", "Israel", "and", "Brazil)."], "wordsB": ["Under", "the", "terms", "and", "conditions", "of", "the", "Chiesi", "Agreement,", "Protalix", "Ltd.", "retained", "the", "right", "to", "commercialize", "pegunigalsidase", "alfa", "in", "the", "United", "States."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p1_s0", "idA": "1006281_17_item7_p1_s0", "sentA": "We are a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on our proprietary ProCellEx system.", "sentB": "We are a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on our proprietary ProCellEx protein expression system.", "type": 2, "words": ["<tag1>", "We", "are", "a", "biopharmaceutical", "company", "focused", "on", "the", "development", "and", "commercialization", "of", "recombinant", "therapeutic", "proteins", "based", "on", "our", "proprietary", "ProCellEx", "system.", "<tag2>", "We", "are", "a", "biopharmaceutical", "company", "focused", "on", "the", "development", "and", "commercialization", "of", "recombinant", "therapeutic", "proteins", "based", "on", "our", "proprietary", "ProCellEx", "protein", "expression", "system.", "<tag3>"], "wordsA": ["We", "are", "a", "biopharmaceutical", "company", "focused", "on", "the", "development", "and", "commercialization", "of", "recombinant", "therapeutic", "proteins", "based", "on", "our", "proprietary", "ProCellEx", "system."], "wordsB": ["We", "are", "a", "biopharmaceutical", "company", "focused", "on", "the", "development", "and", "commercialization", "of", "recombinant", "therapeutic", "proteins", "based", "on", "our", "proprietary", "ProCellEx", "protein", "expression", "system."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p1_s2", "idA": "1006281_17_item7_p1_s2", "sentA": "With our experience to date, we believe ProCellEx will enable us to develop additional proprietary recombinant proteins that are therapeutically superior to existing recombinant proteins currently marketed for the same indications.", "sentB": "With our experience to date, we believe ProCellEx will enable us to develop additional proprietary recombinant proteins that are therapeutically superior to existing recombinant proteins currently marketed for the same indications including applying the unique properties of our ProCellEx system for the oral delivery of therapeutic proteins.", "type": 2, "words": ["<tag1>", "With", "our", "experience", "to", "date,", "we", "believe", "ProCellEx", "will", "enable", "us", "to", "develop", "additional", "proprietary", "recombinant", "proteins", "that", "are", "therapeutically", "superior", "to", "existing", "recombinant", "proteins", "currently", "marketed", "for", "the", "same", "indications.", "<tag2>", "With", "our", "experience", "to", "date,", "we", "believe", "ProCellEx", "will", "enable", "us", "to", "develop", "additional", "proprietary", "recombinant", "proteins", "that", "are", "therapeutically", "superior", "to", "existing", "recombinant", "proteins", "currently", "marketed", "for", "the", "same", "indications", "including", "applying", "the", "unique", "properties", "of", "our", "ProCellEx", "system", "for", "the", "oral", "delivery", "of", "therapeutic", "proteins.", "<tag3>"], "wordsA": ["With", "our", "experience", "to", "date,", "we", "believe", "ProCellEx", "will", "enable", "us", "to", "develop", "additional", "proprietary", "recombinant", "proteins", "that", "are", "therapeutically", "superior", "to", "existing", "recombinant", "proteins", "currently", "marketed", "for", "the", "same", "indications."], "wordsB": ["With", "our", "experience", "to", "date,", "we", "believe", "ProCellEx", "will", "enable", "us", "to", "develop", "additional", "proprietary", "recombinant", "proteins", "that", "are", "therapeutically", "superior", "to", "existing", "recombinant", "proteins", "currently", "marketed", "for", "the", "same", "indications", "including", "applying", "the", "unique", "properties", "of", "our", "ProCellEx", "system", "for", "the", "oral", "delivery", "of", "therapeutic", "proteins."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p32_s1", "idA": "1006281_17_item7_p23_s3", "sentA": "The Amended Pfizer Agreement eliminated Pfizer s entitlement to annual payments of up to $12.5 million in relation to commercialization of Elelyso in Brazil.", "sentB": "In addition, under the Chiesi Agreement, Protalix Ltd. is entitled to payments of up to $25 million to cover development costs for pegunigalsidase alfa, capped at $10 million per year.", "type": 2, "words": ["<tag1>", "The", "Amended", "Pfizer", "Agreement", "eliminated", "Pfizer", "s", "entitlement", "to", "annual", "payments", "of", "up", "to", "$12.5", "million", "in", "relation", "to", "commercialization", "of", "Elelyso", "in", "Brazil.", "<tag2>", "In", "addition,", "under", "the", "Chiesi", "Agreement,", "Protalix", "Ltd.", "is", "entitled", "to", "payments", "of", "up", "to", "$25", "million", "to", "cover", "development", "costs", "for", "pegunigalsidase", "alfa,", "capped", "at", "$10", "million", "per", "year.", "<tag3>"], "wordsA": ["The", "Amended", "Pfizer", "Agreement", "eliminated", "Pfizer", "s", "entitlement", "to", "annual", "payments", "of", "up", "to", "$12.5", "million", "in", "relation", "to", "commercialization", "of", "Elelyso", "in", "Brazil."], "wordsB": ["In", "addition,", "under", "the", "Chiesi", "Agreement,", "Protalix", "Ltd.", "is", "entitled", "to", "payments", "of", "up", "to", "$25", "million", "to", "cover", "development", "costs", "for", "pegunigalsidase", "alfa,", "capped", "at", "$10", "million", "per", "year."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p35_s1", "idA": "1006281_17_item7_p33_s1", "sentA": "While we are currently focused on advancing each of our product development programs, our future research and development expenses will depend on the clinical success of each product candidate, as well as ongoing assessments of each product candidate s commercial potential.", "sentB": "Our future research and development expenses for pegunigalsidase alfa and the other product candidates will depend on the clinical success of each product candidate, as well as ongoing assessments of each product candidate s commercial potential.", "type": 2, "words": ["<tag1>", "While", "we", "are", "currently", "focused", "on", "advancing", "each", "of", "our", "product", "development", "programs,", "our", "future", "research", "and", "development", "expenses", "will", "depend", "on", "the", "clinical", "success", "of", "each", "product", "candidate,", "as", "well", "as", "ongoing", "assessments", "of", "each", "product", "candidate", "s", "commercial", "potential.", "<tag2>", "Our", "future", "research", "and", "development", "expenses", "for", "pegunigalsidase", "alfa", "and", "the", "other", "product", "candidates", "will", "depend", "on", "the", "clinical", "success", "of", "each", "product", "candidate,", "as", "well", "as", "ongoing", "assessments", "of", "each", "product", "candidate", "s", "commercial", "potential.", "<tag3>"], "wordsA": ["While", "we", "are", "currently", "focused", "on", "advancing", "each", "of", "our", "product", "development", "programs,", "our", "future", "research", "and", "development", "expenses", "will", "depend", "on", "the", "clinical", "success", "of", "each", "product", "candidate,", "as", "well", "as", "ongoing", "assessments", "of", "each", "product", "candidate", "s", "commercial", "potential."], "wordsB": ["Our", "future", "research", "and", "development", "expenses", "for", "pegunigalsidase", "alfa", "and", "the", "other", "product", "candidates", "will", "depend", "on", "the", "clinical", "success", "of", "each", "product", "candidate,", "as", "well", "as", "ongoing", "assessments", "of", "each", "product", "candidate", "s", "commercial", "potential."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p36_s0", "idA": "1006281_17_item7_p34_s0", "sentA": "We expect our research and development expenses to continue to be our primary expense in the future as we continue the advancement of our clinical trials and preclinical product development programs for our product candidates.", "sentB": "We expect our research and development expenses to continue to be our primary expense in the future as we continue the advancement of our clinical trials and preclinical product development programs for our product candidates, particularly with respect to the development of pegunigalsidase alfa.", "type": 2, "words": ["<tag1>", "We", "expect", "our", "research", "and", "development", "expenses", "to", "continue", "to", "be", "our", "primary", "expense", "in", "the", "future", "as", "we", "continue", "the", "advancement", "of", "our", "clinical", "trials", "and", "preclinical", "product", "development", "programs", "for", "our", "product", "candidates.", "<tag2>", "We", "expect", "our", "research", "and", "development", "expenses", "to", "continue", "to", "be", "our", "primary", "expense", "in", "the", "future", "as", "we", "continue", "the", "advancement", "of", "our", "clinical", "trials", "and", "preclinical", "product", "development", "programs", "for", "our", "product", "candidates,", "particularly", "with", "respect", "to", "the", "development", "of", "pegunigalsidase", "alfa.", "<tag3>"], "wordsA": ["We", "expect", "our", "research", "and", "development", "expenses", "to", "continue", "to", "be", "our", "primary", "expense", "in", "the", "future", "as", "we", "continue", "the", "advancement", "of", "our", "clinical", "trials", "and", "preclinical", "product", "development", "programs", "for", "our", "product", "candidates."], "wordsB": ["We", "expect", "our", "research", "and", "development", "expenses", "to", "continue", "to", "be", "our", "primary", "expense", "in", "the", "future", "as", "we", "continue", "the", "advancement", "of", "our", "clinical", "trials", "and", "preclinical", "product", "development", "programs", "for", "our", "product", "candidates,", "particularly", "with", "respect", "to", "the", "development", "of", "pegunigalsidase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p9_s0", "idA": "1006281_17_item7_p3_s0", "sentA": "Taliglucerase alfa is called alfataliglicerase in Brazil and certain other Latin American countries, where it is marketed under the name Uplyso TM .", "sentB": "Taliglucerase alfa is called alfataliglicerase in Brazil and certain other Latin American countries, where it is marketed under the name alfataliglicerase.", "type": 2, "words": ["<tag1>", "Taliglucerase", "alfa", "is", "called", "alfataliglicerase", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries,", "where", "it", "is", "marketed", "under", "the", "name", "Uplyso", "TM", ".", "<tag2>", "Taliglucerase", "alfa", "is", "called", "alfataliglicerase", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries,", "where", "it", "is", "marketed", "under", "the", "name", "alfataliglicerase.", "<tag3>"], "wordsA": ["Taliglucerase", "alfa", "is", "called", "alfataliglicerase", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries,", "where", "it", "is", "marketed", "under", "the", "name", "Uplyso", "TM", "."], "wordsB": ["Taliglucerase", "alfa", "is", "called", "alfataliglicerase", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries,", "where", "it", "is", "marketed", "under", "the", "name", "alfataliglicerase."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p23_s2", "idA": "1006281_17_item7_p44_s1", "sentA": "The remaining term of the bonds used for each valuation was equal to the expected term of the grant.", "sentB": "Therefore payments received from Chiesi prior to the fulfillment of the one unit of account will be deferred until the commencement of the commercial manufacturing.", "type": 2, "words": ["<tag1>", "The", "remaining", "term", "of", "the", "bonds", "used", "for", "each", "valuation", "was", "equal", "to", "the", "expected", "term", "of", "the", "grant.", "<tag2>", "Therefore", "payments", "received", "from", "Chiesi", "prior", "to", "the", "fulfillment", "of", "the", "one", "unit", "of", "account", "will", "be", "deferred", "until", "the", "commencement", "of", "the", "commercial", "manufacturing.", "<tag3>"], "wordsA": ["The", "remaining", "term", "of", "the", "bonds", "used", "for", "each", "valuation", "was", "equal", "to", "the", "expected", "term", "of", "the", "grant."], "wordsB": ["Therefore", "payments", "received", "from", "Chiesi", "prior", "to", "the", "fulfillment", "of", "the", "one", "unit", "of", "account", "will", "be", "deferred", "until", "the", "commencement", "of", "the", "commercial", "manufacturing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p51_s0", "idA": "1006281_17_item7_p49_s0", "sentA": "We recorded revenues of $9.2 million for the year ended December 31, 2016, an increase of approximately $4.8 million, or 111%, compared to revenues of $4.4 million for the year ended December 31, 2015.", "sentB": "We recorded revenues of $19.2 million for the year ended December 31, 2017, an increase of approximately $10.0 million, or 109%, compared to revenues of $9.2 million for the year ended December 31, 2016.", "type": 2, "words": ["<tag1>", "We", "recorded", "revenues", "of", "$9.2", "million", "for", "the", "year", "ended", "December", "31,", "2016,", "an", "increase", "of", "approximately", "$4.8", "million,", "or", "111%,", "compared", "to", "revenues", "of", "$4.4", "million", "for", "the", "year", "ended", "December", "31,", "2015.", "<tag2>", "We", "recorded", "revenues", "of", "$19.2", "million", "for", "the", "year", "ended", "December", "31,", "2017,", "an", "increase", "of", "approximately", "$10.0", "million,", "or", "109%,", "compared", "to", "revenues", "of", "$9.2", "million", "for", "the", "year", "ended", "December", "31,", "2016.", "<tag3>"], "wordsA": ["We", "recorded", "revenues", "of", "$9.2", "million", "for", "the", "year", "ended", "December", "31,", "2016,", "an", "increase", "of", "approximately", "$4.8", "million,", "or", "111%,", "compared", "to", "revenues", "of", "$4.4", "million", "for", "the", "year", "ended", "December", "31,", "2015."], "wordsB": ["We", "recorded", "revenues", "of", "$19.2", "million", "for", "the", "year", "ended", "December", "31,", "2017,", "an", "increase", "of", "approximately", "$10.0", "million,", "or", "109%,", "compared", "to", "revenues", "of", "$9.2", "million", "for", "the", "year", "ended", "December", "31,", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p51_s1", "idA": "1006281_17_item7_p49_s1", "sentA": "Revenues represent products sold in Brazil and drug substance sold to Pfizer.", "sentB": "Revenues include $7.1 million of products sold in Brazil and $12.1 million of drug substance sold to Pfizer The increase resulted from an increase in the amount of $3.1 million of product sold to Brazil and $7.0 million of drug substance sold to Pfizer.", "type": 2, "words": ["<tag1>", "Revenues", "represent", "products", "sold", "in", "Brazil", "and", "drug", "substance", "sold", "to", "Pfizer.", "<tag2>", "Revenues", "include", "$7.1", "million", "of", "products", "sold", "in", "Brazil", "and", "$12.1", "million", "of", "drug", "substance", "sold", "to", "Pfizer", "The", "increase", "resulted", "from", "an", "increase", "in", "the", "amount", "of", "$3.1", "million", "of", "product", "sold", "to", "Brazil", "and", "$7.0", "million", "of", "drug", "substance", "sold", "to", "Pfizer.", "<tag3>"], "wordsA": ["Revenues", "represent", "products", "sold", "in", "Brazil", "and", "drug", "substance", "sold", "to", "Pfizer."], "wordsB": ["Revenues", "include", "$7.1", "million", "of", "products", "sold", "in", "Brazil", "and", "$12.1", "million", "of", "drug", "substance", "sold", "to", "Pfizer", "The", "increase", "resulted", "from", "an", "increase", "in", "the", "amount", "of", "$3.1", "million", "of", "product", "sold", "to", "Brazil", "and", "$7.0", "million", "of", "drug", "substance", "sold", "to", "Pfizer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p10_s0", "idA": "1006281_17_item7_p4_s0", "sentA": "Since its approval by the FDA, taliglucerase alfa has been marketed mainly in the United States by Pfizer, as provided in the Pfizer Agreement.", "sentB": "Since its approval by the FDA, taliglucerase alfa has been marketed by Pfizer, as provided in the Pfizer Agreement.", "type": 2, "words": ["<tag1>", "Since", "its", "approval", "by", "the", "FDA,", "taliglucerase", "alfa", "has", "been", "marketed", "mainly", "in", "the", "United", "States", "by", "Pfizer,", "as", "provided", "in", "the", "Pfizer", "Agreement.", "<tag2>", "Since", "its", "approval", "by", "the", "FDA,", "taliglucerase", "alfa", "has", "been", "marketed", "by", "Pfizer,", "as", "provided", "in", "the", "Pfizer", "Agreement.", "<tag3>"], "wordsA": ["Since", "its", "approval", "by", "the", "FDA,", "taliglucerase", "alfa", "has", "been", "marketed", "mainly", "in", "the", "United", "States", "by", "Pfizer,", "as", "provided", "in", "the", "Pfizer", "Agreement."], "wordsB": ["Since", "its", "approval", "by", "the", "FDA,", "taliglucerase", "alfa", "has", "been", "marketed", "by", "Pfizer,", "as", "provided", "in", "the", "Pfizer", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p3_s4", "idA": "1006281_17_item7_p4_s4", "sentA": "We will continue to manufacture drug substance for Pfizer, subject to certain terms and conditions.", "sentB": "Protalix Ltd. agreed to manufacture all of the PRX-102 needed for all purposes under the agreement, subject to certain exceptions, and Chiesi will purchase pegunigalsidase alfa from Protalix, subject to certain terms and conditions.", "type": 2, "words": ["<tag1>", "We", "will", "continue", "to", "manufacture", "drug", "substance", "for", "Pfizer,", "subject", "to", "certain", "terms", "and", "conditions.", "<tag2>", "Protalix", "Ltd.", "agreed", "to", "manufacture", "all", "of", "the", "PRX-102", "needed", "for", "all", "purposes", "under", "the", "agreement,", "subject", "to", "certain", "exceptions,", "and", "Chiesi", "will", "purchase", "pegunigalsidase", "alfa", "from", "Protalix,", "subject", "to", "certain", "terms", "and", "conditions.", "<tag3>"], "wordsA": ["We", "will", "continue", "to", "manufacture", "drug", "substance", "for", "Pfizer,", "subject", "to", "certain", "terms", "and", "conditions."], "wordsB": ["Protalix", "Ltd.", "agreed", "to", "manufacture", "all", "of", "the", "PRX-102", "needed", "for", "all", "purposes", "under", "the", "agreement,", "subject", "to", "certain", "exceptions,", "and", "Chiesi", "will", "purchase", "pegunigalsidase", "alfa", "from", "Protalix,", "subject", "to", "certain", "terms", "and", "conditions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p52_s0", "idA": "1006281_17_item7_p50_s0", "sentA": "Cost of revenues was $8.4 million for the year ended December 31, 2016 compared to the cost of revenues of $730,000 for the year ended December 31, 2015.", "sentB": "Cost of revenues was $15.2 million for the year ended December 31, 2017, an increase of $6.8 million or 81%, compared to the cost of revenues of $8.4 million for the year ended December 31, 2016.", "type": 2, "words": ["<tag1>", "Cost", "of", "revenues", "was", "$8.4", "million", "for", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "cost", "of", "revenues", "of", "$730,000", "for", "the", "year", "ended", "December", "31,", "2015.", "<tag2>", "Cost", "of", "revenues", "was", "$15.2", "million", "for", "the", "year", "ended", "December", "31,", "2017,", "an", "increase", "of", "$6.8", "million", "or", "81%,", "compared", "to", "the", "cost", "of", "revenues", "of", "$8.4", "million", "for", "the", "year", "ended", "December", "31,", "2016.", "<tag3>"], "wordsA": ["Cost", "of", "revenues", "was", "$8.4", "million", "for", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "cost", "of", "revenues", "of", "$730,000", "for", "the", "year", "ended", "December", "31,", "2015."], "wordsB": ["Cost", "of", "revenues", "was", "$15.2", "million", "for", "the", "year", "ended", "December", "31,", "2017,", "an", "increase", "of", "$6.8", "million", "or", "81%,", "compared", "to", "the", "cost", "of", "revenues", "of", "$8.4", "million", "for", "the", "year", "ended", "December", "31,", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p53_s0", "idA": "1006281_17_item7_p51_s0", "sentA": "Research and development expenses were $30.4 million for the year ended December 31, 2016, an increase of $5.5 million, or 22% from $24.9 million for the year ended December 31, 2015.", "sentB": "Research and development expenses were $32.2 million for the year ended December 31, 2017, an increase of $1.8 million, or 6% from $30.4 million for the year ended December 31, 2016.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expenses", "were", "$30.4", "million", "for", "the", "year", "ended", "December", "31,", "2016,", "an", "increase", "of", "$5.5", "million,", "or", "22%", "from", "$24.9", "million", "for", "the", "year", "ended", "December", "31,", "2015.", "<tag2>", "Research", "and", "development", "expenses", "were", "$32.2", "million", "for", "the", "year", "ended", "December", "31,", "2017,", "an", "increase", "of", "$1.8", "million,", "or", "6%", "from", "$30.4", "million", "for", "the", "year", "ended", "December", "31,", "2016.", "<tag3>"], "wordsA": ["Research", "and", "development", "expenses", "were", "$30.4", "million", "for", "the", "year", "ended", "December", "31,", "2016,", "an", "increase", "of", "$5.5", "million,", "or", "22%", "from", "$24.9", "million", "for", "the", "year", "ended", "December", "31,", "2015."], "wordsB": ["Research", "and", "development", "expenses", "were", "$32.2", "million", "for", "the", "year", "ended", "December", "31,", "2017,", "an", "increase", "of", "$1.8", "million,", "or", "6%", "from", "$30.4", "million", "for", "the", "year", "ended", "December", "31,", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p53_s1", "idA": "1006281_17_item7_p51_s1", "sentA": "The increase resulted primarily from an increase of $3.7 million in clinical trial related costs.", "sentB": "The increase resulted primarily from an increase of $2.4 million in clinical trial related costs, which was partially offset by a decrease of $0.7 million in materials.", "type": 2, "words": ["<tag1>", "The", "increase", "resulted", "primarily", "from", "an", "increase", "of", "$3.7", "million", "in", "clinical", "trial", "related", "costs.", "<tag2>", "The", "increase", "resulted", "primarily", "from", "an", "increase", "of", "$2.4", "million", "in", "clinical", "trial", "related", "costs,", "which", "was", "partially", "offset", "by", "a", "decrease", "of", "$0.7", "million", "in", "materials.", "<tag3>"], "wordsA": ["The", "increase", "resulted", "primarily", "from", "an", "increase", "of", "$3.7", "million", "in", "clinical", "trial", "related", "costs."], "wordsB": ["The", "increase", "resulted", "primarily", "from", "an", "increase", "of", "$2.4", "million", "in", "clinical", "trial", "related", "costs,", "which", "was", "partially", "offset", "by", "a", "decrease", "of", "$0.7", "million", "in", "materials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p54_s0", "idA": "1006281_17_item7_p52_s0", "sentA": "We expect research and development expenses to continue to be our primary expense as we enter into a more advanced stage of preclinical and clinical trials for certain of our product candidates .", "sentB": "We expect research and development expenses to continue to be our primary expense as we enter into a more advanced stage of preclinical and clinical trials for certain of our product candidates, primarily with respect to pegunigalsidase alfa .", "type": 2, "words": ["<tag1>", "We", "expect", "research", "and", "development", "expenses", "to", "continue", "to", "be", "our", "primary", "expense", "as", "we", "enter", "into", "a", "more", "advanced", "stage", "of", "preclinical", "and", "clinical", "trials", "for", "certain", "of", "our", "product", "candidates", ".", "<tag2>", "We", "expect", "research", "and", "development", "expenses", "to", "continue", "to", "be", "our", "primary", "expense", "as", "we", "enter", "into", "a", "more", "advanced", "stage", "of", "preclinical", "and", "clinical", "trials", "for", "certain", "of", "our", "product", "candidates,", "primarily", "with", "respect", "to", "pegunigalsidase", "alfa", ".", "<tag3>"], "wordsA": ["We", "expect", "research", "and", "development", "expenses", "to", "continue", "to", "be", "our", "primary", "expense", "as", "we", "enter", "into", "a", "more", "advanced", "stage", "of", "preclinical", "and", "clinical", "trials", "for", "certain", "of", "our", "product", "candidates", "."], "wordsB": ["We", "expect", "research", "and", "development", "expenses", "to", "continue", "to", "be", "our", "primary", "expense", "as", "we", "enter", "into", "a", "more", "advanced", "stage", "of", "preclinical", "and", "clinical", "trials", "for", "certain", "of", "our", "product", "candidates,", "primarily", "with", "respect", "to", "pegunigalsidase", "alfa", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p55_s0", "idA": "1006281_17_item7_p53_s0", "sentA": "Selling, general and administrative expenses were $9.4 million for the year ended December 31, 2016, an increase of $2.1 million, or 29%, from $7.3 million for the year ended December 31, 2015.", "sentB": "Selling, general and administrative expenses were $11.5 million for the year ended December 31, 2017, an increase of $2.2 million, or 23%, from $9.4 million for the year ended December 31, 2016.", "type": 2, "words": ["<tag1>", "Selling,", "general", "and", "administrative", "expenses", "were", "$9.4", "million", "for", "the", "year", "ended", "December", "31,", "2016,", "an", "increase", "of", "$2.1", "million,", "or", "29%,", "from", "$7.3", "million", "for", "the", "year", "ended", "December", "31,", "2015.", "<tag2>", "Selling,", "general", "and", "administrative", "expenses", "were", "$11.5", "million", "for", "the", "year", "ended", "December", "31,", "2017,", "an", "increase", "of", "$2.2", "million,", "or", "23%,", "from", "$9.4", "million", "for", "the", "year", "ended", "December", "31,", "2016.", "<tag3>"], "wordsA": ["Selling,", "general", "and", "administrative", "expenses", "were", "$9.4", "million", "for", "the", "year", "ended", "December", "31,", "2016,", "an", "increase", "of", "$2.1", "million,", "or", "29%,", "from", "$7.3", "million", "for", "the", "year", "ended", "December", "31,", "2015."], "wordsB": ["Selling,", "general", "and", "administrative", "expenses", "were", "$11.5", "million", "for", "the", "year", "ended", "December", "31,", "2017,", "an", "increase", "of", "$2.2", "million,", "or", "23%,", "from", "$9.4", "million", "for", "the", "year", "ended", "December", "31,", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p52_s1", "idA": "1006281_17_item7_p53_s1", "sentA": "The increase resulted primarily from an increase in sales and marketing activities in connection with the sale of alfataliglicerase in Brazil.", "sentB": "The increase resulted primarily from costs related to the production of drug substance for sale to Pfizer, and of drug product for sale to Brazil.", "type": 2, "words": ["<tag1>", "The", "increase", "resulted", "primarily", "from", "an", "increase", "in", "sales", "and", "marketing", "activities", "in", "connection", "with", "the", "sale", "of", "alfataliglicerase", "in", "Brazil.", "<tag2>", "The", "increase", "resulted", "primarily", "from", "costs", "related", "to", "the", "production", "of", "drug", "substance", "for", "sale", "to", "Pfizer,", "and", "of", "drug", "product", "for", "sale", "to", "Brazil.", "<tag3>"], "wordsA": ["The", "increase", "resulted", "primarily", "from", "an", "increase", "in", "sales", "and", "marketing", "activities", "in", "connection", "with", "the", "sale", "of", "alfataliglicerase", "in", "Brazil."], "wordsB": ["The", "increase", "resulted", "primarily", "from", "costs", "related", "to", "the", "production", "of", "drug", "substance", "for", "sale", "to", "Pfizer,", "and", "of", "drug", "product", "for", "sale", "to", "Brazil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p56_s0", "idA": "1006281_17_item7_p54_s0", "sentA": "Financial income was $4.0 million for the year ended December 31, 2016, compared to financial expense of $3.6 million for the year ended December 31, 2015.", "sentB": "Financial expense was $48.9 million for the year ended December 31, 2017, compared to financial income of $4.0 million for the year ended December 31, 2016.", "type": 2, "words": ["<tag1>", "Financial", "income", "was", "$4.0", "million", "for", "the", "year", "ended", "December", "31,", "2016,", "compared", "to", "financial", "expense", "of", "$3.6", "million", "for", "the", "year", "ended", "December", "31,", "2015.", "<tag2>", "Financial", "expense", "was", "$48.9", "million", "for", "the", "year", "ended", "December", "31,", "2017,", "compared", "to", "financial", "income", "of", "$4.0", "million", "for", "the", "year", "ended", "December", "31,", "2016.", "<tag3>"], "wordsA": ["Financial", "income", "was", "$4.0", "million", "for", "the", "year", "ended", "December", "31,", "2016,", "compared", "to", "financial", "expense", "of", "$3.6", "million", "for", "the", "year", "ended", "December", "31,", "2015."], "wordsB": ["Financial", "expense", "was", "$48.9", "million", "for", "the", "year", "ended", "December", "31,", "2017,", "compared", "to", "financial", "income", "of", "$4.0", "million", "for", "the", "year", "ended", "December", "31,", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p56_s1", "idA": "1006281_17_item7_p54_s3", "sentA": "The financial income was partially offset by $3.2 million of expenses resulting primarily from interest expense related to our outstanding convertible notes and by $6.5 million of change in fair value of convertible notes embedded derivative.", "sentB": "Financial expenses included a charge of $38.1 million as a result of the re-measurement of the fair value of the 7.5% convertible notes embedded derivative.", "type": 2, "words": ["<tag1>", "The", "financial", "income", "was", "partially", "offset", "by", "$3.2", "million", "of", "expenses", "resulting", "primarily", "from", "interest", "expense", "related", "to", "our", "outstanding", "convertible", "notes", "and", "by", "$6.5", "million", "of", "change", "in", "fair", "value", "of", "convertible", "notes", "embedded", "derivative.", "<tag2>", "Financial", "expenses", "included", "a", "charge", "of", "$38.1", "million", "as", "a", "result", "of", "the", "re-measurement", "of", "the", "fair", "value", "of", "the", "7.5%", "convertible", "notes", "embedded", "derivative.", "<tag3>"], "wordsA": ["The", "financial", "income", "was", "partially", "offset", "by", "$3.2", "million", "of", "expenses", "resulting", "primarily", "from", "interest", "expense", "related", "to", "our", "outstanding", "convertible", "notes", "and", "by", "$6.5", "million", "of", "change", "in", "fair", "value", "of", "convertible", "notes", "embedded", "derivative."], "wordsB": ["Financial", "expenses", "included", "a", "charge", "of", "$38.1", "million", "as", "a", "result", "of", "the", "re-measurement", "of", "the", "fair", "value", "of", "the", "7.5%", "convertible", "notes", "embedded", "derivative."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p56_s2", "idA": "1006281_17_item7_p60_s1", "sentA": "Financial expenses resulted primarily from interest expense of $3.1 million for our outstanding 4.5% convertible notes.", "sentB": "In addition, financial expenses is comprised primarily from interest expense on convertible notes.", "type": 2, "words": ["<tag1>", "Financial", "expenses", "resulted", "primarily", "from", "interest", "expense", "of", "$3.1", "million", "for", "our", "outstanding", "4.5%", "convertible", "notes.", "<tag2>", "In", "addition,", "financial", "expenses", "is", "comprised", "primarily", "from", "interest", "expense", "on", "convertible", "notes.", "<tag3>"], "wordsA": ["Financial", "expenses", "resulted", "primarily", "from", "interest", "expense", "of", "$3.1", "million", "for", "our", "outstanding", "4.5%", "convertible", "notes."], "wordsB": ["In", "addition,", "financial", "expenses", "is", "comprised", "primarily", "from", "interest", "expense", "on", "convertible", "notes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p65_s2", "idA": "1006281_17_item7_p63_s1", "sentA": "In December 2016, we completed a private placement of $22.5 million in aggregate principal amount of 7.5% convertible notes due 2021.", "sentB": "Finally, on July 25, 2017, we completed a private placement of an additional $10.0 million in aggregate principal amount of 7.5% convertible notes due 2021.", "type": 2, "words": ["<tag1>", "In", "December", "2016,", "we", "completed", "a", "private", "placement", "of", "$22.5", "million", "in", "aggregate", "principal", "amount", "of", "7.5%", "convertible", "notes", "due", "2021.", "<tag2>", "Finally,", "on", "July", "25,", "2017,", "we", "completed", "a", "private", "placement", "of", "an", "additional", "$10.0", "million", "in", "aggregate", "principal", "amount", "of", "7.5%", "convertible", "notes", "due", "2021.", "<tag3>"], "wordsA": ["In", "December", "2016,", "we", "completed", "a", "private", "placement", "of", "$22.5", "million", "in", "aggregate", "principal", "amount", "of", "7.5%", "convertible", "notes", "due", "2021."], "wordsB": ["Finally,", "on", "July", "25,", "2017,", "we", "completed", "a", "private", "placement", "of", "an", "additional", "$10.0", "million", "in", "aggregate", "principal", "amount", "of", "7.5%", "convertible", "notes", "due", "2021."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p3_s2", "idA": "1006281_17_item7_p64_s0", "sentA": "Pfizer paid Protalix Ltd. $60.0 million as an upfront payment in connection with the execution of the Pfizer Agreement and subsequently paid to Protalix Ltd. an additional $5.0 million upon Protalix Ltd. s meeting a certain milestone.", "sentB": "Under the Chiesi Agreement, Chiesi made an upfront payment to Protalix Ltd. of $25.0 million in connection with the execution of the agreement and Protalix Ltd. is entitled to additional payments of up to $25 million in development costs, capped at $10 million per year.", "type": 2, "words": ["<tag1>", "Pfizer", "paid", "Protalix", "Ltd.", "$60.0", "million", "as", "an", "upfront", "payment", "in", "connection", "with", "the", "execution", "of", "the", "Pfizer", "Agreement", "and", "subsequently", "paid", "to", "Protalix", "Ltd.", "an", "additional", "$5.0", "million", "upon", "Protalix", "Ltd.", "s", "meeting", "a", "certain", "milestone.", "<tag2>", "Under", "the", "Chiesi", "Agreement,", "Chiesi", "made", "an", "upfront", "payment", "to", "Protalix", "Ltd.", "of", "$25.0", "million", "in", "connection", "with", "the", "execution", "of", "the", "agreement", "and", "Protalix", "Ltd.", "is", "entitled", "to", "additional", "payments", "of", "up", "to", "$25", "million", "in", "development", "costs,", "capped", "at", "$10", "million", "per", "year.", "<tag3>"], "wordsA": ["Pfizer", "paid", "Protalix", "Ltd.", "$60.0", "million", "as", "an", "upfront", "payment", "in", "connection", "with", "the", "execution", "of", "the", "Pfizer", "Agreement", "and", "subsequently", "paid", "to", "Protalix", "Ltd.", "an", "additional", "$5.0", "million", "upon", "Protalix", "Ltd.", "s", "meeting", "a", "certain", "milestone."], "wordsB": ["Under", "the", "Chiesi", "Agreement,", "Chiesi", "made", "an", "upfront", "payment", "to", "Protalix", "Ltd.", "of", "$25.0", "million", "in", "connection", "with", "the", "execution", "of", "the", "agreement", "and", "Protalix", "Ltd.", "is", "entitled", "to", "additional", "payments", "of", "up", "to", "$25", "million", "in", "development", "costs,", "capped", "at", "$10", "million", "per", "year."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p67_s0", "idA": "1006281_17_item7_p64_s0", "sentA": "Pfizer paid Protalix Ltd. $60.0 million as an upfront payment in connection with the execution of the Pfizer Agreement and subsequently paid to Protalix Ltd. an additional $5.0 million upon Protalix Ltd. s meeting a certain milestone.", "sentB": "In the fourth quarter of 2017, Chiesi made an upfront payment to Protalix Ltd. of $25.0 million in connection with the execution of the Chiesi Agreement.", "type": 2, "words": ["<tag1>", "Pfizer", "paid", "Protalix", "Ltd.", "$60.0", "million", "as", "an", "upfront", "payment", "in", "connection", "with", "the", "execution", "of", "the", "Pfizer", "Agreement", "and", "subsequently", "paid", "to", "Protalix", "Ltd.", "an", "additional", "$5.0", "million", "upon", "Protalix", "Ltd.", "s", "meeting", "a", "certain", "milestone.", "<tag2>", "In", "the", "fourth", "quarter", "of", "2017,", "Chiesi", "made", "an", "upfront", "payment", "to", "Protalix", "Ltd.", "of", "$25.0", "million", "in", "connection", "with", "the", "execution", "of", "the", "Chiesi", "Agreement.", "<tag3>"], "wordsA": ["Pfizer", "paid", "Protalix", "Ltd.", "$60.0", "million", "as", "an", "upfront", "payment", "in", "connection", "with", "the", "execution", "of", "the", "Pfizer", "Agreement", "and", "subsequently", "paid", "to", "Protalix", "Ltd.", "an", "additional", "$5.0", "million", "upon", "Protalix", "Ltd.", "s", "meeting", "a", "certain", "milestone."], "wordsB": ["In", "the", "fourth", "quarter", "of", "2017,", "Chiesi", "made", "an", "upfront", "payment", "to", "Protalix", "Ltd.", "of", "$25.0", "million", "in", "connection", "with", "the", "execution", "of", "the", "Chiesi", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p3_s6", "idA": "1006281_17_item7_p64_s2", "sentA": "Pfizer has also paid Protalix Ltd. $8.3 million in connection with the successful achievement of certain milestones under a clinical development agreement between Pfizer and Protalix Ltd.", "sentB": "The Chiesi Agreement also provides for reimbursement by Chiesi of certain costs to be incurred by Protalix Ltd.", "type": 2, "words": ["<tag1>", "Pfizer", "has", "also", "paid", "Protalix", "Ltd.", "$8.3", "million", "in", "connection", "with", "the", "successful", "achievement", "of", "certain", "milestones", "under", "a", "clinical", "development", "agreement", "between", "Pfizer", "and", "Protalix", "Ltd.", "<tag2>", "The", "Chiesi", "Agreement", "also", "provides", "for", "reimbursement", "by", "Chiesi", "of", "certain", "costs", "to", "be", "incurred", "by", "Protalix", "Ltd.", "<tag3>"], "wordsA": ["Pfizer", "has", "also", "paid", "Protalix", "Ltd.", "$8.3", "million", "in", "connection", "with", "the", "successful", "achievement", "of", "certain", "milestones", "under", "a", "clinical", "development", "agreement", "between", "Pfizer", "and", "Protalix", "Ltd."], "wordsB": ["The", "Chiesi", "Agreement", "also", "provides", "for", "reimbursement", "by", "Chiesi", "of", "certain", "costs", "to", "be", "incurred", "by", "Protalix", "Ltd."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p68_s0", "idA": "1006281_17_item7_p65_s0", "sentA": "Net cash used in operations was $32.1 million for the year ended December 31, 2016.", "sentB": "Net cash used in operations was $10.0 million for the year ended December 31, 2017.", "type": 2, "words": ["<tag1>", "Net", "cash", "used", "in", "operations", "was", "$32.1", "million", "for", "the", "year", "ended", "December", "31,", "2016.", "<tag2>", "Net", "cash", "used", "in", "operations", "was", "$10.0", "million", "for", "the", "year", "ended", "December", "31,", "2017.", "<tag3>"], "wordsA": ["Net", "cash", "used", "in", "operations", "was", "$32.1", "million", "for", "the", "year", "ended", "December", "31,", "2016."], "wordsB": ["Net", "cash", "used", "in", "operations", "was", "$10.0", "million", "for", "the", "year", "ended", "December", "31,", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p68_s3", "idA": "1006281_17_item7_p65_s3", "sentA": "Net cash provided by financing activities was $19.7 million and consisted primarily of proceeds from the private offering of our 7.5% convertible notes.", "sentB": "Net cash used in financing activities was $1.4 million which consisted of cash settlement of $11.0 million for certain conversions of our convertible notes which was partially offset by $9.5 million of net proceeds from the issuance of our 7.5% convertible notes.", "type": 2, "words": ["<tag1>", "Net", "cash", "provided", "by", "financing", "activities", "was", "$19.7", "million", "and", "consisted", "primarily", "of", "proceeds", "from", "the", "private", "offering", "of", "our", "7.5%", "convertible", "notes.", "<tag2>", "Net", "cash", "used", "in", "financing", "activities", "was", "$1.4", "million", "which", "consisted", "of", "cash", "settlement", "of", "$11.0", "million", "for", "certain", "conversions", "of", "our", "convertible", "notes", "which", "was", "partially", "offset", "by", "$9.5", "million", "of", "net", "proceeds", "from", "the", "issuance", "of", "our", "7.5%", "convertible", "notes.", "<tag3>"], "wordsA": ["Net", "cash", "provided", "by", "financing", "activities", "was", "$19.7", "million", "and", "consisted", "primarily", "of", "proceeds", "from", "the", "private", "offering", "of", "our", "7.5%", "convertible", "notes."], "wordsB": ["Net", "cash", "used", "in", "financing", "activities", "was", "$1.4", "million", "which", "consisted", "of", "cash", "settlement", "of", "$11.0", "million", "for", "certain", "conversions", "of", "our", "convertible", "notes", "which", "was", "partially", "offset", "by", "$9.5", "million", "of", "net", "proceeds", "from", "the", "issuance", "of", "our", "7.5%", "convertible", "notes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p68_s1", "idA": "1006281_17_item7_p66_s5", "sentA": "The net loss from continuing operations for the year ended December 31, 2014 of $33.3 million was further increased by an increase of $3.5 million in inventories, but was partially offset by $3.1 million in depreciation, $1.4 million in accounts payable.", "sentB": "The net loss from continuing operations for the year ended December 31, 2017 of $85.3 million was partially offset by a change of $38.1 million in the fair value of convertible notes embedded derivative and an increase of $26 million in deferred revenues.", "type": 2, "words": ["<tag1>", "The", "net", "loss", "from", "continuing", "operations", "for", "the", "year", "ended", "December", "31,", "2014", "of", "$33.3", "million", "was", "further", "increased", "by", "an", "increase", "of", "$3.5", "million", "in", "inventories,", "but", "was", "partially", "offset", "by", "$3.1", "million", "in", "depreciation,", "$1.4", "million", "in", "accounts", "payable.", "<tag2>", "The", "net", "loss", "from", "continuing", "operations", "for", "the", "year", "ended", "December", "31,", "2017", "of", "$85.3", "million", "was", "partially", "offset", "by", "a", "change", "of", "$38.1", "million", "in", "the", "fair", "value", "of", "convertible", "notes", "embedded", "derivative", "and", "an", "increase", "of", "$26", "million", "in", "deferred", "revenues.", "<tag3>"], "wordsA": ["The", "net", "loss", "from", "continuing", "operations", "for", "the", "year", "ended", "December", "31,", "2014", "of", "$33.3", "million", "was", "further", "increased", "by", "an", "increase", "of", "$3.5", "million", "in", "inventories,", "but", "was", "partially", "offset", "by", "$3.1", "million", "in", "depreciation,", "$1.4", "million", "in", "accounts", "payable."], "wordsB": ["The", "net", "loss", "from", "continuing", "operations", "for", "the", "year", "ended", "December", "31,", "2017", "of", "$85.3", "million", "was", "partially", "offset", "by", "a", "change", "of", "$38.1", "million", "in", "the", "fair", "value", "of", "convertible", "notes", "embedded", "derivative", "and", "an", "increase", "of", "$26", "million", "in", "deferred", "revenues."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p68_s2", "idA": "1006281_17_item7_p66_s6", "sentA": "Net cash used in investing activities for the year ended December 31, 2014 was $1.0 million and consisted primarily of purchases of property and equipment.", "sentB": "Net cash used in investing activities for the year ended December 31, 2017 was $1.1 million and consisted primarily of purchase of property and equipment.", "type": 2, "words": ["<tag1>", "Net", "cash", "used", "in", "investing", "activities", "for", "the", "year", "ended", "December", "31,", "2014", "was", "$1.0", "million", "and", "consisted", "primarily", "of", "purchases", "of", "property", "and", "equipment.", "<tag2>", "Net", "cash", "used", "in", "investing", "activities", "for", "the", "year", "ended", "December", "31,", "2017", "was", "$1.1", "million", "and", "consisted", "primarily", "of", "purchase", "of", "property", "and", "equipment.", "<tag3>"], "wordsA": ["Net", "cash", "used", "in", "investing", "activities", "for", "the", "year", "ended", "December", "31,", "2014", "was", "$1.0", "million", "and", "consisted", "primarily", "of", "purchases", "of", "property", "and", "equipment."], "wordsB": ["Net", "cash", "used", "in", "investing", "activities", "for", "the", "year", "ended", "December", "31,", "2017", "was", "$1.1", "million", "and", "consisted", "primarily", "of", "purchase", "of", "property", "and", "equipment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p70_s0", "idA": "1006281_17_item7_p67_s0", "sentA": "We expect to continue to incur significant expenditures in the near future, including significant research and development expenses related primarily to the clinical trials of PRX-102, alidornase alfa and OPRX-106, and the advancement of our other product candidates into anticipated later stage clinical trials.", "sentB": "We expect to continue to incur significant expenditures in the near future, including significant research and development expenses related primarily to the clinical trials of PRX-102.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "continue", "to", "incur", "significant", "expenditures", "in", "the", "near", "future,", "including", "significant", "research", "and", "development", "expenses", "related", "primarily", "to", "the", "clinical", "trials", "of", "PRX-102,", "alidornase", "alfa", "and", "OPRX-106,", "and", "the", "advancement", "of", "our", "other", "product", "candidates", "into", "anticipated", "later", "stage", "clinical", "trials.", "<tag2>", "We", "expect", "to", "continue", "to", "incur", "significant", "expenditures", "in", "the", "near", "future,", "including", "significant", "research", "and", "development", "expenses", "related", "primarily", "to", "the", "clinical", "trials", "of", "PRX-102.", "<tag3>"], "wordsA": ["We", "expect", "to", "continue", "to", "incur", "significant", "expenditures", "in", "the", "near", "future,", "including", "significant", "research", "and", "development", "expenses", "related", "primarily", "to", "the", "clinical", "trials", "of", "PRX-102,", "alidornase", "alfa", "and", "OPRX-106,", "and", "the", "advancement", "of", "our", "other", "product", "candidates", "into", "anticipated", "later", "stage", "clinical", "trials."], "wordsB": ["We", "expect", "to", "continue", "to", "incur", "significant", "expenditures", "in", "the", "near", "future,", "including", "significant", "research", "and", "development", "expenses", "related", "primarily", "to", "the", "clinical", "trials", "of", "PRX-102."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p71_s0", "idA": "1006281_17_item7_p68_s0", "sentA": "Our future capital requirements will depend on many other factors, including our progress in commercializing Uplyso in Brazil, the progress and results of our clinical trials, the duration and cost of discovery and preclinical development and laboratory testing and clinical trials for our product candidates, conversions of our convertible notes from time to time, the timing and outcome of regulatory review of our product candidates, the costs involved in preparing, filing, prosecuting, maintaining, defending and enforcing patent claims and other intellectual property rights, the number and development requirements of other product candidates that we pursue and the costs of commercialization activities, including product marketing, sales and distribution.", "sentB": "Our future capital requirements will depend on many other factors, including our progress in commercializing alfataliglicerase in Brazil, the progress and results of our clinical trials, the duration and cost of discovery and preclinical development and laboratory testing and clinical trials for our product candidates, conversions of our convertible notes from time to time, the timing and outcome of regulatory review of our product candidates, the costs involved in preparing, filing, prosecuting, maintaining, defending and enforcing patent claims and other intellectual property rights, the number and development requirements of other product candidates that we pursue and the costs of commercialization activities, including product marketing, sales and distribution.", "type": 2, "words": ["<tag1>", "Our", "future", "capital", "requirements", "will", "depend", "on", "many", "other", "factors,", "including", "our", "progress", "in", "commercializing", "Uplyso", "in", "Brazil,", "the", "progress", "and", "results", "of", "our", "clinical", "trials,", "the", "duration", "and", "cost", "of", "discovery", "and", "preclinical", "development", "and", "laboratory", "testing", "and", "clinical", "trials", "for", "our", "product", "candidates,", "conversions", "of", "our", "convertible", "notes", "from", "time", "to", "time,", "the", "timing", "and", "outcome", "of", "regulatory", "review", "of", "our", "product", "candidates,", "the", "costs", "involved", "in", "preparing,", "filing,", "prosecuting,", "maintaining,", "defending", "and", "enforcing", "patent", "claims", "and", "other", "intellectual", "property", "rights,", "the", "number", "and", "development", "requirements", "of", "other", "product", "candidates", "that", "we", "pursue", "and", "the", "costs", "of", "commercialization", "activities,", "including", "product", "marketing,", "sales", "and", "distribution.", "<tag2>", "Our", "future", "capital", "requirements", "will", "depend", "on", "many", "other", "factors,", "including", "our", "progress", "in", "commercializing", "alfataliglicerase", "in", "Brazil,", "the", "progress", "and", "results", "of", "our", "clinical", "trials,", "the", "duration", "and", "cost", "of", "discovery", "and", "preclinical", "development", "and", "laboratory", "testing", "and", "clinical", "trials", "for", "our", "product", "candidates,", "conversions", "of", "our", "convertible", "notes", "from", "time", "to", "time,", "the", "timing", "and", "outcome", "of", "regulatory", "review", "of", "our", "product", "candidates,", "the", "costs", "involved", "in", "preparing,", "filing,", "prosecuting,", "maintaining,", "defending", "and", "enforcing", "patent", "claims", "and", "other", "intellectual", "property", "rights,", "the", "number", "and", "development", "requirements", "of", "other", "product", "candidates", "that", "we", "pursue", "and", "the", "costs", "of", "commercialization", "activities,", "including", "product", "marketing,", "sales", "and", "distribution.", "<tag3>"], "wordsA": ["Our", "future", "capital", "requirements", "will", "depend", "on", "many", "other", "factors,", "including", "our", "progress", "in", "commercializing", "Uplyso", "in", "Brazil,", "the", "progress", "and", "results", "of", "our", "clinical", "trials,", "the", "duration", "and", "cost", "of", "discovery", "and", "preclinical", "development", "and", "laboratory", "testing", "and", "clinical", "trials", "for", "our", "product", "candidates,", "conversions", "of", "our", "convertible", "notes", "from", "time", "to", "time,", "the", "timing", "and", "outcome", "of", "regulatory", "review", "of", "our", "product", "candidates,", "the", "costs", "involved", "in", "preparing,", "filing,", "prosecuting,", "maintaining,", "defending", "and", "enforcing", "patent", "claims", "and", "other", "intellectual", "property", "rights,", "the", "number", "and", "development", "requirements", "of", "other", "product", "candidates", "that", "we", "pursue", "and", "the", "costs", "of", "commercialization", "activities,", "including", "product", "marketing,", "sales", "and", "distribution."], "wordsB": ["Our", "future", "capital", "requirements", "will", "depend", "on", "many", "other", "factors,", "including", "our", "progress", "in", "commercializing", "alfataliglicerase", "in", "Brazil,", "the", "progress", "and", "results", "of", "our", "clinical", "trials,", "the", "duration", "and", "cost", "of", "discovery", "and", "preclinical", "development", "and", "laboratory", "testing", "and", "clinical", "trials", "for", "our", "product", "candidates,", "conversions", "of", "our", "convertible", "notes", "from", "time", "to", "time,", "the", "timing", "and", "outcome", "of", "regulatory", "review", "of", "our", "product", "candidates,", "the", "costs", "involved", "in", "preparing,", "filing,", "prosecuting,", "maintaining,", "defending", "and", "enforcing", "patent", "claims", "and", "other", "intellectual", "property", "rights,", "the", "number", "and", "development", "requirements", "of", "other", "product", "candidates", "that", "we", "pursue", "and", "the", "costs", "of", "commercialization", "activities,", "including", "product", "marketing,", "sales", "and", "distribution."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p72_s0", "idA": "1006281_17_item7_p69_s0", "sentA": "We may need to finance our future cash needs through corporate collaboration, licensing or similar arrangements, public or private equity offerings or debt financings.", "sentB": "We may need to finance our future cash needs through corporat e collaboration, licensing or similar arrangements, public or private equity offerings or debt financings.", "type": 2, "words": ["<tag1>", "We", "may", "need", "to", "finance", "our", "future", "cash", "needs", "through", "corporate", "collaboration,", "licensing", "or", "similar", "arrangements,", "public", "or", "private", "equity", "offerings", "or", "debt", "financings.", "<tag2>", "We", "may", "need", "to", "finance", "our", "future", "cash", "needs", "through", "corporat", "e", "collaboration,", "licensing", "or", "similar", "arrangements,", "public", "or", "private", "equity", "offerings", "or", "debt", "financings.", "<tag3>"], "wordsA": ["We", "may", "need", "to", "finance", "our", "future", "cash", "needs", "through", "corporate", "collaboration,", "licensing", "or", "similar", "arrangements,", "public", "or", "private", "equity", "offerings", "or", "debt", "financings."], "wordsB": ["We", "may", "need", "to", "finance", "our", "future", "cash", "needs", "through", "corporat", "e", "collaboration,", "licensing", "or", "similar", "arrangements,", "public", "or", "private", "equity", "offerings", "or", "debt", "financings."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p5_s2", "idA": "1006281_17_item7_p69_s1", "sentA": "We currently do not have any commitments for future external funding.", "sentB": "The market exclusivity will not have any effect on Fabry disease treatments already approved at that time.", "type": 2, "words": ["<tag1>", "We", "currently", "do", "not", "have", "any", "commitments", "for", "future", "external", "funding.", "<tag2>", "The", "market", "exclusivity", "will", "not", "have", "any", "effect", "on", "Fabry", "disease", "treatments", "already", "approved", "at", "that", "time.", "<tag3>"], "wordsA": ["We", "currently", "do", "not", "have", "any", "commitments", "for", "future", "external", "funding."], "wordsB": ["The", "market", "exclusivity", "will", "not", "have", "any", "effect", "on", "Fabry", "disease", "treatments", "already", "approved", "at", "that", "time."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p72_s1", "idA": "1006281_17_item7_p69_s1", "sentA": "We currently do not have any commitments for future external funding.", "sentB": "We currently do not have any commitments for future external funding, except with respect to the development-related payments and milestone payments that may become payable under the Chiesi Agreement.", "type": 2, "words": ["<tag1>", "We", "currently", "do", "not", "have", "any", "commitments", "for", "future", "external", "funding.", "<tag2>", "We", "currently", "do", "not", "have", "any", "commitments", "for", "future", "external", "funding,", "except", "with", "respect", "to", "the", "development-related", "payments", "and", "milestone", "payments", "that", "may", "become", "payable", "under", "the", "Chiesi", "Agreement.", "<tag3>"], "wordsA": ["We", "currently", "do", "not", "have", "any", "commitments", "for", "future", "external", "funding."], "wordsB": ["We", "currently", "do", "not", "have", "any", "commitments", "for", "future", "external", "funding,", "except", "with", "respect", "to", "the", "development-related", "payments", "and", "milestone", "payments", "that", "may", "become", "payable", "under", "the", "Chiesi", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p35_s0", "idA": "1006281_17_item7_p69_s2", "sentA": "We may need to raise additional funds more quickly if one or more of our assumptions prove to be incorrect or if we choose to expand our product development efforts more rapidly than we presently anticipate.", "sentB": "The current focus of our product development efforts are on pegunigalsidase alfa.", "type": 2, "words": ["<tag1>", "We", "may", "need", "to", "raise", "additional", "funds", "more", "quickly", "if", "one", "or", "more", "of", "our", "assumptions", "prove", "to", "be", "incorrect", "or", "if", "we", "choose", "to", "expand", "our", "product", "development", "efforts", "more", "rapidly", "than", "we", "presently", "anticipate.", "<tag2>", "The", "current", "focus", "of", "our", "product", "development", "efforts", "are", "on", "pegunigalsidase", "alfa.", "<tag3>"], "wordsA": ["We", "may", "need", "to", "raise", "additional", "funds", "more", "quickly", "if", "one", "or", "more", "of", "our", "assumptions", "prove", "to", "be", "incorrect", "or", "if", "we", "choose", "to", "expand", "our", "product", "development", "efforts", "more", "rapidly", "than", "we", "presently", "anticipate."], "wordsB": ["The", "current", "focus", "of", "our", "product", "development", "efforts", "are", "on", "pegunigalsidase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p73_s1", "idA": "1006281_17_item7_p70_s1", "sentA": "We do not believe that inflation has had a material effect on our results of operations during the years ended December 31, 2014, 2015 or 2016.", "sentB": "We do not believe that inflation has had a material effect on our results of operations during the years ended December 31, 2015, 2016 or 2017.", "type": 2, "words": ["<tag1>", "We", "do", "not", "believe", "that", "inflation", "has", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2014,", "2015", "or", "2016.", "<tag2>", "We", "do", "not", "believe", "that", "inflation", "has", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2015,", "2016", "or", "2017.", "<tag3>"], "wordsA": ["We", "do", "not", "believe", "that", "inflation", "has", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2014,", "2015", "or", "2016."], "wordsB": ["We", "do", "not", "believe", "that", "inflation", "has", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2015,", "2016", "or", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p74_s1", "idA": "1006281_17_item7_p71_s1", "sentA": "We do not believe currency fluctuations have had a material effect on our results of operations during the years ended December 31, 2014, 2015 or 2016.", "sentB": "We do not believe currency fluctuations have had a material effect on our results of operations during the years ended December 31, 2015, 2016 or 2017.", "type": 2, "words": ["<tag1>", "We", "do", "not", "believe", "currency", "fluctuations", "have", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2014,", "2015", "or", "2016.", "<tag2>", "We", "do", "not", "believe", "currency", "fluctuations", "have", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2015,", "2016", "or", "2017.", "<tag3>"], "wordsA": ["We", "do", "not", "believe", "currency", "fluctuations", "have", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2014,", "2015", "or", "2016."], "wordsB": ["We", "do", "not", "believe", "currency", "fluctuations", "have", "had", "a", "material", "effect", "on", "our", "results", "of", "operations", "during", "the", "years", "ended", "December", "31,", "2015,", "2016", "or", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p75_s0", "idA": "1006281_17_item7_p72_s0", "sentA": "We have no off-balance sheet arrangements as of December 31, 2015 and 2016.", "sentB": "We have no off-balance sheet arrangements as of December 31, 2016 and 2017.", "type": 2, "words": ["<tag1>", "We", "have", "no", "off-balance", "sheet", "arrangements", "as", "of", "December", "31,", "2015", "and", "2016.", "<tag2>", "We", "have", "no", "off-balance", "sheet", "arrangements", "as", "of", "December", "31,", "2016", "and", "2017.", "<tag3>"], "wordsA": ["We", "have", "no", "off-balance", "sheet", "arrangements", "as", "of", "December", "31,", "2015", "and", "2016."], "wordsB": ["We", "have", "no", "off-balance", "sheet", "arrangements", "as", "of", "December", "31,", "2016", "and", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p76_s0", "idA": "1006281_17_item7_p73_s0", "sentA": "Certain recently issued accounting pronouncements are discussed in Note 1(p) of the financial statements included in Item 8 of this Annual Report on Form 10-K.", "sentB": "Certain recently issued accounting pronouncements are discussed in Note 1(q) of the financial statements included in Item 8 of this Annual Report on Form 10-K.", "type": 2, "words": ["<tag1>", "Certain", "recently", "issued", "accounting", "pronouncements", "are", "discussed", "in", "Note", "1(p)", "of", "the", "financial", "statements", "included", "in", "Item", "8", "of", "this", "Annual", "Report", "on", "Form", "10-K.", "<tag2>", "Certain", "recently", "issued", "accounting", "pronouncements", "are", "discussed", "in", "Note", "1(q)", "of", "the", "financial", "statements", "included", "in", "Item", "8", "of", "this", "Annual", "Report", "on", "Form", "10-K.", "<tag3>"], "wordsA": ["Certain", "recently", "issued", "accounting", "pronouncements", "are", "discussed", "in", "Note", "1(p)", "of", "the", "financial", "statements", "included", "in", "Item", "8", "of", "this", "Annual", "Report", "on", "Form", "10-K."], "wordsB": ["Certain", "recently", "issued", "accounting", "pronouncements", "are", "discussed", "in", "Note", "1(q)", "of", "the", "financial", "statements", "included", "in", "Item", "8", "of", "this", "Annual", "Report", "on", "Form", "10-K."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p77_s0", "idA": "1006281_17_item7_p74_s0", "sentA": "The following table summarizes our significant contractual obligations at December 31, 2016:", "sentB": "The following table summarizes our significant contractual obligations at December 31, 2017:", "type": 2, "words": ["<tag1>", "The", "following", "table", "summarizes", "our", "significant", "contractual", "obligations", "at", "December", "31,", "2016:", "<tag2>", "The", "following", "table", "summarizes", "our", "significant", "contractual", "obligations", "at", "December", "31,", "2017:", "<tag3>"], "wordsA": ["The", "following", "table", "summarizes", "our", "significant", "contractual", "obligations", "at", "December", "31,", "2016:"], "wordsB": ["The", "following", "table", "summarizes", "our", "significant", "contractual", "obligations", "at", "December", "31,", "2017:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p78_s0", "idA": "1006281_17_item7_p75_s0", "sentA": "1) Represents open purchase orders issued to certain suppliers and other vendors mainly in connection with our research and development activities that were outstanding as of December 31, 2016.", "sentB": "(1) Represents open purchase orders issued to certain suppliers and other vendors mainly in connection with our research and development activities that were outstanding as of December 31, 2017.", "type": 2, "words": ["<tag1>", "1)", "Represents", "open", "purchase", "orders", "issued", "to", "certain", "suppliers", "and", "other", "vendors", "mainly", "in", "connection", "with", "our", "research", "and", "development", "activities", "that", "were", "outstanding", "as", "of", "December", "31,", "2016.", "<tag2>", "(1)", "Represents", "open", "purchase", "orders", "issued", "to", "certain", "suppliers", "and", "other", "vendors", "mainly", "in", "connection", "with", "our", "research", "and", "development", "activities", "that", "were", "outstanding", "as", "of", "December", "31,", "2017.", "<tag3>"], "wordsA": ["1)", "Represents", "open", "purchase", "orders", "issued", "to", "certain", "suppliers", "and", "other", "vendors", "mainly", "in", "connection", "with", "our", "research", "and", "development", "activities", "that", "were", "outstanding", "as", "of", "December", "31,", "2016."], "wordsB": ["(1)", "Represents", "open", "purchase", "orders", "issued", "to", "certain", "suppliers", "and", "other", "vendors", "mainly", "in", "connection", "with", "our", "research", "and", "development", "activities", "that", "were", "outstanding", "as", "of", "December", "31,", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p2_s0", "idA": "1006281_17_item7_p7_s0", "sentA": "On June 18, 2013, we entered into the Brazil Agreement with Fiocruz, an arm of the Brazilian MoH, for taliglucerase alfa.", "sentB": "On October 19, 2017, Protalix Ltd., our wholly-owned subsidiary, and Chiesi entered into the Chiesi Agreement pursuant to which Chiesi was granted an exclusive, license for all markets outside of the United States to commercialize pegunigalsidase alfa.", "type": 2, "words": ["<tag1>", "On", "June", "18,", "2013,", "we", "entered", "into", "the", "Brazil", "Agreement", "with", "Fiocruz,", "an", "arm", "of", "the", "Brazilian", "MoH,", "for", "taliglucerase", "alfa.", "<tag2>", "On", "October", "19,", "2017,", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary,", "and", "Chiesi", "entered", "into", "the", "Chiesi", "Agreement", "pursuant", "to", "which", "Chiesi", "was", "granted", "an", "exclusive,", "license", "for", "all", "markets", "outside", "of", "the", "United", "States", "to", "commercialize", "pegunigalsidase", "alfa.", "<tag3>"], "wordsA": ["On", "June", "18,", "2013,", "we", "entered", "into", "the", "Brazil", "Agreement", "with", "Fiocruz,", "an", "arm", "of", "the", "Brazilian", "MoH,", "for", "taliglucerase", "alfa."], "wordsB": ["On", "October", "19,", "2017,", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary,", "and", "Chiesi", "entered", "into", "the", "Chiesi", "Agreement", "pursuant", "to", "which", "Chiesi", "was", "granted", "an", "exclusive,", "license", "for", "all", "markets", "outside", "of", "the", "United", "States", "to", "commercialize", "pegunigalsidase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p13_s0", "idA": "1006281_17_item7_p8_s0", "sentA": "In December 2016, we received a letter from Fiocruz regarding an order from the Brazilian MoH to purchase alfataliglicerase to treat Gaucher patients in Brazil.", "sentB": "In 2017, we received a purchase order from the Brazilian MoH for the purchase of approximately $24.3 million of alfataliglicerase for the treatment of Gaucher patients in Brazil.", "type": 2, "words": ["<tag1>", "In", "December", "2016,", "we", "received", "a", "letter", "from", "Fiocruz", "regarding", "an", "order", "from", "the", "Brazilian", "MoH", "to", "purchase", "alfataliglicerase", "to", "treat", "Gaucher", "patients", "in", "Brazil.", "<tag2>", "In", "2017,", "we", "received", "a", "purchase", "order", "from", "the", "Brazilian", "MoH", "for", "the", "purchase", "of", "approximately", "$24.3", "million", "of", "alfataliglicerase", "for", "the", "treatment", "of", "Gaucher", "patients", "in", "Brazil.", "<tag3>"], "wordsA": ["In", "December", "2016,", "we", "received", "a", "letter", "from", "Fiocruz", "regarding", "an", "order", "from", "the", "Brazilian", "MoH", "to", "purchase", "alfataliglicerase", "to", "treat", "Gaucher", "patients", "in", "Brazil."], "wordsB": ["In", "2017,", "we", "received", "a", "purchase", "order", "from", "the", "Brazilian", "MoH", "for", "the", "purchase", "of", "approximately", "$24.3", "million", "of", "alfataliglicerase", "for", "the", "treatment", "of", "Gaucher", "patients", "in", "Brazil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p13_s1", "idA": "1006281_17_item7_p8_s1", "sentA": "The Brazilian MoH s order consists of a number of shipments during 2017 for a total of approximately $24.3 million.", "sentB": "The purchase order consists of a number of shipments in increasing volumes.", "type": 2, "words": ["<tag1>", "The", "Brazilian", "MoH", "s", "order", "consists", "of", "a", "number", "of", "shipments", "during", "2017", "for", "a", "total", "of", "approximately", "$24.3", "million.", "<tag2>", "The", "purchase", "order", "consists", "of", "a", "number", "of", "shipments", "in", "increasing", "volumes.", "<tag3>"], "wordsA": ["The", "Brazilian", "MoH", "s", "order", "consists", "of", "a", "number", "of", "shipments", "during", "2017", "for", "a", "total", "of", "approximately", "$24.3", "million."], "wordsB": ["The", "purchase", "order", "consists", "of", "a", "number", "of", "shipments", "in", "increasing", "volumes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p13_s2", "idA": "1006281_17_item7_p8_s3", "sentA": "Fiocruz s purchases of Uplyso to date have been significantly below certain agreed upon purchase milestones and, accordingly, we have the right to terminate the Brazil Agreement.", "sentB": "Fiocruz s purchases of alfataliglicerase to date have been significantly below certain agreed upon purchase milestones and, accordingly, we have the right to terminate the Brazil Agreement.", "type": 2, "words": ["<tag1>", "Fiocruz", "s", "purchases", "of", "Uplyso", "to", "date", "have", "been", "significantly", "below", "certain", "agreed", "upon", "purchase", "milestones", "and,", "accordingly,", "we", "have", "the", "right", "to", "terminate", "the", "Brazil", "Agreement.", "<tag2>", "Fiocruz", "s", "purchases", "of", "alfataliglicerase", "to", "date", "have", "been", "significantly", "below", "certain", "agreed", "upon", "purchase", "milestones", "and,", "accordingly,", "we", "have", "the", "right", "to", "terminate", "the", "Brazil", "Agreement.", "<tag3>"], "wordsA": ["Fiocruz", "s", "purchases", "of", "Uplyso", "to", "date", "have", "been", "significantly", "below", "certain", "agreed", "upon", "purchase", "milestones", "and,", "accordingly,", "we", "have", "the", "right", "to", "terminate", "the", "Brazil", "Agreement."], "wordsB": ["Fiocruz", "s", "purchases", "of", "alfataliglicerase", "to", "date", "have", "been", "significantly", "below", "certain", "agreed", "upon", "purchase", "milestones", "and,", "accordingly,", "we", "have", "the", "right", "to", "terminate", "the", "Brazil", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_18_item7_p13_s3", "idA": "1006281_17_item7_p8_s4", "sentA": "Notwithstanding the low purchase amounts, we are, at this time, continuing to supply Uplyso to Fiocruz under the Brazil Agreement, and patients continue to be treated with Uplyso in Brazil.", "sentB": "Notwithstanding, we are, at this time, continuing to supply alfataliglicerase to Fiocruz under the Brazil Agreement, and patients continue to be treated with alfataliglicerase in Brazil.", "type": 2, "words": ["<tag1>", "Notwithstanding", "the", "low", "purchase", "amounts,", "we", "are,", "at", "this", "time,", "continuing", "to", "supply", "Uplyso", "to", "Fiocruz", "under", "the", "Brazil", "Agreement,", "and", "patients", "continue", "to", "be", "treated", "with", "Uplyso", "in", "Brazil.", "<tag2>", "Notwithstanding,", "we", "are,", "at", "this", "time,", "continuing", "to", "supply", "alfataliglicerase", "to", "Fiocruz", "under", "the", "Brazil", "Agreement,", "and", "patients", "continue", "to", "be", "treated", "with", "alfataliglicerase", "in", "Brazil.", "<tag3>"], "wordsA": ["Notwithstanding", "the", "low", "purchase", "amounts,", "we", "are,", "at", "this", "time,", "continuing", "to", "supply", "Uplyso", "to", "Fiocruz", "under", "the", "Brazil", "Agreement,", "and", "patients", "continue", "to", "be", "treated", "with", "Uplyso", "in", "Brazil."], "wordsB": ["Notwithstanding,", "we", "are,", "at", "this", "time,", "continuing", "to", "supply", "alfataliglicerase", "to", "Fiocruz", "under", "the", "Brazil", "Agreement,", "and", "patients", "continue", "to", "be", "treated", "with", "alfataliglicerase", "in", "Brazil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
